<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<Template name="PICO: Organ Transplant Template" version="">
  <Description>Template for extracting PICO elements for Organ Transplant domain</Description>
  <TemplateItems>
    <TemplateItem concept="OTE:Study_Design" name="Study Design" type="finding" value.domain="self">
      <Filters>
        <Filter type="section">(MH|TI)</Filter>
        <Filter type="section">AB[-2]</Filter>
      </Filters>
    </TemplateItem>
    <TemplateItem concept="OTE:Intervention_Comparator_Category" name="Intervention / Comparator Category" type="finding" value.domain="self"/>
    <TemplateItem concept="OTE:Gender_Category" name="Gender Category" type="finding" value.domain="self">
      <Filters>
        <Filter type="section">MH</Filter>
      </Filters>
    </TemplateItem>
    <TemplateItem concept="OTE:Outcome_Category" name="Outcome Category" type="finding" value.domain="self"/>
    <TemplateItem concept="OTE:Language_Category" name="Language Category" type="finding" value.domain="self"/>
    <TemplateItem concept="OTE:Population_Type_Category" name="Population Type Category" type="finding" value.domain="self"/>
    <TemplateItem concept="OTE:Ehnicity_Category" name="Ehnicity Category" type="finding" value.domain="self">
      <Filters>
        <Filter type="section">MH</Filter>
      </Filters>
    </TemplateItem>
    <TemplateItem concept="OTE:Publication_Type" name="Publication Type" type="finding" value.domain="self">
      <Filters>
        <Filter type="section">MH</Filter>
      </Filters>
    </TemplateItem>
    <TemplateItem concept="OTE:Age_Category" name="Age Category" type="finding" value.domain="self">
      <Filters>
        <Filter type="section">MH</Filter>
      </Filters>
    </TemplateItem>
    <TemplateItem concept="OTE:Species_Category" name="Species Category" type="finding" value.domain="self">
      <Filters>
        <Filter type="section">MH</Filter>
      </Filters>
    </TemplateItem>
  </TemplateItems>
  <Terminology format="index finder tables" location="memory" name="OrganTransplantExtraction" uri="http://edda.dbmi.pitt.edu/ontologies/OrganTransplantExtraction.owl" version="null">
    <Description>Template for extracting PICO elements for Organ Transplant domain</Description>
    <Sources>
      <Source code="OrganTransplantExtraction" name="OrganTransplantExtraction">Template for extracting PICO elements for Organ Transplant domain</Source>
    </Sources>
    <Relations>
      <Source code="Broader" inverse="false" name="Broader"/>
      <Source code="Narrower" inverse="false" name="Narrower"/>
      <Source code="Similar" inverse="false" name="Similar"/>
    </Relations>
    <Languages>ENG</Languages>
    <Roots>OTE:Slot, OTE:Terminology, OTE:Template</Roots>
    <Concepts>
      <Concept code="OTE:IL1R1_protein_human" name="IL1R1 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL1R1 protein, human</Term>
        <Term>interleukin 1 receptor, type I, human</Term>
        <Codes>
          <Code code="C1700970" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_Interleukin-1_Type_I</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly6i_protein_mouse" name="Ly6i protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly6i protein, mouse</Term>
        <Term>Ly-6I protein, mouse</Term>
        <Term>Ly-6M protein, mouse</Term>
        <Term>Ly6I antigen, mouse</Term>
        <Term>Ly6m protein, mouse</Term>
        <Term>lymphocyte antigen 6 complex, locus I protein, mouse</Term>
        <Codes>
          <Code code="C0287672" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:TORID_protein_rat" name="TORID protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">TORID protein, rat</Term>
        <Codes>
          <Code code="C1667370" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD20</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SIGLEC9_protein_human" name="SIGLEC9 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SIGLEC9 protein, human</Term>
        <Term>Siglec-9 protein, human</Term>
        <Term>sialic acid binding Ig-like lectin 9, human</Term>
        <Term>FOAP-9 protein, human</Term>
        <Codes>
          <Code code="C0916595" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:RIII_Mouse" name="RIII Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">RIII Mouse</Term>
        <Term>RIII</Term>
        <Codes>
          <Code code="C1514653" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Diptera" name="Diptera">
        <Definition>have one pair of membraneous wings, 3 segmented antennae, compound eye, sucking mouth parts, and 5 segmented tarsi; metamorphosis is complete; many larvae are parasitic; some species of adults are disease vectors.</Definition>
        <Definition>An order of the class Insecta. Wings, when present, number two and distinguish Diptera from other so-called flies, while the halteres, or reduced hindwings, separate Diptera from other insects with one pair of wings. The order includes the families Calliphoridae, Oestridae, Phoridae, SARCOPHAGIDAE, Scatophagidae, Sciaridae, SIMULIIDAE, Tabanidae, Therevidae, Trypetidae, CERATOPOGONIDAE; CHIRONOMIDAE; CULICIDAE; DROSOPHILIDAE; GLOSSINIDAE; MUSCIDAE; TEPHRITIDAE; and PSYCHODIDAE. The larval form of Diptera species are called maggots (see LARVA).</Definition>
        <Definition>A large order of insects having a single pair of wings and sucking or piercing mouths; includes true flies and mosquitoes and gnats and crane flies.</Definition>
        <SemanticType code="T204" name="Eukaryote"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Diptera</Term>
        <Term>fly</Term>
        <Term>True Flies</Term>
        <Term>Flies, True</Term>
        <Term>Fly</Term>
        <Term>Flies</Term>
        <Term>Fly, NOS</Term>
        <Term>Order Diptera (organism)</Term>
        <Term>ORDER DIPTERA - BITING GNATS</Term>
        <Term>62-63 ORDER DIPTERA - BITING GNATS</Term>
        <Term>Order: Diptera</Term>
        <Term>True Fly</Term>
        <Term>Dipteras</Term>
        <Term>Order Diptera</Term>
        <Term>Fly, True</Term>
        <Codes>
          <Code code="C14197" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Insect</Relation>
          <Relation name="Narrower">OTE:Drosophila, OTE:Aedes_taeniorhynchus, OTE:Musca_domestica</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Icos_protein_rat" name="Icos protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Icos protein, rat</Term>
        <Term>inducible T-cell co-stimulator protein, rat</Term>
        <Codes>
          <Code code="C1570401" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inducible_T_Cell_Co_Stimulator_Protein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin_7_Receptor_alpha_Subunit" name="Interleukin 7 Receptor alpha Subunit">
        <Definition>A low affinity interleukin-7 receptor subunit that combines with the INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT to form a high affinity receptor for INTERLEUKIN-7.</Definition>
        <Definition>Interleukin-7 receptor subunit alpha (459 aa, ~52 kDa) is encoded by the human IL7R gene. This protein is involved in both interleukin binding and signal transduction.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin 7 Receptor alpha Subunit</Term>
        <Term>IL-7RA</Term>
        <Term>Interleukin-7 Receptor Subunit Alpha</Term>
        <Term>INTERLEUKIN 007 RECEPTOR ALPHA SUBUNIT</Term>
        <Term>Interleukin-7 Receptor alpha Subunit</Term>
        <Term>Antigen, CD127</Term>
        <Term>CD127 Antigens</Term>
        <Term>Antigens, CD127</Term>
        <Term>Interleukin-7 Receptor alpha Subunit [Chemical/Ingredient]</Term>
        <Term>CD 127 ANTIGENS</Term>
        <Term>IL-7 Receptor Subunit Alpha</Term>
        <Term>ANTIGENS CD 127</Term>
        <Term>CDw127</Term>
        <Term>IL-7R Subunit Alpha</Term>
        <Term>CD127 Antigen</Term>
        <Term>IL-7R-Alpha</Term>
        <Codes>
          <Code code="C1721045" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SLURP-1_protein_mouse" name="SLURP-1 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SLURP-1 protein, mouse</Term>
        <Codes>
          <Code code="C2742339" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:double_blind_clinical_design" name="double blind clinical design">
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">double blind clinical design</Term>
        <Term>double-blind clinical trial</Term>
        <Term>double blind clinical studies</Term>
        <Term>double-blind clinical designs</Term>
        <Term>double blind clinical designs</Term>
        <Term>double blind clinical study</Term>
        <Term>double-blind clinical trials</Term>
        <Term>double-blind clinical design</Term>
        <Term>double blind clinical trials</Term>
        <Term>double-blind clinical studies</Term>
        <Term>Research design [1977-1989]</Term>
        <Term>double-blind clinical study</Term>
        <Term>double blind clinical trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#double_blind_clinical_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:double_blind_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD22_protein_human" name="CD22 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD22 protein, human</Term>
        <Term>CD22 antigen, human</Term>
        <Term>BL-CAM protein, human</Term>
        <Term>SIGLEC-2 protein, human</Term>
        <Codes>
          <Code code="C1505685" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD22_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:quasi_randomized_controlled_design" name="quasi randomized controlled design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">quasi randomized controlled design</Term>
        <Term>quasi randomised controlled designs</Term>
        <Term>quasi randomized controlled designs</Term>
        <Term>quasi randomised controlled design</Term>
        <Term>quasi-randomized controlled designs</Term>
        <Term>quasi-randomized controlled design</Term>
        <Term>quasi-randomized controlled trial</Term>
        <Term>quasi-randomised controlled study</Term>
        <Term>quasi randomized controlled trials</Term>
        <Term>quasi rcts</Term>
        <Term>quasi-randomised controlled designs</Term>
        <Term>quasi rct</Term>
        <Term>quasi-randomised controlled trials</Term>
        <Term>quasi-randomized controlled trials</Term>
        <Term>quasi-randomised controlled studies</Term>
        <Term>quasi randomized controlled studies</Term>
        <Term>quasi randomized controlled trial</Term>
        <Term>quasi randomised controlled study</Term>
        <Term>quasi-randomised controlled design</Term>
        <Term>quasi-randomised controlled trial</Term>
        <Term>quasi randomised controlled studies</Term>
        <Term>quasi-randomized controlled studies</Term>
        <Term>quasi-randomized controlled study</Term>
        <Term>quasi randomised controlled trials</Term>
        <Term>quasi randomised controlled trial</Term>
        <Term>quasi randomized controlled study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#quasi_randomized_controlled_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:quasi_randomized_design</Relation>
          <Relation name="Narrower">OTE:cluster_quasi_randomized_controlled_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd151_protein_rat" name="Cd151 protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd151 protein, rat</Term>
        <Term>Tspan24 protein, rat</Term>
        <Term>PETA-3 protein, rat</Term>
        <Codes>
          <Code code="C2974879" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD151</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NCR3_protein_human" name="NCR3 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NCR3 protein, human</Term>
        <Term>p30 natural killer cell receptor, human</Term>
        <Term>natural cytotoxicity triggering receptor 3 protein, human</Term>
        <Term>NKp30 protein, human</Term>
        <Codes>
          <Code code="C1432202" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Natural_Cytotoxicity_Triggering_Receptor_3</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin-10_Receptor_beta_Subunit" name="Interleukin-10 Receptor beta Subunit">
        <Definition>A subunit of the interleukin-10 receptor. It plays a role in receptor signaling by associating with TYK2 KINASE.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin-10 Receptor beta Subunit</Term>
        <Term>CDW210B Antigen</Term>
        <Term>Interleukin-10 Receptor 2</Term>
        <Term>Interleukin 10 Receptor 2</Term>
        <Term>CDW210B Antigens</Term>
        <Term>Antigens, CDW210B</Term>
        <Term>Interleukin-10 Receptor, beta Chain</Term>
        <Term>ANTIGENS CD 210 W B</Term>
        <Term>INTERLEUKIN 010 RECEPTOR BETA SUBUNIT</Term>
        <Term>Antigen, CDW210B</Term>
        <Term>Interleukin 10 Receptor beta Subunit</Term>
        <Term>CD 210 W B ANTIGENS</Term>
        <Term>Interleukin 10 Receptor, beta Chain</Term>
        <Codes>
          <Code code="C1721052" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:IL10RB_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:desaminotyrosylfibrinopeptide_A" name="desaminotyrosylfibrinopeptide A">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">desaminotyrosylfibrinopeptide A</Term>
        <Term>deaminotyrosyl-fibrinopeptide A</Term>
        <Term>Fibrinopeptide A, N-(3-(4-hydroxyphenyl)-1-oxopropyl)-</Term>
        <Term>DATFP-A</Term>
        <Codes>
          <Code code="C0057514" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Fibrinopeptide_A</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:interleukin-5-_receptor_alpha_mouse" name="interleukin-5- receptor alpha, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">interleukin-5- receptor alpha, mouse</Term>
        <Term>IL-5Ralpha protein, mouse</Term>
        <Codes>
          <Code code="C2352109" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_5_Receptor_alpha_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:5_-nucleotidase" name="5'(3')-nucleotidase">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">5'(3')-nucleotidase</Term>
        <Codes>
          <Code code="C0640731" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-Nucleotidase</Relation>
          <Relation name="Narrower">OTE:5_-deoxyribonucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FCGR1A_protein_human" name="FCGR1A protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FCGR1A protein, human</Term>
        <Term>Fc fragment of IgG, high affinity Ia, receptor, human</Term>
        <Term>CD64A protein, human</Term>
        <Term>Fc gamma receptor RI, human</Term>
        <Term>FcgammaRIA protein, human</Term>
        <Term>FcgammaRI protein, human</Term>
        <Codes>
          <Code code="C1505865" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly9_1_glycoprotein_human" name="Ly9.1 glycoprotein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly9.1 glycoprotein, human</Term>
        <Codes>
          <Code code="C1448024" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:LY9_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:n-of-1_design" name="n-of-1 design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">n-of-1 design</Term>
        <Term>single-subject study</Term>
        <Term>single-subject design</Term>
        <Term>single-case studies</Term>
        <Term>single subject design</Term>
        <Term>single case studies</Term>
        <Term>n-of-one study</Term>
        <Term>single subject trials</Term>
        <Term>single-case trials</Term>
        <Term>single-case study</Term>
        <Term>n-of-1 study</Term>
        <Term>single-subject studies</Term>
        <Term>single-subject trials</Term>
        <Term>single subject study</Term>
        <Term>single-subject designs</Term>
        <Term>single-case trial</Term>
        <Term>single case designs</Term>
        <Term>single-case design</Term>
        <Term>n-of-one trial</Term>
        <Term>single subject studies</Term>
        <Term>n-of-one trials</Term>
        <Term>single case trial</Term>
        <Term>single subject trial</Term>
        <Term>n-of-one studies</Term>
        <Term>n-of-1 studies</Term>
        <Term>n-of-one designs</Term>
        <Term>single case study</Term>
        <Term>n-of-1 trial</Term>
        <Term>n-of-1 designs</Term>
        <Term>n-of-1 trials</Term>
        <Term>n-of-one design</Term>
        <Term>single-case designs</Term>
        <Term>single case design</Term>
        <Term>single-subject trial</Term>
        <Term>single case trials</Term>
        <Term>single subject designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#n-of-1_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:case_series" name="case series">
        <Definition>a study that identifies and samples individuals with a particular disease or condition, noting characteristics of the disease or condition and persons afflicted. Case studies are often used to call attention to new diseases or to diseases entering new populations. [Case study | Emtree_2014] [Dorland's Medical Dictionary_2011]</Definition>
        <Definition>A series of patients with a defined disorder. Usually, the term is used to describe a study reporting on a consecutive collection of patients treated in a similar manner, without a concurrent control group. For example, a surgeon might describe the characteristics of and outcomes for 100 consecutive patients with cerebral ischemia who received a revascularization procedure. See also CONSECUTIVE SAMPLE.</Definition>
        <Definition> A group or series of case reports involving patients who were given similar treatment. Reports of case series usually contain detailed information about the individual patients. This includes demographic information (for example, age, gender, ethnic origin) and information on diagnosis, treatment, response to treatment, and follow-up after treatment. [NCIT_14.05d]</Definition>
        <Definition>A group or series of case reports involving patients who were given similar treatment. Reports of case series usually contain detailed information about the individual patients. This includes demographic information (for example, age, gender, ethnic origin) and information on diagnosis, treatment, response to treatment, and follow-up after treatment.</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">case series</Term>
        <Term>CASE SERIES</Term>
        <Term>case series trial</Term>
        <Term>case series design</Term>
        <Term>case series study</Term>
        <Term>large case series</Term>
        <Term>case series trials</Term>
        <Term>case series studies</Term>
        <Term>case series designs</Term>
        <Term>Case Series</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#case_series" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:consecutive_case_series, OTE:retrospective_case_series, OTE:nonconsecutive_case_series, OTE:prospective_case_series</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tnfrsf13b_protein_mouse" name="Tnfrsf13b protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tnfrsf13b protein, mouse</Term>
        <Term>Taci protein, mouse</Term>
        <Term>tumor necrosis factor receptor superfamily, member 13b protein, mouse</Term>
        <Term>transmembrane activator and CAML interactor protein, mouse</Term>
        <Codes>
          <Code code="C1434882" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Transmembrane_Activator_and_CAML_Interactor_Protein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BALB_cHeA_Mouse" name="BALB/cHeA Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BALB/cHeA Mouse</Term>
        <Term>BALB/cHeA</Term>
        <Codes>
          <Code code="C37362" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:101_H_Mouse" name="101/H Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">101/H Mouse</Term>
        <Term>101/H</Term>
        <Codes>
          <Code code="C37318" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:E3_Rat_Strain" name="E3, Rat Strain">
        <Definition>Has platelet storage disease associated with the red-eyed yellow locus, as described by Raymond and Dodds (1975) for the FH strain.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">E3, Rat Strain</Term>
        <Codes>
          <Code code="C14400" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Nov_protein_mouse" name="Nov protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Nov protein, mouse</Term>
        <Term>nephroblastoma overexpressed protein, mouse</Term>
        <Codes>
          <Code code="C0535357" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Nephroblastoma_Overexpressed_Protein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:OM_N_substrain" name="OM/N, substrain">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">OM/N, substrain</Term>
        <Codes>
          <Code code="C14415" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:OM_Rat_Strain</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BUB_BnJ_Mouse" name="BUB/BnJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BUB/BnJ Mouse</Term>
        <Term>BUB/BnJ</Term>
        <Codes>
          <Code code="C14987" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ex_post_facto_design" name="ex post facto design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ex post facto design</Term>
        <Term>ex post facto study</Term>
        <Term>ex post facto designs</Term>
        <Term>ex post facto trial</Term>
        <Term>ex post facto studies</Term>
        <Term>ex post facto trials</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#ex_post_facto_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:retrospective_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Macaque" name="Macaque">
        <Definition>A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of 16 species inhabiting forests of Africa, Asia, and the islands of Borneo, Philippines, and Celebes.</Definition>
        <Definition>Any of several species of short-tailed monkeys of the genus Macacus.</Definition>
        <Definition>large genus of Old World monkeys (family Cercopithecidae) that includes the macaque and rhesus monkeys, and the Barbary apes; Macaca mulatta, the rhesus monkey, is used as a research animal.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Macaque</Term>
        <Term>macaque</Term>
        <Term>macaca</Term>
        <Term>Genus Macaca</Term>
        <Term>Macaques</Term>
        <Term>Macaca, NOS</Term>
        <Term>Macaque, NOS</Term>
        <Term>macaques</Term>
        <Term>Macaca</Term>
        <Term>Macacas</Term>
        <Term>Macacus</Term>
        <Term>Genus Macaca (organism)</Term>
        <Codes>
          <Code code="C14231" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Monkey</Relation>
          <Relation name="Narrower">OTE:Cynomolgus_Monkey, OTE:Rhesus_Monkey</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C3HeB_FeJ_Mouse" name="C3HeB/FeJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C3HeB/FeJ Mouse</Term>
        <Term>C3HeB/FeJ</Term>
        <Codes>
          <Code code="C37374" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Infant_Low_Birth_Weight" name="Infant, Low Birth Weight">
        <Definition>an infant weighing 5-1/2 pounds or less at birth.</Definition>
        <Definition>An infant having a birth weight of 2500 gm. (5.5 lb.) or less but INFANT, VERY LOW BIRTH WEIGHT is available for infants having a birth weight of 1500 grams (3.3 lb.) or less.</Definition>
        <SemanticType code="T101" name="Patient or Disabled Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Infant, Low Birth Weight</Term>
        <Term>Low-Birth-Weight Infants</Term>
        <Term>Infant, Low-Birth-Weight</Term>
        <Term>LBW INFANT</Term>
        <Term>Low-Birth-Weight Infant</Term>
        <Term>Infants, Low-Birth-Weight</Term>
        <Term>INFANT LBW</Term>
        <Term>Low Birth Weight Infant</Term>
        <Codes>
          <Code code="C0021288" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Infants_Newborn</Relation>
          <Relation name="Narrower">OTE:Infant_Very_Low_Birth_Weight, OTE:Infant_Small_for_Gestational_Age, OTE:Infant_Extremely_Low_Birth_Weight</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:festschrift" name="festschrift">
        <Definition>Work consisting of a collection of essays or other writings contributed by students, teachers, colleagues, and associates to honor a person or institution, usually on the occasion of an anniversary celebration or other event of importance. [MeSH_2014]</Definition>
        <Definition>Work consisting of a collection of essays or other writings contributed by students, teachers, colleagues, and associates to honor a person or institution, usually on the occasion of an anniversary celebration or other event of importance.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">festschrift</Term>
        <Term>Current Biog-Obit (1966-1990)</Term>
        <Term>Festschriften</Term>
        <Term>festschriften</Term>
        <Term>Festschrift</Term>
        <Term>Historical Biography (1966-1990)</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#festschrift" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:TCTP_protein_Drosophila" name="TCTP protein, Drosophila">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">TCTP protein, Drosophila</Term>
        <Term>translationally controlled tumor protein, Drosophila</Term>
        <Codes>
          <Code code="C1872251" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ICOS_protein_human" name="ICOS protein, human">
        <Definition>Inducible T-cell costimulator (199 aa, ~23 kDa) is encoded by the human ICOS gene. This protein is involved in the regulation of T-cell antigen-mediated responses.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ICOS protein, human</Term>
        <Term>inducible T-cell co-stimulator protein, human</Term>
        <Term>CD278 antigen, human</Term>
        <Codes>
          <Code code="C1570399" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inducible_T_Cell_Co_Stimulator_Protein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:O20_A_Mouse" name="O20/A Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">O20/A Mouse</Term>
        <Term>O20/A</Term>
        <Codes>
          <Code code="C37427" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:non-controlled_design" name="non-controlled design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">non-controlled design</Term>
        <Term>noncontrolled studies</Term>
        <Term>non-controlled designs</Term>
        <Term>noncontrolled trial</Term>
        <Term>uncontrolled trials</Term>
        <Term>uncontrolled trial</Term>
        <Term>non-controlled trials</Term>
        <Term>non-controlled studies</Term>
        <Term>noncontrolled study</Term>
        <Term>noncontrolled designs</Term>
        <Term>uncontrolled design</Term>
        <Term>non-controlled trial</Term>
        <Term>non-controlled study</Term>
        <Term>uncontrolled studies</Term>
        <Term>uncontrolled designs</Term>
        <Term>noncontrolled  design</Term>
        <Term>uncontrolled study</Term>
        <Term>noncontrolled trials</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#non-controlled_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tumor_Necrosis_Factor_Receptor_1A" name="Tumor Necrosis Factor Receptor 1A">
        <Definition>A tumor necrosis factor receptor subtype that has specificity for TUMOR NECROSIS FACTOR ALPHA and LYMPHOTOXIN ALPHA. It is constitutively expressed in most tissues and is a key mediator of tumor necrosis factor signaling in the vast majority of cells. The activated receptor signals via a conserved death domain that associates with specific TNF RECEPTOR-ASSOCIATED FACTORS in the CYTOPLASM.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tumor Necrosis Factor Receptor 1A</Term>
        <Term>Antigen, CD 120a</Term>
        <Term>RECEPTORS TUMOR NECROSIS FACTOR MEMBER 01 A</Term>
        <Term>RECEPT TUMOR NECROSIS FACTOR TYPE I</Term>
        <Term>Antigens, CD120a</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPT TYPE I</Term>
        <Term>CD120a Antigen</Term>
        <Term>Tumor Necrosis Factor Receptor Superfamily, Member 1A</Term>
        <Term>TNFR p60</Term>
        <Term>Receptor, TNFRSF1A</Term>
        <Term>CD 120a Antigen</Term>
        <Term>TNFR-I</Term>
        <Term>CD120a Antigens</Term>
        <Term>Tumor Necrosis Factor Receptor Type I</Term>
        <Term>TNFRSF1A RECEPT</Term>
        <Term>RECEPT TUMOR NECROSIS FACTOR MEMBER 1A</Term>
        <Term>TNFR1</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPT 1A</Term>
        <Term>CD 120 A ANTIGENS</Term>
        <Term>TNFRSF1A (Tumor Necrosis Factor Receptor Superfamily, Member 1A)</Term>
        <Term>Receptors, Tumor Necrosis Factor, Member 1A</Term>
        <Term>Tumor Necrosis Factor Receptor Type 1</Term>
        <Term>Receptors, Tumor Necrosis Factor, Type I</Term>
        <Term>120a Antigen, CD</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPT TYPE 1</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPT SUPERFAMILY MEMBER 1A</Term>
        <Term>ANTIGENS CD 120 A</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 01 A</Term>
        <Term>Antigen, CD120a</Term>
        <Term>TNFRSF1A Receptor</Term>
        <Term>TNFRSF1A TUMOR NECROSIS FACTOR RECEPT SUPERFAMILY MEMBER 1A</Term>
        <Codes>
          <Code code="C0255808" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Tnfrsf1a_protein_mouse, OTE:TNFRSF1A_protein_human, OTE:Onercept, OTE:Tnfrsf1a_protein_rat, OTE:recombinant_human_tumor_necrosis_factor-binding_protein-1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:factorial_design" name="factorial design">
        <Definition>Two or more interventions, each alone and in combination, are evaluated in parallel against a control group.  [NCIT_14.05d] [Contributing_Source_CDISC]</Definition>
        <Definition>A type of clinical study in which two or more treatments are given alone and in combination, such that all possible combinations are represented across the treatment arms, and are compared in parallel against the study control group. [NCIT_14.05d] </Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">factorial design</Term>
        <Term>factorial trial</Term>
        <Term>factorial designs</Term>
        <Term>factorial studies</Term>
        <Term>factorial trials</Term>
        <Term>Factorial</Term>
        <Term>factorial study</Term>
        <Codes>
          <Code code="C0681865" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Pancreas_Transplantation" name="Pancreas Transplantation">
        <Definition>&lt;p&gt;The pancreas is a gland behind your stomach and in front of your spine. It produces the juices that help break down food and the hormones that help control blood sugar levels. A pancreas transplant is surgery to place a healthy pancreas from a donor into a person with a diseased pancreas. It is mostly done for people with severe &lt;a href='http://www.nlm.nih.gov/medlineplus/diabetestype1.html'&gt;type 1 diabetes&lt;/a&gt;. It can allow them to give up insulin shots. An experimental procedure called &lt;a href='http://www.nlm.nih.gov/medlineplus/isletcelltransplantation.html'&gt;islet cell transplantation&lt;/a&gt; transplants only the parts of the pancreas that make insulin.&lt;/p&gt;&lt;p&gt;People who have transplants must take drugs to keep their body from rejecting the new pancreas for the rest of their lives. They must also have regular follow-up care. Because of the risks, it is not a common treatment for type 1 diabetes.&lt;/p&gt;</Definition>
        <Definition>The transference of a pancreas from one human or animal to another.</Definition>
        <Definition>transferring pancreatic cells or tissue, or whole pancreas, within an individual or between individuals of the same or different species; for specific pancreatic islet cells use PANCREATIC ISLET CELL TRANSPLANTATION.</Definition>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Pancreas Transplantation</Term>
        <Term>pancreatic transplant</Term>
        <Term>Grafting, Pancreas</Term>
        <Term>Pancreas Transplantation Procedures</Term>
        <Term>pancreas transplantation</Term>
        <Term>Pancreas transplant</Term>
        <Term>Pancreatic transplant</Term>
        <Term>Pancreat transplant NOS</Term>
        <Term>TRANSPL PANCREAS</Term>
        <Term>Pancreas replaced by transplant</Term>
        <Term>pancreas grafting</Term>
        <Term>Graftings, Pancreas</Term>
        <Term>presence; pancreas transplant</Term>
        <Term>Transplantation of pancreas</Term>
        <Term>Transplant of pancreas</Term>
        <Term>pancreas transplant</Term>
        <Term>pancreatic transplantation (treatment)</Term>
        <Term>Transplantation of pancreas (procedure)</Term>
        <Term>pancreas of transplantation</Term>
        <Term>presence; graft, pancreas</Term>
        <Term>pancreas replaced by transplant</Term>
        <Term>Pancreas Graftings</Term>
        <Term>transplantation pancreas</Term>
        <Term>pancreatic transplantation</Term>
        <Term>Transplantation, Pancreas</Term>
        <Term>Transplantations, Pancreas</Term>
        <Term>transplant pancreas</Term>
        <Term>PANCREAS TRANSPL</Term>
        <Term>Trnspl status-pancreas</Term>
        <Term>Pancreatic transplant, not otherwise specified</Term>
        <Term>Pancreas Transplantations</Term>
        <Term>Transplantation of pancreas, NOS</Term>
        <Term>Pancreas Grafting</Term>
        <Term>pancreas transplants</Term>
        <Codes>
          <Code code="C0030275" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Organ_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antxr1_protein_mouse" name="Antxr1 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antxr1 protein, mouse</Term>
        <Term>anthrax toxin receptor 1 protein, mouse</Term>
        <Term>TEM8 protein, mouse</Term>
        <Codes>
          <Code code="C2002393" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:binding" name="binding">
        <Definition>The selective, non-covalent, often stoichiometric, interaction of a molecule with one or more specific sites on another molecule. [GOC:ceb, GOC:mah, ISBN:0198506732]</Definition>
        <Definition>Involves temporary, non-covalent binding of two or more molecules as a result of intermolecular physical forces and often involves spatial complementarity between the interacting objects.</Definition>
        <Definition>The action of attracting something and forming a bond with it.</Definition>
        <SemanticType code="T052" name="Activity"/>
        <SemanticType code="T044" name="Molecular Function"/>
        <SemanticType code="T169" name="Functional Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">binding</Term>
        <Term>Physical Interaction</Term>
        <Term>Bind</Term>
        <Term>Binding - action</Term>
        <Term>Molecular Interaction Process</Term>
        <Term>bind</Term>
        <Term>binds</Term>
        <Term>molecular interaction</Term>
        <Term>Binding aspects</Term>
        <Term>Binding - action (qualifier value)</Term>
        <Term>Binding action</Term>
        <Term>Bound</Term>
        <Term>Molecular Interaction</Term>
        <Term>binding action</Term>
        <Term>Binding (Molecular Function)</Term>
        <Term>Binding</Term>
        <Term>binding [molecular function]</Term>
        <Codes>
          <Code code="C1145667" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Pharmacokinetics</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klra2_protein_mouse" name="Klra2 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klra2 protein, mouse</Term>
        <Term>Ly-49b antigen, mouse</Term>
        <Term>killer cell lectin-like receptor, subfamily A, member 2, mouse</Term>
        <Term>Ly49b antigen, mouse</Term>
        <Codes>
          <Code code="C0906189" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Myd88_protein_Drosophila" name="Myd88 protein, Drosophila">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Myd88 protein, Drosophila</Term>
        <Term>kra protein, Drosophila</Term>
        <Term>MyD88 adapter protein, Drosophila</Term>
        <Term>krapfen protein, Drosophila</Term>
        <Codes>
          <Code code="C1101147" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:5_-Nucleotidase" name="5'-Nucleotidase">
        <Definition>A class of enzymes present in various organs and in many cells that catalyze the hydrolysis of a 5'-ribonucleotide to a ribonucleoside and orthophosphate in the presence of water. Serum 5'-N'Tase is measured as an indicator of liver damage resulting primarily from interference with the secretion of bile. Serum 5'-N'Tase is not as sensitive as some other enzymes (for example, ALP, AST, and ALT) to liver damage, but it is a more liver-specific enzyme. The level of this enzyme parallels alkaline phosphatase (ALP). It is used mostly to differentiate elevations in the above enzymes due to liver damage from damage to skeletal muscle.</Definition>
        <Definition>A glycoprotein enzyme present in various organs and in many cells. The enzyme catalyzes the hydrolysis of a 5'-ribonucleotide to a ribonucleoside and orthophosphate in the presence of water. It is cation-dependent and exists in a membrane-bound and soluble form. EC 3.1.3.5.</Definition>
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">5'-Nucleotidase</Term>
        <Term>CD73 Antigen</Term>
        <Term>Inosinate Phosphatase</Term>
        <Term>PYRIMIDINE 5 NUCLEOTIDASE</Term>
        <Term>Antigens, CD73</Term>
        <Term>5' Nucleotidase</Term>
        <Term>NUCLEOTIDASE 05</Term>
        <Term>ANTIGENS CD 073</Term>
        <Term>Pyrimidine 5' Nucleotidase</Term>
        <Term>URIDYLATE NUCLEOTIDASE 05</Term>
        <Term>Adenylate Phosphatase</Term>
        <Term>IMPase</Term>
        <Term>IMP Phosphatase</Term>
        <Term>5' Nucleotidase Phosphoribolase</Term>
        <Term>CD73 Antigens</Term>
        <Term>AMP NUCLEOTIDASE 05</Term>
        <Term>5'-AMP Nucleotidase</Term>
        <Term>Pyrimidine 5'-Nucleotidase</Term>
        <Term>Ecto-5'-Nucleotidase</Term>
        <Term>AMP Phosphatase</Term>
        <Term>Uridylate 5'-Nucleotidase</Term>
        <Term>PYRIMIDINE NUCLEOTIDASE 05</Term>
        <Term>5'-Nucleotidase Phosphoribolase</Term>
        <Term>5' AMP Nucleotidase</Term>
        <Term>IMP Nucleotidase</Term>
        <Term>Antigen, CD73</Term>
        <Term>5'-Ribonucleotide phosphohydrolase</Term>
        <Term>Thymidine Phosphatase</Term>
        <Term>Cytidylate Phosphatase</Term>
        <Term>Uridylate 5' Nucleotidase</Term>
        <Term>ECTO NUCLEOTIDASE 05</Term>
        <Term>Ecto 5' Nucleotidase</Term>
        <Term>CD 073 ANTIGENS</Term>
        <Codes>
          <Code code="C0000530" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:NT5M_protein_human, OTE:SDT1_protein_S_cerevisiae, OTE:NT5E_protein_human, OTE:Uridine_5-Prime_Monophosphate_Hydrolase_Deficiency_Hemolytic_Anemia_due_to, OTE:NT5C3_protein_human, OTE:5-Nucleotidase_syndrome, OTE:Nt5e_protein_mouse, OTE:NT5C1A_protein_human, OTE:Nt5e_protein_Streptococcus_sanguinis, OTE:Nt5e_protein_rat, OTE:NT5C1B_protein_human, OTE:Nt5c3_protein_mouse, OTE:NT5C2_protein_human, OTE:5_-nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CA-15-3_Antigen" name="CA-15-3 Antigen">
        <Definition>MUC-1 antigen is a mammary-type apomucin, a high molecular weight transmembrane glycoprotein, of which the extracellular domain is formed by a repeating 20 amino acid sequence (in tandem) with a high content of serine and threonine on which are O-linked carbohydrate chains. MUC-1 synthesis and secretion are features of glandular epithelial tissues; MUC-1 is overexpressed in lactating breast and in breast, ovary, lung, and prostate malignancies.</Definition>
        <Definition>A substance found on certain epithelial cells (cells that cover organs, glands, and other body surfaces) and on breast cells involved in making milk. It is also found on tumors of the breast, ovary, lung, and prostate. MUC-1 is a type of tumor marker.</Definition>
        <Definition>MUC-1 antigen is a mammary-type apomucin, a high molecular weight transmembrane glycoprotein, of which the extracellular domain is formed by a repeating 20 amino acid sequence (in tandem) with a high content of serine and threonine on which are O-linked carbohydrate chains. MUC-1 synthesis and secretion are features of glandular epithelial tissues, and is overexpressed in lactating breast and in breast, ovary, lung, and prostate malignancies. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42454&amp;idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42454&amp;idtype=1&amp;closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;code=C2407" NCI Thesaurus)</Definition>
        <Definition>Carbohydrate antigen elevated in patients with tumors of the breast, ovary, lung, and prostate as well as other disorders. The mucin is expressed normally by most glandular epithelia but shows particularly increased expression in the breast at lactation and in malignancy. It is thus an established serum marker for breast cancer.</Definition>
        <SemanticType code="T118" name="Carbohydrate"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CA-15-3 Antigen</Term>
        <Term>Epithelial Membrane Antigen</Term>
        <Term>MUC MUCIN 001</Term>
        <Term>Antigen, CA 15-3</Term>
        <Term>ANTIGEN CA 015 003</Term>
        <Term>Mucin 1</Term>
        <Term>Episialin</Term>
        <Term>Antigen, CA 15.3</Term>
        <Term>CA 15.3 Antigen</Term>
        <Term>CD227 Antigens</Term>
        <Term>CA 15 3 Antigen</Term>
        <Term>Mucin, Muc1</Term>
        <Term>Antigen, CA-15-3</Term>
        <Term>Antigen, CD227</Term>
        <Term>Epithelial Mucin, Polymorphic</Term>
        <Term>CA ANTIGEN 015 003</Term>
        <Term>Antigens, CD227</Term>
        <Term>Membrane Antigen, Epithelial</Term>
        <Term>CA 15-3 Antigen</Term>
        <Term>CA-15-3, Antigen</Term>
        <Term>Mucin, Polymorphic Epithelial</Term>
        <Term>Polymorphic Epithelial Mucin</Term>
        <Term>Antigen, Epithelial Membrane</Term>
        <Term>Antigen CA 15 3</Term>
        <Term>Mucin-1</Term>
        <Term>CD227 Antigen</Term>
        <Term>Muc1 Mucin</Term>
        <Term>Antigen CA-15-3</Term>
        <Codes>
          <Code code="C0006611" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:MUC1_protein_human, OTE:CAM_123-6_antigen, OTE:MUC-1_protein_human, OTE:MUC1_tandem_repeat_peptide, OTE:muc1_protein_mouse, OTE:MUC-X_protein_human, OTE:MUC1_protein_rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Il2rb_protein_rat" name="Il2rb protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Il2rb protein, rat</Term>
        <Term>interleukin 2 receptor, beta chain, rat</Term>
        <Codes>
          <Code code="C1701424" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_2_Receptor_beta</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Serum_Markers" name="Serum Markers">
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Serum Markers</Term>
        <Term>Serum Marker</Term>
        <Term>serum markers</Term>
        <Term>serum marker</Term>
        <Term>Markers, Serum</Term>
        <Term>Marker, Serum</Term>
        <Codes>
          <Code code="C0162491" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:antigen_CD100" name="antigen CD100">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">antigen CD100</Term>
        <Term>sema4D</Term>
        <Term>semaphorin 4D</Term>
        <Term>CD100 antigen</Term>
        <Term>CD100 semaphorin</Term>
        <Term>semaphorin CD100</Term>
        <Codes>
          <Code code="C0296790" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:SEMA4D_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:overview_of_reviews_" name="overview of reviews'">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">overview of reviews'</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#overview_of_reviews'" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:review_of_literature_</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CR1_protein_human" name="CR1 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CR1 protein, human</Term>
        <Term>CD35 protein, human</Term>
        <Term>CD35 antigen, human</Term>
        <Term>complement component (3b/4b) receptor 1 (Knops blood group) protein, human</Term>
        <Codes>
          <Code code="C1721462" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Complement_3b_Receptors</Relation>
          <Relation name="Narrower">OTE:CRIg_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MUC-X_protein_human" name="MUC-X protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MUC-X protein, human</Term>
        <Term>mucin X protein, human</Term>
        <Term>MUC-X mucin, human</Term>
        <Codes>
          <Code code="C1122674" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CA-15-3_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD79A_protein_human" name="CD79A protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD79A protein, human</Term>
        <Term>immunoglobulin-associated alpha protein, human</Term>
        <Term>mb-1 protein, human</Term>
        <Term>Ig-alpha protein, human</Term>
        <Term>CD79A antigen (immunoglobulin-associated alpha) protein, human</Term>
        <Codes>
          <Code code="C1506239" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD79</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:albumin_ischemia-modified" name="albumin, ischemia-modified">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">albumin, ischemia-modified</Term>
        <Term>serum albumin, ischemia-modified</Term>
        <Term>ischemia-modified serum albumin</Term>
        <Term>ischemia-modified albumin</Term>
        <Codes>
          <Code code="C3266190" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD68_protein_rat" name="CD68 protein, rat">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD68 protein, rat</Term>
        <Term>CD68 antigen, rat</Term>
        <Codes>
          <Code code="C2714637" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd52_protein_mouse" name="Cd52 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd52 protein, mouse</Term>
        <Term>CAMPATH-1 antigen, mouse</Term>
        <Term>CD52 antigen, mouse</Term>
        <Codes>
          <Code code="C1609929" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD52_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tubingen_Zebrafish" name="Tubingen Zebrafish">
        <Definition>The wild-type short fin zebrafish line used by the Sanger institute for the Zebrafish sequencing project. The line was cleaned up to remove embryonic lethal mutations from the background before being used for mutagenesis and sequencing.(ZFin)</Definition>
        <Definition>The wild-type short fin zebrafish line used by the Sanger institute for the Zebrafish sequencing project. The line was cleaned up to remove embryonic lethal mutations from the background before being used for mutagenesis and sequencing.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tubingen Zebrafish</Term>
        <Term>TU</Term>
        <Term>Tubingen</Term>
        <Term>Tubingen - zebrafish</Term>
        <Codes>
          <Code code="C79982" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:pragmatic_clinical_trial" name="pragmatic clinical trial">
        <Definition>Randomized clinical trials that compare interventions in clinical settings and which look at a range of effectiveness outcomes and impacts. [MeSH_2015]</Definition>
        <Definition>Randomized clinical trials that compare interventions in clinical settings and which look at a range of effectiveness outcomes and impacts.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">pragmatic clinical trial</Term>
        <Term>pragmatic clinical trials</Term>
        <Term>Real World Clinical Trials</Term>
        <Term>pragmatic clinical designs</Term>
        <Term>pragmatic clinical studies</Term>
        <Term>Clinical Trials, Pragmatic</Term>
        <Term>Trials, Practical Clinical</Term>
        <Term>Pragmatic Clinical Trials</Term>
        <Term>Pragmatic Trials</Term>
        <Term>Trials, Pragmatic Clinical</Term>
        <Term>pragmatic clinical design</Term>
        <Term>Naturalistic Randomized Clinical Trial</Term>
        <Term>Pragmatic Clinical Trial</Term>
        <Term>Trials, Pragmatic</Term>
        <Term>Practical Clinical Trials</Term>
        <Term>Clinical Trials, Practical</Term>
        <Term>pragmatic clinical study</Term>
        <Term>Pragmatic Clinical Trials as Topic</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#pragmatic_clinical_trial" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:dictionary" name="dictionary">
        <Definition>Lists of words, usually in alphabetical order, giving information about form, pronunciation, etymology, grammar, and meaning.</Definition>
        <Definition>A reference book containing a list of words - usually in alphabetical order - giving information about form, pronunciation, etymology, grammar, and meaning. A foreign-language dictionary is an alphabetical list of words of one language with their meaning and equivalents in another language.</Definition>
        <Definition>A reference book containing a list of words - usually in alphabetical order - giving information about form, pronunciation, etymology, grammar, and meaning. A foreign-language dictionary is an alphabetical list of words of one language with their meaning and equivalents in another language. [MeSH_2014]</Definition>
        <SemanticType code="T185" name="Classification"/>
        <SemanticType code="T073" name="Manufactured Object"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">dictionary</Term>
        <Term>Dictionary</Term>
        <Term>Dictionary [Publication Type]</Term>
        <Term>Terminology</Term>
        <Term>Dictionaries as Topics</Term>
        <Term>Dictionaries as Topic</Term>
        <Term>dictionaries</Term>
        <Term>Dictionaries</Term>
        <Codes>
          <Code code="C1101726" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Chinese_Syrian_Gold_Hamster" name="Chinese Syrian Gold Hamster">
        <Definition>Derived from a cross between a Chinese hamster and a Syrian hamster, with a golden-colored coat.</Definition>
        <Definition>A hamster derived from a cross between a Chinese hamster and a Syrian hamster, with a golden-colored coat.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Chinese Syrian Gold Hamster</Term>
        <Term>Chinese Syrian Gold</Term>
        <Term>CHINESE SYRIAN GOLD</Term>
        <Codes>
          <Code code="C2699175" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Hamster</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:resistin-like_gamma_rat" name="resistin-like gamma, rat">
        <SemanticType code="T125" name="Hormone"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">resistin-like gamma, rat</Term>
        <Term>resistin-like molecule gamma, rat</Term>
        <Term>RELMgamma protein, rat</Term>
        <Term>RETNLgamma, rat</Term>
        <Term>RELMgamma, rat</Term>
        <Term>RETNLG protein, rat</Term>
        <Codes>
          <Code code="C1436606" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Hormones_Ectopic</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD68_antigen_human" name="CD68 antigen, human">
        <Definition>Macrosialin (354 aa, ~37 kDa) is encoded by the human CD68 gene. This protein may be involved in both pathogen phagocytosis and macrophage targeting.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD68 antigen, human</Term>
        <Term>CD68 antigen</Term>
        <Codes>
          <Code code="C0108799" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:KP1_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tumor_Necrosis_Factor_Receptor_Type_II" name="Tumor Necrosis Factor Receptor Type II">
        <Definition>A tumor necrosis factor receptor subtype that is expressed primarily in IMMUNE SYSTEM cells. It has specificity for membrane-bound form of TUMOR NECROSIS FACTORS and mediates intracellular-signaling through TNF RECEPTOR ASSOCIATED FACTORS.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tumor Necrosis Factor Receptor Type II</Term>
        <Term>TNF-R2</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 01 B</Term>
        <Term>TNF-RII</Term>
        <Term>Tumor Necrosis Factor Receptor 75</Term>
        <Term>Receptors, Tumor Necrosis Factor, Type II</Term>
        <Term>Tumor Necrosis Factor Receptor Type 2</Term>
        <Term>Tumor Necrosis Factor Receptor 2</Term>
        <Term>CD 120b Antigen</Term>
        <Term>Receptors, Tumor Necrosis Factor, Member 1B</Term>
        <Term>Antigen, CD120b</Term>
        <Term>Antigens, CD120b</Term>
        <Term>Receptor, TNFRSF1B</Term>
        <Term>TNFRSF1B Receptor</Term>
        <Term>Tumor Necrosis Factor Receptor Superfamily, Member 1B</Term>
        <Term>TNF-R75</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPT TYPE II</Term>
        <Term>RECEPT TUMOR NECROSIS FACTOR MEMBER 1B</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPT 2</Term>
        <Term>TNFR2</Term>
        <Term>TNFRSF1B RECEPT</Term>
        <Term>RECEPTORS TUMOR NECROSIS FACTOR MEMBER 01 B</Term>
        <Term>120b Antigen, CD</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPT 75</Term>
        <Term>CD120b Antigen</Term>
        <Term>Antigen, CD 120b</Term>
        <Term>CD120b Antigens</Term>
        <Term>CD 120 B ANTIGENS</Term>
        <Term>RECEPT TUMOR NECROSIS FACTOR TYPE II</Term>
        <Term>ANTIGENS CD 120 B</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPT TYPE 2</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPT SUPERFAMILY MEMBER 1B</Term>
        <Term>TNFR p75</Term>
        <Codes>
          <Code code="C0255813" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:TNFR_p80, OTE:TNFRSF1B_protein_human, OTE:TNF-sR75, OTE:micp75TNFR_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klrd1_protein_mouse" name="Klrd1 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klrd1 protein, mouse</Term>
        <Term>killer cell lectin-like receptor, subfamily D, member 1 protein, mouse</Term>
        <Codes>
          <Code code="C1506362" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_D</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SDT1_protein_S_cerevisiae" name="SDT1 protein, S cerevisiae">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SDT1 protein, S cerevisiae</Term>
        <Term>SSM1 protein, S cerevisiae</Term>
        <Term>YGL224C protein, S cerevisiae</Term>
        <Codes>
          <Code code="C1506068" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-Nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:phase_IIIa_trial" name="phase IIIa trial">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">phase IIIa trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#phase_IIIa_trial" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Intervention_Comparator_Slot" name="Intervention / Comparator Slot">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Intervention / Comparator Slot</Term>
        <Relations>
          <Relation name="Broader">OTE:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:experimental_design" name="experimental design">
        <Definition>studies concerned with the design of an experiment or research project.</Definition>
        <Definition>Describes the role the study plays in determining the interventions a subject receives.</Definition>
        <Definition> Describes the role the study plays in determining the interventions a subject receives. [NCIT_14.05d] [Contributing_Source_CDISC]</Definition>
        <Definition>General procedural plan for conducting an experiment or other research study in view of the specific data desired. This may include identification of the independent and dependent variables; selection of subjects and their assignment to specific experimental conditions/treatments; the sequence of experimental conditions/treatments; and a method of analysis. Consider also EXPERIMENTAL METHODS.</Definition>
        <Definition>A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.</Definition>
        <Definition>A plan detailing how a study will be performed in order to represent the phenomenon under examination, to answer the research questions that have been asked, and defining the methods of data analysis. Study design is driven by research hypothesis being posed, study subject/population/sample available, logistics/resources: technology, support, networking, collaborative support, etc. [Study design | NCIT_14.05d] </Definition>
        <Definition>A plan detailing how a study will be performed in order to represent the phenomenon under examination, to answer the research questions that have been asked, and defining the methods of data analysis. Study design is driven by research hypothesis being posed, study subject/population/sample available, logistics/resources: technology, support, networking, collaborative support, etc.</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">experimental design</Term>
        <Term>experimental designs</Term>
        <Term>study design</Term>
        <Term>Design, Research</Term>
        <Term>experimental study</Term>
        <Term>Experimental design</Term>
        <Term>research design</Term>
        <Term>Design (Experimental)</Term>
        <Term>Study Type</Term>
        <Term>Experiment Design</Term>
        <Term>EXPER DESIGN</Term>
        <Term>Experimental Design</Term>
        <Term>Designs, Experimental</Term>
        <Term>research strategy (individual study)</Term>
        <Term>Research Designs</Term>
        <Term>experimental trial</Term>
        <Term>Design, Experimental</Term>
        <Term>Study Design</Term>
        <Term>DESIGNS EXPER</Term>
        <Term>experimental trials</Term>
        <Term>Stype</Term>
        <Term>Experimental Designs</Term>
        <Term>Research Design</Term>
        <Term>experimental studies</Term>
        <Term>design research</Term>
        <Term>EXPER DESIGNS</Term>
        <Term>STYPE</Term>
        <Term>DESIGN EXPER</Term>
        <Term>Designs, Research</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#experimental_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly-49L_antigen" name="Ly-49L antigen">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly-49L antigen</Term>
        <Codes>
          <Code code="C0769517" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C3H_HeH_Mouse" name="C3H/HeH Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C3H/HeH Mouse</Term>
        <Term>C3H/HeH</Term>
        <Codes>
          <Code code="C37368" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SHR_Rat_Strain" name="SHR, Rat Strain">
        <Definition>The spontaneous hypertensive rat was derived by Okamoto at the Kyoto school of medicine (1963) from a cross between an outbred Wistar Kyoto male with a significant elevation of blood pressure and a female Wistar Kyoto with elevated blood pressure. SHR rats develop hypertension spontaneously without exception at the age of 7-15 weeks with a systolic blood pressure plateau of about 200 mmHg. The genetic basis is polygenic, with at least three major genes involved (Tanase and Suzuki 1971, Yen et al 1974).</Definition>
        <Definition>SHR: rats develop hypertension spontaneously without exception at the age of 7-15 weeks. There is a systolic blood pressure plateau of about 200 mmHg. The genetic basis is polygenic, with at least three major genes involved (Tanase and Suzuki 1971, Yen et al 1974). There is a high incidence of cardiovascular disease (Okamoto et al 1973), but a low incidence of stroke which can be increased to about 30% with chronic stress (Yamori 1984).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SHR, Rat Strain</Term>
        <Term>SHR</Term>
        <Codes>
          <Code code="C14412" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Proto_Oncogene_Proteins_c_kit" name="Proto Oncogene Proteins c kit">
        <Definition>Mast/stem cell growth factor receptor Kit (976 aa, ~110 kDa) is encoded by the human KIT gene. This protein is involved in cell survival, tyrosine phosphorylation and ligand-mediated signaling.</Definition>
        <Definition>A protein on the surface of some cells that binds to biologic substance called stem cell factor (SCF). SCF causes certain types of blood cells to grow. The stem cell factor receptor is found at high levels or in a changed form on some types of cancer cells. This may cause these cells to grow rapidly when SCF is present. The stem cell factor receptor is a type of receptor tyrosine kinase.</Definition>
        <Definition>A protein-tyrosine kinase receptor that is specific for STEM CELL FACTOR. This interaction is crucial for the development of hematopoietic, gonadal, and pigment stem cells. Genetic mutations that disrupt the expression of PROTO-ONCOGENE PROTEINS C-KIT are associated with PIEBALDISM, while overexpression or constitutive activation of the c-kit protein-tyrosine kinase is associated with tumorigenesis.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Proto Oncogene Proteins c kit</Term>
        <Term>p145c kit</Term>
        <Term>CD117 Antigens</Term>
        <Term>c kit Protein</Term>
        <Term>Proto Oncogene Protein kit</Term>
        <Term>STEM CELL FACTOR RECEPT</Term>
        <Term>Proto Oncogene Protein c kit</Term>
        <Term>Antigens, CD117</Term>
        <Term>c-kit, Proto-Oncogene Protein</Term>
        <Term>c-kit Protein</Term>
        <Term>p145 c-kit</Term>
        <Term>kit Proto Oncogene Protein</Term>
        <Term>Proto-Oncogene Protein c-kit</Term>
        <Term>p145(c-kit)</Term>
        <Term>SCF Receptor</Term>
        <Term>ANTIGENS CD 117</Term>
        <Term>c-kit, p145</Term>
        <Term>Stem Cell Factor Receptor</Term>
        <Term>P A 145 C KIT</Term>
        <Term>Proto-Oncogene Proteins c-kit</Term>
        <Term>c kit Receptor</Term>
        <Term>p145 c kit</Term>
        <Term>CD 117 ANTIGENS</Term>
        <Term>Proto-Oncogene Protein, kit</Term>
        <Term>p145c-kit</Term>
        <Term>c-kit, Proto-Oncogene Proteins</Term>
        <Term>SCF RECEPT</Term>
        <Term>kit Proto-Oncogene Protein</Term>
        <Term>Receptor, Stem Cell Factor</Term>
        <Term>RECEPT STEM CELL FACTOR</Term>
        <Term>CD117 Antigen</Term>
        <Term>Proto-Oncogene Protein kit</Term>
        <Term>c-kit Receptor</Term>
        <Codes>
          <Code code="C0072470" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:xkrk1_protein_Xenopus</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klrd1_protein_rat" name="Klrd1 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klrd1 protein, rat</Term>
        <Term>killer cell lectin-like receptor, subfamily D, member 1 protein, rat</Term>
        <Codes>
          <Code code="C1506363" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_D</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:follow-up_study" name="follow-up study">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">follow-up study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#follow-up_study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:longitudinal_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Syrian_Hamster" name="Syrian Hamster">
        <Definition>All Syrian hamsters in captivity are derived from a mother and eight pups that were captured in the wild in Aleppo, Syria by Dr. Israel Aharoni in 1930. Syrian Hamsters exhibit multiple coat colors, gold being the most common, and have a life span of about two to three years. Syrian hamsters are extremely territorial and are prone to attacking other hamsters so cannot be housed together under most circumstances. Females come into estrus every four days and embryo gestation is 16-18 days long. Syrian hamsters may exhibit diarrhea, neoplasms, amyloidosis, polycystic disease, and pregnancy-associated toxemia.</Definition>
        <Definition>A captive hamster strain derived from a mother and eight pups that were captured in the wild in Aleppo, Syria by Dr. Israel Aharoni in 1930.</Definition>
        <Definition>All Syrian hamsters in captivity are derived from a mother and eight pups that were captured in the wild in Aleppo, Syria by Dr. Israel Aharoni in 1930. Syrian Hamsters exhibit multiple coat colors, gold being the most common, and have a life span of about two to three years. Syrian hamsters are extremely territorial and are prone to attacking other hamsters so cannot be housed together under most circumstances. Females come into estrus every four days and embryo gestation is 16-18 days long.  Syrian hamsters may exhibit diarrhea, neoplasms, amyloidosis, polycystic disease, and pregnancy-associated toxemia.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Syrian Hamster</Term>
        <Term>Syrian</Term>
        <Term>Syrian golden hamster</Term>
        <Term>Syrian Hamsters, Golden</Term>
        <Term>Hamster, Golden</Term>
        <Term>Golden hamster</Term>
        <Term>Hamsters, Golden</Term>
        <Term>Golden Hamster</Term>
        <Term>Syrian golden hamsters</Term>
        <Term>Golden Hamsters</Term>
        <Term>Syrian hamsters</Term>
        <Term>syrian hamster</Term>
        <Term>SYRIAN</Term>
        <Term>Mesocricetus auratus (organism)</Term>
        <Term>Golden Syrian Hamsters</Term>
        <Term>Mesocricetus auratus Waterhouse, 1839</Term>
        <Term>Hamsters, Golden Syrian</Term>
        <Term>Golden hamsters</Term>
        <Term>Hamsters, Syrian</Term>
        <Term>Syrian Hamsters</Term>
        <Term>Mesocricetus auratus</Term>
        <Term>Syrian hamster</Term>
        <Codes>
          <Code code="C77095" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Hamster</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129T2_SvEmsJ_Mouse" name="129T2/SvEmsJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129T2/SvEmsJ Mouse</Term>
        <Term>129T2/SvEmsJ</Term>
        <Codes>
          <Code code="C37346" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly7_protein_mouse" name="Ly7 protein, mouse">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly7 protein, mouse</Term>
        <Term>Ly7 antigen, mouse</Term>
        <Term>Ly-7 protein, mouse</Term>
        <Term>lymphocyte antigen 7, mouse</Term>
        <Codes>
          <Code code="C2351665" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:surveillance" name="surveillance">
        <Definition>Purposeful and ongoing acquisition, interpretation, and synthesis of patient data for clinical decision making</Definition>
        <Definition>The systematic collection, analysis, and interpretation of health data on an ongoing basis. [NCIT_14.08d]</Definition>
        <Definition>In medicine, the ongoing collection of information about a disease, such as cancer, in a certain group of people. The information collected may include where the disease occurs in a population and whether it affects people of a certain gender, age, or ethnic group. [NCIT_14.08d]</Definition>
        <Definition>Activities such as detection, measurement, critical analysis, and monitoring intended to identify the status of the individual, family, or community's status in relation to a given condition or phenomenon.</Definition>
        <Definition>The systematic collection, analysis, and interpretation of health data on an ongoing basis.</Definition>
        <Definition>In medicine, the ongoing collection of information about a disease, such as cancer, in a certain group of people. The information collected may include where the disease occurs in a population and whether it affects people of a certain gender, age, or ethnic group.</Definition>
        <SemanticType code="T058" name="Health Care Activity"/>
        <SemanticType code="T057" name="Occupational Activity"/>
        <SemanticType code="T169" name="Functional Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">surveillance</Term>
        <Term>Surveillance (regime/therapy)</Term>
        <Term>Surveillance</Term>
        <Term>Epidemiology / Surveillance</Term>
        <Term>legal surveillance</Term>
        <Term>surveillance aspects</Term>
        <Term>medical surveillance</Term>
        <Term>Medical Surveillance</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#surveillance" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:health_survey</Relation>
          <Relation name="Narrower">OTE:population_surveillance</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C3H_Mouse" name="C3H Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C3H Mouse</Term>
        <Term>C3H Mice, Inbred</Term>
        <Term>C3H Mouse, Inbred</Term>
        <Term>Mouse, C3H</Term>
        <Term>Inbred C3H Mouse</Term>
        <Term>Mouse, Inbred C3H</Term>
        <Term>Mice, C3H</Term>
        <Term>C3H</Term>
        <Term>C3H Mice</Term>
        <Term>Inbred C3H Mice</Term>
        <Term>Mice, Inbred C3H</Term>
        <Term>MICE INBRED CA03H</Term>
        <Codes>
          <Code code="C37366" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ferret" name="Ferret">
        <Definition>brand of ferrous fumarate</Definition>
        <Definition>The common domestic mammal, Mustela putorious.</Definition>
        <Definition>animal of the weasel family (Mustela or Putorius furo), about fourteen inches in length.</Definition>
        <Definition>A small domestic mammal of the type Mustela putorious, with an elongated body and brown, black, white, or mixed fur. The ferret is carnivorous and crepuscular, spending 14-18 hours a day sleeping. This animal is prone to adrenal cancers, insulinoma, and lymphoma. In pre-clinical research, the ferret is used most commonly in toxicological screening and studies involving human influenza virus, as well as studies in reproductive physiology, anatomy, endocrinology and neuroscience.</Definition>
        <Definition>Semidomesticated variety of European polecat much used for hunting RODENTS and/or RABBITS and as a laboratory animal. It is in the subfamily Mustelinae, family MUSTELIDAE.</Definition>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T015" name="Mammal"/>
        <SemanticType code="T197" name="Inorganic Chemical"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ferret</Term>
        <Term>Mustela putorius subspecies furo</Term>
        <Term>ferret</Term>
        <Term>Ferrets</Term>
        <Term>Domestic Ferret</Term>
        <Term>Mustela putorius furo</Term>
        <Term>Ferret brand</Term>
        <Term>ferrets</Term>
        <Term>Mustela putorius subspecies furo (organism)</Term>
        <Term>FERRET</Term>
        <Term>Ferret, NOS</Term>
        <Term>Ferret brand of ferrous fumarate</Term>
        <Term>European ferret</Term>
        <Term>Mustela furo</Term>
        <Codes>
          <Code code="C0720417" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mustelidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:cross-sectional_study" name="cross-sectional study">
        <Definition>Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. [MeSH_2014]</Definition>
        <Definition>A study in which participants are examined at only a single time for characteristics of a disease. [NCIT_14.05d] </Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">cross-sectional study</Term>
        <Term>cross-sectional research</Term>
        <Term>cross sectional studies</Term>
        <Term>cross-sectional studies</Term>
        <Term>Prevalence studies [1989]</Term>
        <Term>cross-sectional design</Term>
        <Term>cross-sectional trials</Term>
        <Term>cross sectional trial</Term>
        <Term>cross-sectional designs</Term>
        <Term>cross-sectional survey</Term>
        <Term>cross sectional design</Term>
        <Term>cross sectional designs</Term>
        <Term>Epidemiologic methods [1975-1989]</Term>
        <Term>cross-sectional trial</Term>
        <Term>cross sectional trials</Term>
        <Term>cross sectional study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#cross_sectional_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:ecological_cross-sectional_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BSG_protein_human" name="BSG protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BSG protein, human</Term>
        <Term>5F7 protein, human</Term>
        <Term>EMMPRIN protein, human</Term>
        <Term>basigin protein, human</Term>
        <Term>collagenase stimulatory factor protein, human</Term>
        <Term>basigin (OK blood group) protein, human</Term>
        <Term>CD147 antigen, human</Term>
        <Term>human leukocyte activation antigen M6</Term>
        <Term>HAb18G protein, human</Term>
        <Term>M6 activation antigen, human</Term>
        <Codes>
          <Code code="C1505110" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD147</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SSLP-1_protein_mouse" name="SSLP-1 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SSLP-1 protein, mouse</Term>
        <Term>secreted seminal vesicle Ly-6 protein 1, mouse</Term>
        <Codes>
          <Code code="C1957436" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Platelet_Membrane_Glycoprotein_IIb" name="Platelet Membrane Glycoprotein IIb">
        <Definition>Platelet membrane glycoprotein IIb is an integrin alpha subunit that heterodimerizes with INTEGRIN BETA3 to form PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX. It is synthesized as a single polypeptide chain which is then postranslationally cleaved and processed into two disulfide-linked subunits of approximately 18 and 110 kDa in size.</Definition>
        <Definition>Integrin alpha-IIb (1039 aa, ~113 kDa) is encoded by the human ITGA2B gene. This protein is involved in the mediation of platelet clotting.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Platelet Membrane Glycoprotein IIb</Term>
        <Term>Membrane Glycoprotein IIb</Term>
        <Term>Integrin alphaIIb</Term>
        <Term>CD41 Antigens</Term>
        <Term>CD41 Antigen</Term>
        <Term>alphaIIb, Integrin</Term>
        <Term>Glycoprotein IIb, Membrane</Term>
        <Term>ANTIGENS CD 041</Term>
        <Term>GPalpha IIb</Term>
        <Term>CD41 Cell Surface Antigen</Term>
        <Term>Plasma Membrane Glycoprotein IIb</Term>
        <Term>GP IIb</Term>
        <Term>Antigen, HUPL-ml Surface</Term>
        <Term>Antigens, CD41</Term>
        <Term>Antigen, CD41</Term>
        <Term>HUPL ml Surface Antigen</Term>
        <Term>INTEGRIN ALPHA A 02B</Term>
        <Term>HUPL-ml Surface Antigen</Term>
        <Term>Integrin alpha IIb</Term>
        <Term>CD 041 ANTIGENS</Term>
        <Term>Surface Antigen, HUPL-ml</Term>
        <Codes>
          <Code code="C0032191" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:recombinant_human_tumor_necrosis_factor-binding_protein-1" name="recombinant human tumor necrosis factor-binding protein-1">
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">recombinant human tumor necrosis factor-binding protein-1</Term>
        <Term>recombinant human soluble p55 tumour necrosis factor receptor</Term>
        <Term>r-hTBP-1</Term>
        <Term>TNFRp55</Term>
        <Codes>
          <Code code="C1100612" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Necrosis_Factor_Receptor_1A</Relation>
          <Relation name="Narrower">OTE:Onercept</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CSF2RB_protein_human" name="CSF2RB protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CSF2RB protein, human</Term>
        <Term>IL-3 IL-5 GM-CSF receptor beta subunit protein, human</Term>
        <Term>IL-3, IL-5, GM-CSFR receptor beta chain protein, human</Term>
        <Term>betac protein, human</Term>
        <Term>CD131 antigen, human</Term>
        <Term>beta(c) protein, human</Term>
        <Term>colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage), human</Term>
        <Codes>
          <Code code="C1449195" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:GM-CSF_IL-3_IL-5_Receptor_Common_beta-Chain</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Hispanic_Americans" name="Hispanic Americans">
        <Definition>Persons living in the United States of Mexican (MEXICAN AMERICANS), Puerto Rican, Cuban, Central or South American, or other Spanish culture or origin. The concept does not include Brazilian Americans or Portuguese Americans.</Definition>
        <Definition>a person of Mexican, Puerto Rican, Cuban, Central or South American or other western hemisphere Hispanic culture or origin, regardless of race; index NTs instead where possible; for inhabitants of countries outside the United States of America index geographical region as well.</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Hispanic Americans</Term>
        <Term>hispanic americans</Term>
        <Term>Hispanic American</Term>
        <Term>Hispano</Term>
        <Term>Spanish American</Term>
        <Term>Americans, Hispanic</Term>
        <Term>Americans, Spanish</Term>
        <Term>Spanish Americans</Term>
        <Term>American, Hispanic</Term>
        <Term>Spanish surname</Term>
        <Codes>
          <Code code="C0019576" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ethnic_Groups</Relation>
          <Relation name="Narrower">OTE:Mexican_Americans, OTE:Cuban_Americans, OTE:Puerto_Ricans</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:B6_129-Rag1-tm1Mom_Mouse" name="B6;129-Rag1-tm1Mom Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">B6;129-Rag1-tm1Mom Mouse</Term>
        <Term>B6,129-Rag1-tm1Mom</Term>
        <Term>B6;129-Rag1-tm1Mom</Term>
        <Codes>
          <Code code="C15170" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rag1_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:WH_Rat_Strain" name="WH, Rat Strain">
        <Definition>A Wistar substrain established in Hanover, Germany (1964), this rat breed is a white albino with pink eyes, genotype c.  The WH rat has a low incidence of overall spontaneous tumor formation; the most common in males being pituitary adenomas while females exhibit spontaneous mammary, thyroid, and pituitary adenomas. This is a multi-purpose research strain and applications include aging, oncology, toxicology, and safety and efficacy testing.</Definition>
        <Definition>A Wistar substrain established in Hanover, Germany (1964), this rat breed is a white albino with pink eyes, genotype c.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">WH, Rat Strain</Term>
        <Term>WISTAR HAN</Term>
        <Term>Wistar Han</Term>
        <Codes>
          <Code code="C76191" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Frog" name="Frog">
        <Definition>An amphibian in the order Anura, which includes the toads. The commonest frog genera are Rana (grass frogs) and Hyla (tree frogs).</Definition>
        <Definition>one of the three orders of extant amphibians, comprising the frogs and toads.</Definition>
        <Definition>An order of the class Amphibia, which includes several families of frogs and toads. They are characterized by well developed hind limbs adapted for jumping, fused head and trunk and webbed toes. The term "toad" is ambiguous and is properly applied only to the family Bufonidae.</Definition>
        <Definition>An amphibian in the order Anura, which includes the toads. (NCI)</Definition>
        <Definition>genus of frog; tailess amphibian with long hind legs adapted for jumping; lives in damp or aquatic environments.</Definition>
        <SemanticType code="T011" name="Amphibian"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Frog</Term>
        <Term>Frog (organism)</Term>
        <Term>rana</Term>
        <Term>Order Anura (organism)</Term>
        <Term>Salientia</Term>
        <Term>Frogs and Toads</Term>
        <Term>Toads and Frogs</Term>
        <Term>Frogs</Term>
        <Term>FROGS TOADS</Term>
        <Term>Order Anura</Term>
        <Term>Genus Rana (organism)</Term>
        <Term>Rana &lt;genus&gt;</Term>
        <Term>Anuras</Term>
        <Term>Genus Rana</Term>
        <Term>frogs</Term>
        <Term>frog</Term>
        <Term>anura</Term>
        <Term>TOADS FROGS</Term>
        <Term>Rana</Term>
        <Term>Pseudorana</Term>
        <Term>FROG</Term>
        <Term>Anura</Term>
        <Term>anurans</Term>
        <Codes>
          <Code code="C0003459" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Amphibia</Relation>
          <Relation name="Narrower">OTE:Xenopus</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tnfrsf1a_protein_rat" name="Tnfrsf1a protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tnfrsf1a protein, rat</Term>
        <Term>Tnfr1 protein, rat</Term>
        <Term>tumor necrosis factor receptor superfamily, member 1a protein, rat</Term>
        <Codes>
          <Code code="C1453723" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Necrosis_Factor_Receptor_1A</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:letter_to_the_editor" name="letter to the editor">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">letter to the editor</Term>
        <Term>letters to the editor</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#letter_to_the_editor" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:letter</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:non-randomized_cross-over_design" name="non-randomized cross-over design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">non-randomized cross-over design</Term>
        <Term>non-randomized crossover trial</Term>
        <Term>non-randomized crossover trials</Term>
        <Term>non-randomised crossover studies</Term>
        <Term>non-randomized crossover studies</Term>
        <Term>nonrandomised crossover design</Term>
        <Term>non-randomised cross-over designs</Term>
        <Term>non-randomized cross-over studies</Term>
        <Term>nonrandomised cross-over design</Term>
        <Term>nonrandomised cross-over designs</Term>
        <Term>non-randomised cross-over design</Term>
        <Term>nonrandomized cross-over design</Term>
        <Term>nonrandomized crossover trial</Term>
        <Term>nonrandomized crossover studies</Term>
        <Term>nonrandomized crossover designs</Term>
        <Term>nonrandomized cross-over trials</Term>
        <Term>nonrandomised cross-over trials</Term>
        <Term>nonrandomised crossover trials</Term>
        <Term>nonrandomized crossover trials</Term>
        <Term>nonrandomized cross-over study</Term>
        <Term>non-randomised crossover study</Term>
        <Term>nonrandomised cross-over study</Term>
        <Term>nonrandomized cross-over designs</Term>
        <Term>non-randomized crossover design</Term>
        <Term>non-randomised crossover designs</Term>
        <Term>non-randomised cross-over trial</Term>
        <Term>nonrandomised cross-over studies</Term>
        <Term>non-randomized crossover designs</Term>
        <Term>nonrandomized cross-over studies</Term>
        <Term>non-randomized crossover study</Term>
        <Term>non-randomised crossover design</Term>
        <Term>nonrandomized cross-over trial</Term>
        <Term>non-randomised cross-over trials</Term>
        <Term>non-randomised cross-over study</Term>
        <Term>non-randomized cross-over trials</Term>
        <Term>nonrandomised crossover designs</Term>
        <Term>non-randomized cross-over designs</Term>
        <Term>nonrandomised crossover studies</Term>
        <Term>nonrandomised crossover trial</Term>
        <Term>non-randomised crossover trials</Term>
        <Term>nonrandomized crossover design</Term>
        <Term>nonrandomised cross-over trial</Term>
        <Term>non-randomized cross-over trial</Term>
        <Term>non-randomised crossover trial</Term>
        <Term>nonrandomized crossover study</Term>
        <Term>non-randomised cross-over studies</Term>
        <Term>non-randomized cross-over study</Term>
        <Term>nonrandomised crossover study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#non-randomized_cross-over_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cross-over_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LDL_Receptor_Related_Protein_1" name="LDL Receptor Related Protein 1">
        <Definition>A LDL-receptor related protein involved in clearance of chylomicron remnants and of activated ALPHA-MACROGLOBULINS from plasma.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LDL Receptor Related Protein 1</Term>
        <Term>ALPHA 2 MACROGLOBULIN RECEPT</Term>
        <Term>LDL RECEPT RELAT PROTEIN</Term>
        <Term>CD91 Antigens</Term>
        <Term>ALPHA MACROGLOBULIN RECEPTOR 002</Term>
        <Term>ApoE Receptor</Term>
        <Term>Low Density Lipoprotein Receptor-Related Protein-1 [Chemical/Ingredient]</Term>
        <Term>alpha2-Macroglobulin Signaling Receptor</Term>
        <Term>LDL-Receptor Related Protein</Term>
        <Term>CD91 Antigen</Term>
        <Term>RECEPTOR ALPHA MACROGLOBULIN AA 02</Term>
        <Term>APO E RECEPT</Term>
        <Term>Antigens, CD91</Term>
        <Term>LDL Receptor Related Protein</Term>
        <Term>LDL RECEPT RELAT PROTEIN 1</Term>
        <Term>RECEPT APOLIPOPROTEIN E</Term>
        <Term>Receptor, ApoE</Term>
        <Term>LDL-Receptor Related Protein 1</Term>
        <Term>alpha2 Macroglobulin Signaling Receptor</Term>
        <Term>alpha-2 Macroglobulin Receptor</Term>
        <Term>Low Density Lipoprotein Receptor Related Protein 1</Term>
        <Term>RECEPT APO E</Term>
        <Term>Receptor, Apolipoprotein E</Term>
        <Term>Apo E Receptor</Term>
        <Term>APOLIPOPROTEIN E RECEPT</Term>
        <Term>Low Density Lipoprotein Receptor-Related Protein-1</Term>
        <Term>Antigen, CD91</Term>
        <Term>ALPHA2 MACROGLOBULIN SIGNALING RECEPT</Term>
        <Term>Apolipoprotein E Receptor</Term>
        <Term>alpha 2 Macroglobulin Receptor</Term>
        <Term>alpha-2-Macroglobulin Receptor</Term>
        <Term>LDL RECEPTOR RELATED PROTEIN 001</Term>
        <Term>RECEPT ALPHA 2 MACROGLOBULIN</Term>
        <Term>Receptor, Apo E</Term>
        <Term>Receptor, alpha-2 Macroglobulin</Term>
        <Codes>
          <Code code="C0051300" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:low_density_lipoprotein_receptor-related_protein_1_Xenopus, OTE:LRP1_protein_human, OTE:LDLR-related_protein_1A_human, OTE:LRP12_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SIRPG_protein_human" name="SIRPG protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SIRPG protein, human</Term>
        <Term>SIRPgamma protein, human</Term>
        <Term>signal-regulatory protein gamma, human</Term>
        <Term>CD172g antigen, human</Term>
        <Codes>
          <Code code="C1506734" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_Differentiation" name="Antigens, Differentiation">
        <Definition>Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation.(MeSH)</Definition>
        <Definition>antigens normally only seen at particular phases of differentiation of a cell type.</Definition>
        <Definition>Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, Differentiation</Term>
        <Term>Differentiation Antigens</Term>
        <Term>Marker Antigens</Term>
        <Term>DIFFER ANTIGENS</Term>
        <Term>Antigens, Marker</Term>
        <Term>MARKERS DIFFER</Term>
        <Term>ANTIGENS DIFFER</Term>
        <Term>Markers, Differentiation</Term>
        <Term>Differentiation Markers</Term>
        <Term>DIFFER MARKERS</Term>
        <Codes>
          <Code code="C0003324" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
          <Relation name="Narrower">OTE:SBSN_protein_human, OTE:CMRF-56_antigen, OTE:senescent_cell_differentiation_antigen, OTE:Gadd45b_protein_rat, OTE:Antigens_CD, OTE:suprabasin_protein_mouse, OTE:MECA-99_antigen, OTE:GADD45B_protein_human, OTE:antigen_GL7, OTE:oligodendrocyte_O_antigen_mouse, OTE:antigen_X-80, OTE:hairy_cell_leukemia_antigen_HC2_human, OTE:deltaIK17_antigen, OTE:oligodendrocyte_O_antigen_rat, OTE:PTPNS1_protein_human, OTE:Myd116_protein_mouse, OTE:HB-6_antigen, OTE:leu_13_antigen, OTE:OX-62_antigen_rat, OTE:Myd116_protein_rat, OTE:neutrophil_differentiation_antigens, OTE:MKW_antigen, OTE:Myd88_protein_Drosophila, OTE:Leu_Antigens, OTE:OX40Ig, OTE:H-type-1_antigen, OTE:SIRPG_protein_human, OTE:monocyte-macrophage_differentiation_antigen, OTE:Differentiation_Antigens_Hairy_Cell_Leukemia, OTE:Antigens_Ly, OTE:Gadd45b_protein_mouse, OTE:oval_cell_marker_OV-6, OTE:MyD88_protein_Xenopus, OTE:cytotoxic_T-lymphocyte_antigen-2alpha_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129S4_SvJae_Mouse" name="129S4/SvJae Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129S4/SvJae Mouse</Term>
        <Term>129S4/SvJae</Term>
        <Codes>
          <Code code="C37340" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NFS_N_Mouse" name="NFS/N Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NFS/N Mouse</Term>
        <Term>NFS/N</Term>
        <Codes>
          <Code code="C37415" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NOR_Mouse" name="NOR Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NOR Mouse</Term>
        <Term>NOR</Term>
        <Codes>
          <Code code="C37420" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:closed_cohort_study" name="closed cohort study">
        <SemanticType code="T081" name="Quantitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">closed cohort study</Term>
        <Term>studies, closed cohort</Term>
        <Term>Study, Closed Cohort</Term>
        <Term>Closed Cohort Study</Term>
        <Term>Closed Cohort Studies</Term>
        <Term>cohort study, closed</Term>
        <Term>study, closed cohort</Term>
        <Term>Studies, Closed Cohort</Term>
        <Term>Cohort Studies, Closed</Term>
        <Term>cohort studies, closed</Term>
        <Term>closed cohort studies</Term>
        <Term>Cohort Study, Closed</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#closed_cohort_study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cohort_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD97_protein_human" name="CD97 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD97 protein, human</Term>
        <Term>leukocyte activation antigen CD97, human</Term>
        <Term>leukocyte antigen CD97, human</Term>
        <Term>CD97 antigen, human</Term>
        <Codes>
          <Code code="C1505149" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL2RG_protein_human" name="IL2RG protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL2RG protein, human</Term>
        <Term>interleukin-2 receptor gamma, human</Term>
        <Term>CD132 antigen, human</Term>
        <Term>CD132 protein, human</Term>
        <Term>IL2Rgamma, human</Term>
        <Term>interleukin 2 receptor, gamma protein, human</Term>
        <Term>interleukin 2 receptor, gamma (severe combined immunodeficiency) protein, human</Term>
        <Codes>
          <Code code="C1568975" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_gamma-Chain_Protein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:controlled_cohort_before-after_design_" name="controlled cohort before-after design'">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">controlled cohort before-after design'</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#controlled_cohort_before-after_design'" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cohort_before-after_design_</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:randomized_cross-over_design" name="randomized cross-over design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">randomized cross-over design</Term>
        <Term>randomized crossover trials</Term>
        <Term>randomized cross-over designs</Term>
        <Term>randomized cross-over study</Term>
        <Term>randomized crossover studies</Term>
        <Term>randomized crossover trial</Term>
        <Term>randomised crossover trial</Term>
        <Term>randomized crossover design</Term>
        <Term>randomised crossover study</Term>
        <Term>randomised cross-over trial</Term>
        <Term>randomised cross-over designs</Term>
        <Term>randomized crossover study</Term>
        <Term>randomised cross-over studies</Term>
        <Term>randomized cross-over trials</Term>
        <Term>randomised crossover designs</Term>
        <Term>randomized cross-over studies</Term>
        <Term>randomised cross-over study</Term>
        <Term>randomised crossover design</Term>
        <Term>randomised cross-over design</Term>
        <Term>randomised cross-over trials</Term>
        <Term>randomized crossover designs</Term>
        <Term>randomised crossover studies</Term>
        <Term>randomised crossover trials</Term>
        <Term>randomized cross-over trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#randomized_cross-over_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:randomized_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BL_6Pas_Mouse" name="C57BL/6Pas Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BL/6Pas Mouse</Term>
        <Term>C57BL/6Pas</Term>
        <Codes>
          <Code code="C37386" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MPL_protein_human" name="MPL protein, human">
        <Definition>Thrombopoietin receptor (635 aa, 71 kD) is a cell division process protein that is encoded by the human MPL gene and has roles in cell proliferation and signal transduction.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MPL protein, human</Term>
        <Term>TPOR protein, human</Term>
        <Term>thrombopoietin receptor, human</Term>
        <Term>MPL ligand receptor, human</Term>
        <Term>CD110 antigen, human</Term>
        <Term>Mpl receptor, human</Term>
        <Term>c-MPL protein, human</Term>
        <Term>myeloproliferative leukemia virus oncogene protein, human</Term>
        <Codes>
          <Code code="C0218227" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptor_Thrombopoietin</Relation>
          <Relation name="Narrower">OTE:MPLP_protein_human, OTE:MPLK_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BALB_cAnPt_Mouse" name="BALB/cAnPt Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BALB/cAnPt Mouse</Term>
        <Term>BALB/cAnPt</Term>
        <Codes>
          <Code code="C37358" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Insect" name="Insect">
        <Definition>have 3 pairs of legs, 3 body regions, 1 pair of antennae, and often 1-2 pairs of wings; 26 Orders, 703,500 known species.</Definition>
        <Definition>Insects are a class, Insecta, of Arthropoda whose members are characterized by division into three parts: head, thorax, and abdomen. They are the dominant group of animals on earth, several hundred thousand different kinds having been described. They have lived on earth for about 350 million years, as compared with less than 2 million for man. While insects are often commercially valuable and useful as scavengers, many species are harmful, causing enormous losses in agriculture and storage. Three orders, HEMIPTERA, DIPTERA, and Siphonaptera, are of medical interest in that they cause disease in man and animal. (From Dorland, 27th ed; Borror et al., An Introduction to the Study of Insects, 4th ed, p1)</Definition>
        <Definition>The class Insecta, in the phylum ARTHROPODA, whose members are characterized by division into three parts: head, thorax, and abdomen. They are the dominant group of animals on earth; several hundred thousand different kinds having been described. Three orders, HEMIPTERA; DIPTERA; and SIPHONAPTERA; are of medical interest in that they cause disease in humans and animals. (From Borror et al., An Introduction to the Study of Insects, 4th ed, p1)</Definition>
        <Definition>A taxonomic class of arthropods that includes praying mantises, dragonflies, grasshoppers, true bugs, flies, bees, wasps, ants, butterflies, moths, and beetles.</Definition>
        <SemanticType code="T204" name="Eukaryote"/>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Insect</Term>
        <Term>Insects</Term>
        <Term>Insect Extract</Term>
        <Term>INSECT</Term>
        <Term>Invertebrates, Insects</Term>
        <Term>Insect Specimen Code</Term>
        <Term>Insect Extracts</Term>
        <Term>Class: Insecta</Term>
        <Term>Class Insecta</Term>
        <Term>CLASS INSECTA - INSECTS</Term>
        <Term>insects</Term>
        <Term>60-65 CLASS INSECTA - INSECTS</Term>
        <Term>insect</Term>
        <Term>Class Insecta (organism)</Term>
        <Term>Insect, NOS</Term>
        <Term>Insecta</Term>
        <Codes>
          <Code code="C1546678" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Arthropoda</Relation>
          <Relation name="Narrower">OTE:Diptera, OTE:Lice, OTE:Lampyridae, OTE:Blatella_germanica</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LILRB3_protein_human" name="LILRB3 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LILRB3 protein, human</Term>
        <Term>leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 protein, human</Term>
        <Term>leukocyte Ig-like receptor B3, human</Term>
        <Codes>
          <Code code="C2352529" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ectonucleoside_triphosphate_diphosphohydrolase_1" name="ectonucleoside triphosphate diphosphohydrolase 1">
        <Definition>This gene is involved in platelet activation.</Definition>
        <Definition>Ectonucleoside triphosphate diphosphohydrolase 1 (510 aa, ~58 kDa) is encoded by the human ENTPD1 gene. This protein is involved in the activation of platelets.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ectonucleoside triphosphate diphosphohydrolase 1</Term>
        <Term>Ecto-ATP Diphosphohydrolase 1</Term>
        <Term>NTPDase-1</Term>
        <Term>CD39 Antigen</Term>
        <Term>SPG64</Term>
        <Term>Ectonucleoside Triphosphate Diphosphohydrolase 1</Term>
        <Term>CD39 antigen</Term>
        <Term>ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1</Term>
        <Term>ENTPD1</Term>
        <Term>Lymphocyte antigen CD39 (substance)</Term>
        <Term>Cluster of differentiation antigen 39</Term>
        <Term>Ectonucleoside Triphosphate Diphosphohydrolase 1 Gene</Term>
        <Term>Ecto-ATPase 1</Term>
        <Term>NTPDase 1</Term>
        <Term>EC 3.6.1.5</Term>
        <Term>APYRASE</Term>
        <Term>CD39</Term>
        <Term>ENTPD1 Gene</Term>
        <Term>NTPDase1</Term>
        <Term>ENTPD1 gene</Term>
        <Term>ectoADPase</Term>
        <Term>CD39 ANTIGEN</Term>
        <Term>ecto-ATP diphosphohydrolase</Term>
        <Term>VASCULAR ATP DIPHOSPHOHYDROLASE</Term>
        <Term>Ecto-apyrase</Term>
        <Term>Vascular ATP Diphosphohydrolase</Term>
        <Term>Lymphocyte antigen CD39</Term>
        <Term>Ecto-ATPDase 1</Term>
        <Term>CD39 - Cluster of diff ag 39</Term>
        <Term>ATPDase</Term>
        <Term>Lymphoid Cell Activation Antigen</Term>
        <Term>ecto-apyrase</Term>
        <Term>Apyrase</Term>
        <Term>Cluster of diff antigen 39</Term>
        <Term>CD39 - Cluster of differentiation antigen 39</Term>
        <Term>ecto-ADPase</Term>
        <Codes>
          <Code code="C0108783" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CR1L_protein_human" name="CR1L protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CR1L protein, human</Term>
        <Term>complement component (3b/4b) receptor 1-like protein, human</Term>
        <Term>CR1-like protein, human</Term>
        <Codes>
          <Code code="C1436280" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Complement_3b_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Integrin_beta3B" name="Integrin beta3B">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Integrin beta3B</Term>
        <Term>Integrin, beta3B</Term>
        <Term>INTEGRIN BETA A 03B</Term>
        <Term>beta3B Integrin</Term>
        <Codes>
          <Code code="C1136349" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Integrin_beta3</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Integrin_beta3C" name="Integrin beta3C">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Integrin beta3C</Term>
        <Term>Integrin, beta3C</Term>
        <Term>beta3C Integrin</Term>
        <Term>INTEGRIN BETA A 03C</Term>
        <Codes>
          <Code code="C1136350" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Integrin_beta3</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klra3_protein_mouse" name="Klra3 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klra3 protein, mouse</Term>
        <Term>Ly-49C antigen, mouse</Term>
        <Term>Nk2.1 protein, mouse</Term>
        <Term>NK-2.1 protein, mouse</Term>
        <Term>Ly49C antigen, mouse</Term>
        <Term>killer cell lectin-like receptor, subfamily A, member 3, mouse</Term>
        <Term>Ly49C protein, mouse</Term>
        <Codes>
          <Code code="C2351932" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:trend_design" name="trend design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">trend design</Term>
        <Term>trend studies</Term>
        <Term>trend trials</Term>
        <Term>trend study</Term>
        <Term>trend designs</Term>
        <Term>trend trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#trend_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NOD_Mouse" name="NOD Mouse">
        <Definition>A strain of non-obese diabetic mice developed in Japan that has been widely studied as a model for T-cell-dependent autoimmune insulin-dependent diabetes mellitus in which insulitis is a major histopathologic feature, and in which genetic susceptibility is strongly MHC-linked.</Definition>
        <Definition>non-obese diabetic mouse; has genetic predisposition to autoimmune diabetes.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NOD Mouse</Term>
        <Term>Diabetic Mouse, Non-Obese</Term>
        <Term>Mice, NOD</Term>
        <Term>Diabetic Mouse, Nonobese</Term>
        <Term>Mice, Nonobese Diabetic</Term>
        <Term>Non Obese Diabetic Mice</Term>
        <Term>Mouse, Inbred NOD</Term>
        <Term>Non-Obese Diabetic Mouse</Term>
        <Term>Mouse, NOD</Term>
        <Term>Diabetic Mice, Non-Obese</Term>
        <Term>NOD Mice, Inbred</Term>
        <Term>nod mice</Term>
        <Term>Mice, Non-Obese Diabetic</Term>
        <Term>NOD Mouse, Inbred</Term>
        <Term>NOD Mice</Term>
        <Term>NOD</Term>
        <Term>Diabetic Mice, Nonobese</Term>
        <Term>Non Obese Diabetic Mouse</Term>
        <Term>NOD mouse</Term>
        <Term>Mouse, Nonobese Diabetic</Term>
        <Term>Inbred NOD Mouse</Term>
        <Term>Non-Obese Diabetic Mice</Term>
        <Term>NONOBESE DIABETIC MICE</Term>
        <Term>Mice, Inbred NOD</Term>
        <Term>Mouse, Non-Obese Diabetic</Term>
        <Term>Inbred NOD Mice</Term>
        <Term>Nonobese Diabetic Mice</Term>
        <Term>Nonobese Diabetic Mouse</Term>
        <Codes>
          <Code code="C0085243" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Integrin_beta3A" name="Integrin beta3A">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Integrin beta3A</Term>
        <Term>INTEGRIN BETA A 03A</Term>
        <Term>Integrin, beta3A</Term>
        <Term>beta3A Integrin</Term>
        <Codes>
          <Code code="C1101365" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Integrin_beta3</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD9_protein_human" name="CD9 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD9 protein, human</Term>
        <Term>TSPAN29 protein, human</Term>
        <Term>CD9 antigen, human</Term>
        <Term>human leukemia-associated antigen p24</Term>
        <Term>CD9 antigen (p24) protein, human</Term>
        <Codes>
          <Code code="C1701084" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD9</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Aves" name="Aves">
        <Definition>Warm-blooded VERTEBRATES possessing FEATHERS and belonging to the class Aves.</Definition>
        <Definition>A taxonomic class of egg-laying, endothermic vertebrates. The forelimbs of these bipedal animals have been modified to form wings. Modern birds have beaks with no teeth and their bodies are covered in feathers.</Definition>
        <Definition>warmblooded oviparous tetrapods with feathers, one occipital condyle, forelimb modified into wings, heart with 2 ventricles.</Definition>
        <SemanticType code="T012" name="Bird"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Aves</Term>
        <Term>Birds</Term>
        <Term>avians</Term>
        <Term>Avian</Term>
        <Term>bird</Term>
        <Term>Class Aves</Term>
        <Term>aves</Term>
        <Term>birds</Term>
        <Term>avian</Term>
        <Term>Bird</Term>
        <Term>Class Aves (organism)</Term>
        <Codes>
          <Code code="C0005595" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Vertebrata</Relation>
          <Relation name="Narrower">OTE:Quail, OTE:Chicken, OTE:Pigeon</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:epidemiological_design" name="epidemiological design">
        <Definition>Epidemiological methods involve sophisticated statistics and higher mathematics. These methods allow epidemiologists to address issues like non-experimental studies of mechanistic questions in disease etiology, including studies of the impact of the social position of individuals in different social contexts.[Epidemiological method | NCIT_14.05d] </Definition>
        <Definition>Studies designed to examine associations, commonly, hypothesized causal relations. They are usually concerned with identifying or measuring the effects of risk factors or exposures. [MeSH_2014]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">epidemiological design</Term>
        <Term>Epidemiology, Method</Term>
        <Term>epidemiologic trials</Term>
        <Term>epidemiological trials</Term>
        <Term>epidemiologic studies</Term>
        <Term>epidemiologic designs</Term>
        <Term>epidemiologic design</Term>
        <Term>Epidemiological Method</Term>
        <Term>epidemiological studies</Term>
        <Term>Epidemiological Technique</Term>
        <Term>epidemiologic study</Term>
        <Term>epidemiological designs</Term>
        <Term>epidemiological trial</Term>
        <Term>epidemiologic trial</Term>
        <Term>epidemiological study</Term>
        <Term>studies, epidemiologic</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#epidemiological_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BL26_protein_mouse" name="BL26 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BL26 protein, mouse</Term>
        <Term>BL26 antigen, mouse</Term>
        <Codes>
          <Code code="C0649246" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SJL_J_Mouse" name="SJL/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SJL/J Mouse</Term>
        <Term>SJL/J</Term>
        <Codes>
          <Code code="C14448" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD209b_protein_rat" name="CD209b protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD209b protein, rat</Term>
        <Codes>
          <Code code="C2715232" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FH_Rat_Strain" name="FH, Rat Strain">
        <Definition>It has been suggested that FH rats represent a genetic model of depression They have altered serotonergic function (Aulka et al, 1994a), they exhibit differential responses to serotonin agonists and antagonists compared with other strains (Meehan and Schechter, 1994), and long-term treatment with imipramine, clomipramine and clorgyline produced significant decreases in plasma corticosterone levels, supporting this suggestion (Aulka et al, 1993).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FH, Rat Strain</Term>
        <Codes>
          <Code code="C14402" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Sema7a_protein_mouse" name="Sema7a protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Sema7a protein, mouse</Term>
        <Term>semaphorin-L protein, mouse</Term>
        <Term>sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A protein, mouse</Term>
        <Term>M-Sema-L protein, mouse</Term>
        <Codes>
          <Code code="C0757498" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:review_of_literature_" name="review of literature'">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">review of literature'</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#review_of_literature'" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
          <Relation name="Narrower">OTE:systematic_review_, OTE:rapid_review_, OTE:narrative_review_, OTE:umbrella_review_, OTE:overview_of_reviews_, OTE:scoping_review_, OTE:evidence_report_</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:asialofetuin-polylysine-5_-uridine_monophosphate_conjugate_125-labeled" name="asialofetuin-polylysine-5'-uridine monophosphate conjugate, 125-labeled">
        <SemanticType code="T109" name="Organic Chemical"/>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">asialofetuin-polylysine-5'-uridine monophosphate conjugate, 125-labeled</Term>
        <Term>125I-AsF-PL-UMP</Term>
        <Codes>
          <Code code="C0641480" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:asialofetuin-polylysine-5_-uridine_monophosphate_conjugate</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin_18_Receptor_beta_Subunit" name="Interleukin 18 Receptor beta Subunit">
        <Definition>A subunit of the interleukin-18 receptor that plays a role in receptor signaling by association of its cytoplasmic domain with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin 18 Receptor beta Subunit</Term>
        <Term>CD 218B ANTIGENS W</Term>
        <Term>CDw218b Antigens</Term>
        <Term>ANTIGENS CD 218B W</Term>
        <Term>Interleukin-18 Receptor beta Subunit</Term>
        <Term>CDw218b Antigen</Term>
        <Term>Interleukin-18 Receptor Accessory Protein</Term>
        <Term>Antigens, CDw218b</Term>
        <Term>Antigen, CDw218b</Term>
        <Term>INTERLEUKIN 018 RECEPTOR BETA SUBUNIT</Term>
        <Term>Interleukin-18 Receptor beta Subunit [Chemical/Ingredient]</Term>
        <Term>Interleukin 18 Receptor Accessory Protein</Term>
        <Codes>
          <Code code="C1706563" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:IL18rap_protein_mouse, OTE:IL18RAP_protein_human, OTE:Il18rap_protein_rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Markers_DNA" name="Markers, DNA">
        <SemanticType code="T086" name="Nucleotide Sequence"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Markers, DNA</Term>
        <Term>DNA Marker</Term>
        <Term>Marker, DNA</Term>
        <Term>DNA Markers</Term>
        <Codes>
          <Code code="C0012872" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Genetic_Marker</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klra8_protein_mouse" name="Klra8 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klra8 protein, mouse</Term>
        <Term>Ly-49h antigen, mouse</Term>
        <Term>Cmv1 protein, mouse</Term>
        <Term>killer cell lectin-like receptor, subfamily A, member 8, mouse</Term>
        <Term>Ly49h antigen, mouse</Term>
        <Codes>
          <Code code="C2351937" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly6k_protein_mouse" name="Ly6k protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly6k protein, mouse</Term>
        <Codes>
          <Code code="C2973783" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NT5M_protein_human" name="NT5M protein, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NT5M protein, human</Term>
        <Term>5',3'-nucleotidase, mitochondrial protein, human</Term>
        <Codes>
          <Code code="C2973303" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-Nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:phase_III_trial" name="phase III trial">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">phase III trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#phase_III_trial" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:KIR2DL1_protein_human" name="KIR2DL1 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">KIR2DL1 protein, human</Term>
        <Term>killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 protein, human</Term>
        <Term>NKAT1 protein, human</Term>
        <Codes>
          <Code code="C1430233" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_KIR2DL1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:KP1_antigen" name="KP1 antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">KP1 antigen</Term>
        <Codes>
          <Code code="C0246447" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD68_antigen_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD109_protein_human" name="CD109 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD109 protein, human</Term>
        <Term>CD109 antigen (Gov platelet alloantigens), human</Term>
        <Term>CD109 antigen, human</Term>
        <Term>8A3 antigen, human</Term>
        <Codes>
          <Code code="C0907895" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:HPA-15a_protein_human, OTE:HPA-15b_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Child_Preschool" name="Child, Preschool">
        <Definition>A child between the ages of 2 and 5.</Definition>
        <Definition>a human child aged 1 through 5 years of age; may include kindergarten age group; also index with appropriate human and clinical research terms.</Definition>
        <Definition>Students from infancy to entrance in kindergarten or 1st grade.</Definition>
        <SemanticType code="T100" name="Age Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Child, Preschool</Term>
        <Term>Children, Preschool</Term>
        <Term>Preschool Children</Term>
        <Term>Preschool Child</Term>
        <Codes>
          <Code code="C0008100" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Child</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Integrin_alphav" name="Integrin, alphav">
        <Definition>Integrin alpha V (1148 aa, 116 kD) is a cell adhesion process protein that is encoded by the human ITGAV gene and may have a role in cell-matrix adhesion.</Definition>
        <Definition>An alpha integrin with a molecular weight of 160-kDa that is found in a variety of cell types. It undergoes posttranslational cleavage into a heavy and a light chain that are connected by disulfide bonds. Integrin alphaV can combine with several different beta subunits to form heterodimers that generally bind to RGD sequence-containing extracellular matrix proteins.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Integrin, alphav</Term>
        <Term>Antigens, CD51</Term>
        <Term>CD51 Antigen</Term>
        <Term>Antigen, CD51</Term>
        <Term>alpha V, Integrin</Term>
        <Term>CD 051 ANTIGENS</Term>
        <Term>CD51 Antigens</Term>
        <Term>Integrin alphaV</Term>
        <Term>alpha(V) Integrin</Term>
        <Term>alphaV, Integrin</Term>
        <Term>Integrin alpha V</Term>
        <Term>alphav Integrin</Term>
        <Term>INTEGRIN ALPHA V</Term>
        <Term>ANTIGENS CD 051</Term>
        <Codes>
          <Code code="C0253930" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:endopeptidase_24_11_Bombyx" name="endopeptidase 24.11, Bombyx">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">endopeptidase 24.11, Bombyx</Term>
        <Codes>
          <Code code="C1101636" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Neprilysin</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly49s3_protein_rat" name="Ly49s3 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly49s3 protein, rat</Term>
        <Codes>
          <Code code="C3711912" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:acarboxy_prothrombin" name="acarboxy prothrombin">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">acarboxy prothrombin</Term>
        <Term>descarboxyprothrombin</Term>
        <Term>des-gamma-carboxyprothrombin</Term>
        <Term>Acarboxyprothrombin</Term>
        <Term>des(gamma-carboxy)prothrombin</Term>
        <Term>acarboxyprothrombin</Term>
        <Term>decarboxyprothrombin</Term>
        <Term>pre-blood-coagulation factor II</Term>
        <Term>des-gamma-carboxy prothrombin</Term>
        <Term>PIVKA II</Term>
        <Term>DCP (prothrombin)</Term>
        <Term>non-carboxylated factor II</Term>
        <Term>PIVKA-II (protein induced by vitamin K absence or antagonist-II)</Term>
        <Term>PIVKA-II</Term>
        <Term>descarboxylated prothrombin</Term>
        <Codes>
          <Code code="C0950248" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:angiotensin_converting_enzyme_2" name="angiotensin converting enzyme 2">
        <Definition>Angiotensin-converting enzyme 2 (805 aa, ~92 kDa) is encoded by the human ACE2 gene. This protein plays a role in both vasodilation and protein cleavage.</Definition>
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">angiotensin converting enzyme 2</Term>
        <Term>ACE-related carboxypeptidase</Term>
        <Term>ACE2 enzyme</Term>
        <Term>Angiotensin-Converting Enzyme 2</Term>
        <Term>ACE-Related Carboxypeptidase</Term>
        <Term>Angiotensin-Converting Enzyme Homolog</Term>
        <Term>Angiotensin-converting enzyme-related carboxypeptidase</Term>
        <Term>ACEH</Term>
        <Term>EC 3.4.17.23</Term>
        <Term>Metalloprotease MPROT15</Term>
        <Codes>
          <Code code="C0960880" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Peptidyl_Dipeptidase_A</Relation>
          <Relation name="Narrower">OTE:ACE2_protein_human, OTE:Ace2_protein_mouse, OTE:Ace2_protein_rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:validity_design" name="validity design">
        <Definition>Validating that the device meets the user's needs and intended uses.</Definition>
        <Definition>Works consisting of research using processes by which the reliability and relevance of a procedure for a specific purpose are established. [MeSH_2014]</Definition>
        <SemanticType code="T169" name="Functional Concept"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">validity design</Term>
        <Term>validity trials</Term>
        <Term>validation study</Term>
        <Term>validity study</Term>
        <Term>validation studies</Term>
        <Term>validity studies</Term>
        <Term>Device Design Validation Evaluation Method</Term>
        <Term>validity designs</Term>
        <Term>DESIGN VALIDATION</Term>
        <Term>validity trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#validity_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd36_protein_rat" name="Cd36 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd36 protein, rat</Term>
        <Term>CD36 antigen, rat</Term>
        <Codes>
          <Code code="C1256767" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD36</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SD_Rat_Strain" name="SD, Rat Strain">
        <Definition>Derived from Wistar rats at Sprague-Dawley farms, this rat strain is characterized by a calm temperament which lends itself to ease of handling. This rat strain has the following anatomical features: absent gallbladder, a one-lobed left lung and a four-lobed right lunch, the inability to vomit, and the production of dark colored eye secretions during periods of stress.</Definition>
        <Definition>Derived from Wistar rats at Sprague-Dawley farms, this rat strain is characterized by a calm temperament which lends itself to ease of handling. This rat strain has the following anatomical features: absent gallbladder, a one-lobed left lung and a four-lobed right lunch, the inability to vomit, and the production of dark colored eye secretions during periods of stress. The SD rat has good breeding performance and a lifespan of 2.5-3.5 years.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SD, Rat Strain</Term>
        <Term>SPRAGUE-DAWLEY</Term>
        <Term>Sprague-Dawley</Term>
        <Codes>
          <Code code="C76189" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:complement_activation_blocker_2_human" name="complement activation blocker 2, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">complement activation blocker 2, human</Term>
        <Term>CAB-2 protein, human</Term>
        <Term>complement activation blocker-2 protein, human</Term>
        <Term>complement activation blocker 2 protein, human</Term>
        <Codes>
          <Code code="C0915519" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Man" name="Man">
        <Definition>A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)</Definition>
        <Definition>An adult, male human.</Definition>
        <Definition>Human males as cultural, psychological, sociological, political, and economic entities.</Definition>
        <Definition>&lt;p&gt;Male&lt;/p&gt;</Definition>
        <Definition>use in conjunction with a disease, disorder, dysfunction, body system, or function which is gender specific.</Definition>
        <Definition>Used for all-male populations when sex is pertinent to the focus of the study. For comparison of sexes use HUMAN SEX DIFFERENCES.</Definition>
        <Definition>A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both.</Definition>
        <SemanticType code="T032" name="Organism Attribute"/>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Man</Term>
        <Term>men</Term>
        <Term>Male structure (body structure)</Term>
        <Term>MALE</Term>
        <Term>Male (finding)</Term>
        <Term>male gender</Term>
        <Term>Male</Term>
        <Term>Male structure</Term>
        <Term>human male</Term>
        <Term>males</Term>
        <Term>Sex Male</Term>
        <Term>M</Term>
        <Term>man</Term>
        <Term>Male individual, NOS</Term>
        <Term>male</Term>
        <Term>Male Gender</Term>
        <Term>Males (Human)</Term>
        <Term>Male population group</Term>
        <Term>Man (person)</Term>
        <Term>MAN</Term>
        <Term>Human Males</Term>
        <Term>MALE SEX</Term>
        <Term>Male, NOS</Term>
        <Term>Male individual</Term>
        <Term>Males</Term>
        <Term>sex male</Term>
        <Term>Male Gender [Disease/Finding]</Term>
        <Term>Human, Male</Term>
        <Term>Men</Term>
        <Codes>
          <Code code="C0086582" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MRL_MpJ_Mouse" name="MRL/MpJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MRL/MpJ Mouse</Term>
        <Term>MRL/MpJ</Term>
        <Codes>
          <Code code="C37413" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Age_Groups" name="Age Groups">
        <Definition>general term for grouping age group terms; do not index.</Definition>
        <Definition>a general term for grouping human age group terms; prefer NTs.</Definition>
        <Definition>Subgroups of populations based on age.</Definition>
        <Definition>Persons classified by age from birth (INFANT, NEWBORN) to octogenarians and older (AGED, 80 AND OVER).</Definition>
        <SemanticType code="T201" name="Clinical Attribute"/>
        <SemanticType code="T100" name="Age Group"/>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Age Groups</Term>
        <Term>Groups, Age</Term>
        <Term>Age Group</Term>
        <Term>age group</Term>
        <Term>Age Group Unspecified</Term>
        <Term>human age group</Term>
        <Term>Age group:Type:Point in time:^Patient:Ordinal</Term>
        <Term>Age group</Term>
        <Term>Group, Age</Term>
        <Term>Age groups</Term>
        <Term>Human Age Group</Term>
        <Term>Age Cohort</Term>
        <Term>age groups</Term>
        <Term>Age group:Type:Pt:^Patient:Ord</Term>
        <Codes>
          <Code code="C1830159" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Age_Category</Relation>
          <Relation name="Narrower">OTE:Adolescent, OTE:Child, OTE:Adults, OTE:Infant</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Animal" name="Animal">
        <Definition>Multicellular organisms of the kingdom Animalia, differing from plants in certain typical characteristics such as capacity for locomotion, non-photosynthetic metabolism, pronounced response to stimuli, restricted growth, and fixed bodily structure, such as wild or farm animals, reptiles, birds, fish and mammals.</Definition>
        <Definition>A non-human living organism that has membranous cell walls, requires oxygen and organic foods, and is capable of voluntary movement, as distinguished from a plant or mineral. EXAMPLE(S): dog, cat, mouse, microorganism.</Definition>
        <Definition>Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.</Definition>
        <Definition>A living organism that has membranous cell walls, requires oxygen and organic foods, and is capable of voluntary movement, as distinguished from a plant or mineral.</Definition>
        <Definition>&lt;p&gt;A living subject from the animal kingdom.&lt;/p&gt;</Definition>
        <Definition>Conceptually broad term. Use a more specific term if possible (e.g., VERTEBRATES, MAMMALS, DOGS).</Definition>
        <Definition>Jednobuněčné nebo mnohobuněčné heterotrofní organismy, které mají smyslové vnímání a schopnost volního pohybu. Ve starším modelu pěti živočišných říší byla Animalia jednou z těchto říší. V novém modelu tří domén představují Animalia jednu z mnoha skupin domény EUKARYOTA.</Definition>
        <Definition>multicellular organisms whose classification is based on tissues or organ arrangement; heterotrophic; use sexual reproduction in which a fertilized egg develops in stages; vertebrate and invertebrate types; index specific animal when possible.</Definition>
        <SemanticType code="T008" name="Animal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Animal</Term>
        <Term>Animalia</Term>
        <Term>animal kingdom</Term>
        <Term>Animals</Term>
        <Term>Kingdom Animalia</Term>
        <Term>animals</Term>
        <Term>animal</Term>
        <Term>Animal, NOS</Term>
        <Term>Kingdom Animalia (organism)</Term>
        <Term>multicellular animals</Term>
        <Term>animalia</Term>
        <Term>ANIMAL</Term>
        <Codes>
          <Code code="C14182" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Species_Category</Relation>
          <Relation name="Narrower">OTE:Arthropoda, OTE:Vertebrata, OTE:Nematoda</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:L985P_protein_human" name="L985P protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">L985P protein, human</Term>
        <Codes>
          <Code code="C1567266" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD23</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:phase_I_trial" name="phase I trial">
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">phase I trial</Term>
        <Term>Trial Phase 1</Term>
        <Term>Clinical Trials, Phase I</Term>
        <Term>Early-Stage Clinical Trials</Term>
        <Term>Phase I Study</Term>
        <Term>Phase I Protocol</Term>
        <Term>Phase I Clinical Trials</Term>
        <Term>Phase 1 Study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#phase_i_clinical_trial" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MECA-99_antigen" name="MECA-99 antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MECA-99 antigen</Term>
        <Term>antigen MECA99</Term>
        <Codes>
          <Code code="C0910728" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DBA_1_Mouse" name="DBA/1 Mouse">
        <Definition>Derived from crosses made by Little in 1929-1930 between DBA progenitors. The DBA/1 mouse has a q H2 haplotype and carries the Cdh23^ahl mutation that results in progressive hearing loss after 10 months of age. The DBA/1 and DBA/2 mice differ at loci Car2, Ce2, Hc, H2, If1, Lsh, Tla, and Qa3. The strain is commonly used as a model for rheumatoid arthritis as it mimics hallmarks of the human disease when immunized with type II collagen. (NCI)</Definition>
        <Definition>Derived from crosses made by Little in 1929-1930 between DBA progenitors. The DBA/1 mouse has a q H2 haplotype and carries the Cdh23^ahl mutation that results in progressive hearing loss after 10 months of age. The DBA/1 and DBA/2 mice differ at loci Car2, Ce2, Hc, H2, If1, Lsh, Tla, and Qa3. The strain is commonly used as a model for rheumatoid arthritis as it mimics hallmarks of the human disease when immunized with type II collagen.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DBA/1 Mouse</Term>
        <Term>DBA/1</Term>
        <Codes>
          <Code code="C14606" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD16_Antigens" name="CD16 Antigens">
        <Definition>Fc-Gamma Receptor III is expressed on natural killer cells, granulocytes, and monocytes. It is included in the zeta natural killer cell receptor complex. Fc receptor III is encoded by two separate genes: one for the neutrophil receptor (CD16) and another for the receptor on natural killer cells and macrophages. Some gamma-delta T-cells express CD16. Mitogenic stimulation of circulating gamma-delta T-cells results in decreased expression of CD16. (from OMIM 146740 and NCI)</Definition>
        <Definition>expressed on natural killer cells, granulocytes, and monocytes; its gene has been mapped to chromosome 1.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD16 Antigens</Term>
        <Term>CD16</Term>
        <Term>FcR III - Fc receptor III</Term>
        <Term>ANTIGENS CD 016</Term>
        <Term>CD16 - Cluster of diff ag 16</Term>
        <Term>Fc receptor III</Term>
        <Term>Fc-Gamma Receptor III</Term>
        <Term>Fc gamma RIII</Term>
        <Term>Lymphocyte antigen CD16 (substance)</Term>
        <Term>FcRIII</Term>
        <Term>Low affinity IgG Fc receptor</Term>
        <Term>Cluster of diff antigen 16</Term>
        <Term>CD16 molecule</Term>
        <Term>CD16 - Cluster of differentiation antigen 16</Term>
        <Term>Antigens, CD16</Term>
        <Term>CD 16 Antigens</Term>
        <Term>CD 016 ANTIGENS</Term>
        <Term>Leukocyte 11</Term>
        <Term>CD16 Antigen</Term>
        <Term>Leucocyte 11</Term>
        <Term>Antigens, CD 16</Term>
        <Term>gamma RIII, Fc</Term>
        <Term>Cluster of differentiation antigen 16</Term>
        <Term>Lymphocyte antigen CD16</Term>
        <Term>CD16 antigen</Term>
        <Term>CD16 Ag</Term>
        <Codes>
          <Code code="C0108747" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:AEJ_Gn_Mouse" name="AEJ/Gn Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">AEJ/Gn Mouse</Term>
        <Term>AEJ/Gn</Term>
        <Codes>
          <Code code="C37353" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:B6_Cg-Foxn1-nu_Mouse" name="B6.Cg-Foxn1-nu Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">B6.Cg-Foxn1-nu Mouse</Term>
        <Term>B6.Cg-Foxn1-nu</Term>
        <Term>C57BL/6J-Hfh1l-nu</Term>
        <Codes>
          <Code code="C15160" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Nude_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd86_protein_rat" name="Cd86 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd86 protein, rat</Term>
        <Term>B7-2 protein, rat</Term>
        <Term>CD86 antigen, rat</Term>
        <Codes>
          <Code code="C1528562" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD86</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:OX-62_antigen_rat" name="OX-62 antigen, rat">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">OX-62 antigen, rat</Term>
        <Term>OX62 antigen, rat</Term>
        <Codes>
          <Code code="C1138504" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:G7_protein_Sus_scrofa" name="G7 protein, Sus scrofa">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">G7 protein, Sus scrofa</Term>
        <Term>PNK-E antigen, porcine</Term>
        <Codes>
          <Code code="C1437811" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Complement_3b_Receptors" name="Complement 3b Receptors">
        <Definition>Molecular sites on or in some B-lymphocytes and macrophages that recognize and combine with COMPLEMENT C3B. The primary structure of these receptors reveal that they contain transmembrane and cytoplasmic domains, with their extracellular portion composed entirely of thirty short consensus repeats each having 60 to 70 amino acids.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Complement 3b Receptors</Term>
        <Term>CR 01 RECEPTORS</Term>
        <Term>RECEPTORS COMPLEMENT 03 B</Term>
        <Term>Complement receptor CRI</Term>
        <Term>C A 003B RECEPTORS</Term>
        <Term>CD35 Antigens</Term>
        <Term>Complement receptor I</Term>
        <Term>35 Antigens, CD</Term>
        <Term>CD35 Antigen</Term>
        <Term>RECEPT C3B</Term>
        <Term>RECEPT C 3B</Term>
        <Term>Antigens, CD35</Term>
        <Term>Cluster of differentiation antigen 35</Term>
        <Term>C3b Receptors</Term>
        <Term>C 3B RECEPT</Term>
        <Term>C3B RECEPT</Term>
        <Term>Receptors, Complement 3b [Chemical/Ingredient]</Term>
        <Term>Complement 3b Receptor</Term>
        <Term>CD35 Ag</Term>
        <Term>Complement receptor 1</Term>
        <Term>Antigens, CD 35</Term>
        <Term>Receptors, C3b</Term>
        <Term>CD35 - Cluster of diff ag 35</Term>
        <Term>CD 35 Antigens</Term>
        <Term>CR1 Receptors</Term>
        <Term>RECEPT CR1</Term>
        <Term>CD35</Term>
        <Term>Antigen, CD35</Term>
        <Term>CD 035 ANTIGENS</Term>
        <Term>Receptors, CR1</Term>
        <Term>CD35 - Cluster of differentiation antigen 35</Term>
        <Term>COMPLEMENT A 03 B RECEPTORS</Term>
        <Term>Complement receptor CRI (substance)</Term>
        <Term>CR1 RECEPT</Term>
        <Term>Lymphocyte antigen CD35</Term>
        <Term>CR1</Term>
        <Term>RECEPTORS CR 01</Term>
        <Term>CRI - Complement receptor I</Term>
        <Term>complement receptor 1</Term>
        <Term>Cluster of diff antigen 35</Term>
        <Term>Receptors, Complement 3b</Term>
        <Term>ANTIGENS CD 035</Term>
        <Term>c3b receptor</Term>
        <Term>complement 3b receptor</Term>
        <Term>RECEPTORS C 03 B</Term>
        <Term>Receptor, Complement 3b</Term>
        <Codes>
          <Code code="C0056182" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:CR1_protein_human, OTE:CR1L_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Coronary_Artery_Graft" name="Coronary Artery Graft">
        <Definition>A vessel segment attached to a coronary artery to facilitate myocardial perfusion. (ACC)</Definition>
        <Definition>A vessel segment attached to a coronary artery to facilitate myocardial perfusion.</Definition>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Coronary Artery Graft</Term>
        <Term>anomalous coronary artery graft with cardiopulmonary bypass (treatment)</Term>
        <Term>coronary artery graft</Term>
        <Term>Coronary artery graft</Term>
        <Term>Coronary artery graft (morphologic abnormality)</Term>
        <Term>Graft of anomalous coronary artery with cardiopulmonary bypass</Term>
        <Term>arteries coronary grafting</Term>
        <Term>CORONARY ARTERY GRAFT</Term>
        <Term>Repair of anomalous coronary artery from pulmonary artery origin; by graft, without cardiopulmonary bypass</Term>
        <Term>artery coronary grafting</Term>
        <Term>Graft of anomalous coronary artery without cardiopulmonary bypass</Term>
        <Term>anomalous coronary artery graft with cardiopulmonary bypass</Term>
        <Term>RPR ANOM CORONARY ART PULM ART ORIGIN GRF W/BYP</Term>
        <Term>Repair of anomalous coronary artery from pulmonary artery origin; by graft, with cardiopulmonary bypass</Term>
        <Term>RPR ANOM CORONARY ARTERY PULM ART ORIGIN GRAFT</Term>
        <Codes>
          <Code code="C100064" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Graft</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LY6K_protein_human" name="LY6K protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LY6K protein, human</Term>
        <Term>cancer-testis antigen lymphocyte antigen 6 complex locus K protein, human</Term>
        <Codes>
          <Code code="C2003478" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CEACAM1_protein_human" name="CEACAM1 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CEACAM1 protein, human</Term>
        <Term>CD66A antigen, human</Term>
        <Term>carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein), human</Term>
        <Codes>
          <Code code="C1610997" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD66_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LOU_C_Rat_Strain" name="LOU/C, Rat Strain">
        <Definition>Develop spontaneous plasmacytomas after about 8 months of age, with an incidence of about 30% in males and 16% in females. These develop rapidly, and may be detected by palpation. They usually develop in the ileocoecal lymph nodes, and about 60% of them synthesis monoclonal immunoglobulins (Bence-Jones proteins) of IgG1 (35%), IgE (36%) or IgA classes.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LOU/C, Rat Strain</Term>
        <Codes>
          <Code code="C14383" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Functionally-Impaired_Elderly" name="Functionally-Impaired Elderly">
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Functionally-Impaired Elderly</Term>
        <Term>Elderly, Functionally-Impaired</Term>
        <Term>Functionally Impaired Elderly</Term>
        <Codes>
          <Code code="C0079385" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Elderly_Frail</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Lice" name="Lice">
        <Definition>An order of insects comprising the sucking lice, which are blood-sucking ectoparasites of mammals. Recognized families include: Echinphthiriidae, Haematopinidae, and Pediculidae. The latter contains the medically important genera affecting humans: PEDICULUS and PHTHIRUS.</Definition>
        <Definition>small, wingless, parasitic insects; though exact taxonomy is still controversial, they can be grouped in the orders Anoplura (sucking lice), Mallophaga (biting lice), and Rhynchophthirina (elephant-lice).</Definition>
        <Definition>Zavšivení. Na člověku parazitují tři druhy vší, nejčastěji veš vlasová. Způsobuje svědění hlavy a často se šíří v dětských kolektivech. Veš šatní může přenášet některé ricketsiózy (skvrnitý tyfus). Veš ohanbí (muňka) se přenáší zejm. pohlavním stykem. K odstranění vší existují průmyslově vyráběné přípravky na bázi insekticidů, důležitá je léčba celého kolektivu. (cit. Velký lékařský slovník online, 2013 http://lekarske.slovniky.cz/ )</Definition>
        <Definition>&lt;p&gt;Lice are parasitic insects that can be found on people's heads and bodies. They survive by feeding on human blood. Lice found on each area of the body are different from each other. The three types of lice that live on humans are &lt;a href='http://www.nlm.nih.gov/medlineplus/headlice.html'&gt;head lice&lt;/a&gt;, body lice (also called clothes lice), and pubic lice ("crabs").&lt;/p&gt;&lt;p&gt;Symptoms of lice may include&lt;ul&gt;&lt;li&gt;Intense itching&lt;/li&gt;&lt;li&gt;Rash&lt;/li&gt;&lt;li&gt;Visible nits (lice eggs) or crawling lice&lt;/li&gt;&lt;/ul&gt;&lt;/p&gt;&lt;p&gt;Lice spread most commonly by close person-to-person contact. Dogs, cats, and other pets do not spread human lice. Lice move by crawling. They cannot hop or fly. If you get lice, both over-the-counter and prescription medicines are available for treatment.&lt;/p&gt;&lt;p &gt;Centers for Disease Control and Prevention&lt;/p&gt;</Definition>
        <Definition>A taxonomic order of wingless insects that are obligate ectoparasites of birds and mammals. Lice attach tightly to hair, fur, and feathers of the host organism and feed on blood, skin, and sebaceous secretions.</Definition>
        <Definition>An order of small, wingless parasitic insects, commonly known as lice. The suborders include ANOPLURA (sucking lice); AMBLYCERA; ISCHNOCERA; and Rhynchophthirina (elephant and warthog lice).</Definition>
        <Definition>Parasitic attack or subsistence on the skin by members of the order Phthiraptera, especially on humans by Pediculus humanus of the family Pediculidae. The hair of the head, eyelashes, and pubis is a frequent site of infestation. (From Dorland, 28th ed; Stedman, 26th ed)</Definition>
        <Definition>A general name for small, wingless, parasitic insects, previously of the order Phthiraptera. Though exact taxonomy is still controversial, they can be grouped in the orders ANOPLURA (sucking lice), MALLOPHAGA (biting lice), and Rhynchophthirina (elephant-lice).</Definition>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <SemanticType code="T204" name="Eukaryote"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Lice</Term>
        <Term>Lice infestation</Term>
        <Term>Phthiraptera</Term>
        <Term>ORDER ANOPLURA - SUCKING LICE</Term>
        <Term>Lice infestation, NOS</Term>
        <Term>Family Pediculidae</Term>
        <Term>Order Anoplura - sucking louse</Term>
        <Term>Infestation by Pediculus, NOS</Term>
        <Term>Lices, Sucking</Term>
        <Term>Pediculosis</Term>
        <Term>Louses, Sucking</Term>
        <Term>Order Anoplura (organism)</Term>
        <Term>Sucking Lice</Term>
        <Term>Infestation by Pediculus (disorder)</Term>
        <Term>Louse, Sucking</Term>
        <Term>Family Pediculidae (organism)</Term>
        <Term>Biting and sucking lice</Term>
        <Term>Pediculosis, unspecified</Term>
        <Term>Sucking Louses</Term>
        <Term>Pediculidae</Term>
        <Term>Lice, NOS</Term>
        <Term>louse</Term>
        <Term>Lice Infestations [Disease/Finding]</Term>
        <Term>Lice NOS</Term>
        <Term>Order Anoplura</Term>
        <Term>Pediculosis NOS</Term>
        <Term>infestation; Pediculus</Term>
        <Term>Sucking louse, NOS</Term>
        <Term>primate body lice</Term>
        <Term>lice</Term>
        <Term>Louse infestation (disorder)</Term>
        <Term>pediculosis (diagnosis)</Term>
        <Term>Sucking Lices</Term>
        <Term>Order Phthiraptera</Term>
        <Term>Louse infestation</Term>
        <Term>Sucking lice, NOS</Term>
        <Term>Lice, Sucking</Term>
        <Term>human body louse</Term>
        <Term>phthiraptera</Term>
        <Term>Infestation by Pediculus</Term>
        <Term>Infestations, Lice</Term>
        <Term>pediculosis</Term>
        <Term>lice infestation</Term>
        <Term>Louse, NOS</Term>
        <Term>Pediculoses</Term>
        <Term>Pediculus; infestation</Term>
        <Term>Order Phthiraptera (organism)</Term>
        <Term>PEDICULOSIS</Term>
        <Term>Infestation, Lice</Term>
        <Term>Louse</Term>
        <Term>pediculidae</Term>
        <Term>Anoplura</Term>
        <Term>Sucking Louse</Term>
        <Term>Family: Pediculidae</Term>
        <Term>Lice Infestations</Term>
        <Term>Anopluras</Term>
        <Term>Lice Infestation</Term>
        <Term>615-616 ORDER ANOPLURA - SUCKING LICE</Term>
        <Codes>
          <Code code="C34776" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Insect</Relation>
          <Relation name="Narrower">OTE:Human_Body_Louse, OTE:Human_Head_Louse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:comparative_study" name="comparative study">
        <Definition>Comparison of outcomes, results, responses, etc for different techniques, therapeutic approaches or other inputs.</Definition>
        <Definition>Comparison of outcomes, results, responses, etc for different techniques, therapeutic approaches or other inputs.  [Comparitive study | MeSH_2014]</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">comparative study</Term>
        <Term>comparative trials</Term>
        <Term>comparative design</Term>
        <Term>Comparative Studies</Term>
        <Term>comparative studies</Term>
        <Term>comparison study</Term>
        <Term>comparative study research</Term>
        <Term>Comparative Study</Term>
        <Term>comparative designs</Term>
        <Term>comparisons study</Term>
        <Term>comparative trial</Term>
        <Term>comparative study publication</Term>
        <Codes>
          <Code code="C0009491" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:non-randomized_comparative_design, OTE:case_comparison_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:KSN_Mouse" name="KSN Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">KSN Mouse</Term>
        <Term>KSN</Term>
        <Codes>
          <Code code="C1517650" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:BALB_c-Hfh11nu_X_DD_1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MKW_antigen" name="MKW antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MKW antigen</Term>
        <Codes>
          <Code code="C0654558" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Receptors_Interleukin-17" name="Receptors, Interleukin-17">
        <Definition>Cell surface receptors for INTERLEUKIN-17. Several subtypes of receptors have been found, each with its own in specificity for interleukin-17 subtype.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Receptors, Interleukin-17</Term>
        <Term>Interleukin-17 Receptors</Term>
        <Term>Receptors, IL-17</Term>
        <Term>Interleukin 17 Receptors</Term>
        <Term>Receptors, Interleukin 17</Term>
        <Term>RECEPTORS INTERLEUKIN 017</Term>
        <Term>IL 017 RECEPTORS</Term>
        <Term>IL-17 Receptors</Term>
        <Term>IL 17 Receptors</Term>
        <Term>INTERLEUKIN 017 RECEPTORS</Term>
        <Codes>
          <Code code="C1721056" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Il17rb_protein_mouse, OTE:IL17RA_protein_human, OTE:Interleukin_17_Receptor, OTE:Il17r_protein_mouse, OTE:IL17REL_protein_human, OTE:Interleukin_17_Receptor_B, OTE:Interleukin_17_Receptor_C, OTE:Interleukin_17_Receptor_D, OTE:Interleukin_17_Receptor_E</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LEW_Rat_Strain" name="LEW, Rat Strain">
        <Definition>Of the large spectrum of 52 histologically different types of tumors, the highest incidence was observed for adenomas of the pituitary and adenomas/adenocarcinomas of the adrenal cortex in both sexes, mammary gland tumors and endometrial carcinomas (45%) in females, and C-cell adenomas/adenocarcinomas of the thyroid gland and tumors of the hemopoietic system (28%) in males (Baum et al, 1995).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LEW, Rat Strain</Term>
        <Codes>
          <Code code="C14407" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Leporidae" name="Leporidae">
        <Definition>Taxonomic family which includes rabbits and hares.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Leporidae</Term>
        <Term>Family Leporidae (organism)</Term>
        <Term>Rabbitts and Hares</Term>
        <Term>Family Leporidae</Term>
        <Term>86B FAMILY LEPORIDAE</Term>
        <Term>Leporidae Fischer, 1817</Term>
        <Term>FAMILY LEPORIDAE</Term>
        <Codes>
          <Code code="C14358" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Lagomorpha</Relation>
          <Relation name="Narrower">OTE:Rabbit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BALB_cJ_Mouse" name="BALB/cJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BALB/cJ Mouse</Term>
        <Term>BALB/cJ</Term>
        <Codes>
          <Code code="C14657" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mcam_protein_mouse" name="Mcam protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mcam protein, mouse</Term>
        <Term>CD146 protein, mouse</Term>
        <Term>melanoma cell adhesion molecule, mouse</Term>
        <Term>Muc18 protein, mouse</Term>
        <Codes>
          <Code code="C1566889" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD146_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Landrace_Pig" name="Landrace Pig">
        <Definition>Developed in Denmark by crossing native pigs with the Large White pig breed. The Landrace pig was imported into the UK in 1949 and disseminated worldwide beginning in the 1950s. This breed is characterized by white skin and the absence of black hair as well as lop ears and a long middle, light forequarter. The Landrace breed is susceptible to Porcine stress syndrome and malignant hyperthermia under anesthetic. This is one of the largest breeds in use in biomedical research. (NCI)</Definition>
        <Definition>Developed in Denmark by crossing native pigs with the Large White pig breed. The Landrace pig was imported into the UK in 1949 and disseminated worldwide beginning in the 1950s. This breed is characterized by white skin and the absence of black hair as well as lop ears and a long middle, light forequarter. The Landrace breed is susceptible to Porcine stress syndrome and malignant hyperthermia under anesthetic. This is one of the largest breeds in use in biomedical research.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Landrace Pig</Term>
        <Term>Landrace pig, NOS</Term>
        <Term>Landrace pig</Term>
        <Term>Landrace-cross</Term>
        <Term>Landrace pig (organism)</Term>
        <Term>LANDRACE-CROSS</Term>
        <Codes>
          <Code code="C0324255" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Pig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MMEL1_protein_human" name="MMEL1 protein, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MMEL1 protein, human</Term>
        <Term>neprilysin II, human</Term>
        <Term>membrane metallo-endopeptidase-like 2 protein, human</Term>
        <Term>neprilysin-2, human</Term>
        <Term>MMEL2 protein, human</Term>
        <Term>membrane metallo-endopeptidase-like 1 protein, human</Term>
        <Codes>
          <Code code="C1097834" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Neprilysin</Relation>
          <Relation name="Narrower">OTE:NEP2delta_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Rat_Strains" name="Rat Strains">
        <Definition>Breeds of rats utilized for biological research.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Rat Strains</Term>
        <Term>Common Rat Strains</Term>
        <Codes>
          <Code code="C14417" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CDR3_AME" name="CDR3.AME(82-89)">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CDR3.AME(82-89)</Term>
        <Codes>
          <Code code="C0911000" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD4</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CE_J_Mouse" name="CE/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CE/J Mouse</Term>
        <Term>CE/J</Term>
        <Codes>
          <Code code="C15109" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Bovidae" name="Bovidae">
        <Definition>Taxonomic family which includes domestic cattle, goats, and sheep.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Bovidae</Term>
        <Term>Family Bovidae</Term>
        <Term>FAMILY BOVIDAE - BOVIDS</Term>
        <Term>Bovids</Term>
        <Term>Family Bovidae (organism)</Term>
        <Term>Bovid</Term>
        <Term>8B9-8C3 FAMILY BOVIDAE - BOVIDS</Term>
        <Term>Bovine</Term>
        <Codes>
          <Code code="C14323" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Artiodactyla</Relation>
          <Relation name="Narrower">OTE:Goat, OTE:Cow, OTE:Sheep</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:New_Zealand_Black_Rabbit" name="New Zealand Black Rabbit">
        <Definition>A New Zealand rabbit with black coat color and coat genotype Si, VV, E, D, C, B. The New Zealand black is commonly utilized in biomedical research in a variety of studies including developmental toxicity studies, toxicology studies, asthma research, and antibody production.</Definition>
        <Definition>A New Zealand rabbit with black coat color and coat genotype Si, VV, E, D, C, B.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">New Zealand Black Rabbit</Term>
        <Term>New Zealand black rabbit (organism)</Term>
        <Term>NEW ZEALAND BLACK</Term>
        <Term>New Zealand black rabbit</Term>
        <Term>New Zealand Black</Term>
        <Codes>
          <Code code="C77109" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rabbit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:patient_survival" name="patient survival">
        <Definition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.</Definition>
        <Definition>Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.</Definition>
        <Definition>In cancer, survivorship covers the physical, psychosocial, and economic issues of cancer, from diagnosis until the end of life. It focuses on the health and life of a person with cancer beyond the diagnosis and treatment phases. Survivorship includes issues related to the ability to get health care and follow-up treatment, late effects of treatment, second cancers, and quality of life. Family members, friends, and caregivers are also part of the survivorship experience.</Definition>
        <Definition>Persons under medical care. Use a more specific term if possible. Consider also CLIENTS.</Definition>
        <Definition>&lt;p&gt;&lt;b&gt;Description:&lt;/b&gt;A Role of a LivingSubject (player) as a recipient of health care services from a healthcare provider (scoper).&lt;/p&gt;</Definition>
        <Definition>A patient is the subject of observations.</Definition>
        <Definition>Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival.</Definition>
        <Definition>Jednotlivci, kteří jsou účastni v systému zdravotní péče za účelem přijímání terapeutických, diagnostických nebo preventivních procedur.</Definition>
        <Definition>Person under a physician's care for a particular disease or condition. NOTE: A subject in a clinical trial is not necessarily a patient, but a patient in a clinical trial is a subject. See also subject, trial subject, healthy volunteer. Often used interchangeably as a synonym for subject but healthy volunteers are not, strictly speaking, patients.</Definition>
        <Definition>&lt;p&gt;The recipient for the service(s) and/or product(s) when they are not the covered party.&lt;/p&gt;</Definition>
        <Definition>A non-human animal that is a subject in a study.</Definition>
        <Definition>&lt;p&gt;A specimen that has been collected from a patient.&lt;/p&gt;</Definition>
        <SemanticType code="T052" name="Activity"/>
        <SemanticType code="T101" name="Patient or Disabled Group"/>
        <SemanticType code="T169" name="Functional Concept"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T031" name="Body Substance"/>
        <SemanticType code="T078" name="Idea or Concept"/>
        <SemanticType code="T001" name="Organism"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">patient survival</Term>
        <Term>LAY USER/PATIENT</Term>
        <Term>Specimen Source Codes - Patient</Term>
        <Term>Veterinary Patient</Term>
        <Term>Survival</Term>
        <Term>Report source - Patient</Term>
        <Term>survivals</Term>
        <Term>Specimen Type - Patient</Term>
        <Term>Mail Claim Party - Patient</Term>
        <Term>*^patient</Term>
        <Term>Role Code - Patient recipient</Term>
        <Term>Role Class - patient</Term>
        <Term>survivorship</Term>
        <Term>Patients</Term>
        <Term>Relationship modifier - Patient</Term>
        <Term>Survivorship</Term>
        <Term>Continuance of life</Term>
        <Term>Role Code - Patient specimen</Term>
        <Term>patients</Term>
        <Term>survival</Term>
        <Term>Survivorship Issues</Term>
        <Term>survival aspects</Term>
        <Term>Patient</Term>
        <Term>Disabled Person Code - Patient</Term>
        <Term>patient</Term>
        <Term>Patient (person)</Term>
        <Term>PATIENT</Term>
        <Term>^Patient</Term>
        <Term>PT</Term>
        <Codes>
          <Code code="C0030705" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Outcome_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:cohort_before-after_design" name="cohort before-after design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">cohort before-after design</Term>
        <Term>cohort before-after trials</Term>
        <Term>cohort before-and-after study</Term>
        <Term>cohort before-after designs</Term>
        <Term>cohort before-after study</Term>
        <Term>cohort before-and-after trials</Term>
        <Term>cohort before-and-after studies</Term>
        <Term>cohort before-after trial</Term>
        <Term>cohort before-and-after trial</Term>
        <Term>cohort before-and-after design</Term>
        <Term>cohort before-after studies</Term>
        <Term>cohort before-and-after designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#cohort_before-after_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:before-after_design</Relation>
          <Relation name="Narrower">OTE:controlled_cohort_before-after_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Rodentia" name="Rodentia">
        <Definition>rodents; the largest order of placental mammals (class Eutheria), all possessing one pair of chisel-like upper incisors for gnawing and flat-crowned premolars and molars for grinding; it includes the mice, rats, guinea pigs, squirrels, beavers, and many more.</Definition>
        <Definition>The taxonomic order of mammals that includes mice, rats, guinea pigs, squirrels, beavers, and many others.</Definition>
        <Definition>A mammalian order which consists of 29 families and many genera.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Rodentia</Term>
        <Term>Rodentias</Term>
        <Term>87 ORDER RODENTIA - RODENTS OR GNAWING ANIMALS</Term>
        <Term>Order Rodentia (organism)</Term>
        <Term>Order Rodentia</Term>
        <Term>Rodent, NOS</Term>
        <Term>Mammals, Rodents</Term>
        <Term>rodents</Term>
        <Term>Rodents</Term>
        <Term>rodentia</Term>
        <Term>rodent</Term>
        <Term>ORDER RODENTIA - RODENTS OR GNAWING ANIMALS</Term>
        <Term>Rodent</Term>
        <Codes>
          <Code code="C0035804" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mammalia</Relation>
          <Relation name="Narrower">OTE:Muridae, OTE:Caviidae, OTE:Cotton_Rat, OTE:Cricetidae, OTE:Chinchillidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Integrin_alpha6" name="Integrin, alpha6">
        <Definition>An integrin alpha subunit that primarily associates with INTEGRIN BETA1 or INTEGRIN BETA4 to form laminin-binding heterodimers. Integrin alpha6 has two alternatively spliced isoforms: integrin alpha6A and integrin alpha6B, which differ in their cytoplasmic domains and are regulated in a tissue-specific and developmental stage-specific manner.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Integrin, alpha6</Term>
        <Term>alpha6, Integrin</Term>
        <Term>CD 049F ANTIGENS</Term>
        <Term>INTEGRIN ALPHA A 06</Term>
        <Term>alpha(6) Integrin</Term>
        <Term>ANTIGENS CD 049F</Term>
        <Term>CD49f Antigens</Term>
        <Term>CD49f Antigen</Term>
        <Term>Antigen, CD49f</Term>
        <Term>Integrin alpha6</Term>
        <Term>Antigens, CD49f</Term>
        <Term>alpha6 Integrin</Term>
        <Codes>
          <Code code="C0289325" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Integrin_alpha6B, OTE:ITGA6_protein_human, OTE:Integrin_alpha6A</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Integrin_alpha5" name="Integrin, alpha5">
        <Definition>This integrin alpha subunit combines with INTEGRIN BETA1 to form a receptor (INTEGRIN ALPHA5BETA1) that binds FIBRONECTIN and LAMININ. It undergoes posttranslational cleavage into a heavy and a light chain that are connected by disulfide bonds.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Integrin, alpha5</Term>
        <Term>alpha5, Integrin</Term>
        <Term>VLA-5 alpha Chain</Term>
        <Term>Chain, VLA-5 alpha</Term>
        <Term>Platelet Glycoprotein Ic</Term>
        <Term>ANTIGENS CD 049E</Term>
        <Term>Antigen, CD49e</Term>
        <Term>Antigens, CD49e</Term>
        <Term>Glycoprotein Ic, Platelet</Term>
        <Term>CD49e Antigen</Term>
        <Term>INTEGRIN ALPHA A 05</Term>
        <Term>VLA 5 alpha Chain</Term>
        <Term>alphaF, Integrin</Term>
        <Term>CD49e Antigens</Term>
        <Term>alpha Chain, VLA-5</Term>
        <Term>Ic, Platelet Glycoprotein</Term>
        <Term>alpha5 Integrin</Term>
        <Term>Integrin alphaF</Term>
        <Term>CD 049E ANTIGENS</Term>
        <Term>Integrin alpha5</Term>
        <Term>alpha(5) Integrin</Term>
        <Codes>
          <Code code="C0298340" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Integrin_alpha4" name="Integrin, alpha4">
        <Definition>An integrin alpha subunit that is unique in that it does not contain an I domain, and its proteolytic cleavage site is near the middle of the extracellular portion of the polypeptide rather than close to the membrane as in other integrin alpha subunits.</Definition>
        <Definition>Integrin alpha-4 (1032 aa, ~115 kDa) is encoded by the human ITGA4 gene. This protein is involved in the mediation of both cell-cell and cell-matrix interactions in leukocytes.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Integrin, alpha4</Term>
        <Term>CD 049D ANTIGENS</Term>
        <Term>CD49d Antigen</Term>
        <Term>Antigens, CD49d</Term>
        <Term>ANTIGENS CD 049D</Term>
        <Term>INTEGRIN ALPHA A 04</Term>
        <Term>alpha4 Integrin</Term>
        <Term>Antigen, CD49d</Term>
        <Term>CD49d Antigens</Term>
        <Term>Integrin alpha4</Term>
        <Codes>
          <Code code="C0252194" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD300LG_protein_human" name="CD300LG protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD300LG protein, human</Term>
        <Term>CD300 antigen like family member G, human</Term>
        <Codes>
          <Code code="C3710626" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD48_protein_human" name="CD48 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD48 protein, human</Term>
        <Term>BCM1 antigen, human</Term>
        <Term>Blast-1 antigen, human</Term>
        <Term>B-cell membrane protein, human</Term>
        <Term>OX45 antigen, human</Term>
        <Term>CD48 antigen, human</Term>
        <Term>Blast-1 protein, human</Term>
        <Term>LOC65424 protein, human</Term>
        <Codes>
          <Code code="C0081820" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD48_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:INSR_protein_human" name="INSR protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">INSR protein, human</Term>
        <Term>insulin receptor, human</Term>
        <Term>CD220 antigen, human</Term>
        <Codes>
          <Code code="C1448132" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Insulin_receptor_beta_subunit_human, OTE:insulin_receptor_alpha_subunit_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:AFPep_peptide" name="AFPep peptide">
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">AFPep peptide</Term>
        <Term>TOVNO peptide</Term>
        <Codes>
          <Code code="C2717473" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Integrin_alpha2" name="Integrin, alpha2">
        <Definition>An integrin alpha subunit that primarily combines with INTEGRIN BETA1 to form the INTEGRIN ALPHA2BETA1 heterodimer. It contains a domain which has homology to collagen-binding domains found in von Willebrand factor.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Integrin, alpha2</Term>
        <Term>alpha2 Integrin</Term>
        <Term>alpha Chain, VLA-2</Term>
        <Term>GPIa</Term>
        <Term>Antigens, CD49b</Term>
        <Term>Platelet Glycoprotein Ia</Term>
        <Term>Glycoprotein Ia, Platelet</Term>
        <Term>INTEGRIN ALPHA A 02</Term>
        <Term>Integrin alpha2</Term>
        <Term>CD49b Antigen</Term>
        <Term>ANTIGENS CD 049B</Term>
        <Term>CD49b Antigens</Term>
        <Term>VLA 2 alpha Chain</Term>
        <Term>VLA-2 alpha Chain</Term>
        <Term>Antigen, CD49b</Term>
        <Term>alpha2, Integrin</Term>
        <Term>Chain, VLA-2 alpha</Term>
        <Term>CD 049B ANTIGENS</Term>
        <Codes>
          <Code code="C0249229" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:ITGA2B_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CBA_CaJ_Mouse" name="CBA/CaJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CBA/CaJ Mouse</Term>
        <Term>CBA/CaJ</Term>
        <Codes>
          <Code code="C37398" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Integrin_alpha1" name="Integrin, alpha1">
        <Definition>An integrin alpha subunit that binds COLLAGEN and LAMININ though its I domain. It combines with INTEGRIN BETA1 to form the heterodimer INTEGRIN ALPHA1BETA1.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Integrin, alpha1</Term>
        <Term>alpha1 Integrin</Term>
        <Term>Integrin alpha1</Term>
        <Term>VLA 1 alpha Subunit</Term>
        <Term>CD49a Antigens</Term>
        <Term>Antigens, CD49a</Term>
        <Term>INTEGRIN ALPHA A 01</Term>
        <Term>CD49a Antigen</Term>
        <Term>CD 049A ANTIGENS</Term>
        <Term>Antigen, CD49a</Term>
        <Term>Integrin alpha(1)</Term>
        <Term>ANTIGENS CD 045A</Term>
        <Term>VLA-1 alpha Subunit</Term>
        <Term>alpha Subunit, VLA-1</Term>
        <Codes>
          <Code code="C0254613" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Receptor_Macrophage_Colony-Stimulating_Factor" name="Receptor, Macrophage Colony-Stimulating Factor">
        <Definition>Macrophage colony-stimulating factor 1 receptor (972 aa, 108 kD) is a cell division process protein that is encoded by the human CSF1R gene and has roles in macrophage differentiation and regulation of cell proliferation.</Definition>
        <Definition>A receptor for MACROPHAGE COLONY-STIMULATING FACTOR encoded by the c-fms proto-oncogene (GENES, FMS). It contains an intrinsic protein-tyrosine kinase activity. When activated the receptor undergoes autophosphorylation, phosphorylation of down-stream signaling molecules and rapid down-regulation.</Definition>
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Receptor, Macrophage Colony-Stimulating Factor</Term>
        <Term>Receptor, CSF-1</Term>
        <Term>ANTIGENS CD 115</Term>
        <Term>Macrophage Colony-Stimulating Factor Receptors</Term>
        <Term>Receptor, CSF 1</Term>
        <Term>CSF-1 Receptor</Term>
        <Term>M-CSF Receptors</Term>
        <Term>M CSF RECEPT</Term>
        <Term>CSF 1 RECEPT</Term>
        <Term>Receptors, CSF-1</Term>
        <Term>Receptors, Macrophage Colony-Stimulating Factor</Term>
        <Term>c fms Protein</Term>
        <Term>Macrophage Colony Stimulating Factor Receptors</Term>
        <Term>CD 115 ANTIGENS</Term>
        <Term>Antigen, CD115</Term>
        <Term>RECEPT CSF 1</Term>
        <Term>Proto-Oncogene Protein fms</Term>
        <Term>CD115 Antigen</Term>
        <Term>CSF-1 Receptors</Term>
        <Term>fms Proto-Oncogene Protein</Term>
        <Term>Receptors, CSF 1</Term>
        <Term>Receptors, Macrophage Colony Stimulating Factor</Term>
        <Term>fms Proto Oncogene Protein</Term>
        <Term>RECEPTOR CSF A 01</Term>
        <Term>CD115 Antigens</Term>
        <Term>Proto-Oncogene Protein, fms</Term>
        <Term>CSF A 01 RECEPTOR</Term>
        <Term>Receptors, M-CSF</Term>
        <Term>Antigens, CD115</Term>
        <Term>c-fms Protein</Term>
        <Term>Receptor, Macrophage Colony Stimulating Factor</Term>
        <Term>RECEPT MCSF</Term>
        <Term>Receptors, M CSF</Term>
        <Term>RECEPT M CSF</Term>
        <Codes>
          <Code code="C0080092" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:descriptive_study" name="descriptive study">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">descriptive study</Term>
        <Term>descriptive research</Term>
        <Term>descriptive trials</Term>
        <Term>descriptive trial</Term>
        <Term>descriptive designs</Term>
        <Term>descriptive studies</Term>
        <Term>descriptive design</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#descriptive_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SPE_Pas_Mouse" name="SPE/Pas Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SPE/Pas Mouse</Term>
        <Term>SPE/Pas</Term>
        <Codes>
          <Code code="C37439" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:controlled_cohort_before-after_design" name="controlled cohort before-after design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">controlled cohort before-after design</Term>
        <Term>controlled cohort before-and-after studies</Term>
        <Term>controlled cohort before-and-after design</Term>
        <Term>controlled cohort before-after studies</Term>
        <Term>controlled cohort before-and-after trial</Term>
        <Term>controlled cohort before-after study</Term>
        <Term>controlled cohort before-and-after study</Term>
        <Term>controlled cohort before-after designs</Term>
        <Term>controlled cohort before-after trial</Term>
        <Term>controlled cohort before-and-after designs</Term>
        <Term>controlled cohort before-and-after trials</Term>
        <Term>controlled cohort before-after trials</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#controlled_cohort_before-after_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cohort_before-after_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Natural_Cytotoxicity_Triggering_Receptor_3" name="Natural Cytotoxicity Triggering Receptor 3">
        <Definition>This gene plays a role in natural killer cell function.</Definition>
        <Definition>Natural cytotoxicity triggering receptor 3 (201 aa, ~22 kDa) is encoded by the human NCR3 gene. This protein plays a role in natural killer cell function.</Definition>
        <Definition>A 30 kDa stimulatory receptor found on resting and activated NATURAL KILLER CELLS.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Natural Cytotoxicity Triggering Receptor 3</Term>
        <Term>NK p30 Receptor</Term>
        <Term>CD337</Term>
        <Term>CD337 Antigens</Term>
        <Term>ACTIVATING NATURAL KILLER RECEPTOR p30</Term>
        <Term>Antigens, CD337</Term>
        <Term>NCR3 gene</Term>
        <Term>NCR3</Term>
        <Term>natural cytotoxicity triggering receptor 3</Term>
        <Term>Lymphocyte Antigen 117</Term>
        <Term>NK-p30 Receptor</Term>
        <Term>NKp30</Term>
        <Term>CD337 Antigen</Term>
        <Term>Activating NK-A1 Receptor</Term>
        <Term>CD337 ANTIGEN</Term>
        <Term>Antigen, CD337</Term>
        <Term>1C7</Term>
        <Term>p30 Natural Killer Cell Receptor</Term>
        <Term>NCR3 Gene</Term>
        <Term>Natural Cytotoxicity Triggering Receptor 3 Gene</Term>
        <Term>Natural Killer Cell p30-Related Protein</Term>
        <Term>Receptor, NK-p30</Term>
        <Term>Activating Natural Killer Receptor p30</Term>
        <Term>NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3</Term>
        <Term>NKp30 Receptor</Term>
        <Term>Receptor, NKp30</Term>
        <Term>Natural Cytotoxicity Triggering Receptor 3 [Chemical/Ingredient]</Term>
        <Codes>
          <Code code="C2757035" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:NCR3_protein_human, OTE:Ncr3_protein_rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Natural_Cytotoxicity_Triggering_Receptor_2" name="Natural Cytotoxicity Triggering Receptor 2">
        <Definition>This gene is involved in natural killer cell function.</Definition>
        <Definition>Natural cytotoxicity triggering receptor 2 (276 aa, ~30 kDa) is encoded by the human NCR2 gene. This protein is involved in natural killer cell function.</Definition>
        <Definition>A 44-kD stimulatory receptor found on activated NATURAL KILLER CELLS. It has specificity for VIRAL HEMAGGLUTININS that are expressed on infected cells.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Natural Cytotoxicity Triggering Receptor 2</Term>
        <Term>Receptor, NK-p44</Term>
        <Term>NK-p44 Receptor</Term>
        <Term>NK Cell-Activating Receptor</Term>
        <Term>NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2</Term>
        <Term>NK p44 Receptor</Term>
        <Term>Antigens, CD336</Term>
        <Term>LY95</Term>
        <Term>Natural Cytotoxicity Triggering Receptor 2 [Chemical/Ingredient]</Term>
        <Term>ACTIVATING NK RECEPTOR NKp44</Term>
        <Term>Lymphocyte Antigen 95 Homolog</Term>
        <Term>Antigen, CD336</Term>
        <Term>NKp44 Receptor</Term>
        <Term>p44 Natural Killer Cell Receptor</Term>
        <Term>NCR2 gene</Term>
        <Term>CD336 Antigen</Term>
        <Term>CD336</Term>
        <Term>NK-p44</Term>
        <Term>LYMPHOCYTE ANTIGEN 95, MOUSE, HOMOLOG OF</Term>
        <Term>natural cytotoxicity triggering receptor 2</Term>
        <Term>Receptor, NKp44</Term>
        <Term>NCR2</Term>
        <Term>NKp44</Term>
        <Term>Natural Cytotoxicity Triggering Receptor 2 Gene</Term>
        <Term>NCR2 Gene</Term>
        <Term>CD336 Antigens</Term>
        <Term>Natural Killer Cell p44-Related Protein</Term>
        <Codes>
          <Code code="C2757034" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:NCR2_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:PTPRC_protein_human" name="PTPRC protein, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">PTPRC protein, human</Term>
        <Term>protein tyrosine phosphatase, receptor type C protein, human</Term>
        <Term>protein tyrosine phosphatase, receptor type, C protein, human</Term>
        <Term>CD45 antigen, human</Term>
        <Codes>
          <Code code="C1870006" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD45_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Natural_Cytotoxicity_Triggering_Receptor_1" name="Natural Cytotoxicity Triggering Receptor 1">
        <Definition>A 46-kD stimulatory receptor found on resting and activated NATURAL KILLER CELLS. It has specificity for VIRAL HEMAGGLUTININS that are expressed on infected cells.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Natural Cytotoxicity Triggering Receptor 1</Term>
        <Term>NCR1</Term>
        <Term>CD335 Antigen</Term>
        <Term>NCR1 gene</Term>
        <Term>LYMPHOCYTE ANTIGEN 94, MOUSE, HOMOLOG OF</Term>
        <Term>Natural Killer Cell p46-Related Protein</Term>
        <Term>Receptor, NK-p46</Term>
        <Term>Antigen, CD335</Term>
        <Term>Receptor, NKp46</Term>
        <Term>Natural Killer Cell p46 Related Protein</Term>
        <Term>NK-p46</Term>
        <Term>NKp46</Term>
        <Term>NKP46</Term>
        <Term>ACTIVATING NATURAL KILLER RECEPTOR p46</Term>
        <Term>CD335</Term>
        <Term>NK-p46 Receptor</Term>
        <Term>NK p46 Receptor</Term>
        <Term>NKp46 Receptor</Term>
        <Term>NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1</Term>
        <Term>Antigens, CD335</Term>
        <Term>Natural Cytotoxicity Triggering Receptor 1 [Chemical/Ingredient]</Term>
        <Term>LY94</Term>
        <Term>natural cytotoxicity triggering receptor 1</Term>
        <Term>CD335 Antigens</Term>
        <Codes>
          <Code code="C2757033" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Ncr1_protein_rat, OTE:NCR1_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SOST_protein_human" name="SOST protein, human">
        <SemanticType code="T130" name="Indicator, Reagent, or Diagnostic Aid"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SOST protein, human</Term>
        <Term>sclerosteosis protein, human</Term>
        <Term>sclerostin protein, human</Term>
        <Codes>
          <Code code="C1447914" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Genetic_Marker</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:T-cell_surface_glycoprotein_E2_human" name="T-cell surface glycoprotein E2, human">
        <Definition>CD99 antigen (185 aa, ~19 kDa) is encoded by the human CD99 gene. This protein plays a role in cell adhesion.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">T-cell surface glycoprotein E2, human</Term>
        <Term>CD99 antigen, human</Term>
        <Term>MIC2Y protein, human</Term>
        <Term>CD99X protein, human</Term>
        <Term>CD99 protein, human</Term>
        <Term>12E7 antigen, human</Term>
        <Term>MIC2X protein, human</Term>
        <Term>E2 antigen, human</Term>
        <Term>pseudoautosomal protein MIC2, human</Term>
        <Codes>
          <Code code="C0058889" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Itgae_protein_mouse" name="Itgae protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Itgae protein, mouse</Term>
        <Term>integrin alpha E1, mouse</Term>
        <Term>alpha-E1 protein, mouse</Term>
        <Term>integrin, alpha E, epithelial-associated protein, mouse</Term>
        <Term>integrin alphaE1</Term>
        <Term>CD103 protein, mouse</Term>
        <Codes>
          <Code code="C0663023" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_E_integrins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD109_protein_mouse" name="CD109 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD109 protein, mouse</Term>
        <Term>CD109 antigen, mouse</Term>
        <Codes>
          <Code code="C2933068" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Leghorn_Chicken" name="Leghorn Chicken">
        <Definition>A small, commonly white-colored breed of poultry that is renowned for its ability to produce up to 300 chalk white eggs per year. The fully-grown leghorn chicken averages 3-6 pounds in weight and is characterized by being noisy, flighty, and easily excited. The leghorn has a lifespan of 5-11 years in the wild. In pre-clinical research, the leghorn is a consistent provider of eggs for embryonic, angiogenic, and vasculogenic research. (NCI)</Definition>
        <Definition>A small, commonly white-colored breed of poultry that is renowned for its ability to produce up to 300 chalk white eggs per year. The fully-grown leghorn chicken averages 3-6 pounds in weight and is characterized by being noisy, flighty, and easily excited. The leghorn has a lifespan of 5-11 years in the wild. In pre-clinical research, the leghorn is a consistent provider of eggs for embryonic, angiogenic, and vasculogenic research.</Definition>
        <SemanticType code="T012" name="Bird"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Leghorn Chicken</Term>
        <Term>Leghorn</Term>
        <Term>LEGHORNS</Term>
        <Term>Red Leghorn Chicken</Term>
        <Term>Leghorn chicken</Term>
        <Term>Leghorn chicken (organism)</Term>
        <Term>Livornese Chicken</Term>
        <Term>White Leghorn Chicken</Term>
        <Codes>
          <Code code="C77098" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Chicken</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd69_protein_mouse" name="Cd69 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd69 protein, mouse</Term>
        <Term>CD69 antigen, mouse</Term>
        <Codes>
          <Code code="C2744536" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:antigens_CD69</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly6G_antigen_mouse" name="Ly6G antigen, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly6G antigen, mouse</Term>
        <Term>Gr1protein, mouse</Term>
        <Term>Ly-6G antigen, mouse</Term>
        <Codes>
          <Code code="C1433476" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FcepsilonRIalpha_protein_mouse" name="FcepsilonRIalpha protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FcepsilonRIalpha protein, mouse</Term>
        <Codes>
          <Code code="C3659874" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD23</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:P_J_Mouse" name="P/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">P/J Mouse</Term>
        <Term>P/J</Term>
        <Codes>
          <Code code="C14598" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BALB_cBy_Mouse" name="BALB/cBy Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BALB/cBy Mouse</Term>
        <Term>BALB/cBy</Term>
        <Codes>
          <Code code="C37359" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:cytotoxic_T-lymphocyte_antigen-2alpha_mouse" name="cytotoxic T-lymphocyte antigen-2alpha, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">cytotoxic T-lymphocyte antigen-2alpha, mouse</Term>
        <Term>TLA-2alpha protein, mouse</Term>
        <Term>CTLA-2alpha protein, mouse</Term>
        <Codes>
          <Code code="C1430474" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:controlled_interrupted_time_series" name="controlled interrupted time series">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">controlled interrupted time series</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#controlled_interrupted_time_series" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:interrupted_time_series_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:journal_article" name="journal article">
        <Definition>The predominant publication type for articles and other items indexed for NLM databases. [MeSH_2015]</Definition>
        <Definition>The predominant publication type for articles and other items indexed for NLM databases.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">journal article</Term>
        <Term>journal articles</Term>
        <Term>Journal Article</Term>
        <Codes>
          <Code code="C0282420" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:article</Relation>
          <Relation name="Narrower">OTE:introductory_journal_article</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:insulin_receptor_alpha_subunit_human" name="insulin receptor alpha subunit, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">insulin receptor alpha subunit, human</Term>
        <Codes>
          <Code code="C1721314" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:INSR_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Baboon" name="Baboon">
        <Definition>Multiple species of large terrestrial monkeys in the genus Papio, including P. hamadryas, P. papio, P. anubis, P. cynocephalus and P. ursinus.</Definition>
        <Definition>large terrestrial monkey found in Africa and Arabia; has long doglike muzzle, large cheek pouches, and a short tail.</Definition>
        <Definition>A species of baboon in the family CERCOPITHECIDAE found in southern equatorial and east Africa. They are smaller than PAPIO ANUBIS and have a thinner mane.</Definition>
        <Definition>A species of baboon in the family CERCOPITHECIDAE with a somewhat different social structure than PAPIO HAMADRYAS. They inhabit several areas in Africa south of the Sahara.</Definition>
        <Definition>A species of baboon in the family CERCOPITHECIDAE, which has a well-studied trilevel social structure consisting of troops, bands, and clans.</Definition>
        <Definition>A species of baboon in the family CERCOPITHECIDAE found in southern Africa. They are dark colored and have a variable social structure.</Definition>
        <Definition>A large terrestrial monkey found in Africa and Arabia, it is the largest non-hominid member of the primate order. This primate has a long dog-like muzzles, close-set eyes, heavy powerful jaws, thick fur, a short tail and often brightly colored ischial callosities.</Definition>
        <Definition>A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of five named species: PAPIO URSINUS (chacma baboon), PAPIO CYNOCEPHALUS (yellow baboon), PAPIO PAPIO (western baboon), PAPIO ANUBIS (or olive baboon), and PAPIO HAMADRYAS (hamadryas baboon). Members of the Papio genus inhabit open woodland, savannahs, grassland, and rocky hill country. Some authors consider MANDRILLUS a subgenus of Papio.</Definition>
        <Definition>A species of baboon in the family CERCOPITHECIDAE, often used as an animal model for cognitive studies.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Baboon</Term>
        <Term>Baboon, Olive</Term>
        <Term>Papio cynocephalus papio</Term>
        <Term>Savanna Baboon</Term>
        <Term>Baboons</Term>
        <Term>Baboon, Guinea</Term>
        <Term>Savanna baboon</Term>
        <Term>Papio ursinus</Term>
        <Term>Papio hamadryas anubis</Term>
        <Term>Papio hamadryas doguera</Term>
        <Term>Chacma Baboon</Term>
        <Term>baboon</Term>
        <Term>Papio anubis (organism)</Term>
        <Term>Papio papio sensu Groves</Term>
        <Term>Papios</Term>
        <Term>papio</Term>
        <Term>sacred baboon</Term>
        <Term>Hamadryas Baboons</Term>
        <Term>Baboons, Savanna</Term>
        <Term>red baboon</Term>
        <Term>Anubis baboon</Term>
        <Term>Papio hamadryas papio</Term>
        <Term>Baboon, NOS</Term>
        <Term>Baboon, Yellow</Term>
        <Term>Hamadryas Baboon</Term>
        <Term>Papio ursinus (organism)</Term>
        <Term>Papio cynocephalus anubis</Term>
        <Term>Arabian hamadryas</Term>
        <Term>baboons</Term>
        <Term>Papio Erxleben, 1777</Term>
        <Term>Papio hamadryas subsp.</Term>
        <Term>Baboons, Yellow</Term>
        <Term>Baboons, Olive</Term>
        <Term>Papio hamadryas cynocephalus</Term>
        <Term>Savanna Baboons</Term>
        <Term>Yellow Baboon</Term>
        <Term>Olive Baboon</Term>
        <Term>Papio doguera</Term>
        <Term>Papio anubis</Term>
        <Term>Western baboon</Term>
        <Term>Kenya baboon</Term>
        <Term>Olive baboon</Term>
        <Term>Baboons, Chacma</Term>
        <Term>Olive Baboons</Term>
        <Term>Hamadryas baboon</Term>
        <Term>Papio papio</Term>
        <Term>Baboon, Savanna</Term>
        <Term>Papio cynocephalus</Term>
        <Term>Baboon, Hamadryas</Term>
        <Term>Chacma baboon</Term>
        <Term>Guinea Baboon</Term>
        <Term>Papio hamadryas (organism)</Term>
        <Term>Guinea baboon</Term>
        <Term>Doguera baboon</Term>
        <Term>Hamadryas</Term>
        <Term>Papio cynocephalus (Linnaeus, 1766)</Term>
        <Term>Papio hamadryas ursinus</Term>
        <Term>hamadryas, Papio</Term>
        <Term>Papio papio (Desmarest, 1820)</Term>
        <Term>Papio, NOS</Term>
        <Term>Baboon, Chacma</Term>
        <Term>Genus Papio</Term>
        <Term>Papio anubis (Lesson, 1827)</Term>
        <Term>Papio</Term>
        <Term>Yellow baboon</Term>
        <Term>Papio cynocephalus (organism)</Term>
        <Term>western baboon</Term>
        <Term>BABOON</Term>
        <Term>Yellow Baboons</Term>
        <Term>Chacma Baboons</Term>
        <Term>Papio ursinus (Kerr, 1792)</Term>
        <Term>Genus Papio (organism)</Term>
        <Term>Papio hamadryas</Term>
        <Term>Papio hamadryas (Linnaeus, 1758)</Term>
        <Term>Papio papio (organism)</Term>
        <Term>Baboons, Hamadryas</Term>
        <Codes>
          <Code code="C0324820" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Monkey</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd8a_protein_rat" name="Cd8a protein, rat">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd8a protein, rat</Term>
        <Term>CD8 antigen, alpha chain, rat</Term>
        <Codes>
          <Code code="C1721293" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD8_antigen_alpha_chain</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:cohort_before-after_design_" name="cohort before-after design'">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">cohort before-after design'</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#cohort_before-after_design'" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cohort_study</Relation>
          <Relation name="Narrower">OTE:controlled_cohort_before-after_design_</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CEACAM6_protein_human" name="CEACAM6 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CEACAM6 protein, human</Term>
        <Term>carcinoembryonic antigen-related cell adhesion molecule 6, human</Term>
        <Term>NCA-50 antigen, human</Term>
        <Term>CD66c antigen, human</Term>
        <Term>NCA-90 antigen, human</Term>
        <Codes>
          <Code code="C0376900" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:retrospective_cohort_study" name="retrospective cohort study">
        <Definition>A research study in which the medical records of groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke and those who do not smoke) are compared for a particular outcome (such as lung cancer).</Definition>
        <Definition>A research study in which the medical records of groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke and those who do not smoke) are compared for a particular outcome (such as lung cancer). [NCIT_14.08d]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">retrospective cohort study</Term>
        <Term>retrospective cohort studies</Term>
        <Term>historical cohort trials</Term>
        <Term>historical cohort studies</Term>
        <Term>retrospective cohort design</Term>
        <Term>cohort study, historical</Term>
        <Term>studies, historical cohort</Term>
        <Term>retrospective cohort designs</Term>
        <Term>Retrospective Cohort Study</Term>
        <Term>cohort studies, historical</Term>
        <Term>retrospective cohort trial</Term>
        <Term>historical cohort design</Term>
        <Term>study, historical cohort</Term>
        <Term>historical cohort designs</Term>
        <Term>historic cohort study</Term>
        <Term>historical cohort study</Term>
        <Term>historical cohort trial</Term>
        <Term>historic cohort studies</Term>
        <Term>retrospective cohort trials</Term>
        <Codes>
          <Code code="C2985505" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cohort_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:concurrent_design" name="concurrent design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">concurrent design</Term>
        <Term>concurrent study</Term>
        <Term>concurrent trial</Term>
        <Term>concurrent designs</Term>
        <Term>concurrent trials</Term>
        <Term>concurrent studies</Term>
        <Term>studies, concurrent</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#concurrent_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cohort_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DDY_Mouse" name="DDY Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DDY Mouse</Term>
        <Term>DDY</Term>
        <Codes>
          <Code code="C1511654" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BDII_Rat_Strain" name="BDII, Rat Strain">
        <Definition>Frequent microphthalmia. Genetic markers described for sublines of this strain in the USA differ from those in Europe, suggesting that the US sublines were contaminated at some time in the past with LEW (Czerwinski and Crowell 1986). Mean life-span of BDII/Han 33.6 +/-4.7 months in males and 22.5+/-4.4 months in females, with 91% of females developing endometrial carcinomas, but with a more varied range of tumors in males. These include 26% adrenal pheochromocytomas, 23% histiocytic sarcomas, 18% pituitary tumors and 14% hemangiomas. About 12% of aged male BDII/Han develop diverticula of the stomach (Kaspareit-Rittinghausen and Deerberg 1987). High incidence of hormone-dependent endometrial adenocarcinoma.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BDII, Rat Strain</Term>
        <Codes>
          <Code code="C14388" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:controlled_design" name="controlled design">
        <Definition>Used for original studies with a control group, i.e. in which previously defined groups are compared with each other. Also used for studies with control material or control procedures. Retrospective studies may also be included. [Emtree_2014]</Definition>
        <Definition>An experiment or clinical trial that includes a comparison (control) group. [NCIT_14.05d] </Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">controlled design</Term>
        <Term>controlled study</Term>
        <Term>controlled trials</Term>
        <Term>controlled designs</Term>
        <Term>controlled trial</Term>
        <Term>controlled studies</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#controlled_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:non-randomized_controlled_design, OTE:case_control_design, OTE:historically_controlled_design, OTE:randomized_controlled_trial, OTE:quasi-experimental_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tnfrsf4_protein_rat" name="Tnfrsf4 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tnfrsf4 protein, rat</Term>
        <Term>tumor necrosis factor receptor superfamily, member 4, rat</Term>
        <Term>Txgp1 protein, rat</Term>
        <Term>Ox40 protein, rat</Term>
        <Codes>
          <Code code="C1680591" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptor_OX40</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Adults" name="Adults">
        <Definition>A human who has reached reproductive age.</Definition>
        <Definition>A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.</Definition>
        <SemanticType code="T100" name="Age Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Adults</Term>
        <Term>21+ years old</Term>
        <Term>adult</Term>
        <Term>21 old year</Term>
        <Term>Human, Adult</Term>
        <Term>21 year old</Term>
        <Term>Adult</Term>
        <Term>adults</Term>
        <Term>Adult (person)</Term>
        <Term>Adult Human (21+)</Term>
        <Term>adult human (21+)</Term>
        <Term>ADULT</Term>
        <Term>Adult [Disease/Finding]</Term>
        <Codes>
          <Code code="C0001675" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Age_Groups</Relation>
          <Relation name="Narrower">OTE:Young_Adult, OTE:Middle_Aged, OTE:Aged</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Icam1_protein_mouse" name="Icam1 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Icam1 protein, mouse</Term>
        <Term>murine lymphocyte activation antigen MALA-2</Term>
        <Term>intercellular adhesion molecule, mouse</Term>
        <Term>MALA-2 antigen, mouse</Term>
        <Codes>
          <Code code="C0291005" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Intercellular_Adhesion_Molecule-1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:xkrk1_protein_Xenopus" name="xkrk1 protein, Xenopus">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">xkrk1 protein, Xenopus</Term>
        <Term>kit-related kinase, Xenopus</Term>
        <Term>Xenopus kit-related kinase</Term>
        <Codes>
          <Code code="C1100906" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Proto_Oncogene_Proteins_c_kit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Nadia_Zebrafish" name="Nadia Zebrafish">
        <Definition>A wild-type zebrafish line, the stock of which was obtained from an area east of Calcutta in a district called Nadia.</Definition>
        <Definition>A wild-type zebrafish line, the stock of which was obtained from an area east of Calcutta in a district called Nadia.(ZFin)</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Nadia Zebrafish</Term>
        <Term>NA</Term>
        <Term>Nadia - zebrafish</Term>
        <Term>Nadia</Term>
        <Codes>
          <Code code="C2700321" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD48_antigen" name="CD48 antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD48 antigen</Term>
        <Term>CD48 ANTIGEN</Term>
        <Term>CD48</Term>
        <Term>B-CELL ACTIVATION MARKER</Term>
        <Term>mCD48</Term>
        <Term>Lymphocyte antigen CD48 (substance)</Term>
        <Term>SLAM FAMILY, MEMBER 2</Term>
        <Term>MRC OX-45 antigen</Term>
        <Term>BLAST1</Term>
        <Term>hCD48</Term>
        <Term>Cluster of diff antigen 48</Term>
        <Term>CD48 gene</Term>
        <Term>Blast1 antigen</Term>
        <Term>BCM1</Term>
        <Term>CD48 - Cluster of differentiation antigen 48</Term>
        <Term>Cluster of differentiation antigen 48</Term>
        <Term>CD48 - Cluster of diff ag 48</Term>
        <Term>CD48 molecule</Term>
        <Term>signal-transducing glycoprotein-60</Term>
        <Term>SLAMF2</Term>
        <Term>Lymphocyte antigen CD48</Term>
        <Term>BLAST</Term>
        <Codes>
          <Code code="C1457877" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cd48_protein_rat, OTE:Cd48_protein_mouse, OTE:CD48_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Polysomnographies" name="Polysomnographies">
        <Definition>A multisubunit proteasome complex that localizes in the cytoplasm as dot-like structures when cells are in a quiescent state. [GOC:rb, PMID:18504300]</Definition>
        <Definition>A group of recordings taken during sleep that shows brain wave changes, eye movements, breathing rate, blood pressure, heart rate, and the electrical activity of the heart and other muscles. A polysomnogram may be used to help diagnose sleep disorders.</Definition>
        <Definition>Measurement of physiologic parameters during sleep.</Definition>
        <Definition>Simultaneous and continuous monitoring of several parameters during sleep to study normal and abnormal sleep. The study includes monitoring of brain waves, to assess sleep stages, and other physiological variables such as breathing, eye movements, and blood oxygen levels which exhibit a disrupted pattern with sleep disturbances.</Definition>
        <Definition>A group of tests taken during sleep to capture and record brain wave changes, eye movements, breathing rate, blood pressure, heart rate, and the electrical activity of the heart and other muscles.</Definition>
        <Definition>simultaneous and continuous monitoring of relevant normal and abnormal physiological activity during sleep.</Definition>
        <Definition>Simultaneous recording of electrophysiologic activity during sleep.</Definition>
        <SemanticType code="T026" name="Cell Component"/>
        <SemanticType code="T060" name="Diagnostic Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Polysomnographies</Term>
        <Term>SLEEP DISORDER TESTS AND PROCEDURES</Term>
        <Term>proteasome storage granule</Term>
        <Term>polysomnogram</Term>
        <Term>Somnographies</Term>
        <Term>Polysomnogram, NOS</Term>
        <Term>Sleep recording</Term>
        <Term>study sleep</Term>
        <Term>Full sleep study</Term>
        <Term>polysomnograms</Term>
        <Term>Sleep Study</Term>
        <Term>POLYSOMNOGRAPHY</Term>
        <Term>sleep test</Term>
        <Term>Somnography</Term>
        <Term>sleep tests</Term>
        <Term>sleep measurement</Term>
        <Term>Polysomnography, NOS</Term>
        <Term>Sleep Monitoring</Term>
        <Term>sleep study (procedure)</Term>
        <Term>sleeping studying</Term>
        <Term>Polysomnography (procedure)</Term>
        <Term>sleep study</Term>
        <Term>Sleep study</Term>
        <Term>POLYSOMNOGR</Term>
        <Term>polysomnography (procedure)</Term>
        <Term>Monitoring, Sleep</Term>
        <Term>Sleep studies (procedure)</Term>
        <Term>monitor sleep</Term>
        <Term>2-95 SLEEP DISORDER TESTS AND PROCEDURES</Term>
        <Term>Polysomnography</Term>
        <Term>Sleep studies</Term>
        <Term>Polysomnogram</Term>
        <Term>PSG</Term>
        <Term>polysomnography</Term>
        <Term>sleep testing (procedure)</Term>
        <Term>sleep studies</Term>
        <Term>SOMNOGR</Term>
        <Term>sleep testing</Term>
        <Codes>
          <Code code="C0162701" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Physiologic_Monitoring</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:retrospective_design" name="retrospective design">
        <Definition>A study in which known outcomes are examined in hindsight using existing records. [NCIT_14.05d] </Definition>
        <Definition>A study that compares two groups of people: those with the disease or condition under study (cases) and a very similar group of people who do not have the disease or condition (controls). Researchers study the medical and lifestyle histories of the people in each group to learn what factors may be associated with the disease or condition. For example, one group may have been exposed to a particular substance that the other was not. [NCIT_14.05d] </Definition>
        <Definition>Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. [MeSH_2014]</Definition>
        <Definition>a longitudinal epidemiologic study in which participating individuals are classified as either having (cases) or lacking (controls) some outcome and their histories are examined for the presence of specific factors possibly associated with that outcome. Cases and controls are often matched with respect to certain demographic or other variables but need not be. As compared with prospective studies, retrospective studies suffer from drawbacks: although they can measure the odds ratio, which often approximates relative risk, they cannot reveal true incidence rates or attributable risk. Also, large biases can be introduced both in the selection of controls and in the recall of past exposure to risk factors. The advantage of the retrospective study is its small scale, usually short time for completion, and its applicability to rare diseases, which would require study of very large cohorts in prospective studies. [Emtree_2014] [ Dorland's Medical Dictionary_2011]</Definition>
        <SemanticType code="T081" name="Quantitative Concept"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">retrospective design</Term>
        <Term>study, retrospective</Term>
        <Term>retrospective designs</Term>
        <Term>retrospective trials</Term>
        <Term>retrospective studies</Term>
        <Term>retrospective trial</Term>
        <Term>retrospective study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#retrospective_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:retrospective_panel_study, OTE:retrospective_case_control_design, OTE:ex_post_facto_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ACI_Seg_Rat_Strain" name="ACI/Seg, Rat Strain">
        <Definition>Derived by Curtiss and Dunning (1926) at Columbia University by crossing an inbred August rat with an inbred Copenhagen rat, to Heston (1945) and then to the NIH in 1950. Disseminated to Harlan Sprague-Dawley from laboratory of Segaloff (Alton Ochsner Medican Foundation) in 1956. The ACI/Seg rat is agouti in color, with a white belly and feet, genotype A hi.</Definition>
        <Definition>Derived by Curtiss and Dunning (1926) at Columbia University by crossing an inbred August rat with an inbred Copenhagen rat, to Heston (1945) and then to the NIH in 1950. Disseminated to Harlan Sprague-Dawley from laboratory of Segaloff (Alton Ochsner Medican Foundation) in 1956. The ACI/Seg rat is agouti in color, with a white belly and feet, genotype A hi. This strain is susceptible to a variety of neoplasms including testicular, adrenal, pituitary, and skin and ear duct tumors in males and pituitary, uterine, mammary, and adrenal tumors in females. Additionally, 20-30% of ACI/Seg rats have been shown to have an absent, hypoplastic, or cystic kidney on one side. This strain develops spontaneous prostate cancer with age and is used as a rat model of human prostate cancer in biomedical research. This strain has a average life span of two years and exhibits poor breeding performance and low litter size.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ACI/Seg, Rat Strain</Term>
        <Term>ACI:SEG</Term>
        <Term>ACI:Seg</Term>
        <Codes>
          <Code code="C76184" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DDK_Mouse" name="DDK Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DDK Mouse</Term>
        <Term>DDK</Term>
        <Codes>
          <Code code="C1511653" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129P4_RrRkJ_Mouse" name="129P4/RrRkJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129P4/RrRkJ Mouse</Term>
        <Term>129P4/RrRkJ</Term>
        <Codes>
          <Code code="C37331" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129S1_Sv_Mouse" name="129S1/Sv Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129S1/Sv Mouse</Term>
        <Term>129S1/Sv</Term>
        <Codes>
          <Code code="C37335" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Hamster" name="Hamster">
        <Definition>A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS.</Definition>
        <Definition>Any member of four genera of the rodent family Cricetidae; short-tailed Old World burrowing rodents with large cheek pouches.</Definition>
        <Definition>A common name used to describe a subfamily of the Muridae. Four of the more common genera are Cricetus, CRICETULUS, MESOCRICETUS, and PHODOPUS.</Definition>
        <Definition>Any member of the subfamily cricetinae and the genuses Mesocricetus, Phodopus, Cricetus, Cricetulus, Allocricetulus, Cansumys and Tscherskia.</Definition>
        <Definition>any of a subfamily (Cricetinae) of small Old World rodents having very large cheek pouches.</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Hamster</Term>
        <Term>Cricetinae</Term>
        <Term>Mammals, Hamsters</Term>
        <Term>Mesocricetus</Term>
        <Term>hamsters</Term>
        <Term>allergy testing hamster</Term>
        <Term>HAMSTER</Term>
        <Term>allergy testing hamster (lab test)</Term>
        <Term>Subfamily Cricetinae</Term>
        <Term>Subfamily Cricetinae (organism)</Term>
        <Term>Hamster, NOS</Term>
        <Term>Hamsters</Term>
        <Term>hamster</Term>
        <Codes>
          <Code code="C0018557" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Cricetidae</Relation>
          <Relation name="Narrower">OTE:Chinese_Hamster, OTE:Chinese_Syrian_Hamster, OTE:LVG_Hamster, OTE:Chinese_Syrian_Gold_Hamster, OTE:Syrian_Hamster</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CBA_Mouse" name="CBA Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CBA Mouse</Term>
        <Term>Inbred CBA Mouse</Term>
        <Term>CBA Mice, Inbred</Term>
        <Term>Mice, CBA</Term>
        <Term>Mouse, CBA</Term>
        <Term>Mouse, Inbred CBA</Term>
        <Term>CBA Mouse, Inbred</Term>
        <Term>Inbred CBA Mice</Term>
        <Term>CBA Mice</Term>
        <Term>Mice, Inbred CBA</Term>
        <Term>CBA</Term>
        <Codes>
          <Code code="C37395" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Foreign" name="Foreign">
        <Definition>An indication that all or part of the research on a grant to a US institution is either conducted in a foreign country, uses foreign subjects or their tissues or medical data, or involves collaboration with foreign researchers.</Definition>
        <Definition>Not belonging to that in which it is contained; introduced from an outside source.</Definition>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <SemanticType code="T078" name="Idea or Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Foreign</Term>
        <Term>Foreign Subpart</Term>
        <Term>Aspect, Multinational</Term>
        <Term>Aspect, International</Term>
        <Term>International Aspect</Term>
        <Term>Aspects, International</Term>
        <Term>foreign</Term>
        <Term>Foreign or Foreign Component</Term>
        <Term>Multinational Aspects</Term>
        <Term>international aspects</Term>
        <Term>FOREIGN</Term>
        <Term>International Aspects</Term>
        <Term>Aspects, Multinational</Term>
        <Term>Foreign Component</Term>
        <Term>Multinational Aspect</Term>
        <Codes>
          <Code code="C0376327" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Language_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:GM-CSF_IL-3_IL-5_Receptor_Common_beta-Chain" name="GM-CSF, IL-3, IL-5 Receptor Common beta-Chain">
        <Definition>A receptor subunit that is a shared component of the INTERLEUKIN-3 RECEPTOR; the INTERLEUKIN-5 RECEPTOR; and the GM-CSF RECEPTOR. High affinity receptor complexes are formed with each of these receptors when their respective alpha subunits are combined with this shared beta subunit.</Definition>
        <Definition>Colony Stimulating Factor 2 Receptor, Beta, Low-Affinity (CSF2RB), encoded by the CSF2RB gene, is a common beta chain of the high affinity receptor for IL-3, IL-5 and CSF. Defective CSF2RB has been reported to be associated with protein alveolar proteinosis. (From LocusLink)</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">GM-CSF, IL-3, IL-5 Receptor Common beta-Chain</Term>
        <Term>IL 5 Receptor beta Subunit</Term>
        <Term>Antigens, CD131</Term>
        <Term>Interleukin-3 Receptor beta Subunit</Term>
        <Term>CSF2RB Receptor</Term>
        <Term>Interleukin 3 Receptor beta Subunit</Term>
        <Term>IL 3 Receptor beta Subunit</Term>
        <Term>GM-CSF Receptor beta Subunit</Term>
        <Term>betaC Interleukin Receptor Subunit</Term>
        <Term>INTERLEUKIN 005 RECEPTOR BETA SUBUNIT</Term>
        <Term>Cytokine Receptor Common beta Subunit</Term>
        <Term>IL-5 Receptor beta Subunit</Term>
        <Term>CD 131 ANTIGENS</Term>
        <Term>Interleukin 5 Receptor beta Subunit</Term>
        <Term>INTERLEUKIN 003 RECEPTOR BETA SUBUNIT</Term>
        <Term>ANTIGENS CD 131</Term>
        <Term>CD131 Antigens</Term>
        <Term>IL-3 Receptor beta Subunit</Term>
        <Term>IL 003 RECEPTOR BETA SUBUNIT</Term>
        <Term>IL 005 RECEPTOR BETA SUBUNIT</Term>
        <Term>Antigen, CD131</Term>
        <Term>Interleukin-3, 5, GM-CSF Receptor beta Subunit</Term>
        <Term>GM CSF Receptor beta Subunit</Term>
        <Term>Receptors, Cytokine, Common beta Chain</Term>
        <Term>CD131 Antigen</Term>
        <Term>Receptor, CSF2RB</Term>
        <Term>Cytokine Receptor Common beta Chain</Term>
        <Term>Interleukin-5 Receptor beta Subunit</Term>
        <Codes>
          <Code code="C1333105" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Csf2rb1_protein_mouse, OTE:CSF2RB_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Integrin_beta4" name="Integrin, beta4">
        <Definition>Also known as CD104 antigen, this protein is distinguished from other beta integrins by its relatively long cytoplasmic domain (approximately 1000 amino acids vs. approximately 50). Five alternatively spliced isoforms have been described.</Definition>
        <Definition>Integrin beta-4 (1822 aa, 202 kD) is a cell adhesion process protein that is encoded by the human ITGB4 gene and has a role in cell adhesion.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Integrin, beta4</Term>
        <Term>Antigens, CD104</Term>
        <Term>beta4, Integrin</Term>
        <Term>Antigen, CD104</Term>
        <Term>ANTIGENS CD 104</Term>
        <Term>CD 104 ANTIGENS</Term>
        <Term>INTEGRIN BETA A 04</Term>
        <Term>CD104 Antigens</Term>
        <Term>Integrin beta4</Term>
        <Term>CD104 Antigen</Term>
        <Term>beta4 Integrin</Term>
        <Term>Integrin beta(4)</Term>
        <Codes>
          <Code code="C0253906" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:ITGB4_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD146_Antigen" name="CD146 Antigen">
        <Definition>A cell adhesion molecule of the immunoglobulin superfamily that is expressed in ENDOTHELIAL CELLS and is involved in INTERCELLULAR JUNCTIONS.</Definition>
        <Definition>Melanoma adhesion molecule (646 aa, 72 kD) is a cell adhesion process protein that is encoded by the human MCAM gene and has roles in anatomical structure morphogenesis and cell adhesion.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD146 Antigen</Term>
        <Term>CD 146 ANTIGENS</Term>
        <Term>CD146 Antigens</Term>
        <Term>MUC18 Glycoprotein</Term>
        <Term>MUC18, Glycoprotein</Term>
        <Term>ANTIGENS CD 146</Term>
        <Term>P1H12 protein, human</Term>
        <Term>Glycoprotein MUC18</Term>
        <Term>muc-18</Term>
        <Term>CD146 antigen</Term>
        <Term>CD146 antigen, human</Term>
        <Term>melanoma-associated antigen A32, human</Term>
        <Term>MCAM</Term>
        <Term>MUC18 antigen, human</Term>
        <Term>S-Endo</Term>
        <Term>Gicerin</Term>
        <Term>Antigen, CD146</Term>
        <Term>Antigens, CD146</Term>
        <Term>MCAM protein, human</Term>
        <Term>Mel-CAM</Term>
        <Term>Antigens, CD146 [Chemical/Ingredient]</Term>
        <Term>Melanoma Cell Adhesive Molecule</Term>
        <Term>A32</Term>
        <Term>S-Endo 1 Endothelial-Associated Antigen</Term>
        <Term>Melanoma Cell Adhesion Molecule</Term>
        <Term>muc 18</Term>
        <Term>Melanoma Adhesion Molecule</Term>
        <Term>melanoma cell adhesion molecule protein, human</Term>
        <Term>CD146 protein, human</Term>
        <Codes>
          <Code code="C1457876" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Mcam_protein_mouse, OTE:MCAM_protein_human, OTE:Mcam_protein_rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:records_review" name="records review">
        <SemanticType code="T033" name="Finding"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">records review</Term>
        <Term>Record review</Term>
        <Term>review of records</Term>
        <Term>record review</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#review_of_records" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:file_review, OTE:medical_record_review, OTE:medical_audit, OTE:clinical_audit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Integrin_beta3" name="Integrin, beta3">
        <Definition>An integrin beta subunit of approximately 85-kDa in size which has been found in INTEGRIN ALPHAIIB-containing and INTEGRIN ALPHAV-containing heterodimers. Integrin beta3 occurs as three alternatively spliced isoforms, designated beta3A-C.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Integrin, beta3</Term>
        <Term>Integrin beta3</Term>
        <Term>GPIIIa</Term>
        <Term>CD61 Antigens</Term>
        <Term>CD61 Antigen</Term>
        <Term>INTEGRIN BETA A 03</Term>
        <Term>Platelet Membrane Glycoprotein IIIa</Term>
        <Term>beta3 Integrin</Term>
        <Term>Antigens, CD61</Term>
        <Term>beta3, Integrin</Term>
        <Term>Antigen, CD61</Term>
        <Term>Platelet Glycoprotein IIIa</Term>
        <Term>CD 061 ANTIGENS</Term>
        <Term>Platelet GPIIIa</Term>
        <Term>Glycoprotein IIIa, Platelet</Term>
        <Term>beta(3) Integrin</Term>
        <Term>ANTIGENS CD 061</Term>
        <Codes>
          <Code code="C0245726" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Integrin_beta3A, OTE:Integrin_beta3B, OTE:Integrin_beta3C, OTE:ITGB3_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BALB_c_Mouse" name="BALB/c Mouse">
        <Definition>Derived from albino mice stocks originally disseminated by Bagg (1913) to Snell in 1932 that has an albino coat with genotype A,b,c.</Definition>
        <Definition>Derived from albino mice stocks originally disseminated by Bagg (1913) to Snell in 1932 that has an albino coat with genotype A,b,c. The BALB/c mouse develops plasmacytomas upon injection with mineral oil, which form the mouse cell component of the mouse-human hybrid cells that are used in the production of monoclonal antibodies. This strain exhibits excellent breeding performance and a long life span which contribute to its being one of the most highly utilized of all available mouse strains.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BALB/c Mouse</Term>
        <Term>BALB/C</Term>
        <Term>BALB/c</Term>
        <Codes>
          <Code code="C37357" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MUC-1_protein_human" name="MUC-1 protein, human (950-958)">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MUC-1 protein, human (950-958)</Term>
        <Term>MUC-1(950-958), human</Term>
        <Codes>
          <Code code="C1957600" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CA-15-3_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Hartley_Albino_Hairless_Guinea_Pig" name="Hartley Albino Hairless Guinea Pig">
        <Definition>Derived from inbred Hartley stocks at the Eastman Kodak Company and Montreal's Institute Armand Frappier, having undergone spontaneous mutation that led to hairlessness and athymicity. The mutation that spawned the Hartley Hairless Guinea Pig was then re-derived at Charles River to restore thymus function while maintaining hairlessness. The skin of the Hartley Hairless guinea pig resembles many physical and physiological aspects of human skin and spontaneous formation of melanoma is common to this strain. It is therefore used in a variety of pre-clinical dermatological studies.</Definition>
        <Definition>Derived from inbred Hartley stocks at the Eastman Kodak Company and Montreal's Institute Armand Frappier, having undergone spontaneous mutation that led to hairlessness and athymicity. The mutation that spawned the Hartley Hairless Guinea Pig was then re-derived at Charles River to restore thymus function while maintaining hairlessness.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Hartley Albino Hairless Guinea Pig</Term>
        <Term>HARTLEY ALBINO HAIRLESS</Term>
        <Term>Hartley Albino Hairless</Term>
        <Codes>
          <Code code="C77089" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Guinea_Pig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:soluble_LAG-3_protein_human" name="soluble LAG-3 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">soluble LAG-3 protein, human</Term>
        <Term>sLAG-3 protein, human</Term>
        <Codes>
          <Code code="C1743686" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD223_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:A_WySnJ_Mouse" name="A/WySnJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">A/WySnJ Mouse</Term>
        <Term>A/WySnJ</Term>
        <Codes>
          <Code code="C37351" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:qualitative_evaluation" name="qualitative evaluation">
        <Definition>A type of evaluation that is primarily descriptive and interpretative, and may or may not lend itself to quantification. Mainly concerned with the properties, the state, and the character (i.e., the nature) of phenomena. It implies an emphasis on processes and meanings that are rigorously examined, but not measured in terms of quantity, amount, or frequency. (www.unfpa.org/monitoring/toolkit/glossary.pdf and Nonprofit Good Practice Guide Glossary)</Definition>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">qualitative evaluation</Term>
        <Term>qualitative evaluations</Term>
        <Term>Evaluations, Qualitative</Term>
        <Term>Evaluation, Qualitative</Term>
        <Term>Qualitative Evaluations</Term>
        <Term>Qualitative Evaluation</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#qualitative_evaluation" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:evaluation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tnfsf8_protein_mouse" name="Tnfsf8 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tnfsf8 protein, mouse</Term>
        <Term>tumor necrosis factor (ligand) superfamily, member 8, mouse</Term>
        <Term>CD153 antigen, mouse</Term>
        <Term>CD30LG protein, mouse</Term>
        <Term>Cd30L protein, mouse</Term>
        <Codes>
          <Code code="C1679340" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD30_Ligand</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mastomys" name="Mastomys">
        <Definition>A genus of rodent in the family muridae.</Definition>
        <Definition>A genus of rodent in the family muridae comprising the multimammate mice.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mastomys</Term>
        <Term>Genus Mastomys</Term>
        <Term>MASTOMYS</Term>
        <Term>Genus Mastomys (organism)</Term>
        <Codes>
          <Code code="C91816" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Muridae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:historically_controlled_design" name="historically controlled design">
        <Definition>A study that compares a group of participants receiving an intervention with a similar group from the past who did not. [Historically Controlled Study | MeSH_2015]</Definition>
        <SemanticType code="T081" name="Quantitative Concept"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">historically controlled design</Term>
        <Term>historical control designs</Term>
        <Term>historical control design</Term>
        <Term>historical control studies</Term>
        <Term>historically controlled studies</Term>
        <Term>historical control trials</Term>
        <Term>historical control trial</Term>
        <Term>historically controlled trial</Term>
        <Term>historically controlled study</Term>
        <Term>historically controlled trials</Term>
        <Term>historically controlled designs</Term>
        <Term>historical control study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#historically_controlled_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:controlled_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129P1_ReJ_Mouse" name="129P1/ReJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129P1/ReJ Mouse</Term>
        <Term>129P1/ReJ</Term>
        <Codes>
          <Code code="C37322" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BDVI_Rat_Strain" name="BDVI, Rat Strain">
        <Definition>About 4% of spontaneous peripheral nerve tumors, with cystic schwannomas being the most frequent type. 24 spontaneous and 28 ethylnitrosourea-induced tumors has been described by Turusov and Cabral, (1994).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BDVI, Rat Strain</Term>
        <Codes>
          <Code code="C14386" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NT5C2_protein_human" name="NT5C2 protein, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NT5C2 protein, human</Term>
        <Term>5'-nucleotidase, cytosolic II, human</Term>
        <Term>cN-II protein, human</Term>
        <Codes>
          <Code code="C1701467" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-Nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Blatella_germanica" name="Blatella germanica">
        <SemanticType code="T204" name="Eukaryote"/>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Blatella germanica</Term>
        <Term>bugs water</Term>
        <Term>Blatella germanica (antigen)</Term>
        <Term>blattella germanica</Term>
        <Term>Croton bug</Term>
        <Term>Blattella germanica</Term>
        <Term>Blattella germanica (invertebrate)</Term>
        <Term>Blatte germanique</Term>
        <Term>Water bug</Term>
        <Term>water bug</Term>
        <Term>ALLERGENIC EXTRACT- COCKROACH, GERMAN BLATELLA GERMANICA</Term>
        <Term>Blatella germanica extract</Term>
        <Term>German cockroach</Term>
        <Term>BLATELLA GERMANICA</Term>
        <Term>Blatella germanica extract (product)</Term>
        <Term>German cockroach allergenic extract</Term>
        <Term>Blattella germanica (organism)</Term>
        <Term>Blattella germanica (Linnaeus, 1767)</Term>
        <Term>German Cockroach</Term>
        <Codes>
          <Code code="C1963005" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Insect</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:biochemical_transport" name="biochemical transport">
        <SemanticType code="T169" name="Functional Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">biochemical transport</Term>
        <Codes>
          <Code code="C0243143" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Pharmacokinetics</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd8a_protein_mouse" name="Cd8a protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd8a protein, mouse</Term>
        <Term>Ly-2 antigen, mouse</Term>
        <Term>Ly-B antigen, mouse</Term>
        <Term>Ly-35 antigen, mouse</Term>
        <Term>CD8 antigen, alpha chain, mouse</Term>
        <Codes>
          <Code code="C1721292" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD8_antigen_alpha_chain</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Viral_Markers" name="Viral Markers">
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Viral Markers</Term>
        <Term>Marker, Viral</Term>
        <Term>Viral Marker</Term>
        <Term>Markers, Viral</Term>
        <Codes>
          <Code code="C0162492" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Onercept" name="Onercept">
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Onercept</Term>
        <Term>ONERCEPT</Term>
        <Codes>
          <Code code="C1100611" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Necrosis_Factor_Receptor_1A, OTE:recombinant_human_tumor_necrosis_factor-binding_protein-1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LYPD7_protein_human" name="LYPD7 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LYPD7 protein, human</Term>
        <Codes>
          <Code code="C2716051" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:quantitative_evaluation" name="quantitative evaluation">
        <SemanticType code="T081" name="Quantitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">quantitative evaluation</Term>
        <Term>Quantitative Evaluation</Term>
        <Term>quantitative evaluations</Term>
        <Term>Quantitative Evaluations</Term>
        <Term>Evaluations, Quantitative</Term>
        <Term>Evaluation, Quantitative</Term>
        <Codes>
          <Code code="C0034384" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:evaluation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:phase_IIIb_trial" name="phase IIIb trial">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">phase IIIb trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#phase_IIIb_trial" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:New_Zealand_Rabbit" name="New Zealand Rabbit">
        <Definition>One of the larger rabbit breeds, the New Zealand was derived by Don Johnson in 1916 by crossing unknown breeds. This rabbit weighs between 9-12 lbs. fully grown and may come in a variety of coat colors.</Definition>
        <Definition>An albino New Zealand rabbit with coat genotype c, VV and eye color genotype np.</Definition>
        <Definition>An albino New Zealand rabbit with coat genotype c, VV and eye color genotype np. This lagomorph has non-pigmented skin and long slender ears which allows for ease of visualization of peripheral vasculature, thus facilitating phlebotomical procedures. Most common breed utilized in biomedical research and is used in a variety of studies including developmental toxicity studies, toxicology studies, asthma research, and antibody production.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">New Zealand Rabbit</Term>
        <Term>New Zealand White Rabbit</Term>
        <Term>New Zealand white rabbit (organism)</Term>
        <Term>New Zealand rabbit breed (organism)</Term>
        <Term>New Zealand rabbit</Term>
        <Term>New Zealand White</Term>
        <Term>New Zealand white rabbit</Term>
        <Term>Rabbit, NZW</Term>
        <Term>Rabbits, NZW</Term>
        <Term>New Zealand Rabbits</Term>
        <Term>New Zealand Albino</Term>
        <Term>Rabbit, New Zealand</Term>
        <Term>New Zealand White Rabbits</Term>
        <Term>NZW Rabbit</Term>
        <Term>New Zealand rabbit breed</Term>
        <Term>NZW Rabbits</Term>
        <Term>NEW ZEALAND WHITE</Term>
        <Term>Rabbits, New Zealand</Term>
        <Term>NEW ZEALAND</Term>
        <Codes>
          <Code code="C0324547" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rabbit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Asian_Americans" name="Asian Americans">
        <Definition>Persons living in the United States having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent.</Definition>
        <Definition>any person with Asian ethnic background whose home or birthplace is in the Americas.</Definition>
        <Definition>Denotes a person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent, and who was either born in the United States or who was naturalized as a citizen of the United States.</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Asian Americans</Term>
        <Term>American, Asian</Term>
        <Term>Asian American</Term>
        <Term>Americans, Asian</Term>
        <Term>asian americans</Term>
        <Term>Oriental American</Term>
        <Term>Asian-American</Term>
        <Codes>
          <Code code="C0003988" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ethnic_Groups</Relation>
          <Relation name="Narrower">OTE:Japanese_Americans, OTE:Korean_Americans, OTE:Chinese_Americans</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Prdl-a_protein_Hydra_attenuata" name="Prdl-a protein, Hydra attenuata">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Prdl-a protein, Hydra attenuata</Term>
        <Codes>
          <Code code="C1308571" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD1A2_antigen" name="CD1A2 antigen">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD1A2 antigen</Term>
        <Codes>
          <Code code="C0963784" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD1a_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Palestinians" name="Palestinians">
        <Definition>Denotes those persons of mainly Arabic speakers who regard themselves as a distinct branch of the Arabic-speaking peoples, with family origin in Palestine being the defining characteristic.</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Palestinians</Term>
        <Term>Palestinian race</Term>
        <Term>palestinian</Term>
        <Term>palestinians</Term>
        <Term>Palestinian</Term>
        <Codes>
          <Code code="C0282539" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Arabs</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD45RCAntigens" name="CD45RCAntigens">
        <Definition>A splicing isoform of CD45 antigen that includes exon C.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD45RCAntigens</Term>
        <Codes>
          <Code code="C0282466" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD45_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:adverse_events" name="adverse events">
        <Definition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to an adverse event.</Definition>
        <Definition>Adverse events may be captured either as free text or a pre-specified list of terms.</Definition>
        <Definition>unintended negative effect of treatments</Definition>
        <Definition>An unexpected medical problem that happens during treatment with a drug or other therapy. Adverse effects do not have to be caused by the drug or therapy, and they may be mild, moderate, or severe.</Definition>
        <Definition>Any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure. Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s).</Definition>
        <Definition>Any unfavorable and unintended sign, symptom, disease, or other medical occurrence with a temporal association with the use of a medical product, procedure or other therapy, or in conjunction with a research study, regardless of causal relationship. EXAMPLE(S): death, back pain, headache, pulmonary embolism, heart attack</Definition>
        <Definition>Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. NOTE: For further information, see the ICH Guideline for Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. [Modified from ICH E2A] Synonyms: side effect, adverse experience. See also serious adverse event, serious adverse experience. (CDISC glossary)</Definition>
        <SemanticType code="T046" name="Pathologic Function"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">adverse events</Term>
        <Term>Adverse event NOS</Term>
        <Term>AdverseEvent</Term>
        <Term>Adverse Event Domain</Term>
        <Term>Adverse event</Term>
        <Term>Adverse Event</Term>
        <Term>AE</Term>
        <Term>ADVERSE EVENT</Term>
        <Term>Adverse Experience</Term>
        <Term>Adverse Events</Term>
        <Term>adverse event</Term>
        <Codes>
          <Code code="C1705413" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Outcome_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Genetic_Marker" name="Genetic Marker">
        <Definition>any allele of interest, whose phenotype expression is usually easily discerned, used to identify an individual or a cell that carries it, or as a probe to mark a chromosome or locus.</Definition>
        <Definition>Alteration in DNA that may indicate an increased risk of developing a specific disease or disorder.</Definition>
        <Definition>A segment of DNA with an identifiable physical location on a chromosome and whose inheritance can be followed.</Definition>
        <Definition>A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event.</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T045" name="Genetic Function"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Genetic Marker</Term>
        <Term>genetic marker</Term>
        <Term>Genetic marker, NOS</Term>
        <Term>MARKERS GENET</Term>
        <Term>Genetic Markers</Term>
        <Term>Genetic markers</Term>
        <Term>Genetic Marker Expression</Term>
        <Term>genetic markers</Term>
        <Term>GENET MARKERS</Term>
        <Term>GENET MARKER</Term>
        <Term>Marker, Genetic</Term>
        <Term>Genetic Markers [Chemical/Ingredient]</Term>
        <Term>E07 GENETIC MARKERS</Term>
        <Term>Markers, Genetic</Term>
        <Term>Genetic marker</Term>
        <Term>Genetic marker, function</Term>
        <Term>Genetic marker, function (observable entity)</Term>
        <Term>GENETIC MARKERS</Term>
        <Term>MARKER GENET</Term>
        <Codes>
          <Code code="C0017393" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
          <Relation name="Narrower">OTE:Sost_protein_rat, OTE:Chromosome_Marker, OTE:HUMDNAMB_protein_human, OTE:BAT26_microsatellite_DNA, OTE:Markers_DNA, OTE:SOST_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Scarb2_protein_mouse" name="Scarb2 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Scarb2 protein, mouse</Term>
        <Term>CD36 antigen-like 2 protein, mouse</Term>
        <Term>LGP85 protein, mouse</Term>
        <Term>Cd36l2 protein, mouse</Term>
        <Term>LIMP II protein, mouse</Term>
        <Term>scavenger receptor class B, member 2 protein, mouse</Term>
        <Codes>
          <Code code="C1505586" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD36</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SELE_protein_human" name="SELE protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SELE protein, human</Term>
        <Term>E-selectin, human</Term>
        <Codes>
          <Code code="C2742136" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:E_Selectin</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:asialofetuin-polylysine-5_-uridine_monophosphate_conjugate" name="asialofetuin-polylysine-5'-uridine monophosphate conjugate">
        <SemanticType code="T109" name="Organic Chemical"/>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">asialofetuin-polylysine-5'-uridine monophosphate conjugate</Term>
        <Term>AsF-PL-UMP</Term>
        <Codes>
          <Code code="C0641482" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
          <Relation name="Narrower">OTE:asialofetuin-polylysine-5_-uridine_monophosphate_conjugate_125-labeled</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Dunkin_Hartley_Guinea_Pig" name="Dunkin Hartley Guinea Pig">
        <Definition>Albino outbred guinea pig belonging to the English (short-haired) breed. The Dunkin Hartley guinea pig is a crepuscular mammalian herbivore that is tailless with short legs and a large head. The Dunkin Hartley guinea pig has a white coat color (acromelanic albino) and red eyes and requires a nutritional source of vitamin C to sustain normal function. This guinea pig breed is used as an animal model for studying human diseases and toxins harmful to man, as well as the development of serums and vaccines.</Definition>
        <Definition>Albino outbred guinea pig belonging to the English (short-haired) breed. The Dunkin Hartley guinea pig has a white coat color (acromelanic albino) and red eyes and requires a nutritional source of vitamin C to sustain normal function.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Dunkin Hartley Guinea Pig</Term>
        <Term>Dunkin-Hartley</Term>
        <Term>DUNKIN-HARTLEY</Term>
        <Codes>
          <Code code="C77088" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Guinea_Pig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD8_antigen_alpha_chain" name="CD8 antigen, alpha chain">
        <Definition>T-cell surface glycoprotein CD8 alpha chain (235 aa, ~26 kDa) is encoded by the human CD8A gene. This protein is involved in cell-cell interactions during antigen recognition by T-cells.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD8 antigen, alpha chain</Term>
        <Term>T-cell surface glycoprotein CD8 alpha chain</Term>
        <Term>CD8 antigen, alpha polypeptide p32</Term>
        <Term>CD8 alphaalpha antigen</Term>
        <Term>Cd8a antigen</Term>
        <Term>CD8alphaalpha antigen</Term>
        <Codes>
          <Code code="C0914908" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD8</Relation>
          <Relation name="Narrower">OTE:Cd8a_protein_rat, OTE:CD8A_protein_human, OTE:Cd8a_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:A2G_Mouse" name="A2G Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">A2G Mouse</Term>
        <Term>A2G</Term>
        <Codes>
          <Code code="C14647" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd53_protein_mouse" name="Cd53 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd53 protein, mouse</Term>
        <Term>CD53 antigen, mouse</Term>
        <Term>Tspan25 protein, mouse</Term>
        <Codes>
          <Code code="C2975740" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD53</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:introductory_journal_article" name="introductory journal article">
        <Definition>Prefactory summary to a special issue or section of a journal devoted to a specific topic. This introductory text can be of varying length and substance.</Definition>
        <Definition>Prefactory summary to a special issue or section of a journal devoted to a specific topic. This introductory text can be of varying length and substance. [MeSH_2014]</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">introductory journal article</Term>
        <Term>prefatory journal articles</Term>
        <Term>Prefatory Journal Article</Term>
        <Term>introductory journal articles</Term>
        <Term>prefatory journal article</Term>
        <Term>Introductory Journal Article</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#introductory_journal_article" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:journal_article</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mki67_protein_mouse" name="Mki67 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mki67 protein, mouse</Term>
        <Term>Ki-67 antigen, mouse</Term>
        <Term>antigen identified by monoclonal antibody Ki 67, mouse</Term>
        <Codes>
          <Code code="C1567207" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_Ki_67</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:randomized_controlled_clinical_trial" name="randomized controlled clinical trial">
        <Definition>A study in which the participants are assigned by chance to separate groups to evaluate treatments. The study also includes a control group, which is undergoing the same rigors of the study with placebo treatment or standard treatment. The trial can also be controlled by the addition of a test group to ensure there are no factors present to skew the results and by the inclusion of peer-review analysis by appropriate government officials. [NCIT_14.08d]</Definition>
        <Definition>A study in which the participants are assigned by chance to separate groups to evaluate treatments. The study also includes a control group, which is undergoing the same rigors of the study with placebo treatment or standard treatment. The trial can also be controlled by the addition of a test group to ensure there are no factors present to skew the results and by the inclusion of peer-review analysis by appropriate government officials. 2005</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">randomized controlled clinical trial</Term>
        <Term>CONTROLLED CLIN TRIALS RANDOMIZED</Term>
        <Term>Controlled Clinical Trials, Randomized</Term>
        <Term>Randomized Controlled Clinical Trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#randomized_controlled_clinical_trial" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:controlled_clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129S7_SvEvBrd_Mouse" name="129S7/SvEvBrd Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129S7/SvEvBrd Mouse</Term>
        <Term>129S7/SvEvBrd</Term>
        <Codes>
          <Code code="C37344" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NZB_Mouse" name="NZB Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NZB Mouse</Term>
        <Term>NZB Mice</Term>
        <Term>NZB</Term>
        <Term>NZB Mouse, Inbred</Term>
        <Term>Mouse, NZB</Term>
        <Term>Mice, NZB</Term>
        <Term>Inbred NZB Mouse</Term>
        <Term>NZB Mice, Inbred</Term>
        <Term>Mice, Inbred NZB</Term>
        <Term>Inbred NZB Mice</Term>
        <Term>Mouse, Inbred NZB</Term>
        <Codes>
          <Code code="C0025926" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD68_protein_mouse" name="CD68 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD68 protein, mouse</Term>
        <Term>macrosialin protein, mouse</Term>
        <Term>CD68 antigen, mouse</Term>
        <Codes>
          <Code code="C0215872" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ehnicity_Category" name="Ehnicity Category">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ehnicity Category</Term>
        <Relations>
          <Relation name="Broader">OTE:Population_Category</Relation>
          <Relation name="Narrower">OTE:Population_Groups</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:AC133_antigen" name="AC133 antigen">
        <Definition>Prominin-1 (865 aa, ~97 kDa) is encoded by the human PROM1 gene. This protein may play a role in hematopoiesis, but an exact function has yet to be elucidated. The protein has been implicated in tumor pathogenesis and formation in several cancers, including retinoblastoma, hemangioma, and glioblastoma phenotypes. Additionally, the protein has been used as a marker to distinguish cells that have the potential to become cancerous from the larger normal cell population.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">AC133 antigen</Term>
        <Term>prominin-like PROML1</Term>
        <Term>CD133 Antigen</Term>
        <Term>prominin</Term>
        <Term>CD133</Term>
        <Term>AC133-1 antigen</Term>
        <Term>AC 133 antigen</Term>
        <Term>CD133 antigen</Term>
        <Term>PROML1</Term>
        <Term>Prominin-1</Term>
        <Term>fudenine</Term>
        <Term>Prominin-like protein 1</Term>
        <Term>prominin-1</Term>
        <Term>Antigen AC133</Term>
        <Codes>
          <Code code="C0673028" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Prom1_protein_mouse, OTE:AC133-2_antigen, OTE:PROM1_protein_human, OTE:Prom1_protein_rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LEC_Rat_Strain" name="LEC, Rat Strain">
        <Definition>Carries a mutation causing fulminated hepatitis and jaundice at about four months of age. Clinical symptoms include severe jaundice, bleeding, oliguria, loss of body weight and elevation of serum levels of bilirubin and hepatic enzymes. About half the animals die within a week of onset, and in survivors hepatocellular carcinoma spontaneously appears after 1-1.5 years (Kasai et al 1990,Sasaki 1985, Wirth et al 1990).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LEC, Rat Strain</Term>
        <Codes>
          <Code code="C14406" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD1A1_antigen" name="CD1A1 antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD1A1 antigen</Term>
        <Codes>
          <Code code="C0963783" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD1a_antigen, OTE:Antigen_CD1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BAT26_microsatellite_DNA" name="BAT26 microsatellite DNA">
        <SemanticType code="T114" name="Nucleic Acid, Nucleoside, or Nucleotide"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BAT26 microsatellite DNA</Term>
        <Term>BAT26 mononucleotide repeat DNA</Term>
        <Codes>
          <Code code="C3254358" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Genetic_Marker</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BL_10SnJ_Mouse" name="C57BL/10SnJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BL/10SnJ Mouse</Term>
        <Term>C57BL/10SnJ</Term>
        <Codes>
          <Code code="C37380" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL4R_protein_human" name="IL4R protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL4R protein, human</Term>
        <Term>interleukin-4 receptor alpha chain, human</Term>
        <Term>CD124 antigen, human</Term>
        <Term>interleukin 4 receptor, human</Term>
        <Codes>
          <Code code="C1620077" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin-4_Receptor_alpha_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klra5_protein_mouse" name="Klra5 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klra5 protein, mouse</Term>
        <Term>Ly49E antigen, mouse</Term>
        <Term>killer cell lectin-like receptor, subfamily A, member 5, mouse</Term>
        <Codes>
          <Code code="C2351934" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Gender_Category" name="Gender Category">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Gender Category</Term>
        <Relations>
          <Relation name="Broader">OTE:Population_Category</Relation>
          <Relation name="Narrower">OTE:Male, OTE:Female</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:6C2_molecule" name="6C2 molecule">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">6C2 molecule</Term>
        <Codes>
          <Code code="C0964777" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CDw60_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129X1_Sv_Mouse" name="129X1/Sv Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129X1/Sv Mouse</Term>
        <Term>129X1/Sv</Term>
        <Codes>
          <Code code="C37347" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:EWI-2wint_protein_human" name="EWI-2wint protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">EWI-2wint protein, human</Term>
        <Codes>
          <Code code="C2350804" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IGSF8_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd160_protein_mouse" name="Cd160 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd160 protein, mouse</Term>
        <Term>CD160 receptor, mouse</Term>
        <Term>CD160 antigen, mouse</Term>
        <Codes>
          <Code code="C1623436" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:HK_SING_Zebrafish" name="HK/SING Zebrafish">
        <Definition>A wild-type zebrafish line that is extinct.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">HK/SING Zebrafish</Term>
        <Term>HK/SING</Term>
        <Codes>
          <Code code="C79974" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:HUMDNAMB_protein_human" name="HUMDNAMB protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">HUMDNAMB protein, human</Term>
        <Term>human DNA marker B</Term>
        <Codes>
          <Code code="C0250776" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Genetic_Marker</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:sialyl-trimeric-Lewis_X" name="sialyl-trimeric-Lewis X">
        <SemanticType code="T118" name="Carbohydrate"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">sialyl-trimeric-Lewis X</Term>
        <Term>sialyl-trimeric-Le(X)</Term>
        <Codes>
          <Code code="C0914404" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD15_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:OX52_antigen" name="OX52 antigen">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">OX52 antigen</Term>
        <Codes>
          <Code code="C1175008" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD6_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_CD1d" name="Antigens, CD1d">
        <Definition>A major histocompatibily complex class I-like protein that plays a unique role in the presentation of lipid ANTIGENS to NATURAL KILLER T-CELLS.</Definition>
        <Definition>Antigen-presenting glycoprotein CD1d (335 aa, ~38 kDa) is encoded by the human CD1D gene. This protein is involved in lipid antigen presentation.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, CD1d</Term>
        <Term>Antigen, CD1d</Term>
        <Term>CD1d Antigen</Term>
        <Term>CD1d Antigens</Term>
        <Codes>
          <Code code="C2350465" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD1</Relation>
          <Relation name="Narrower">OTE:CD1d_antigen_mouse, OTE:CD1D_protein_human, OTE:Cd1d1_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:TPT1_protein_human" name="TPT1 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">TPT1 protein, human</Term>
        <Term>TCTP protein, human</Term>
        <Term>tumor protein, translationally-controlled 1, human</Term>
        <Term>HRF protein, human</Term>
        <Term>histamine-releasing factor protein, human</Term>
        <Codes>
          <Code code="C1100850" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:translationally_controlled_tumor_protein_p23</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Age_Category" name="Age Category">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Age Category</Term>
        <Relations>
          <Relation name="Broader">OTE:Population_Category</Relation>
          <Relation name="Narrower">OTE:Age_Groups</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:cohort_study" name="cohort study">
        <Definition>Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. [Cohort studies | MeSH_2014]</Definition>
        <Definition> A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke). [NCIT_14.05d] </Definition>
        <Definition>A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).</Definition>
        <Definition>Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.</Definition>
        <Definition>Prospective investigation of the factors that might cause a disorder in which a cohort of individuals who do not have evidence of an outcome of interest but who are exposed to the putative cause are compared with a concurrent cohort who are also free of the outcome but not exposed to the putative cause.  Both cohorts are then followed to compare the incidence of the outcome of interest.</Definition>
        <SemanticType code="T081" name="Quantitative Concept"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">cohort study</Term>
        <Term>cohort studies</Term>
        <Term>Concurrent Study</Term>
        <Term>analysis, cohort</Term>
        <Term>COHORT ANALYTIC STUDY</Term>
        <Term>cohort analysis</Term>
        <Term>cohort design</Term>
        <Term>Cohort Studies</Term>
        <Term>Studies, Cohort</Term>
        <Term>Study, Cohort</Term>
        <Term>Cohort Study</Term>
        <Term>cohort trials</Term>
        <Term>Concurrent Studies</Term>
        <Term>COHORT STUDIES</Term>
        <Term>Study, Concurrent</Term>
        <Term>cohort trial</Term>
        <Term>Studies, Concurrent</Term>
        <Term>cohort designs</Term>
        <Codes>
          <Code code="C0009247" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:concurrent_design, OTE:incidence_study, OTE:nonconcurrent_cohort_study, OTE:retrospective_cohort_study, OTE:cohort_before-after_design_, OTE:closed_cohort_study, OTE:prospective_cohort_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ENG_protein_human" name="ENG protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ENG protein, human</Term>
        <Term>CD105 antigen, human</Term>
        <Term>endoglin protein, human</Term>
        <Term>Osler-Rendu-Weber syndrome 1 protein, human</Term>
        <Codes>
          <Code code="C1437287" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:L-endoglin_protein_human, OTE:S-endoglin_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Gottingen_Pig" name="Gottingen Pig">
        <Definition>The smallest of the common miniature breeds, this breed is 10-14kg at sexual maturity with a shortened snout and rounded appearance. The Gottingen pig has white skin and hair. It is used in a variety of applications in biomedical research including cardiovascular studies, and its small size makes it an ideal animal model due to its relative ease of handling and smaller housing requirements.</Definition>
        <Definition>The smallest of the common miniature breeds, this breed is 10-14kg at sexual maturity with a shortened snout and rounded appearance. The Gottingen pig has white skin and hair. It is used in a variety of applications in biomedical research including cardiovascular studies, and its small size makes it an ideal animal model due to its relative ease of handling and smaller housing requirements. (NCI)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Gottingen Pig</Term>
        <Term>GOTTINGEN</Term>
        <Term>Gottingen</Term>
        <Codes>
          <Code code="C2697517" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Pig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Infant_Extremely_Premature" name="Infant, Extremely Premature">
        <Definition>A human infant born before 28 weeks of GESTATION.</Definition>
        <SemanticType code="T100" name="Age Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Infant, Extremely Premature</Term>
        <Term>Infant, Extremely Preterm</Term>
        <Term>Extremely Premature Infants</Term>
        <Term>Preterm Infants, Extremely</Term>
        <Term>Premature Infant, Extremely</Term>
        <Term>Extremely Preterm Infant</Term>
        <Term>Infants, Extremely Premature</Term>
        <Term>Preterm Infant, Extremely</Term>
        <Term>Infants, Extremely Preterm</Term>
        <Term>Premature Infants, Extremely</Term>
        <Term>Extremely Preterm Infants</Term>
        <Term>Extremely Premature Infant</Term>
        <Codes>
          <Code code="C3494262" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Infants_Premature</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Integrin_alpha6A" name="Integrin alpha6A">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Integrin alpha6A</Term>
        <Term>alpha6A, Integrin</Term>
        <Codes>
          <Code code="C0380296" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Integrin_alpha6</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Integrin_alpha6B" name="Integrin alpha6B">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Integrin alpha6B</Term>
        <Term>alpha6B, Integrin</Term>
        <Term>INTEGRIN ALPHA A 06B</Term>
        <Codes>
          <Code code="C0380297" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Integrin_alpha6</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C_129S7-Rag1-tm1Mom_Mouse" name="C.129S7-Rag1-tm1Mom Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C.129S7-Rag1-tm1Mom Mouse</Term>
        <Term>BALB/c-Rag1-tm1Mom</Term>
        <Term>C.129S7-Rag1-tm1Mom</Term>
        <Codes>
          <Code code="C15169" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rag1_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:asialofetuin" name="asialofetuin">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">asialofetuin</Term>
        <Term>fetuin, asialo derivative</Term>
        <Term>asialo-fetuin</Term>
        <Codes>
          <Code code="C0052492" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
          <Relation name="Narrower">OTE:asialogalactofetuin</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_CD23" name="Antigens, CD23">
        <Definition>Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RII) and high affinity receptors (Fc epsilon RI).</Definition>
        <Definition>A measurement of the CD23 expressing cells per unit in a biological specimen.</Definition>
        <Definition>The determination of the amount of CD23 expressing cells per unit present in a sample.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, CD23</Term>
        <Term>Receptors, Fc epsilon</Term>
        <Term>ANTIGENS CD 023</Term>
        <Term>Receptors, epsilon Fc</Term>
        <Term>IgE Receptors</Term>
        <Term>CD 23 Antigens</Term>
        <Term>CD23 Antigen</Term>
        <Term>Fc epsilon Receptors</Term>
        <Term>IGE RECEPT</Term>
        <Term>FC EPSILON RECEPT</Term>
        <Term>RECEPT IGE</Term>
        <Term>CD23 Antigens</Term>
        <Term>CD 023 ANTIGENS</Term>
        <Term>epsilon Receptors, Fc</Term>
        <Term>FC RECEPT EPSILON</Term>
        <Term>Receptor, Immunoglobulin E</Term>
        <Term>Immunoglobulin E Receptor</Term>
        <Term>Fc Receptors, epsilon</Term>
        <Term>Antigens, CD 23</Term>
        <Term>EPSILON FC RECEPT</Term>
        <Term>Receptors, IgE</Term>
        <Term>RECEPT FC EPSILON</Term>
        <Term>epsilon Fc Receptors</Term>
        <Term>Antigen, CD23</Term>
        <Codes>
          <Code code="C0123242" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Fc_epsilon_RI, OTE:FcepsilonRI_alpha-chain_human, OTE:L985P_protein_human, OTE:FCER1A_protein_human, OTE:FcepsilonRIalpha_protein_mouse, OTE:FCER2_protein_human, OTE:MS4A2_protein_human, OTE:FcepsilonRI_protein_rat, OTE:FcepsilonRI_gamma-chain_human, OTE:Fc-epsilon_receptor_I_beta-chain_mouse, OTE:Fc_epsilon_RII</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MUC1_tandem_repeat_peptide" name="MUC1 tandem repeat peptide">
        <SemanticType code="T118" name="Carbohydrate"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MUC1 tandem repeat peptide</Term>
        <Codes>
          <Code code="C0760810" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CA-15-3_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FcgammaRIIB1" name="FcgammaRIIB1">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FcgammaRIIB1</Term>
        <Codes>
          <Code code="C0753724" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Fc_gamma_IIB_receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129S_Sv_Mouse" name="129S/Sv Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129S/Sv Mouse</Term>
        <Term>129S/Sv</Term>
        <Codes>
          <Code code="C37333" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Darjeeling_Zebrafish" name="Darjeeling Zebrafish">
        <Definition>A wild-type zebrafish line, the stock of which was collected in Darjeeling, India in 1987. This line has been maintained through inbreeding. It is used for gene mapping due to the presence of several polymorphic markers.</Definition>
        <Definition>A wild-type zebrafish line, the stock of which was collected in Darjeeling, India in 1987. This line has been maintained through inbreeding. It is used for gene mapping due to the presence of several polymorphic markers.(ZFin)</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Darjeeling Zebrafish</Term>
        <Term>Darjeeling - zebrafish</Term>
        <Term>DAR</Term>
        <Term>Darjeeling</Term>
        <Codes>
          <Code code="C79969" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Population_Category" name="Population Category">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Population Category</Term>
        <Relations>
          <Relation name="Broader">OTE:Terminology</Relation>
          <Relation name="Narrower">OTE:Species_Category, OTE:Age_Category, OTE:Population_Type_Category, OTE:Gender_Category, OTE:Ehnicity_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Singapore_Zebrafish" name="Singapore Zebrafish">
        <Definition>A wild-type zebrafish line, the stock of which was obtained from a fish dealer in Singapore.(ZFin)</Definition>
        <Definition>A wild-type zebrafish line, the stock of which was obtained from a fish dealer in Singapore.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Singapore Zebrafish</Term>
        <Term>Singapore</Term>
        <Term>SING</Term>
        <Codes>
          <Code code="C3154892" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:longitudinal_design" name="longitudinal design">
        <Definition>Studies in which variables relating to an individual or group of individuals are assessed over a period of time. [MeSH_2014]</Definition>
        <Definition>a study in which participants, processes, or systems are studied over time, with data being collected at multiple intervals. The two main types are prospective s. and retrospective s. Cf. cross-sectional study [Emtree_2014] [Doralnd's Medaical Dictionary_2011]</Definition>
        <SemanticType code="T081" name="Quantitative Concept"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">longitudinal design</Term>
        <Term>longitudinal survey</Term>
        <Term>longitudinal studies</Term>
        <Term>longitudinal evaluation</Term>
        <Term>longitudinal trials</Term>
        <Term>longitudinal trial</Term>
        <Term>longitudinal study</Term>
        <Term>Epidemiologic Methods [1966-1974]</Term>
        <Term>longitudinal designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#longitudinal_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:follow-up_study, OTE:uncontrolled_longitudinal_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CEACAM6_protein_mouse" name="CEACAM6 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CEACAM6 protein, mouse</Term>
        <Term>carcinoembryonic antigen-related cell adhesion molecule 6, mouse</Term>
        <Codes>
          <Code code="C3502598" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD70_protein_human" name="CD70 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD70 protein, human</Term>
        <Term>tumor necrosis factor (ligand) superfamily, member 7, human</Term>
        <Term>TNFSF7 protein, human</Term>
        <Term>CD27LG protein, human</Term>
        <Codes>
          <Code code="C1664176" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD70</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NK_Cell_Lectin_Like_Receptor_Subfamily_B_Member_1" name="NK Cell Lectin Like Receptor Subfamily B, Member 1">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NK Cell Lectin Like Receptor Subfamily B, Member 1</Term>
        <Term>Receptor, NKR-P1</Term>
        <Term>NKR-P1 Receptor</Term>
        <Term>NKR-P1 Receptors</Term>
        <Term>Antigen, CD161</Term>
        <Term>Receptors, NKR P1</Term>
        <Term>NK Cell Lectin-Like Receptor Subfamily B, Member 1</Term>
        <Term>CD161 Antigen</Term>
        <Term>NKR P1 Receptor</Term>
        <Term>NKR P1 Receptors</Term>
        <Term>CD161 Antigens</Term>
        <Term>Antigens, CD161</Term>
        <Term>Receptors, NKR-P1</Term>
        <Codes>
          <Code code="C2350495" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_B</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Plasminogen_Activator_Urokinase_Receptors" name="Plasminogen Activator, Urokinase Receptors">
        <Definition>An extracellular receptor specific for UROKINASE-TYPE PLASMINOGEN ACTIVATOR. It is attached to the cell membrane via a GLYCOSYLPHOSPHATIDYLINOSITOL LINKAGE and plays a role in the co-localization of urokinase-type plasminogen activator with PLASMINOGEN.</Definition>
        <Definition>High affinity cellular receptor for urokinase plasminogen activator (uPA). Plays a role in plasminogen activation by facilitating the conversion of uPA to an enzymatically active form anchored to the cell membrane, where plasminogen activation occurs. Affects tissue remodeling (surface proteolysis, cell adhesion, cell migration), and cancer invasion.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Plasminogen Activator, Urokinase Receptors</Term>
        <Term>Plasminogen Activator Receptor, Urokinase Type</Term>
        <Term>Receptor, Upar</Term>
        <Term>Urokinase-Type Plasminogen Activator Receptors</Term>
        <Term>Urokinase Type Plasminogen Activator Receptors</Term>
        <Term>Urokinase Plasminogen Activator Receptors</Term>
        <Term>CD87 Antigens</Term>
        <Term>Receptor, Pro-Urokinase</Term>
        <Term>Receptor, Pro Urokinase</Term>
        <Term>Pro-Urokinase Receptor</Term>
        <Term>Receptor, U-PA</Term>
        <Term>U-PA Receptor</Term>
        <Term>CD87 Antigen</Term>
        <Term>Plasminogen Activator, Urokinase Receptor</Term>
        <Term>Receptors, Urokinase Plasminogen Activator</Term>
        <Term>U PA Receptor</Term>
        <Term>Antigen, CD87</Term>
        <Term>Receptor, Urokinase Plasminogen Activator</Term>
        <Term>Upar Receptor</Term>
        <Term>Antigens, CD87</Term>
        <Codes>
          <Code code="C0071216" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Plaur_protein_rat, OTE:plasminogen_activator_urokinase_receptor_human, OTE:haldisin_protein_human, OTE:Plaur_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:HRS_J_Mouse" name="HRS/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">HRS/J Mouse</Term>
        <Term>HRS/J</Term>
        <Codes>
          <Code code="C37407" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:fibrinopeptide_A_des-Ala-" name="fibrinopeptide A, des-Ala(1)-">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">fibrinopeptide A, des-Ala(1)-</Term>
        <Term>fibrinopeptide A, desalanyl(1)-</Term>
        <Term>FpAY peptide</Term>
        <Term>1-des-Ala-fibrinopeptide A</Term>
        <Codes>
          <Code code="C1569806" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Fibrinopeptide_A</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD19" name="Antigen, CD19">
        <Definition>CD antigen expressed on B cell surface; forms signal transduction complex with CD21 (CR2) and CD81 (TAPA-1).</Definition>
        <Definition>Expressed on early B-cells by human CD19 Gene (Ig Superfamily), 95-kDa CD19_Antigen is a type I cell surface protein with 2 extracellular IgC2 domains, a cytoplasmic tail with 9 conserved Tyr residues, and no significant homology with other known proteins. Assembled with BCR, CD19 decreases the threshold for antigen receptor-dependent stimulation of B lymphocyte proliferation and intersects with many intracellular signaling pathways. CD19 functions as an adaptor protein for Src family kinase amplification, crucial for antigen receptor-induced signal transduction. Following BCR/CD19 ligation, LYN (Src kinase) phosphorylates CD19-Y513, binds to the CD19-SH2 domain and phosphorylates CD19-Y482. CD19-pY482 recruits more LYN, leading to LYN phosphorylation and CD19-Y391 phosphorylation. CD19-pY391 recruits VAV, phosphorylated by LYN. (NCI)</Definition>
        <Definition>Differentiation antigens expressed on B-lymphocytes and B-cell precursors. They are involved in regulation of B-cell proliferation.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD19</Term>
        <Term>CD19 Antigen</Term>
        <Term>CD19 Antigens</Term>
        <Term>Antigens, CD19</Term>
        <Term>B Cell Antigen CD19</Term>
        <Term>CD 019 ANTIGENS</Term>
        <Term>ANTIGENS CD 019</Term>
        <Codes>
          <Code code="C0108748" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD20" name="Antigen, CD20">
        <Definition>Unglycosylated phosphoproteins expressed only on B-cells. They are regulators of transmembrane Ca2+ conductance and thought to play a role in B-cell activation and proliferation.</Definition>
        <Definition>B-lymphocyte antigen CD20 (297 aa, ~33 kDa) is encoded by the human MS4A1 gene. This protein plays a role in both the activation and proliferation of B-cells.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD20</Term>
        <Term>CD20 Antigen</Term>
        <Term>ANTIGENS CD 020</Term>
        <Term>Antigens, CD20</Term>
        <Term>CD20 Antigens</Term>
        <Term>CD 020 ANTIGENS</Term>
        <Codes>
          <Code code="C0054946" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:TORID_protein_rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD15_Antigen" name="CD15 Antigen">
        <Definition>A carbohydrate molecule found on the surface of neutrophils, eosinophils and monocytes. It is involved in neutrophil chemotaxis and phagocytosis. Expression of this antigen is associated with Hodgkin disease, chronic lymphocytic leukemia, and acute lymphoblastic leukemia.</Definition>
        <Definition>A trisaccharide antigen expressed on glycolipids and many cell-surface glycoproteins. In the blood the antigen is found on the surface of NEUTROPHILS; EOSINOPHILS; and MONOCYTES. In addition, CD15 antigen is a stage-specific embryonic antigen.</Definition>
        <SemanticType code="T118" name="Carbohydrate"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD15 Antigen</Term>
        <Term>Lymphocyte antigen CD15</Term>
        <Term>SSEA A 01</Term>
        <Term>LEU M ANTIGENS 001</Term>
        <Term>Antigens, CD15 [Chemical/Ingredient]</Term>
        <Term>SSEA-1</Term>
        <Term>LeX</Term>
        <Term>CD15</Term>
        <Term>SSEA-1 Determinant</Term>
        <Term>Hapten X</Term>
        <Term>Leu M1 Antigens</Term>
        <Term>CD15 - Cluster of diff ag 15</Term>
        <Term>Galbeta(1-4)Fucalpha(1-3)GlcNAc</Term>
        <Term>CD 015 ANTIGENS</Term>
        <Term>Cluster of diff antigen 15</Term>
        <Term>Lewis X Antigen</Term>
        <Term>LE X ANTIGEN</Term>
        <Term>3-Fucosyl-N-Acetyl-Lactosamine</Term>
        <Term>SSEA1</Term>
        <Term>Lewis X Hapten</Term>
        <Term>SSEA 1 Determinant</Term>
        <Term>Le(X) Antigen</Term>
        <Term>Embryonic Antigen-1, Stage-Specific</Term>
        <Term>ANTIGENS CD 015</Term>
        <Term>SSEA1 DETERMINANT</Term>
        <Term>X Antigen, Lewis</Term>
        <Term>Leukocyte M1</Term>
        <Term>CD15 Ag</Term>
        <Term>3 alpha Fucosyl N Acetyl Lactosamine</Term>
        <Term>LEX ANTIGEN</Term>
        <Term>Cluster of differentiation antigen 15</Term>
        <Term>STAGE SPECIFIC EMBRYONIC ANTIGEN 001</Term>
        <Term>My1</Term>
        <Term>Antigen, Lewis X</Term>
        <Term>CD15 - Cluster of differentiation antigen 15</Term>
        <Term>CD15 Antigens</Term>
        <Term>Leucocyte M1</Term>
        <Term>SSEA DETERMINANT 01</Term>
        <Term>Lewis X</Term>
        <Term>LewisX Antigen</Term>
        <Term>Stage-Specific Embryonic Antigen-1</Term>
        <Term>3 alpha-Fucosyl-N-Acetyl Lactosamine</Term>
        <Term>Stage-Specific Embryonic Antigen 1</Term>
        <Term>Antigens, CD15</Term>
        <Term>SSEA 1</Term>
        <Term>Lymphocyte antigen CD15 (substance)</Term>
        <Term>X Hapten, Lewis</Term>
        <Term>Leu-M1 Antigens</Term>
        <Term>Stage Specific Embryonic Antigen 1</Term>
        <Codes>
          <Code code="C0080188" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:6-O-sulfo_de-N-acetylsialyl_Lewis_X, OTE:sialyl_Lewis_X_antigen, OTE:sialyl-trimeric-Lewis_X, OTE:Leu-M1_antigen, OTE:sialosyl_dimeric_Leantigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cuban_Americans" name="Cuban Americans">
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cuban Americans</Term>
        <Term>Cuban American</Term>
        <Term>Americans, Cuban</Term>
        <Codes>
          <Code code="C0010436" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Hispanic_Americans</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD24" name="Antigen, CD24">
        <Definition>A cell adhesion protein that was originally identified as a heat stable antigen in mice. It is involved in METASTASIS and is highly expressed in many NEOPLASMS.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD24</Term>
        <Term>CD24 Antigens</Term>
        <Term>Heat-Stable Antigen CD24</Term>
        <Term>Heat Stable Antigen CD24</Term>
        <Term>CD24, Heat-Stable Antigen</Term>
        <Term>CD24 Antigen</Term>
        <Term>Nectadrin</Term>
        <Term>ANTIGENS CD 024</Term>
        <Term>Antigens, CD24</Term>
        <Term>CD 024 ANTIGENS</Term>
        <Codes>
          <Code code="C0054948" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cd24a_protein_mouse, OTE:CD24_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD76_antigen" name="CD76 antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD76 antigen</Term>
        <Term>CD76 - Cluster of differentiation antigen 76</Term>
        <Term>Lymphocyte antigen CD76 (substance)</Term>
        <Term>Cluster of differentiation antigen 76</Term>
        <Term>CD76 - Cluster of diff ag 76</Term>
        <Term>Cluster of diff antigen 76</Term>
        <Term>Lymphocyte antigen CD76</Term>
        <Term>CD 76 antigen</Term>
        <Codes>
          <Code code="C0081945" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Vascular_Cell_Adhesion_Molecule_1" name="Vascular Cell Adhesion Molecule 1">
        <Definition>The determination of the amount of vascular cell adhesion molecule 1 present in a sample.</Definition>
        <Definition>This gene is involved in the regulation of leukocyte-endothelial cell adhesion interactions.</Definition>
        <Definition>Cytokine-induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of inflammation. (From Pigott &amp; Power, The Adhesion Molecule FactsBook, 1993, p154)</Definition>
        <Definition>A measurement of the vascular cell adhesion molecule 1 in a biological specimen.</Definition>
        <Definition>cytokine induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts and myotubes; important for the recruitment of leukocytes to sites of inflammation.</Definition>
        <Definition>Vascular cell adhesion molecule-1 (739 aa, ~81 kDa) is encoded by the human VCAM1 gene. This protein is involved in the adhesion of immune cells.</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Vascular Cell Adhesion Molecule 1</Term>
        <Term>VCAM1 gene</Term>
        <Term>vascular cell adhesion molecule</Term>
        <Term>ANTIGENS CD 106</Term>
        <Term>vascular cell adhesion molecule 1</Term>
        <Term>V-CAM 1</Term>
        <Term>CD106 Antigens</Term>
        <Term>VCAM</Term>
        <Term>Vascular Cell Adhesion Molecule</Term>
        <Term>VASCULAR CELL ADHESION MOLECULE 1</Term>
        <Term>Antigen, CD106</Term>
        <Term>Lymphocyte antigen CD106 (substance)</Term>
        <Term>Vascular Cell Adhesion Molecule-1</Term>
        <Term>Vascular Cell Adhesion Molecule-1 Gene</Term>
        <Term>Vascular Cell Adhesion Molecule-1 [Chemical/Ingredient]</Term>
        <Term>INCAM-100</Term>
        <Term>CD106</Term>
        <Term>Inducible Cell Adhesion Molecule 110</Term>
        <Term>VASCULAR CELL ADHESION MOLECULE 001</Term>
        <Term>Lymphocyte antigen CD106</Term>
        <Term>INCAM-110</Term>
        <Term>Vascular Cell Adhesion Molecule 1 Measurement</Term>
        <Term>VCAM1 Gene</Term>
        <Term>vcam-1</Term>
        <Term>Antigens, CD106</Term>
        <Term>VCAM1</Term>
        <Term>VCAM-1</Term>
        <Term>CD106 Antigen</Term>
        <Term>CD 106 ANTIGENS</Term>
        <Term>VCAM 001</Term>
        <Term>VCAM 1</Term>
        <Codes>
          <Code code="C2825916" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Complement_3d_Receptor" name="Complement 3d Receptor">
        <Definition>Molecular sites on or in B-lymphocytes, follicular dendritic cells, lymphoid cells, and epithelial cells that recognize and combine with COMPLEMENT C3D. Human complement receptor 2 (CR2) serves as a receptor for both C3dg and the gp350/220 glycoprotein of HERPESVIRUS 4, HUMAN, and binds the monoclonal antibody OKB7, which blocks binding of both ligands to the receptor.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Complement 3d Receptor</Term>
        <Term>ANTIGENS CD 021</Term>
        <Term>Receptors, Complement 3d [Chemical/Ingredient]</Term>
        <Term>C3d Receptors</Term>
        <Term>CD21 - Cluster of diff ag 21</Term>
        <Term>Receptors, C3d</Term>
        <Term>Cluster of diff antigen 21</Term>
        <Term>Complement receptor II</Term>
        <Term>CR II - Complement receptor II</Term>
        <Term>Antigens, CD 21</Term>
        <Term>2, Complement Receptors</Term>
        <Term>Epstein Barr Virus Receptors</Term>
        <Term>Lymphocyte antigen CD21 (substance)</Term>
        <Term>CD21 Antigen</Term>
        <Term>Receptor 2, Complement</Term>
        <Term>RECEPT CR2</Term>
        <Term>Receptors, Epstein-Barr Virus</Term>
        <Term>CD21 Ag</Term>
        <Term>RECEPTORS C 03 D</Term>
        <Term>Receptors, Epstein Barr Virus</Term>
        <Term>Virus Receptors, Epstein-Barr</Term>
        <Term>RECEPT C 3D</Term>
        <Term>Epstein-Barr Virus Receptor</Term>
        <Term>Lymphocyte antigen CD21</Term>
        <Term>RECEPT EPSTEIN BARR VIRUS</Term>
        <Term>Epstein-Barr Virus Receptors</Term>
        <Term>Epstein-Barr virus receptor</Term>
        <Term>Epstein Barr Virus Receptor</Term>
        <Term>CD 021 ANTIGEN</Term>
        <Term>C A 003D RECEPTORS</Term>
        <Term>CR2 Receptors</Term>
        <Term>Complement Receptors 2</Term>
        <Term>CD21</Term>
        <Term>CD 021 ANTIGENS</Term>
        <Term>CD21 Antigens</Term>
        <Term>EPSTEIN BARR VIRUS RECEPT</Term>
        <Term>Receptor, Epstein-Barr Virus</Term>
        <Term>Herpesvirus 4 Receptors, Human</Term>
        <Term>CR2 RECEPT</Term>
        <Term>CD21 - Cluster of differentiation antigen 21</Term>
        <Term>Receptors, Complement 3d</Term>
        <Term>RECEPTORS CR 02</Term>
        <Term>Receptor, Complement 3d</Term>
        <Term>Receptors, CR2</Term>
        <Term>COMPLEMENT A 03 D RECEPTORS</Term>
        <Term>C3D RECEPT</Term>
        <Term>EBV - Epstein-Barr virus receptor</Term>
        <Term>RECEPTORS COMPLEMENT 03 D</Term>
        <Term>2, Complement Receptor</Term>
        <Term>CR 02 RECEPTORS</Term>
        <Term>RECEPT C3D</Term>
        <Term>CD 21 Antigens</Term>
        <Term>C 3D RECEPT</Term>
        <Term>Complement receptor 2</Term>
        <Term>Receptors 2, Complement</Term>
        <Term>Complement Receptor 2</Term>
        <Term>C3d receptor</Term>
        <Term>Complement 3d Receptors</Term>
        <Term>Antigens, CD21</Term>
        <Term>EBV - Epstein-Barr virus recep</Term>
        <Term>Virus Receptor, Epstein-Barr</Term>
        <Term>HERPESVIRUS 4 RECEPT HUMAN</Term>
        <Term>CR2</Term>
        <Term>Cluster of differentiation antigen 21</Term>
        <Term>Antigen, CD21</Term>
        <Codes>
          <Code code="C0056184" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:KIR3DL1_protein_human" name="KIR3DL1 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">KIR3DL1 protein, human</Term>
        <Term>natural killer-associated transcript 3 protein, human</Term>
        <Term>killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 protein, human</Term>
        <Term>NKAT3 protein, human</Term>
        <Codes>
          <Code code="C1430234" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Killer_Cell_Immunoglobulin_Like_Receptor_3DL1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Hartley_Guinea_Pig" name="Hartley Guinea Pig">
        <Definition>Albino outbred guinea pig belonging to the English (short-haired) breed. The Hartley guinea pig was imported from the Medical Research Council, Millhill, England, to Charles River in 1968 for propagation. The animal is a crepuscular mammalian herbivore that is tailless with short legs and a large head. The Hartley Guinea Pig has a white coat color (acromelanic albino) and red eyes and requires a nutritional source of vitamin C to sustain normal function. The Hartley guinea pig is used as an animal model for studying human diseases and toxins harmful to man, as well as the development of serums and vaccines.</Definition>
        <Definition>Albino outbred guinea pig belonging to the English (short-haired) breed. The Hartley guinea pig was imported from the Medical Research Council, Millhill, England, to Charles River in 1968 for propagation. The Hartley Guinea Pig has a white coat color (acromelanic albino) and red eyes and requires a nutritional source of vitamin C to sustain normal function.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Hartley Guinea Pig</Term>
        <Term>HARTLEY</Term>
        <Term>Hartley</Term>
        <Term>Hartley guinea pig (organism)</Term>
        <Term>Hartley guinea pig</Term>
        <Codes>
          <Code code="C0324525" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Guinea_Pig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Neprilysin" name="Neprilysin">
        <Definition>This gene is involved in the inactivation of peptide hormones.</Definition>
        <Definition>Enzyme that is a major constituent of kidney brush-border membranes and is also present to a lesser degree in the brain and other tissues. It preferentially catalyzes cleavage at the amino group of hydrophobic residues of the B-chain of insulin as well as opioid peptides and other biologically active peptides. The enzyme is inhibited primarily by EDTA, phosphoramidon, and thiorphan and is reactivated by zinc. Neprilysin is identical to common acute lymphoblastic leukemia antigen (CALLA Antigen), an important marker in the diagnosis of human acute lymphocytic leukemia. There is no relationship with CALLA PLANT.</Definition>
        <Definition>Neprilysin (750 aa, ~86 kDa) is encoded by the human MME gene. This protein is involved in the metabolism of biologically active peptides.</Definition>
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Neprilysin</Term>
        <Term>Endopeptidase 24.11, Neutral</Term>
        <Term>Neutral Endopeptidase</Term>
        <Term>CD 010 ANTIGENS</Term>
        <Term>EC 3.4.24.11</Term>
        <Term>YGG-Forming Enzyme</Term>
        <Term>Neutral Proteinase, Kidney-Brush-Border</Term>
        <Term>MME</Term>
        <Term>Antigens, CD10</Term>
        <Term>Membrane metallo-endopeptidase</Term>
        <Term>Thermolysin-Like Metalloendopeptidase</Term>
        <Term>Atriopeptidase</Term>
        <Term>c-ALL - Common acute lymphoblastic leukemia antigen</Term>
        <Term>Membrane Metallo Endopeptidase</Term>
        <Term>Cluster of differentiation antigen 10</Term>
        <Term>neutral endopeptidase</Term>
        <Term>Comm acute lymphobl leukaem ag</Term>
        <Term>CD10 Antigen</Term>
        <Term>NEPRILYSIN</Term>
        <Term>Endopeptidase, Neutral</Term>
        <Term>Metalloendopeptidase, Thermolysin-Like</Term>
        <Term>Antigen CD10</Term>
        <Term>Common Acute Lymphoblastic Leukemia Antigen</Term>
        <Term>NEP</Term>
        <Term>CD10</Term>
        <Term>CD10 Ag</Term>
        <Term>Enkephalin Dipeptidyl Carboxypeptidase</Term>
        <Term>ANTIGENS CD 010</Term>
        <Term>CALLA - Common acute lymphoblastic leukaemia antigen</Term>
        <Term>NEUTRAL ENDOPEPTIDASE, MEMBRANE-ASSOCIATED</Term>
        <Term>Enkephalinase 24.11</Term>
        <Term>C10</Term>
        <Term>Enkephalinase-24.11</Term>
        <Term>CALLA Antigen</Term>
        <Term>MME Gene</Term>
        <Term>cALLa</Term>
        <Term>common acute lymphoblastic leukemia antigen (CALLA)</Term>
        <Term>ATRIOPEPTIDASE</Term>
        <Term>Carboxypeptidase, Enkephalin Dipeptidyl</Term>
        <Term>Endopeptidase 24.11</Term>
        <Term>Neprilysin [Chemical/Ingredient]</Term>
        <Term>CD10 - Cluster of diff ag 10</Term>
        <Term>Antigens, Leukemia, Common Acute Lymphoblastic</Term>
        <Term>COMMON ACUTE LYMPHOCYTIC LEUKEMIA ANTIGEN</Term>
        <Term>Membrane Metallo-Endopeptidase (Neutral Endopeptidase, Enkephalinase, CALLA, CD10) Gene</Term>
        <Term>neprilysin</Term>
        <Term>Enkephalinase</Term>
        <Term>MEMBRANE METALLOENDOPEPTIDASE</Term>
        <Term>Membrane Metallo-Endopeptidase</Term>
        <Term>CALLA</Term>
        <Term>MME gene</Term>
        <Term>CD10 Antigens</Term>
        <Term>Lymphocyte antigen CD10</Term>
        <Term>membrane metallo-endopeptidase</Term>
        <Term>Endopeptidase-24.11</Term>
        <Term>c10</Term>
        <Term>Skin Fibroblast Elastase</Term>
        <Term>Kidney-brush-border neutral proteinase</Term>
        <Term>enkephalinase</Term>
        <Term>CALLA-Comm ac lymphobl leuk ag</Term>
        <Term>c-ALL-Comm ac lymphobl leuk ag</Term>
        <Term>Antigen, CD10</Term>
        <Term>kidney brush border neutral peptidase</Term>
        <Term>ENKEPHALINASE</Term>
        <Term>c-ALL - Common acute lymphoblastic leukaemia antigen</Term>
        <Term>Common Acute Lymphoblastic Leukemia Antigens</Term>
        <Term>Membrane Metalloendopeptidase</Term>
        <Term>Neutral Endopeptidase 24.11</Term>
        <Term>Kidney-Brush-Border Neutral Proteinase</Term>
        <Term>YGG Forming Enzyme</Term>
        <Term>Dipeptidyl Carboxypeptidase, Enkephalin</Term>
        <Term>Enzyme, YGG-Forming</Term>
        <Term>Thermolysin Like Metalloendopeptidase</Term>
        <Term>CALLA - Common acute lymphoblastic leukemia antigen</Term>
        <Term>Common acute lymphoblastic leukaemia antigen</Term>
        <Term>nep</Term>
        <Term>Common ALL Antigen</Term>
        <Term>Common acute lymphoblastic leukemia antigen</Term>
        <Term>Kidney Brush Border Neutral Proteinase</Term>
        <Term>CD10 - Cluster of differentiation antigen 10</Term>
        <Term>neutral endopeptidase (NEP)</Term>
        <Term>Cluster of diff antigen 10</Term>
        <Term>Metallo-Endopeptidase, Membrane</Term>
        <Term>cd10 antigen</Term>
        <Term>Neutral endopeptidase</Term>
        <Term>Lymphocyte antigen CD10 (substance)</Term>
        <Term>SFE</Term>
        <Codes>
          <Code code="C0025250" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:neprilysin_2_rat, OTE:neprilysin_2_mouse, OTE:MMEL1_protein_human, OTE:NEP-2_protein_C_elegans, OTE:endopeptidase_24_11_Bombyx</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:prospective_cohort_study" name="prospective cohort study">
        <Definition>A research study that follows over time groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke and those who do not smoke) and compares them for a particular outcome (such as lung cancer).</Definition>
        <Definition>A research study that follows over time groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke and those who do not smoke) and compares them for a particular outcome (such as lung cancer). [NCIT_14.05d] </Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">prospective cohort study</Term>
        <Term>Prospective Study</Term>
        <Term>prospective cohort studies</Term>
        <Term>prospective cohort designs</Term>
        <Term>prospective cohort design</Term>
        <Term>prospective cohort trial</Term>
        <Term>Prospective Cohort Study</Term>
        <Term>prospective cohort trials</Term>
        <Codes>
          <Code code="C1709709" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cohort_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:HMT_Rat_Strain" name="HMT, Rat Strain">
        <Definition>About 50% incidence of squamous-cell carcinoma of the mouth late in life. Mean life-span 27-30 months with or without mouth tumors (Hulse 1979, Buckley et al 1980).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">HMT, Rat Strain</Term>
        <Codes>
          <Code code="C14384" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_CD32" name="Antigens, CD32">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, CD32</Term>
        <Term>CD32 Antigens</Term>
        <Term>ANTIGENS CD 032</Term>
        <Term>Fc gamma RII</Term>
        <Term>CD 32 Antigens</Term>
        <Term>CD 032 ANTIGENS</Term>
        <Term>Antigens, CD 32</Term>
        <Term>gamma RII, Fc</Term>
        <Codes>
          <Code code="C0054951" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd82_protein_rat" name="Cd82 protein, rat">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd82 protein, rat</Term>
        <Term>suppression of tumorigenicity 6 prostate protein, rat</Term>
        <Term>Kai1 protein, rat</Term>
        <Term>kangai 1 protein, rat</Term>
        <Codes>
          <Code code="C1528439" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:KAI1_Protein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Skin_Transplantation" name="Skin Transplantation">
        <Definition>grafting skin from one site to another within an individual or between individuals of the same or different species.</Definition>
        <Definition>The grafting of skin in humans or animals from one site to another to replace a lost portion of the body surface skin.</Definition>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Skin Transplantation</Term>
        <Term>Skin Graftings</Term>
        <Term>dermatoplasty</Term>
        <Term>Skin grafting</Term>
        <Term>Skin grafting, NOS</Term>
        <Term>Transplantations, Skin</Term>
        <Term>skin grafts</Term>
        <Term>Skin grafts</Term>
        <Term>SKIN TRANSPL</Term>
        <Term>TRANSPL SKIN</Term>
        <Term>Encounter due to skin transplanted</Term>
        <Term>Skin-grafting</Term>
        <Term>graft skin</Term>
        <Term>Dermatoplasty, NOS</Term>
        <Term>Grafting, Skin</Term>
        <Term>Repair of skin</Term>
        <Term>SKIN GRAFT</Term>
        <Term>Dermatoplasties</Term>
        <Term>Skin Grafting</Term>
        <Term>Transplantation, Skin</Term>
        <Term>Transplanted skin (body structure)</Term>
        <Term>Skin Transplantations</Term>
        <Term>skin graft (treatment)</Term>
        <Term>skin transplant</Term>
        <Term>Graftings, Skin</Term>
        <Term>skin grafting</Term>
        <Term>Skin graft</Term>
        <Term>Skin graft operation (procedure)</Term>
        <Term>Skin graft NOS</Term>
        <Term>skin graft</Term>
        <Term>Dermatoplasty</Term>
        <Term>Skin graft operation</Term>
        <Term>Graft;skin</Term>
        <Term>skin transplants</Term>
        <Term>Transplanted skin</Term>
        <Term>skin transplanted</Term>
        <Term>Repair of skin (procedure)</Term>
        <Term>skin transplantation</Term>
        <Codes>
          <Code code="C0037291" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Organ_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD27" name="Antigen, CD27">
        <Definition>CD27 antigen (260 aa, ~29 kDa) is encoded by the human CD27 gene. This protein is involved in regulating B-cell activation, immunoglobulin synthesis, and apoptosis.</Definition>
        <Definition>A member of the tumor necrosis factor receptor superfamily found on most T-LYMPHOCYTES. Activation of the receptor by CD70 ANTIGEN results in the increased proliferation of CD4-POSITIVE T-LYMPHOCYTES and CD8-POSITIVE T-LYMPHOCYTES. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD27</Term>
        <Term>CD27 Antigen</Term>
        <Term>Activation Antigen, T-Cell</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 07</Term>
        <Term>TNFRSF7 Receptor</Term>
        <Term>ANTIGENS CD 027</Term>
        <Term>CD 027 ANTIGENS</Term>
        <Term>T-Cell Activation Antigen</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPT SUPERFAMILY MEMBER 7</Term>
        <Term>Antigens, CD27</Term>
        <Term>T Cell Activation Antigen</Term>
        <Term>CD27 Antigens</Term>
        <Term>Receptor, TNFRSF7</Term>
        <Term>Antigen, T-Cell Activation</Term>
        <Term>TNFRSF7 RECEPT</Term>
        <Term>Tumor Necrosis Factor Receptor Superfamily, Member 7</Term>
        <Codes>
          <Code code="C0054949" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Adnab-9" name="Adnab-9">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Adnab-9</Term>
        <Codes>
          <Code code="C1871844" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:HBME-1_antigen" name="HBME-1 antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">HBME-1 antigen</Term>
        <Term>human mesothelial antigen</Term>
        <Codes>
          <Code code="C0968671" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD29" name="Antigen, CD29">
        <Definition>Integrin beta-1 (798 aa, ~88 kDa) is encoded by the human ITGB1 gene. This protein plays a role in leukocyte migration, signal transduction, ligand binding and cell adhesion.</Definition>
        <Definition>Integrin beta-1 chains which are expressed as heterodimers that are noncovalently associated with specific alpha-chains of the CD49 family (CD49a-f). CD29 is expressed on resting and activated leukocytes and is a marker for all of the very late activation antigens on cells. (from: Barclay et al., The Leukocyte Antigen FactsBook, 1993, p164)</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD29</Term>
        <Term>beta1 Integrin</Term>
        <Term>Antigen, 4B4</Term>
        <Term>Antigen, CDw29</Term>
        <Term>Integrin beta1</Term>
        <Term>CD29 Antigen</Term>
        <Term>CD29 Antigens</Term>
        <Term>INTEGRIN BETA A 01</Term>
        <Term>CD 029 ANTIGENS</Term>
        <Term>ANTIGENS CD 029</Term>
        <Term>Integrin, beta1</Term>
        <Term>Antigens, CD29</Term>
        <Term>4B4 Antigen</Term>
        <Term>CDw29 Antigen</Term>
        <Codes>
          <Code code="C0081938" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:integrin_beta1C, OTE:pactolus</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD30_Ligand" name="CD30 Ligand">
        <Definition>A membrane-bound tumor necrosis family member found primarily on activated T-LYMPHOCYTES that binds specifically to CD30 ANTIGEN. It may play a role in INFLAMMATION and immune regulation.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD30 Ligand</Term>
        <Term>CD153 Antigen</Term>
        <Term>ANTIGENS CD 153</Term>
        <Term>TNFSF8 gene</Term>
        <Term>TNF Superfamily, Member 8</Term>
        <Term>CD 153 ANTIGENS</Term>
        <Term>TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 8</Term>
        <Term>CD30L</Term>
        <Term>Antigens, CD153</Term>
        <Term>CD153</Term>
        <Term>TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 008</Term>
        <Term>CD30 LIGAND</Term>
        <Term>TNFSF8</Term>
        <Term>CD 030 LIGAND</Term>
        <Term>tumor necrosis factor (ligand) superfamily, member 8</Term>
        <Term>CD30LG</Term>
        <Term>CD30 Ligand [Chemical/Ingredient]</Term>
        <Term>Antigen, CD153</Term>
        <Term>Tumor Necrosis Factor Ligand Superfamily Member 8</Term>
        <Term>CD153 Antigens</Term>
        <Codes>
          <Code code="C1420820" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Tnfsf8_protein_mouse, OTE:TNFSF8_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ICAM3_protein_human" name="ICAM3 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ICAM3 protein, human</Term>
        <Term>CD50 antigen, human</Term>
        <Term>intercellular adhesion molecule R, human</Term>
        <Term>ICAM-R protein, human</Term>
        <Term>intercellular adhesion molecule 3, human</Term>
        <Term>CDw50 antigen, human</Term>
        <Codes>
          <Code code="C1450173" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:African_Americans" name="African Americans">
        <Definition>A person having origins in any of the black racial groups of Africa. Terms such as "Haitian" or "Negro" can be used in addition to "Black or African American." (FDA)</Definition>
        <Definition>A person having origins in any of the Black racial groups of Africa. Terms such as "Haitian" or "Negro" can be used in addition to "Black or African American". (OMB)</Definition>
        <Definition>Persons living in the United States having origins in any of the black groups of Africa.</Definition>
        <Definition>any person with African ethnic background whose home or birthplace is in the Americas, exluding AFRICAN CARIBBEAN.</Definition>
        <Definition>A person having origins in any of the black racial groups of Africa. Terms such as "Haitian" or "Negro" can be used in addition to "Black or African American."</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">African Americans</Term>
        <Term>afroamerican</Term>
        <Term>United States Black</Term>
        <Term>black American</Term>
        <Term>African-American</Term>
        <Term>AFRICAN AMERICAN</Term>
        <Term>Black Populations</Term>
        <Term>RaceBlackOrAfricanAmerican</Term>
        <Term>Black or African American</Term>
        <Term>African American</Term>
        <Term>Afro American</Term>
        <Term>Black American</Term>
        <Term>Black or African-American</Term>
        <Term>AFROAMERICAN</Term>
        <Term>Americans, African</Term>
        <Term>BLACK OR AFRICAN AMERICAN</Term>
        <Term>Black</Term>
        <Term>Afroamerican</Term>
        <Term>U.S. Blacks</Term>
        <Term>African American (ethnic group)</Term>
        <Codes>
          <Code code="C0085756" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ethnic_Groups</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Horse" name="Horse">
        <Definition>The domestic horse, Equus caballus. (NCI)</Definition>
        <Definition>género que abarca a caballos, asnos y mulas</Definition>
        <Definition>The domestic horse, Equus caballus.</Definition>
        <Definition>Taxonomic family which includes horses, zebras, and asses.</Definition>
        <Definition>A family of hoofed MAMMALS consisting of HORSES, donkeys, and zebras. Members of this family are strict herbivores and can be classified as either browsers or grazers depending on how they feed.</Definition>
        <Definition>large solid-hoofed herbivorous mammal (Equus caballus, family Equidae, the horse family) domesticated since a prehistoric period and used as a beast of burden, a draft animal, or for riding.</Definition>
        <Definition>Horse, donkey, mule genus</Definition>
        <Definition>Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest.</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T015" name="Mammal"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Horse</Term>
        <Term>Horses</Term>
        <Term>8A1 FAMILY EQUIDAE - EQUIDS</Term>
        <Term>domestic horse</Term>
        <Term>EQUINE SPECIES</Term>
        <Term>Equine Species</Term>
        <Term>Equus caballus caballus</Term>
        <Term>Genus Equus</Term>
        <Term>stallions</Term>
        <Term>Domestic Horses</Term>
        <Term>Equus caballus Linnaeus, 1758</Term>
        <Term>HORSE</Term>
        <Term>allergy testing horse</Term>
        <Term>Genus equus</Term>
        <Term>Equus przewalskii f. caballus</Term>
        <Term>allergy testing - horse</Term>
        <Term>Equus ferus caballus</Term>
        <Term>equine</Term>
        <Term>Domestic Horse</Term>
        <Term>Genus Equus (organism)</Term>
        <Term>Equine species</Term>
        <Term>Equus caballus (organism)</Term>
        <Term>Equus caballus</Term>
        <Term>Equus</Term>
        <Term>allergy testing horse (lab test)</Term>
        <Term>horse</Term>
        <Term>Horse antigen</Term>
        <Term>Family Equidae (organism)</Term>
        <Term>Equine</Term>
        <Term>Stallion</Term>
        <Term>stallion</Term>
        <Term>Family Equidae</Term>
        <Term>Equus przewalskii forma caballus</Term>
        <Term>804 EQUINE SPECIES</Term>
        <Term>FAMILY EQUIDAE - EQUIDS</Term>
        <Term>Equidae</Term>
        <Term>Horse, Domestic</Term>
        <Term>Equine, NOS</Term>
        <Term>Horses, Domestic</Term>
        <Codes>
          <Code code="C1455737" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Equidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD1D_protein_human" name="CD1D protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD1D protein, human</Term>
        <Term>CD1d antigen, human</Term>
        <Term>CD1d molecule protein, human</Term>
        <Codes>
          <Code code="C2351710" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD1d</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD36" name="Antigen, CD36">
        <Definition>Leukocyte differentiation antigens and major platelet membrane glycoproteins present on MONOCYTES; ENDOTHELIAL CELLS; PLATELETS; and mammary EPITHELIAL CELLS. They play major roles in CELL ADHESION; SIGNAL TRANSDUCTION; and regulation of angiogenesis. CD36 is a receptor for THROMBOSPONDINS and can act as a scavenger receptor that recognizes and transports oxidized LIPOPROTEINS and FATTY ACIDS.</Definition>
        <Definition>Platelet glycoprotein 4 (472 aa, 53 kD) is a cell adhesion process protein that is encoded by the human CD36 gene and has roles in blood coagulation and cell adhesion.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD36</Term>
        <Term>Receptors, Thrombospondin</Term>
        <Term>GPIV Platelet Glycoprotein</Term>
        <Term>Thrombospondin Receptor</Term>
        <Term>Platelet Glycoprotein IIIb</Term>
        <Term>SR-BI Protein</Term>
        <Term>RECEPT THROMBOSPONDIN</Term>
        <Term>CD36 Antigen</Term>
        <Term>CD36 Fatty Acid Transporter</Term>
        <Term>OKM5 Antigen</Term>
        <Term>GPIIIb Platelet Glycoprotein</Term>
        <Term>CD36 Antigens</Term>
        <Term>Platelet Membrane Glycoprotein IIIb</Term>
        <Term>THROMBOSPONDIN RECEPT</Term>
        <Term>Antigens, CD36</Term>
        <Term>Glycoprotein IIIb, Platelet</Term>
        <Term>OKM 005 ANTIGEN</Term>
        <Term>FAT (Fatty Acid Translocase) - CD36 Antigen</Term>
        <Term>CD36 Antigen (Collagen Type I Receptor, Thrombospondin Receptor)</Term>
        <Term>Platelet Glycoprotein, GPIIIb</Term>
        <Term>Receptor, Thrombospondin</Term>
        <Term>ANTIGENS CD 036</Term>
        <Term>CD 036 ANTIGENS</Term>
        <Term>Platelet Glycoprotein IV</Term>
        <Term>Adipocyte Membrane Protein p88</Term>
        <Term>Antigen, OKM5</Term>
        <Term>Thrombospondin Receptors</Term>
        <Term>Platelet Glycoprotein, GPIV</Term>
        <Term>CD36 Protein</Term>
        <Term>Platelet Membrane Glycoprotein IV</Term>
        <Term>SR-BI Receptor</Term>
        <Term>Scavenger Receptors, Class B, Type I</Term>
        <Term>Glycoprotein IV, Platelet</Term>
        <Codes>
          <Code code="C0054954" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cd36_protein_rat, OTE:PAS-4_protein_Bos_taurus, OTE:Scarb2_protein_mouse, OTE:Cd36l2_protein_rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Il6st_protein_mouse" name="Il6st protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Il6st protein, mouse</Term>
        <Term>interleukin 6 signal transducer protein, mouse</Term>
        <Term>gp130 protein, mouse</Term>
        <Term>CD130 protein, mouse</Term>
        <Codes>
          <Code code="C1506541" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Cytokine_Receptor_gp130</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Vascular_Endothelial_Junctional_Adhesion_Molecule" name="Vascular Endothelial Junctional Adhesion Molecule">
        <Definition>A junctional adhesion molecule subtype that is localized to high endothelial VENULES, heart ENDOTHELIUM, TROPHOBLASTS of the PLANCENTA, and in the ENDOTHELIUM of ARTERIOLES.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Vascular Endothelial Junctional Adhesion Molecule</Term>
        <Term>JAM2 gene</Term>
        <Term>Junctional Adhesion Molecule B</Term>
        <Term>VE-JAM</Term>
        <Term>Antigen, CD322</Term>
        <Term>JAMB</Term>
        <Term>JUNCTIONAL ADHESION MOLECULE 2</Term>
        <Term>CD322 Antigen</Term>
        <Term>junctional adhesion molecule 2</Term>
        <Term>Antigens CD322</Term>
        <Term>CD322</Term>
        <Term>Junctional Adhesion Molecule 2</Term>
        <Term>JAM-B</Term>
        <Term>VEJAM</Term>
        <Term>Junctional Adhesion Molecule B [Chemical/Ingredient]</Term>
        <Term>CD322, Antigens</Term>
        <Term>JAM2</Term>
        <Term>JAM, VASCULAR ENDOTHELIAL</Term>
        <Codes>
          <Code code="C1422840" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD34" name="Antigen, CD34">
        <Definition>surface glycophosphoprotein that is expressed on hematopoietic stem cells but not on mature blood cells.</Definition>
        <Definition>Hematopoietic progenitor cell antigen CD34 (385 aa, 41 kD) is a cell motility process protein that is encoded by the human CD34 gene and has a role in cell-cell adhesion and may have a role in leukocyte migration.</Definition>
        <Definition>Glycoproteins found on immature hematopoietic cells and endothelial cells. They are the only molecules to date whose expression within the blood system is restricted to a small number of progenitor cells in the bone marrow.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD34</Term>
        <Term>CD34 Antigens</Term>
        <Term>CD 034 ANTIGENS</Term>
        <Term>ANTIGENS CD 034</Term>
        <Term>CD34 Antigen</Term>
        <Term>Antigens, CD34</Term>
        <Codes>
          <Code code="C0054953" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD31" name="Antigen, CD31">
        <Definition>Cell adhesion molecules present on virtually all monocytes, platelets, and granulocytes. CD31 is highly expressed on endothelial cells and concentrated at the junctions between them.</Definition>
        <Definition>CD31 antigen (738 aa, 83 kD) is a cell communication protein that is encoded by the human PECAM1 gene and has a role in cell recognition and signal transduction.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD31</Term>
        <Term>Platelet Endothelial Cell Adhesion Molecule 1</Term>
        <Term>CD31 Antigens</Term>
        <Term>CD 031 ANTIGENS</Term>
        <Term>PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 001</Term>
        <Term>ANTIGENS CD 031</Term>
        <Term>PECAM-1</Term>
        <Term>PECAM 001</Term>
        <Term>Platelet Endothelial Cell Adhesion Molecule-1</Term>
        <Term>CD31 Antigen</Term>
        <Term>Antigens, CD31</Term>
        <Codes>
          <Code code="C0081939" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Japanese_Americans" name="Japanese Americans">
        <Definition>any person with Japanese ethnic background whose home or birthplace is in the Americas.</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Japanese Americans</Term>
        <Term>Japanese American</Term>
        <Term>Americans, Japanese</Term>
        <Term>American, Japanese</Term>
        <Codes>
          <Code code="C0022343" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Asian_Americans</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:senescent_cell_differentiation_antigen" name="senescent cell differentiation antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">senescent cell differentiation antigen</Term>
        <Term>SCA antigen</Term>
        <Term>SCD-antigen</Term>
        <Codes>
          <Code code="C0074326" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:cluster_randomized_controlled_design" name="cluster randomized controlled design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">cluster randomized controlled design</Term>
        <Term>cluster randomised controlled study</Term>
        <Term>cluster randomised controlled studies</Term>
        <Term>cluster randomized controlled designs</Term>
        <Term>cluster randomised controlled designs</Term>
        <Term>cluster randomized controlled trial</Term>
        <Term>cluster randomized controlled trials</Term>
        <Term>cluster randomised controlled design</Term>
        <Term>cluster randomised controlled trials</Term>
        <Term>cluster randomized controlled study</Term>
        <Term>cluster randomized controlled studies</Term>
        <Term>cluster randomised controlled trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#cluster_randomized_controlled_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cluster_randomized_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fasl_protein_mouse" name="Fasl protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fasl protein, mouse</Term>
        <Term>Tnfsf6 protein, mouse</Term>
        <Term>APT1LG1 protein, mouse</Term>
        <Term>Fas ligand (TNF superfamily, member 6) protein, mouse</Term>
        <Codes>
          <Code code="C1664179" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Necrosis_Factor_Ligand_Superfamily_Member_6</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Arthropoda" name="Arthropoda">
        <Definition>body is semented into 2 or 3 regions, with paired, segmented appendages, and a hardened body wall; periodically sheds and renews the exoskeleton.</Definition>
        <Definition>Members of the phylum Arthropoda, composed of organisms having a hard, jointed exoskeleton and paired jointed legs. It includes the class INSECTS and the subclass ARACHNIDA, many species of which are important medically as parasites or as vectors of organisms capable of causing disease in man.</Definition>
        <Definition>The taxonomic phylum whose members are invertebrates with hard exoskeletons and segmented joints. Organisms in this phylum include the Arachnids, Centipedes, Crustaceans, Insects and the extinct Trilobites.</Definition>
        <SemanticType code="T204" name="Eukaryote"/>
        <SemanticType code="T008" name="Animal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Arthropoda</Term>
        <Term>Phylum Arthopoda (organism)</Term>
        <Term>arthropods</Term>
        <Term>Phylum Arthopoda</Term>
        <Term>arthropod</Term>
        <Term>Arthropod, NOS</Term>
        <Term>PHYLUM ARTHROPODA - ARTHROPODS</Term>
        <Term>Arthropod</Term>
        <Term>Arthopoda</Term>
        <Term>Phylum: Arthropoda</Term>
        <Term>arthropoda</Term>
        <Term>Arthropods</Term>
        <Term>SECTION 6 PHYLUM ARTHROPODA - ARTHROPODS</Term>
        <Term>Phylum arthropoda - arthropod</Term>
        <Codes>
          <Code code="C0003903" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Animal</Relation>
          <Relation name="Narrower">OTE:Insect</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL1R1_protein_rat" name="IL1R1 protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL1R1 protein, rat</Term>
        <Term>interleukin 1 receptor, type I, rat</Term>
        <Term>interleukin-4 receptor subunit alpha, rat</Term>
        <Codes>
          <Code code="C3657570" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_Interleukin-1_Type_I</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Icos_protein_mouse" name="Icos protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Icos protein, mouse</Term>
        <Term>inducible T-cell co-stimulator protein, mouse</Term>
        <Codes>
          <Code code="C1570400" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inducible_T_Cell_Co_Stimulator_Protein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Autologous_Ovarian_Tissue_Transplantation" name="Autologous Ovarian Tissue Transplantation">
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Autologous Ovarian Tissue Transplantation</Term>
        <Codes>
          <Code code="C116463" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Organ_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FcgammaRIIIA_protein_mouse" name="FcgammaRIIIA protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FcgammaRIIIA protein, mouse</Term>
        <Term>Fcgr3a protein, mouse</Term>
        <Codes>
          <Code code="C1870618" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:registry_study" name="registry study">
        <Definition>An organization (typically a government agency) that administers the registration of studies.</Definition>
        <Definition>An organization (typically a government agency) that administers the registration of studies. EXAMPLE(S): ClinicalTrials.gov (CT.gov); Netherlands National Trial Register (NTR). NOTE(S): The study registry should contain basic information about each trial sufficient to inform potential StudySubjects (and their healthcare providers) how to enroll in the study.</Definition>
        <SemanticType code="T092" name="Organization"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">registry study</Term>
        <Term>register study</Term>
        <Term>StudyRegistry</Term>
        <Term>Study Registry</Term>
        <Term>register studies</Term>
        <Term>registry studies</Term>
        <Codes>
          <Code code="C2985664" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DBA_1LacJ_Mouse" name="DBA/1LacJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DBA/1LacJ Mouse</Term>
        <Term>DBA/1LacJ</Term>
        <Codes>
          <Code code="C37404" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Differentiation_Antigens_Hairy_Cell_Leukemia" name="Differentiation Antigens, Hairy Cell Leukemia">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Differentiation Antigens, Hairy Cell Leukemia</Term>
        <Term>DIFFER ANTIGENS HAIRY CELL LEUKEMIA</Term>
        <Codes>
          <Code code="C0012214" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CF-1_Mouse" name="CF-1 Mouse">
        <Definition>Thought to be wild albino in origin, this strain was obtained by Carworth farms from a Missouri laboratory. It was intensely inbred by N. Goto in 1978 from a single Carworth pair, the progeny of which is used today. The CF-1 mouse has an albino coat with genotype c and is used as a multi-purpose strain for a variety of applications including infectious disease modeling, embryological studies, and safety and efficacy testing. In this mouse model, cleft palate formation can be induced by cortisone while alloxan treatment induces diabetes in a high percentage of CF-1 mice.</Definition>
        <Definition>Thought to be wild albino in origin, this strain was obtained by Carworth farms from a Missouri laboratory. It was intensely inbred by N. Goto in 1978 from a single Carworth pair, the progeny of which is used today. The CF-1 mouse has an albino coat with genotype c.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CF-1 Mouse</Term>
        <Term>CF-1</Term>
        <Codes>
          <Code code="C77116" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ST6GAL1_protein_human" name="ST6GAL1 protein, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ST6GAL1 protein, human</Term>
        <Term>sialyltransferase-1, human</Term>
        <Term>ST6 beta-galactosamide alpha-2,6-sialyltranferase 1, human</Term>
        <Term>CD75 antigen, human</Term>
        <Term>SIAT1 protein, human</Term>
        <Term>sialyltransferase 1 protein, human</Term>
        <Term>CDw75 antigen, human</Term>
        <Term>beta-galactoside alpha-2,6-sialyltransferase protein, human</Term>
        <Codes>
          <Code code="C0108802" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:interrupted_time_series_design" name="interrupted time series design">
        <Definition>A study that uses observations at multiple time points before and after an intervention (the "interruption"), in an attempt to detect whether the intervention has had an effect significantly greater than any underlying trend over time. [Interrupted Time Series Analysis | MeSH_2015]</Definition>
        <SemanticType code="T081" name="Quantitative Concept"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">interrupted time series design</Term>
        <Term>interrupted time series designs</Term>
        <Term>interrupted time series studies</Term>
        <Term>interrupted time series analyses</Term>
        <Term>interrupted time series study</Term>
        <Term>ITS study</Term>
        <Term>ITS studies</Term>
        <Term>interrupted time series trial</Term>
        <Term>interrupted time series trials</Term>
        <Term>interrupted time series analysis</Term>
        <Term>interrupted time series</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#interrupted_time_series_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:time_design</Relation>
          <Relation name="Narrower">OTE:interrupted_time_series_without_comparison_group, OTE:interrupted_time_series_with_comparison_group, OTE:controlled_interrupted_time_series</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_CD8" name="Antigens, CD8">
        <Definition>Differentiation antigens found on thymocytes and on cytotoxic and suppressor T-lymphocytes. CD8 antigens are members of the immunoglobulin supergene family and are associative recognition elements in MHC (Major Histocompatibility Complex) Class I-restricted interactions.</Definition>
        <Definition>suppressor T-lymphocyte marker that functions as a receptor for MHC class I antigen.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, CD8</Term>
        <Term>T8 Antigens, T Cell</Term>
        <Term>T-Cell T8 Antigens</Term>
        <Term>Antigens, T-Cell T8</Term>
        <Term>CD 008 ANTIGENS</Term>
        <Term>T AAD ANTIGENS 08 T CELL</Term>
        <Term>Leu-2 Antigens</Term>
        <Term>Antigen, CD8</Term>
        <Term>Leu 2 Antigens</Term>
        <Term>T8 Antigens, T-Cell</Term>
        <Term>CD8 Antigens</Term>
        <Term>CD8 Antigen</Term>
        <Term>LEU ANTIGENS 02</Term>
        <Term>Antigens, Leu-2</Term>
        <Term>ANTIGENS CD 008</Term>
        <Codes>
          <Code code="C0085358" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:CD8alpha_antigen, OTE:CD8alphabeta_antigen, OTE:CD8_antigen_alpha_chain, OTE:CD8beta_antigen, OTE:Cd8b1_protein_mouse, OTE:CD8beta_antigen_rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:GH_Rat_Strain" name="GH, Rat Strain">
        <Definition>GH: Develops hypertension, cardiac hypertrophy and vascular disease (Phelan 1968, Simpson and Phelan 1984, Simpson et al, 1994). Genetic hypertension in GH (but not SHR) may be associated with a defect in renal prostaglandin catabolism (Armstronag et al 1976).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">GH, Rat Strain</Term>
        <Codes>
          <Code code="C14404" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:pre-test_post-test_control_group_design" name="pre-test post-test control group design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">pre-test post-test control group design</Term>
        <Term>pretest posttest control group trial</Term>
        <Term>pretest posttest control group designs</Term>
        <Term>pre-test post-test control group studies</Term>
        <Term>pre-test post-test control group study</Term>
        <Term>pretest posttest control group design</Term>
        <Term>pre-test post-test control group trial</Term>
        <Term>pretest posttest control group studies</Term>
        <Term>pre-test post-test control group trials</Term>
        <Term>pretest posttest control group trials</Term>
        <Term>pre-test post-test control group designs</Term>
        <Term>pretest posttest control group study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#pre-test_post-test_control_group_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:pre-and-post_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:consecutive_case_series" name="consecutive case series">
        <Definition>A clinical study that includes all eligible patients identified by the researchers during the study registration period. The patients are treated in the order in which they are identified. This type of study usually does not have a control group. [NCIT_14.08d]</Definition>
        <Definition>A clinical study that includes all eligible patients identified by the researchers during the study registration period. The patients are treated in the order in which they are identified. This type of study usually does not have a control group.</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">consecutive case series</Term>
        <Term>Consecutive Case Series</Term>
        <Codes>
          <Code code="C2985408" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:case_series</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NZB_BlNJ_Mouse" name="NZB/BlNJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NZB/BlNJ Mouse</Term>
        <Term>NZB/BlNJ</Term>
        <Codes>
          <Code code="C37422" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_CD4" name="Antigens, CD4">
        <Definition>55-kDa antigens found on HELPER-INDUCER T-LYMPHOCYTES and on a variety of other immune cell types. CD4 antigens are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MAJOR HISTOCOMPATIBILITY COMPLEX class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. CD4 antigens also serve as INTERLEUKIN-15 receptors and bind to the HIV receptors, binding directly to the HIV ENVELOPE PROTEIN GP120.</Definition>
        <Definition>helper T-lymphocyte marker that functions as a receptor for MHC class II antigen; also acts as the receptor for HIV.</Definition>
        <Definition>CD4 Antigen, encoded by the CD4 gene, is a T-cell surface glycoprotein. CD4 has a role in cell-cell interactions and may act in signal transduction. CD4 is a accessory protein for MHC class-II antigen/T-cell receptor interaction and functions to initiate or augment the early phase of T-cell activation. CD4 enhances T-cell sensitivity to antigen and binds to LCK, which phosphorylates CD3-zeta. CD4 Antigen also serves as an HIV receptor, binding directly to the envelope protein gp120 on HIV. (From LocusLink, OMIM and NCI)</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, CD4</Term>
        <Term>Receptors, Surface CD4</Term>
        <Term>CD 004 MOLECULE</Term>
        <Term>CD4 Antigens</Term>
        <Term>Antigens, T-Cell T4</Term>
        <Term>CD4 RECEPT</Term>
        <Term>CD 004 ANTIGENS</Term>
        <Term>Antigen, CD4</Term>
        <Term>T4 Antigens, T Cell</Term>
        <Term>SURFACE CD4 RECEPT</Term>
        <Term>RECEPT CD4</Term>
        <Term>CD4 Molecule</Term>
        <Term>T4 Antigens, T-Cell</Term>
        <Term>CD4 Antigen</Term>
        <Term>Receptors, CD4</Term>
        <Term>T-Cell T4 Antigens</Term>
        <Term>Surface CD4 Receptors</Term>
        <Term>T AAB ANTIGENS T CELL 04</Term>
        <Term>Surface CD4 Receptor</Term>
        <Term>RECEPTORS CD 004</Term>
        <Term>CD4 Receptors</Term>
        <Term>RECEPT SURFACE CD4</Term>
        <Term>CD 004 RECEPTORS</Term>
        <Term>ANTIGENS CD 004</Term>
        <Term>CD4 Receptor, Surface</Term>
        <Term>CD4 Receptors, Surface</Term>
        <Codes>
          <Code code="C0003323" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:CD4, OTE:DAB389CD4, OTE:CD4-IgG1_hinge_fusion_protein_recombinant, OTE:recombinant_soluble_CD4, OTE:CD4-ricin_A_chain_conjugate, OTE:CDR3_AME, OTE:CD4_S1_peptide</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Monitoring_Intraoperative" name="Monitoring, Intraoperative">
        <Definition>The constant checking on the state or condition of a patient during the course of a surgical operation (e.g., checking of vital signs).</Definition>
        <SemanticType code="T060" name="Diagnostic Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Monitoring, Intraoperative</Term>
        <Term>INTRAOP MONITORING</Term>
        <Term>Intraoperative Monitoring</Term>
        <Term>MONITORING INTRAOP</Term>
        <Codes>
          <Code code="C0079637" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Physiologic_Monitoring</Relation>
          <Relation name="Narrower">OTE:Intraoperative_Neurophysiological_Monitoring</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:5_-deoxyribonucleotidase" name="5'(3')-deoxyribonucleotidase">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">5'(3')-deoxyribonucleotidase</Term>
        <Codes>
          <Code code="C0904274" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Pdcd1_protein_mouse" name="Pdcd1 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Pdcd1 protein, mouse</Term>
        <Term>PD-1 antigen, mouse</Term>
        <Term>PD-1 receptor, mouse</Term>
        <Term>programmed cell death 1 protein, mouse</Term>
        <Term>Cd279 protein, mouse</Term>
        <Term>PD-1 protein, mouse</Term>
        <Codes>
          <Code code="C1137273" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Programmed_Cell_Death_1_Protein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:retrospective_panel_study" name="retrospective panel study">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">retrospective panel study</Term>
        <Term>retrospective panel studies</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#retrospective_panel_study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:retrospective_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:I_LnJ_Mouse" name="I/LnJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">I/LnJ Mouse</Term>
        <Term>I/LnJ</Term>
        <Codes>
          <Code code="C14594" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD6_antigen" name="CD6 antigen">
        <Definition>T-cell differentiation antigen CD6 (668 aa, ~72 kDa) is encoded by the human CD6 gene. This protein plays a role in the adherence of immature thymus cells to thymic epithelial cells.</Definition>
        <Definition>This gene plays a role in cell-cell adhesion.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD6 antigen</Term>
        <Term>CD6 molecule</Term>
        <Term>T-CELL DIFFERENTIATION ANTIGEN CD6</Term>
        <Term>CD6-Cluster of diff antigen 6</Term>
        <Term>CD6 - Cluster of differentiation antigen 6</Term>
        <Term>T-Cell Differentiation Antigen CD6</Term>
        <Term>Lymphocyte antigen CD6 (substance)</Term>
        <Term>TP120</Term>
        <Term>CD6 Molecule Gene</Term>
        <Term>T12 - T-cell lineage 12</Term>
        <Term>T-cell lineage 12</Term>
        <Term>Tp120</Term>
        <Term>CD 6 antigen</Term>
        <Term>Cluster of differentiation antigen 6</Term>
        <Term>CD6</Term>
        <Term>Cluster of diff antigen 6</Term>
        <Term>T12</Term>
        <Term>Lymphocyte antigen CD6</Term>
        <Term>CD6 Antigen</Term>
        <Term>CD6 ANTIGEN</Term>
        <Term>CD6 gene</Term>
        <Term>CD6 Gene</Term>
        <Codes>
          <Code code="C0054967" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:OX52_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD46" name="Antigen, CD46">
        <Definition>A ubiquitously expressed complement receptor that binds COMPLEMENT C3B and COMPLEMENT C4B and serves as a cofactor for their inactivation. CD46 also interacts with a wide variety of pathogens and mediates immune response.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD46</Term>
        <Term>ANTIGENS CD 046</Term>
        <Term>Membrane Cofactor Protein</Term>
        <Term>Antigens, CD46</Term>
        <Term>CD46 Antigens</Term>
        <Term>Common Antigen, Trophoblast-Leukocyte</Term>
        <Term>CD 046 ANTIGENS</Term>
        <Term>Trophoblast-Leukocyte Common Antigen</Term>
        <Term>Trophoblast Leukocyte Common Antigen</Term>
        <Term>CD46 Antigen</Term>
        <Codes>
          <Code code="C0285488" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Mcp_protein_rat, OTE:Mcp_protein_mouse, OTE:CD46_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD47" name="Antigen, CD47">
        <Definition>Leukocyte Surface Antigen CD47 (323 aa, 35 kD) is a cellular division process protein that is encoded by the human CD47 gene and has roles in positive regulation of cell-cell adhesion, positive regulation of cell proliferation and positive regulation of T cell activation.</Definition>
        <Definition>A ubiquitously expressed membrane glycoprotein. It interacts with a variety of INTEGRINS and mediates responses to EXTRACELLULAR MATRIX PROTEINS.</Definition>
        <Definition>transmembrane protein without tissue specificity that is involved in membrane cation flux.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD47</Term>
        <Term>Integrin Associated Protein p50</Term>
        <Term>Antigens, CD47</Term>
        <Term>ANTIGENS CD 047</Term>
        <Term>IAP 50 Antigen</Term>
        <Term>Thrombospondin-1 Receptor CD47</Term>
        <Term>CD47 Antigen</Term>
        <Term>Integrin-Associated Protein p50</Term>
        <Term>CD47 Antigens</Term>
        <Term>Antigen, IAP-50</Term>
        <Term>IAP-50 Antigen</Term>
        <Term>CD 047 ANTIGENS</Term>
        <Term>CD47, Thrombospondin-1 Receptor</Term>
        <Codes>
          <Code code="C0220248" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cd47_protein_mouse, OTE:CD47_protein_rat, OTE:CD47_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD40" name="Antigen, CD40">
        <Definition>Tumor necrosis factor receptor superfamily member 5 (277 aa, 31 kD) is a cell fate protein that is encoded by the human CD40 gene and has roles in inflammatory response, B-cell proliferation and apoptosis.</Definition>
        <Definition>A member of the tumor necrosis factor receptor superfamily with specificity for CD40 LIGAND. It is found on mature B-LYMPHOCYTES and some EPITHELIAL CELLS, lymphoid DENDRITIC CELLS. Evidence suggests that CD40-dependent activation of B-cells is important for generation of memory B-cells within the germinal centers. Mutations of the gene for CD40 antigen result in HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 3. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.</Definition>
        <Definition>50 kD glycoprotein expressed on all B cells; plays an important role in B cell development and activation.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD40</Term>
        <Term>Tumor Necrosis Factor Receptor Superfamily, Member 5</Term>
        <Term>Antigen, CDw40</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 05</Term>
        <Term>TNFRSF5 Receptor</Term>
        <Term>Antigens, CD40</Term>
        <Term>CDw40 Antigen</Term>
        <Term>CD40 Antigens</Term>
        <Term>TNFRSF5 RECEPT</Term>
        <Term>CD 040 ANTIGENS</Term>
        <Term>Receptor, TNFRSF5</Term>
        <Term>ANTIGENS CD 040</Term>
        <Term>CD40 Antigen</Term>
        <Codes>
          <Code code="C0054959" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD43" name="Antigen, CD43">
        <Definition>Leukosialin (400 aa, ~40 kDa) is encoded by the human SPN gene. This protein is involved in immune cell function.</Definition>
        <Definition>A sialic acid-rich protein and an integral cell membrane mucin. It plays an important role in activation of T-LYMPHOCYTES.</Definition>
        <Definition>integral membrane sialoglycoprotein expressed on the surface of virtually all cells of hematopoietc origin; involved in signal transduction and adhesion.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD43</Term>
        <Term>CD43 Antigen</Term>
        <Term>Sialoglycoprotein, Leukocyte</Term>
        <Term>Leukosialin</Term>
        <Term>CD43 Antigens</Term>
        <Term>Antigens, CD43</Term>
        <Term>CD 043 ANTIGENS</Term>
        <Term>Leukocyte Sialoglycoprotein</Term>
        <Term>ANTIGENS CD 043</Term>
        <Term>Sialophorin</Term>
        <Codes>
          <Code code="C0074479" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Spn_protein_rat, OTE:UN1_sialoglycoprotein_human, OTE:Spn_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BL_6By_Mouse" name="C57BL/6By Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BL/6By Mouse</Term>
        <Term>C57BL/6By</Term>
        <Codes>
          <Code code="C37381" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LY9_protein_human" name="LY9 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LY9 protein, human</Term>
        <Term>CD229 protein, human</Term>
        <Term>lymphocyte antigen 9 protein, human</Term>
        <Term>T-lymphocyte surface antigen Ly-9, human</Term>
        <Term>SLAMF3 protein, human</Term>
        <Codes>
          <Code code="C1453161" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Ly9_2_glycoprotein_human, OTE:Ly9_1_glycoprotein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL18R1_protein_human" name="IL18R1 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL18R1 protein, human</Term>
        <Term>IL1RRP protein, human</Term>
        <Term>IL-1Rrp protein, human</Term>
        <Term>IL1 receptor-related protein, human</Term>
        <Term>interleukin 18 receptor 1 protein, human</Term>
        <Codes>
          <Code code="C1447429" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_18_Receptor_alpha_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cologne_Zebrafish" name="Cologne Zebrafish">
        <Definition>A wild-type Zebrafish line.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cologne Zebrafish</Term>
        <Term>Cologne</Term>
        <Term>Cologne - Zebrafish</Term>
        <Term>KOLN</Term>
        <Codes>
          <Code code="C2709265" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:A_Mouse" name="A Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">A Mouse</Term>
        <Term>A</Term>
        <Codes>
          <Code code="C1522424" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cytokine_Receptor_gp130" name="Cytokine Receptor gp130">
        <Definition>A cytokine receptor that acts through the formation of oligomeric complexes of itself with a variety of CYTOKINE RECEPTORS.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cytokine Receptor gp130</Term>
        <Term>Receptor gp130, Signal-Transducing</Term>
        <Term>gp130 Transducing Protein</Term>
        <Term>gp130, Cytokine Receptor</Term>
        <Term>CD 130 ANTIGENS</Term>
        <Term>Signal Transducing Receptor gp130</Term>
        <Term>Receptor gp130, Cytokine</Term>
        <Term>CD130 Antigens</Term>
        <Term>IL-6 Receptor Signal Transducer gp130</Term>
        <Term>gp130 IL 6 Family Receptor</Term>
        <Term>gp130, Signal Transducer</Term>
        <Term>gp130, Signal-Transducing Receptor</Term>
        <Term>Antigens, CD130</Term>
        <Term>Signal-Transducing Receptor gp130</Term>
        <Term>Signal Transducer gp130</Term>
        <Term>gp130 Signal Transducer</Term>
        <Term>IL6ST gp130</Term>
        <Term>ANTIGENS CD 130</Term>
        <Term>Signal Transducer, gp130</Term>
        <Term>IL-6 Family Receptor gp130</Term>
        <Term>CYTOKINE RECEPTOR GP 130</Term>
        <Term>Cytokine Receptor gp130 [Chemical/Ingredient]</Term>
        <Term>gp130 IL-6 Family Receptor</Term>
        <Codes>
          <Code code="C0082758" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Il6st_protein_mouse, OTE:Il6st_protein_rat, OTE:IL6ST_protein_human, OTE:Soluble_Glycoprotein_130</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:case_base_design" name="case base design">
        <Definition>Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group .[Case-Control Studies | MeSH_2014] </Definition>
        <Definition>A study that compares two groups of people: those with the disease or condition under study (cases) and a very similar group of people who do not have the disease or condition (controls). Researchers study the medical and lifestyle histories of the people in each group to learn what factors may be associated with the disease or condition. For example, one group may have been exposed to a particular substance that the other was not. Also called retrospective study.  [Case- control study | NCIT_14.05d]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">case base design</Term>
        <Term>Case-Compeer Studies</Term>
        <Term>case base trial</Term>
        <Term>case-base trial</Term>
        <Term>case-base trials</Term>
        <Term>Case-Referrent Studies</Term>
        <Term>case-control study</Term>
        <Term>Case-Comparison Studies</Term>
        <Term>case-base studies</Term>
        <Term>case base studies</Term>
        <Term>case-base design</Term>
        <Term>Case Control Studies</Term>
        <Term>retrospective study</Term>
        <Term>case-base designs</Term>
        <Term>case base trials</Term>
        <Term>Nested Case-Control Studies</Term>
        <Term>case base study</Term>
        <Term>Case-Referent Studies</Term>
        <Term>Matched Case-Control Studies</Term>
        <Term>case base designs</Term>
        <Term>case-base study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#case_base_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:case_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD46_protein_human" name="CD46 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD46 protein, human</Term>
        <Term>trophoblast leucocyte common antigen, human</Term>
        <Term>trophoblast-lymphocyte cross-reactive antigen, human</Term>
        <Term>MIC10 protein, human</Term>
        <Term>measles virus receptor, human</Term>
        <Term>MCP protein, human</Term>
        <Term>membrane cofactor protein, human</Term>
        <Term>TLX-B antigen, human</Term>
        <Term>TRA2 protein, human</Term>
        <Term>gp45-70 protein, human</Term>
        <Term>hCD46 protein, human</Term>
        <Term>HuLY-m5 protein, human</Term>
        <Codes>
          <Code code="C1505678" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD46</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:evidence_report" name="evidence report">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">evidence report</Term>
        <Term>report of evidence</Term>
        <Term>evidence reports</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#evidence_report" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:literature_review</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:double_blind_crossover_design_" name="double blind crossover design'">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">double blind crossover design'</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#double_blind_crossover_design'" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cross-over_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NIH-III_Mouse" name="NIH-III Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NIH-III Mouse</Term>
        <Term>N:NIH-bg-nu-xidBR</Term>
        <Term>NIH-III</Term>
        <Codes>
          <Code code="C15154" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Immunodeficient_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:A990_Rat_Strain" name="A990, Rat Strain">
        <Definition>Resistant to Cysticercus. Susceptible to estrogen-induced mammary and adrenal tumors. Good reproduction. High open-field defecation (2/12, males, 3/12 females) and low ambulation (11/12), Harrington (1972). Low wheel activity (12/12) (Harrington 1971b). Aggressive towards handlers (Harrington 1981).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">A990, Rat Strain</Term>
        <Codes>
          <Code code="C14389" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_CD14" name="Antigens, CD14">
        <Definition>CD antigen expressed on surface of monocytes, macrophages, eosinophils, neutrophils; lipopolysaccharide receptor; signals production of tumor necrosis factor.</Definition>
        <Definition>Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including monocytes, macrophages, and some granulocytes. They function as receptors for the complex of lipopolysaccharide (LPS) and LPS-binding protein.</Definition>
        <Definition>Monocyte Differentiation Antigen CD14 (375 aa, 40 kD) is a cell fate protein that is encoded by the human CD14 gene and has a role in apoptosis and phagocytosis.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, CD14</Term>
        <Term>RECEPT LPS</Term>
        <Term>LPS Receptor</Term>
        <Term>LPS RECEPT</Term>
        <Term>Receptor, LPS</Term>
        <Term>LIPOGLYCAN RECEPT</Term>
        <Term>Lipoglycan Receptor</Term>
        <Term>RECEPT LIPOGLYCAN</Term>
        <Term>Lipopolysaccharide Receptors</Term>
        <Term>ANTIGENS CD 014</Term>
        <Term>CD14 Antigen</Term>
        <Term>Receptors, Lipopolysaccharide</Term>
        <Term>CD14 Monocyte Differentiation Antigen</Term>
        <Term>CD 014 ANTIGENS</Term>
        <Term>RECEPT LIPOPOLYSACCHARIDE</Term>
        <Term>Receptor, Lipoglycan</Term>
        <Term>CD14 Antigens</Term>
        <Term>LIPOPOLYSACCHARIDE RECEPT</Term>
        <Codes>
          <Code code="C0108768" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:periodical_index" name="periodical index">
        <Definition>Work consisting of a subject approach to the contents of a periodical issuing an annual, biennial, quinquennial, decennial, etc., index. The heading is used for the overall body of articles published by a periodical in the same sense that BIBLIOGRAPHY is useful when published as a single article. [MeSH_2014]</Definition>
        <Definition>Work consisting of a subject approach to the contents of a periodical issuing an annual, biennial, quinquennial, decennial, etc., index. The heading is used for the overall body of articles published by a periodical in the same sense that BIBLIOGRAPHY is useful when published as a single article.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">periodical index</Term>
        <Term>Indexes</Term>
        <Term>Index</Term>
        <Term>Bibliography (1968-1989)</Term>
        <Term>Periodical Index</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#periodical_index" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:twit_protein_Drosophila" name="twit protein, Drosophila">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">twit protein, Drosophila</Term>
        <Codes>
          <Code code="C3659071" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LIFR_protein_human" name="LIFR protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LIFR protein, human</Term>
        <Term>STWS protein, human</Term>
        <Term>SJS2 protein, human</Term>
        <Term>Leukemia Inhibitory Factor Receptor alpha Subunit, human</Term>
        <Term>leukemia inhibitory factor receptor, human</Term>
        <Codes>
          <Code code="C1506606" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Leukemia_Inhibitory_Factor_Receptor_alpha_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:cost-effectiveness" name="cost-effectiveness">
        <Definition>tangible economic benefits produced by money spent; use in conjunction with another term describing what is being cost effective.</Definition>
        <SemanticType code="T081" name="Quantitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">cost-effectiveness</Term>
        <Term>COST EFF</Term>
        <Term>Effectiveness, Cost</Term>
        <Term>cost effectiveness</Term>
        <Term>Cost Effectiveness</Term>
        <Term>Cost effectiveness</Term>
        <Codes>
          <Code code="C0010181" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Outcome_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Long-Term_Effects_Secondary_to_Cancer_Therapy_in_Adults" name="Long-Term Effects Secondary to Cancer Therapy in Adults">
        <Definition>Side effects of cancer treatment received during adulthood occurring a long time after the treatment was completed.</Definition>
        <SemanticType code="T033" name="Finding"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Long-Term Effects Secondary to Cancer Therapy in Adults</Term>
        <Codes>
          <Code code="C115227" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Long-Term_Effects_Secondary_to_Cancer_Therapy</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD47_protein_rat" name="CD47 protein, rat">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD47 protein, rat</Term>
        <Term>leukocyte surface antigen CD47, rat</Term>
        <Term>CD47 antigen, rat</Term>
        <Codes>
          <Code code="C3711102" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD47</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_CD18" name="Antigens, CD18">
        <Definition>Cell-surface glycoprotein beta-chains that are non-covalently linked to specific alpha-chains of the CD11 family of leukocyte-adhesion molecules (RECEPTORS, LEUKOCYTE-ADHESION). A defect in the gene encoding CD18 causes LEUKOCYTE-ADHESION DEFICIENCY SYNDROME.</Definition>
        <Definition>Integrin beta-2 (769 aa, 85 kD) is a cell motility process protein that is encoded by the human ITGB2 gene and has roles in leukocyte adhesion and neutrophil chemotaxis.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, CD18</Term>
        <Term>Integrin beta2</Term>
        <Term>Integrin, beta2</Term>
        <Term>CD 018 ANTIGENS</Term>
        <Term>beta2 Integrin</Term>
        <Term>CD18 Antigen</Term>
        <Term>beta-Subunit, p150,95</Term>
        <Term>INTEGRIN BETA A 02</Term>
        <Term>ANTIGENS CD 018</Term>
        <Term>p150,95 beta-Subunit</Term>
        <Term>beta2, Integrin</Term>
        <Term>CD18 Antigens</Term>
        <Term>p150,95 beta Subunit</Term>
        <Codes>
          <Code code="C0064830" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LT_SvJ_Mouse" name="LT/SvJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LT/SvJ Mouse</Term>
        <Term>LT/SvJ</Term>
        <Codes>
          <Code code="C37410" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Kalaallits" name="Kalaallits">
        <Definition>An Inuit ethnic group geographically-associated with GREENLAND; (KALAALLIT NUNAAT).</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Kalaallits</Term>
        <Term>Kalaallit</Term>
        <Codes>
          <Code code="C1258939" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inuits</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Body_of_Graft" name="Body of Graft">
        <Definition>The portion of the graft that lies between its anastomoses. (ACC)</Definition>
        <Definition>The portion of the graft that lies between its anastomoses.</Definition>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Body of Graft</Term>
        <Term>BODY OF THE GRAFT</Term>
        <Codes>
          <Code code="C99918" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Graft</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ITGB3_protein_human" name="ITGB3 protein, human">
        <Definition>Integrin beta-3 (788 aa, 87 kD) is a cell adhesion process protein that is encoded by the human ITGB3 gene and has roles in cell adhesion and blood coagulation.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ITGB3 protein, human</Term>
        <Term>integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61), human</Term>
        <Term>CD61 antigen, human</Term>
        <Term>platelet membrane glycoprotein IIIa, human</Term>
        <Codes>
          <Code code="C0638262" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Integrin_beta3</Relation>
          <Relation name="Narrower">OTE:P1A_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fcgr1_protein_rat" name="Fcgr1 protein, rat">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fcgr1 protein, rat</Term>
        <Term>FcgammaRI protein, rat</Term>
        <Term>Fc gamma receptor RI, rat</Term>
        <Codes>
          <Code code="C3849588" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:TNFRSF1B_protein_human" name="TNFRSF1B protein, human">
        <Definition>TNFR2 is a 70 kD high-affinity cell surface receptor for tumor necrosis factor. TNFBR is the larger of the two TNF receptors, has a single membrane-spanning domain, and has an extracellular domain with sequence similarity to NGF receptor and B-cell activation protein BP50. TNFBR is present on many cell types, especially of myeloid origin, and is strongly expressed on stimulated T- and B-lymphocytes. TNFBR is the main TNF receptor on circulating T-cells and the major mediator of autoregulatory apoptosis in CD8+ cells. TNFBR may act with TNFR1 to kill nonlymphoid cells. (from OMIM 191191 and NCI)</Definition>
        <Definition>A 70-kDa high-affinity cell surface receptor for tumor necrosis factor.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">TNFRSF1B protein, human</Term>
        <Term>tumor necrosis factor receptor type II, human</Term>
        <Term>CD120b antigen, human</Term>
        <Term>tumor necrosis factor receptor superfamily, member 1B protein, human</Term>
        <Codes>
          <Code code="C1447786" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Necrosis_Factor_Receptor_Type_II</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BL_6JEiJ_Mouse" name="C57BL/6JEiJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BL/6JEiJ Mouse</Term>
        <Term>C57BL/6JEiJ</Term>
        <Codes>
          <Code code="C37383" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_CD79" name="Antigens, CD79">
        <Definition>A component of the B-cell antigen receptor that is involved in B-cell antigen receptor heavy chain transport to the PLASMA MEMBRANE. It is expressed almost exclusively in B-LYMPHOCYTES and serves as a useful marker for B-cell NEOPLASMS.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, CD79</Term>
        <Term>ANTIGENS CD 079</Term>
        <Term>CD79 Antigens</Term>
        <Term>CD79 Antigen</Term>
        <Term>Antigen, CD79</Term>
        <Term>CD 079 ANTIGENS</Term>
        <Codes>
          <Code code="C1533645" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Antigen_CD79b, OTE:Cd79a_protein_mouse, OTE:Antigen_CD79a, OTE:CD79B_protein_human, OTE:CD79A_protein_human, OTE:Igb_protein_rat, OTE:Cd79b_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD4_D-Ile" name="CD4 (81-92), D-Ile">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD4 (81-92), D-Ile</Term>
        <Codes>
          <Code code="C0959473" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD4</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CTLA4_protein_human" name="CTLA4 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CTLA4 protein, human</Term>
        <Term>CD152 antigen, human</Term>
        <Term>cytotoxic T-lymphocyte-associated protein 4, human</Term>
        <Codes>
          <Code code="C2350360" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Cytotoxic_T_Lymphocyte_Antigen_4</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BMS-PTX-837" name="BMS-PTX-837">
        <SemanticType code="T130" name="Indicator, Reagent, or Diagnostic Aid"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BMS-PTX-837</Term>
        <Codes>
          <Code code="C1529782" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BL_6ByJ_Mouse" name="C57BL/6ByJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BL/6ByJ Mouse</Term>
        <Term>C57BL/6ByJ</Term>
        <Codes>
          <Code code="C37382" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD84_protein_human" name="CD84 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD84 protein, human</Term>
        <Term>leukocyte antigen CD84, human</Term>
        <Term>CD84 antigen, human</Term>
        <Term>Ly9b antigen, human</Term>
        <Term>Ly9b glycoprotein, human</Term>
        <Term>SLAMF5 protein, human</Term>
        <Codes>
          <Code code="C0666283" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C3H_HeOuJ_Mouse" name="C3H/HeOuJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C3H/HeOuJ Mouse</Term>
        <Term>C3H/HeOuJ</Term>
        <Codes>
          <Code code="C37371" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL13RA1_protein_human" name="IL13RA1 protein, human">
        <Definition>IL13 receptor alpha 1 protein (427 aa, 49 kD) is a cell communication process protein that is encoded by the human IL13RA1 gene and has a role in signal transduction.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL13RA1 protein, human</Term>
        <Term>CD213a1 antigen, human</Term>
        <Term>IL-13RA protein, human</Term>
        <Term>interleukin 13 receptor, alpha 1 protein, human</Term>
        <Codes>
          <Code code="C1528378" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_13_Receptor_alpha1_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_CD80" name="Antigens, CD80">
        <Definition>A costimulatory ligand expressed by ANTIGEN-PRESENTING CELLS that binds to CTLA-4 ANTIGEN with high specificity and to CD28 ANTIGEN with low specificity. The interaction of CD80 with CD28 ANTIGEN provides a costimulatory signal to T-LYMPHOCYTES, while its interaction with CTLA-4 ANTIGEN may play a role in inducing PERIPHERAL TOLERANCE.</Definition>
        <Definition>CD80 antigen (288 aa, 33 kD) is a cell communication protein that is encoded by the human CD80 gene and has a role in regulation of peptidyl-tyrosine phosphorylation.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, CD80</Term>
        <Term>B7-1 Costimulatory Molecule</Term>
        <Term>B7 1 Antigen</Term>
        <Term>Antigen, B7 1</Term>
        <Term>B Cell Activation Antigen</Term>
        <Term>CD 080 ANTIGENS</Term>
        <Term>Costimulatory Molecule, B7-1</Term>
        <Term>CD80 Antigens</Term>
        <Term>B7-1 Antigen</Term>
        <Term>B7-1 Ligand</Term>
        <Term>Antigen, B7-1</Term>
        <Term>CD80 Antigen</Term>
        <Term>B7 1 Costimulatory Molecule</Term>
        <Term>Ligand, B7-1</Term>
        <Term>B A 007 001 COSTIMULATORY MOLECULE</Term>
        <Term>B7 1 Ligand</Term>
        <Term>ANTIGENS CD 080</Term>
        <Term>B-Cell Activation Antigen</Term>
        <Codes>
          <Code code="C0104998" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:antigen_GL7" name="antigen GL7">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">antigen GL7</Term>
        <Term>GL7 antigen</Term>
        <Codes>
          <Code code="C0383775" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Hong_Kong_Zebrafish" name="Hong Kong Zebrafish">
        <Definition>A wild-type zebrafish line, the stock of which was obtained from a fish dealer in Honk Kong, China.(ZFin)</Definition>
        <Definition>A wild-type zebrafish line, the stock of which was obtained from a fish dealer in Honk Kong, China.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Hong Kong Zebrafish</Term>
        <Term>Hong Kong</Term>
        <Term>HK</Term>
        <Codes>
          <Code code="C79975" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ALR_Mouse" name="ALR Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ALR Mouse</Term>
        <Term>ALR</Term>
        <Codes>
          <Code code="C37356" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LILRB1_protein_human" name="LILRB1 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LILRB1 protein, human</Term>
        <Term>leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 protein, human</Term>
        <Term>ILT-2 protein, human</Term>
        <Term>CD85 antigen, human</Term>
        <Term>leukocyte-immunoglobulin-like receptor 1, human</Term>
        <Term>ILT2 protein, human</Term>
        <Term>LIR-1 receptor, human</Term>
        <Codes>
          <Code code="C1741325" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:CD85j_antigen_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:diagnostic_test_accuracy_study" name="diagnostic test accuracy study">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">diagnostic test accuracy study</Term>
        <Term>diagnostic test accuracy studies</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#diagnostic_test_accuracy_study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:diagnostic_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:cluster_randomized_design" name="cluster randomized design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">cluster randomized design</Term>
        <Term>cluster randomised study</Term>
        <Term>cluster randomised studies</Term>
        <Term>cluster randomized trials</Term>
        <Term>cluster randomized designs</Term>
        <Term>cluster randomized trial</Term>
        <Term>cluster randomised designs</Term>
        <Term>cluster randomized studies</Term>
        <Term>cluster randomised trial</Term>
        <Term>cluster randomised trials</Term>
        <Term>cluster randomized study</Term>
        <Term>cluster randomised design</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#cluster_randomized_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:randomized_design</Relation>
          <Relation name="Narrower">OTE:cluster_randomized_controlled_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Chinchilla" name="Chinchilla">
        <Definition>A genus of the family Chinchillidae which consists of three species: C. brevicaudata, C. lanigera, and C. villidera. They are used extensively in biomedical research.</Definition>
        <Definition>A member of the Chinchillidae family of crepuscular rodents.</Definition>
        <Definition>A member of the Chinchillidae family of crepuscular rodents native to the Andes mountains in South America. These animals are highly prized for their fur and are used in biomedical research for auditory system research as well as bacterial infections caused by Listeria, Yersinia and Pseudomonas.</Definition>
        <Definition>either of two small South American rodents (Chinchilla laniger and Chinchilla brevicaudata) of the high Andes that are the size of large squirrels, have very soft pearly gray fur, and are extensively bred in captivity.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Chinchilla</Term>
        <Term>Chinchilla&lt;genus&gt;</Term>
        <Term>Genus Chinchilla (organism)</Term>
        <Term>Chinchilla antigen</Term>
        <Term>Domesticated chinchilla</Term>
        <Term>Chinchillas</Term>
        <Term>Wild chinchilla</Term>
        <Term>Chinchilla lanigara (organism)</Term>
        <Term>chinchilla</Term>
        <Term>Chinchilla lanigara</Term>
        <Term>Chinchilla, NOS</Term>
        <Term>Long-tailed chinchilla</Term>
        <Term>Domesticated chinchilla, NOS</Term>
        <Term>CHINCHILLA</Term>
        <Term>Genus Chinchilla</Term>
        <Codes>
          <Code code="C91815" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Chinchillidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:HPA-15a_protein_human" name="HPA-15a protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">HPA-15a protein, human</Term>
        <Term>HPA-15a antigen, human</Term>
        <Codes>
          <Code code="C1569040" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD109_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fc-epsilon_receptor_I_beta-chain_mouse" name="Fc-epsilon receptor I beta-chain, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fc-epsilon receptor I beta-chain, mouse</Term>
        <Term>FcepsilonRI beta-chain, mouse</Term>
        <Term>membrane-spanning 4-domains, subfamily A, member 2 protein, mouse</Term>
        <Codes>
          <Code code="C1959248" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD23</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD63" name="Antigen, CD63">
        <Definition>Ubiquitously-expressed tetraspanin proteins that are found in late ENDOSOMES and LYSOSOMES and have been implicated in intracellular transport of proteins.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD63</Term>
        <Term>Antigens, CD63</Term>
        <Term>Granulophysin</Term>
        <Term>Melanoma Antigen ME491</Term>
        <Term>Platelet Glycoprotein 40 kDa</Term>
        <Term>Antigen ME491, Melanoma</Term>
        <Term>Pltgp40</Term>
        <Term>CD63 Antigen</Term>
        <Term>Tetraspanin 30</Term>
        <Term>CD63 Antigens</Term>
        <Term>LIMP-CD63</Term>
        <Codes>
          <Code code="C0083298" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:CD63_protein_human, OTE:Cd63_protein_rat, OTE:Cd63_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BTBRTF_Mouse" name="BTBRTF Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BTBRTF Mouse</Term>
        <Term>BTBRTF</Term>
        <Codes>
          <Code code="C1511027" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Neuromuscular_Monitoring" name="Neuromuscular Monitoring">
        <Definition>The use of peripheral nerve stimulation to assess transmission at the NEUROMUSCULAR JUNCTION, especially in the response to anesthetics, such as the intensity of NEUROMUSCULAR BLOCKADE by NEUROMUSCULAR BLOCKING AGENTS.</Definition>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Neuromuscular Monitoring</Term>
        <Term>Neuromuscular monitoring</Term>
        <Term>Monitoring, Neuromuscular</Term>
        <Codes>
          <Code code="C3494225" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Physiologic_Monitoring</Relation>
          <Relation name="Narrower">OTE:Neuromuscular_Blockade_Monitoring, OTE:Train-of-Four_Monitoring</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Lung_Transplantation" name="Lung Transplantation">
        <Definition>transference of lung between individuals of the same species, or between individuals of different species.</Definition>
        <Definition>&lt;p&gt;Lung transplantation is surgery to replace one or both diseased lungs with a healthy lung or lungs from a donor. During the operation, the surgeon makes a cut in the chest and removes the diseased lung. The surgeon then sews the new lung to the main blood vessels and air passage. &lt;/p&gt;&lt;p&gt;Your doctor may recommend a lung transplant if you have disease that cannot be controlled any other way. These diseases include&lt;/p&gt;&lt;ul&gt;&lt;li&gt; &lt;a href='http://www.nlm.nih.gov/medlineplus/copdchronicobstructivepulmonarydisease.html'&gt;COPD &lt;/a&gt; (chronic obstructive pulmonary disease)&lt;/li&gt;&lt;li&gt; &lt;a href='http://www.nlm.nih.gov/medlineplus/cysticfibrosis.html'&gt;Cystic fibrosis&lt;/a&gt;&lt;/li&gt;&lt;li&gt; Idiopathic &lt;a href='http://www.nlm.nih.gov/medlineplus/pulmonaryfibrosis.html'&gt;pulmonary fibrosis&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href='http://www.nlm.nih.gov/medlineplus/interstitiallungdiseases.html'&gt;Interstitial lung diseases&lt;/a&gt;&lt;/li&gt;&lt;li&gt; Primary &lt;a href='http://www.nlm.nih.gov/medlineplus/pulmonaryhypertension.html'&gt;pulmonary hypertension&lt;/a&gt; &lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Complications of lung transplantation include rejection of the transplanted lung and infection. &lt;/p&gt;</Definition>
        <Definition>The transference of either one or both of the lungs from one human or animal to another.</Definition>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Lung Transplantation</Term>
        <Term>Entire transplanted lung</Term>
        <Term>Lung Transplantations</Term>
        <Term>Graftings, Lung</Term>
        <Term>Lung transplantation, not otherwise specified</Term>
        <Term>Transplantation of lung</Term>
        <Term>Transplantation, Lung</Term>
        <Term>Transplantations, Lung</Term>
        <Term>Transplant of lung, NOS</Term>
        <Term>Transplant;lung</Term>
        <Term>1-28D LUNGS AND PLEURA: TRANSPLANTATIONS AND TRANSPOSITIONS</Term>
        <Term>surgery lung transplant</Term>
        <Term>Structure of transplanted lung</Term>
        <Term>Grafting, Lung</Term>
        <Term>Transplant of lung (procedure)</Term>
        <Term>Entire transplanted lung (body structure)</Term>
        <Term>Lung transplant NOS</Term>
        <Term>lung grafting</Term>
        <Term>Lung Grafting</Term>
        <Term>Transplanted lung</Term>
        <Term>Lungs--Transplantation</Term>
        <Term>Lung Transplantation Procedures</Term>
        <Term>TRANSPL LUNG</Term>
        <Term>Structure of transplanted lung (body structure)</Term>
        <Term>LUNG TRANSPL</Term>
        <Term>Lung Graftings</Term>
        <Term>lung transplantation</Term>
        <Term>lung transplant (treatment)</Term>
        <Term>Lung transplant</Term>
        <Term>lung transplantations</Term>
        <Term>En bloc lung transplantation</Term>
        <Term>lung transplants</Term>
        <Term>LTx - Lung transplant</Term>
        <Term>lung transplant</Term>
        <Term>Transplant of lung</Term>
        <Term>LUNGS AND PLEURA: TRANSPLANTATIONS AND TRANSPOSITIONS</Term>
        <Codes>
          <Code code="C0278427" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Organ_Transplantation</Relation>
          <Relation name="Narrower">OTE:Single_Lung_Transplantation, OTE:Double_Lung_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:phase_II_III_trial" name="phase II/III trial">
        <Definition>A trial to study response to a new treatment and the effectiveness of the treatment compared with the standard treatment regimen. [NCIT_14.08d]</Definition>
        <Definition>A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials. [NCIT_14.08d] [Contributing_Source_CDISC]</Definition>
        <Definition>A type of clinical study that combines elements characteristic of traditional Phase II and Phase III trials. [NCIT_14.08d]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">phase II/III trial</Term>
        <Term>trial phase 2-3</Term>
        <Term>trial phase 2/3</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#phase_II/III_trial" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ep_459-asialofetuin_conjugate" name="Ep 459-asialofetuin conjugate">
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ep 459-asialofetuin conjugate</Term>
        <Term>asialofetuin-Ep 459</Term>
        <Term>Ep-459-AF</Term>
        <Codes>
          <Code code="C0623170" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_Ly" name="Antigens, Ly">
        <Definition>A group of lymphocyte surface antigens located on mouse LYMPHOCYTES. Specific Ly antigens are useful markers for distinguishing subpopulations of lymphocytes.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, Ly</Term>
        <Term>Ly Antigens</Term>
        <Codes>
          <Code code="C0003334" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
          <Relation name="Narrower">OTE:Ly-49L_antigen, OTE:Ly-49W2_receptor, OTE:Ly-49W1_receptor, OTE:Ncr1_protein_mouse, OTE:Ly49I_antigen, OTE:Klrb1c_protein_mouse, OTE:Ly33_protein_mouse, OTE:Ly6_protein_mouse, OTE:Ly7_protein_mouse, OTE:Ly6a_protein_mouse, OTE:Ly-6C_antigen_mouse, OTE:Ly6i_protein_mouse, OTE:Ncr3_protein_mouse, OTE:Ly11_protein_mouse, OTE:Ly-49_Antigen, OTE:LYPD6_protein_human, OTE:Klra10_protein_mouse, OTE:ARS_protein_human, OTE:Ly6G_antigen_mouse, OTE:SSLP-1_protein_mouse, OTE:LY6K_protein_human, OTE:SLURP-1_protein_mouse, OTE:Ly6d_protein_mouse, OTE:Ly108_protein_mouse, OTE:Ly6k_protein_mouse, OTE:SLURP-1_protein_rat, OTE:Ly-49W_receptor, OTE:Tpre, OTE:LYPD7_protein_human, OTE:twit_protein_Drosophila</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Terminology" name="terminology">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">terminology</Term>
        <Relations>
          <Relation name="Broader">owl:Thing</Relation>
          <Relation name="Narrower">OTE:Language_Category, OTE:Population_Category, OTE:Publication_Type, OTE:Study_Design, OTE:Intervention_Comparator_Category, OTE:Outcome_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cytotoxic_T_Lymphocyte_Antigen_4" name="Cytotoxic T Lymphocyte Antigen 4">
        <Definition>CTLA-4 is an inhibitory T-cell surface receptor for B7 ligands on antigen presenting cells. It contains an extracellular V-like domain, a transmembrane region, and a putative cytoplasmic domain. It shares significant homology with CD28. Both bind the same ligands, however CTLA-4 binds to B7 with a greater affinity. B7 antigen-presenting cells regulate T-cell activation by delivering antigen-independent stimulatory signals through CD28 and inhibitory signals through CTLA-4. While CD28 is on the membrane of resting T-cells, CTLA-4 is detectable only on cells activated after antigen presentation. A CTLA-4 splice variant with a deleted transmembrane segment is preferentially expressed in non-activated T-cells. Activation of lymphocytes results in the disappearance of sCTLA-4 followed by its gradual reappearance, whereas CTLA-4 increases after activation. CTLA-4 may play an inhibitory role in regulating lymphocyte expansion. (from OMIM 123890 and NCI)</Definition>
        <Definition>An inhibitory T CELL receptor that is closely related to CD28 ANTIGEN. It has specificity for CD80 ANTIGEN and CD86 ANTIGEN and acts as a negative regulator of peripheral T cell function. CTLA-4 antigen is believed to play role in inducing PERIPHERAL TOLERANCE.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cytotoxic T Lymphocyte Antigen 4</Term>
        <Term>Antigen, CTLA-4</Term>
        <Term>Cytotoxic T Lymphocyte Associated Antigen 4</Term>
        <Term>CTLA 4 Antigen</Term>
        <Term>CD152 Antigens</Term>
        <Term>Antigen, CD152</Term>
        <Term>CD152 Antigen</Term>
        <Term>CTLA-4 Antigen</Term>
        <Term>Antigens, CD152</Term>
        <Term>Cytotoxic T-Lymphocyte-Associated Antigen 4</Term>
        <Term>Cytotoxic T-Lymphocyte Antigen 4</Term>
        <Codes>
          <Code code="C0111208" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:CTLA4_protein_human, OTE:Ctla4_protein_rat, OTE:Ctla4_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD8A_protein_human" name="CD8A protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD8A protein, human</Term>
        <Term>wt CD8</Term>
        <Term>CD8 antigen, alpha polypeptide p32, human</Term>
        <Term>CD8a molecule protein, human</Term>
        <Codes>
          <Code code="C1721291" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD8_antigen_alpha_chain</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:WIK_AB_Zebrafish" name="WIK/AB Zebrafish">
        <Definition>A wild-type zebrafish line.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">WIK/AB Zebrafish</Term>
        <Term>WIK/AB</Term>
        <Codes>
          <Code code="C79989" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Language_Category" name="Language Category">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Language Category</Term>
        <Relations>
          <Relation name="Broader">OTE:Terminology</Relation>
          <Relation name="Narrower">OTE:Foreign, OTE:English</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Il2ra_protein_mouse" name="Il2ra protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Il2ra protein, mouse</Term>
        <Term>CD25 protein, mouse</Term>
        <Term>interleukin 2 receptor, alpha chain protein, mouse</Term>
        <Codes>
          <Code code="C1700322" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_2_Receptor_alpha</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin_3_Receptor_alpha_Subunit" name="Interleukin 3 Receptor alpha Subunit">
        <Definition>A low affinity interleukin-3 receptor subunit that combines with the CYTOKINE RECEPTOR COMMON BETA SUBUNIT to form a high affinity receptor for INTERLEUKIN-3.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin 3 Receptor alpha Subunit</Term>
        <Term>alpha-Subunit, Receptor, Interleukin-3</Term>
        <Term>Interleukin-3 Receptor alpha Chain</Term>
        <Term>Antigen, CD123</Term>
        <Term>Interleukin-3 Receptor alpha Subunit</Term>
        <Term>Antigens, CD123</Term>
        <Term>Interleukin-3 Receptor alpha Subunit [Chemical/Ingredient]</Term>
        <Term>CD123 Antigen</Term>
        <Term>CD 123 ANTIGENS</Term>
        <Term>CD123 Antigens</Term>
        <Term>Interleukin 3 Receptor alpha Chain</Term>
        <Term>INTERLEUKIN 003 RECEPTOR ALPHA SUBUNIT</Term>
        <Term>CD123 Ag</Term>
        <Term>ANTIGENS CD 123</Term>
        <Codes>
          <Code code="C1706415" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:IL3RA_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Human_Head_Louse" name="Human Head Louse">
        <Definition>Small parasitic insects that can cause a itching red rash to the skin of the waist, shoulders, armpits, neck and pubic area. Commonly spread from person-to-person via close contact. The eggs (nits) of head lice can be mistaken for dandruff, but they are adherent to the hair shafts.</Definition>
        <Definition>Small parasitic insects that can cause a itching red rash to the skin of the waist, shoulders, armpits, neck and pubic area. Commonly spread from person-to-person via close contact. The eggs (nits) of head lice can be mistaken for dandruff, but they are adherent to the hair shafts.(On-line Medical Dictionary)</Definition>
        <Definition>&lt;p&gt;Head lice are parasitic wingless insects. They live on people's heads and feed on their blood. An adult louse is about the size of a sesame seed. The eggs, called nits, are even smaller - about the size of a knot in thread. Lice and nits are easiest to detect at the neckline and behind the ears.&lt;/p&gt;&lt;p&gt;Head lice are extremely contagious. Close contact or sharing personal belongings, such as hats or hairbrushes, puts people at risk. Children ages 3-11 and their families get head lice most often. Personal hygiene has nothing to do with getting head lice. Head lice do not spread disease.&lt;/p&gt;&lt;p&gt;Symptoms are &lt;/p&gt;&lt;ul&gt;&lt;li&gt;Tickling feeling in the hair&lt;/li&gt;&lt;li&gt;Frequent itching&lt;/li&gt;&lt;li&gt;Sores from scratching&lt;/li&gt;&lt;li&gt;Irritability and difficulty sleeping. Head lice are most active in the dark.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Treatment for head lice is recommended for people with an active infestation. All household members and other close contacts should be checked. Anyone who has an active infestation should be treated. All infested people and their bedmates should be treated at the same time.&lt;/p&gt;&lt;p &gt;Centers for Disease Control and Prevention &lt;/p&gt;</Definition>
        <SemanticType code="T204" name="Eukaryote"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Human Head Louse</Term>
        <Term>Pediculus americanus</Term>
        <Term>Louses, Head</Term>
        <Term>Pediculus cervicalis</Term>
        <Term>Pediculus humanus capitis (eukaryote)</Term>
        <Term>pediculus capitis</Term>
        <Term>Lices, Head</Term>
        <Term>Nit, NOS</Term>
        <Term>Head Lice</Term>
        <Term>head lice nits</Term>
        <Term>Head Lices</Term>
        <Term>head louse</Term>
        <Term>Lice, Head</Term>
        <Term>Head Louses</Term>
        <Term>Head louse</Term>
        <Term>Pediculus capitis - head lice</Term>
        <Term>Pediculus maculatus</Term>
        <Term>Pediculus humanus capitis (organism)</Term>
        <Term>Pediculus pubescens</Term>
        <Term>Pediculus humanus capitis</Term>
        <Term>Pediculus capitis</Term>
        <Term>Head Louse</Term>
        <Term>nits</Term>
        <Term>Pediculus angustus</Term>
        <Term>Nits</Term>
        <Term>pediculus humanus capitis</Term>
        <Term>nit</Term>
        <Term>head lice</Term>
        <Term>Nits - head lice</Term>
        <Term>Louse, Head</Term>
        <Codes>
          <Code code="C34905" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Lice</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mac-3" name="Mac-3">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mac-3</Term>
        <Term>macrophage-3 antigen</Term>
        <Codes>
          <Code code="C0126722" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:monocyte-macrophage_differentiation_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:transplant_rejection" name="transplant rejection">
        <Definition>Failure of transplanted tissue to become functional or operational, often as a result of destruction by the host's immune system.</Definition>
        <Definition>cell-mediated immune response by the host body to a surgically grafted organ or tissue that results in failure of the organ or tissue to survive; can be acute or chronic.</Definition>
        <Definition>An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.</Definition>
        <SemanticType code="T042" name="Organ or Tissue Function"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">transplant rejection</Term>
        <Term>Cellular graft rejection</Term>
        <Term>REJECTION TRANSPL</Term>
        <Term>rejection graft</Term>
        <Term>Graft rejection, immunologic</Term>
        <Term>Graft Rejections</Term>
        <Term>Transplant Rejections</Term>
        <Term>graft rejection</Term>
        <Term>rejection; transplant</Term>
        <Term>Rejection, Transplantation</Term>
        <Term>Rejections, Graft</Term>
        <Term>Graft rejection (finding)</Term>
        <Term>Graft Rejection</Term>
        <Term>Rejection, Transplant</Term>
        <Term>Transplant rejections</Term>
        <Term>graft rejections</Term>
        <Term>Graft rejection</Term>
        <Term>Cellular graft rejection, NOS</Term>
        <Term>Transplantation Rejection</Term>
        <Term>Rejections, Transplant</Term>
        <Term>Graft rejection, NOS</Term>
        <Term>Transplantation Rejections</Term>
        <Term>TRANSPL REJECTION</Term>
        <Term>Transplant Rejection</Term>
        <Term>TRANSPLANT REJECTION</Term>
        <Term>transplant; rejection</Term>
        <Term>Rejections, Transplantation</Term>
        <Term>rejection transplant</Term>
        <Term>transplant rejections</Term>
        <Term>Transplant rejection</Term>
        <Term>transplantation rejection</Term>
        <Term>Transplant failure due to rejection</Term>
        <Term>Immunologic graft rejection, NOS</Term>
        <Term>Immunologic graft rejection</Term>
        <Term>Rejection, Graft</Term>
        <Codes>
          <Code code="C0018129" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Outcome_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Leukemia_Inhibitory_Factor_Receptor_alpha_Subunit" name="Leukemia Inhibitory Factor Receptor alpha Subunit">
        <Definition>A receptor subunit that combines with CYTOKINE RECEPTOR GP130 to form the dual specificity receptor for LEUKEMIA INHIBITORY FACTOR and ONCOSTATIN M. The subunit is also a component of the CILIARY NEUROTROPHIC FACTOR RECEPTOR. Both membrane-bound and secreted isoforms of the receptor subunit exist due to ALTERNATIVE SPLICING of its mRNA. The secreted isoform is believed to act as an inhibitory receptor, while the membrane-bound form is a signaling receptor.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Leukemia Inhibitory Factor Receptor alpha Subunit</Term>
        <Term>ANTIGENS CD 118</Term>
        <Term>LIF Receptor alpha Subunit</Term>
        <Term>CD118 Antigens</Term>
        <Term>Antigen, CD118</Term>
        <Term>Leukemia Inhibitory Factor Receptor alpha Subunit [Chemical/Ingredient]</Term>
        <Term>Antigens, CD118</Term>
        <Term>CD118 Antigen</Term>
        <Term>CD 118 ANTIGENS</Term>
        <Codes>
          <Code code="C1721043" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Lifr_protein_rat, OTE:Lifr_protein_mouse, OTE:LIFR_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CBy_Cg-Foxn1-nu" name="CBy.Cg-Foxn1-nu">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CBy.Cg-Foxn1-nu</Term>
        <Term>BALB/cByJ-Hfh1l-nu</Term>
        <Codes>
          <Code code="C15161" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Nude_Mouse</Relation>
          <Relation name="Narrower">OTE:BALB_c-Hfh11nu_X_DD_1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Korean_Americans" name="Korean Americans">
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Korean Americans</Term>
        <Term>American Korean</Term>
        <Term>Americans, Korean</Term>
        <Term>Korean American</Term>
        <Term>americans korean</Term>
        <Term>American, Korean</Term>
        <Codes>
          <Code code="C0597921" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Asian_Americans</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:before-after_design" name="before-after design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">before-after design</Term>
        <Term>before-and-after design</Term>
        <Term>before-and-after trials</Term>
        <Term>before-after designs</Term>
        <Term>before-and-after trial</Term>
        <Term>before-after studies</Term>
        <Term>before-after trials</Term>
        <Term>before-and-after study</Term>
        <Term>before-and-after designs</Term>
        <Term>before-and-after studies</Term>
        <Term>before-after trial</Term>
        <Term>before-after study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#before-after_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:cohort_before-after_design, OTE:pre-and-post_design, OTE:controlled_before-after_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Neuromuscular_Blockade_Monitoring" name="Neuromuscular Blockade Monitoring">
        <SemanticType code="T058" name="Health Care Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Neuromuscular Blockade Monitoring</Term>
        <Term>Monitoring, Neuromuscular Blockade</Term>
        <Term>Neuromuscular block monitoring</Term>
        <Term>Neuromuscular blockade monitoring</Term>
        <Term>Neuromuscular blockade monitoring (regime/therapy)</Term>
        <Term>Blockade Monitoring, Neuromuscular</Term>
        <Codes>
          <Code code="C0561865" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Neuromuscular_Monitoring</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:adverse_reaction" name="adverse reaction">
        <Definition>An unexpected medical problem that happens during treatment with a drug or other therapy. Adverse effects do not have to be caused by the drug or therapy, and they may be mild, moderate, or severe.</Definition>
        <Definition>&lt;p&gt;Indicates that the observation is of an unexpected negative occurrence in the subject suspected to result from the subject's exposure to one or more agents. Observation values would be the symptom resulting from the reaction.&lt;/p&gt;</Definition>
        <Definition>Any noxious and unintended response(s) to a medical product or procedure, for which a causal relationship with this product or procedure is at least a reasonable possibility i.e., the relationship cannot be ruled out.</Definition>
        <SemanticType code="T033" name="Finding"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">adverse reaction</Term>
        <Term>reactions adverse</Term>
        <Term>adverse effect</Term>
        <Term>ADR</Term>
        <Term>adverse reactions</Term>
        <Term>ADVERSE REACTION</Term>
        <Term>Adverse Effect</Term>
        <Term>Adverse reaction</Term>
        <Term>Adverse reactions</Term>
        <Term>Adverse Reaction</Term>
        <Term>Adverse reaction (disorder)</Term>
        <Term>AR</Term>
        <Codes>
          <Code code="C0559546" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Outcome_Category</Relation>
          <Relation name="Narrower">OTE:Tumor_Flare_Reaction, OTE:Long-Term_Effects_Secondary_to_Cancer_Therapy, OTE:Skin_Reaction_Secondary_to_Radiation_Therapy, OTE:Late_Adverse_Effect</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:neprilysin_2_mouse" name="neprilysin 2, mouse">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">neprilysin 2, mouse</Term>
        <Term>NEP2 protein, mouse</Term>
        <Codes>
          <Code code="C2603417" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Neprilysin</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NZO_HlLt_Mouse" name="NZO/HlLt Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NZO/HlLt Mouse</Term>
        <Term>NZO/HlLt</Term>
        <Codes>
          <Code code="C37424" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD56" name="Antigen, CD56">
        <Definition>The 140 kDa isoform of NCAM (neural cell adhesion molecule) containing a transmembrane domain and short cytoplasmic tail. It is expressed by all lymphocytes mediating non-MHC restricted cytotoxicity and is present on some neural tissues and tumors.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD56</Term>
        <Term>NKH 1 Antigen</Term>
        <Term>Leu 19 Antigen</Term>
        <Term>Antigen, NKH-1</Term>
        <Term>Antigens, CD56</Term>
        <Term>NKH-1 Antigen</Term>
        <Term>CD56 Antigen</Term>
        <Term>CD 056 ANTIGENS</Term>
        <Term>ANTIGENS CD 056</Term>
        <Term>Leu-19 Antigen</Term>
        <Term>CD56 Antigens</Term>
        <Term>Antigen, Leu-19</Term>
        <Codes>
          <Code code="C0108754" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Ncam1_protein_mouse, OTE:NCAM1_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:New_Zealand_White_Rabbit" name="New Zealand White Rabbit">
        <Definition>One of the larger rabbit breeds, the New Zealand was derived by Don Johnson in 1916 by crossing unknown breeds. This rabbit weighs between 9-12 lbs. fully grown and may come in a variety of coat colors.</Definition>
        <Definition>An albino New Zealand rabbit with coat genotype c, VV and eye color genotype np.</Definition>
        <Definition>An albino New Zealand rabbit with coat genotype c, VV and eye color genotype np. This lagomorph has non-pigmented skin and long slender ears which allows for ease of visualization of peripheral vasculature, thus facilitating phlebotomical procedures. Most common breed utilized in biomedical research and is used in a variety of studies including developmental toxicity studies, toxicology studies, asthma research, and antibody production.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">New Zealand White Rabbit</Term>
        <Term>New Zealand white rabbit (organism)</Term>
        <Term>New Zealand rabbit breed (organism)</Term>
        <Term>New Zealand Rabbit</Term>
        <Term>New Zealand rabbit</Term>
        <Term>New Zealand White</Term>
        <Term>New Zealand white rabbit</Term>
        <Term>Rabbit, NZW</Term>
        <Term>Rabbits, NZW</Term>
        <Term>New Zealand Albino</Term>
        <Term>New Zealand Rabbits</Term>
        <Term>Rabbit, New Zealand</Term>
        <Term>New Zealand White Rabbits</Term>
        <Term>NZW Rabbit</Term>
        <Term>New Zealand rabbit breed</Term>
        <Term>NZW Rabbits</Term>
        <Term>NEW ZEALAND WHITE</Term>
        <Term>Rabbits, New Zealand</Term>
        <Term>NEW ZEALAND</Term>
        <Codes>
          <Code code="C0324547" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rabbit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD58" name="Antigen, CD58">
        <Definition>Glycoproteins with a wide distribution on hematopoietic and non-hematopoietic cells and strongly expressed on macrophages. CD58 mediates cell adhesion by binding to CD2; (ANTIGENS, CD2); and this enhances antigen-specific T-cell activation.</Definition>
        <Definition>Lymphocyte function-associated antigen 3 (250 aa, 28 kD) is a cell adhesion process protein that is encoded by the human CD58 gene and may have a role in cell-cell adhesion.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD58</Term>
        <Term>LYMPHOCYTE FUNCTION ASSOCIATED 03 ANTIGEN</Term>
        <Term>CD58 Antigen</Term>
        <Term>LYMPHOCYTE FUNCTION ASSOC ANTIGEN 3</Term>
        <Term>LFA-3</Term>
        <Term>LFA 3</Term>
        <Term>Lymphocyte Function Associated Antigen 3</Term>
        <Term>Antigens, CD58</Term>
        <Term>CD58 Antigens</Term>
        <Term>ANTIGENS CD 058</Term>
        <Term>Lymphocyte Function Associated Antigen-3</Term>
        <Term>LFA 003</Term>
        <Term>CD 058 ANTIGENS</Term>
        <Codes>
          <Code code="C0081942" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cdh5_protein_mouse" name="Cdh5 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cdh5 protein, mouse</Term>
        <Term>cadherin 5 protein, mouse</Term>
        <Codes>
          <Code code="C1739739" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cadherin-5</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:matched_case_control_design" name="matched case control design">
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">matched case control design</Term>
        <Term>matched case-control design</Term>
        <Term>matched case control</Term>
        <Term>matched case control trials</Term>
        <Term>matched case-control trial</Term>
        <Term>matched case-control designs</Term>
        <Term>matched case control study</Term>
        <Term>matched case-control trials</Term>
        <Term>matched case-control study</Term>
        <Term>matched case-control studies</Term>
        <Term>matched case control trial</Term>
        <Term>matched case control designs</Term>
        <Term>matched case control studies</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#matched_case_control" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:case_control_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Nt5e_protein_Streptococcus_sanguinis" name="Nt5e protein, Streptococcus sanguinis">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Nt5e protein, Streptococcus sanguinis</Term>
        <Codes>
          <Code code="C3529147" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-Nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD57" name="Antigen, CD57">
        <Definition>Oligosaccharide antigenic determinants found principally on NK cells and T-cells. Their role in the immune response is poorly understood.</Definition>
        <Definition>A carbohydrate molecule that contains a sulfoglucuronyl residue and found predominantly on the surface of natural killer cells. It is involved in the modulation of cell-cell and cell-matrix interactions.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD57</Term>
        <Term>Leu 7 Antigen</Term>
        <Term>HNK 1 Antigen</Term>
        <Term>Antigen, Leu-7</Term>
        <Term>ANTIGENS CD 057</Term>
        <Term>Antigens, CD57</Term>
        <Term>CD57 Antigen</Term>
        <Term>CD57 Antigens</Term>
        <Term>HNK-1 Antigen</Term>
        <Term>CD 057 ANTIGENS</Term>
        <Term>Antigen, HNK-1</Term>
        <Term>Leu-7 Antigen</Term>
        <Codes>
          <Code code="C0054965" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ACE_protein_human" name="ACE protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ACE protein, human</Term>
        <Term>angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 protein, human</Term>
        <Codes>
          <Code code="C1452534" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Peptidyl_Dipeptidase_A</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly108_protein_mouse" name="Ly108 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly108 protein, mouse</Term>
        <Term>lymphocyte antigen 108 protein, mouse</Term>
        <Codes>
          <Code code="C1570560" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD53" name="Antigen, CD53">
        <Definition>Tetraspanin proteins found at high levels in cells of the lymphoid-myeloid lineage. CD53 antigens may be involved regulating the differentiation of T-LYMPHOCYTES and the activation of B-LYMPHOCYTES.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD53</Term>
        <Term>CD53 Antigen</Term>
        <Term>Antigens, CD53</Term>
        <Term>Tetraspanin-25</Term>
        <Term>CD53 Antigens</Term>
        <Term>Tetraspanin 25</Term>
        <Codes>
          <Code code="C0108791" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cd53_protein_mouse, OTE:CD53_protein_human, OTE:Cd53_protein_rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Lifr_protein_mouse" name="Lifr protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Lifr protein, mouse</Term>
        <Term>leukemia inhibitory factor receptor alpha subunit, mouse</Term>
        <Term>mouse D-factor receptors</Term>
        <Term>receptor, mouse D-factor</Term>
        <Term>mouse D-factor receptor</Term>
        <Term>leukemia inhibitory factor receptor, mouse</Term>
        <Codes>
          <Code code="C0246432" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Leukemia_Inhibitory_Factor_Receptor_alpha_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fcreceptors" name="Fc(alpha) receptors">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fc(alpha) receptors</Term>
        <Term>Fc IGA receptors</Term>
        <Term>receptor, Fc(alpha)</Term>
        <Term>IgAFc (T alpha) receptor</Term>
        <Term>Fc(alpha) receptor</Term>
        <Term>CD89 antigen</Term>
        <Term>Fc alpha RI</Term>
        <Term>IGA Fc receptor</Term>
        <Codes>
          <Code code="C0060105" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:FCAR_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:WAG_Rat_Strain" name="WAG, Rat Strain">
        <Definition>Tumors: medullary thyroid carcinoma 27%, chromophobe adenoma of the pituitary 68%, adrenal cortical adenoma 29%, pheochromocytoma 2%, islet cell adenoma 1%. Mean life-span more than 31 months in females and 22 months in males (Boorman et al 1972). Mean life-span 31 months in females with pituitary tumors found in 69% of females. Other common tumors include medullary thyroid carcinoma 40%, adrenal cortical adenoma 29%, fibroadenoma of breast 21% with 19 other types of tumor found in 290 animals (Boorman and Hollander 1973).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">WAG, Rat Strain</Term>
        <Codes>
          <Code code="C14414" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LG_J_Mouse" name="LG/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LG/J Mouse</Term>
        <Term>LG/J</Term>
        <Codes>
          <Code code="C15043" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FAS_protein_human" name="FAS protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FAS protein, human</Term>
        <Term>FAS1 protein, human</Term>
        <Term>CD95 antigen, human</Term>
        <Term>Fas (TNF receptor superfamily, member 6), human</Term>
        <Term>tumor necrosis factor receptor superfamily, member 6 protein, human</Term>
        <Term>TNFRSF6 protein, human</Term>
        <Codes>
          <Code code="C1454645" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD95</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FCGR3A_protein_human" name="FCGR3A protein, human">
        <Definition>Expressed on natural killer cells, macrophages, T cells, immature thymocytes, and trophoblasts by human FCGR3A Gene, 254-aa 29-kDa (precursor) glycosylated IgG Fc Receptor IIIA is a putative type I membrane protein containing 2 IgC2 domains and a receptor for the Fc region of monomeric or aggregated IgG that mediates antibody-dependent responses, such as phagocytosis and antibody-dependent cellular cytotoxicity. FCGR3B exists in a hetero-oligomeric complex with the Fc epsilon receptor I gamma subunit and/or the CD3 zeta subunit, as a soluble receptor produced by proteolytic cleavage. Amino acid conservation between CD16, other Fc receptors, and related Ig suggest similar structures and modes of association. (NCI)</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FCGR3A protein, human</Term>
        <Term>Fc gamma receptor IV, human</Term>
        <Term>Fc gamma RIV, human</Term>
        <Term>FcgammaRIIIa protein, human</Term>
        <Term>Fc gamma receptor IIIa, human</Term>
        <Term>Fc fragment of IgG, low affinity IIIa, receptor, human</Term>
        <Term>FcgammaRIV, human</Term>
        <Term>Fc fragment of IgG, low affinity IIIa, receptor (CD16a) protein, human</Term>
        <Term>CD16a protein, human</Term>
        <Codes>
          <Code code="C1521898" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Swiss_Webster_Mouse" name="Swiss Webster Mouse">
        <Definition>Derived from inbreeding of Swiss mice at the Rockefeller Institute in 1926 by Dr. Leslie Webster, the Swiss Webster is a white albino mouse with genotype TyrC. The superior nurturing ability of the Swiss Webster makes it ideal for embryo transfers. (NCI)</Definition>
        <Definition>Derived from inbreeding of Swiss mice at the Rockefeller Institute in 1926 by Dr. Leslie Webster, the Swiss Webster is a white albino mouse with genotype TyrC. The superior nurturing ability of the Swiss Webster makes it ideal for embryo transfers.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Swiss Webster Mouse</Term>
        <Term>Swiss Webster mouse</Term>
        <Term>Swiss Webster mouse breed</Term>
        <Term>SWISS WEBSTER</Term>
        <Term>Swiss Webster mouse breed (organism)</Term>
        <Codes>
          <Code code="C106573" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FVB_N_Mouse" name="FVB/N Mouse">
        <Definition>NIH general purpose Swiss mice were selected for resistance or sensitivity to histamine challenge following pertussis vaccination. The sensitive strain, HFSF/N, was subsequently found to have the Fv1b allele, which sensitizes the mice to B strain Friend Leukemia virus. The FVB/N strain has an albino coat with genotype A,B,c,D,P, and has a vigorous reproductive performance. This strain is commonly used in the generation of transgenic mice due to the fact that the pronuclei of FVB/N fertilized oocytes are prominent, which allows for ease of microinjection.</Definition>
        <Definition>NIH general purpose Swiss mice were selected for resistance or sensitivity to histamine challenge following pertussis vaccination. The sensitive strain, HFSF/N, was subsequently found to have the Fv1b allele, which sensitizes the mice to B strain Friend Leukemia virus. The FVB/N strain has an albino coat with genotype A,B,c,D,P, and has a vigorous reproductive performance.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FVB/N Mouse</Term>
        <Term>FVB/N</Term>
        <Codes>
          <Code code="C14474" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:P149_protein_human" name="P149 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">P149 protein, human</Term>
        <Codes>
          <Code code="C1569245" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tumor_Flare_Reaction" name="Tumor Flare Reaction">
        <Definition>A side effect of cancer treatment. It has been described in patients with chronic lymphocytic leukemia treated with lenalidomide, breast cancer patients during the initial phase of hormonal treatment, and in prostate cancer patients treated with luteinizing hormone-releasing hormone agonists. Symptoms include a sudden and painful increase in the tumor size, rash, low grade fever, bone pain, hypercalcemia, and an increase in the tumor markers levels.</Definition>
        <SemanticType code="T033" name="Finding"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tumor Flare Reaction</Term>
        <Term>TFR</Term>
        <Codes>
          <Code code="C2700092" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:adverse_reaction</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Human_Chorionic_Gonadotropin_beta_Subunit" name="Human Chorionic Gonadotropin, beta Subunit">
        <Definition>The beta subunit of human CHORIONIC GONADOTROPIN. Its structure is similar to the beta subunit of LUTEINIZING HORMONE, except for the additional 30 amino acids at the carboxy end with the associated carbohydrate residues. HCG-beta is used as a diagnostic marker for early detection of pregnancy, spontaneous abortion (ABORTION, SPONTANEOUS); ECTOPIC PREGNANCY; HYDATIDIFORM MOLE; CHORIOCARCINOMA; or DOWN SYNDROME.</Definition>
        <Definition>A hormone normally found in the blood and urine during pregnancy. It may also be produced by some tumor cells. An increased level of beta-human chorionic gonadotropin may be a sign of cancer of the testis, uterus, ovary, liver, stomach, pancreas, or lung. Beta-human chorionic gonadotropin may also be produced in response to certain conditions that are not cancer. Beta-human chorionic gonadotropin is being studied in the treatment of Kaposi sarcoma.</Definition>
        <Definition>Choriogonadotropin subunit beta (165 aa, ~18 kDa) is encoded by the human CGB gene. This protein is involved in the regulation of steroid synthesis during pregnancy.</Definition>
        <SemanticType code="T125" name="Hormone"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Human Chorionic Gonadotropin, beta Subunit</Term>
        <Term>Chorionic Gonadotropin, beta Subunit, Human</Term>
        <Term>HCG, beta Subunit</Term>
        <Term>HUMAN CHORIONIC GONADOTROPIN BETA SUBUNIT</Term>
        <Term>HCG-beta</Term>
        <Term>Chorionic Gonadotropin, beta Chain, Human</Term>
        <Term>Chorionic Gonadotropin, beta Polypeptide, Human</Term>
        <Term>CHORIONIC GONADOTROPIN BETA SUBUNIT HUMAN</Term>
        <Term>HCG beta</Term>
        <Codes>
          <Code code="C0106132" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:health_care_survey" name="health care survey">
        <Definition>Statistical measures of utilization and other aspects of the provision of health care services including hospitalization and ambulatory care. [Health care surveys | MeSH_2014]</Definition>
        <Definition>Statistical measures of utilization and other aspects of the provision of health care services including hospitalization and ambulatory care.</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">health care survey</Term>
        <Term>healthcare surveys</Term>
        <Term>Surveys, Health Care</Term>
        <Term>healthcare survey</Term>
        <Term>Health Care Surveys</Term>
        <Term>Survey, Health Care</Term>
        <Term>Care Surveys, Health</Term>
        <Term>Health Care Survey</Term>
        <Term>Healthcare Surveys</Term>
        <Term>Survey, Healthcare</Term>
        <Term>Surveys, Healthcare</Term>
        <Term>Care Survey, Health</Term>
        <Term>health care surveys</Term>
        <Term>Healthcare Survey</Term>
        <Codes>
          <Code code="C0376688" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:survey</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:TFRC_protein_human" name="TFRC protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">TFRC protein, human</Term>
        <Term>CD71 antigen, human</Term>
        <Term>transferrin receptor 1, human</Term>
        <Term>TfR1, human</Term>
        <Codes>
          <Code code="C0108801" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD71_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_CD59" name="Antigens, CD59">
        <Definition>CD59 glycoprotein (128 aa, ~14 kDa) is encoded by the human CD59 gene. This protein is involved in the inhibition of the assembly of the membrane attack complex in the complement cascade.</Definition>
        <Definition>Small glycoproteins found on both hematopoietic and non-hematopoietic cells. CD59 restricts the cytolytic activity of homologous complement by binding to C8 and C9 and blocking the assembly of the membrane attack complex. (From Barclay et al., The Leukocyte Antigen FactsBook, 1993, p234)</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, CD59</Term>
        <Term>HRF20</Term>
        <Term>CD59 Antigens</Term>
        <Term>Homologous Restriction Factor 20</Term>
        <Term>Membrane Attack Complex Inhibition Factor</Term>
        <Term>CD59 Antigen</Term>
        <Term>MACIF</Term>
        <Term>ANTIGENS CD 059</Term>
        <Term>Membrane Inhibitor of Reactive Lysis</Term>
        <Term>CD 059 ANTIGENS</Term>
        <Term>MIRL</Term>
        <Term>Protectin</Term>
        <Term>HRF 020</Term>
        <Term>HOMOLOGOUS RESTRICTION FACTOR 020</Term>
        <Codes>
          <Code code="C0054966" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:CD59a_protein_mouse, OTE:CD59_protein_human, OTE:CD59b_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Leukocyte_Differentiation_Antigens_Human" name="Leukocyte Differentiation Antigens, Human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Leukocyte Differentiation Antigens, Human</Term>
        <Term>Differentiation Antigens, Leukocyte, Human</Term>
        <Codes>
          <Code code="C0917780" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Suidae" name="Suidae">
        <Definition>Taxonomic family which includes the domestic pig</Definition>
        <Definition>any of various stout-bodied short-legged omnivorous mammals (family Suidae) with a thick bristly skin and a long flexible snout; especially a domesticated member of the species (Sus scrofa) that includes the European wild boar.</Definition>
        <Definition>Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Suidae</Term>
        <Term>Family Suidae</Term>
        <Term>Family Suidae (organism)</Term>
        <Term>8B1 FAMILY SUIDAE</Term>
        <Term>boars</Term>
        <Term>pig</Term>
        <Term>boar</Term>
        <Term>swine</Term>
        <Term>FAMILY SUIDAE</Term>
        <Term>Pigs</Term>
        <Term>Swine</Term>
        <Term>Suids</Term>
        <Term>Suid</Term>
        <Term>suid</Term>
        <Term>Family suidae</Term>
        <Term>Pig</Term>
        <Term>pigs</Term>
        <Term>porcine</Term>
        <Codes>
          <Code code="C0039005" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Artiodactyla</Relation>
          <Relation name="Narrower">OTE:Pig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:pactolus" name="pactolus">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">pactolus</Term>
        <Codes>
          <Code code="C0674044" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD29</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_CD64" name="Antigens, CD64">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, CD64</Term>
        <Term>Antigens, CD 64</Term>
        <Term>CD 64 Antigens</Term>
        <Term>Fc gamma RI</Term>
        <Term>CD 064 ANTIGENS</Term>
        <Term>gamma RI, Fc</Term>
        <Term>ANTIGENS CD 064</Term>
        <Term>CD64 Antigens</Term>
        <Codes>
          <Code code="C0108796" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CRIg_protein_human" name="CRIg protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CRIg protein, human</Term>
        <Codes>
          <Code code="C1956452" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CR1_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:tissue_distribution" name="tissue distribution">
        <Definition>Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios.</Definition>
        <Definition>Nahromadění lékových nebo chemických látek v různých orgánech (včetně těch, které nejsou předem určené k farmakologickému nebo terapeutickému ovlivnění). Distribuce těchto látek spočívá v krevní cestě nebo v rychlosti prokrvení orgánu, ve schopnosti léku proniknout membránami orgánu, jeho tkáňové specifikaci a vazbě na protein. Distribuce je obvykle vyjádřena jako stav podílů léčiv ve tkáních ku plasmě.</Definition>
        <SemanticType code="T081" name="Quantitative Concept"/>
        <SemanticType code="T169" name="Functional Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">tissue distribution</Term>
        <Term>Drug or chemical Tissue Distribution</Term>
        <Term>Distribution, Tissue</Term>
        <Term>Tissue Distribution</Term>
        <Term>tissue distribution aspects</Term>
        <Term>Distributions, Tissue</Term>
        <Term>Tissue Distributions</Term>
        <Codes>
          <Code code="C0220927" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Pharmacokinetics</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Xenopus_laevis" name="Xenopus laevis">
        <Definition>The commonest and widest ranging species of the clawed "frog" (Xenopus) in Africa. This species is used extensively in research. There is now a significant population in California derived from escaped laboratory animals.</Definition>
        <Definition>A species of South African aquatic frog of the genus Xenopus. It is up to 12 cm long with a flattened head and body but no tongue. Its name derives from its three short claws on each of its hind feet. It is an important model organism in developmental biology.</Definition>
        <SemanticType code="T011" name="Amphibian"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Xenopus laevis</Term>
        <Term>X. laevis</Term>
        <Term>Bufo laevis</Term>
        <Term>Platanna</Term>
        <Term>common platanna</Term>
        <Term>platanna</Term>
        <Term>African clawed frog</Term>
        <Term>African Clawed Frog</Term>
        <Term>Tongueless frog</Term>
        <Term>Xenopus laevis (Daudin, 1802)</Term>
        <Term>Tongueless frog, NOS</Term>
        <Term>laevis, Xenopus</Term>
        <Term>Platannas</Term>
        <Term>Tongueless frog (organism)</Term>
        <Term>Xenopus</Term>
        <Term>clawed frog</Term>
        <Term>Clawed Frog</Term>
        <Codes>
          <Code code="C61089" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Xenopus</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NZW_LacJ_Mouse" name="NZW/LacJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NZW/LacJ Mouse</Term>
        <Term>NZW/LacJ</Term>
        <Codes>
          <Code code="C37426" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BL_6JN_Mouse" name="C57BL/6JN Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BL/6JN Mouse</Term>
        <Term>C57BL/6JN</Term>
        <Codes>
          <Code code="C37384" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD86" name="Antigen, CD86">
        <Definition>A costimulatory ligand expressed by ANTIGEN-PRESENTING CELLS that binds to CD28 ANTIGEN with high specificity and to CTLA-4 ANTIGEN with low specificity. The interaction of CD86 with CD28 ANTIGEN provides a stimulatory signal to T-LYMPHOCYTES, while its interaction with CTLA-4 ANTIGEN may play a role in inducing PERIPHERAL TOLERANCE.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD86</Term>
        <Term>B7-2 Antigen</Term>
        <Term>B7-2 Costimulatory Molecule</Term>
        <Term>CD 086 ANTIGENS</Term>
        <Term>B7 2 Antigen</Term>
        <Term>Costimulatory Molecule, B70</Term>
        <Term>ANTIGENS CD 086</Term>
        <Term>B A 007 002 COSTIMULATORY MOLECULE</Term>
        <Term>Antigens, CD86</Term>
        <Term>Early T Cell Costimulatory Molecule 1</Term>
        <Term>Antigen, B7 2</Term>
        <Term>Costimulatory Molecule, B7-2</Term>
        <Term>Antigen, B7-2</Term>
        <Term>B70 Costimulatory Molecule</Term>
        <Term>CD86 Antigen</Term>
        <Term>CD86 Antigens</Term>
        <Codes>
          <Code code="C0527903" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:CD86_protein_human, OTE:Cd86_protein_rat, OTE:Cd86_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:neutrophil_differentiation_antigens" name="neutrophil differentiation antigens">
        <SemanticType code="T109" name="Organic Chemical"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">neutrophil differentiation antigens</Term>
        <Term>neutrophil DF antigen</Term>
        <Term>differentiation antigens, neutrophil</Term>
        <Codes>
          <Code code="C0057990" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MUC1_protein_rat" name="MUC1 protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MUC1 protein, rat</Term>
        <Term>mucin 1, transmembrane, rat</Term>
        <Codes>
          <Code code="C1671156" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CA-15-3_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd84_protein_mouse" name="Cd84 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd84 protein, mouse</Term>
        <Term>SLAMF5 protein, mouse</Term>
        <Term>CD84 antigen, mouse</Term>
        <Codes>
          <Code code="C1453160" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:RF_J_Mouse" name="RF/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">RF/J Mouse</Term>
        <Term>RF/J</Term>
        <Codes>
          <Code code="C14683" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:non-randomized_comparative_design" name="non-randomized comparative design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">non-randomized comparative design</Term>
        <Term>nonrandomized comparative designs</Term>
        <Term>non-randomized comparative studies</Term>
        <Term>nonrandomised comparative trial</Term>
        <Term>non-randomised comparative trial</Term>
        <Term>nonrandomized comparative trials</Term>
        <Term>non-randomised comparative designs</Term>
        <Term>nonrandomized comparative studies</Term>
        <Term>nonrandomised comparative study</Term>
        <Term>nonrandomized comparative design</Term>
        <Term>non-randomised comparative studies</Term>
        <Term>nonrandomised comparative studies</Term>
        <Term>nonrandomised comparative trials</Term>
        <Term>non-randomised comparative study</Term>
        <Term>non-randomized comparative study</Term>
        <Term>non-randomised comparative design</Term>
        <Term>nonrandomised comparative design</Term>
        <Term>non-randomized comparative designs</Term>
        <Term>non-randomized comparative trial</Term>
        <Term>nonrandomized comparative study</Term>
        <Term>non-randomized comparative trials</Term>
        <Term>nonrandomized comparative trial</Term>
        <Term>nonrandomised comparative designs</Term>
        <Term>non-randomised comparative trials</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#non-randomized_comparative_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:comparative_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD59b_protein_mouse" name="CD59b protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD59b protein, mouse</Term>
        <Codes>
          <Code code="C2714591" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD59</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:RIKEN_WT_Zebrafish" name="RIKEN WT Zebrafish">
        <Definition>A wild-type zebrafish line that is currently available from the National BioResource Project, Zebrafish, NRBP/Brain Science Institute, RIKEN.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">RIKEN WT Zebrafish</Term>
        <Term>RW</Term>
        <Term>RIKEN WT</Term>
        <Codes>
          <Code code="C79979" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SBSN_protein_human" name="SBSN protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SBSN protein, human</Term>
        <Term>suprabasin protein, human</Term>
        <Codes>
          <Code code="C3657755" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Allograft" name="Allograft">
        <Definition>Tissues, cells, or organs transplanted between genetically different individuals of the same species.</Definition>
        <Definition>Trasplante en el cual los sitios receptor y donante pertenecen a distintos individuos de la misma especie</Definition>
        <Definition>A graft transferred from a donor of one species to a recipient of the same species but different genetic makeup.</Definition>
        <Definition>Grafting or transplanting cells, tissues, or organs between genetically non-identical individuals.</Definition>
        <Definition>A transplantation where the donor and recipient spots are from antigenically distinct individuals of the same species</Definition>
        <Definition>transplantation between individuals of the same species.</Definition>
        <Definition>Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals.</Definition>
        <Definition>The transplant of an organ, tissue, or cells from one individual to another individual of the same species who is not an identical twin.</Definition>
        <Definition>Skin, bone, or other tissue taken from an individual used to replace or regenerate diseased or injured tissue in another individual of the same species.</Definition>
        <SemanticType code="T122" name="Biomedical or Dental Material"/>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Allograft</Term>
        <Term>Allogeneic transplantation</Term>
        <Term>Transplantation, Homologous</Term>
        <Term>allogeneic transplantation</Term>
        <Term>Allogeneic Transplantation</Term>
        <Term>homografting</Term>
        <Term>Homologous Transplantation</Term>
        <Term>ALLOGENEIC TRANSPL</Term>
        <Term>TRANSPL ALLOGENEIC</Term>
        <Term>Homotransplantation</Term>
        <Term>TRANSPL HOMOL</Term>
        <Term>Allograft (substance)</Term>
        <Term>HOMOL TRANSPL</Term>
        <Term>allografts</Term>
        <Term>Homologous graft</Term>
        <Term>Allogeneic graft</Term>
        <Term>Allografts</Term>
        <Term>ALLOGRAFT, PROCESSED</Term>
        <Term>allograft</Term>
        <Term>Allografting</Term>
        <Term>Transplants, Homologous</Term>
        <Term>homografts</Term>
        <Term>allografting</Term>
        <Term>Homografts</Term>
        <Term>Allograft surgical material</Term>
        <Term>Homograft</Term>
        <Term>Transplantation, allogeneic</Term>
        <Term>homograft</Term>
        <Term>Allograft source code</Term>
        <Term>Homologous Transplants</Term>
        <Term>homologous transplantation</Term>
        <Term>Allogeneic transplantation (procedure)</Term>
        <Term>Transplantation, Allogeneic</Term>
        <Term>Homologous Transplant</Term>
        <Term>Homografting</Term>
        <Term>Transplant, Homologous</Term>
        <Codes>
          <Code code="C0450127" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Graft</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd79b_protein_mouse" name="Cd79b protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd79b protein, mouse</Term>
        <Term>CD79B antigen, mouse</Term>
        <Codes>
          <Code code="C1506379" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD79</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:technical_report" name="technical report">
        <Definition>Work consisting of a formal report giving details of the investigation and results of a medical or other scientific problem. When issued by a government agency or comparable official body, its contents may be classified, unclassified, or declassified with regard to security clearance. This publication type may also cover a scientific paper or article that records the current state or current position of scientific research and development. If so labeled by the editor or publisher, this publication type may be properly used for journal articles. [MeSH_2015]</Definition>
        <Definition>Work consisting of a formal report giving details of the investigation and results of a medical or other scientific problem. When issued by a government agency or comparable official body, its contents may be classified, unclassified, or declassified with regard to security clearance. This publication type may also cover a scientific paper or article that records the current state or current position of scientific research and development. If so labeled by the editor or publisher, this publication type may be properly used for journal articles.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">technical report</Term>
        <Term>reports technical</Term>
        <Term>report technical</Term>
        <Term>technical reports</Term>
        <Term>Technical Report</Term>
        <Codes>
          <Code code="C0282419" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Woman" name="Woman">
        <Definition>Human females as cultural, psychological, sociological, political, and economic entities.</Definition>
        <Definition>Used for all-female populations when sex is pertinent to the focus of the study. For comparison of sexes use HUMAN SEX DIFFERENCES.</Definition>
        <Definition>An adult, female human.</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Woman</Term>
        <Term>Women</Term>
        <Term>human female</Term>
        <Term>woman</Term>
        <Term>female human</Term>
        <Term>Human, Female</Term>
        <Term>female humans</Term>
        <Term>adult female?</Term>
        <Term>Females (Human)</Term>
        <Term>WOMAN</Term>
        <Term>female</Term>
        <Term>women</Term>
        <Term>Woman (person)</Term>
        <Term>Human Females</Term>
        <Codes>
          <Code code="C0043210" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Race_protein_Drosophila" name="Race protein, Drosophila">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Race protein, Drosophila</Term>
        <Codes>
          <Code code="C0535934" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Peptidyl_Dipeptidase_A</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CDw65_antigen_human" name="CDw65 antigen, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CDw65 antigen, human</Term>
        <Term>CDw65 antigen</Term>
        <Codes>
          <Code code="C0383882" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD70" name="Antigen, CD70">
        <Definition>CD70 antigen (193 aa, ~21 kDa) is encoded by the human CD70 gene. This protein is involved in T-cell activation and proliferation and may also play a role in B-cell activation.</Definition>
        <Definition>A transmembrane protein belonging to the tumor necrosis factor superfamily that specifically binds to CD27 ANTIGEN. It is found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; and DENDRITIC CELLS where it plays a role in stimulating the proliferation of CD4-POSITIVE T-LYMPHOCYTES and CD8-POSITIVE T-LYMPHOCYTES.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD70</Term>
        <Term>TNF Superfamily, Member 7</Term>
        <Term>ANTIGENS CD 070</Term>
        <Term>CD 070 ANTIGENS</Term>
        <Term>Antigens, CD70</Term>
        <Term>CD27 Ligand</Term>
        <Term>TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 007</Term>
        <Term>Ligand, CD27</Term>
        <Term>CD70 Antigen</Term>
        <Term>Tumor Necrosis Factor Ligand Superfamily Member 7</Term>
        <Term>CD27L Protein</Term>
        <Term>CD70 Antigens</Term>
        <Codes>
          <Code code="C0215991" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Tnfsf7_protein_mouse, OTE:CD70_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly9_2_glycoprotein_human" name="Ly9.2 glycoprotein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly9.2 glycoprotein, human</Term>
        <Codes>
          <Code code="C1448025" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:LY9_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:WIK_Zebrafish" name="WIK Zebrafish">
        <Definition>A wild-type zebrafish line that is polymorphic relative to the Tubingen line.</Definition>
        <Definition>A wild-type zebrafish line that is polymorphic relative to the Tubingen line.(ZFin)</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">WIK Zebrafish</Term>
        <Term>WIK</Term>
        <Codes>
          <Code code="C79954" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ceacam1_protein_rat" name="Ceacam1 protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ceacam1 protein, rat</Term>
        <Term>CEA-related cell adhesion molecule 1, rat</Term>
        <Codes>
          <Code code="C1609892" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD66_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD45RA_Antigens" name="CD45RA Antigens">
        <Definition>A splicing isoform of CD45 antigen that includes exon A.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD45RA Antigens</Term>
        <Term>2H4</Term>
        <Term>CD45RA-Clust differ antig 45RA</Term>
        <Term>Antigens, CD45RA</Term>
        <Term>CD45 RA-Clust of diff ag 45 RA</Term>
        <Term>CD45 RA - Cluster of differentiation antigen 45 RA</Term>
        <Term>Cluster of differentiation antigen 45 RA</Term>
        <Term>CD45RA</Term>
        <Term>2H4 Antigens</Term>
        <Term>Cluster of diff antigen 45 RA</Term>
        <Term>CD45RA - Cluster of differentiation antigen 45 RA</Term>
        <Term>Naive T-cell marker</Term>
        <Term>Lymphocyte antigen CD45RA</Term>
        <Term>CD 045 RA ANTIGENS</Term>
        <Term>Antigens, 2H4</Term>
        <Term>Lymphocyte antigen CD45RA (substance)</Term>
        <Codes>
          <Code code="C0108789" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD45_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mexican_Americans" name="Mexican Americans">
        <Definition>Populations of Mexican descent residing permanently in the U.S.</Definition>
        <Definition>Denotes an american citizen of Mexican decent.</Definition>
        <Definition>Persons living in the United States of Mexican descent.</Definition>
        <Definition>use this term to index residents of the U.S. or other American country, including Mexico, who are of Mexican origin or ancestry (typo in SN MBL).</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mexican Americans</Term>
        <Term>chicanas</Term>
        <Term>Chicanas</Term>
        <Term>Mexican American</Term>
        <Term>Chicana</Term>
        <Term>American, Mexican</Term>
        <Term>Chicano</Term>
        <Term>mexican americans</Term>
        <Term>chicanos</Term>
        <Term>chicano</Term>
        <Term>Chicanos</Term>
        <Term>americans mexican</Term>
        <Term>American Mexican</Term>
        <Term>Americans, Mexican</Term>
        <Codes>
          <Code code="C0025884" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Hispanic_Americans</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:4C8_antigen_human" name="4C8 antigen, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">4C8 antigen, human</Term>
        <Codes>
          <Code code="C1143488" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:tumor_endothelial_marker_1_mouse" name="tumor endothelial marker 1, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">tumor endothelial marker 1, mouse</Term>
        <Term>Tem1 protein, mouse</Term>
        <Term>endosialin, mouse</Term>
        <Codes>
          <Code code="C1701495" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Long-Term_Effects_Secondary_to_Cancer_Therapy" name="Long-Term Effects Secondary to Cancer Therapy">
        <Definition>Side effects of cancer treatment occurring a long time after the treatment was completed.</Definition>
        <SemanticType code="T033" name="Finding"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Long-Term Effects Secondary to Cancer Therapy</Term>
        <Codes>
          <Code code="C115226" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:adverse_reaction</Relation>
          <Relation name="Narrower">OTE:Long-Term_Effects_Secondary_to_Cancer_Therapy_in_Children, OTE:Long-Term_Effects_Secondary_to_Cancer_Therapy_in_Adults</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mus_musculus" name="Mus musculus">
        <Definition>the scientific name of the common house mouse; for inbred and mutant strain mice used in research, use LABORATORY MOUSE or narrower terms.</Definition>
        <Definition>The common house mouse, often used as an experimental organism.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mus musculus</Term>
        <Term>House Mice</Term>
        <Term>house mouse</Term>
        <Term>Old World mouse</Term>
        <Term>Mice</Term>
        <Term>Common house mouse</Term>
        <Term>mice</Term>
        <Term>Mouse (organism)</Term>
        <Term>mouse</Term>
        <Term>Mus musculus (organism)</Term>
        <Term>House Mouse</Term>
        <Term>mouse, mice</Term>
        <Term>Mouse, NOS</Term>
        <Term>Mouse, House</Term>
        <Term>Old World mouse (organism)</Term>
        <Term>Mus musculus Linnaeus, 1758</Term>
        <Term>Mouse</Term>
        <Term>House mouse</Term>
        <Term>house mice</Term>
        <Term>mus musculus</Term>
        <Term>Mice, House</Term>
        <Term>House mice</Term>
        <Codes>
          <Code code="C45247" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mouse</Relation>
          <Relation name="Narrower">OTE:Mus_musculus_castaneus</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ace3_protein_mouse" name="Ace3 protein, mouse">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ace3 protein, mouse</Term>
        <Term>ACE-3 protein, mouse</Term>
        <Term>angiotensin I converting enzyme (peptidyl-dipeptidase A) 3, mouse</Term>
        <Term>angiotensin converting enzyme 3, mouse</Term>
        <Codes>
          <Code code="C1999840" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Peptidyl_Dipeptidase_A</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NEP2delta_protein_human" name="NEP2delta protein, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NEP2delta protein, human</Term>
        <Term>NEP2(delta) protein, human</Term>
        <Codes>
          <Code code="C2604751" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:MMEL1_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129P3_J_Mouse" name="129P3/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129P3/J Mouse</Term>
        <Term>129P3/J</Term>
        <Codes>
          <Code code="C37327" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CBA_N_Mouse" name="CBA/N Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CBA/N Mouse</Term>
        <Term>CBA/N</Term>
        <Codes>
          <Code code="C37400" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129S6_SvEvTac_Mouse" name="129S6/SvEvTac Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129S6/SvEvTac Mouse</Term>
        <Term>129S6/SvEvTac</Term>
        <Codes>
          <Code code="C37343" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Outcome_Slot" name="Outcome Slot">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Outcome Slot</Term>
        <Relations>
          <Relation name="Broader">OTE:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Rabbit" name="Rabbit">
        <Definition>Various members of the family Leporidae, especially those of the genus Sylvilagus. (NCI)</Definition>
        <Definition>Various members of the family Leporidae, especially those of the genus Sylvilagus.</Definition>
        <Definition>The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.</Definition>
        <SemanticType code="T168" name="Food"/>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T015" name="Mammal"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Rabbit</Term>
        <Term>allergy testing rabbit</Term>
        <Term>Rabbit - meat</Term>
        <Term>rabbit allergenic extract</Term>
        <Term>Rabbit (organism)</Term>
        <Term>Rabbit, NOS</Term>
        <Term>rabbit</Term>
        <Term>Rabbit - meat (substance)</Term>
        <Term>Rabbit antigen</Term>
        <Term>Rabbit, Domestic</Term>
        <Term>Domestic Rabbit</Term>
        <Term>Rabbits, Domestic</Term>
        <Term>RABBIT</Term>
        <Term>rabbits</Term>
        <Term>rabbit allergenic extract (medication)</Term>
        <Term>Domestic Rabbits</Term>
        <Term>allergy testing rabbit (lab test)</Term>
        <Term>Mammals, Rabbits</Term>
        <Term>Rabbits</Term>
        <Codes>
          <Code code="C2097383" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Leporidae</Relation>
          <Relation name="Narrower">OTE:New_Zealand_Black_Rabbit, OTE:Dutch_Belted_Rabbit, OTE:New_Zealand_Red_Rabbit, OTE:Japanese_White_Rabbit, OTE:New_Zealand_Hybrid_Rabbit, OTE:New_Zealand_Rabbit, OTE:New_Zealand_White_Rabbit, OTE:California_Rabbit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MCAM_protein_human" name="MCAM protein, human">
        <Definition>Melanoma adhesion molecule (646 aa, 72 kD) is a cell adhesion process protein that is encoded by the human MCAM gene and has roles in anatomical structure morphogenesis and cell adhesion.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MCAM protein, human</Term>
        <Term>CD146 antigen, human</Term>
        <Term>melanoma-associated antigen A32, human</Term>
        <Term>MUC18 antigen, human</Term>
        <Term>P1H12 protein, human</Term>
        <Term>CD146 protein, human</Term>
        <Term>melanoma cell adhesion molecule protein, human</Term>
        <Codes>
          <Code code="C0386212" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD146_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd9_protein_mouse" name="Cd9 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd9 protein, mouse</Term>
        <Term>CD9 antigen, mouse</Term>
        <Term>Tspan29 protein, mouse</Term>
        <Codes>
          <Code code="C1701116" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD9</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly49i2_protein_rat" name="Ly49i2 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly49i2 protein, rat</Term>
        <Term>Ly49 inhibitory receptor 2, rat</Term>
        <Term>LY49I2 antigen</Term>
        <Codes>
          <Code code="C1138311" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly49I_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD150_antigen" name="CD150 antigen">
        <Definition>Signaling lymphocytic activation molecule (335 aa, ~37 kDa) is encoded by the human SLAMF1 gene. This protein is involved in immune cell regulation and acts as a microbial sensor.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD150 antigen</Term>
        <Term>SLAM protein</Term>
        <Term>signaling lymphocytic activation molecule family member 1</Term>
        <Term>IPO-3</Term>
        <Term>CD150</Term>
        <Term>CDw150 protein</Term>
        <Term>signaling lymphocytic activation molecule</Term>
        <Term>Signaling Lymphocytic Activation Molecule</Term>
        <Term>CDw150</Term>
        <Term>Signaling Lymphocytic Activation Molecule Family Member 1</Term>
        <Codes>
          <Code code="C0299811" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:SLAMF1_protein_human, OTE:Slamf1protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:mortality" name="mortality">
        <Definition>The state of being mortal (destined to die). Mortality also refers to the death rate, or the number of deaths in a certain group of people in a certain period of time. Mortality may be reported for people who have a certain disease, live in one area of the country, or who are of a certain gender, age, or ethnic group.</Definition>
        <Definition>All deaths reported in a given population.</Definition>
        <Definition>The ratio of deaths in an area to the population of that area, expressed as deaths per 1000 per year.</Definition>
        <SemanticType code="T081" name="Quantitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">mortality</Term>
        <Term>mortality rate</Term>
        <Term>Mortality</Term>
        <Term>mortality rating</Term>
        <Term>Mortality rate</Term>
        <Term>Death rate</Term>
        <Term>mortality rates</Term>
        <Term>death rate</Term>
        <Term>MORTAL</Term>
        <Term>Mortality rates</Term>
        <Term>mortalities</Term>
        <Term>Mortality Vital Statistics</Term>
        <Term>Mortality rate (observable entity)</Term>
        <Term>Mortalities</Term>
        <Term>Mortality Rate</Term>
        <Codes>
          <Code code="C0026565" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Outcome_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129S4_SvJaeSor_Mouse" name="129S4/SvJaeSor Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129S4/SvJaeSor Mouse</Term>
        <Term>129S4/SvJaeSor</Term>
        <Codes>
          <Code code="C37341" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD79b" name="Antigen, CD79b">
        <Definition>B-cell antigen receptor complex-associated protein beta chain (229 aa, ~26 kDa) is encoded by the human CD79B gene. This protein plays a role in B-cell receptor signaling.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD79b</Term>
        <Term>Igbeta Antigen</Term>
        <Term>CD 079B ANTIGENS</Term>
        <Term>Antigens, CD79b</Term>
        <Term>B Cell Antigen Receptor Complex Associated Protein Beta Chain</Term>
        <Term>Antigen, Igbeta</Term>
        <Term>Immunoglobulin-Associated Beta Protein</Term>
        <Term>CD79b Antigen</Term>
        <Term>B-Cell Antigen Receptor Complex Associated Protein Beta-Chain</Term>
        <Term>Immunoglobulin Associated Beta Protein</Term>
        <Term>ANTIGENS CD 079B</Term>
        <Term>CD79b Antigens</Term>
        <Codes>
          <Code code="C0104979" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD79</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MSM_Ms_Mouse" name="MSM/Ms Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MSM/Ms Mouse</Term>
        <Term>MSM/Ms</Term>
        <Codes>
          <Code code="C37414" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD79a" name="Antigen, CD79a">
        <Definition>B-cell antigen receptor complex-associated protein alpha chain (226 aa, ~25 kDa) is encoded by the human CD79A gene. This protein is involved in the modulation of signaling in and proliferation of B-cells.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD79a</Term>
        <Term>IgM Alpha Component</Term>
        <Term>IgM-Alpha Component</Term>
        <Term>CD79a Antigens</Term>
        <Term>Immunoglobulin Associated Alpha Protein</Term>
        <Term>Antigens, CD79a</Term>
        <Term>ANTIGENS CD 079A</Term>
        <Term>Immunoglobulin-Associated Alpha Protein</Term>
        <Term>CD79a Antigen</Term>
        <Term>CD 079A ANTIGENS</Term>
        <Codes>
          <Code code="C0286618" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD79</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SJD_Zebrafish" name="SJD Zebrafish">
        <Definition>A wild-type zebrafish line.</Definition>
        <Definition>A wild-type zebrafish line.(ZFin)</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SJD Zebrafish</Term>
        <Term>SJD</Term>
        <Codes>
          <Code code="C79987" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd8b1_protein_mouse" name="Cd8b1 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd8b1 protein, mouse</Term>
        <Term>Ly-3 antigen, mouse</Term>
        <Term>Lyt-3 antigen, mouse</Term>
        <Term>Ly-C antigens, mouse</Term>
        <Term>CD8 antigen, beta chain 1, mouse</Term>
        <Codes>
          <Code code="C2351678" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD8</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Igb_protein_rat" name="Igb protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Igb protein, rat</Term>
        <Term>immunoglobulin-associated beta protein, rat</Term>
        <Codes>
          <Code code="C1506380" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD79</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Xenopus" name="Xenopus">
        <Definition>The commonest and widest ranging species of the clawed "frog" (Xenopus) in Africa. This species is used extensively in research. There is now a significant population in California derived from escaped laboratory animals.</Definition>
        <Definition>A species of South African aquatic frog of the genus Xenopus. It is up to 12 cm long with a flattened head and body but no tongue. Its name derives from its three short claws on each of its hind feet. It is an important model organism in developmental biology.</Definition>
        <Definition>An aquatic genus of the family, Pipidae, occurring in Africa and distinguished by having black horny claws on three inner hind toes.</Definition>
        <Definition>Any of various aquatic, tongueless, clawed frogs of the genus Xenopus, native to southern Africa, especially X. laevis, widely used in the study of vertebrate development.</Definition>
        <Definition>Any of various aquatic, tongueless, clawed frogs of the genus Xenopus, native to southern Africa, especially X. laevis, widely used in the study of vertebrate development.(Bartleby.com)</Definition>
        <Definition>aquatic amphibian genus of the family Pipidae, occurring in Africa and distinguished by having black horny claws on three inner hind toes.</Definition>
        <SemanticType code="T011" name="Amphibian"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Xenopus</Term>
        <Term>X. laevis</Term>
        <Term>Xenopus &lt;genus&gt;</Term>
        <Term>Xenopus (organism)</Term>
        <Term>xenopus</Term>
        <Term>Bufo laevis</Term>
        <Term>Platanna</Term>
        <Term>platanna</Term>
        <Term>common platanna</Term>
        <Term>African clawed frog</Term>
        <Term>African Clawed Frog</Term>
        <Term>Xenopus laevis</Term>
        <Term>Tongueless frog</Term>
        <Term>Xenopus subgenus</Term>
        <Term>Xenopus laevis (Daudin, 1802)</Term>
        <Term>Tongueless frog, NOS</Term>
        <Term>laevis, Xenopus</Term>
        <Term>Xenopus, NOS</Term>
        <Term>Platannas</Term>
        <Term>Tongueless frog (organism)</Term>
        <Term>clawed frog</Term>
        <Term>Clawed Frog</Term>
        <Codes>
          <Code code="C1504663" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Frog</Relation>
          <Relation name="Narrower">OTE:Xenopus_laevis</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BLKS_Mouse" name="C57BLKS Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BLKS Mouse</Term>
        <Term>C57BLKS</Term>
        <Codes>
          <Code code="C14545" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:asialofetuin_21-45_peptide" name="asialofetuin 21-45 peptide">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">asialofetuin 21-45 peptide</Term>
        <Term>AsF 21-45 peptide</Term>
        <Codes>
          <Code code="C0251383" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mycophenolic_Acid" name="Mycophenolic Acid">
        <Definition>An antineoplastic antibiotic derived from various Penicillium fungal species.  Mycophenolic acid is an active metabolite of the prodrug mycophenolate mofetil.  Mycophenolic acid inhibits inosine monophosphate dehydrogenase (IMPDH), preventing the formation of guanosine monophosphate and synthesis of lymphocyte DNA that results in inhibition of lymphocyte proliferation, antibody production, cellular adhesion, and migration of T and B lymphocytes.  Mycophenolic acid also has antibacterial, antifungal, and antiviral activities. (NCI04)</Definition>
        <Definition>An antibiotic substance derived from Penicillium stoloniferum, and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase. Mycophenolic acid is important because of its selective effects on the immune system. It prevents the proliferation of T-cells, lymphocytes, and the formation of antibodies from B-cells. It also may inhibit recruitment of leukocytes to inflammatory sites. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1301)</Definition>
        <Definition>antibiotic substance derived from Penicillium stoloniferum and related species which blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase; mycophenolic acid has selective effects on the immune system, preventing the proliferation of T cells, lymphocytes, and the formation of antibodies from B cells.</Definition>
        <Definition>An antineoplastic antibiotic derived from various Penicillium fungal species. Mycophenolic acid is an active metabolite of the prodrug mycophenolate mofetil. Mycophenolic acid inhibits inosine monophosphate dehydrogenase (IMPDH), preventing the formation of guanosine monophosphate and synthesis of lymphocyte DNA that results in inhibition of lymphocyte proliferation, antibody production, cellular adhesion, and migration of T and B lymphocytes. Mycophenolic acid also has antibacterial, antifungal, and antiviral activities. (NCI04)</Definition>
        <SemanticType code="T119" name="Lipid"/>
        <SemanticType code="T109" name="Organic Chemical"/>
        <SemanticType code="T200" name="Clinical Drug"/>
        <SemanticType code="T195" name="Antibiotic"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mycophenolic Acid</Term>
        <Term>Ly 68618</Term>
        <Term>-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (E)-</Term>
        <Term>MYCOPHENOLIC ACID, ORAL, 180 MG ADMINISTERED</Term>
        <Term>Mycophenolic acid, oral, 180 mg</Term>
        <Term>mycophenolic acid</Term>
        <Term>Mycophenolic acid</Term>
        <Term>Acide mycophenolique</Term>
        <Term>MPA</Term>
        <Term>Lilly-68618</Term>
        <Term>Acid, Mycophenolic</Term>
        <Term>Acido micofenolico</Term>
        <Term>Myfortic</Term>
        <Term>mycophenolic acid (medication)</Term>
        <Term>Mycophenolic acid (product)</Term>
        <Term>4-Hexenoic acid, 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-, (E)-</Term>
        <Term>4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (E)-</Term>
        <Term>Mycophenolic Acid [Chemical/Ingredient]</Term>
        <Term>MYCOPHENOLIC ACID</Term>
        <Term>Acidum mycophenolicum</Term>
        <Term>Mycophenolic acid (substance)</Term>
        <Codes>
          <Code code="C673" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Intervention_Comparator_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BMS-PTX-265" name="BMS-PTX-265">
        <SemanticType code="T130" name="Indicator, Reagent, or Diagnostic Aid"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BMS-PTX-265</Term>
        <Codes>
          <Code code="C1529783" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BALB_c_Nude_Mouse" name="BALB/c Nude Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BALB/c Nude Mouse</Term>
        <Term>BALB/cAnNCr1-nuBR</Term>
        <Term>BALB/c Nude</Term>
        <Codes>
          <Code code="C15153" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Nude_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:asialofetuin_69-28_peptide" name="asialofetuin 69-28 peptide">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">asialofetuin 69-28 peptide</Term>
        <Term>AsF 69-28 peptide</Term>
        <Codes>
          <Code code="C0251385" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD101_antigen_human" name="CD101 antigen, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD101 antigen, human</Term>
        <Term>membrane glycoprotein V7, human</Term>
        <Term>IGSF2 protein, human</Term>
        <Term>V7 protein, human</Term>
        <Term>immunoglobulin superfamily, member 2 protein, human</Term>
        <Codes>
          <Code code="C1430249" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:open_clinical_design" name="open clinical design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">open clinical design</Term>
        <Term>open clinical designs</Term>
        <Term>open clinical trials</Term>
        <Term>open clinical trial</Term>
        <Term>open clinical studies</Term>
        <Term>open clinical study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#open_clinical_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:open_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tpt1_protein_mouse" name="Tpt1 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tpt1 protein, mouse</Term>
        <Term>TCTP protein, mouse</Term>
        <Term>tumor protein, translationally-controlled 1, mouse</Term>
        <Term>fortilin protein, mouse</Term>
        <Term>lens epithelial protein, mouse</Term>
        <Term>Trt protein, mouse</Term>
        <Term>translationally controlled tumor protein, mouse</Term>
        <Codes>
          <Code code="C1436626" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:translationally_controlled_tumor_protein_p23</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Leu_Antigens" name="Leu Antigens">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Leu Antigens</Term>
        <Term>Antigens, Leu</Term>
        <Codes>
          <Code code="C0023383" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IgG_Receptors" name="IgG Receptors">
        <Definition>Receptors belonging to the immunoglobulin superfamily that bind to the Fc portion of IgG molecules and play a role in the phagocytosis of opsonized bacteria.</Definition>
        <Definition>Specific molecular sites on the surface of various cells, including B-lymphocytes and macrophages, that combine with IMMUNOGLOBULIN Gs. Three subclasses exist: Fc gamma RI (the CD64 antigen, a low affinity receptor), Fc gamma RII (the CD32 antigen, a high affinity receptor), and Fc gamma RIII (the CD16 antigen, a low affinity receptor).</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IgG Receptors</Term>
        <Term>gamma Fc Receptors</Term>
        <Term>Fc gamma Receptors</Term>
        <Term>IGG RECEPT</Term>
        <Term>RECEPT IGG</Term>
        <Term>Receptors, gamma Fc</Term>
        <Term>Fc Receptors, gamma</Term>
        <Term>Fc Gamma R</Term>
        <Term>GAMMA FC RECEPT</Term>
        <Term>Immunoglobulin G Receptor</Term>
        <Term>Receptor, Immunoglobulin G</Term>
        <Term>Receptors, IgG</Term>
        <Term>gamma Receptors, Fc</Term>
        <Term>RECEPT FC GAMMA</Term>
        <Term>Receptors, Fc gamma</Term>
        <Term>Fc-Gamma R</Term>
        <Term>FC GAMMA RECEPT</Term>
        <Term>Fc Gamma Receptor</Term>
        <Term>FC RECEPT GAMMA</Term>
        <Term>FCGR</Term>
        <Term>Fc-Gamma Receptor</Term>
        <Term>Receptors, IgG [Chemical/Ingredient]</Term>
        <Codes>
          <Code code="C0123263" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Antigens_CD32, OTE:CDw32_Antigens, OTE:Fcgr3_protein_mouse, OTE:Fcgr3_protein_rat, OTE:CD32c_antigen, OTE:CD16_Antigens, OTE:G7_protein_Sus_scrofa, OTE:Antigens_CD64, OTE:Fcgr2b_protein_mouse, OTE:Fcgr2b_protein_rat, OTE:FCGR1A_protein_human, OTE:Fcgr1_protein_rat, OTE:FCGR2A_protein_human, OTE:Fcgr1_protein_mouse, OTE:FCGR3A_protein_human, OTE:Fc_gamma_IIB_receptors, OTE:FCGR3B_protein_human, OTE:FCGR2B_protein_human, OTE:FcgammaRIIIA_protein_mouse, OTE:Fcgr4_protein_mouse, OTE:Leu-11_Antigens, OTE:IgG2c_receptor, OTE:Fc_gamma_receptor_IIA</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:meta_analysis" name="meta analysis">
        <Definition>quantitative method of combining results of independent studies (usually drawn from published literature) and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc., with application chiefly in areas of research and medicine.</Definition>
        <Definition>A set of statistical procedures designed to accumulate experimental and correlational results across independent studies that address a related set of research questions. [NCIT_14.05d] </Definition>
        <Definition>A quantitative method of combining the results of independent studies (usually drawn from the published literature) and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc., with application chiefly in the areas of research and medicine.</Definition>
        <Definition>Used in records discussing issues involved in the process of conducting a statistical analysis of a large collection of integrated findings.</Definition>
        <Definition>The formal evaluation of the quantitative evidence from two or more trials bearing on the same question. NOTE: This most commonly involves the statistical combination of summary statistics from the various trials, but the term is sometimes also used to refer to the combination of the raw data. [from ICH E9 Glossary] [NCIT_14.05d] 
[Contributing_Source_CDISC]
</Definition>
        <Definition>Works consisting of studies using a quantitative method of combining the results of independent studies (usually drawn from the published literature) and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc. It is often an overview of clinical trials. It is usually called a meta-analysis by the author or sponsoring body and should be differentiated from reviews of literature.</Definition>
        <Definition>The formal evaluation of the quantitative evidence from two or more trials bearing on the same question. NOTE: This most commonly involves the statistical combination of summary statistics from the various trials, but the term is sometimes also used to refer to the combination of the raw data. [from ICH E9 Glossary]</Definition>
        <Definition>Used for original reports evaluating medical interventions by the statistical analysis of a large collection of analysis results from individual studies, for the purpose of integrating the findings; not limited to clinical trials. [Emtree_2014]</Definition>
        <Definition>A set of statistical procedures designed to accumulate experimental and correlational results across independent studies that address a related set of research questions.</Definition>
        <Definition>Works consisting of studies using a quantitative method of combining the results of independent studies (usually drawn from the published literature) and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc. It is often an overview of clinical trials. It is usually called a meta-analysis by the author or sponsoring body and should be differentiated from reviews of literature. [MeSH_2014]</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">meta analysis</Term>
        <Term>Overview, Clinical Trial</Term>
        <Term>meta analysis pt</Term>
        <Term>Overviews, Clinical Trial</Term>
        <Term>Meta-analysis</Term>
        <Term>Meta-Analysis</Term>
        <Term>Meta Analysis as Topic</Term>
        <Term>Meta Analysis (statistical procedure)</Term>
        <Term>analysis, meta</Term>
        <Term>OVERVIEWS CLIN TRIAL</Term>
        <Term>meta-analysis</Term>
        <Term>metaanalysis</Term>
        <Term>Data Pooling</Term>
        <Term>CLIN TRIAL OVERVIEWS</Term>
        <Term>Meta Analysis</Term>
        <Term>Meta-Analysis as Topic</Term>
        <Term>Clinical Trial Overviews</Term>
        <Term>Meta-Analysis (publications)</Term>
        <Term>Clinical Trial Overview</Term>
        <Term>Data Poolings</Term>
        <Term>meta-analyses</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#meta_analysis" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:meta_analysis_of_individual_participant_data</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LYPD6_protein_human" name="LYPD6 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LYPD6 protein, human</Term>
        <Codes>
          <Code code="C2934328" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Il6st_protein_rat" name="Il6st protein, rat">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Il6st protein, rat</Term>
        <Term>interleukin 6 signal transducer protein, rat</Term>
        <Codes>
          <Code code="C1506542" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Cytokine_Receptor_gp130</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SWV_Mouse" name="SWV Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SWV Mouse</Term>
        <Term>SWV</Term>
        <Codes>
          <Code code="C1519166" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Dipeptidyl-Peptidase_IV" name="Dipeptidyl-Peptidase IV">
        <Definition>A serine protease that catalyses the release of an N-terminal dipeptide. Several biologically-active peptides have been identified as dipeptidyl peptidase 4 substrates including INCRETINS; NEUROPEPTIDES; and CHEMOKINES. The protein is also found bound to ADENOSINE DEAMINASE on the T-CELL surface and is believed to play a role in T-cell activation.</Definition>
        <Definition>Dipeptidyl peptidase 4 (766 aa, ~88 kDa) is encoded by the human DPP4 gene. This protein is involved in proteolytic regulation of T cell activation.</Definition>
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Dipeptidyl-Peptidase IV</Term>
        <Term>Antigens, CD26</Term>
        <Term>Adenosine Deaminase Complexing Protein 2</Term>
        <Term>CD26 Antigens</Term>
        <Term>Dipeptidyl Peptidase IV</Term>
        <Term>Antigen, CD26</Term>
        <Term>CD 026 ANTIGENS</Term>
        <Term>Dipeptidyl Peptidase 4</Term>
        <Term>ANTIGENS CD 026</Term>
        <Term>CD26 Antigen</Term>
        <Codes>
          <Code code="C0081937" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:DPP4_protein_human, OTE:Dpp4_protein_mouse, OTE:omega_protein_Drosophila</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:lecture" name="lecture">
        <Definition>Works consisting of speeches read or delivered before an audience or class, especially for instruction or to set forth some subject. They are differentiated from ADDRESSES [PUBLICATION TYPE] which are less didactic and more informational, entertaining, inspirational, or polemic. (From Random House Unabridged Dictionary, 2d ed)</Definition>
        <Definition>Works consisting of speeches read or delivered before an audience or class, especially for instruction or to set forth some subject. They are differentiated from ADDRESSES [PUBLICATION TYPE] which are less didactic and more informational, entertaining, inspirational, or polemic. (From Random House Unabridged Dictionary, 2d ed) [MeSH_2014]</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">lecture</Term>
        <Term>Lectures</Term>
        <Term>lectures</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#lecture" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:AFP_protein_human" name="AFP protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">AFP protein, human</Term>
        <Term>alpha-glycoprotein, fetospecific, human</Term>
        <Term>alpha-fetospecific glycoprotein, human</Term>
        <Term>AF glycoprotein, human</Term>
        <Term>glycosylated AFP protein, human</Term>
        <Term>alpha-fetoprotein, human</Term>
        <Codes>
          <Code code="C1307640" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD163_antigen" name="CD163 antigen">
        <Definition>This gene plays a role in endocytosis by macrophages.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD163 antigen</Term>
        <Term>RM3-1 antigen</Term>
        <Term>CD163 Gene</Term>
        <Term>CD163 gene</Term>
        <Term>MM130</Term>
        <Term>CD163</Term>
        <Term>CD163 Molecule Gene</Term>
        <Term>CD163 Antigen</Term>
        <Term>CD163 Ag</Term>
        <Term>CD163 ANTIGEN</Term>
        <Term>CD163 protein</Term>
        <Term>M130 protein</Term>
        <Term>CD163 molecule</Term>
        <Term>M130</Term>
        <Term>HEMOGLOBIN SCAVENGER RECEPTOR</Term>
        <Codes>
          <Code code="C0251113" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cd163_protein_mouse, OTE:CD163_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly-49_Antigen" name="Ly-49 Antigen">
        <Definition>An inhibitory subclass of NK cell lectin-like receptors that interacts with CLASS I MAJOR HISTOCOMPATIBILITY ANTIGENS and prevents the activation of NK CELLS.</Definition>
        <Definition>A surface receptor on NK cells involved in binding to MHC Class I molecules presented on somatic cells as part of a recognition mechanism.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly-49 Antigen</Term>
        <Term>Natural Killer Cell Lectin-Like Receptor Subfamily A</Term>
        <Term>Ly49 Antigen</Term>
        <Term>Killer Cell Lectin Like Receptor Subfamily A</Term>
        <Term>NK Cell Lectin Like Receptor Subfamily A</Term>
        <Term>NK Cell Lectin-Like Receptor Subfamily A</Term>
        <Term>Killer Cell Lectin-Like Receptor Subfamily A</Term>
        <Term>Ly 49 Antigen</Term>
        <Term>Antigen, Ly-49</Term>
        <Term>Natural Killer Cell Lectin Like Receptor Subfamily A</Term>
        <Term>Antigen, Ly49</Term>
        <Codes>
          <Code code="C1337103" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
          <Relation name="Narrower">OTE:Klra4_protein_mouse, OTE:Klra3_protein_mouse, OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_7, OTE:Klra8_protein_mouse, OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_8, OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_3, OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_4, OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_5, OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_6, OTE:Klra17_protein_mouse, OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_2, OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_1, OTE:Klra1_protein_mouse, OTE:Ly49s3_protein_rat, OTE:Klra5_protein_mouse, OTE:Klra7_protein_mouse, OTE:Klra2_protein_mouse, OTE:Klra6_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd36l2_protein_rat" name="Cd36l2 protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd36l2 protein, rat</Term>
        <Term>LIMP II protein, rat</Term>
        <Term>CD36 antigen-like 2 protein, rat</Term>
        <Term>LGP85 protein, rat</Term>
        <Codes>
          <Code code="C1448672" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD36</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klrb1c_protein_mouse" name="Klrb1c protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klrb1c protein, mouse</Term>
        <Term>NK-1.1 protein, mouse</Term>
        <Term>NK1.1 antigen, mouse</Term>
        <Term>Ly55c protein, mouse</Term>
        <Term>NK-1.2 protein, mouse</Term>
        <Term>Nkrp1-c protein, mouse</Term>
        <Term>NK-RP1 protein, mouse</Term>
        <Term>Ly-59 protein, mouse</Term>
        <Term>killer cell lectin-like receptor subfamily B member 1C protein, mouse</Term>
        <Term>Nk-1 protein, mouse</Term>
        <Codes>
          <Code code="C0132630" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:PAS-4_protein_Bos_taurus" name="PAS-4 protein, Bos taurus">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">PAS-4 protein, Bos taurus</Term>
        <Term>epithelial membrane glycoprotein PAS-IV, bovine</Term>
        <Term>PAS-IV glycoprotein, Bos taurus</Term>
        <Codes>
          <Code code="C1437379" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD36</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_Thy-1" name="Antigen, Thy-1">
        <Definition>A group of differentiation surface antigens, among the first to be discovered on thymocytes and T-lymphocytes. Originally identified in the mouse, they are also found in other species including humans, and are expressed on brain neurons and other cells.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, Thy-1</Term>
        <Term>Antigen, CD90</Term>
        <Term>Antigens, CD90</Term>
        <Term>Thy-1 Antigen</Term>
        <Term>Antigens, Thy 1</Term>
        <Term>THY ANTIGENS 001</Term>
        <Term>CD90 Antigen</Term>
        <Term>CD 090 ANTIGENS</Term>
        <Term>Thy-1 Antigens</Term>
        <Term>ANTIGENS CD 090</Term>
        <Term>Thy 1 Antigens</Term>
        <Term>Antigens, Thy-1</Term>
        <Term>CD90 Antigens</Term>
        <Term>Thy 1 Antigen</Term>
        <Term>ANTIGENS THY 001</Term>
        <Codes>
          <Code code="C0076570" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Thy-1_2_Antigen, OTE:Thy-1_1_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:government_publication" name="government publication">
        <Definition>Works consisting of documents issued by local, regional, or national governments or by their agencies or subdivisions. [MeSH_2014]</Definition>
        <Definition>Works consisting of documents issued by local, regional, or national governments or by their agencies or subdivisions.</Definition>
        <SemanticType code="T073" name="Manufactured Object"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">government publication</Term>
        <Term>Government Documents</Term>
        <Term>Government Document</Term>
        <Term>Government Publications</Term>
        <Term>Government publications</Term>
        <Term>government publications</Term>
        <Codes>
          <Code code="C0018107" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
          <Relation name="Narrower">OTE:white_paper</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klra17_protein_mouse" name="Klra17 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klra17 protein, mouse</Term>
        <Term>Ly49Q protein, mouse</Term>
        <Term>Ly-49Q antigen</Term>
        <Term>killer cell lectin-like receptor, subfamily A, member 17, mouse</Term>
        <Codes>
          <Code code="C1568326" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:case_control_design" name="case control design">
        <Definition>A study that compares two groups of people: those with the disease or condition under study (cases) and a very similar group of people who do not have the disease or condition (controls). Researchers study the medical and lifestyle histories of the people in each group to learn what factors may be associated with the disease or condition. For example, one group may have been exposed to a particular substance that the other was not. Also called retrospective study.  [NCIT_14.05d]</Definition>
        <Definition>Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group. [MeSH_2014]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">case control design</Term>
        <Term>Case-Control Studies</Term>
        <Term>control study, case</Term>
        <Term>Case-Compeer Studies</Term>
        <Term>case control study</Term>
        <Term>case-control design</Term>
        <Term>Case-Referrent Studies</Term>
        <Term>case control trial</Term>
        <Term>case-control study</Term>
        <Term>Case-Comparison Studies</Term>
        <Term>case control studies</Term>
        <Term>case control trials</Term>
        <Term>case control designs</Term>
        <Term>case-control trial</Term>
        <Term>case-control studies</Term>
        <Term>case-control trials</Term>
        <Term>Case-Referent Studies</Term>
        <Term>case-control designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#case_control_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:controlled_design</Relation>
          <Relation name="Narrower">OTE:hospital-based_case_control_design, OTE:nested_case_control_design, OTE:matched_case_control_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD94" name="Antigen CD94">
        <Definition>Natural killer cells antigen CD94 (179 aa, 20 kD) is a cell communication protein that is encoded by the human KLRD1 gene and has a role in cell surface receptor-linked signal transduction.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen CD94</Term>
        <Term>NK Cell Lectin Like Receptor Subfamily D, Member 1</Term>
        <Term>ANTIGENS CD 094</Term>
        <Term>CD94, Antigen</Term>
        <Term>CD 094 ANTIGENS</Term>
        <Term>Antigens, CD94</Term>
        <Term>Killer Cell Lectin-Like Receptor Subfamily D, Member 1</Term>
        <Term>CD94 Antigen</Term>
        <Term>Antigen, CD94</Term>
        <Term>NK Cell Lectin-Like Receptor Subfamily D, Member 1</Term>
        <Term>Killer Cell Lectin Like Receptor Subfamily D, Member 1</Term>
        <Term>CD94 Antigens</Term>
        <Codes>
          <Code code="C0382839" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_D, OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Plaur_protein_mouse" name="Plaur protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Plaur protein, mouse</Term>
        <Term>plasminogen activator, urokinase receptor, mouse</Term>
        <Term>urokinase-type plasminogen activator receptor, mouse</Term>
        <Term>CD87 antigen, mouse</Term>
        <Codes>
          <Code code="C2002172" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Plasminogen_Activator_Urokinase_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Bst1_protein_rat" name="Bst1 protein, rat">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Bst1 protein, rat</Term>
        <Term>bone marrow stromal cell antigen 1, rat</Term>
        <Codes>
          <Code code="C2930538" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:bone_marrow_stromal_cell_antigen_1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:directory" name="directory">
        <Definition> A document that points out the location of people, places, or objects. [NCIT_14.05d]</Definition>
        <Definition>Work consisting of an alphabetical or classified list of names, organizations, subjects, etc., giving usually titles, addresses, affiliations, and other professional data.</Definition>
        <Definition>Work consisting of an alphabetical or classified list of names, organizations, subjects, etc., giving usually titles, addresses, affiliations, and other professional data. [MeSH_2014]</Definition>
        <Definition>A document that points out the location of people, places, or objects.</Definition>
        <SemanticType code="T073" name="Manufactured Object"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">directory</Term>
        <Term>Published Directory</Term>
        <Term>Directory</Term>
        <Term>Registries</Term>
        <Term>Registers</Term>
        <Term>Directories</Term>
        <Term>published directories</Term>
        <Term>Registry</Term>
        <Term>published directory</Term>
        <Term>Register</Term>
        <Term>directories</Term>
        <Codes>
          <Code code="C0282426" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Monkey" name="Monkey">
        <Definition>Any haplorhine primate not belonging to the family Tarsiidae, Hylobatidae, Pongidae, or Hominidae; this does not correspond to any taxon. This group is divided into Old World monkeys (Cercopithecidae) and New World monkeys (Callitrichidae and Cebidae). Many types are used as an experimental model for human disease and drug testing.</Definition>
        <Definition>Any haplorhine primate not belonging to the family Tarsiidae, Hylobatidae, Pongidae, or Hominidae; this does not correspond to any taxon. This group is divided into Old World monkeys (Cercopithecidae) and New World monkeys (Callitrichidae and Cebidae).  Many types are used as an experimental model for human disease and drug testing.</Definition>
        <Definition>Any haplorhine primate not belonging to the family Tarsiidae, Hylobatidae, Pongidae, or Hominidae; this does not correspond to any taxon. This group is divided into Old World monkeys (Cercopithecidae) and New World monkeys (Callitrichidae and Cebidae).</Definition>
        <Definition>An infraorder of New World monkeys, comprised of the families AOTIDAE; ATELIDAE; CEBIDAE; and PITHECIIDAE. They are found exclusively in the Americas.</Definition>
        <Definition>The family of Old World monkeys and baboons consisting of two subfamilies: CERCOPITHECINAE and COLOBINAE. They are found in Africa and part of Asia.</Definition>
        <Definition>A non-taxonomic, non-specific term for the smaller longer-tailed PRIMATES.</Definition>
        <Definition>African and Asian monkeys with tail as balancing organ, opposable thumb and large toe, nostrils close together and directed downward; social in large groups, some ground dwelling.</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Monkey</Term>
        <Term>allergy testing monkey (lab test)</Term>
        <Term>Family Cercopithecidae</Term>
        <Term>Monkey, NOS</Term>
        <Term>Old World monkey, NOS</Term>
        <Term>Family Cercopithecidae (organism)</Term>
        <Term>Old World Monkeys</Term>
        <Term>Cercopithecidae</Term>
        <Term>Old World Monkey</Term>
        <Term>World Monkey, Old</Term>
        <Term>monkey</Term>
        <Term>allergy testing monkey</Term>
        <Term>World Monkeys, Old</Term>
        <Term>Old World monkey</Term>
        <Term>World Monkey, New</Term>
        <Term>MONKEY</Term>
        <Term>Monkeys, New World</Term>
        <Term>New World Monkey</Term>
        <Term>Monkeys, Old World</Term>
        <Term>Monkey, Old World</Term>
        <Term>Monkey, New World</Term>
        <Term>Platyrrhini</Term>
        <Term>856-857 FAMILY CERCOPITHECIDAE</Term>
        <Term>Monkeys</Term>
        <Term>Old World monkeys</Term>
        <Term>monkeys</Term>
        <Term>World Monkeys, New</Term>
        <Term>FAMILY CERCOPITHECIDAE</Term>
        <Term>New World Monkeys</Term>
        <Term>Monkey (organism)</Term>
        <Term>New World monkeys</Term>
        <Codes>
          <Code code="C2097382" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Primate</Relation>
          <Relation name="Narrower">OTE:Macaque, OTE:Marmoset, OTE:Squirrel_Monkey, OTE:African_Green_Monkey, OTE:Baboon</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BL_10J_Mouse" name="C57BL/10J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BL/10J Mouse</Term>
        <Term>C57BL/10J</Term>
        <Codes>
          <Code code="C37377" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C5L2_protein_rat" name="C5L2 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C5L2 protein, rat</Term>
        <Term>C5L2 receptor, rat</Term>
        <Codes>
          <Code code="C1566110" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptor_Anaphylatoxin_C5a</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Bsg_protein_Gallus_gallus" name="Bsg protein, Gallus gallus">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Bsg protein, Gallus gallus</Term>
        <Term>blood-brain barrier HT7 antigen, Gallus gallus</Term>
        <Term>5A11 antigen, Gallus gallus</Term>
        <Term>Basigin protein, Gallus gallus</Term>
        <Term>5A11 protein, chicken</Term>
        <Term>neurothelin</Term>
        <Term>5A11 protein, Gallus gallus</Term>
        <Codes>
          <Code code="C1430524" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD147</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Sinclair_Minipig" name="Sinclair Minipig">
        <Definition>A strain of pig developed by the Hormel Institute at the University of Minnesota in 1949, acquired by the University of Missouri in 1965 and now exclusively bred at the Sinclair Research Center. This strain of pig grows to be no larger than 70 kg and exhibits multiple coat colors and patterns. The Sinclair minipig is used in biomedical research for a variety of applications.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Sinclair Minipig</Term>
        <Term>Sinclair S-1 Minipig</Term>
        <Term>SINCLAIR MINIPIG</Term>
        <Term>Sinclair Miniature Swine</Term>
        <Codes>
          <Code code="C91819" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Minipig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:5-tyrosine_fibrinopeptide_A" name="5-tyrosine fibrinopeptide A">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">5-tyrosine fibrinopeptide A</Term>
        <Term>5-Tyr-gFPA</Term>
        <Codes>
          <Code code="C0658106" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Fibrinopeptide_A</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:embryonin" name="embryonin">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">embryonin</Term>
        <Codes>
          <Code code="C0059058" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CDw32_Antigens" name="CDw32 Antigens">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CDw32 Antigens</Term>
        <Term>Cluster of differentiation antigen (workshop) 32</Term>
        <Term>Fc receptor II</Term>
        <Term>CDw32-Clust dif ag workshop 32</Term>
        <Term>Cluster of differentiation antigen (workshop) 32 (substance)</Term>
        <Term>Low affinity immunoglobulin G Fc receptor</Term>
        <Term>Antigens, CDw32</Term>
        <Term>FcR II - Fc receptor II</Term>
        <Term>Low affinity IgG Fc receptor</Term>
        <Term>CDw32 - Cluster of differentiation antigen (workshop) 32</Term>
        <Term>Clust of diff ag (workshop) 32</Term>
        <Codes>
          <Code code="C0443956" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:diagnostic_study" name="diagnostic study">
        <Definition>heading term for tests not treed elsewhere under DIAGNOSIS.</Definition>
        <Definition>A type of study designed to evaluate method(s) aimed at identifying a disease or condition.</Definition>
        <Definition>A type of study protocol designed to evaluate intervention(s) aimed at identifying a disease or condition. (NCI)</Definition>
        <SemanticType code="T060" name="Diagnostic Procedure"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">diagnostic study</Term>
        <Term>Diagnostic tests</Term>
        <Term>TESTS DIAG</Term>
        <Term>diagnostic trial</Term>
        <Term>diagnostic designs</Term>
        <Term>diagnostic design</Term>
        <Term>diagnostics test</Term>
        <Term>DIAG TESTS</Term>
        <Term>Tests, Diagnostic</Term>
        <Term>Test, Diagnostic</Term>
        <Term>diagnostic testing</Term>
        <Term>diagnostic tests</Term>
        <Term>Diagnostic studies</Term>
        <Term>Diagnosis Study</Term>
        <Term>Diagnostic Study</Term>
        <Term>Diagnostic Test</Term>
        <Term>diagnostic trials</Term>
        <Term>DIAGNOSIS</Term>
        <Term>Diagnostic Tests</Term>
        <Term>diagnostic studies</Term>
        <Term>diagnostic test</Term>
        <Codes>
          <Code code="C1704656" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:diagnostic_test_accuracy_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NKG2D-S_protein_mouse" name="NKG2D-S protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NKG2D-S protein, mouse</Term>
        <Codes>
          <Code code="C2713637" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Klrk1_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:B6C3_Mouse" name="B6C3 Mouse">
        <Definition>Derived from a cross between a C57BL/6 female and a C3H male, this hybrid strain is commonly used in the production of transgenic mice.</Definition>
        <Definition>Derived from a cross between a C57BL/6 female and a C3H male, this hybrid strain is commonly used in the production of transgenic mice. B6C3F1 hybrid females are used as egg donors in the creation of transgenic mice as their breeding performance is robust and the pronuclei of their fertilized eggs are prominent, allowing for ease of microinjection.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">B6C3 Mouse</Term>
        <Term>B6C3F1</Term>
        <Codes>
          <Code code="C2698297" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129P4_Rr_Mouse" name="129P4/Rr Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129P4/Rr Mouse</Term>
        <Term>129P4/Rr</Term>
        <Codes>
          <Code code="C37329" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:pilot_study" name="pilot study&#10;">
        <Definition>Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. [Pilot Projects | MeSH_2015]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">pilot study
</Term>
        <Term>pilot projects</Term>
        <Term>pilot studies</Term>
        <Term>pilot project</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#pilot_study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Sost_protein_rat" name="Sost protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Sost protein, rat</Term>
        <Term>sclerostin protein, rat</Term>
        <Codes>
          <Code code="C1450127" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Genetic_Marker</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IFITM1_protein_rat" name="IFITM1 protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IFITM1 protein, rat</Term>
        <Codes>
          <Code code="C3489468" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:leu_13_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:COP_Rat_Strain" name="COP, Rat Strain">
        <Definition>Spontaneous tumors of the thymus (Dunning and Curtis 1946, Dunning et al 1947)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">COP, Rat Strain</Term>
        <Codes>
          <Code code="C14397" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Adam8_protein_mouse" name="Adam8 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Adam8 protein, mouse</Term>
        <Term>MS2 antigen, mouse</Term>
        <Term>CD156 antigen, mouse</Term>
        <Term>a disintegrin and metalloprotease domain 8 protein, mouse</Term>
        <Codes>
          <Code code="C1313291" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:evaluation" name="evaluation">
        <Definition>Studies determining the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. [Evaluation Studies as Topic | MeSH_2015]</Definition>
        <Definition>Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.</Definition>
        <Definition>Determination of a value, conclusion, or inference by evaluating evidence</Definition>
        <Definition>Conceptually broad term referring to the appraisal of the characteristics, significance, importance, or relative value of a person, organization, or thing.</Definition>
        <Definition>The act or process of a systematic and thorough examination; research, study; the process of inquiring into or following up, intended to develop facts.</Definition>
        <Definition>Determinación de un valor, conclusión o suposición mediante la evaluación de la evidencia</Definition>
        <SemanticType code="T058" name="Health Care Activity"/>
        <SemanticType code="T078" name="Idea or Concept"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">evaluation</Term>
        <Term>Evaluation procedure</Term>
        <Term>Evaluated</Term>
        <Term>Evaluation Procedure</Term>
        <Term>Investigations</Term>
        <Term>Evaluate</Term>
        <Term>efficacy assessment</Term>
        <Term>assessments</Term>
        <Term>Processing type - Evaluation</Term>
        <Term>Evaluation</Term>
        <Term>Assessment Procedures</Term>
        <Term>Evaluation - action (qualifier value)</Term>
        <Term>evaluation design</Term>
        <Term>Patient evaluation - action</Term>
        <Term>Evaluation - action</Term>
        <Term>Evaluation procedure (procedure)</Term>
        <Term>effectiveness assessment</Term>
        <Term>Inv</Term>
        <Term>assessment</Term>
        <Term>Investigation Report</Term>
        <Term>clinical investigation</Term>
        <Term>evaluation study</Term>
        <Term>Clinical evaluation</Term>
        <Term>Investigation</Term>
        <Term>evaluation studies</Term>
        <Term>evaluation designs</Term>
        <Term>Clinical investigation</Term>
        <Term>Patient evaluation procedure</Term>
        <Term>Assessment</Term>
        <Term>Investigation NOS</Term>
        <Term>evaluations</Term>
        <Term>assessment procedure</Term>
        <Term>Evaluations</Term>
        <Codes>
          <Code code="C1261322" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:qualitative_evaluation, OTE:quantitative_evaluation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Peptidyl_Dipeptidase_A" name="Peptidyl Dipeptidase A">
        <Definition>A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, -Xaa-*-Xbb-Xcc, when neither Xaa nor Xbb is Pro. It is a Cl(-)-dependent, zinc glycoprotein that is generally membrane-bound and active at neutral pH. It may also have endopeptidase activity on some substrates. (From Enzyme Nomenclature, 1992) EC 3.4.15.1.</Definition>
        <Definition>Cl- dependent, zinc glycoprotein that is generally membrane bound.</Definition>
        <Definition>Angiotensin-converting enzyme (1306 aa, ~150 kDa) is encoded by the human ACE gene. This protein plays a role in the hydrolysis of angiotensin I to form angiotensin II and the solubilization of glycophophoinositol-anchored proteins from the plasma membrane.</Definition>
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Peptidyl Dipeptidase A</Term>
        <Term>Dipeptidyl Peptidase A</Term>
        <Term>Angiotensin I Converting Enzyme</Term>
        <Term>Angiotensin I-Converting Enzyme</Term>
        <Term>Peptidyl-Dipeptidase A</Term>
        <Term>Carboxycathepsin</Term>
        <Term>Kininase II</Term>
        <Term>Antigens, CD143</Term>
        <Term>Angiotensin Converting Enzyme</Term>
        <Term>CD143 Antigens</Term>
        <Term>CD 143 ANTIGENS</Term>
        <Term>ANTIGENS CD 143</Term>
        <Term>Kininase A</Term>
        <Codes>
          <Code code="C0022709" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Ace3_protein_mouse, OTE:ACE_protein_human, OTE:Race_protein_Drosophila, OTE:angiotensin_converting_enzyme_2</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C58_J_Mouse" name="C58/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C58/J Mouse</Term>
        <Term>C58/J</Term>
        <Codes>
          <Code code="C14515" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:phase_IIb_trial" name="phase IIb trial">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">phase IIb trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#phase_IIb_trial" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Hanford_Pig" name="Hanford Pig">
        <Definition>The largest of the miniature breeds, it reaches 25-40kg at sexual maturity. The Hanford pig is white with an elongated snout and has the largest heart and blood vessels of all pig breeds. It is used in biomedical research, among other things, in the testing of implantable devices in human cardiovascular research.</Definition>
        <Definition>The largest of the miniature breeds, it reaches 25-40kg at sexual maturity. The Hanford pig is white with an elongated snout and has the largest heart and blood vessels of all pig breeds. It is used in biomedical research, among other things, in the testing of implantable devices in human cardiovascular research. (NCI)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Hanford Pig</Term>
        <Term>Hanford</Term>
        <Term>HANFORD</Term>
        <Codes>
          <Code code="C2697563" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Pig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Xenograft" name="Xenograft">
        <Definition>procedures in which live cells, tissues, or organs derived from one species are transplanted, implanted, or infused into another species; includes those procedures from an animal into a human or from one animal into another; also includes procedures in which human body fluids, cells, tissues, or organs are removed from the body, come into contact with live animal cells, tissues, or organs, and are then placed back into a human patient; this definition is based upon the DHHS definition; where appropriate, index donor and recipient species.</Definition>
        <Definition>A graft transferred from a donor of one species to a recipient of another species.</Definition>
        <Definition>The transplant of an organ, tissue, or cells to an individual of another species.</Definition>
        <Definition>Transplantation between animals of different species.</Definition>
        <Definition>Tissues, cells or organs transplanted between animals of different species.</Definition>
        <SemanticType code="T122" name="Biomedical or Dental Material"/>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Xenograft</Term>
        <Term>TRANSPL HETEROL</Term>
        <Term>Xenotransplantation</Term>
        <Term>Xenografts</Term>
        <Term>Heterografting</Term>
        <Term>Animal-human transplantation</Term>
        <Term>Xenogeneic transplantation</Term>
        <Term>Xenograft Transplantation</Term>
        <Term>Heterografts</Term>
        <Term>HETEROL TRANSPL</Term>
        <Term>Transplantation, xenogeneic</Term>
        <Term>Transplantation, Xenograft</Term>
        <Term>Heterologous transplantation</Term>
        <Term>xenograft</Term>
        <Term>Xenogeneic transplantation (procedure)</Term>
        <Term>heterologous transplantation</Term>
        <Term>grafts heteroplastic</Term>
        <Term>Xenograft type of graft</Term>
        <Term>XENOTRANSPL</Term>
        <Term>Heterograft</Term>
        <Term>xenotransplantation</Term>
        <Term>Heteroplastic graft</Term>
        <Term>Xenograft procedure</Term>
        <Term>Heterograft Transplantation</Term>
        <Term>Transplantation, Heterograft</Term>
        <Term>heteroplastic graft</Term>
        <Term>xenografting</Term>
        <Term>Heterologous graft</Term>
        <Term>Xenograft (substance)</Term>
        <Term>Xg - Xenograft</Term>
        <Term>xenografts</Term>
        <Term>Transplantation, animal-human</Term>
        <Term>Xenografting</Term>
        <Term>Heterologous Transplantation</Term>
        <Term>Transplantation, Heterologous</Term>
        <Codes>
          <Code code="C0522537" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Graft</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129T2_SvEms_Mouse" name="129T2/SvEms Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129T2/SvEms Mouse</Term>
        <Term>129T2/SvEms</Term>
        <Codes>
          <Code code="C37345" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Dog" name="Dog">
        <Definition>refers to all members of the dog family, from all breeds of domestic dogs through wolves.</Definition>
        <Definition>The domestic dog, Canis familiaris.</Definition>
        <Definition>The domestic dog, Canis familiaris. (NCI)</Definition>
        <Definition>The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)</Definition>
        <Definition>Domestic dog subspecies</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T015" name="Mammal"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Dog</Term>
        <Term>DOG</Term>
        <Term>Dog family</Term>
        <Term>allergy testing dog (lab test)</Term>
        <Term>Canine</Term>
        <Term>dogs</Term>
        <Term>Canine Species</Term>
        <Term>Canine species</Term>
        <Term>dog family</Term>
        <Term>domestic dog</Term>
        <Term>familiaris, Canis</Term>
        <Term>canine</Term>
        <Term>807-809 CANINE SPECIES</Term>
        <Term>CANINE SPECIES</Term>
        <Term>Canis familiaris</Term>
        <Term>Domestic dog ancestor</Term>
        <Term>Canis lupus subspecies familiaris (organism)</Term>
        <Term>Dog antigen</Term>
        <Term>animals in a dog family</Term>
        <Term>canines</Term>
        <Term>Dog (organism)</Term>
        <Term>Canine, NOS</Term>
        <Term>Dogs</Term>
        <Term>Canis lupus subspecies familiaris</Term>
        <Term>Domestic dog</Term>
        <Term>allergy testing dog</Term>
        <Term>Mammals, Dogs</Term>
        <Term>dog</Term>
        <Term>Canis lupus familiaris</Term>
        <Codes>
          <Code code="C0012984" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Canidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Blood" name="Blood">
        <Definition>A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.</Definition>
        <Definition>A tissue with red blood cells, white blood cells, platelets, and other substances suspended in fluid called plasma. Blood takes oxygen and nutrients to the tissues, and carries away wastes.</Definition>
        <Definition>Used for the presence or analysis of substances in the blood; also for examination of, or changes in, the blood in disease states. It excludes serodiagnosis, for which the subheading "diagnosis" is used, and serology, for which "immunology" is used.</Definition>
        <Definition>Any deviation from the normal structure or function of the blood or lymphatic system that is manifested by a characteristic set of symptoms and signs.</Definition>
        <Definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide. It supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</Definition>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <SemanticType code="T031" name="Body Substance"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Blood</Term>
        <Term>blood</Term>
        <Term>Peripheral blood (substance)</Term>
        <Term>BLOOD</Term>
        <Term>Peripheral blood</Term>
        <Term>Blood and Lymphatic Disorders</Term>
        <Term>peripheral blood</Term>
        <Term>Hematopoietic and Lymphoid System Disorder</Term>
        <Term>BL</Term>
        <Term>Blood - peripheral</Term>
        <Term>Reticuloendothelial System, Blood</Term>
        <Term>Peripheral Blood</Term>
        <Term>Hematopoietic and Lymphoid System Disease</Term>
        <Term>Peripheral blood, NOS</Term>
        <Term>Blood and lymphatic system disorders</Term>
        <Term>blood peripheral</Term>
        <Term>In Blood</Term>
        <Codes>
          <Code code="C0229664" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Intervention_Comparator_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NT5C1B_protein_human" name="NT5C1B protein, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NT5C1B protein, human</Term>
        <Term>5'-nucleotidase, cytosolic IB protein, human</Term>
        <Codes>
          <Code code="C2973299" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-Nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SLAMF1_protein_human" name="SLAMF1 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SLAMF1 protein, human</Term>
        <Term>CD150 antigen, human</Term>
        <Term>CD150 protein, human</Term>
        <Term>signaling lymphocytic activation molecule family member 1, human</Term>
        <Codes>
          <Code code="C1742788" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD150_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:non-randomized_controlled_design" name="non-randomized controlled design">
        <Definition>A study where participants are assigned to a treatment, procedure, or intervention my methods that are not random. Non-randomized clinical trials are sometimes referred to as quasi-experimental clinical trials or non-equivalent control group designs. [Non-Randomized Controlled Trials as Topic | MeSH_2015]</Definition>
        <SemanticType code="T081" name="Quantitative Concept"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">non-randomized controlled design</Term>
        <Term>non-randomized controlled study</Term>
        <Term>nonrandomised controlled trial</Term>
        <Term>nonrandomised controlled studies</Term>
        <Term>non-randomised controlled designs</Term>
        <Term>non-randomized controlled trials</Term>
        <Term>non-randomized controlled trial</Term>
        <Term>nonrandomised controlled trials</Term>
        <Term>non-randomised controlled studies</Term>
        <Term>nonrandomized controlled study</Term>
        <Term>non-randomised controlled study</Term>
        <Term>nonrandomized controlled design</Term>
        <Term>nonrandomized controlled trial</Term>
        <Term>non-randomised controlled trial</Term>
        <Term>nonrandomised controlled designs</Term>
        <Term>non-randomised controlled trials</Term>
        <Term>nonrandomized controlled designs</Term>
        <Term>non-randomized controlled studies</Term>
        <Term>nonrandomised controlled design</Term>
        <Term>nonrandomized controlled trials</Term>
        <Term>non-randomised controlled design</Term>
        <Term>nonrandomized controlled studies</Term>
        <Term>nonrandomised controlled study</Term>
        <Term>non-randomized controlled designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#non-randomized_controlled_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:controlled_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BST2_protein_human" name="BST2 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BST2 protein, human</Term>
        <Term>CD317 antigen, human</Term>
        <Term>bone marrow stromal antigen 2, human</Term>
        <Term>BST-2 protein, human</Term>
        <Term>tetherin protein, human</Term>
        <Term>HM1.24 antigen, human</Term>
        <Term>HM1.24 protein, human</Term>
        <Codes>
          <Code code="C0299634" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CDCP1_protein_human" name="CDCP1 protein, human">
        <Definition>CUB domain-containing protein 1 (836 aa, ~93 kDa) is encoded by the human CDCP1 gene. This protein may play a role in matrix-dependent cell signaling.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CDCP1 protein, human</Term>
        <Term>CUB domain containing protein 1, human</Term>
        <Term>80-kDa membrane glycoprotein, human</Term>
        <Term>trask protein, human</Term>
        <Term>CD318 antigen, human</Term>
        <Codes>
          <Code code="C0968315" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd48_protein_mouse" name="Cd48 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd48 protein, mouse</Term>
        <Term>Sgp-60 protein, mouse</Term>
        <Term>Blast-1 protein, mouse</Term>
        <Term>BCM1 protein, mouse</Term>
        <Term>Bcm-1 protein, mouse</Term>
        <Term>CD48 antigen, mouse</Term>
        <Term>BLAST1 protein, mouse</Term>
        <Codes>
          <Code code="C1609392" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD48_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Infant_Small_for_Gestational_Age" name="Infant, Small for Gestational Age">
        <Definition>An infant having a birth weight lower than expected for its gestational age.</Definition>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Infant, Small for Gestational Age</Term>
        <Term>INFANT SGA</Term>
        <Codes>
          <Code code="C0021296" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Infant_Low_Birth_Weight</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:observational_study" name="observational study">
        <Definition>Studies in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study. [NCIT_14.05d] [Contributing_Source_CDISC]
</Definition>
        <Definition>Studies among cancer patients and healthy populations that involve no intervention or alteration in the status of the participants.</Definition>
        <Definition> A type of study in which individuals are observed or certain outcomes are measured. No attempt is made to affect the outcome (for example, no treatment is given). [NCIT_14.05d] </Definition>
        <Definition>A clinical study in which participants may receive diagnostic, therapeutic, or other types of interventions, but the investigator does not assign participants to specific interventions (as in an interventional study).</Definition>
        <Definition>A type of study in which individuals are observed or certain outcomes are measured. No attempt is made to affect the outcome (for example, no treatment is given).</Definition>
        <Definition> Studies among cancer patients and healthy populations that involve no intervention or alteration in the status of the participants. [NCIT_14.05d] </Definition>
        <Definition>Studies in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study.</Definition>
        <SemanticType code="T169" name="Functional Concept"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">observational study</Term>
        <Term>observation trials</Term>
        <Term>observation study</Term>
        <Term>observational trials</Term>
        <Term>Observational Study</Term>
        <Term>Study observation</Term>
        <Term>observational studies</Term>
        <Term>observational trial</Term>
        <Term>observation design</Term>
        <Term>OBSERVATIONAL</Term>
        <Term>observational design</Term>
        <Term>observation studies</Term>
        <Term>Observational Trial</Term>
        <Term>observation designs</Term>
        <Term>observational designs</Term>
        <Term>observation trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#observational_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:B220_Antigens" name="B220 Antigens">
        <Definition>A full-length splicing isoform of CD45 antigen.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">B220 Antigens</Term>
        <Term>CD45R Antigens</Term>
        <Term>Antigen, B220</Term>
        <Term>Antigens, CD45R</Term>
        <Term>B220 Antigen</Term>
        <Term>CD 045 R ANTIGENS</Term>
        <Term>Antigens, B220</Term>
        <Codes>
          <Code code="C0081692" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD45_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:randomized_controlled_trial" name="randomized controlled trial">
        <Definition>Work consisting of a clinical trial that involves at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.</Definition>
        <Definition>Work consisting of a clinical trial that involves at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. [MeSH_2014]</Definition>
        <Definition>Clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">randomized controlled trial</Term>
        <Term>randomized controlled design</Term>
        <Term>rcts</Term>
        <Term>controlled trial randomized</Term>
        <Term>randomized controlled study</Term>
        <Term>Randomized Controlled Trials as Topic</Term>
        <Term>RANDOMIZED CONTROLLED TRIALS</Term>
        <Term>randomised controlled designs</Term>
        <Term>randomized controlled trials</Term>
        <Term>controlled randomized trial</Term>
        <Term>Randomized Controlled Trial (publication)</Term>
        <Term>randomised controlled trials</Term>
        <Term>Randomized Controlled Trial</Term>
        <Term>randomised control trial</Term>
        <Term>controll randomized trial</Term>
        <Term>randomised controlled studies</Term>
        <Term>randomised controlled study</Term>
        <Term>randomized control trial</Term>
        <Term>controlled trial, randomized</Term>
        <Term>randomised controlled design</Term>
        <Term>randomized controlled designs</Term>
        <Term>controlled randomizes trials</Term>
        <Term>rct</Term>
        <Term>randomized controlled studies</Term>
        <Term>trial, randomized controlled</Term>
        <Term>randomised controlled  trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#randomized_controlled_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:controlled_design</Relation>
          <Relation name="Narrower">OTE:open_label_randomized_controlled_design, OTE:double_blinded_randomized_controlled_trial, OTE:single_blinded_randomized_controlled_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd22_protein_mouse" name="Cd22 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd22 protein, mouse</Term>
        <Term>Lyb-8 protein, mouse</Term>
        <Term>CD22 antigen, mouse</Term>
        <Codes>
          <Code code="C1505686" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD22_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_CD95" name="Antigens, CD95">
        <Definition>Tumor necrosis factor receptor superfamily member 6 (335 aa, 38 kD) is a cell fate protein that is encoded by the human FAS gene and has roles in signal transduction, induction of apoptosis, and prevention of apoptosis.</Definition>
        <Definition>differentiation antigens expressed on a variety of cell lines; regulate peripheral immune responses.</Definition>
        <Definition>A tumor necrosis factor receptor subtype found in a variety of tissues and on activated LYMPHOCYTES. It has specificity for FAS LIGAND and plays a role in regulation of peripheral immune responses and APOPTOSIS. Multiple isoforms of the protein exist due to multiple ALTERNATIVE SPLICING. The activated receptor signals via a conserved death domain that associates with specific TNF RECEPTOR-ASSOCIATED FACTORS in the CYTOPLASM.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, CD95</Term>
        <Term>TNFRSF6 Receptor</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPT SUPERFAMILY MEMBER 6</Term>
        <Term>fas Antigen</Term>
        <Term>APO 1 Antigen</Term>
        <Term>APO 001 ANTIGEN</Term>
        <Term>Receptors, fas</Term>
        <Term>ANTIGENS CD 095</Term>
        <Term>FAS RECEPT</Term>
        <Term>CD95 Antigens</Term>
        <Term>Receptor, TNFRSF6</Term>
        <Term>TNFRSF6 RECEPT</Term>
        <Term>CD95 Antigen</Term>
        <Term>RECEPT FAS</Term>
        <Term>Tumor Necrosis Factor Receptor Superfamily, Member 6</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 06</Term>
        <Term>Receptor, fas</Term>
        <Term>CD 095 ANTIGENS</Term>
        <Term>APO-1 Antigen</Term>
        <Term>fas Receptors</Term>
        <Term>fas Receptor</Term>
        <Term>fas Antigens</Term>
        <Codes>
          <Code code="C0245662" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:FAS_protein_human, OTE:Tnfrsf6_protein_rat, OTE:Fas_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Thy-1_1_Antigen" name="Thy-1.1 Antigen">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Thy-1.1 Antigen</Term>
        <Term>Thy 1.1 Antigen</Term>
        <Term>Antigen, Thy-1.1</Term>
        <Codes>
          <Code code="C0243022" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_Thy-1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:database_study" name="database study">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">database study</Term>
        <Term>data base trial</Term>
        <Term>data base design</Term>
        <Term>database designs</Term>
        <Term>data base designs</Term>
        <Term>data base trials</Term>
        <Term>database trial</Term>
        <Term>database trials</Term>
        <Term>database studies</Term>
        <Term>data base studies</Term>
        <Term>data base study</Term>
        <Term>database design</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#data_base_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BL_6_Mouse" name="C57BL/6 Mouse">
        <Definition>Derived by Little (1921) from A Lathrop stocks and separated out before 1937, the C57BL/6 mouse has a black coat and is one of the most widely used inbred strains. It accounts for 14% of all mouse inbred strain laboratory usage. The strain carries a Y chromosome of Asian Mus musculus origin and a LINE-1 element from Mus spretus, suggesting that up to 6.5% of the genome is Mus spretus in origin. Substrain C57BL/6 differs from other substrains at multiple loci, including H9, Igh2 and Lv, on chromosome 4. This mouse model is prone to the development of fatty lesions in the aorta similar to atheromatous plaque in humans, as well as hyperglycemia, hyperinsulinemia, hypercholesterolemia and non-insulin-dependent diabetes mellitus in response to a high fat diet. The C57BL/6 strain exhibits good reproductive performance and hermaphroditism in this substrain has been shown to occur.</Definition>
        <Definition>Derived by Little (1921) from A Lathrop stocks and separated out before 1937, the C57BL/6 mouse has a black coat and carries a Y chromosome of Asian Mus musculus origin and a LINE-1 element from Mus spretus. Substrain C57BL/6 differs from other substrains at multiple loci, including H9, Igh2 and Lv, on chromosome 4. This mouse model is prone to the development of fatty lesions in the aorta similar to atheromatous plaque in humans, as well as hyperglycemia, hyperinsulinemia, hypercholesterolemia and non-insulin-dependent diabetes mellitus in response to a high fat diet.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BL/6 Mouse</Term>
        <Term>C57BL/6</Term>
        <Term>B6</Term>
        <Codes>
          <Code code="C14424" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:threonyl-leucyl-histidine-N-methylamide" name="threonyl-leucyl-histidine-N-methylamide">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">threonyl-leucyl-histidine-N-methylamide</Term>
        <Term>Thr-Leu-His-N-methylamide</Term>
        <Codes>
          <Code code="C0636374" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klra7_protein_mouse" name="Klra7 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klra7 protein, mouse</Term>
        <Term>Ly49g1 antigen, mouse</Term>
        <Term>Ly-49g2 antigen, mouse</Term>
        <Term>Ly49g2 antigen, mouse</Term>
        <Term>Ly-49g1 antigen, mouse</Term>
        <Term>killer cell lectin-like receptor, subfamily A, member 7, mouse</Term>
        <Codes>
          <Code code="C2351936" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SEG_Mouse" name="SEG Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SEG Mouse</Term>
        <Term>SEG</Term>
        <Codes>
          <Code code="C37435" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Sheep" name="Sheep">
        <Definition>Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS.</Definition>
        <Definition>Domestic sheep species</Definition>
        <Definition>Any one of several species in the genus Ovis, most commonly Ovis aries.</Definition>
        <Definition>Any one of several species of ruminants of the genus Ovis, native of the higher mountains of both hemispheres, but most numerous in Asia; the domestic sheep, Ovis aries.</Definition>
        <Definition>A species of sheep, Ovis aries, descended from Near Eastern wild forms, especially mouflon.</Definition>
        <Definition>any of various ruminant mammals (genus Ovis) related to the goats but stockier and lacking a beard in the male; specifically, one (O. aries) long domesticated especially for its flesh and wool.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Sheep</Term>
        <Term>Domestic sheep</Term>
        <Term>lamb</Term>
        <Term>Ovis ammon aries</Term>
        <Term>Genus Ovis (organism)</Term>
        <Term>ovis</Term>
        <Term>Genus Ovis</Term>
        <Term>sheeps</Term>
        <Term>Ovine, NOS</Term>
        <Term>Ovis aries aries</Term>
        <Term>Wild sheep, NOS</Term>
        <Term>Ovis aries (organism)</Term>
        <Term>wild sheep</Term>
        <Term>Sheep antigen</Term>
        <Term>Ovis, NOS</Term>
        <Term>OVINE SPECIES</Term>
        <Term>domestic sheep</Term>
        <Term>sheep</Term>
        <Term>ovi</Term>
        <Term>803 OVINE SPECIES</Term>
        <Term>SHEEP</Term>
        <Term>Ovis aries Linnaeus, 1758</Term>
        <Term>Sheep, Domestic</Term>
        <Term>Sheep (organism)</Term>
        <Term>Ovis musimon</Term>
        <Term>Ovine species</Term>
        <Term>lambs</Term>
        <Term>Ovis orientalis aries</Term>
        <Term>Ovine</Term>
        <Term>Ovis ovis</Term>
        <Term>Ovis</Term>
        <Term>Ovine (qualifier value)</Term>
        <Term>ovine</Term>
        <Term>Ovis aries</Term>
        <Term>Mouflon</Term>
        <Term>Domestic Sheep</Term>
        <Codes>
          <Code code="C1442923" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Bovidae</Relation>
          <Relation name="Narrower">OTE:Suffolk_Sheep</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_5" name="NK Cell Lectin-Like Receptor Subfamily A, Member 5">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NK Cell Lectin-Like Receptor Subfamily A, Member 5</Term>
        <Term>NK Cell Lectin Like Receptor Subfamily A, Member 5</Term>
        <Term>Antigen, Ly49E</Term>
        <Term>Ly49E Antigen</Term>
        <Codes>
          <Code code="C2350489" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Serum" name="Serum">
        <Definition>The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins.</Definition>
        <Definition>The clear liquid part of the blood that remains after blood cells and clotting proteins have been removed.</Definition>
        <Definition>The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins. (NCI)</Definition>
        <Definition>Body substance derived from plasma by the elimination of fibrinogen.</Definition>
        <Definition>Nažloutlá tekutina, která vzniká po sražení krve (krevní buňky, s některými bílkovinami vytvoří koagulum a s. je vytlačeno ven). Je podobné plasmě, ale neobsahuje některé bílkoviny, které jsou nutné ke vzniku sraženiny a které se při její tvorbě spotřebovaly. (cit. Velký lékařský slovník online, 2013 http://lekarske.slovniky.cz/ )</Definition>
        <Definition>The clear portion of BLOOD that is left after BLOOD COAGULATION to remove BLOOD CELLS and clotting proteins.</Definition>
        <Definition>clear liquid that separates from blood on clotting; blood plasma from which fibrinogen has been removed in the process of clotting.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T031" name="Body Substance"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Serum</Term>
        <Term>serum</Term>
        <Term>SERUM</Term>
        <Term>Serum (Blood)</Term>
        <Term>Ser</Term>
        <Term>Blood serum</Term>
        <Term>Serum (substance)</Term>
        <Term>serums</Term>
        <Term>Specimen Type - Serum</Term>
        <Term>Serum, Blood</Term>
        <Term>blood serum</Term>
        <Term>Specimen Source Codes - Serum</Term>
        <Term>Sera</Term>
        <Term>Serum, NOS (not otherwise specified)</Term>
        <Term>Serums</Term>
        <Term>Blood Serum</Term>
        <Codes>
          <Code code="C13325" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Intervention_Comparator_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:interview" name="interview">
        <Definition>Work consisting of a conversation with an individual regarding his or her background and other personal and professional details, opinions on specific subjects posed by the interviewer, etc.</Definition>
        <Definition>Used for the methods, techniques, principles, and practice of interviewing.</Definition>
        <Definition>A conversation with an individual regarding his or her background and other personal and professional details, opinions on specific subjects posed by the interviewer, etc.</Definition>
        <Definition>Work consisting of a conversation with an individual regarding his or her background and other personal and professional details, opinions on specific subjects posed by the interviewer, etc. [MeSH_2014]</Definition>
        <Definition>A conversation with an individual regarding his or her background and other personal and professional details, opinions on specific subjects posed by the interviewer, etc. [NCIT_14.05d]</Definition>
        <Definition>Conversations with an individual or individuals held in order to obtain information about their background and other personal biographical data, their attitudes and opinions, etc. It includes school admission or job interviews.</Definition>
        <Definition>contact or meeting to obtain information from an individual.</Definition>
        <SemanticType code="T052" name="Activity"/>
        <SemanticType code="T057" name="Occupational Activity"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">interview</Term>
        <Term/>
        <Term>Interview</Term>
        <Term>Interviewing</Term>
        <Term>interviews</Term>
        <Term>Interviews as Topic</Term>
        <Term>interview studies</Term>
        <Term>Interviews</Term>
        <Term>oral history</Term>
        <Term>interview study</Term>
        <Term>Published Interview</Term>
        <Term>published interview</Term>
        <Term>interviewing</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#interview_study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type, OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:semi-structured_interview, OTE:face-to-face_interview</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_4" name="NK Cell Lectin-Like Receptor Subfamily A, Member 4">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NK Cell Lectin-Like Receptor Subfamily A, Member 4</Term>
        <Term>NK Cell Lectin Like Receptor Subfamily A, Member 4</Term>
        <Term>Antigen, Ly49D</Term>
        <Term>Ly49D Antigen</Term>
        <Codes>
          <Code code="C2350493" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_7" name="NK Cell Lectin-Like Receptor Subfamily A, Member 7">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NK Cell Lectin-Like Receptor Subfamily A, Member 7</Term>
        <Term>NK Cell Lectin Like Receptor Subfamily A, Member 7</Term>
        <Term>Antigen, Ly49G</Term>
        <Term>Ly49G Antigen</Term>
        <Codes>
          <Code code="C2350491" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129_Mouse" name="129 Mouse">
        <Definition>Strains of mice arising from a parental inbred stock that was subsequently used to produce substrains of knockout and other mutant mice with targeted mutations.</Definition>
        <Definition>Inbr and colour depends on substrain (see below). Origin: Dunn 1928 from crosses of coat colour stocks from English fanciers and a chinchilla stock from Castle. This strain has a common origin with strain 101. Most substrains carry the white-bellied agouti gene AW though only a subset have the agouti pattern as many carry albino or chinchilla and/or the pink-eyed dilution gene, p, which is derived from Asian mice of the Mus musculus type (see also strains SJL, P/J and FS/Ei). (Jackson Labs/Festing)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129 Mouse</Term>
        <Term>129 Strain Mice</Term>
        <Term>Strain 129 Mice</Term>
        <Term>129</Term>
        <Term>129 Strain Mouse</Term>
        <Term>Mouse, 129</Term>
        <Term>129 Mice</Term>
        <Term>Mice, 129 Strain</Term>
        <Term>Mice, Strain 129</Term>
        <Term>Bar Harbor 129 Mice</Term>
        <Term>Strain Mice, 129</Term>
        <Term>Mice, 129</Term>
        <Term>Bar Harbor 129 Mouse</Term>
        <Term>Mouse, 129 Strain</Term>
        <Codes>
          <Code code="C15151" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_6" name="NK Cell Lectin-Like Receptor Subfamily A, Member 6">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NK Cell Lectin-Like Receptor Subfamily A, Member 6</Term>
        <Term>NK Cell Lectin Like Receptor Subfamily A, Member 6</Term>
        <Term>Antigen, Ly49F</Term>
        <Term>Ly49F Antigen</Term>
        <Codes>
          <Code code="C2350490" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD72_antigen_mouse" name="CD72 antigen, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD72 antigen, mouse</Term>
        <Codes>
          <Code code="C1743885" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_1" name="NK Cell Lectin-Like Receptor Subfamily A, Member 1">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NK Cell Lectin-Like Receptor Subfamily A, Member 1</Term>
        <Term>Ly-49A Antigen</Term>
        <Term>Ly 49A Antigen</Term>
        <Term>Antigen, Ly-49A</Term>
        <Term>Ly49A Antigen</Term>
        <Term>Antigen, Ly49A</Term>
        <Term>NK Cell Lectin Like Receptor Subfamily A, Member 1</Term>
        <Codes>
          <Code code="C2350492" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:alpha-fetoprotein_related_protein_mouse" name="alpha-fetoprotein related protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">alpha-fetoprotein related protein, mouse</Term>
        <Term>ARG protein, mouse</Term>
        <Codes>
          <Code code="C2742043" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Adolescent" name="Adolescent">
        <Definition>A juvenile between the onset of puberty and maturity; in the state of development between puberty and maturity.</Definition>
        <Definition>Osoba mezi 13 a 18 lety věku.</Definition>
        <Definition>A person 13 to 18 years of age.</Definition>
        <SemanticType code="T100" name="Age Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Adolescent</Term>
        <Term>Adolescent (age group)</Term>
        <Term>teenager</Term>
        <Term>Adolescent [Disease/Finding]</Term>
        <Term>adolescents</Term>
        <Term>teenagers</Term>
        <Term>teens</Term>
        <Term>adolescent</Term>
        <Term>pubescent</Term>
        <Term>Adolescent (person)</Term>
        <Term>ADOLESCENT</Term>
        <Term>Adolescent Youth</Term>
        <Term>Adolescents</Term>
        <Term>teen</Term>
        <Codes>
          <Code code="C0205653" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Age_Groups</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL3RA_protein_human" name="IL3RA protein, human">
        <Definition>Encoded by human IL3RA Gene (Type I Cytokine Receptor 5 Family), 378-aa 43-kDa (precursor) Interleukin 3 Receptor Alpha is a type I membrane protein with a box 1 motif for JAK interaction/activation; a WSXWS motif for protein folding, intracellular transport, and cell-surface receptor binding; and the ligand-binding alpha subunit of a heterodimeric cytokine receptor for Interleukin 3. Receptor binding to IL3 depends on the signal transducing beta subunit, shared by IL3-, IL5-, and CSF2/GM-CSF receptors. (NCI)</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL3RA protein, human</Term>
        <Term>CD123 protein, human</Term>
        <Term>CD123 antigen, human</Term>
        <Term>interleukin 3 receptor, alpha (low affinity) protein, human</Term>
        <Term>interleukin 3 receptor alpha subunit, human</Term>
        <Term>human interleukin 3 receptor alpha subunit</Term>
        <Term>IL-3Ralpha, human</Term>
        <Codes>
          <Code code="C0758637" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_3_Receptor_alpha_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_3" name="NK Cell Lectin-Like Receptor Subfamily A, Member 3">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NK Cell Lectin-Like Receptor Subfamily A, Member 3</Term>
        <Term>Antigen, Ly49C</Term>
        <Term>Ly49C Antigen</Term>
        <Term>NK Cell Lectin Like Receptor Subfamily A, Member 3</Term>
        <Codes>
          <Code code="C2350487" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ethnic_Groups" name="Ethnic Groups">
        <Definition>Terminology codelist used with Ethnic Group within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model.</Definition>
        <Definition>A group of people with a common cultural heritage that sets them apart from others in a variety of social relationships.</Definition>
        <Definition>a group of people with a common cultural heritage that sets them apart from others in a variety of social relationships.</Definition>
        <Definition>A social group characterized by a distinctive social and cultural tradition that is maintained from generation to generation. Members share a common history and origin and a sense of identification with the group. They have similar and distinctive features in their lifestyle habits and shared experiences. They often have a common genetic heritage which may be reflected in their experience of health and disease.</Definition>
        <Definition>A social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of life, shared experiences and often a common genetic heritage; these features may be reflected in their experience of health and disease. (NCI)</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ethnic Groups</Term>
        <Term>ethnic groups</Term>
        <Term>Ethnic background, NOS</Term>
        <Term>Ethnic Origin</Term>
        <Term>CDISC SDTM Ethnic Group Terminology</Term>
        <Term>Ethnic group, NOS</Term>
        <Term>ethnic background</Term>
        <Term>ethnic group</Term>
        <Term>60 ETHNIC GROUPS: GENERAL TERMS</Term>
        <Term>Ethnicity</Term>
        <Term>Ethnic group finding</Term>
        <Term>Group, Ethnic</Term>
        <Term>Ethnic group</Term>
        <Term>ethnicity (history)</Term>
        <Term>Ethnic group (ethnic group)</Term>
        <Term>Ethnic group (observable entity)</Term>
        <Term>CDISC SDTM Patient Ethnic Group Terminology</Term>
        <Term>Ethnic groups</Term>
        <Term>ethnicity</Term>
        <Term>Ethnic Group</Term>
        <Term>Ethnic Origins</Term>
        <Term>ethnic populations</Term>
        <Term>Ethnic background</Term>
        <Term>SDTM-ETHNIC</Term>
        <Term>Ethnicity, NOS</Term>
        <Term>Ethnic category</Term>
        <Term>ETHNIC GROUPS AND POPULATIONS</Term>
        <Term>ETHNIC GROUPS: GENERAL TERMS</Term>
        <Term>ethnics groups</Term>
        <Term>SECTION 6 ETHNIC GROUPS AND POPULATIONS</Term>
        <Term>Groups, Ethnic</Term>
        <Term>ETHNIC</Term>
        <Term>Ethnic group finding (finding)</Term>
        <Term>Ethnic population, NOS</Term>
        <Term>Ethnic background (finding)</Term>
        <Codes>
          <Code code="C1879937" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Population_Groups</Relation>
          <Relation name="Narrower">OTE:Inuits, OTE:Hispanic_Americans, OTE:African_Americans, OTE:Jew, OTE:Asian_Americans, OTE:Gypsies, OTE:Amish, OTE:Arabs</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_2" name="NK Cell Lectin-Like Receptor Subfamily A, Member 2">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NK Cell Lectin-Like Receptor Subfamily A, Member 2</Term>
        <Term>Antigen, Ly49B</Term>
        <Term>NK Cell Lectin Like Receptor Subfamily A, Member 2</Term>
        <Term>Ly49B Antigen</Term>
        <Codes>
          <Code code="C2350486" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mcp_protein_mouse" name="Mcp protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mcp protein, mouse</Term>
        <Term>membrane cofactor protein, mouse</Term>
        <Term>CD46 protein, mouse</Term>
        <Codes>
          <Code code="C1505679" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD46</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:KLRB1_protein_human" name="KLRB1 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">KLRB1 protein, human</Term>
        <Term>CD161 protein, human</Term>
        <Term>NKR-P1A protein, human</Term>
        <Term>killer cell lectin-like receptor subfamily B, member 1 protein, human</Term>
        <Term>NKR-P1 protein, human</Term>
        <Term>NKRP1A protein, human</Term>
        <Codes>
          <Code code="C1689853" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_B</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DPP4_protein_human" name="DPP4 protein, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DPP4 protein, human</Term>
        <Term>DPP-IV protein, human</Term>
        <Term>adenosine deaminase complexing protein 2, human</Term>
        <Term>CD26 protein, human</Term>
        <Term>Dipeptidyl peptidase IV protein, human</Term>
        <Term>ADCP2 protein, human</Term>
        <Term>dipeptidylpeptidase 4 protein, human</Term>
        <Codes>
          <Code code="C1447020" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Dipeptidyl-Peptidase_IV</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:OXYS_Rat_Strain" name="OXYS, Rat Strain">
        <Definition>Inherited overproduction of free radicals, high levels of lipid peroxidation, protein oxidation, DNA rearrangements, morbid conditions mimicking human degenerative diseases: cataract, emphysema, cardiomyopathy, carcinogenesis; short life-span and low fecundity. Intensive transport of monosaccharides into the cells (Salganik et al 1994).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">OXYS, Rat Strain</Term>
        <Codes>
          <Code code="C14413" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:A_HeJ_Mouse" name="A/HeJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">A/HeJ Mouse</Term>
        <Term>A/HeJ</Term>
        <Codes>
          <Code code="C37349" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD180_protein_human" name="CD180 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD180 protein, human</Term>
        <Term>LY64 protein, human</Term>
        <Term>radioprotective 105kD protein, human</Term>
        <Term>lymphocyte antigen 64 homolog, radioprotective 105kDa (mouse) protein, human</Term>
        <Term>lymphocyte antigen 64 protein, human</Term>
        <Term>LY64 antigen, human</Term>
        <Term>RP105 protein, human</Term>
        <Term>CD180 antigen, human</Term>
        <Codes>
          <Code code="C1122354" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_A_Member_8" name="NK Cell Lectin-Like Receptor Subfamily A, Member 8">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NK Cell Lectin-Like Receptor Subfamily A, Member 8</Term>
        <Term>NK Cell Lectin Like Receptor Subfamily A, Member 8</Term>
        <Term>Antigen, Ly49H</Term>
        <Term>Ly49H Antigen</Term>
        <Codes>
          <Code code="C2350488" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Gypsies" name="Gypsies">
        <Definition>Ethnic group originating in India and entering Europe in the 14th or 15th century.</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Gypsies</Term>
        <Term>Gipsies</Term>
        <Term>gypsy</Term>
        <Term>gypsies</Term>
        <Term>Gypsies (ethnic group)</Term>
        <Term>Gypsy</Term>
        <Codes>
          <Code code="C0018422" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ethnic_Groups</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:non-randomized_clinical_trial" name="non-randomized clinical trial">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">non-randomized clinical trial</Term>
        <Term>non-randomized clinical trials</Term>
        <Term>non-randomised clinical trial</Term>
        <Term>non-randomised clinical trials</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#non-randomized_clinical_trial" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:clinical_trial</Relation>
          <Relation name="Narrower">OTE:non-equivalent_control_group_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly6d_protein_mouse" name="Ly6d protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly6d protein, mouse</Term>
        <Term>antigens, ThB, mouse</Term>
        <Term>Ly61 antigen, mouse</Term>
        <Term>lymphocyte antigen 6 complex, locus D, mouse</Term>
        <Term>lymphocyte antigen 6 complex locus D, mouse</Term>
        <Term>Ly-61 protein, mouse</Term>
        <Codes>
          <Code code="C0052054" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Frail_Older_Adults" name="Frail Older Adults">
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Frail Older Adults</Term>
        <Term>Frail Older Adult</Term>
        <Term>Older Adult, Frail</Term>
        <Term>Older Adults, Frail</Term>
        <Term>Adults, Frail Older</Term>
        <Term>Adult, Frail Older</Term>
        <Codes>
          <Code code="C0079379" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Elderly_Frail</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NZW_Mouse" name="NZW Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NZW Mouse</Term>
        <Term>NZW</Term>
        <Codes>
          <Code code="C37425" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Canidae" name="Canidae">
        <Definition>Taxonomic family which includes the domestic dog, wolves and foxes.</Definition>
        <Definition>A family of terrestrial carnivores with long snouts and non-retractable claws. Members include COYOTES; DOGS; FOXES; JACKALS; RACCOON DOGS; and WOLVES.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Canidae</Term>
        <Term>881 FAMILY CANIDAE</Term>
        <Term>Family Canidae (organism)</Term>
        <Term>Canid</Term>
        <Term>FAMILY CANIDAE</Term>
        <Term>Family Canidae</Term>
        <Term>Canids</Term>
        <Term>canidae</Term>
        <Term>Family canidae</Term>
        <Codes>
          <Code code="C14331" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Carnivora</Relation>
          <Relation name="Narrower">OTE:Dog</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Orthotopic_Liver_Transplantation" name="Orthotopic Liver Transplantation">
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Orthotopic Liver Transplantation</Term>
        <Term>orthotopic hepatic transplant</Term>
        <Term>orthotopic liver transplant (treatment)</Term>
        <Term>orthotopic liver transplant</Term>
        <Term>Orthotopic liver transplant</Term>
        <Term>Orthotopic liver transplant (procedure)</Term>
        <Term>Orthotopic Liver Transplant</Term>
        <Codes>
          <Code code="C0400447" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Liver_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LRP12_protein_human" name="LRP12 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LRP12 protein, human</Term>
        <Term>low density lipoprotein-related protein 12, human</Term>
        <Codes>
          <Code code="C1450603" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:LDL_Receptor_Related_Protein_1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LE_Rat_Strain" name="LE, Rat Strain">
        <Definition>Derived by Long and Evans (1915) by crossing female Wistar rats with a wild gray male, the Long-Evans rat was disseminated to Charles River from Canadian Breeding Farm and Laboratories (1978). This outbred rat breed is white with a black or brown hood.</Definition>
        <Definition>Derived by Long and Evans (1915) by crossing female Wistar rats with a wild gray male, the Long-Evans rat was disseminated to Charles River from Canadian Breeding Farm and Laboratories (1978). This outbred rat breed is white with a black or brown hood. The Long-Evans rat is utilized in a variety of research applications including obesity and behavioral research.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LE, Rat Strain</Term>
        <Term>Long Evans</Term>
        <Term>LONG EVANS</Term>
        <Codes>
          <Code code="C76188" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:editorial" name="editorial">
        <Definition>Work consisting of a statement of the opinions, beliefs, and policy of the editor or publisher of a journal, usually on current matters of medical or scientific significance to the medical community or society at large. The editorials published by editors of journals representing the official organ of a society or organization are generally substantive. [MeSH_2014]</Definition>
        <Definition>Work consisting of a statement of the opinions, beliefs, and policy of the editor or publisher of a journal, usually on current matters of medical or scientific significance to the medical community or society at large. The editorials published by editors of journals representing the official organ of a society or organization are generally substantive.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">editorial</Term>
        <Term>Editorial</Term>
        <Term>editorials</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#editorial" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LVG_Hamster" name="LVG Hamster">
        <Definition>Derived from the original group of Syrian hamsters captured by Dr. Israel Aharoni in 1930 and imported into the United States in 1938, followed by colony derivation at Lakeview in 1949 and 1951 and to Charles River in 1969, where the strain is propagated today.</Definition>
        <Definition>Derived from the original group of Syrian hamsters captured by Dr. Israel Aharoni in 1930 and imported into the United States in 1938, followed by colony derivation at Lakeview in 1949 and 1951 and to Charles River in 1969, where the strain is propagated today. This breed is used in toxicological studies and is prone to amyloidosis of the kidneys, liver, and adrenal glands after twelve months of age.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LVG Hamster</Term>
        <Term>Lakeview LVG</Term>
        <Term>LAKEVIEW LVG</Term>
        <Codes>
          <Code code="C2697862" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Hamster</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:English" name="English">
        <Definition>Denotes the inhabitants of England, a person from there, or their descendants elsewhere.</Definition>
        <Definition>An Indo-European language belonging to the West Germanic branch; the official language of Britain and the United States, and most of the Commonwealth countries.</Definition>
        <SemanticType code="T171" name="Language"/>
        <SemanticType code="T098" name="Population Group"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">English</Term>
        <Term>English Language</Term>
        <Term>ENGLISH</Term>
        <Term>English (ethnic group)</Term>
        <Term>English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)</Term>
        <Term>English race</Term>
        <Term>English language (qualifier value)</Term>
        <Term>English language</Term>
        <Term>english language</Term>
        <Term>English [people]</Term>
        <Term>English [International Organization for Standardization 639-1 code en] language reference set</Term>
        <Codes>
          <Code code="C0376245" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Language_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:sialyl_Lewis_X_antigen" name="sialyl Lewis X antigen">
        <SemanticType code="T118" name="Carbohydrate"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">sialyl Lewis X antigen</Term>
        <Term>NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAc-R</Term>
        <Term>CD15s antigen</Term>
        <Term>sialyl SSEA-1</Term>
        <Term>sialyl Lewis(x) antigen</Term>
        <Term>sialyl stage-specific embryonic antigen-1</Term>
        <Codes>
          <Code code="C2352839" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD15_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Transplant_Recipient" name="Transplant Recipient">
        <Definition>Individuals receiving tissues or organs transferred from another individual of the same or different species, or from within the same individual.</Definition>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T101" name="Patient or Disabled Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Transplant Recipient</Term>
        <Term>Recipient, Transplant</Term>
        <Term>transplant recipient</Term>
        <Term>transplant recipients</Term>
        <Term>TRANSPL RECIPIENT</Term>
        <Term>Transplant Recipients</Term>
        <Term>Recipient of transplantation (finding)</Term>
        <Term>recipients transplant</Term>
        <Term>Recipient of transplantation</Term>
        <Term>RECIPIENT TRANSPL</Term>
        <Term>RECIPIENTS TRANSPL</Term>
        <Term>Recipients, Transplant</Term>
        <Term>TRANSPL RECIPIENTS</Term>
        <Codes>
          <Code code="C0376387" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Population_Type_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Marmoset" name="Marmoset">
        <Definition>The common marmoset, Callithrix jacchus.</Definition>
        <Definition>The common marmoset, Callithrix jacchus, is a small primate characterized by a hairless face with a white mark on the forehead and is covered in grey fur with white tufts of hair surrounding its ears. This primate has a life span of 10 years in the wild and 16 years in captivity. The marmoset has claws instead of nails and walks on all four legs. Fully mature 20-24 month old females typically give birth to twins after a 150 day gestational period. The marmoset is genetically similar to humans and is a useful model for studying human diseases such as Lassa fever, multiple sclerosis, and viral infections.</Definition>
        <Definition>A genus of the subfamily CALLITRICHINAE occurring in forests of Brazil and Bolivia and containing seventeen species.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Marmoset</Term>
        <Term>MARMOSET</Term>
        <Term>callithrix</Term>
        <Term>Short-tusked marmoset</Term>
        <Term>Marmoset, Short-Tusked</Term>
        <Term>Marmosets, Short-Tusked</Term>
        <Term>Hapale</Term>
        <Term>Callithrix, NOS</Term>
        <Term>Marmoset, Short Tusked</Term>
        <Term>Callithrix jacchus</Term>
        <Term>Short-Tusked Marmosets</Term>
        <Term>marmoset</Term>
        <Term>marmosets</Term>
        <Term>Marmoset, NOS</Term>
        <Term>Genus Callithrix</Term>
        <Term>Common Marmoset</Term>
        <Term>Cotton-eared Marmoset</Term>
        <Term>Callithrix</Term>
        <Term>Marmosets</Term>
        <Term>Cebuella</Term>
        <Term>Genus Callithrix (organism)</Term>
        <Term>Short-Tusked Marmoset</Term>
        <Codes>
          <Code code="C0006764" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Monkey</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:conference_proceedings" name="conference proceedings">
        <SemanticType code="T073" name="Manufactured Object"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">conference proceedings</Term>
        <Term>Conference Proceedings as Topic</Term>
        <Term>Conferences and Proceedings</Term>
        <Term>Proceedings and Conferences</Term>
        <Codes>
          <Code code="C0009664" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C3H_He_Mouse" name="C3H/He Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C3H/He Mouse</Term>
        <Term>C3H/He</Term>
        <Codes>
          <Code code="C37367" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Infant" name="Infant">
        <Definition>A young child between one month and two years of age.</Definition>
        <Definition>A child between 1 and 23 months of age.</Definition>
        <SemanticType code="T100" name="Age Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Infant</Term>
        <Term>Baby</Term>
        <Term>Infant [Disease/Finding]</Term>
        <Term>infant</Term>
        <Term>Infant (person)</Term>
        <Term>baby</Term>
        <Term>INFANT</Term>
        <Term>infants</Term>
        <Term>Infant child (person)</Term>
        <Term>Infant child</Term>
        <Term>babies</Term>
        <Term>Infants</Term>
        <Term>BABY</Term>
        <Codes>
          <Code code="C0021270" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Age_Groups</Relation>
          <Relation name="Narrower">OTE:Infants_Newborn</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CAST_Ei_Mouse" name="CAST/Ei Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CAST/Ei Mouse</Term>
        <Term>CAST/Ei</Term>
        <Codes>
          <Code code="C14867" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Graft" name="Graft">
        <Definition>A slip of skin or of other tissue for implantation. (NCI)</Definition>
        <Definition>Tissues obtained from a donor or produced artificially that are intended to replace a patient's diseased or injured tissue (i.e., grafts). Grafts used in humans may be of biological origin, obtained from the body of the same person (i.e., autograft), from another person (i.e., allograft), or from a different species (i.e., xenografts); of artificial origin, made from synthetic (e.g., Dacron, ceramic) materials; or made from a combination of natural and synthetic materials, including living elements and synthetic materials developed using bioengineering techniques (i.e., bioartificial). Dedicated grafts for particular tissues are available, including bone, skin, blood vessel, tendon, and dura mater.</Definition>
        <Definition>Tissue or organ transplanted from a donor to a recipient.</Definition>
        <Definition>Organs, tissues, or cells taken from the body for grafting into another area of the same body or into another individual.</Definition>
        <Definition>A solid composed of a piece of skin or other tissue intended for implantation into or on the body.</Definition>
        <Definition>Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body.</Definition>
        <SemanticType code="T122" name="Biomedical or Dental Material"/>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T024" name="Tissue"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Graft</Term>
        <Term>Transplants</Term>
        <Term>Grafting procedure (procedure)</Term>
        <Term>transplanted organ</Term>
        <Term>Graft - Specimen Source Codes</Term>
        <Term>{Transplant}</Term>
        <Term>Graft (substance)</Term>
        <Term>Graft material (attribute)</Term>
        <Term>Grafts</Term>
        <Term>Grafting procedure</Term>
        <Term>graft material</Term>
        <Term>Transplant (body structure)</Term>
        <Term>Graft material</Term>
        <Term>Graft Dosage Form</Term>
        <Term>grafting</Term>
        <Term>Grafting</Term>
        <Term>Graft, NOS</Term>
        <Term>{Graft}</Term>
        <Term>Transplant</Term>
        <Term>GRAFT</Term>
        <Term>{transplant}</Term>
        <Term>GRAFT NOS</Term>
        <Term>155 TRANSPLANTS</Term>
        <Term>Graft procedure, NOS</Term>
        <Term>TRANSPLANTS</Term>
        <Term>transplants</Term>
        <Term>Graft Procedures on the Head</Term>
        <Term>transplanting</Term>
        <Term>Transplant, NOS</Term>
        <Term>transplanted tissue or organ</Term>
        <Term>Grafting - action</Term>
        <Term>Transplanted tissue</Term>
        <Term>transplant</Term>
        <Term>grafts</Term>
        <Term>Grafting procedure, NOS</Term>
        <Term>Grafting - action (qualifier value)</Term>
        <Term>Graft Dose Form</Term>
        <Term>graft procedure</Term>
        <Term>transplanted</Term>
        <Term>graft</Term>
        <Term>Transplanted organ</Term>
        <Codes>
          <Code code="C0181074" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Population_Type_Category</Relation>
          <Relation name="Narrower">OTE:Skin_Graft, OTE:Xenograft, OTE:Allograft, OTE:Autograft, OTE:Coronary_Artery_Graft, OTE:Body_of_Graft</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:overview_of_reviews" name="overview of reviews">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">overview of reviews</Term>
        <Term>overview review</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#overview_of_reviews" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:literature_review</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD1a_antigen" name="CD1a antigen">
        <Definition>T-cell surface glycoprotein CD1a (327 aa, ~37 kDa) is encoded by the human CD1A gene. This protein is involved in the mediation of lipid and glycolipid antigen presentation.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD1a antigen</Term>
        <Term>T6 - T-cell lineage 6</Term>
        <Term>CD1a - Cluster of differentiation antigen 1a</Term>
        <Term>Cluster of diff antigen 1a</Term>
        <Term>Lymphocyte antigen CD1a</Term>
        <Term>Antigen CD1a</Term>
        <Term>CD1a Antigen</Term>
        <Term>Differentiation Antigen CD1-Alpha-3</Term>
        <Term>OKT6 - Ortho Kung T6</Term>
        <Term>Ortho Kung T6</Term>
        <Term>Epidermal Dendritic Cell Marker CD1a</Term>
        <Term>Lymphocyte antigen CD1a (substance)</Term>
        <Term>Leucocyte 6</Term>
        <Term>Cortical Thymocyte Antigen CD1A</Term>
        <Term>CD1a</Term>
        <Term>T-Cell Surface Antigen T6/Leu-6</Term>
        <Term>CD1a Ag</Term>
        <Term>Leukocyte 6</Term>
        <Term>T-Cell Surface Glycoprotein CD1a</Term>
        <Term>hTa1 Thymocyte Antigen</Term>
        <Term>T-cell lineage 6</Term>
        <Term>CD1a - Cluster of diff ag 1a</Term>
        <Term>Cluster of differentiation antigen 1a</Term>
        <Codes>
          <Code code="C0963782" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD1</Relation>
          <Relation name="Narrower">OTE:CD1A1_antigen, OTE:CD1A2_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mus_spretus" name="Mus spretus">
        <Definition>A species of mouse in the Muridae family found in northern Africa, Portugal, Spain, and France.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mus spretus</Term>
        <Term>Western Wild Mouse</Term>
        <Term>Mus spretus (organism)</Term>
        <Term>Algerian Mouse</Term>
        <Term>Algerian mouse</Term>
        <Term>Mus musculus spretus</Term>
        <Codes>
          <Code code="C0999677" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Equidae" name="Equidae">
        <Definition>Taxonomic family which includes horses, zebras, and asses.</Definition>
        <Definition>A family of hoofed MAMMALS consisting of HORSES, donkeys, and zebras. Members of this family are strict herbivores and can be classified as either browsers or grazers depending on how they feed.</Definition>
        <Definition>A family of hoofed mammals consisting of HORSES, asses, donkeys, and zebras. Members of this family are strict herbivores and can be classified as either browsers or grazers depending on how they feed.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Equidae</Term>
        <Term>Horse</Term>
        <Term>Family Equidae (organism)</Term>
        <Term>8A1 FAMILY EQUIDAE - EQUIDS</Term>
        <Term>Family Equidae</Term>
        <Term>FAMILY EQUIDAE - EQUIDS</Term>
        <Codes>
          <Code code="C14313" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Perissodactyla</Relation>
          <Relation name="Narrower">OTE:Horse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BST1_protein_human" name="BST1 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BST1 protein, human</Term>
        <Term>BST-1 protein, human</Term>
        <Term>CD157 antigen, human</Term>
        <Term>bone marrow stromal cell antigen 1 protein, human</Term>
        <Codes>
          <Code code="C1623381" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:bone_marrow_stromal_cell_antigen_1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Receptors_Interleukin-1_Type_II" name="Receptors, Interleukin-1 Type II">
        <Definition>An interleukin-1 receptor subtype that competes with the INTERLEUKIN-1 RECEPTOR TYPE I for binding to INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The interleukin-1 type II receptor appears to lack signal transduction capability. Therefore it may act as a "decoy" receptor that modulates the activity of its ligands. Both membrane-bound and soluble forms of the receptor have been identified.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Receptors, Interleukin-1 Type II</Term>
        <Term>ANTIGENS CD 121B W</Term>
        <Term>Interleukin-1 Receptors Type II</Term>
        <Term>Interleukin 1 Receptor, Type 2</Term>
        <Term>CDw121b Antigens</Term>
        <Term>Interleukin 1 Receptor Type II</Term>
        <Term>Receptors, Interleukin 1 Type II</Term>
        <Term>INTERLEUKIN 001 RECEPTOR TYPE II</Term>
        <Term>CD 121B W ANTIGENS</Term>
        <Term>Interleukin-1 Receptor Type II</Term>
        <Term>Interleukin-1 Receptor, Type 2</Term>
        <Term>RECEPTORS INTERLEUKIN 001 TYPE II</Term>
        <Term>Antigens, CDw121b</Term>
        <Term>Interleukin 1 Receptors Type II</Term>
        <Codes>
          <Code code="C0388580" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:IL1R2_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:double_blind_design" name="double blind design">
        <Definition>A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.  [Double-blind method | MeSH_2014]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">double blind design</Term>
        <Term>double-masked study</Term>
        <Term>double-blind test</Term>
        <Term>double blind designs</Term>
        <Term>double masked designs</Term>
        <Term>double blind trials</Term>
        <Term>double-blind trials</Term>
        <Term>double masked study</Term>
        <Term>double-masked trial</Term>
        <Term>double blind method</Term>
        <Term>double blind tests</Term>
        <Term>double-blind tests</Term>
        <Term>double-blind method</Term>
        <Term>double-blind design</Term>
        <Term>double-masked studies</Term>
        <Term>double-blind designs</Term>
        <Term>double-blind studies</Term>
        <Term>double-masked trials</Term>
        <Term>double-masked designs</Term>
        <Term>double blind study</Term>
        <Term>double masked studies</Term>
        <Term>Research design [1977-1989]</Term>
        <Term>double-masked design</Term>
        <Term>double-blind study</Term>
        <Term>double blind trial</Term>
        <Term>double-masked method</Term>
        <Term>double-blind trial</Term>
        <Term>double blind studies</Term>
        <Term>double blind test</Term>
        <Term>double masked design</Term>
        <Term>double masked trials</Term>
        <Term>double masked trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#double_blind_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:double_blind_clinical_design, OTE:double_blinded_randomized_controlled_trial_, OTE:double_blind_crossover_design, OTE:double_blind_comparison</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD200_protein_mouse" name="CD200 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD200 protein, mouse</Term>
        <Codes>
          <Code code="C1619980" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD200_membrane_glycoprotein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Yucatan_Pig" name="Yucatan Pig">
        <Definition>Originating from Mexico and Central America, this breed has a straight back and no potbelly, short snout, sparse hair coat and medium size ears. The Yucatan pig is slate gray to black in color. Its uses in biomedical research are varied and include diabetes research, cardiovascular research, angiogenesis, and ophthalmological research among others.</Definition>
        <Definition>Originating from Mexico and Central America, this breed has a straight back and no potbelly, short snout, sparse hair coat and medium size ears. The Yucatan pig is slate gray to black in color. Its uses in biomedical research are varied and include diabetes research, cardiovascular research, angiogenesis, and ophthalmological research among others. (NCI)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Yucatan Pig</Term>
        <Term>Mexican Hairless</Term>
        <Term>Yucatan Miniature pig breed (organism)</Term>
        <Term>Yucatan Miniature pig breed</Term>
        <Term>Yucatan</Term>
        <Term>YUCATAN</Term>
        <Term>Yucatan Miniature pig</Term>
        <Codes>
          <Code code="C1269265" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Pig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129P3_JEmsJ_Mouse" name="129P3/JEmsJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129P3/JEmsJ Mouse</Term>
        <Term>129P3/JEmsJ</Term>
        <Codes>
          <Code code="C37328" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DBA_Mouse" name="DBA Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DBA Mouse</Term>
        <Term>DBA Mice</Term>
        <Term>DBA Mice, Inbred</Term>
        <Term>Inbred DBA Mouse</Term>
        <Term>Mice, DBA</Term>
        <Term>Mice, Inbred DBA</Term>
        <Term>Mouse, Inbred DBA</Term>
        <Term>DBA</Term>
        <Term>DBA Mouse, Inbred</Term>
        <Term>Inbred DBA Mice</Term>
        <Term>Mouse, DBA</Term>
        <Codes>
          <Code code="C0025923" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD8alpha_antigen" name="CD8alpha antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD8alpha antigen</Term>
        <Codes>
          <Code code="C0968162" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD8</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SELP_protein_human" name="SELP protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SELP protein, human</Term>
        <Term>CD62P protein, human</Term>
        <Term>selectin-P, human</Term>
        <Codes>
          <Code code="C2742134" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:P_Selectin</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LY75_protein_human" name="LY75 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LY75 protein, human</Term>
        <Term>lymphocyte antigen 75 protein, human</Term>
        <Term>gp200-MR6 protein, human</Term>
        <Term>CD205 antigen, human</Term>
        <Codes>
          <Code code="C1743375" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:DEC-205_receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IFITM1_protein_human" name="IFITM1 protein, human">
        <Definition>Encoded by human IFITM1 Gene (IFN-Induced Transmembrane Protein Family), 125-amino acid 14-kD Interferon-Induced Transmembrane Protein 1 is an IFN-alpha- and -gamma-inducible membrane protein subunit of a multimeric complex involved in antiproliferative and homotypic adhesion signal transduction. IFITM1 Protein appears to demarcate germ cells from somatic neighbors and to mark the onset of germ cell competence. (from LocusLink, Swiss-Prot, OMIM, and NCI)</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IFITM1 protein, human</Term>
        <Term>LEU13 protein, human</Term>
        <Term>CD225 Antigen, human</Term>
        <Term>interferon-induced transmembrane protein 1, human</Term>
        <Codes>
          <Code code="C1312248" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:leu_13_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Pig" name="Pig">
        <Definition>Taxonomic family which includes the domestic pig</Definition>
        <Definition>Subespecie de cerdo doméstico</Definition>
        <Definition>The domestic pig Sus scrofa domestica.</Definition>
        <Definition>any of various stout-bodied short-legged omnivorous mammals (family Suidae) with a thick bristly skin and a long flexible snout; especially a domesticated member of the species (Sus scrofa) that includes the European wild boar.</Definition>
        <Definition>Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA).</Definition>
        <Definition>The domestic pig Sus scrofa domestica. (NCI)</Definition>
        <Definition>Domestic pig subspecies</Definition>
        <Definition>Having to do with or coming from pigs.</Definition>
        <Definition>A species of SWINE, in the family Suidae, comprising a number of subspecies including the domestic pig Sus scrofa domestica.</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Pig</Term>
        <Term>Family Suidae</Term>
        <Term>Boars, Wild</Term>
        <Term>Sus scrofa (organism)</Term>
        <Term>Family Suidae (organism)</Term>
        <Term>Porcine</Term>
        <Term>Suidae</Term>
        <Term>Suinae</Term>
        <Term>8B1 FAMILY SUIDAE</Term>
        <Term>805-806 PORCINE SPECIES</Term>
        <Term>Boar, Wild</Term>
        <Term>boar</Term>
        <Term>swine</Term>
        <Term>Porcine species</Term>
        <Term>Sus scrofa domestica</Term>
        <Term>Mammals, Pigs</Term>
        <Term>Wild pig, NOS</Term>
        <Term>Wild Boar</Term>
        <Term>allergy testing pig</Term>
        <Term>PIG</Term>
        <Term>Sus scrofa Linnaeus, 1758</Term>
        <Term>Family suidae</Term>
        <Term>suid</Term>
        <Term>pigs</Term>
        <Term>allergy testing pig (lab test)</Term>
        <Term>porcine</Term>
        <Term>Porcine Species</Term>
        <Term>Sus scrofa</Term>
        <Term>boars</Term>
        <Term>pig</Term>
        <Term>Feral pig</Term>
        <Term>Subfamily Suinae (organism)</Term>
        <Term>FAMILY SUIDAE</Term>
        <Term>Subfamily Suinae</Term>
        <Term>Wild Boars</Term>
        <Term>wild boar</Term>
        <Term>Pigs</Term>
        <Term>Wild boar</Term>
        <Term>Swine</Term>
        <Term>Suids</Term>
        <Term>PORCINE SPECIES</Term>
        <Term>Suid</Term>
        <Term>Porcine, NOS</Term>
        <Term>Wild pig</Term>
        <Term>Pig (organism)</Term>
        <Codes>
          <Code code="C1135183" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Suidae</Relation>
          <Relation name="Narrower">OTE:Landrace_Pig, OTE:Minipig, OTE:Duroc_Pig, OTE:Hampshire_Pig, OTE:Yucatan_Pig, OTE:Micropig, OTE:Gottingen_Pig, OTE:Hanford_Pig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:death" name="death">
        <Definition>The absence of life or state of being dead. (NCI)</Definition>
        <Definition>Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.</Definition>
        <Definition>cessation of life; permanent cessation of all vital bodily functions.</Definition>
        <Definition>Dead.</Definition>
        <Definition>A permanent cessation of all vital functions: the end of life; can be applied to a whole organism or to a part of an organism. [GOC:mah, ISBN:0877797099]</Definition>
        <Definition>An adverse event resulting in death.</Definition>
        <Definition>A cessation of life that cannot be attributed to a CTCAE term associated with Grade 5.</Definition>
        <Definition>The cessation of life.</Definition>
        <SemanticType code="T040" name="Organism Function"/>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T078" name="Idea or Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">death</Term>
        <Term>Died</Term>
        <Term>Has died</Term>
        <Term>On examination - dead</Term>
        <Term>DEATH</Term>
        <Term>dead</Term>
        <Term>Death NOS</Term>
        <Term>Death (excluding perinatal)</Term>
        <Term>Death [Disease/Finding]</Term>
        <Term>Cessation of life</Term>
        <Term>Adverse Event Associated with Death</Term>
        <Term>Death (event)</Term>
        <Term>Expired</Term>
        <Term>Deceased</Term>
        <Term>DEATHS</Term>
        <Term>Death</Term>
        <Term>Death (finding)</Term>
        <Term>Patient died</Term>
        <Term>has died</Term>
        <Term>deaths</Term>
        <Term>Death (excl perinatal)</Term>
        <Term>deceased</Term>
        <Term>EXPIRED/DEATH</Term>
        <Term>Event Consequence - Death</Term>
        <Term>dies patient</Term>
        <Term>O/E - dead - condition fatal</Term>
        <Term>F-D0 DEATHS</Term>
        <Term>death; found</Term>
        <Term>patient died</Term>
        <Term>Death Adverse Event Not Associated with More Specific CTCAE Term NOS</Term>
        <Term>O/E - dead</Term>
        <Term>died</Term>
        <Term>Patient died (finding)</Term>
        <Term>Death, NOS</Term>
        <Term>On examination - dead (finding)</Term>
        <Term>biological death</Term>
        <Term>DIED</Term>
        <Term>Dead</Term>
        <Codes>
          <Code code="C1306577" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Outcome_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Inbred_Mouse_Strains" name="Inbred Mouse Strains">
        <Definition>Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation.</Definition>
        <Definition>Any strain of mouse that is the product of a mating between close relatives. In biological research, inbreeding allows for the selection of specific genotypes or phenotypes that are of particular importance to the study being carried out.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Inbred Mouse Strains</Term>
        <Term>Inbred Mouse Strain</Term>
        <Term>Strains, Inbred Mouse</Term>
        <Term>Mouse Inbred Strains</Term>
        <Term>Inbred Strains of Mice</Term>
        <Term>Mouse Strain, Inbred</Term>
        <Term>Mice, Inbred Strains</Term>
        <Term>Mouse, Inbred Strain</Term>
        <Term>Inbred Strain of Mouse</Term>
        <Term>Inbred Strain of Mice</Term>
        <Term>Mouse Inbred Strain</Term>
        <Term>Strain, Inbred Mouse</Term>
        <Term>Mouse Strains, Inbred</Term>
        <Term>Inbred Mouse</Term>
        <Codes>
          <Code code="C0025927" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mouse_Strains</Relation>
          <Relation name="Narrower">OTE:FVB_Mouse, OTE:129P4_RrRkJ_Mouse, OTE:CBA_J_Mouse, OTE:129S_SvEv_Mouse, OTE:C57BL_10J_Mouse, OTE:129T2_SvEms_Mouse, OTE:NZB_BlNJ_Mouse, OTE:C3H_He_Mouse, OTE:NZW_LacJ_Mouse, OTE:DDY_Mouse, OTE:NZO_HlLt_Mouse, OTE:129S_Sv_Mouse, OTE:AKR_J_Mouse, OTE:MRL_MpJ_Mouse, OTE:101_Mouse, OTE:A_J_Mouse, OTE:BALB_c_Mouse, OTE:CAST_Ei_Mouse, OTE:BUB_BnJ_Mouse, OTE:C3H_HeJ_Mouse, OTE:129X1_SvJ_Mouse, OTE:A_He_Mouse, OTE:NZC_Mouse, OTE:ALR_Mouse, OTE:129S6_SvEvTac_Mouse, OTE:MOLD_RkJ_Mouse, OTE:C58_J_Mouse, OTE:I_LnJ_Mouse, OTE:C3HeB_FeJ_Mouse, OTE:BALB_cJ_Mouse, OTE:SWR_Mouse, OTE:SPRET_EiJ_Mouse, OTE:129P3_JEmsJ_Mouse, OTE:C57BL_6_Mouse, OTE:SWV_Mouse, OTE:ABH_Mouse, OTE:CBA_Ca_Mouse, OTE:129P2_Ola_Mouse, OTE:LG_J_Mouse, OTE:129S2_SvPas_Mouse, OTE:A_JOlaHsd_Mouse, OTE:BALB_cRl_Mouse, OTE:129P1_ReJ_Mouse, OTE:A2G_Mouse, OTE:SPE_Pas_Mouse, OTE:NOD_Mouse, OTE:O20_A_Mouse, OTE:C57L_Mouse, OTE:129S1_SvImJ_Mouse, OTE:NIH_Mouse, OTE:C57BL_6ByJ_Mouse, OTE:YBR_Ki_Mouse, OTE:SM_J_Mouse, OTE:C57BL_6N_Mouse, OTE:C3H_HeSnJ_Mouse, OTE:C3H_Mouse, OTE:AKR_Mouse, OTE:ST_bJ_Mouse, OTE:C57BL_Ka_Mouse, OTE:C57BL_10ScSnJ_Mouse, OTE:HRS_J_Mouse, OTE:C57BR_Mouse, OTE:BALB_cBy_Mouse, OTE:C57L_J_Mouse, OTE:C57BL_6By_Mouse, OTE:SJL_Mouse, OTE:A_Mouse, OTE:ABP_LeJ_Mouse, OTE:C57BL_10_Mouse, OTE:SF_CamEiJ_Mouse, OTE:PERA_EiJ_Mouse, OTE:A_HeJ_Mouse, OTE:NZW_Mouse, OTE:129S3_SvImJ_Mouse, OTE:129S2_SvPasIco_Mouse, OTE:129P3_J_Mouse, OTE:MOLF_EiJ_Mouse, OTE:DW_J_Mouse, OTE:AEJ_Gn_Mouse, OTE:AKR_N_Mouse, OTE:YBR_Mouse, OTE:DBA_1_Mouse, OTE:NOD_Lt_Mouse, OTE:NOR_Mouse, OTE:C57BL_6JEiJ_Mouse, OTE:B6C3_Mouse, OTE:BALB_cByJ_Mouse, OTE:129P2_SvOla_Mouse, OTE:129S1_Sv_Mouse, OTE:NZB_Mouse, OTE:C57BL_6Pas_Mouse, OTE:LT_SvJ_Mouse, OTE:AU_SsJ_Mouse, OTE:129P1_ReJLacFib_Mouse, OTE:FVB_N_Mouse, OTE:C57BL_Mouse, OTE:RIII_2J_Mouse, OTE:BALB_cHeA_Mouse, OTE:CZECHII_Mouse, OTE:RF_J_Mouse, OTE:RIII_Mouse, OTE:RIIIS_J_Mouse, OTE:129T2_SvEmsJ_Mouse, OTE:CF-1_Mouse, OTE:BTBR_Mouse, OTE:PWK_Mouse, OTE:RBF_DnJ_Mouse, OTE:BTBRTF_Mouse, OTE:C58_Mouse, OTE:BALB_cCrl_Mouse, OTE:DBA_Mouse, OTE:129X1_Sv_Mouse, OTE:C57BLKS_J_Mouse, OTE:P_J_Mouse, OTE:129S5_SvEvBrd_Mouse, OTE:C57BL_6JN_Mouse, OTE:BALB_cAnPt_Mouse, OTE:DBA_2_Mouse, OTE:C3H_HeH_Mouse, OTE:CBA_CaH_Mouse, OTE:DBA_1LacJ_Mouse, OTE:DBA_2N_Mouse, OTE:129P1_Re_Mouse, OTE:SEA_GnJ_Mouse, OTE:C57BL_10SnJ_Mouse, OTE:ICR_Mouse, OTE:101_Rl_Mouse, OTE:SJL_J_Mouse, OTE:129P2_OlaHsd_Mouse, OTE:C57BLKS_Mouse, OTE:129S4_SvJaeSor_Mouse, OTE:B6_129-Trp53tm1Brd_N5, OTE:C57BL_10Sn_Mouse, OTE:BDP_J_Mouse, OTE:129S4_SvJae_Mouse, OTE:NON_Mouse, OTE:CBA_CaJ_Mouse, OTE:NFS_N_Mouse, OTE:C3H_HeOuJ_Mouse, OTE:CE_J_Mouse, OTE:SKH1-Hr_hr, OTE:CBA_N_Mouse, OTE:LP_J_Mouse, OTE:129P4_RrJ_Mouse, OTE:WMP_Mouse, OTE:SKIVE_Mouse, OTE:129S7_SvEvBrd_Mouse, OTE:ICR_BR_Mouse, OTE:DDK_Mouse, OTE:129P4_RrSv_Mouse, OTE:129_Mouse, OTE:SEG_Mouse, OTE:A_WySnJ_Mouse, OTE:129_Sv_Mouse, OTE:Swiss_Webster_Mouse, OTE:C3H_Rl_Mouse, OTE:NOD_LtJ_Mouse, OTE:MA_MyJ_Mouse, OTE:STS_A_Mouse, OTE:PL_J_Mouse, OTE:NMRI_Mouse, OTE:101_H_Mouse, OTE:CAST_EiJ_Mouse, OTE:CASA_RkJ_Mouse, OTE:SWR_J_Mouse, OTE:C57BR_cdJ_Mouse, OTE:DBA_1J_Mouse, OTE:C3H_HeN_Mouse, OTE:MSM_Ms_Mouse, OTE:129P4_Rr_Mouse, OTE:CBA_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ICAM2_protein_human" name="ICAM2 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ICAM2 protein, human</Term>
        <Term>intercellular adhesion molecule-2, human</Term>
        <Term>ICAM-2, human</Term>
        <Term>intercellular adhesion molecule 2, human</Term>
        <Term>CD102 antigen, human</Term>
        <Codes>
          <Code code="C0083027" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ncam1_protein_mouse" name="Ncam1 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ncam1 protein, mouse</Term>
        <Term>NCAM-1 protein, mouse</Term>
        <Term>neural cell adhesion molecule 1 protein, mouse</Term>
        <Codes>
          <Code code="C1569901" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD56</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Inducible_T_Cell_Co_Stimulator_Protein" name="Inducible T Cell Co Stimulator Protein">
        <Definition>A costimulatory receptor that is specific for INDUCIBLE T-CELL CO-STIMULATOR LIGAND. The receptor is associated with a diverse array of immunologically-related effects including the increased synthesis of INTERLEUKIN 10 in REGULATORY T-LYMPHOCYTES and the induction of PERIPHERAL TOLERANCE.</Definition>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Inducible T Cell Co Stimulator Protein</Term>
        <Term>T-Cell Co-Stimulator, Inducible</Term>
        <Term>ICOS Inducible T Cell Co Stimulator</Term>
        <Term>Activation Inducible Lymphocyte Immunomediatory Molecule</Term>
        <Term>CD278 Antigen</Term>
        <Term>Antigens, CD278</Term>
        <Term>Inducible T-Cell Co-Stimulator Protein</Term>
        <Term>Inducible Costimulator (ICOS)</Term>
        <Term>Inducible Co-Stimulator (ICOS)</Term>
        <Term>Inducible T-Cell Co-Stimulator</Term>
        <Term>ICOS Inducible T-Cell Co-Stimulator</Term>
        <Term>CD278 Antigens</Term>
        <Term>Antigen, CD278</Term>
        <Term>Inducible T Cell Co Stimulator</Term>
        <Term>Activation-Inducible Lymphocyte Immunomediatory Molecule</Term>
        <Term>Co-Stimulator, Inducible T-Cell</Term>
        <Codes>
          <Code code="C3203085" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Icos_protein_mouse, OTE:Icos_protein_rat, OTE:ICOS_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD151_antigen_human" name="CD151 antigen, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD151 antigen, human</Term>
        <Term>Tspan24 protein, human</Term>
        <Term>platelet-endothelial cell tetra-span antigen 3, human</Term>
        <Term>antigen SFA-1, human</Term>
        <Term>CD151 protein, human</Term>
        <Term>PETA-3 antigen, human</Term>
        <Codes>
          <Code code="C0389372" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD151</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Killer_Cell_Immunoglobulin_Like_Receptor_3DL1" name="Killer Cell Immunoglobulin Like Receptor 3DL1">
        <Definition>A KIR receptor that has specificity for HLA-B ANTIGENS. It is an inhibitory receptor that contains D0, D1, and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail.</Definition>
        <Definition>Killer cell immunoglobulin-like receptor 3DL1 (444 aa, ~49 kDa) is encoded by the human KIR3DL1 gene. This protein plays a role in the modulation of cell-mediated cytotoxicity.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Killer Cell Immunoglobulin Like Receptor 3DL1</Term>
        <Term>Receptor, NKB1</Term>
        <Term>NKB1 Receptor</Term>
        <Term>CD 158 E ANTIGENS</Term>
        <Term>RECEPTORS KIR 03 DL 01</Term>
        <Term>Receptor, Kirl1</Term>
        <Term>NKB1 Receptors</Term>
        <Term>NK Cell Receptor NKB1</Term>
        <Term>Receptors, KIR3DL1</Term>
        <Term>Receptors, NKB1</Term>
        <Term>KIR3DL1 Receptors</Term>
        <Term>ANTIGENS CD 158 E</Term>
        <Term>Antigens, CD158e</Term>
        <Term>Kirl1 Receptor</Term>
        <Term>CD158e Antigens</Term>
        <Term>Killer Cell Immunoglobulin-Like Receptor 3DL1</Term>
        <Codes>
          <Code code="C1743029" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:KIR3DL1_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Human_Body_Louse" name="Human Body Louse">
        <Definition>Body lice are tiny parasitic insects (Pediculus humanus corporis) that spread through close contact with other people. Body lice may be 2 - 3 mm long, whereas head and public lice are much smaller. They feed on human blood, and they lay their eggs and deposit their fecal matter on the skin (they may also lay their eggs in clothing). Infestation by body lice causes intense itching. When body lice are not feeding on blood, they live in the seams and folds of clothing. Body lice are transmitted by contact with infected clothing and bedding as well as by direct contact with an infected person. Risk factors include close (overcrowded) living conditions, and poor hygiene. (MedlinePlus Medical Encyclopedia)</Definition>
        <SemanticType code="T204" name="Eukaryote"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Human Body Louse</Term>
        <Term>Pediculus nititarum</Term>
        <Term>Pediculus tabescentium</Term>
        <Term>Pediculus humanus corporis</Term>
        <Term>human body louse</Term>
        <Term>pediculus humanus corporis</Term>
        <Term>Pediculus humanus, NOS</Term>
        <Term>pediculus humanus</Term>
        <Term>Body lice</Term>
        <Term>Family Pediculidae</Term>
        <Term>Pediculus humanus (organism)</Term>
        <Term>Pediculus nigrescens</Term>
        <Term>Pediculus humanus humanus</Term>
        <Term>body lice</Term>
        <Term>Body Lice</Term>
        <Term>body louse</Term>
        <Term>human lice</Term>
        <Term>Pediculus albidior</Term>
        <Term>Family Pediculidae (organism)</Term>
        <Term>Pediculus humanus Linnaeus, 1758</Term>
        <Term>Pediculus vestementi</Term>
        <Term>Pediculidae</Term>
        <Term>Lices, Body</Term>
        <Term>Body Louses</Term>
        <Term>louse</Term>
        <Term>Body Louse</Term>
        <Term>Pediculus marginatus</Term>
        <Term>Louses, Body</Term>
        <Term>Pediculus humanus</Term>
        <Term>Louse, Body</Term>
        <Term>pediculidae</Term>
        <Term>Body Lices</Term>
        <Term>Lice, Body</Term>
        <Term>Pediculus corporis</Term>
        <Term>Pediculus corporis - body lice</Term>
        <Term>Body louse</Term>
        <Term>Pediculus chinensis</Term>
        <Term>primate body lice</Term>
        <Term>lice</Term>
        <Term>head lice</Term>
        <Term>Family: Pediculidae</Term>
        <Term>human body lice</Term>
        <Codes>
          <Code code="C34906" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Lice</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD4_S1_peptide" name="CD4 S1 peptide">
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD4 S1 peptide</Term>
        <Codes>
          <Code code="C0217710" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD4</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ARS_protein_human" name="ARS protein, human">
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ARS protein, human</Term>
        <Term>ANUP protein, human</Term>
        <Term>SLURP-1 protein, human</Term>
        <Term>ARS component B protein, human</Term>
        <Term>SLURP1 protein, human</Term>
        <Term>antineoplastic urinary protein, human</Term>
        <Codes>
          <Code code="C0526090" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:TNFRSF9_protein_human" name="TNFRSF9 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">TNFRSF9 protein, human</Term>
        <Term>tumor necrosis factor receptor superfamily, member 9, human</Term>
        <Term>4-1BB receptor, human</Term>
        <Codes>
          <Code code="C0247111" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD137</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:alpha_Fetoproteins" name="alpha Fetoproteins">
        <Definition>A protein normally produced by a fetus. AFP levels are usually undetectable in the blood of healthy adult men or women (who are not pregnant). An elevated level of AFP suggests the presence of either a primary liver cancer or germ cell tumor.</Definition>
        <Definition>class of embryonic serum alpha globulins which appear in early development; in adult serum, the presence of AFP indicates certain pathologic states, especially liver neoplasms.</Definition>
        <Definition>Alpha-fetoprotein is a major plasma protein produced by the yolk sac and the liver during fetal life. Alpha-fetoprotein expression in adults is often associated with hepatoma or teratoma. However, hereditary persistence of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the alpha-fetoprotein and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. Alpha-fetoprotein is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin. The level of alpha-fetoprotein in amniotic fluid is used to measure renal loss of protein to screen for spina bifida and anencephaly. (from LocusLink)</Definition>
        <Definition>The determination of the amount of alpha-fetoprotein present in a sample.</Definition>
        <Definition>A measurement of the alpha fetoprotein in a biological specimen.</Definition>
        <Definition>The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life.</Definition>
        <Definition>This gene plays a role in fetal progression.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">alpha Fetoproteins</Term>
        <Term>Alpha-1-Fetoprotein Measurement</Term>
        <Term>AFP - Alpha-fetoprotein</Term>
        <Term>AFP measurement</Term>
        <Term>alpha-Fetoproteins [Chemical/Ingredient]</Term>
        <Term>alpha Foetoprotein</Term>
        <Term>Alpha Fetoprotein measurement</Term>
        <Term>alpha Fetoprotein (substance)</Term>
        <Term>alpha foetoprotein</Term>
        <Term>alpha-Fetoprotein</Term>
        <Term>alpha Fetoprotein</Term>
        <Term>alpha fetoprotein testing</Term>
        <Term>Alpha-fetoprotein Measurement</Term>
        <Term>alpha fetoprotein</Term>
        <Term>alpha fetoproteins</Term>
        <Term>Alpha Foetoprotein measurement</Term>
        <Term>ALPHA-FETOPROTEIN</Term>
        <Term>alpha-fetoprotein</Term>
        <Term>Alpha-1-Fetoprotein measurement</Term>
        <Term>Fetuin (substance)</Term>
        <Term>Fetuins</Term>
        <Term>AFP Gene</Term>
        <Term>AFP gene</Term>
        <Term>Test;alpha fetoprotein</Term>
        <Term>Alpha-1-Fetoprotein</Term>
        <Term>Alpha 1 foetoprotein</Term>
        <Term>Alpha-fetoprotein</Term>
        <Term>Alphafoetoprotein</Term>
        <Term>Alpha-1-Foetoprotein measurement</Term>
        <Term>Alpha one fetoprotein (AFP) test</Term>
        <Term>alpha fetoprotein test</Term>
        <Term>Alpha Fetoprotein</Term>
        <Term>Alpha 1 fetoprotein</Term>
        <Term>alpha-fetoprotein (AFP)</Term>
        <Term>alpha-Fetoproteins</Term>
        <Term>Alpha fetoproteins</Term>
        <Term>Alpha-Fetoprotein</Term>
        <Term>Alpha-Fetoprotein Gene</Term>
        <Term>Alpha one fetoprotein measurement</Term>
        <Term>Alpha-1-Fetoprotein measurement (procedure)</Term>
        <Term>Alpha Fetoproteins</Term>
        <Term>Alpha-Fetoglobulin</Term>
        <Term>AFP</Term>
        <Term>fetuin</Term>
        <Term>Fetuin</Term>
        <Term>FETA</Term>
        <Term>Alpha-fetoprotein (AFP)</Term>
        <Term>Alphafetoprotein</Term>
        <Codes>
          <Code code="C1367597" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
          <Relation name="Narrower">OTE:asialofetuin_12_peptide, OTE:Ep_459-asialofetuin_conjugate, OTE:asialofetuin_21-45_peptide, OTE:alpha-fetoprotein_related_protein_mouse, OTE:asialofetuin, OTE:P149_protein_human, OTE:asialofetuin_69-28_peptide, OTE:AFP_protein_human, OTE:asialofetuin-polylysine-5_-uridine_monophosphate_conjugate, OTE:asialofetuin-DTPA_complex, OTE:threonyl-leucyl-histidine-N-methylamide, OTE:polyethylene_glycol-asialofetuin_complex, OTE:embryonin, OTE:alpha-Fetoprotein_Deficiency, OTE:growth_inhibitory_peptide-34_human, OTE:Afp_protein_rat, OTE:AFPep_peptide</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129S5_SvEvBrd_Mouse" name="129S5/SvEvBrd Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129S5/SvEvBrd Mouse</Term>
        <Term>129S5/SvEvBrd</Term>
        <Codes>
          <Code code="C37342" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mouse" name="Mouse">
        <Definition>the scientific name of the common house mouse; for inbred and mutant strain mice used in research, use LABORATORY MOUSE or narrower terms.</Definition>
        <Definition>mouse that has been bred or acquired for the purpose of being a research subject in a facility where scientific research and experiments are conducted.</Definition>
        <Definition>The common house mouse, often used as an experimental organism.</Definition>
        <Definition>Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae. (NCI)</Definition>
        <Definition>Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae.</Definition>
        <Definition>The common name for the genus Mus.</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T015" name="Mammal"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mouse</Term>
        <Term>Mice, Laboratory</Term>
        <Term>laboratory mice</Term>
        <Term>Old World mouse</Term>
        <Term>Common house mouse</Term>
        <Term>mice</Term>
        <Term>Mouse, Laboratory</Term>
        <Term>Mouse (organism)</Term>
        <Term>mouse</Term>
        <Term>mouse, mice</Term>
        <Term>Murine</Term>
        <Term>Mouse, laboratory</Term>
        <Term>Laboratory mouse</Term>
        <Term>laboratory mouse</Term>
        <Term>allergy testing mouse</Term>
        <Term>Mouse antigen</Term>
        <Term>House Mice</Term>
        <Term>house mouse</Term>
        <Term>Laboratory Mouse</Term>
        <Term>Mice</Term>
        <Term>Laboratory mice</Term>
        <Term>Laboratory mouse (organism)</Term>
        <Term>Mus musculus</Term>
        <Term>mus</Term>
        <Term>Genus Mus (organism)</Term>
        <Term>House Mouse</Term>
        <Term>Mus musculus (organism)</Term>
        <Term>allergy testing mouse (lab test)</Term>
        <Term>Genus Mus</Term>
        <Term>Mouse, NOS</Term>
        <Term>Mouse, House</Term>
        <Term>MOUSE</Term>
        <Term>Old World mouse (organism)</Term>
        <Term>Laboratory Mice</Term>
        <Term>Mus musculus Linnaeus, 1758</Term>
        <Term>House mouse</Term>
        <Term>Mus</Term>
        <Term>Mammals, Mice</Term>
        <Term>house mice</Term>
        <Term>mus musculus</Term>
        <Term>Mice, House</Term>
        <Term>House mice</Term>
        <Codes>
          <Code code="C0025929" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Muridae</Relation>
          <Relation name="Narrower">OTE:Mus_musculus, OTE:Mouse_Strains, OTE:Mus_spretus</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SIGNR3_protein_mouse" name="SIGNR3 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SIGNR3 protein, mouse</Term>
        <Term>CD209d antigen, mouse</Term>
        <Term>SIGN-R3 protein, mouse</Term>
        <Codes>
          <Code code="C1530410" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NK_Cell_Lectin_Like_Receptor_Subfamily_K_Member_1" name="NK Cell Lectin Like Receptor Subfamily K, Member 1">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NK Cell Lectin Like Receptor Subfamily K, Member 1</Term>
        <Term>NKG2D Receptor</Term>
        <Term>Killer Cell Lectin Like Receptor Subfamily K, Member 1</Term>
        <Term>NKG2 D Receptor</Term>
        <Term>Receptor, NKG2-D</Term>
        <Term>Antigen, CD314</Term>
        <Term>NK Cell Lectin-Like Receptor Subfamily K, Member 1</Term>
        <Term>NK Cell Receptor D</Term>
        <Term>Killer Cell Lectin-Like Receptor Subfamily K, Member 1</Term>
        <Term>NKG2-D Receptor</Term>
        <Term>Receptor, NKG2D</Term>
        <Term>CD314 Antigen</Term>
        <Codes>
          <Code code="C2350498" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_K</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly49I_antigen" name="Ly49I antigen">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly49I antigen</Term>
        <Codes>
          <Code code="C0917648" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
          <Relation name="Narrower">OTE:Ly49i2_protein_rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Aged_80_and_over" name="Aged, 80 and over">
        <Definition>A person 80 years of age and older.</Definition>
        <SemanticType code="T100" name="Age Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Aged, 80 and over</Term>
        <Term>Oldest Old</Term>
        <Term>AGED 80</Term>
        <Codes>
          <Code code="C0001795" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Aged</Relation>
          <Relation name="Narrower">OTE:Nonagenarians, OTE:Octogenarians, OTE:Centenarians</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Language_Slot" name="Language Slot">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Language Slot</Term>
        <Relations>
          <Relation name="Broader">OTE:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CDw17_antigen" name="CDw17 antigen">
        <SemanticType code="T118" name="Carbohydrate"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CDw17 antigen</Term>
        <Term>Cluster of differentiation antigen (workshop) 17 (substance)</Term>
        <Term>lactosylceramide</Term>
        <Term>ceramide lactoside</Term>
        <Term>Lactosylceramide</Term>
        <Term>cytolipin H</Term>
        <Term>CDw17 - Cluster of differentiation antigen (workshop) 17</Term>
        <Term>Clust of diff ag (workshop) 17</Term>
        <Term>Ceramide, 1-O-(4-O-beta-D-galactopyranosyl-beta-glucopyranosyl)-</Term>
        <Term>CDw17-Clus diff ag workshop 17</Term>
        <Term>Cluster of differentiation antigen (workshop) 17</Term>
        <Term>N-lignoceroyl-1-sphingosyl lactoside</Term>
        <Codes>
          <Code code="C0383881" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SPRET_EiJ_Mouse" name="SPRET/EiJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SPRET/EiJ Mouse</Term>
        <Term>SPRET/EiJ</Term>
        <Codes>
          <Code code="C37440" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FCER2_protein_human" name="FCER2 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FCER2 protein, human</Term>
        <Term>CLEC4J protein, human</Term>
        <Term>Fc fragment of IgE, low affinity II, receptor for (CD23) protein, humna</Term>
        <Codes>
          <Code code="C2744538" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD23</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ITGA2B_protein_human" name="ITGA2B protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ITGA2B protein, human</Term>
        <Term>glycoprotein II, human</Term>
        <Term>platelet membrane glycoprotein IIb, human</Term>
        <Term>GP II glycoprotein, human</Term>
        <Term>integrin, alpha 2b protein, human</Term>
        <Term>integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) protein, human</Term>
        <Term>CD41B antigen, human</Term>
        <Term>platelet glycoprotein IIb of IIb/IIIa complex, human</Term>
        <Term>GP2B protein, human</Term>
        <Codes>
          <Code code="C0061671" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Integrin_alpha2</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:human_study" name="human study">
        <Definition>index on all projects using human subjects, except those where other human terms can be substituted; prior to FY 1993 this term was subdivided into CLINICAL (1465-2234) and NONCLINICAL (1465-2800).</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">human study</Term>
        <Term>human experiments</Term>
        <Term>humans studies</Term>
        <Term>human subjects</Term>
        <Term>human studies</Term>
        <Term>human subject</Term>
        <Term>human experiment</Term>
        <Term>human studying</Term>
        <Term>study human</Term>
        <Codes>
          <Code code="C0178693" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Study_Design_Slot" name="Study Design Slot">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Study Design Slot</Term>
        <Relations>
          <Relation name="Broader">OTE:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BL_10Sn_Mouse" name="C57BL/10Sn Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BL/10Sn Mouse</Term>
        <Term>C57BL/10Sn</Term>
        <Codes>
          <Code code="C37379" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Caenorhabditis_elegans" name="Caenorhabditis elegans">
        <Definition>A roundworm of the phylum Nematoda often utilized as a biological model system for research.</Definition>
        <Definition>roundworm important research model in animal biology, especially for the genetic and molecular basis of development and behavior.</Definition>
        <Definition>A species of nematode that is widely used in biological, biochemical, and genetic studies.</Definition>
        <Definition>parasitic roundworm; important research model in animal biology, especially for the genetic and molecular basis of development and behavior.</Definition>
        <SemanticType code="T204" name="Eukaryote"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Caenorhabditis elegans</Term>
        <Term>Rhabditis elegans Maupas, 1900</Term>
        <Term>Caenorhabditis elegan</Term>
        <Term>caenorhabditis elegan</Term>
        <Term>Caenorhabditis elegans (organism)</Term>
        <Term>Rhabditis elegans</Term>
        <Term>elegans, Caenorhabditis</Term>
        <Term>c elegans</Term>
        <Term>caenorhabditis elegans</Term>
        <Term>roundworm &lt;Caenorhabditis elegans&gt;</Term>
        <Term>C ELEGANS</Term>
        <Term>C elegans</Term>
        <Term>C. elegans</Term>
        <Term>elegan, Caenorhabditis</Term>
        <Term>roundworm</Term>
        <Term>Caenorhabditis elegans (Maupas, 1900)</Term>
        <Codes>
          <Code code="C0162610" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Nematoda</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly6A-4_antigen_mouse" name="Ly6A-4 antigen, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly6A-4 antigen, mouse</Term>
        <Codes>
          <Code code="C1571462" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly6a_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:biography" name="biography">
        <Definition>Works consisting of an account of the events, works, and achievements, personal and professional, during a person's life. It includes articles on the activities and accomplishments of living persons as well as the presentation of an obituary.[MeSH_2014]</Definition>
        <Definition>Works consisting of an account of the events, works, and achievements, personal and professional, during a person's life. It includes articles on the activities and accomplishments of living persons as well as the presentation of an obituary.</Definition>
        <Definition>Recorded account of a person's life.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">biography</Term>
        <Term>obituaries</Term>
        <Term>bibliographies</Term>
        <Term>Biobibliography</Term>
        <Term>Autobiography</Term>
        <Term>Biography</Term>
        <Term>biographies</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#biography" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CDw92_antigen" name="CDw92 antigen">
        <Definition>Choline transporter-like protein 1 (657 aa, ~73 kDa) is encoded by the human SLC44A1 gene. This protein plays a role in choline transport.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CDw92 antigen</Term>
        <Term>CD92 Antigen</Term>
        <Term>Solute Carrier Family 44 Member 1</Term>
        <Term>CDw92</Term>
        <Term>Solute Carrier Family 44, Member 1</Term>
        <Term>Choline Transporter-Like Protein 1</Term>
        <Term>RP11-287A8.1</Term>
        <Term>CDW92 Antigen</Term>
        <Codes>
          <Code code="C1099413" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD2</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ICAM-2_protein_mouse" name="ICAM-2 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ICAM-2 protein, mouse</Term>
        <Codes>
          <Code code="C1433179" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Satellite_Imagery" name="Satellite Imagery">
        <Definition>Composition of images of EARTH or other planets from data collected during SPACE FLIGHT by remote sensing instruments onboard SPACECRAFT. The satellite sensor systems measure and record absorbed, emitted, or reflected energy across the spectra, as well as global position and time.</Definition>
        <SemanticType code="T068" name="Human-caused Phenomenon or Process"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Satellite Imagery</Term>
        <Term>Satellite Imageries</Term>
        <Term>Imageries, Satellite</Term>
        <Term>Imagery, Satellite</Term>
        <Codes>
          <Code code="C3658365" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Remote_Sensing_Technology</Relation>
          <Relation name="Narrower">OTE:Moderate_Resolution_Imaging_Spectroradiometer</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CASA_RkJ_Mouse" name="CASA/RkJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CASA/RkJ Mouse</Term>
        <Term>CASA/RkJ</Term>
        <Codes>
          <Code code="C37393" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Centenarians" name="Centenarians">
        <Definition>elderly or aged humans of the age 100 or above; also index with appropriate human and clinical research terms.</Definition>
        <SemanticType code="T100" name="Age Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Centenarians</Term>
        <Term>100+ years old</Term>
        <Term>centenarians</Term>
        <Term>centenarian</Term>
        <Term>centenarian human (100+)</Term>
        <Term>Centenarian</Term>
        <Codes>
          <Code code="C0007667" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Aged_80_and_over</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:KLRK1_protein_human" name="KLRK1 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">KLRK1 protein, human</Term>
        <Term>CD314 antigen, human</Term>
        <Term>killer cell lectin-like receptor subfamily K, member 1 protein, human</Term>
        <Term>NKG2-D protein, human</Term>
        <Term>NKG2D protein, human</Term>
        <Codes>
          <Code code="C1721209" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_K</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Publication_Type_Slot" name="Publication Type Slot">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Publication Type Slot</Term>
        <Relations>
          <Relation name="Broader">OTE:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:non-equivalent_control_group_design" name="non-equivalent control group design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">non-equivalent control group design</Term>
        <Term>non-equivalent control group designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#non-equivalent_control_group_designs" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:non-randomized_clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NT5C1A_protein_human" name="NT5C1A protein, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NT5C1A protein, human</Term>
        <Term>5'-nucleotidase, cytosolic IA protein, human</Term>
        <Codes>
          <Code code="C2973302" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-Nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:phase_IV_trial" name="phase IV trial">
        <Definition>After a treatment has been approved and is being marketed, it is studied in a phase IV trial to evaluate side effects that were not apparent in the phase III trial. Thousands of people are involved in a phase IV trial. [NCIT_14.08d]</Definition>
        <Definition>A randomized, controlled trial that is designed to evaluate the long-term safety and efficacy of a drug for a given indication. Often they are designed to study side effects that may have become apparent after the phase III study was completed. [NCIT_14.08d]</Definition>
        <Definition>Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drug's risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [After FDA CDER Handbook, ICH E8] [Contributing Source_CDISC] [NCIT_14.08d]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">phase IV trial</Term>
        <Term>Clinical Trial, Phase IV</Term>
        <Term>Phase 4 Study</Term>
        <Term>phase IV clinical trial</Term>
        <Term>Phase 4 Studies</Term>
        <Term>Trial Phase 4</Term>
        <Term>Phase IV Clinical Trials</Term>
        <Term>Clinical Trials, Phase IV</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#phase_IV_trial" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:growth_inhibitory_peptide-34_human" name="growth inhibitory peptide-34, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">growth inhibitory peptide-34, human</Term>
        <Term>GIP-34 peptide, human</Term>
        <Codes>
          <Code code="C2975076" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd164_protein_rat" name="Cd164 protein, rat">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd164 protein, rat</Term>
        <Term>Cd164 antigen, rat</Term>
        <Term>endolyn protein, rat</Term>
        <Codes>
          <Code code="C1571499" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD164</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:flt3_protein_zebrafish" name="flt3 protein, zebrafish">
        <SemanticType code="T126" name="Enzyme"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">flt3 protein, zebrafish</Term>
        <Term>FMS-like tyrosine kinase 3 protein, zebrafish</Term>
        <Codes>
          <Code code="C3849931" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:fms_Like_Tyrosine_Kinase_3</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin-6_Receptor_alpha_Subunit" name="Interleukin-6 Receptor alpha Subunit">
        <Definition>Interleukin-6 receptor subunit alpha (468 aa, 52 kD) is a cell division process protein that is encoded by the human IL6R gene and has roles in multicellular organismal development, immune repsonse, cell proliferation and signal transduction.</Definition>
        <Definition>A low affinity interleukin-6 receptor subunit that combines with the CYTOKINE RECEPTOR GP130 to form a high affinity receptor for INTERLEUKIN-6.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin-6 Receptor alpha Subunit</Term>
        <Term>CD 126 ANTIGENS</Term>
        <Term>CD126 Antigens</Term>
        <Term>Interleukin 6 Receptor alpha Subunit</Term>
        <Term>Receptor, CD126</Term>
        <Term>CD126 Receptor</Term>
        <Term>INTERLEUKIN 006 RECEPTOR ALPHA SUBUNIT</Term>
        <Term>Antigens, CD126</Term>
        <Term>ANTIGENS CD 126</Term>
        <Codes>
          <Code code="C1512849" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD28_Antigen" name="CD28 Antigen">
        <Definition>Costimulatory T-LYMPHOCYTE receptors that have specificity for CD80 ANTIGEN and CD86 ANTIGEN. Activation of this receptor results in increased T-cell proliferation, cytokine production and promotion of T-cell survival.</Definition>
        <Definition>This gene plays several roles in cellular functions specific to the T-cell.</Definition>
        <Definition>T-Cell specific surface glycoprotein CD28 (220 aa, 25 kD) is a cell fate protein that is encoded by the human CD28 gene and has roles in regulation of apoptosis and humoral immune response.</Definition>
        <Definition>T lymphocyte surface molecule; involved in T cell activation and IL2 production.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD28 Antigen</Term>
        <Term>T-Cell-Specific Surface Glycoprotein CD28</Term>
        <Term>CD28 - Cluster of diff ag 28</Term>
        <Term>CD28 Gene</Term>
        <Term>Lymphocyte antigen CD28</Term>
        <Term>T-cell-specific surface glycoprotein</Term>
        <Term>CD28 Antigen (Tp44) Gene</Term>
        <Term>CD28 Antigens</Term>
        <Term>TP44 Receptor</Term>
        <Term>CD28 antigen</Term>
        <Term>CD28 gene</Term>
        <Term>ANTIGENS CD 028</Term>
        <Term>T-Cell Specific Surface Glycoprotein CD28</Term>
        <Term>ANTIGEN CD28</Term>
        <Term>Cluster of diff antigen 28</Term>
        <Term>Antigens, CD28</Term>
        <Term>T Cell Specific Surface Glycoprotein CD28</Term>
        <Term>Antigens, CD28 [Chemical/Ingredient]</Term>
        <Term>T-CELL ANTIGEN CD28</Term>
        <Term>CD 028 ANTIGENS</Term>
        <Term>T90/44</Term>
        <Term>Tp44</Term>
        <Term>Receptor, TP44</Term>
        <Term>Cluster of differentiation antigen 28</Term>
        <Term>CD28 - Cluster of differentiation antigen 28</Term>
        <Term>Antigen, CD28</Term>
        <Term>T-Cell Antigen CD28</Term>
        <Term>CD28</Term>
        <Term>CD28 molecule</Term>
        <Term>Lymphocyte antigen CD28 (substance)</Term>
        <Codes>
          <Code code="C1332709" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Vstm3_protein_rat, OTE:CD28h_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ctla4_protein_mouse" name="Ctla4 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ctla4 protein, mouse</Term>
        <Term>Cd152 protein, mouse</Term>
        <Term>cytotoxic T-lymphocyte-associated protein 4, mouse</Term>
        <Codes>
          <Code code="C2350359" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Cytotoxic_T_Lymphocyte_Antigen_4</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD28h_protein_human" name="CD28h protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD28h protein, human</Term>
        <Codes>
          <Code code="C3713075" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD28_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Nonagenarians" name="Nonagenarians">
        <SemanticType code="T100" name="Age Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Nonagenarians</Term>
        <Term>Nonagenarian</Term>
        <Term>nonagenarian</Term>
        <Codes>
          <Code code="C0028296" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Aged_80_and_over</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NZR_Rat_Strain" name="NZR, Rat Strain">
        <Definition>Tumors (atriocaval epithelial mesotheliomas) of right atrium or inferior vena cava occur in approximately 12-20% of animals of both sexes over 1 year. These tumors are slow growing, but apparently malignant, and closely resemble similar tumors found in humans (Goodall et al 1975). In a later study, most common neoplasms of animal over one year of age: atrioclaval mesotheliomas 12%, lung adenomas 10% (males), pituitary adenomas 23%, mammary tumors 7%, liver tumors 3%, cervical tumors 3% (in females) (Goodall and Doesburg 1981).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NZR, Rat Strain</Term>
        <Codes>
          <Code code="C14411" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly11_protein_mouse" name="Ly11 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly11 protein, mouse</Term>
        <Term>lymphocyte antigen 11, mouse</Term>
        <Codes>
          <Code code="C2351658" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DONRYU_Rat_Strain" name="DONRYU, Rat Strain">
        <Definition>DONRYU: Spontaneous tumors 74% in males at 120-weeks, mostly pituitary adenomas, pheochromocytomas and insulinomas. In females incidence 89%, mostly uterine adenocarcinomas, mammary fibroadenomas and pituitary adenomas.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DONRYU, Rat Strain</Term>
        <Codes>
          <Code code="C14399" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Carnivora" name="Carnivora">
        <Definition>An order of MAMMALS, usually flesh eaters with appropriate dentition. Suborders include the terrestrial carnivores Fissipedia, and the aquatic carnivores PINNIPEDIA.</Definition>
        <Definition>A diverse taxonomic order of placental mammals that includes bears, dogs, cats, and ferrets. Carnivora are primarily meat eaters, however bears are omnivorous and herbivorous pandas may consume fish and insects.</Definition>
        <Definition>have 4 or 5 clawed toes, mobile limbs, carnassal molars, bihorned uterus; primarily eat flesh; can be terrestrial or aquatic.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <SemanticType code="T008" name="Animal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Carnivora</Term>
        <Term>Order Carnivora (organism)</Term>
        <Term>carnivore</Term>
        <Term>Order Carnivora</Term>
        <Term>carnivora</Term>
        <Term>carnivores</Term>
        <Term>ORDER CARNIVORA - FLESH-EATERS</Term>
        <Term>88 ORDER CARNIVORA - FLESH-EATERS</Term>
        <Term>Carnivore (organism)</Term>
        <Term>Carnivore</Term>
        <Codes>
          <Code code="C79104" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mammalia</Relation>
          <Relation name="Narrower">OTE:Felidae, OTE:Canidae, OTE:Mustelidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Rat" name="Rat">
        <Definition>The common name for the genus Rattus.</Definition>
        <Definition>The common rat, Rattus norvegicus, often used as an experimental organism.</Definition>
        <Definition>Any one of several species in the genus Rattus.</Definition>
        <Definition>The common name for the species Rattus norvegicus.</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Rat</Term>
        <Term>RAT</Term>
        <Term>rats</Term>
        <Term>Norway Rat</Term>
        <Term>rattus</Term>
        <Term>Mammals, Rats</Term>
        <Term>Brown rat</Term>
        <Term>Rattus norvegicus (organism)</Term>
        <Term>Rattus sp. strain Wistar</Term>
        <Term>Wild rat</Term>
        <Term>Rattus</Term>
        <Term>Genus Rattus</Term>
        <Term>brown rat</Term>
        <Term>Rat, NOS</Term>
        <Term>Old World rat</Term>
        <Term>norway rat</Term>
        <Term>allergy testing rat (lab test)</Term>
        <Term>rat</Term>
        <Term>Genus Rattus (organism)</Term>
        <Term>Rat (organism)</Term>
        <Term>Norway Rats</Term>
        <Term>allergy testing rat</Term>
        <Term>Norway rat</Term>
        <Term>Rattus norvegicus</Term>
        <Term>Rats</Term>
        <Term>Rats, Norway</Term>
        <Codes>
          <Code code="C14266" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Muridae</Relation>
          <Relation name="Narrower">OTE:Common_Rattus_Norvegicus_Strains, OTE:Rat_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MUC1_protein_human" name="MUC1 protein, human">
        <SemanticType code="T130" name="Indicator, Reagent, or Diagnostic Aid"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MUC1 protein, human</Term>
        <Term>CD227 antigen, human</Term>
        <Term>epithelial tumor antigen, H23, human</Term>
        <Term>MUC-1 H23 protein, human</Term>
        <Term>sialated carbohydrate antigen KL-6, human</Term>
        <Term>eta H23 protein, human</Term>
        <Term>Krebs von den Lungen-6 protein, human</Term>
        <Term>BCAA DF3 protein, human</Term>
        <Term>DF3 antigen, human</Term>
        <Term>KL-6 antigen, human</Term>
        <Term>breast tumor-associated antigen H23, human</Term>
        <Term>breast carcinoma-associated antigen DF3, human</Term>
        <Term>breast cancer epithelial tumor antigen, H23, human</Term>
        <Term>KL6 antigen, human</Term>
        <Term>mucin 1, transmembrane protein, human</Term>
        <Codes>
          <Code code="C1612111" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CA-15-3_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Organ_Transplantation" name="Organ Transplantation">
        <Definition>A surgical procedure in which tissue or an organ is transferred from one area of a person's body to another area, or from one person (the donor) to another person (the recipient).</Definition>
        <Definition>Transference of an organ between individuals of the same species or between individuals of different species.</Definition>
        <Definition>Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.</Definition>
        <Definition>&lt;p&gt;You may need an organ transplant if one of your organs has failed. This can happen because of illness or injury. When you have an organ transplant, doctors remove an organ from another person and place it in your body. The organ may come from a living donor or a donor who has died.&lt;/p&gt;&lt;p&gt;The organs that can be transplanted include&lt;/p&gt;&lt;ul&gt;&lt;li&gt; &lt;a href='http://www.nlm.nih.gov/medlineplus/hearttransplantation.html'&gt;Heart&lt;/a&gt; &lt;/li&gt;&lt;li&gt; Intestine &lt;/li&gt;&lt;li&gt; &lt;a href='http://www.nlm.nih.gov/medlineplus/kidneytransplantation.html'&gt;Kidney&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &lt;a href='http://www.nlm.nih.gov/medlineplus/livertransplantation.html'&gt;Liver&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &lt;a href='http://www.nlm.nih.gov/medlineplus/lungtransplantation.html'&gt;Lung&lt;/a&gt; &lt;/li&gt;&lt;li&gt; &lt;a href='http://www.nlm.nih.gov/medlineplus/pancreastransplantation.html'&gt;Pancreas&lt;/a&gt; &lt;/li&gt;&lt;/ul&gt;&lt;p&gt;You often have to wait a long time for an organ transplant. Doctors must match donors to recipients to reduce the risk of transplant rejection. Rejection happens when your immune system attacks the new organ. If you have a transplant, you must take drugs the rest of your life to help keep your body from rejecting the new organ.&lt;/p&gt;</Definition>
        <Definition>The transfer of an organ (or part of one) from one body to another, for the purpose of replacing the recipient's damaged or failing organ with a working one from the donor. Donors can be living, or cadaveric (dead).</Definition>
        <Definition>Tissue or organ transplanted from a donor to a recipient.</Definition>
        <Definition>Organs, tissues, or cells taken from the body for grafting into another area of the same body or into another individual.</Definition>
        <Definition>Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body.</Definition>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T024" name="Tissue"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Organ Transplantation</Term>
        <Term>Transplants</Term>
        <Term>Clinical, Transplantation, Organ</Term>
        <Term>{Transplant}</Term>
        <Term>Organ Grafting</Term>
        <Term>organ grafting</Term>
        <Term>Transplant (body structure)</Term>
        <Term>grafting</Term>
        <Term>Organ Transplantations</Term>
        <Term>Grafting Procedure</Term>
        <Term>Transplantation</Term>
        <Term>GRAFT</Term>
        <Term>organs transplants</Term>
        <Term>organ transplant</Term>
        <Term>155 TRANSPLANTS</Term>
        <Term>Organ Graft</Term>
        <Term>organs transplanted</Term>
        <Term>TRANSPLANTS</Term>
        <Term>Transplanted organ, NOS</Term>
        <Term>Organ Grafts</Term>
        <Term>Transplanted Organs</Term>
        <Term>Transplant, NOS</Term>
        <Term>transplanted tissue or organ</Term>
        <Term>Graft</Term>
        <Term>Transplant Procedure</Term>
        <Term>Transplantation, Organ</Term>
        <Term>Transplantation Surgery</Term>
        <Term>Organ transplant</Term>
        <Term>Transplants (Organ)</Term>
        <Term>Grafts, Organ</Term>
        <Term>transplanted</Term>
        <Term>graft</Term>
        <Term>Organ Transplant</Term>
        <Term>TRANSPL ORGAN</Term>
        <Term>transplanted organ</Term>
        <Term>Transplantations, Organ</Term>
        <Term>Organ Transplants</Term>
        <Term>Grafts</Term>
        <Term>Graft, NOS</Term>
        <Term>Organ Graftings</Term>
        <Term>organ transplantations</Term>
        <Term>transplant organ</Term>
        <Term>Transplant</Term>
        <Term>Organ transplant NOS</Term>
        <Term>{transplant}</Term>
        <Term>Grafting, Organ</Term>
        <Term>Transplants, Organ</Term>
        <Term>Transplant, Organ</Term>
        <Term>Graft, Organ</Term>
        <Term>transplantation</Term>
        <Term>transplants</Term>
        <Term>transplanting</Term>
        <Term>ORGAN TRANSPL</Term>
        <Term>TRNSPLNT.ORGAN</Term>
        <Term>organs transplant</Term>
        <Term>Surgery, Transplantation</Term>
        <Term>Transplanted tissue</Term>
        <Term>organ transplants</Term>
        <Term>Graftings, Organ</Term>
        <Term>organ transplanting</Term>
        <Term>transplant</Term>
        <Term>grafts</Term>
        <Term>Transplanted organ</Term>
        <Term>organ transplantation</Term>
        <Codes>
          <Code code="C15289" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Population_Type_Category</Relation>
          <Relation name="Narrower">OTE:Bone_Graft, OTE:Autologous_Ovarian_Tissue_Transplantation, OTE:Heart_and_Lung_Transplantation, OTE:Kidney_Transplantation, OTE:Pancreatic_Islet_Transplantation, OTE:Skin_Transplantation, OTE:Liver_Transplantation, OTE:Lung_Transplantation, OTE:Heart_Transplantation, OTE:Pancreas_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:AB_Tubingen_Zebrafish" name="AB/Tubingen Zebrafish">
        <Definition>A zebrafish line established from a group of 25 crosses between individual AB and Tubingen fish. The progeny of two crosses that lacked recessive embryonic phenotypes through 5 or 6 days of development were selected as founders of two distinct lethal free lines that were designated TAB-5 and TAB-14.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">AB/Tubingen Zebrafish</Term>
        <Term>TAB-14</Term>
        <Term>AB/Tubingen</Term>
        <Term>AB/TU</Term>
        <Term>TAB-5</Term>
        <Codes>
          <Code code="C79956" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DAB389CD4" name="DAB389CD4">
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DAB389CD4</Term>
        <Term>DAB389-CD4</Term>
        <Codes>
          <Code code="C0756968" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD4</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd86_protein_mouse" name="Cd86 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd86 protein, mouse</Term>
        <Term>Cd28l2 protein, mouse</Term>
        <Term>CD86 antigen, mouse</Term>
        <Term>B70 protein, mouse</Term>
        <Term>B7-2 protein, mouse</Term>
        <Term>CLS1 protein, mouse</Term>
        <Term>Ly-58 protein, mouse</Term>
        <Codes>
          <Code code="C1528561" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD86</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:AU_SsJ_Mouse" name="AU/SsJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">AU/SsJ Mouse</Term>
        <Term>AU/SsJ</Term>
        <Codes>
          <Code code="C14639" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:A_JOlaHsd_Mouse" name="A/JOlaHsd Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">A/JOlaHsd Mouse</Term>
        <Term>A/JOlaHsd</Term>
        <Codes>
          <Code code="C37350" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd99_protein_mouse" name="Cd99 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd99 protein, mouse</Term>
        <Term>CD99 antigen, mouse</Term>
        <Codes>
          <Code code="C2002177" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NOV_protein_human" name="NOV protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NOV protein, human</Term>
        <Term>ccn3 protein, human</Term>
        <Term>nov proto-oncogene protein, human</Term>
        <Term>NOVH protein, human</Term>
        <Term>nephroblastoma overexpressed protein, human</Term>
        <Codes>
          <Code code="C1121443" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Nephroblastoma_Overexpressed_Protein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C7-1_protein_rat" name="C7-1 protein, rat">
        <SemanticType code="T130" name="Indicator, Reagent, or Diagnostic Aid"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C7-1 protein, rat</Term>
        <Codes>
          <Code code="C1309447" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:monocyte-macrophage_differentiation_antigen" name="monocyte-macrophage differentiation antigen">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">monocyte-macrophage differentiation antigen</Term>
        <Term>macrophage differentiation antigen</Term>
        <Codes>
          <Code code="C0128904" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
          <Relation name="Narrower">OTE:differentiation_antigen_F4-80, OTE:Mac-3</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FAM101A_protein_human" name="FAM101A protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FAM101A protein, human</Term>
        <Term>family with sequence similarity 101, member A protein, human</Term>
        <Codes>
          <Code code="C3657225" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL18RAP_protein_human" name="IL18RAP protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL18RAP protein, human</Term>
        <Term>CDw218b antigen, human</Term>
        <Term>AcPL protein, human</Term>
        <Term>interleukin 18 receptor accessory protein, human</Term>
        <Term>IL18Rbeta protein, human</Term>
        <Term>interleukin-18 receptor beta, human</Term>
        <Codes>
          <Code code="C0759895" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_18_Receptor_beta_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DBA_2N_Mouse" name="DBA/2N Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DBA/2N Mouse</Term>
        <Term>DBA/2N</Term>
        <Codes>
          <Code code="C37405" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:theoretical_design" name="theoretical design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">theoretical design</Term>
        <Term>theoretical study</Term>
        <Term>theoretical studies</Term>
        <Term>theoretical designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#theoretical_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tpre" name="Tpre">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tpre</Term>
        <Codes>
          <Code code="C0618073" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CBySmn_CB17-Prkdc-scid_J_Mouse" name="CBySmn.CB17-Prkdc-scid/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CBySmn.CB17-Prkdc-scid/J Mouse</Term>
        <Term>CBySmn.CB17-Prkdc-scid/J</Term>
        <Term>BALB/cBySmn-Prkdc-scid/J</Term>
        <Codes>
          <Code code="C15164" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:SCID_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:medical_record_review" name="medical record review">
        <SemanticType code="T058" name="Health Care Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">medical record review</Term>
        <Term>review of medical records</Term>
        <Term>Medical records review (procedure)</Term>
        <Term>Medical records review</Term>
        <Term>medical record reviews</Term>
        <Term>medical records review</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#medical_record_review" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:records_review</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Il13ra1_protein_mouse" name="Il13ra1 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Il13ra1 protein, mouse</Term>
        <Term>IL-13r(a) protein, mouse</Term>
        <Term>CD213a1 protein, mouse</Term>
        <Term>interleukin 13 receptor, alpha 1 protein, mouse</Term>
        <Term>NR4 protein, mouse</Term>
        <Codes>
          <Code code="C1528379" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_13_Receptor_alpha1_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD8alphabeta_antigen" name="CD8alphabeta antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD8alphabeta antigen</Term>
        <Term>CD8alphabeta</Term>
        <Term>antigen, CD8 alpha beta</Term>
        <Codes>
          <Code code="C0969146" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD8</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129P2_Ola_Mouse" name="129P2/Ola Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129P2/Ola Mouse</Term>
        <Term>129P2/Ola</Term>
        <Codes>
          <Code code="C37324" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klrb1b_protein_mouse" name="Klrb1b protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klrb1b protein, mouse</Term>
        <Term>killer cell lectin-like receptor subfamily B member 1D protein, mouse</Term>
        <Term>NKR-P1D protein, mouse</Term>
        <Term>Nkrp1d protein, mouse</Term>
        <Term>Ly55d protein, mouse</Term>
        <Term>NK cell receptor protein-1B, mouse</Term>
        <Term>killer cell lectin-like receptor subfamily B member 1B, mouse</Term>
        <Term>NKR-P1B protein, mouse</Term>
        <Term>Klrb1d protein, mouse</Term>
        <Codes>
          <Code code="C1621886" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_B</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Felidae" name="Felidae">
        <Definition>refers to all members of the cat family, from the breeds of domestic cats through the great cats.</Definition>
        <Definition>Taxonomic family which includes domestic and wild cats such as lions and tigers.</Definition>
        <Definition>The cat family in the order CARNIVORA comprised of muscular, deep-chested terrestrial carnivores with a highly predatory lifestyle.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Felidae</Term>
        <Term>Felid</Term>
        <Term>cats</Term>
        <Term>cat</Term>
        <Term>catting</Term>
        <Term>Felids</Term>
        <Term>888-889 FAMILY FELIDAE - FELIDS</Term>
        <Term>Family Felidae</Term>
        <Term>Family Felidae (organism)</Term>
        <Term>FAMILY FELIDAE - FELIDS</Term>
        <Term>Cat</Term>
        <Term>feline</Term>
        <Codes>
          <Code code="C0325089" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Carnivora</Relation>
          <Relation name="Narrower">OTE:Cat, OTE:Domestic_Short_Hair_Cat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Surrogate_Markers" name="Surrogate Markers">
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Surrogate Markers</Term>
        <Term>surrogate marker</Term>
        <Term>surrogate markers</Term>
        <Term>Markers, Surrogate</Term>
        <Term>Surrogate Marker</Term>
        <Term>marker surrogate</Term>
        <Term>Marker, Surrogate</Term>
        <Codes>
          <Code code="C0086589" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Gadd45b_protein_mouse" name="Gadd45b protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Gadd45b protein, mouse</Term>
        <Term>Myd118 protein, mouse</Term>
        <Term>Gadd45beta protein, mouse</Term>
        <Term>growth arrest and DNA-damage-inducible 45 beta protein, mouse</Term>
        <Codes>
          <Code code="C1505358" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ITGB4_protein_human" name="ITGB4 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ITGB4 protein, human</Term>
        <Term>integrin, beta 4 protein, human</Term>
        <Term>CD104 antigen, human</Term>
        <Term>GP150 protein, human</Term>
        <Codes>
          <Code code="C0637379" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Integrin_beta4</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LAMP2_protein_human" name="LAMP2 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LAMP2 protein, human</Term>
        <Term>lysosomal-associated membrane protein 2, human</Term>
        <Term>LGP96 protein, human</Term>
        <Term>LGP-B protein, human</Term>
        <Codes>
          <Code code="C1563373" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Lysosomal_Associated_Membrane_Protein_2</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Late_Radiation_Injury" name="Late Radiation Injury">
        <Definition>Late radiation injury (LRI) is the damage to the soft tissue and bone following radiation therapy that occurs weeks and years after the radiation exposure. Pathogenesis of LRI stems from ischemia, interruption of the blood supply and direct cell damage. LRIs include but not limited to the skin atrophy, ulceration and non-healing wounds; cystitis, proctosigmoiditis, resulting to fistulas, abscesses, fibrosis and scaring; laryngitis, osteoradionecrosis; central nervous system injury, optic neuropathy.</Definition>
        <SemanticType code="T046" name="Pathologic Function"/>
        <SemanticType code="T033" name="Finding"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Late Radiation Injury</Term>
        <Term>late effect of radiation</Term>
        <Term>late effects of radiation</Term>
        <Term>Late effect of radiation</Term>
        <Term>Delayed effects of radiation</Term>
        <Term>Delayed effect of radiation</Term>
        <Term>Late effect of radiation (disorder)</Term>
        <Term>late effects of radiation (diagnosis)</Term>
        <Term>effects late radiation</Term>
        <Codes>
          <Code code="C3665" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Late_Adverse_Effect</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CXCR1-like_protein_mouse" name="CXCR1-like protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CXCR1-like protein, mouse</Term>
        <Term>mCXCR1-like protein, mouse</Term>
        <Term>CXC chemokine receptor 1-like protein, mouse</Term>
        <Codes>
          <Code code="C1702311" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_8A_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly9_protein_mouse" name="Ly9 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly9 protein, mouse</Term>
        <Term>CD229 antigen, mouse</Term>
        <Term>lymphocyte antigen 9, mouse</Term>
        <Term>SLAMF3 protein, mouse</Term>
        <Term>T-lymphocyte surface antigen Ly-9, mouse</Term>
        <Codes>
          <Code code="C1453162" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Infant_Extremely_Low_Birth_Weight" name="Infant, Extremely Low Birth Weight">
        <Definition>An infant whose weight at birth is less than 1000 grams (2.2 lbs), regardless of GESTATIONAL AGE.</Definition>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Infant, Extremely Low Birth Weight</Term>
        <Term>Extremely Low Birth Weight Infant</Term>
        <Codes>
          <Code code="C0456065" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Infant_Very_Low_Birth_Weight, OTE:Infant_Low_Birth_Weight</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:animal_study" name="animal study">
        <Definition>A laboratory experiment using animals to study the development and progression of diseases. Animal studies also test how safe and effective new treatments are before they are tested in people. [NCIT_14.08d]</Definition>
        <Definition>A laboratory experiment using animals to study the development and progression of diseases. Animal studies also test how safe and effective new treatments are before they are tested in people.</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <SemanticType code="T008" name="Animal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">animal study</Term>
        <Term>animal experiment</Term>
        <Term>animals studies</Term>
        <Term>animal subject</Term>
        <Term>animal experiments</Term>
        <Term>Animal Study</Term>
        <Term>animal studies</Term>
        <Term>animal subjects</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#animal_study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CBA_Ca_Mouse" name="CBA/Ca Mouse">
        <Definition>The CBA mouse from Strong (1920) was disseminated to Jackson Laboratory and then onto Haldane and Gruneberg (1932) and finally onto Carter (1947). The CBA/Ca female mice have long life spans whilst males have short life spans. Both males and females have high ceruloplasmin levels.</Definition>
        <Definition>The CBA mouse from Strong (1920) was disseminated to Jackson Laboratory and then onto Haldane and Gruneberg (1932) and finally onto Carter (1947). The CBA/Ca female mice have long life spans whilst males have short life spans. Both males and females have high ceruloplasmin levels. The CBA/Ca substrain is used most commonly in British scientific and pre-clinical trial research.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CBA/Ca Mouse</Term>
        <Term>CBA/CA</Term>
        <Term>CBA/Ca</Term>
        <Codes>
          <Code code="C37396" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Primate" name="Primate">
        <Definition>The taxonomic order of mammals that includes man, monkeys, and lemurs.</Definition>
        <Definition>order of mammals, including human beings, apes, monkeys, and lemurs; families include Cercopithecidae, Hominidae, Lemuridae, and Pongidae; this term is used to index non-human primates.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Primate</Term>
        <Term>primates</Term>
        <Term>Primates</Term>
        <Term>Primates Linnaeus, 1758</Term>
        <Term>primate</Term>
        <Term>Primate, NOS</Term>
        <Term>Order Primates</Term>
        <Term>ORDER PRIMATES</Term>
        <Term>85 ORDER PRIMATES</Term>
        <Term>Order Primates (organism)</Term>
        <Term>Mammals, Primates</Term>
        <Term>Primata</Term>
        <Codes>
          <Code code="C14262" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mammalia</Relation>
          <Relation name="Narrower">OTE:Monkey, OTE:Hominidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd79a_protein_mouse" name="Cd79a protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd79a protein, mouse</Term>
        <Term>Ig alpha protein, mouse</Term>
        <Term>Ly54 protein, mouse</Term>
        <Term>CD79A antigen (immunoglobulin-associated alpha) protein, mouse</Term>
        <Codes>
          <Code code="C1506240" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD79</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:biological_markers" name="biological markers">
        <Definition>Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.</Definition>
        <Definition>a fragment of DNA sequence that causes disease or is associated with sensitivity to disease</Definition>
        <Definition>A variation in cellular or biochemical components or processes, structures, or functions that is objectively measurable in a biological system and that characterizes normal biologic processes, pathogenic processes, an organism's state of health or disease, likelihood of developing a disease, prognosis, or response to a particular therapeutic intervention. Biomarkers include but not limited to such phenotypic parameters as specific enzyme or hormone concentration, specific gene phenotype, presence or absence of biological substances.</Definition>
        <Definition>A characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. (From: FDA Guidance for Industry: Pharmacogenomic Data Submissions.)</Definition>
        <Definition>a biological, physiological, behavioral, or molecular indicator of a process, disease, or system; e.g., fish mortality and pollution, behavioral changes and alcoholism, neuroendocrine system changes and aging.</Definition>
        <Definition>A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition.</Definition>
        <SemanticType code="T201" name="Clinical Attribute"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">biological markers</Term>
        <Term>molecular markers</Term>
        <Term>Biologic Markers</Term>
        <Term>Signature Molecule</Term>
        <Term>Biological Marker</Term>
        <Term>biologic marker</Term>
        <Term>Markers, Biologic</Term>
        <Term>Biological Markers [Chemical/Ingredient]</Term>
        <Term>biological marker</Term>
        <Term>biomarker</Term>
        <Term>Molecular Marker</Term>
        <Term>MARKER BIOL</Term>
        <Term>Marker, Biologic</Term>
        <Term>BIOL MARKERS</Term>
        <Term>BIOL MARKER</Term>
        <Term>Biomarker</Term>
        <Term>Marker, Biological</Term>
        <Term>MARKERS BIOL</Term>
        <Term>Marker</Term>
        <Term>biomarkers</Term>
        <Term>molecular marker</Term>
        <Term>signature molecule</Term>
        <Term>Biomarkers</Term>
        <Term>Markers, Biological</Term>
        <Term>marker</Term>
        <Term>Biological Markers</Term>
        <Term>Biologic Marker</Term>
        <Codes>
          <Code code="C0005516" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Outcome_Category</Relation>
          <Relation name="Narrower">OTE:Gtlf3b_protein_mouse, OTE:C7-1_protein_rat, OTE:Genetic_Marker, OTE:albumin_ischemia-modified, OTE:BMS-PTX-265, OTE:Serum_Markers, OTE:Surrogate_Endpoints, OTE:Tumor_Markers_Biological, OTE:Hyp1_protein_Hydra_attenuata, OTE:CAM_5_2_antigen, OTE:acarboxy_prothrombin, OTE:Biomarkers_Pharmacological, OTE:Surrogate_Markers, OTE:proliferating_cell_marker_1_protein_rat, OTE:Human_Chorionic_Gonadotropin_beta_Subunit, OTE:Markers_Immunologic, OTE:Antigens_Differentiation, OTE:Prdl-b_protein_Hydra_attenuata, OTE:DIT33_protein_Dirofilaria_immitis, OTE:Markers_Laboratory, OTE:BMS-PTX-837, OTE:Prdl-a_protein_Hydra_attenuata, OTE:Viral_Markers, OTE:Fibrinopeptide_A</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD4" name="CD4 (76-94)">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD4 (76-94)</Term>
        <Term>threonyl-tyrosyl-isoleucyl-cysteinyl-glutamyl-valyl-glutamyl-aspartyl-glutaminyl-lysyl-glutamyl-glutamic acid</Term>
        <Term>TYICEVEDQKEE</Term>
        <Term>CD4(76-94)</Term>
        <Term>CD4 (81-92)</Term>
        <Term>CD4 (81-92), D-Tyr,D-Cys,D-Glu(5)</Term>
        <Term>CD4(81-92)</Term>
        <Term>Thr-Tyr-Ile-Cys-Glu-Val-Glu-Asp-Gln-Lys-Glu-Glu</Term>
        <Codes>
          <Code code="C0253946" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD4</Relation>
          <Relation name="Narrower">OTE:CD4_D-Tyr, OTE:CD4_D-Ile</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:B_Cell_Activation_Factor_Receptor" name="B Cell Activation Factor Receptor">
        <Definition>Tumor necrosis factor receptor superfamily member 13C (184 aa, ~19 kDa) is encoded by the human TNFRSF13C gene. This protein plays a role in regulating the survival of peripheral B-cells.</Definition>
        <Definition>Receptors present on a wide variety of hematopoietic and non-hematopoietic cell types that are specific for INTERLEUKIN-4. They are involved in signaling a variety of immunological responses related to allergic INFLAMMATION including the differentiation of TH2 CELLS and the regulation of IMMUNOGLOBULIN E production. Two subtypes of receptors exist and are referred to as the TYPE I INTERLEUKIN-4 RECEPTOR and the TYPE II INTERLEUKIN-4 RECEPTOR. Each receptor subtype is defined by its unique subunit composition.</Definition>
        <Definition>A member of the tumor necrosis factor receptor superfamily that specifically binds B-CELL ACTIVATING FACTOR. It is found on B-LYMPHOCYTES and plays a role in maturation and survival of B-cells. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.</Definition>
        <Definition>IL4R when complexed with the common gamma chain (IL2RG) serves as the high-affinity interleukin 4 (IL4) receptor. It plays a major role in immunoglobulin E (IgE) production.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">B Cell Activation Factor Receptor</Term>
        <Term>Receptor, BAFF</Term>
        <Term>Interleukin 4 Receptor Alpha</Term>
        <Term>receptor, B-cell activation factor, human</Term>
        <Term>Receptors, Interleukin-4</Term>
        <Term>CD 268 ANTIGENS</Term>
        <Term>B Cell-Activating Factor Receptor</Term>
        <Term>B Cell Activating Factor Receptor</Term>
        <Term>BAFF Receptor</Term>
        <Term>Receptors, IL-4</Term>
        <Term>TNFRSF13C protein, human</Term>
        <Term>B CELL ACTIVATING FACTOR RECEPT</Term>
        <Term>BR3 B Cell Activation Factor Receptor</Term>
        <Term>Receptors, Interleukin-4 [Chemical/Ingredient]</Term>
        <Term>tumor necrosis factor receptor superfamily, member 13C protein, human</Term>
        <Term>Interleukin-4 Receptor</Term>
        <Term>Interleukin 4 Receptors</Term>
        <Term>RECEPTORS INTERLEUKIN 004</Term>
        <Term>RECEPT B CELL ACTIVATING FACTOR</Term>
        <Term>Receptor, IL4</Term>
        <Term>RECEPT IL4</Term>
        <Term>CD268 Antigens</Term>
        <Term>IL4R</Term>
        <Term>IL 004 RECEPTORS</Term>
        <Term>IL 4 RECEPT</Term>
        <Term>Antigen, CD268</Term>
        <Term>Receptors, Interleukin 4</Term>
        <Term>Receptor, B Cell-Activating Factor</Term>
        <Term>B-Cell Activation Factor Receptor</Term>
        <Term>IL 4 Receptor</Term>
        <Term>B-Cell-Activating Factor Receptor</Term>
        <Term>CD268 Antigen</Term>
        <Term>Receptor, B Cell Activating Factor</Term>
        <Term>Tumor Necrosis Factor Receptor Superfamily, Member 13C</Term>
        <Term>Interleukin-4 Receptors</Term>
        <Term>IL4RA</Term>
        <Term>Interleukin 4 Receptor</Term>
        <Term>Tumor Necrosis Factor Receptor Superfamily Member 13C</Term>
        <Term>IL-4 Receptors</Term>
        <Term>IL4 Receptors</Term>
        <Term>Receptor, IL-4</Term>
        <Term>Receptors, IL4</Term>
        <Term>RECEPTORS IL 004</Term>
        <Term>BLyS Receptor 3</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 13 C</Term>
        <Term>Receptors, IL 4</Term>
        <Term>IL4 RECEPT</Term>
        <Term>B-cell activation factor receptor, human</Term>
        <Term>INTERLEUKIN 4 RECEPT</Term>
        <Term>IL4 Receptor</Term>
        <Term>Receptor, Interleukin 4</Term>
        <Term>CD124</Term>
        <Term>BR3 B-Cell Activation Factor Receptor</Term>
        <Term>BAFF receptor protein, human</Term>
        <Term>IL-4 Receptor</Term>
        <Term>BAFF-R protein, human</Term>
        <Term>ANTIGENS CD 268</Term>
        <Term>Antigens, CD268</Term>
        <Term>RECEPT IL 4</Term>
        <Term>IL 4 Receptors</Term>
        <Term>Interleukin-4 Receptor Alpha</Term>
        <Term>Blys receptor 3 protein, human</Term>
        <Term>INTERLEUKIN 004 RECEPTORS</Term>
        <Term>B-Cell Activation Factor Receptor [Chemical/Ingredient]</Term>
        <Codes>
          <Code code="C1384654" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:TNFRSF13C_protein_human, OTE:Tnfrsf13c_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Prom1_protein_rat" name="Prom1 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Prom1 protein, rat</Term>
        <Term>prominin 1 protein, rat</Term>
        <Term>fudenine protein, rat</Term>
        <Term>CD133 antigen, rat</Term>
        <Codes>
          <Code code="C1612167" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:AC133_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin-10_Receptor_alpha_Subunit" name="Interleukin-10 Receptor alpha Subunit">
        <Definition>A subunit of the interleukin-10 receptor. It plays a role in receptor signaling by associating with JANUS KINASE 1.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin-10 Receptor alpha Subunit</Term>
        <Term>IL-10R1 Receptor</Term>
        <Term>INTERLEUKIN 010 RECEPTOR ALPHA CHAIN</Term>
        <Term>Receptor, IL-10R1</Term>
        <Term>IL 10R1 Receptor</Term>
        <Term>CDW210A Antigens</Term>
        <Term>ANTIGENS CD 210 W A</Term>
        <Term>Antigens, CDW210A</Term>
        <Term>Interleukin 10 Receptor alpha Chain</Term>
        <Term>Interleukin-10 Receptor 1</Term>
        <Term>INTERLEUKIN 010 RECEPTOR ALPHA SUBUNIT</Term>
        <Term>Interleukin 10 Receptor 1</Term>
        <Term>Interleukin 10 Receptor alpha Subunit</Term>
        <Term>Interleukin-10 Receptor alpha Chain</Term>
        <Term>CD 210 W A ANTIGENS</Term>
        <Codes>
          <Code code="C1721051" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:101_Mouse" name="101 Mouse">
        <Definition>Inbr: 66. Genet: A^w. Origin: Dunn, 1936. (Jackson Labs/Festing)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">101 Mouse</Term>
        <Term>101</Term>
        <Codes>
          <Code code="C14567" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:AB_C32_Zebrafish" name="AB/C32 Zebrafish">
        <Definition>A wild-type zebrafish line.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">AB/C32 Zebrafish</Term>
        <Term>AB/C32</Term>
        <Codes>
          <Code code="C79985" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Biomarkers_Pharmacological" name="Biomarkers, Pharmacological">
        <Definition>Measurable biological parameters that serve for drug development, safety and dosing (DRUG MONITORING).</Definition>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Biomarkers, Pharmacological</Term>
        <Term>Pharmacological Biomarkers</Term>
        <Term>Biological Markers, Pharmacological</Term>
        <Term>Pharmacological Biological Markers</Term>
        <Term>Markers, Pharmacological Biological</Term>
        <Codes>
          <Code code="C1955886" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
          <Relation name="Narrower">OTE:Drug_Safety_Biomarkers, OTE:Drug_Dosing_Biomarkers, OTE:Drug_Response_Biomarkers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SLC44A1_protein_human" name="SLC44A1 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SLC44A1 protein, human</Term>
        <Term>solute carrier family 44, member 1 protein, human</Term>
        <Term>CTL1 protein, human</Term>
        <Term>CD92 antigen, human</Term>
        <Term>choline transporter-like protein 1, human</Term>
        <Codes>
          <Code code="C1722194" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd244_protein_mouse" name="Cd244 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd244 protein, mouse</Term>
        <Term>SLAMF4 protein, mouse</Term>
        <Term>CD244 natural killer cell receptor 2B4 protein, mouse</Term>
        <Term>NKR2B4 protein, mouse</Term>
        <Term>2B4 protein, mouse</Term>
        <Codes>
          <Code code="C1432646" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:B6_CB17-Prkdc-scid_SzJ_Mouse" name="B6.CB17-Prkdc-scid/SzJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">B6.CB17-Prkdc-scid/SzJ Mouse</Term>
        <Term>C57BL/6J-Prkdc-scid/SzJ</Term>
        <Term>B6.CB17-Prkdc-scid/SzJ</Term>
        <Codes>
          <Code code="C15166" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:SCID_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Heart_Transplantation" name="Heart Transplantation">
        <Definition>A surgical procedure in which a damaged heart is removed and replaced by another heart from a suitable donor.</Definition>
        <Definition>&lt;p&gt;A heart transplant removes a damaged or diseased heart and replaces it with a healthy one. The healthy heart comes from a donor who has died. It is the last resort for people with &lt;a href='http://www.nlm.nih.gov/medlineplus/heartfailure.html'&gt;heart failure&lt;/a&gt; when all other treatments have failed. The heart failure might have been caused by coronary heart disease, damaged heart valves or heart muscles, congenital heart defects, or viral infections of the heart.&lt;/p&gt;&lt;p&gt;Although heart transplant surgery is a life-saving measure, it has many risks. Careful monitoring, treatment, and regular medical care can prevent or help manage some of these risks.&lt;/p&gt;&lt;p&gt;After the surgery, most heart transplant patients can return to their normal levels of activity. However, fewer than 30 percent return to work for many different reasons.&lt;/p&gt;&lt;p &gt;NIH: National Heart, Lung, and Blood Institute&lt;/p&gt;</Definition>
        <Definition>transference of a heart or heart tissue between individuals of the same species or between individuals of different species.</Definition>
        <Definition>The transference of a heart from one human or animal to another.</Definition>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Heart Transplantation</Term>
        <Term>CTx - Cardiac transplant</Term>
        <Term>HEART TRANSPL</Term>
        <Term>heart transplant</Term>
        <Term>Heart Graftings</Term>
        <Term>Cardiac transplant</Term>
        <Term>heart transplants</Term>
        <Term>HEART TRANSPLANT W/WO RECIPIENT CARDIECTOMY</Term>
        <Term>CARDIAC TRANSPLANT</Term>
        <Term>TRANSPL CARDIAC</Term>
        <Term>Entire transplanted heart</Term>
        <Term>Heart transplantation</Term>
        <Term>cardiac transplants</Term>
        <Term>Transplanted heart</Term>
        <Term>Transplantations, Heart</Term>
        <Term>heart graft</Term>
        <Term>Transplantations, Cardiac</Term>
        <Term>Structure of transplanted heart (body structure)</Term>
        <Term>Graftings, Heart</Term>
        <Term>Heart Transplantations</Term>
        <Term>Transplantation of heart, NOS</Term>
        <Term>Heart--Transplantation</Term>
        <Term>Heart Transplants</Term>
        <Term>cardiac transplant</Term>
        <Term>cardiac transplantation</Term>
        <Term>Cardiac Transplantation</Term>
        <Term>Heart Grafting</Term>
        <Term>transplantation of heart</Term>
        <Term>Grafting, Heart</Term>
        <Term>transplantation of heart (treatment)</Term>
        <Term>CARDIAC TRANSPL</Term>
        <Term>heart transplantation</Term>
        <Term>Transplantation, Cardiac</Term>
        <Term>Transplantation of heart (procedure)</Term>
        <Term>Heart Transplant</Term>
        <Term>HtTx - Heart transplant</Term>
        <Term>Transplant;cardiac</Term>
        <Term>Cardiac Transplantations</Term>
        <Term>Heart transplant</Term>
        <Term>TRANSPLANTATION OF HEART</Term>
        <Term>HTx - Heart transplant</Term>
        <Term>TRANSPL HEART</Term>
        <Term>Heart transplant, with or without recipient cardiectomy</Term>
        <Term>Entire transplanted heart (body structure)</Term>
        <Term>heart transplantations</Term>
        <Term>Structure of transplanted heart</Term>
        <Term>Transplantation of heart</Term>
        <Term>Transplantation, Heart</Term>
        <Codes>
          <Code code="C0040744" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Organ_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LP_J_Mouse" name="LP/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LP/J Mouse</Term>
        <Term>LP/J</Term>
        <Codes>
          <Code code="C37409" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:muc1_protein_mouse" name="muc1 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">muc1 protein, mouse</Term>
        <Term>Muc1 mucin, mouse</Term>
        <Codes>
          <Code code="C3529680" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CA-15-3_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Female" name="Female">
        <Definition>An individual who reports to be female, the sex that ordinarily produces ova.</Definition>
        <Definition>A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both.</Definition>
        <Definition>&lt;p&gt;Female&lt;/p&gt;</Definition>
        <Definition>Human females as cultural, psychological, sociological, political, and economic entities.</Definition>
        <Definition>An individual who reports belonging to the cultural gender role distinction of female.</Definition>
        <Definition>A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)</Definition>
        <Definition>use in conjunction with a disease, disorder, dysfunction, body system, or function which is gender specific.</Definition>
        <Definition>An animal who is observed by researcher or clinician to be female, the sex that ordinarily produces ova.</Definition>
        <Definition>Used for all-female populations when sex is pertinent to the focus of the study. For comparison of sexes use HUMAN SEX DIFFERENCES.</Definition>
        <Definition>An adult, female human.</Definition>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <SemanticType code="T032" name="Organism Attribute"/>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Female</Term>
        <Term>Female Phenotype</Term>
        <Term>Female individual</Term>
        <Term>human female</Term>
        <Term>Female Gender [Disease/Finding]</Term>
        <Term>Female individual, NOS</Term>
        <Term>Female Gender, Self Report</Term>
        <Term>female human</Term>
        <Term>female humans</Term>
        <Term>adult female?</Term>
        <Term>Female, Self-Reported</Term>
        <Term>Female Gender, Self Reported</Term>
        <Term>Female (finding)</Term>
        <Term>Females (Human)</Term>
        <Term>Female Sex, Self-Report</Term>
        <Term>female</Term>
        <Term>Female Gender</Term>
        <Term>Female gender</Term>
        <Term>FEMALE</Term>
        <Term>Female, Self-Report</Term>
        <Term>female sex</Term>
        <Term>Female structure (body structure)</Term>
        <Term>Female structure</Term>
        <Term>females</Term>
        <Term>FEMALE SEX</Term>
        <Term>Sex Female</Term>
        <Term>woman</Term>
        <Term>Women</Term>
        <Term>F</Term>
        <Term>Females</Term>
        <Term>Human, Female</Term>
        <Term>WOMAN</Term>
        <Term>Woman</Term>
        <Term>women</Term>
        <Term>Woman (person)</Term>
        <Term>Human Females</Term>
        <Term>Female, NOS</Term>
        <Codes>
          <Code code="C0015780" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Gender_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IR_Rat_Strain" name="IR, Rat Strain">
        <Definition>Vigorous and healthy, but high incidence of physical abnormalities. Skulls of young fragile through weaning. High death rate from hemorrhage due to blood platelet disease (Harrington 1981). Long latency to emerge into familiar environment (12/12 males, 10/12 females) (Harrington 1971a). High open field exploration in females (3/12) (Harrington 1972). Low wheel activity (11/12 males10/12 females) (Harrington 1971b).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IR, Rat Strain</Term>
        <Codes>
          <Code code="C14405" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Dutch_Belted_Rabbit" name="Dutch Belted Rabbit">
        <Definition>A smaller sized lagomorph, the Dutch belted rabbit has black hindquarters, ears and black patches around the eyes while the feet, face, and front half of the body are white. The Dutch belted rabbit is commonly utilized in biomedical research for toxicology studies, ophthalmological research, and developmental toxicity studies. This lagomorph's small size lends itself to studies in which the study drug is available in smaller quantities or if housing space is a consideration.</Definition>
        <Definition>A smaller sized lagomorph, the Dutch belted rabbit has black hindquarters, ears and black patches around the eyes while the feet, face, and front half of the body are white. The Dutch belted rabbit is commonly utilized in biomedical research for toxicology studies, ophthalmological research, and developmental toxicity studies. This lagomorphs' small size lends itself to studies in which the study drug is available in smaller quantities or if housing space is a consideration.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Dutch Belted Rabbit</Term>
        <Term>DUTCH BELTED</Term>
        <Term>Dutch Belted</Term>
        <Codes>
          <Code code="C2699834" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rabbit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BST2_protein_mouse" name="BST2 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BST2 protein, mouse</Term>
        <Term>bone marrow stromal cell antigen 2, mouse</Term>
        <Term>BST-2 protein, mouse</Term>
        <Term>CD317 antigen, mouse</Term>
        <Term>teetherin protein, mouse</Term>
        <Codes>
          <Code code="C1740173" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD71_antigen" name="CD71 antigen">
        <Definition>Regulated by mitogenic stimulation and cellular iron levels (through IRP1/2), TFRC Gene (M28B Peptidase Family) encodes 760-aa 85-kDa Transferrin Receptor 1, a glycosylated, phosphorylated, and palmitoylated type II membrane disulfide-linked homodimeric glycoprotein involved in cellular uptake of iron via receptor-mediated endocytosis. After intracellular iron release, apotransferrin-receptor is recycled to the cell surface with release of apotransferrin. Transferrin receptor appears necessary for nervous system and erythrocyte development, binds HLA class II histocompatibility antigen DR1, and binds parvoviruses that enter and infect cells. Ligand HFE competes with transferrin for binding to an overlapping C-terminal site. Proteolytic cleavage at Arg100 produces the glycosylated secreted sTfR isoform; used in a diagnostic test for anemia. (NCI)</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD71 antigen</Term>
        <Term>Transferrin Receptor</Term>
        <Term>TFR</Term>
        <Term>Transferrin Receptor Protein 1</Term>
        <Term>Lymphocyte antigen CD71</Term>
        <Term>T9</Term>
        <Term>CD71 Antigen</Term>
        <Term>TFR1</Term>
        <Term>Transferrin Receptor 1</Term>
        <Term>Lymphocyte antigen CD71 (substance)</Term>
        <Term>TR</Term>
        <Term>TRFR</Term>
        <Term>CD71</Term>
        <Term>TFRC</Term>
        <Term>p90</Term>
        <Codes>
          <Code code="C1619635" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:TFRC_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:YBR_Ki_Mouse" name="YBR/Ki Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">YBR/Ki Mouse</Term>
        <Term>YBR/Ki</Term>
        <Codes>
          <Code code="C37445" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:differentiation_antigen_F4-80" name="differentiation antigen F4-80">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">differentiation antigen F4-80</Term>
        <Term>F4-80 antigen</Term>
        <Codes>
          <Code code="C0244377" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:monocyte-macrophage_differentiation_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SWR_Mouse" name="SWR Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SWR Mouse</Term>
        <Term>SWR</Term>
        <Codes>
          <Code code="C37443" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:narrative_review_" name="narrative review'">
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">narrative review'</Term>
        <Term>narrative review</Term>
        <Term>narrative analysis</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#narrative_review'" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:review_of_literature_</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ABH_Mouse" name="ABH Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ABH Mouse</Term>
        <Term>ABH</Term>
        <Codes>
          <Code code="C1510680" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fibrinopeptide_A" name="Fibrinopeptide A">
        <Definition>Two small peptide chains removed from the N-terminal segment of the alpha chains of fibrinogen by the action of thrombin during the blood coagulation process. Each peptide chain contains 18 amino acid residues. In vivo, fibrinopeptide A is used as a marker to determine the rate of conversion of fibrinogen to fibrin by thrombin.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fibrinopeptide A</Term>
        <Term>Fibrinopeptides A</Term>
        <Term>A, Fibrinopeptide</Term>
        <Term>A, Fibrinopeptides</Term>
        <Codes>
          <Code code="C0016022" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
          <Relation name="Narrower">OTE:5-tyrosine_fibrinopeptide_A, OTE:fibrinopeptide_A_phospho-Ser-, OTE:desaminotyrosylfibrinopeptide_A, OTE:fibrinopeptide_A_des-Ala-</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD83_antigen_human" name="CD83 antigen, human">
        <Definition>CD83 antigen (205 aa, ~23 kDa) is encoded by the human CD83 gene. This protein may play a role in antigen presentation.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD83 antigen, human</Term>
        <Term>CD83 protein, human</Term>
        <Term>CD83 antigen (activated B lymphocytes, immunoglobulin superfamily), human</Term>
        <Codes>
          <Code code="C1620157" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD83_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:integrin_alpha7" name="integrin alpha7">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">integrin alpha7</Term>
        <Term>alpha(7)-integrin</Term>
        <Term>CD49g antigen</Term>
        <Term>alpha(7) integrin</Term>
        <Codes>
          <Code code="C0251634" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Itga7_protein_rat, OTE:ITGA7_protein_human, OTE:Itga7_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CDH2_protein_human" name="CDH2 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CDH2 protein, human</Term>
        <Term>cadherin 2, type 1, N-cadherin (neuronal) protein, human</Term>
        <Term>CDw325 antigen, human</Term>
        <Term>adherens junction-specific membrane protein, human</Term>
        <Term>cadherin 2 protein, human</Term>
        <Term>N-cadherin protein, human</Term>
        <Codes>
          <Code code="C1455819" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD8beta_antigen" name="CD8beta antigen">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD8beta antigen</Term>
        <Codes>
          <Code code="C1312165" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD8</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:scoping_review" name="scoping review">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">scoping review</Term>
        <Term>scoping reviews</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#scoping_review" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:literature_review</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:face-to-face_interview" name="face-to-face interview">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">face-to-face interview</Term>
        <Term>face-to-face interviews</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#face-to-face_interview" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:interview</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129P1_Re_Mouse" name="129P1/Re Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129P1/Re Mouse</Term>
        <Term>129P1/Re</Term>
        <Codes>
          <Code code="C37321" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fox_Chase_SCID_Mouse" name="Fox Chase SCID Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fox Chase SCID Mouse</Term>
        <Term>C.B-17/IcrCrl-scid-BR</Term>
        <Term>Fox Chase SCID</Term>
        <Codes>
          <Code code="C15158" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:SCID_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:TNFRSF13C_protein_human" name="TNFRSF13C protein, human">
        <Definition>Tumor necrosis factor receptor superfamily member 13C (184 aa, ~19 kDa) is encoded by the human TNFRSF13C gene. This protein plays a role in regulating the survival of peripheral B-cells.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">TNFRSF13C protein, human</Term>
        <Term>BAFF receptor protein, human</Term>
        <Term>BAFF-R protein, human</Term>
        <Term>tumor necrosis factor receptor superfamily, member 13C protein, human</Term>
        <Term>receptor, B-cell activation factor, human</Term>
        <Term>B-cell activation factor receptor, human</Term>
        <Term>Blys receptor 3 protein, human</Term>
        <Codes>
          <Code code="C1384654" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:B_Cell_Activation_Factor_Receptor</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cotton_Rat" name="Cotton Rat">
        <Definition>From the Sigmodon genus of rodents, Sigmodon hispidus was the first animal model to be used in polio research. The cotton rat has a stout body, small ears and a dark coat that can be dark brown or mixed buff and black, with a tail length that is 35% of its total body length. As its name suggests, this breed has a proclivity for cotton in its nesting, and is a natural Hanta viral reservoir. The cotton rat has wide applications in viral research.</Definition>
        <Definition>The rat of the genus and species Sigmodon hispidus.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cotton Rat</Term>
        <Term>Sigmodon hispidus (organism)</Term>
        <Term>Sigmodon hispidus</Term>
        <Term>Hispid Cotton Rat</Term>
        <Term>Cotton</Term>
        <Term>Cotton Rats</Term>
        <Term>Hispid cotton rat</Term>
        <Term>Rat, Cotton</Term>
        <Term>cotton rat</Term>
        <Term>Genus Sigmodon</Term>
        <Term>Cotton rat</Term>
        <Term>Rats, Cotton</Term>
        <Term>Sigmodon</Term>
        <Term>Cotton rats</Term>
        <Term>COTTON</Term>
        <Term>Genus Sigmodon (organism)</Term>
        <Term>Sigmodon hispiedis</Term>
        <Codes>
          <Code code="C0037070" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rodentia</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin-4_Receptor_alpha_Subunit" name="Interleukin-4 Receptor alpha Subunit">
        <Definition>A receptor subunit that is a component of the TYPE I INTERLEUKIN-4 RECEPTOR and the TYPE II INTERLEUKIN-4 RECEPTOR. It signals through interaction of its cytoplasmic domain with JANUS KINASES such as JANUS KINASE 1.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin-4 Receptor alpha Subunit</Term>
        <Term>Interleukin 4 Receptor alpha Chain</Term>
        <Term>ANTIGENS CD 124</Term>
        <Term>Interleukin-4 Receptor alpha Chain</Term>
        <Term>Interleukin-4 Receptors alpha</Term>
        <Term>CD124 Antigen</Term>
        <Term>Receptor, Interleukin-4, alpha Subunit</Term>
        <Term>CD 124 ANTIGENS</Term>
        <Term>Interleukin 4 Receptor alpha Subunit</Term>
        <Term>INTERLEUKIN 004 RECEPTOR ALPHA SUBUNIT</Term>
        <Term>Receptors alpha, Interleukin-4</Term>
        <Term>Antigens, CD124</Term>
        <Term>Antigen, CD124</Term>
        <Term>Interleukin 4 Receptors alpha</Term>
        <Term>alpha-subunit, Receptor, Interleukin-4</Term>
        <Term>CD124 Antigens</Term>
        <Codes>
          <Code code="C1721038" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Il4r_protein_rat, OTE:IL4R_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BLKS_J_Mouse" name="C57BLKS/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BLKS/J Mouse</Term>
        <Term>C57BLKS/J</Term>
        <Codes>
          <Code code="C37388" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NT5C3_protein_human" name="NT5C3 protein, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NT5C3 protein, human</Term>
        <Term>5'-nucleotidase, cytosolic III protein, human</Term>
        <Term>UMPH1 protein, human</Term>
        <Term>PSN1 protein, human</Term>
        <Term>PN-I protein, human</Term>
        <Term>cN-III protein, human</Term>
        <Term>UMPH protein, human</Term>
        <Codes>
          <Code code="C1439160" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-Nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Drug_Dosing_Biomarkers" name="Drug Dosing Biomarkers">
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Drug Dosing Biomarkers</Term>
        <Term>Dosing Biomarkers, Drug</Term>
        <Term>Biomarkers, Drug Dosing</Term>
        <Codes>
          <Code code="C1955887" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Biomarkers_Pharmacological</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:correlational_design" name="correlational design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">correlational design</Term>
        <Term>correlation studies</Term>
        <Term>correlational trial</Term>
        <Term>correlation trial</Term>
        <Term>correlation designs</Term>
        <Term>correlational trials</Term>
        <Term>correlation trials</Term>
        <Term>correlational studies</Term>
        <Term>correlation design</Term>
        <Term>correlational designs</Term>
        <Term>correlational study</Term>
        <Term>correlation study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#correlational_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Amphibia" name="Amphibia">
        <Definition>VERTEBRATES belonging to the class amphibia such as frogs, toads, newts and salamanders that live in a semiaquatic environment.</Definition>
        <Definition>cold blooded chordates; larva are usually aquatic, breathing by gills; adults are terrestrial or aquatic, breathing by lungs and through moist glandular skin.</Definition>
        <Definition>A taxonomic class of vertebrates that include frogs, toads, newts, salamanders, and gymnophiona. Amphibians are cold blooded land animals that lay eggs in the water. The juveniles of this class metamorphose from water-breathing organisms to air-breathing organisms upon adult maturation.</Definition>
        <SemanticType code="T011" name="Amphibian"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Amphibia</Term>
        <Term>AMPHIBIANS AND REPTILES</Term>
        <Term>Cold-blooded animal, amphibian</Term>
        <Term>Amphibians</Term>
        <Term>B0-B1 CLASS AMPHIBIA</Term>
        <Term>SECTION B AMPHIBIANS AND REPTILES</Term>
        <Term>Cold-blooded amphibian animal</Term>
        <Term>amphibia</Term>
        <Term>amphibians</Term>
        <Term>Class Amphibia</Term>
        <Term>Class Amphibia (organism)</Term>
        <Term>amphibian</Term>
        <Term>Amphibian, NOS</Term>
        <Term>CLASS AMPHIBIA</Term>
        <Term>Amphibian</Term>
        <Term>Ectotherm, amphibian</Term>
        <Codes>
          <Code code="C14180" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Vertebrata</Relation>
          <Relation name="Narrower">OTE:Frog</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD40_Ligand" name="CD40 Ligand">
        <Definition>A recombinant therapeutic agent which is chemically identical to or similar to CD40-ligand. CD40-ligand, also known as CD40L/TRAP and CD154, is a type II membrane protein which binds to CD40, a cell surface receptor that belongs to the tumor necrosis factor receptor family; CD40 is expressed on B lymphocytes, monocytes, dendritic cells (DC), hematopoietic progenitors, endothelial cells and epithelial cells. Recombinant CD40-ligand may be used to activate DC ex vivo via CD40 binding; CD40-ligand-activated DC may provide or augment a protective antitumor immunity when administered in dendritic cell cancer vaccines. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=43639&amp;idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=43639&amp;idtype=1&amp;closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;code=C1437" NCI Thesaurus)</Definition>
        <Definition>A membrane glycoprotein and differentiation antigen expressed on the surface of T-cells that binds to CD40 ANTIGENS on B-LYMPHOCYTES and induces their proliferation. Mutation of the gene for CD40 ligand is a cause of HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 1.</Definition>
        <Definition>CD40 ligand (261 aa, 29 kD) is a cellular division process protein that is encoded by the human CD40LG gene and has roles in inflammatory response, B-cell proliferation and anti-apoptosis.</Definition>
        <Definition>This gene plays a role in the stimulation of B cells in immune responses.</Definition>
        <Definition>The determination of the amount of CD40 ligand present in a sample.</Definition>
        <Definition>A count of the CD40 ligand cells per unit in a biological specimen.</Definition>
        <Definition>A substance that is being studied in the treatment of cancer. It binds to certain immune cells and may suppress cancer growth.</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD40 Ligand</Term>
        <Term>CD154 Antigen</Term>
        <Term>CD 154 ANTIGENS</Term>
        <Term>cd154</Term>
        <Term>CD 040 LIGAND</Term>
        <Term>CD40 ANTIGEN LIGAND</Term>
        <Term>TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 005</Term>
        <Term>CD40LG gene</Term>
        <Term>TNFSF5</Term>
        <Term>HIGM1</Term>
        <Term>T-B cell-activating molecule</Term>
        <Term>hyper-IgM syndrome</Term>
        <Term>CD40 Ligand Measurement</Term>
        <Term>IMD3</Term>
        <Term>T-BAM</Term>
        <Term>GP39</Term>
        <Term>CD40LG</Term>
        <Term>hCD40L</Term>
        <Term>CD40-ligand</Term>
        <Term>CD40 ligand</Term>
        <Term>CD40LG Gene</Term>
        <Term>TRAP</Term>
        <Term>Tumor Necrosis Factor Ligand Superfamily Member 5</Term>
        <Term>tumor necrosis factor (ligand) superfamily member 5</Term>
        <Term>CD154 antigen</Term>
        <Term>TNF-related activation protein</Term>
        <Term>CD40 Ligand (TNF Superfamily, Member 5, Hyper-IgM Syndrome) Gene</Term>
        <Term>Antigens, CD154</Term>
        <Term>Lymphocyte antigen CD154</Term>
        <Term>T-B Cell Activating Molecule</Term>
        <Term>rhu CD40L</Term>
        <Term>CD40 Ligand [Chemical/Ingredient]</Term>
        <Term>T-cell antigen gp39</Term>
        <Term>ANTIGENS CD 154</Term>
        <Term>gp39 Antigen, T Cell</Term>
        <Term>CD40L</Term>
        <Term>CD154 Antigens</Term>
        <Term>CD154</Term>
        <Term>TRAP ligand</Term>
        <Term>CD40-L</Term>
        <Term>gp39 cytokine</Term>
        <Term>cd40 ligand</Term>
        <Term>cd40l</Term>
        <Term>CD40 antigen ligand</Term>
        <Term>Antigen, CD154</Term>
        <Term>gp39</Term>
        <Term>TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 5</Term>
        <Term>CD40 LIGAND</Term>
        <Term>TNF Superfamily, Member 5</Term>
        <Term>T Cell Antigen gp39</Term>
        <Term>gp39 Antigen, T-Cell</Term>
        <Term>TNF-Related Activation Protein</Term>
        <Term>TNF-RELATED ACTIVATION PROTEIN</Term>
        <Term>T-Cell gp39 Antigen</Term>
        <Term>Lymphocyte antigen CD154 (substance)</Term>
        <Codes>
          <Code code="C1539082" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd81_protein_rat" name="Cd81 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T124" name="Neuroreactive Substance or Biogenic Amine"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd81 protein, rat</Term>
        <Term>CD 81 antigen, rat</Term>
        <Term>TAPA protein, rat</Term>
        <Term>target of the anti-proliferative antibody, rat</Term>
        <Term>rTAPA protein, rat</Term>
        <Codes>
          <Code code="C0530621" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD81_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:focus_group" name="focus group">
        <Definition>A method of data collection and a qualitative research tool in which a small group of individuals are brought together and allowed to interact in a discussion of their opinions about topics, issues, or questions. [MeSH_2014]</Definition>
        <Definition>method of data collection and a qualitative research tool in which a small group of individuals are brought together and allowed to interact in a discussion of their opinions about topics, issues, or questions.</Definition>
        <Definition>A method of data collection and a QUALITATIVE RESEARCH tool in which a small group of individuals are brought together and allowed to interact in a discussion of their opinions about topics, issues, or questions.</Definition>
        <SemanticType code="T096" name="Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">focus group</Term>
        <Term>Focus groups</Term>
        <Term>Group, Focus</Term>
        <Term>Focus Groups</Term>
        <Term>Focus Group</Term>
        <Term>focus groups</Term>
        <Term>Groups, Focus</Term>
        <Codes>
          <Code code="C0016400" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:scientific_publication" name="scientific publication">
        <Definition>A class of publication in which original scientific work is described.</Definition>
        <Definition>A class of publication in which original scientific work is described. The format usually includes an introduction in which relevant concepts are identified and the experimental system under study is presented, a section describing the experiments that were performed to test a specific hypothesis and the results and observations that were obtained, a section in which the results are discussed relative to findings by other investigators and the current state of knowledge in the field, and a section describing the experimental methods and procedures in sufficient detail to enable the reproduction of the work by independent investigators. [NCIT_14.10d]</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">scientific publication</Term>
        <Term>Published</Term>
        <Term>Scientific Publication</Term>
        <Term>Publication</Term>
        <Term>scientific publications</Term>
        <Term>Scientific Publications</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#scientific_publication" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IMP321" name="IMP321">
        <Definition>A T-cell immunostimulatory factor, derived from the soluble form of the lymphocyte-activation gene 3 (LAG-3) protein, with potential antineoplastic activity. Upon administration, alone or in combination with tumor antigens, IMP321 binds with high affinity to MHC class II molecules expressed by dendritic cells (DC), potentially resulting in DC maturation, DC migration to lymph nodes, enhanced DC cross-presentation of antigens to T cells, and antitumor cytotoxic T cell responses.</Definition>
        <Definition>A T-cell immunostimulatory factor derived from the soluble form of lymphocyte-activation gene 3 (LAG-3) protein with potential antineoplastic activity. Upon administration, alone or in combination with tumor antigens, IMP321 binds, with high affinity, to MHC class II molecules expressed by dendritic cells (DC), which may result in DC maturation, DC migration to lymph nodes, enhanced DC cross-presentation of antigens to T cells, and antitumor cytotoxic T cell responses. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=496939&amp;idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=496939&amp;idtype=1&amp;closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;code=C62509" NCI Thesaurus)</Definition>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IMP321</Term>
        <Codes>
          <Code code="C1739076" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD223_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:B6_129-Trp53tm1Brd_N5" name="B6.129-Trp53tm1Brd N5">
        <Definition>A partial congenic mouse with background strain of C57BL/6 and 129/Sv chimera, containing a heterozygous or homozygous p53 mutation.</Definition>
        <Definition>A partial congenic mouse with background strain of C57BL/6 and 129/Sv chimera, containing a heterozygous or homozygous p53 mutation. (NCI)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">B6.129-Trp53tm1Brd N5</Term>
        <Codes>
          <Code code="C98707" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Drug_Safety_Biomarkers" name="Drug Safety Biomarkers">
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Drug Safety Biomarkers</Term>
        <Term>Biomarkers, Drug Safety</Term>
        <Term>Safety Biomarkers, Drug</Term>
        <Codes>
          <Code code="C1955889" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Biomarkers_Pharmacological</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C3H_Rl_Mouse" name="C3H/Rl Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C3H/Rl Mouse</Term>
        <Term>C3H/Rl</Term>
        <Codes>
          <Code code="C37373" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Spn_protein_rat" name="Spn protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Spn protein, rat</Term>
        <Term>sialophorin protein, rat</Term>
        <Codes>
          <Code code="C1566875" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD43</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL1R1_protein_mouse" name="IL1R1 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL1R1 protein, mouse</Term>
        <Term>IL-1RI, mouse</Term>
        <Term>interleukin 1 receptor, type I, mouse</Term>
        <Term>IL-1 receptor type I, mouse</Term>
        <Codes>
          <Code code="C3710910" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_Interleukin-1_Type_I</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:evidence_report_" name="evidence report'">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">evidence report'</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#evidence_report'" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:review_of_literature_</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:translationally_controlled_tumor_protein_p23" name="translationally controlled tumor protein, p23">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">translationally controlled tumor protein, p23</Term>
        <Term>histamine-releasing factor (IgE-dependent)</Term>
        <Term>histamine releasing factor (lymphocyte-dependent)</Term>
        <Term>histamine releasing factor</Term>
        <Term>translationally-controlled tumor protein</Term>
        <Term>protein p23, Ehrlich ascites tumor</Term>
        <Codes>
          <Code code="C0539132" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
          <Relation name="Narrower">OTE:TPT1_protein_human, OTE:Tpt1_protein_rat, OTE:Tpt1_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Z_Rat_Strain" name="Z, Rat Strain">
        <Definition>Derived from a spontaneous mutation in the leptin receptor that appeared in a 13M rat colony bred at the Zucker Laboratory of Comparative Pathology (Stow, MA), genotype leprfa. The Zucker rat may come in four principal color variants, including brown, brown and white, black, and black and white. The mutation causes severe obesity, diabetes, abnormal heart function, hypertriglyceridemia, and hypercholesterolemia. The Zucker rat is utilized in biomedical research to study insulin resistance, glucose intolerance, metabolic syndromes, and obesity.</Definition>
        <Definition>Derived from a spontaneous mutation in the leptin receptor that appeared in a 13M rat colony bred at the Zucker Laboratory of Comparative Pathology (Stow, MA), genotype leprfa.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Z, Rat Strain</Term>
        <Term>ZUCKER</Term>
        <Term>Zucker</Term>
        <Codes>
          <Code code="C76194" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129S2_SvPas_Mouse" name="129S2/SvPas Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129S2/SvPas Mouse</Term>
        <Term>129S2/SvPas</Term>
        <Codes>
          <Code code="C37337" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:lymphocyte-activation_gene_3_protein_human" name="lymphocyte-activation gene 3 protein, human">
        <Definition>Lymphocyte activation gene 3 protein (525 aa, ~57 kDa) is encoded by the human LAG3 gene. This protein is involved in the activation of T-cells and natural killer cells.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">lymphocyte-activation gene 3 protein, human</Term>
        <Term>Lag3 protein, human</Term>
        <Term>CD223 antigen, human</Term>
        <Codes>
          <Code code="C1456336" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD223_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Activated_Leukocyte_Cell_Adhesion_Molecule" name="Activated Leukocyte Cell Adhesion Molecule">
        <Definition>This gene plays a role in cellular adhesion events involving immune cells, such as monocytes and leukocytes.</Definition>
        <Definition>Cell adhesion molecule expressed on activated leukocytes, fibroblasts, and neurons. It is a ligand for CD6. ALCAM-CD6 interactions may play a role in the binding of T and B cells to activated leukocytes.</Definition>
        <Definition>CD166 antigen (583 aa, 65 kD) is a cell adhesion process protein that is encoded by the human ALCAM gene and has a role in cell adhesion.</Definition>
        <SemanticType code="T118" name="Carbohydrate"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Activated Leukocyte Cell Adhesion Molecule</Term>
        <Term>Activated-Leukocyte Cell Adhesion Molecule [Chemical/Ingredient]</Term>
        <Term>CD166 Antigen</Term>
        <Term>ANTIGENS CD 166</Term>
        <Term>MEMD</Term>
        <Term>CD 006 LIGAND</Term>
        <Term>activated leukocyte cell adhesion molecule</Term>
        <Term>CD166 Antigens</Term>
        <Term>Antigens, CD166</Term>
        <Term>ALCAM gene</Term>
        <Term>Activated Leukocyte Cell Adhesion Molecule Gene</Term>
        <Term>ALCAM</Term>
        <Term>CD6L</Term>
        <Term>BEN</Term>
        <Term>CD 166 ANTIGENS</Term>
        <Term>ALCAM Gene</Term>
        <Term>CD6 Ligand</Term>
        <Term>Neurolin</Term>
        <Term>ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE</Term>
        <Term>CD166</Term>
        <Term>KG-CAM</Term>
        <Term>Activated-Leukocyte Cell Adhesion Molecule</Term>
        <Codes>
          <Code code="C0295967" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ncr1_protein_rat" name="Ncr1 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ncr1 protein, rat</Term>
        <Term>natural cytotoxicity triggering receptor 1, rat</Term>
        <Term>NKp46 protein, rat</Term>
        <Codes>
          <Code code="C1531299" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Natural_Cytotoxicity_Triggering_Receptor_1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:VWA2_protein_human" name="VWA2 protein, human">
        <SemanticType code="T130" name="Indicator, Reagent, or Diagnostic Aid"/>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">VWA2 protein, human</Term>
        <Term>von Willebrand factor A domain containing 2, human</Term>
        <Term>CCSP-2 protein, human</Term>
        <Term>AMACO protein, human</Term>
        <Term>Colon cancer secreted protein-2, human</Term>
        <Codes>
          <Code code="C1565546" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tnfsf7_protein_mouse" name="Tnfsf7 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tnfsf7 protein, mouse</Term>
        <Term>Cd27l protein, mouse</Term>
        <Term>Ki-24 antigen, mouse</Term>
        <Term>tumor necrosis factor (ligand) superfamily, member 7, mouse</Term>
        <Term>CD27LG protein, mouse</Term>
        <Codes>
          <Code code="C1680624" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD70</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Chinese_Syrian_Hamster" name="Chinese Syrian Hamster">
        <Definition>Derived from a cross between a Chinese hamster and Syrian hamster.</Definition>
        <Definition>A hamster derived from a cross between a Chinese hamster and Syrian hamster.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Chinese Syrian Hamster</Term>
        <Term>CHINESE SYRIAN</Term>
        <Term>Chinese Syrian</Term>
        <Codes>
          <Code code="C2699176" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Hamster</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Sdc1_protein_rat" name="Sdc1 protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Sdc1 protein, rat</Term>
        <Term>syndecan 1 protein, rat</Term>
        <Codes>
          <Code code="C1506026" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Syndecan-1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:nonconcurrent_cohort_study" name="nonconcurrent cohort study">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">nonconcurrent cohort study</Term>
        <Term>nonconcurrent cohort trials</Term>
        <Term>non-concurrent cohort trial</Term>
        <Term>non-concurrent cohort studies</Term>
        <Term>non-concurrent cohort trials</Term>
        <Term>nonconcurrent cohort studies</Term>
        <Term>nonconcurrent cohort designs</Term>
        <Term>nonconcurrent cohort design</Term>
        <Term>non-concurrent cohort design</Term>
        <Term>non-concurrent cohort study</Term>
        <Term>nonconcurrent cohort trial</Term>
        <Term>non-concurrent cohort designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#non-concurrent_cohort_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cohort_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SEA_GnJ_Mouse" name="SEA/GnJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SEA/GnJ Mouse</Term>
        <Term>SEA/GnJ</Term>
        <Codes>
          <Code code="C37434" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:article" name="article">
        <Definition>Nonfictional prose forming an independent part of a publication. [NCIT_14.10d] [Contributing_Source_FDA]</Definition>
        <Definition>Nonfictional prose forming an independent part of a publication.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">article</Term>
        <Term>articles</Term>
        <Term>Article</Term>
        <Codes>
          <Code code="C1706852" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
          <Relation name="Narrower">OTE:journal_article, OTE:historical_article</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:semi-structured_interview" name="semi-structured interview">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">semi-structured interview</Term>
        <Term>semistructured interviews</Term>
        <Term>semi-structured interviews</Term>
        <Term>semistructured interview</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#semi-structured_interview" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:interview</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Population_Groups" name="Population Groups">
        <Definition>&lt;p&gt;A grouping of resources (personnel, material, or places) to be used for scheduling purposes. May be a pool of like-type resources, a team, or combination of personnel, material and places.&lt;/p&gt;</Definition>
        <Definition>Individuals classified according to their sex, racial origin, religion, common place of living, financial or social status, or some other cultural or behavioral attribute. (UMLS, 2003)</Definition>
        <Definition>A group of individuals united by a common factor (e.g., geographic location, ethnicity, disease, age, gender)</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Population Groups</Term>
        <Term>Group</Term>
        <Term>group populations</Term>
        <Term>Population Group</Term>
        <Term>population group</Term>
        <Term>population groups</Term>
        <Term>Group (social concept)</Term>
        <Term>Groups, Population</Term>
        <Term>Subpopulation</Term>
        <Term>groups population</Term>
        <Term>Population</Term>
        <Term>Group, Population</Term>
        <Term>population</Term>
        <Term>group</Term>
        <Codes>
          <Code code="C1257890" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ehnicity_Category</Relation>
          <Relation name="Narrower">OTE:Ethnic_Groups</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Age_Slot" name="Age Slot">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Age Slot</Term>
        <Relations>
          <Relation name="Broader">OTE:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Species_Category" name="Species Category">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Species Category</Term>
        <Relations>
          <Relation name="Broader">OTE:Population_Category</Relation>
          <Relation name="Narrower">OTE:Animal</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd244_protein_rat" name="Cd244 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd244 protein, rat</Term>
        <Term>natural killer cell receptor 2B4, rat</Term>
        <Term>CD244 natural killer cell receptor 2B4, rat</Term>
        <Term>2B4 protein, rat</Term>
        <Term>Nmrk protein, rat</Term>
        <Term>non MHC restricted killing associated protein, rat</Term>
        <Term>transmembrane NK cell receptor 2B4 protein, rat</Term>
        <Codes>
          <Code code="C1432645" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD300A_protein_human" name="CD300A protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD300A protein, human</Term>
        <Term>IRC2 protein, human</Term>
        <Term>CMRF-35-H9 protein, human</Term>
        <Term>CMRF-35H protein, human</Term>
        <Term>IGSF12 protein, human</Term>
        <Term>CMRF-35H antigen, human</Term>
        <Term>CD300a molecule, human</Term>
        <Term>CMRF35H protein, human</Term>
        <Term>CD300a antigen, human</Term>
        <Term>Irp60 protein, human</Term>
        <Term>IRC1 protein, human</Term>
        <Codes>
          <Code code="C1721260" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CZECHII_Mouse" name="CZECHII Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CZECHII Mouse</Term>
        <Term>CZECHII</Term>
        <Codes>
          <Code code="C1511471" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CAR-3_antigen" name="CAR-3 antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CAR-3 antigen</Term>
        <Codes>
          <Code code="C0108325" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:phase_II_trial" name="phase II trial">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">phase II trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#phase_II_trial" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Afp_protein_rat" name="Afp protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Afp protein, rat</Term>
        <Term>alpha-fetospecific glycoprotein, rat</Term>
        <Term>AF glycoprotein, rat</Term>
        <Term>alpha-fetoprotein, rat</Term>
        <Codes>
          <Code code="C1435546" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:double_blind_crossover_design" name="double blind crossover design">
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">double blind crossover design</Term>
        <Term>double-blind crossover designs</Term>
        <Term>Research design [1977-1989]</Term>
        <Term>double-blind crossover studies</Term>
        <Term>double blind crossover trials</Term>
        <Term>double blind crossover trial</Term>
        <Term>double-blind crossover trial</Term>
        <Term>double-blind crossover trials</Term>
        <Term>double-blind crossover design</Term>
        <Term>double blind crossover designs</Term>
        <Term>double-blind crossover study</Term>
        <Term>double blind crossover study</Term>
        <Term>double blind crossover studies</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#double_blind_crossover_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:double_blind_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_CD" name="Antigens, CD">
        <Definition>differentiation antigens (markers) of lymphocyte subsets on cell membrane which are defined by monoclonal antibodies.</Definition>
        <Definition>Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, CD</Term>
        <Term>CD Antigens</Term>
        <Term>Cluster of Differentiation Markers</Term>
        <Term>ANTIGENS CD</Term>
        <Term>Cluster of Differentiation Antigens</Term>
        <Codes>
          <Code code="C0003322" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
          <Relation name="Narrower">OTE:CD320_antigen_human, OTE:Antigen_CD9, OTE:Antigen_CD20, OTE:Antigen_CD7, OTE:Antigen_CD24, OTE:Leukemia_Inhibitory_Factor_Receptor_alpha_Subunit, OTE:CD15_Antigen, OTE:ENG_protein_human, OTE:Interleukin_2_Receptor_beta, OTE:Antigen_CD2, OTE:Antigen_CD1, OTE:BTN3A1_protein_human, OTE:Antigen_CD5, OTE:Tumor_Necrosis_Factor_Ligand_Superfamily_Member_6, OTE:Killer_Cell_Immunoglobulin_Like_Receptor_3DL1, OTE:Antigen_CD19, OTE:Integrin_alphav, OTE:CD22_Antigen, OTE:Antigen_CD31, OTE:IGSF8_protein_human, OTE:CD163_antigen, OTE:Siglece_protein_mouse, OTE:Antigen_CD34, OTE:CDw60_antigen, OTE:CD55_Antigen, OTE:B_Cell_Activation_Factor_Receptor, OTE:SIGLEC6_protein_human, OTE:ALCAM_protein_human, OTE:ICAM3_protein_human, OTE:CD209b_protein_rat, OTE:Tumor_Necrosis_Factor_Receptor_1A, OTE:GM-CSF_IL-3_IL-5_Receptor_Common_beta-Chain, OTE:Antigen_CD27, OTE:SIGLEC9_protein_human, OTE:Antigen_CD29, OTE:CEACAM6_protein_rat, OTE:CD68_protein_rat, OTE:Antigen_CD46, OTE:Antigen_CD43, OTE:Interleukin-4_Receptor_alpha_Subunit, OTE:Antigen_CD40, OTE:Antigens_CD59, OTE:CD300LG_protein_human, OTE:Ly9_protein_mouse, OTE:CEACAM6_protein_human, OTE:CD300A_protein_human, OTE:Transmembrane_Activator_and_CAML_Interactor_Protein, OTE:Intercellular_Adhesion_Molecule-1, OTE:Antigen_CD36, OTE:integrin_alpha7, OTE:Antigen_CD56, OTE:CEACAM6_protein_mouse, OTE:Antigen_Thy-1, OTE:Antigen_CD57, OTE:Antigens_CD4, OTE:Antigen_CD53, OTE:Antigens_CD8, OTE:Antigens_CD321, OTE:CD28_Antigen, OTE:SIGNR3_protein_mouse, OTE:CEACAM8_protein_human, OTE:SEMA7A_protein_human, OTE:Interleukin_13_Receptor_alpha1_Subunit, OTE:Cd160_protein_mouse, OTE:Mic2l1_protein_mouse, OTE:Antigen_CD47, OTE:CD71_antigen, OTE:CD52_antigen, OTE:ectonucleoside_triphosphate_diphosphohydrolase_1, OTE:Sema7a_protein_mouse, OTE:Plasminogen_Activator_Urokinase_Receptors, OTE:CD150_antigen, OTE:Syndecan-1, OTE:Antigen_CD63, OTE:ICAM2_protein_human, OTE:Dipeptidyl-Peptidase_IV, OTE:complement_activation_blocker_2_human, OTE:Receptor_Anaphylatoxin_C5a, OTE:Proto_Oncogene_Proteins_c_kit, OTE:Antigen_CD58, OTE:CD200_membrane_glycoprotein, OTE:Leukocyte_Differentiation_Antigens_Human, OTE:Receptor_OX40, OTE:Antigen_CD70, OTE:BST2_protein_human, OTE:Platelet_Membrane_Glycoprotein_IIb, OTE:CA-15-3_Antigen, OTE:PROCR_protein_human, OTE:Cytotoxic_T_Lymphocyte_Antigen_4, OTE:CDH2_protein_human, OTE:KAI1_Protein, OTE:CD65s_antigen_human, OTE:Antigens_CD14, OTE:Antigens_CD18, OTE:LY9_protein_human, OTE:CD66_antigen, OTE:Antigen_CD86, OTE:Interleukin_2_Receptor_alpha, OTE:Programmed_Cell_Death_1_Protein, OTE:Ly78_protein_mouse, OTE:CDw65_antigen_human, OTE:Receptors_Interleukin-17, OTE:Peptidyl_Dipeptidase_A, OTE:INSR_protein_human, OTE:CD45_Antigen, OTE:Tumor_Necrosis_Factor_Receptor_Type_II, OTE:AC133_antigen, OTE:Inducible_T_Cell_Co_Stimulator_Protein, OTE:Natural_Cytotoxicity_Triggering_Receptor_3, OTE:BL26_protein_mouse, OTE:Natural_Cytotoxicity_Triggering_Receptor_2, OTE:CD244_protein_human, OTE:Natural_Cytotoxicity_Triggering_Receptor_1, OTE:Vascular_Endothelial_Junctional_Adhesion_Molecule, OTE:Receptor_Macrophage_Colony-Stimulating_Factor, OTE:Lyb-2_antigen_human, OTE:CD6_antigen, OTE:CD180_protein_human, OTE:Cd37_protein_mouse, OTE:Interleukin_7_Receptor_alpha_Subunit, OTE:Antigens_CD23, OTE:Antigen_CD94, OTE:Receptors_KIR2DL3, OTE:CD207_protein_human, OTE:Receptors_KIR2DL4, OTE:Receptors_KIR2DL2, OTE:Receptors_KIR2DL1, OTE:CD72_antigen_mouse, OTE:antigen_CD96, OTE:Interleukin_18_Receptor_alpha_Subunit, OTE:semaphorin_7A_protein_rat, OTE:CD146_Antigen, OTE:cadherin-5, OTE:CD231_antigen_human, OTE:CD30_Antigen, OTE:Receptors_Interleukin-1_Type_II, OTE:CD38_Antigens, OTE:Cytokine_Receptor_gp130, OTE:Antigen_CD147, OTE:BY55_protein_human, OTE:Adam8_protein_mouse, OTE:CD97_protein_human, OTE:Common_gamma-Chain_Protein, OTE:CD83_antigen, OTE:CD84_protein_human, OTE:5_-Nucleotidase, OTE:Antigen_CD137, OTE:ICAM-2_protein_mouse, OTE:Interleukin_8A_Receptors, OTE:BST2_protein_mouse, OTE:Cd37_protein_rat, OTE:Integrin_beta4, OTE:Receptor_Thrombopoietin, OTE:Integrin_beta3, OTE:Receptors_KIR3DL2, OTE:CD76_antigen, OTE:CD248_protein_human, OTE:Interleukin_18_Receptor_beta_Subunit, OTE:Complement_3b_Receptors, OTE:E_Selectin, OTE:alpha3_Integrin, OTE:alpha_E_integrins, OTE:fms_Like_Tyrosine_Kinase_3, OTE:bone_marrow_stromal_cell_antigen_1, OTE:Antigen_CD164, OTE:SIGLEC5_protein_human, OTE:CD68_antigen_human, OTE:Interleukin-10_Receptor_alpha_Subunit, OTE:Cd84_protein_mouse, OTE:Antigen_CD151, OTE:Interleukin-13_Receptor_alpha2_Subunit, OTE:tumor_endothelial_marker_1_mouse, OTE:4C8_antigen_human, OTE:Cd99_protein_mouse, OTE:IgG_Receptors, OTE:CDCP1_protein_human, OTE:Lysosomal_Associated_Membrane_Protein_1, OTE:CD109_protein_human, OTE:Lysosomal_Associated_Membrane_Protein_2, OTE:Lysosomal_Associated_Membrane_Protein_3, OTE:Cd244_protein_rat, OTE:antigen_CD100, OTE:Interleukin_3_Receptor_alpha_Subunit, OTE:Antigens_CD80, OTE:BST-2_protein_rat, OTE:antigens_CD69, OTE:Neprilysin, OTE:Interleukin-6_Receptor_alpha_Subunit, OTE:Antigens_CD79, OTE:Interleukin_5_Receptor_alpha_Subunit, OTE:CD48_antigen, OTE:DEC-205_receptors, OTE:CD81_Antigen, OTE:CD109_protein_mouse, OTE:LILRB1_protein_human, OTE:P_Selectin, OTE:SLC44A1_protein_human, OTE:SIGLEC8_protein_human, OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_K, OTE:ST6GAL1_protein_human, OTE:Activated_Leukocyte_Cell_Adhesion_Molecule, OTE:CD68_protein_mouse, OTE:LDL_Receptor_Related_Protein_1, OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_B, OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_D, OTE:LILRB5_protein_human, OTE:Vascular_Cell_Adhesion_Molecule_1, OTE:Fcreceptors, OTE:LILRB3_protein_human, OTE:Integrin_alpha1, OTE:Interleukin-10_Receptor_beta_Subunit, OTE:Antigens_CD95, OTE:Integrin_alpha6, OTE:T-cell_surface_glycoprotein_E2_human, OTE:Integrin_alpha5, OTE:Integrin_alpha4, OTE:Integrin_alpha2, OTE:CD101_antigen_human, OTE:CD40_Ligand, OTE:Complement_3d_Receptor, OTE:Cd101_protein_mouse, OTE:CD30_Ligand, OTE:Receptors_Interleukin-1_Type_I, OTE:CDw17_antigen, OTE:Cd244_protein_mouse, OTE:CD223_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:pragmatic_clinical_trial_" name="pragmatic clinical trial'">
        <Definition>Randomized clinical trials that compare interventions in clinical settings and which look at a range of effectiveness outcomes and impacts.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">pragmatic clinical trial'</Term>
        <Term>Real World Clinical Trials</Term>
        <Term>Trials, Practical Clinical</Term>
        <Term>Clinical Trials, Pragmatic</Term>
        <Term>Pragmatic Clinical Trials</Term>
        <Term>Trials, Pragmatic Clinical</Term>
        <Term>Pragmatic Trials</Term>
        <Term>Naturalistic Randomized Clinical Trial</Term>
        <Term>Pragmatic Clinical Trial</Term>
        <Term>Trials, Pragmatic</Term>
        <Term>Practical Clinical Trials</Term>
        <Term>Clinical Trials, Practical</Term>
        <Term>Pragmatic Clinical Trials as Topic</Term>
        <Codes>
          <Code code="C3658312" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:pragmatic_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Gender_Slot" name="Gender Slot">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Gender Slot</Term>
        <Relations>
          <Relation name="Broader">OTE:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BALB_cByJ_Mouse" name="BALB/cByJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BALB/cByJ Mouse</Term>
        <Term>BALB/cByJ</Term>
        <Codes>
          <Code code="C37360" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_B" name="NK Cell Lectin-Like Receptor Subfamily B">
        <Definition>A subclass of NK cell lectin-like receptors that includes both inhibitory and stimulatory members.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NK Cell Lectin-Like Receptor Subfamily B</Term>
        <Term>Killer Cell Lectin-Like Receptor Subfamily B</Term>
        <Term>NK Cell Lectin Like Receptor Subfamily B</Term>
        <Term>Killer Cell Lectin Like Receptor Subfamily B</Term>
        <Codes>
          <Code code="C2350494" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:NK_Cell_Lectin_Like_Receptor_Subfamily_B_Member_1, OTE:KLRB1_protein_human, OTE:Klrb1b_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Aedes_taeniorhynchus" name="Aedes taeniorhynchus">
        <SemanticType code="T204" name="Eukaryote"/>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Aedes taeniorhynchus</Term>
        <Term>Ochlerotatus taeniorhynchus (Wiedemann, 1821)</Term>
        <Term>Aedes pix</Term>
        <Term>Culex taeniorhynchus</Term>
        <Term>Culex portoricensis</Term>
        <Term>Aedes taeniorhynchus (organism)</Term>
        <Term>Black Salt Marsh Mosquito</Term>
        <Term>Aedes epinolus</Term>
        <Term>Ochlerotatus taeniorhynchus</Term>
        <Term>AEDES TAENIORHYNCHUS</Term>
        <Term>Aedes taeniorhyncus</Term>
        <Term>mosquito allergenic extract</Term>
        <Term>Aedes niger</Term>
        <Term>Culex damnosus</Term>
        <Codes>
          <Code code="C2727802" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Diptera</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_D" name="NK Cell Lectin-Like Receptor Subfamily D">
        <Definition>A subclass of NK cell lectin-like receptors that associates with a variety of members of NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C to form heterodimeric receptors for HLA-E antigen.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NK Cell Lectin-Like Receptor Subfamily D</Term>
        <Term>NK Cell Lectin Like Receptor Subfamily D</Term>
        <Codes>
          <Code code="C2350153" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Antigen_CD94, OTE:Klrd1_protein_mouse, OTE:Klrd1_protein_rat, OTE:KLRD1_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klra6_protein_mouse" name="Klra6 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klra6 protein, mouse</Term>
        <Term>killer cell lectin-like receptor, subfamily A, member 6, mouse</Term>
        <Term>Ly49f antigen, mouse</Term>
        <Term>Ly-49f antigen, mouse</Term>
        <Codes>
          <Code code="C2351935" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:WKY_Rat_Strain" name="WKY, Rat Strain">
        <Definition>An outbred Wistar substrain derived at Kyoto school of medicine and disseminated to the NIH in 1971 and finally to Charles River in 1974. The Wistar Kyoto is a white albino with pink eyes, genotype c.</Definition>
        <Definition>An outbred Wistar substrain derived at Kyoto school of medicine and disseminated to the NIH in 1971 and finally to Charles River in 1974. The Wistar Kyoto is a white albino with pink eyes, genotype c. This rat strain is used in cardiac and behavioral research and as a control for studies involving the spontaneous hypertensive rat.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">WKY, Rat Strain</Term>
        <Term>WISTAR KYOTO</Term>
        <Term>Wistar Kyoto</Term>
        <Codes>
          <Code code="C76192" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_K" name="NK Cell Lectin-Like Receptor Subfamily K">
        <Definition>An activating NK cell lectin-like receptor subfamily that regulates immune responses to INFECTION and NEOPLASMS. Members of this subfamily generally occur as homodimers.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NK Cell Lectin-Like Receptor Subfamily K</Term>
        <Term>Killer Cell Lectin-Like Receptor Subfamily K</Term>
        <Term>Killer Cell Lectin Like Receptor Subfamily K</Term>
        <Term>NK Cell Lectin Like Receptor Subfamily K</Term>
        <Codes>
          <Code code="C2350497" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:NK_Cell_Lectin_Like_Receptor_Subfamily_K_Member_1, OTE:KLRK1_protein_human, OTE:Klrk1_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:controlled_clinical_trial" name="controlled clinical trial">
        <Definition>Work consisting of a clinical trial involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicine, no-treatment, dosage forms and regimens, historical comparisons, etc. [MeSH_2014]</Definition>
        <Definition>A clinical study that includes a comparison (control) group. The comparison group receives a placebo, another treatment, or no treatment at all.</Definition>
        <Definition>Work consisting of a clinical trial involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicine, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trial is characterized as a RANDOMIZED CONTROLLED TRIAL.</Definition>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">controlled clinical trial</Term>
        <Term>Controlled Clinical Trial</Term>
        <Term>controlled clinical designs</Term>
        <Term>Controlled Clinical Trial [Publication Type]</Term>
        <Term>controlled clinical design</Term>
        <Term>controlled clinical study</Term>
        <Term>clinical trial, controlled</Term>
        <Term>controlled clinical studies</Term>
        <Term>controlled clinical trials</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#controlled_clinical_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:clinical_trial</Relation>
          <Relation name="Narrower">OTE:randomized_controlled_clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:S-endoglin_protein_human" name="S-endoglin protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">S-endoglin protein, human</Term>
        <Codes>
          <Code code="C2607816" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:ENG_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:New_Zealand_Red_Rabbit" name="New Zealand Red Rabbit">
        <Definition>A New Zealand rabbit with a red or agouti coat and coat genotype w, VV, en, e.</Definition>
        <Definition>A New Zealand rabbit with a red or agouti coat and coat genotype w, VV, en, e. The New Zealand Red is commonly utilized in biomedical research, in a variety of studies including developmental toxicity studies, toxicology studies, asthma research, and antibody production.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">New Zealand Red Rabbit</Term>
        <Term>New Zealand red rabbit</Term>
        <Term>New Zealand Red rabbit</Term>
        <Term>NEW ZEALAND RED</Term>
        <Term>New Zealand Red</Term>
        <Term>New Zealand Red rabbit breed (organism)</Term>
        <Term>New Zealand Red rabbit breed</Term>
        <Codes>
          <Code code="C0324546" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rabbit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BTBR_Mouse" name="BTBR Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BTBR Mouse</Term>
        <Term>BTBR</Term>
        <Codes>
          <Code code="C1511028" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fcgr1_protein_mouse" name="Fcgr1 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fcgr1 protein, mouse</Term>
        <Term>IgG high affinity Fc receptor, mouse</Term>
        <Term>FcgammaRI protein, mouse</Term>
        <Term>Fc receptor, IgG, high affinity I protein, mouse</Term>
        <Term>Fc gamma receptor RI, mouse</Term>
        <Codes>
          <Code code="C1451692" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BL_6N_Mouse" name="C57BL/6N Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BL/6N Mouse</Term>
        <Term>C57BL/6N</Term>
        <Codes>
          <Code code="C37385" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SKIVE_Mouse" name="SKIVE Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SKIVE Mouse</Term>
        <Term>SKIVE</Term>
        <Codes>
          <Code code="C37438" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C58_Mouse" name="C58 Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C58 Mouse</Term>
        <Term>C58</Term>
        <Codes>
          <Code code="C1511390" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:5-Nucleotidase_syndrome" name="5-Nucleotidase syndrome">
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">5-Nucleotidase syndrome</Term>
        <Term>5'-Nucleotidase syndrome</Term>
        <Codes>
          <Code code="C2930876" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-Nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Yucatan_Micropig" name="Yucatan Micropig">
        <Definition>A strain of Yucatan pig that weighs less than 55 kg when full grown. It was developed at Colorado State University in 1978 and is used extensively in biomedical research.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Yucatan Micropig</Term>
        <Term>YUCATAN MICROPIG</Term>
        <Codes>
          <Code code="C91817" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Micropig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LIS_Rat_Strain" name="LIS, Rat Strain">
        <Definition>This rat comes from Lister stock at the Lister Institute in the 1920s, but the derivation origin is unknown. It has a white body coat color and black coat color over the head.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LIS, Rat Strain</Term>
        <Term>LISTER HOODED</Term>
        <Codes>
          <Code code="C114342" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NOD_129S7-Rag1-tm1Mom_Mouse" name="NOD.129S7(B6)-Rag1-tm1Mom Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NOD.129S7(B6)-Rag1-tm1Mom Mouse</Term>
        <Term>NOD/LtSz-Rag1-tm1Mom</Term>
        <Term>NOD.129S7(B6)-Rag1-tm1Mom</Term>
        <Codes>
          <Code code="C15168" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rag1_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LDLR-related_protein_1A_human" name="LDLR-related protein 1A, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LDLR-related protein 1A, human</Term>
        <Term>LRP-1A receptor, human</Term>
        <Codes>
          <Code code="C1742166" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:LDL_Receptor_Related_Protein_1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Puerto_Ricans" name="Puerto Ricans">
        <Definition>A person of Puerto Rican culture or origin, regardless of race.</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Puerto Ricans</Term>
        <Term>puerto ricans</Term>
        <Term>Puertorican</Term>
        <Term>Puerto Rican</Term>
        <Term>puerto rican</Term>
        <Term>-- Puerto Rican</Term>
        <Term>PUERTO RICAN</Term>
        <Codes>
          <Code code="C0034043" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Hispanic_Americans</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FcgammaRIIb2" name="FcgammaRIIb2">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FcgammaRIIb2</Term>
        <Codes>
          <Code code="C1701832" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Fc_gamma_IIB_receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:integrin_alpha_E2_mouse" name="integrin alpha E2, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">integrin alpha E2, mouse</Term>
        <Term>integrin alphaE2</Term>
        <Codes>
          <Code code="C0663024" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_E_integrins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mammalia" name="Mammalia">
        <Definition>Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.</Definition>
        <Definition>A class of warm-blooded vertebrate animals having the skin more or less covered with hair; young are born alive except for the small subclass of monotremes and nourished with milk.</Definition>
        <Definition>warm-blooded chordates with hair, 7 cervical vertebrates, 4 chambered heart, 5 or fewer digits on each limb, mammary glands with milk for feeding young; can be terrestrial, aerial or aquatic.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mammalia</Term>
        <Term>Mammalian</Term>
        <Term>Mammal</Term>
        <Term>Class Mammalia (organism)</Term>
        <Term>Mammals, General</Term>
        <Term>CLASS MAMMALIA - MAMMALS</Term>
        <Term>mammal</Term>
        <Term>Mammals</Term>
        <Term>Class Mammalia</Term>
        <Term>mammals</Term>
        <Term>83-8C CLASS MAMMALIA - MAMMALS</Term>
        <Codes>
          <Code code="C0024660" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Vertebrata</Relation>
          <Relation name="Narrower">OTE:Carnivora, OTE:Primate, OTE:Artiodactyla, OTE:Perissodactyla, OTE:Rodentia, OTE:Cingulata, OTE:Lagomorpha, OTE:Talpidae_Family_Mole</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Nematoda" name="Nematoda">
        <Definition>A class of unsegmented helminths with fundamental bilateral symmetry and secondary triradiate symmetry of the oral and esophageal structures. Many species are parasites.</Definition>
        <Definition>The taxonomic class whose members are unsegmented worms with an elongated rounded body pointed at both ends.</Definition>
        <Definition>class of unsegmented helminths with fundamental bilateral symmetry and secondary triradiate symmetry of the oral and esophageal structures; many species are parasites.</Definition>
        <SemanticType code="T204" name="Eukaryote"/>
        <SemanticType code="T008" name="Animal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Nematoda</Term>
        <Term>551-578 PHYLUM NEMATODA</Term>
        <Term>Threadworm</Term>
        <Term>Nema</Term>
        <Term>Nematodas</Term>
        <Term>nematoda</Term>
        <Term>Threadworms</Term>
        <Term>nematodes</Term>
        <Term>nematode</Term>
        <Term>Roundworm, NOS</Term>
        <Term>PHYLUM NEMATODA</Term>
        <Term>Nematodes</Term>
        <Term>Phylum Nemata</Term>
        <Term>Phylum Nematoda</Term>
        <Term>roundworm &lt;Nematoda&gt;</Term>
        <Term>roundworm</Term>
        <Term>Nematode, NOS</Term>
        <Term>Roundworms</Term>
        <Term>Nemata</Term>
        <Term>roundworms</Term>
        <Term>Phylum Nemata (organism)</Term>
        <Term>Roundworm</Term>
        <Term>Phylum: Nematoda</Term>
        <Term>Nematode</Term>
        <Codes>
          <Code code="C0027581" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Animal</Relation>
          <Relation name="Narrower">OTE:Caenorhabditis_elegans</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD45_Antigen" name="CD45 Antigen">
        <Definition>Receptor-type tyrosine-protein phosphatase C (1304 aa, ~147 kDa) is encoded by the human PTPRC gene. This protein plays a role in protein dephosphorylation.</Definition>
        <Definition>High-molecular weight glycoproteins uniquely expressed on the surface of LEUKOCYTES and their hemopoietic progenitors. They contain a cytoplasmic protein tyrosine phosphatase activity which plays a role in intracellular signaling from the CELL SURFACE RECEPTORS. The CD45 antigens occur as multiple isoforms that result from alternative mRNA splicing and differential usage of three exons.</Definition>
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD45 Antigen</Term>
        <Term>Leukocyte common Antigen</Term>
        <Term>CD45 - Cluster of diff ag 45</Term>
        <Term>LCA - Leukocyte common antigen</Term>
        <Term>CD45 - Cluster of differentiation antigen 45</Term>
        <Term>L-CA Antigens</Term>
        <Term>Leukocyte Common Antigens</Term>
        <Term>Cluster of differentiation antigen 45</Term>
        <Term>CD 045 ANTIGENS</Term>
        <Term>Lymphocyte antigen CD45</Term>
        <Term>Lymphocyte antigen CD45 (substance)</Term>
        <Term>Antigens, CD45</Term>
        <Term>Leukocyte Common Antigen</Term>
        <Term>Receptor-Type Tyrosine-Protein Phosphatase C</Term>
        <Term>Antigen, CD45</Term>
        <Term>CD45</Term>
        <Term>Antigens, Leukocyte Common</Term>
        <Term>Antigens, L-CA</Term>
        <Term>Antigen, Leukocyte Common</Term>
        <Term>Antigens, CD45 [Chemical/Ingredient]</Term>
        <Term>T200 Glycoprotein</Term>
        <Term>L-CA</Term>
        <Term>EC 3.1.3.48</Term>
        <Term>LCA - Leucocyte common antigen</Term>
        <Term>Leukocyte common antigen</Term>
        <Term>Protein Tyrosine Phosphatase, Receptor Type, C</Term>
        <Term>CD45 Ag</Term>
        <Term>ANTIGENS CD 045</Term>
        <Term>T200 - T-cell lineage 200</Term>
        <Term>Cluster of diff antigen 45</Term>
        <Term>T200 Antigens</Term>
        <Term>Leucocyte common antigen</Term>
        <Term>CD45 antigen</Term>
        <Term>CD45 Antigens</Term>
        <Term>Antigens, T200</Term>
        <Term>T-cell lineage 200</Term>
        <Term>leucocyte common antigen</Term>
        <Term>Leukocyte common Ag</Term>
        <Term>PTPRC</Term>
        <Term>T200</Term>
        <Term>L CA Antigens</Term>
        <Codes>
          <Code code="C0054961" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Ptprc_protein_mouse, OTE:PTPRC_protein_human, OTE:CD45RB_Antigens, OTE:B220_Antigens, OTE:Ptprc_protein_rat, OTE:CD45RCAntigens, OTE:CD45RA_Antigens</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129S3_SvImJ_Mouse" name="129S3/SvImJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129S3/SvImJ Mouse</Term>
        <Term>129S3/SvImJ</Term>
        <Codes>
          <Code code="C37339" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:analytical_design" name="analytical design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">analytical design</Term>
        <Term>analytic research</Term>
        <Term>analytic trial</Term>
        <Term>analytical trial</Term>
        <Term>analytic design</Term>
        <Term>analytic trials</Term>
        <Term>analytic designs</Term>
        <Term>analytic studies</Term>
        <Term>analytical studies</Term>
        <Term>analytical designs</Term>
        <Term>analytic study</Term>
        <Term>analytical trials</Term>
        <Term>analytical study</Term>
        <Term>analytical research</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#analytical_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD45RB_Antigens" name="CD45RB Antigens">
        <Definition>A splicing isoform of CD45 antigen that includes exon B.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD45RB Antigens</Term>
        <Term>Antigens, CD45RB</Term>
        <Term>CD45RB Ag</Term>
        <Term>CD45RB Antigen</Term>
        <Term>CD45 RB - Cluster of differentiation antigen 45 RB</Term>
        <Term>Cluster of differentiation antigen 45 RB</Term>
        <Term>Cluster of diff antigen 45 RB</Term>
        <Term>Lymphocyte antigen CD45RB</Term>
        <Term>CD45RB-Clust differ antig 45RB</Term>
        <Term>Lymphocyte antigen CD45RB (substance)</Term>
        <Term>CD45 RB-Clust of diff ag 45 RB</Term>
        <Term>CD45RB - Cluster of differentiation antigen 45 RB</Term>
        <Term>CD45RB</Term>
        <Codes>
          <Code code="C0108790" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD45_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:duplicate_publication" name="duplicate publication">
        <Definition>Work consisting of an article or book of identical or nearly identical material published simultaneously or successively to material previously published elsewhere, without acknowledgment of the prior publication.</Definition>
        <Definition>Work consisting of an article or book of identical or nearly identical material published simultaneously or successively to material previously published elsewhere, without acknowledgment of the prior publication. [MeSH_2014]</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">duplicate publication</Term>
        <Term>duplicate publications</Term>
        <Term>Duplicate Publication</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#duplicate_publication" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FVB_Mouse" name="FVB Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FVB Mouse</Term>
        <Term>FVB</Term>
        <Codes>
          <Code code="C37406" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:New_Zealand_Hybrid_Rabbit" name="New Zealand Hybrid Rabbit">
        <Definition>A rabbit that is derived from a cross between two different New Zealand strains of determinate or indeterminate coat genotype.</Definition>
        <Definition>A rabbit that is derived from a cross between two different New Zealand strains of determinate or indeterminate coat genotype. The New Zealand hybrid is commonly utilized in biomedical research, in a variety of studies including developmental toxicity studies, toxicology studies, asthma research, and antibody production.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">New Zealand Hybrid Rabbit</Term>
        <Term>NEW ZEALAND HYBRID</Term>
        <Term>New Zealand Hybrid</Term>
        <Codes>
          <Code code="C2698459" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rabbit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:sialosyl_dimeric_Leantigen" name="sialosyl dimeric Le(x) antigen">
        <SemanticType code="T109" name="Organic Chemical"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">sialosyl dimeric Le(x) antigen</Term>
        <Term>sialyl diLe(x)</Term>
        <Term>sialyl dimeric Le(x) antigen</Term>
        <Term>dimeric Le(x)</Term>
        <Term>di-Le(x)</Term>
        <Codes>
          <Code code="C0142255" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD15_Antigen</Relation>
          <Relation name="Narrower">OTE:difucosyl_lactosamine, OTE:FH-4_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ALCAM_protein_human" name="ALCAM protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T124" name="Neuroreactive Substance or Biogenic Amine"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ALCAM protein, human</Term>
        <Term>HCA antigen</Term>
        <Term>antigens CD166, human</Term>
        <Term>HCA antigen, human</Term>
        <Term>activated leukocyte cell adhesion molecule, human</Term>
        <Term>CD166 antigen, human</Term>
        <Term>hematopoietic cell antigen HCA</Term>
        <Codes>
          <Code code="C0538294" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:WMP_Mouse" name="WMP Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">WMP Mouse</Term>
        <Term>WMP</Term>
        <Codes>
          <Code code="C37444" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Drug_Monitoring" name="Drug Monitoring">
        <Definition>The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.</Definition>
        <SemanticType code="T058" name="Health Care Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Drug Monitoring</Term>
        <Term>drugs monitor</Term>
        <Term>Drug monitoring</Term>
        <Term>Medication monitoring (regime/therapy)</Term>
        <Term>Medication.monitoring</Term>
        <Term>Monitor effects of medications</Term>
        <Term>drug monitoring</Term>
        <Term>medication monitoring</Term>
        <Term>Monitor for effects of medication</Term>
        <Term>Medication monitoring</Term>
        <Term>Monitor medication actions</Term>
        <Term>drug monitors</Term>
        <Term>medications monitoring</Term>
        <Term>Monitoring, Drug</Term>
        <Term>drugs monitoring</Term>
        <Codes>
          <Code code="C0085421" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Physiologic_Monitoring</Relation>
          <Relation name="Narrower">OTE:Therapeutic_Drug_Monitoring</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:omega_protein_Drosophila" name="omega protein, Drosophila">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">omega protein, Drosophila</Term>
        <Codes>
          <Code code="C1869685" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Dipeptidyl-Peptidase_IV</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:B6_129S7-Rag1-tm1Mom_Mouse" name="B6.129S7-Rag1-tm1Mom Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">B6.129S7-Rag1-tm1Mom Mouse</Term>
        <Term>B6.129S7-Rag1-tm1Mom</Term>
        <Term>C57BL/6J-Rag1-tm1Mom</Term>
        <Codes>
          <Code code="C15171" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rag1_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:neprilysin_2_rat" name="neprilysin 2, rat">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">neprilysin 2, rat</Term>
        <Term>NEP2 protein, rat</Term>
        <Codes>
          <Code code="C1260198" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Neprilysin</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LH_Rat_Strain" name="LH, Rat Strain">
        <Definition>LH: The strain exhibits mild hypertension (approx 165mmHg in males and 140mmHg in females at 14 weeks of age in 1984) with increased body weight and plasma lipids. There is reduced life-span (compared with LN and LL) with histopathological lesions characteristic of hypertensive disease in rats.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LH, Rat Strain</Term>
        <Codes>
          <Code code="C14408" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:chmadrin" name="chmadrin">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">chmadrin</Term>
        <Codes>
          <Code code="C0909384" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_Ki_67</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:placental_anemia-inducing_factor" name="placental anemia-inducing factor">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">placental anemia-inducing factor</Term>
        <Codes>
          <Code code="C0633403" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD59_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD47_protein_human" name="CD47 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD47 protein, human</Term>
        <Term>CD47 antigen (Rh-related antigen, integrin-associated signal transducer), human</Term>
        <Term>OVTL3 protein, human</Term>
        <Term>integrin-associated protein IAP, human</Term>
        <Term>IAP-50 antigen, human</Term>
        <Term>leukocyte surface antigen CD47, human</Term>
        <Term>OA3 antigen, human</Term>
        <Codes>
          <Code code="C1506697" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD47</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CAM_5_2_antigen" name="CAM 5.2 antigen">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CAM 5.2 antigen</Term>
        <Term>CAM5.2</Term>
        <Term>CAM5.2 antigen</Term>
        <Term>cytokeratin CAM 5.2</Term>
        <Term>CAM 5.2 cytokeratin</Term>
        <Codes>
          <Code code="C0910360" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD163_protein_human" name="CD163 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD163 protein, human</Term>
        <Term>M130 protein, human</Term>
        <Term>CD163 antigen protein, human</Term>
        <Codes>
          <Code code="C1570089" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD163_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:open_label_design" name="open label design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">open label design</Term>
        <Term>open-label designs</Term>
        <Term>open label studies</Term>
        <Term>open-label trials</Term>
        <Term>open-label design</Term>
        <Term>open label study</Term>
        <Term>open label designs</Term>
        <Term>open-label trial</Term>
        <Term>open label trial</Term>
        <Term>open-label studies</Term>
        <Term>open-label study</Term>
        <Term>open label trials</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#open_label_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:open_design</Relation>
          <Relation name="Narrower">OTE:open_label_clinical_design, OTE:open_label_randomized_controlled_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Single_Lung_Transplantation" name="Single Lung Transplantation">
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Single Lung Transplantation</Term>
        <Term>LUNG TRANSPLANT SINGLE</Term>
        <Term>Single lung transplant</Term>
        <Term>LUNG TRANSPLANT 1 W/O CARDIOPULMONARY BYPASS</Term>
        <Term>Unilateral lung transplantation</Term>
        <Term>Lung transplant, single</Term>
        <Term>SLTx - Single lung transplant</Term>
        <Term>single lung transplantation</Term>
        <Term>single lung transplant</Term>
        <Term>Lung transplant, single; without cardiopulmonary bypass</Term>
        <Term>lung transplantation single</Term>
        <Term>Single lung transplant (procedure)</Term>
        <Term>a single lung transplantation</Term>
        <Term>single lung transplantation (treatment)</Term>
        <Term>Lung transplant single</Term>
        <Term>Unilat lung transplant</Term>
        <Codes>
          <Code code="C51672" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Lung_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:medical_audit" name="medical audit">
        <Definition>Determinación de la calidad asistencial realizada en forma retrospectiva</Definition>
        <Definition>A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of medical care.</Definition>
        <Definition>A quality of care determination performed retrospectively</Definition>
        <Definition>A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of medical care. [MeSH_2014]</Definition>
        <SemanticType code="T058" name="Health Care Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">medical audit</Term>
        <Term>Medical Audit</Term>
        <Term>MED AUDITS</Term>
        <Term>Medical audit procedure</Term>
        <Term>Med Audit</Term>
        <Term>MED AUDIT</Term>
        <Term>AUDITS MED</Term>
        <Term>Hospital Administration [1966-1967]</Term>
        <Term>audit medical</Term>
        <Term>Medical audit procedure (procedure)</Term>
        <Term>Audits, Medical</Term>
        <Term>Audit, Medical</Term>
        <Term>Medical Audits</Term>
        <Term>auditing medical</Term>
        <Term>medical audits</Term>
        <Term>AUDIT MED</Term>
        <Term>Medical audit</Term>
        <Term>Medical audit procedure, NOS</Term>
        <Codes>
          <Code code="C0025072" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:records_review</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:plasminogen_activator_urokinase_receptor_human" name="plasminogen activator, urokinase receptor, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">plasminogen activator, urokinase receptor, human</Term>
        <Term>urokinase plasminogen activator surface receptor, human</Term>
        <Term>PLAUR protein, human</Term>
        <Term>CD87 antigen, human</Term>
        <Codes>
          <Code code="C0376277" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Plasminogen_Activator_Urokinase_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129P4_RrSv_Mouse" name="129P4/RrSv Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129P4/RrSv Mouse</Term>
        <Term>129P4/RrSv</Term>
        <Codes>
          <Code code="C37332" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Template" name="template">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">template</Term>
        <Relations>
          <Relation name="Broader">owl:Thing</Relation>
          <Relation name="Narrower">OTE:OrganTransplantExtraction_Template</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD137" name="Antigen, CD137">
        <Definition>Tumor necrosis factor receptor superfamily member 9 (255 aa, ~28 kDa) is encoded by the human TNFRSF9 gene. This protein plays a role in receptor signal transduction in activated T-lymphocytes.</Definition>
        <Definition>A member of the tumor necrosis factor receptor superfamily that is specific for 4-1BB LIGAND. It is found in a variety of immune cell types including activated T-LYMPHOCYTES; NATURAL KILLER CELLS; and DENDRITIC CELLS. Activation of the receptor on T-LYMPHOCYTES plays a role in their expansion, production of cytokines and survival. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD137</Term>
        <Term>CD137 Antigen</Term>
        <Term>CD137 Antigens</Term>
        <Term>4 1BB Receptor</Term>
        <Term>BB RECEPTORS 4 1</Term>
        <Term>Receptor, 4-1BB</Term>
        <Term>4 1BB Receptors</Term>
        <Term>ANTIGENS CD 137</Term>
        <Term>Receptors, 4-1BB</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 09</Term>
        <Term>TNFRSF9 Receptor</Term>
        <Term>Receptor, TNFRSF9</Term>
        <Term>4-1BB Receptors</Term>
        <Term>Antigens, CD137</Term>
        <Term>CD 137 ANTIGENS</Term>
        <Term>Tumor Necrosis Factor Receptor Superfamily, Member 9</Term>
        <Term>4-1BB Receptor</Term>
        <Codes>
          <Code code="C0214721" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:TNFRSF9_protein_human, OTE:Tnfrsf9_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD22_Antigen" name="CD22 Antigen">
        <Definition>A lectin and cell adhesion molecule found in B-LYMPHOCYTES. It interacts with SIALIC ACIDS and mediates signaling from B-CELL ANTIGEN RECEPTORS.</Definition>
        <Definition>B-cell receptor CD22 (847 aa, 95 kD) is a cell adhesion process protein that is encoded by the human CD22 gene and may have a role in cell adhesion.</Definition>
        <Definition>A protein found on some tumor cells.</Definition>
        <Definition>This gene is involved in mediating the adhesion between B cells and is a molecular marker for B-cell precursor acute lymphocytic leukemia.</Definition>
        <Definition>Cell surface carbohydrate molecules of the Lewis Y or Lewis X type that are detectable with monoclonal antibody B3. This group of antigens is found more frequently on tumor cells than normal cells.</Definition>
        <Definition>B cell specific adhesion molecule; active in adhesion to monocytes and T cells.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD22 Antigen</Term>
        <Term>CD 022 ANTIGENS</Term>
        <Term>CD22 - Cluster of diff ag 22</Term>
        <Term>CD22 molecule</Term>
        <Term>CD22 Antigen Gene</Term>
        <Term>B-Cell Antigen CD22</Term>
        <Term>B Lymphocyte Cell Adhesion Molecule</Term>
        <Term>Glycoprotein, CD22</Term>
        <Term>B3 Antigen</Term>
        <Term>Cluster of differentiation antigen 22</Term>
        <Term>B3 antigen</Term>
        <Term>Antigens, CD22</Term>
        <Term>B-CELL ANTIGEN CD22</Term>
        <Term>Lyb8</Term>
        <Term>LYMPHOCYTE CELL ADHESION MOLECULE B</Term>
        <Term>Lymphocyte antigen CD22 (substance)</Term>
        <Term>B-Cell Receptor CD22</Term>
        <Term>B-Lymphocyte Cell Adhesion Molecule</Term>
        <Term>Siglec-2</Term>
        <Term>CD22 Glycoprotein</Term>
        <Term>SIGLEC-2</Term>
        <Term>CD22 ANTIGEN</Term>
        <Term>Sialic Acid Binding Ig-like Lectin 2 [Chemical/Ingredient]</Term>
        <Term>BL-CAM</Term>
        <Term>CD22 Ag</Term>
        <Term>Sialic Acid Binding Ig-like Lectin 2</Term>
        <Term>Leu 14</Term>
        <Term>CD22 gene</Term>
        <Term>SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 2</Term>
        <Term>Sialic Acid-Binding Immunoglobulin-Like Lectin 2</Term>
        <Term>CD22 Antigens</Term>
        <Term>CD22</Term>
        <Term>Antigen, CD22</Term>
        <Term>CD22 - Cluster of differentiation antigen 22</Term>
        <Term>sialic acid binding Ig-like lectin 2</Term>
        <Term>Cluster of diff antigen 22</Term>
        <Term>ANTIGENS CD 022</Term>
        <Term>Lymphocyte antigen CD22</Term>
        <Term>CD22 Gene</Term>
        <Term>CD22 antigen</Term>
        <Term>Sialic Acid Binding Ig like Lectin 2</Term>
        <Term>SIGLEC2</Term>
        <Term>Leukocyte 14</Term>
        <Term>Leucocyte 14</Term>
        <Codes>
          <Code code="C1332708" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cd22_protein_mouse, OTE:CD22_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SEMA7A_protein_human" name="SEMA7A protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SEMA7A protein, human</Term>
        <Term>semaphorin L protein, human</Term>
        <Term>semaphorin-L protein, human</Term>
        <Term>CDw108 protein, human</Term>
        <Term>semaphorin 7A protein, human</Term>
        <Term>sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A protein, human</Term>
        <Term>CDw108 antigen, human</Term>
        <Term>John-Milton-Hagen human blood group Ag</Term>
        <Term>H-Sema-L protein, human</Term>
        <Codes>
          <Code code="C1314854" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL18rap_protein_mouse" name="IL18rap protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL18rap protein, mouse</Term>
        <Term>AcPL protein, mouse</Term>
        <Term>IL-18 accessory protein-like protein, mouse</Term>
        <Term>interleukin 18 receptor accessory protein, mouse</Term>
        <Codes>
          <Code code="C1570036" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_18_Receptor_beta_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD81_protein_human" name="CD81 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD81 protein, human</Term>
        <Term>TSPAN28 protein, human</Term>
        <Term>target of antiproliferative antibody 1 protein, human</Term>
        <Term>CD81 antigen, human</Term>
        <Term>TAPA-1 antigen, human</Term>
        <Codes>
          <Code code="C1452163" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD81_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD83_antigen" name="CD83 antigen">
        <Definition>This gene may play a role in antigen presentation.</Definition>
        <Definition>CD83 antigen (205 aa, ~23 kDa) is encoded by the human CD83 gene. This protein may play a role in antigen presentation.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD83 antigen</Term>
        <Term>Lymphocyte antigen CD83 (substance)</Term>
        <Term>CD83 antigen, human</Term>
        <Term>CD83</Term>
        <Term>hCD83</Term>
        <Term>CD83 Antigen</Term>
        <Term>CD83 protein, human</Term>
        <Term>CD83 gene</Term>
        <Term>CD83 ANTIGEN</Term>
        <Term>BL11</Term>
        <Term>HB15</Term>
        <Term>CD83 Molecule Gene</Term>
        <Term>B-Cell Activation Protein</Term>
        <Term>CD83 antigen (activated B lymphocytes, immunoglobulin superfamily), human</Term>
        <Term>Cell Surface Protein HB15</Term>
        <Term>CD83 molecule</Term>
        <Term>CD83 Gene</Term>
        <Term>Lymphocyte antigen CD83</Term>
        <Codes>
          <Code code="C0296277" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:CD83_antigen_human, OTE:Cd83_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:proliferating_cell_marker_1_protein_rat" name="proliferating cell marker 1 protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">proliferating cell marker 1 protein, rat</Term>
        <Codes>
          <Code code="C1308052" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:abstract" name="abstract">
        <Definition>A concept or idea not associated with any specific instance.</Definition>
        <Definition>A written summary of the important points of a scientific article. [NCIT_14.08d]</Definition>
        <Definition>Works consisting of lists of publications on a subject and that provide full annotated bibliographical information together with substantive summaries or condensations of the facts, ideas, or opinions presented in each publication listed. (From LC Subject Cataloging Manual)</Definition>
        <Definition>A written summary of the important points of a scientific article.</Definition>
        <Definition>&lt;p&gt;Include only the descendents of this concept in the domain or value set, not the concept itself.&lt;/p&gt;</Definition>
        <Definition>shortening or summarizing of documents.</Definition>
        <Definition>The process of creating a summary of the main points of an article, argument, or theory.</Definition>
        <SemanticType code="T057" name="Occupational Activity"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T078" name="Idea or Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">abstract</Term>
        <Term>Abstract Summary</Term>
        <Term>abstracting</Term>
        <Term>Abstracts</Term>
        <Term>Abstracted</Term>
        <Term>Abstract</Term>
        <Term>summary</Term>
        <Term>summaries</Term>
        <Term>Abstract Document</Term>
        <Term>Abstracting as Topic</Term>
        <Term>abstracts</Term>
        <Term>Abstracting</Term>
        <Term>Abstract idea</Term>
        <Codes>
          <Code code="C0600678" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD-1_Nude_Mouse" name="CD-1 Nude Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD-1 Nude Mouse</Term>
        <Term>CD-1 Nude</Term>
        <Term>Cr1:CD-1 -nuBR</Term>
        <Codes>
          <Code code="C15152" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Nude_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SF_CamEiJ_Mouse" name="SF/CamEiJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SF/CamEiJ Mouse</Term>
        <Term>SF/CamEiJ</Term>
        <Codes>
          <Code code="C37436" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD223_antigen" name="CD223 antigen">
        <Definition>This gene is involved in the activation of T-cells and natural killer cells.</Definition>
        <Definition>Lymphocyte activation gene 3 protein (525 aa, ~57 kDa) is encoded by the human LAG3 gene. This protein is involved in the activation of T-cells and natural killer cells.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD223 antigen</Term>
        <Term>CD223 Antigen</Term>
        <Term>lymphocyte activation 3 protein</Term>
        <Term>LYMPHOCYTE ACTIVATION GENE 3</Term>
        <Term>Lymphocyte-Activation Gene 3</Term>
        <Term>Protein FDC</Term>
        <Term>LAG3</Term>
        <Term>antigens, CD223 antigen</Term>
        <Term>lymphocyte-activation gene 3</Term>
        <Term>Lag3 protein, human</Term>
        <Term>LAG3 Gene</Term>
        <Term>CD223 antigen, human</Term>
        <Term>CD223 ANTIGEN</Term>
        <Term>lymphocyte-activation gene 3 protein, human</Term>
        <Term>CD223</Term>
        <Term>Lymphocyte Activation Gene 3 Protein</Term>
        <Term>LAG3 gene</Term>
        <Codes>
          <Code code="C1416771" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:IMP321, OTE:Lag3_protein_mouse, OTE:lymphocyte-activation_gene_3_protein_human, OTE:soluble_LAG-3_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:time_and_motion_study" name="time and motion study">
        <Definition>The observation and analysis of movements in a task with an emphasis on the amount of time required to perform the task. [MeSH_2014]</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">time and motion study</Term>
        <Term>performance, task</Term>
        <Term>task performance and analysis</Term>
        <Term>time and motion studies</Term>
        <Term>test performance</Term>
        <Term>work sampling</Term>
        <Term>Task performance and analysis [1973-74]</Term>
        <Term>Time studies</Term>
        <Term>task performance</Term>
        <Term>work simplification</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#time_and_motion_study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD4_D-Tyr" name="CD4 (81-92), D-Tyr">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD4 (81-92), D-Tyr</Term>
        <Codes>
          <Code code="C0959472" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD4</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:PDCD1_protein_human" name="PDCD1 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">PDCD1 protein, human</Term>
        <Term>hPD-1 protein, human</Term>
        <Term>programmed cell death 1 protein, human</Term>
        <Term>PD1 protein, human</Term>
        <Term>programmed death protein 1, human</Term>
        <Term>PD-1 protein, human</Term>
        <Term>CD279 antigen, human</Term>
        <Codes>
          <Code code="C0135710" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Programmed_Cell_Death_1_Protein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:address" name="address">
        <Definition>A formal speech or report.</Definition>
        <Definition>A formal speech or report. [NCIT_14.08d]</Definition>
        <Definition>A data type comprised of mailing and home or office addresses.</Definition>
        <Definition>Works consisting of speeches, orations, or written statements, usually formal, directed to a particular group of persons. These are different from LECTURES that are usually delivered to classes for instructional purposes.</Definition>
        <Definition>A standardized representation of the location of a person, business, building, or organization.</Definition>
        <Definition>&lt;p&gt;For attributes representing the location at which an organization, person, or item may be found or reached.&lt;/p&gt;</Definition>
        <SemanticType code="T082" name="Spatial Concept"/>
        <SemanticType code="T201" name="Clinical Attribute"/>
        <SemanticType code="T073" name="Manufactured Object"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">address</Term>
        <Term>MDF Attribute Type - Address</Term>
        <Term>Address</Term>
        <Term>Address:Address:Point in time:^Patient:Nominal</Term>
        <Term>Addr</Term>
        <Term>Data types - Address</Term>
        <Term>Addresses</Term>
        <Term>Address Data Type</Term>
        <Term>addresses</Term>
        <Term>Addresses (publication format)</Term>
        <Term>AD</Term>
        <Term>Address (observable entity)</Term>
        <Term>physicalAddress</Term>
        <Term>Value type - Address</Term>
        <Term>Address:Addr:Pt:^Patient:Nom</Term>
        <Codes>
          <Code code="C1578436" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:systematic_review" name="systematic review">
        <Definition>Work in which the author outlines a systematic approach to the relevant literature as part of the review.</Definition>
        <Definition>Used for studies that systematically summarize all relevant evidence pertaining to a defined health question, and including items identified as such by the author. [Emtree_2014]</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">systematic review</Term>
        <Term>Review, Systematic</Term>
        <Term>reviews systematic</Term>
        <Term>review systematic</Term>
        <Term>systematic reviews</Term>
        <Term>review, systematic</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#systematic_review" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:literature_review</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:A28807_Rat_Strain" name="A28807, Rat Strain">
        <Definition>Very docile. Susceptible to the induction of autoimmune thyroiditis. Low and intermediate antibody responses to 1 and 10 g BSA, respectively. Low antibody response to streptococcal group A carbohydrate; not linked to the MHC. High relative heart weight in 10-week old males (20/23).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">A28807, Rat Strain</Term>
        <Codes>
          <Code code="C14393" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mpl_protein_mouse" name="Mpl protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mpl protein, mouse</Term>
        <Term>thrombopoietin receptor, mouse</Term>
        <Term>c-Mpl-L protein, mouse</Term>
        <Codes>
          <Code code="C1434600" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptor_Thrombopoietin</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FCER1A_protein_human" name="FCER1A protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FCER1A protein, human</Term>
        <Term>IgE receptor alpha-chain, human</Term>
        <Term>Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide, human</Term>
        <Term>FCE1A protein, human</Term>
        <Term>Fc IgE receptor, alpha polypeptide, human</Term>
        <Codes>
          <Code code="C1259682" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD23</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Amish" name="Amish">
        <Definition>An ethnic group with shared religious beliefs. Originating in Switzerland in the late 1600s, and first migrating to the mid-Atlantic, they now live throughout Eastern and Mid-Western United States and elsewhere. Communities are usually close-knit and marriage is within the community.</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Amish</Term>
        <Term>amish</Term>
        <Term>Amish religion (religion/philosophy)</Term>
        <Term>Amish religion</Term>
        <Term>AMISH</Term>
        <Codes>
          <Code code="C0238622" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ethnic_Groups</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Lampyridae" name="Lampyridae">
        <Definition>The family Lampyidae, which are bioluminescent BEETLES. They contain FIREFLY LUCIFERIN and LUCIFERASES. Oxidation of firefly luciferin results in luminescence.</Definition>
        <Definition>A beetle in the family Lampyridae noted for its bioluminescence. The organism from which luciferase was first isolated.</Definition>
        <SemanticType code="T204" name="Eukaryote"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Lampyridae</Term>
        <Term>lampyridae</Term>
        <Term>Firefly</Term>
        <Term>firefly</Term>
        <Term>fireflies</Term>
        <Term>firefly beetles</Term>
        <Term>Fireflies</Term>
        <Term>Firefly Family</Term>
        <Codes>
          <Code code="C0162328" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Insect</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD244_protein_human" name="CD244 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD244 protein, human</Term>
        <Term>NKR2B4 protein, human</Term>
        <Term>NAIL protein, human</Term>
        <Term>2B4 protein, human</Term>
        <Term>natural killer cell receptor 2B4 protein, human</Term>
        <Term>NK cell activation-inducing ligand, human</Term>
        <Term>natural killer cell receptor 2B4, human</Term>
        <Codes>
          <Code code="C1432728" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:decay-accelerating_factor_1_mouse" name="decay-accelerating factor 1, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">decay-accelerating factor 1, mouse</Term>
        <Term>Daf1 protein, mouse</Term>
        <Codes>
          <Code code="C1958476" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD55_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd63_protein_mouse" name="Cd63 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd63 protein, mouse</Term>
        <Term>Ad1 antigen, mouse</Term>
        <Term>Cd63 antigen, mouse</Term>
        <Codes>
          <Code code="C0170549" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD63</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD66_antigen" name="CD66 antigen">
        <Definition>This gene is involved in cell-cell interactions.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD66 antigen</Term>
        <Term>CD66a</Term>
        <Term>BGP</Term>
        <Term>BILIARY GLYCOPROTEIN</Term>
        <Term>carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)</Term>
        <Term>CD66 antigens</Term>
        <Term>CEACAM1</Term>
        <Term>BILIARY GLYCOPROTEIN 1</Term>
        <Term>BGP1</Term>
        <Term>CEACAM1 Gene</Term>
        <Term>Lymphocyte antigen CD66</Term>
        <Term>CD66 ANTIGEN</Term>
        <Term>CD66 - Cluster of differentiation antigen 66</Term>
        <Term>Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (Biliary Glycoprotein) Gene</Term>
        <Term>CD66</Term>
        <Term>CD66 - Cluster of diff ag 66</Term>
        <Term>CEACAM1 gene</Term>
        <Term>Cluster of differentiation antigen 66</Term>
        <Term>Cluster of diff antigen 66</Term>
        <Term>CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 1</Term>
        <Term>Lymphocyte antigen CD66 (substance)</Term>
        <Codes>
          <Code code="C0108797" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:biliary_glycoprotein_I, OTE:Ceacam1_protein_rat, OTE:C-CAM2, OTE:CEACAM1_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:WIST_Rat_Strain" name="WIST, Rat Strain">
        <Definition>An outbred strain of albino brown rat, this strain was developed at the Wistar Institute by Donaldson, Greenman, and King (1906). The Wistar rat has a wide head, long ears, and its tail length is always less than its body length. A wide variety of rat inbred strains have been derived from the Wistar.</Definition>
        <Definition>An outbred strain of albino brown rat, this strain was developed at the Wistar Institute by Donaldson, Greenman, and King (1906) and was the first rat strain in use in biomedical research. The Wistar rat has a wide head, long ears, and its tail length is always less than its body length. A wide variety of rat inbred strains have been derived from the Wistar.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">WIST, Rat Strain</Term>
        <Term>Wistar</Term>
        <Term>WISTAR</Term>
        <Codes>
          <Code code="C76190" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:open_label_clinical_design" name="open label clinical design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">open label clinical design</Term>
        <Term>open-label clinical studies</Term>
        <Term>open label clinical designs</Term>
        <Term>open-label clinical design</Term>
        <Term>open-label clinical study</Term>
        <Term>open-label clinical designs</Term>
        <Term>open label clinical trials</Term>
        <Term>open-label clinical trials</Term>
        <Term>open-label clinical trial</Term>
        <Term>open label clinical study</Term>
        <Term>open label clinical studies</Term>
        <Term>open label clinical trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#open_label_clinical_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:open_label_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Spn_protein_mouse" name="Spn protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Spn protein, mouse</Term>
        <Term>Cd43 protein, mouse</Term>
        <Term>sialophorin protein, mouse</Term>
        <Term>Ly-48 protein, mouse</Term>
        <Codes>
          <Code code="C1451027" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD43</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD1" name="Antigen, CD1">
        <Definition>antigen presenting molecule encoded outside of the major histocompatibility complex.</Definition>
        <Definition>Glycoproteins expressed on cortical thymocytes and on some dendritic cells and B-cells. Their structure is similar to that of MHC Class I and their function has been postulated as similar also. CD1 antigens are highly specific markers for human LANGERHANS CELLS.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD1</Term>
        <Term>Antigens, CD1</Term>
        <Term>CD 001 ANTIGENS</Term>
        <Term>ANTIGENS CD 001</Term>
        <Term>CD1 Antigen</Term>
        <Term>CD1 Antigens</Term>
        <Codes>
          <Code code="C0054941" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:CD1a_antigen, OTE:Antigens_CD1d, OTE:CD1e_antigen, OTE:CD1A1_antigen, OTE:CD1b_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD147" name="Antigen, CD147">
        <Definition>A widely distributed cell surface transmembrane glycoprotein that stimulates the synthesis of MATRIX METALLOPROTEINASES. It is found at high levels on the surface of malignant NEOPLASMS and may play a role as a mediator of malignant cell behavior.</Definition>
        <Definition>Basigin (385 aa, ~42 kDa) is encoded by the human BSG gene. This protein is involved in signal transduction that mediates protease gene expression, implantation, sperm formation and neural development.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD147</Term>
        <Term>Emmprin Protein</Term>
        <Term>Basigin Protein</Term>
        <Term>Emmprin</Term>
        <Term>CD 147 ANTIGENS</Term>
        <Term>Extracellular Matrix Metalloproteinase Inducer (EMMPRIN)</Term>
        <Term>Basigin</Term>
        <Term>ANTIGENS CD 147</Term>
        <Term>Antigens, CD147</Term>
        <Term>CD147 Antigens</Term>
        <Term>CD147 Antigen</Term>
        <Codes>
          <Code code="C0081714" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Bsg_protein_mouse, OTE:BSG_protein_human, OTE:Bsg_protein_Gallus_gallus</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin_17_Receptor" name="Interleukin 17 Receptor">
        <Definition>Cell surface receptors for INTERLEUKIN-17. Several subtypes of receptors have been found, each with its own in specificity for interleukin-17 subtype.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin 17 Receptor</Term>
        <Term>Interleukin-17 Receptor</Term>
        <Term>CD 217 ANTIGENS W</Term>
        <Term>interleukin-17 receptor</Term>
        <Term>CDw217 Antigen</Term>
        <Term>Receptors, Interleukin 17</Term>
        <Term>RECEPTORS INTERLEUKIN 017</Term>
        <Term>ANTIGENS CD 217 W</Term>
        <Term>IL-17 Receptors</Term>
        <Term>IL 17 Receptors</Term>
        <Term>Interleukin-17 Receptors</Term>
        <Term>Receptors, Interleukin-17</Term>
        <Term>Receptors, Interleukin-17 [Chemical/Ingredient]</Term>
        <Term>Interleukin-17 Receptor A</Term>
        <Term>Antigen, CDw217</Term>
        <Term>Receptors, IL-17</Term>
        <Term>Cdw217 Antigens</Term>
        <Term>Interleukin 17 Receptors</Term>
        <Term>Antigens, CDw217</Term>
        <Term>IL 017 RECEPTORS</Term>
        <Term>Interleukin 17 Receptor A</Term>
        <Term>Receptor, Interleukin-17</Term>
        <Term>INTERLEUKIN 017 RECEPTORS</Term>
        <Codes>
          <Code code="C1721056" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_Interleukin-17</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Nt5c3_protein_mouse" name="Nt5c3 protein, mouse">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Nt5c3 protein, mouse</Term>
        <Term>lupin protein, mouse</Term>
        <Term>5'-nucleotidase, cytosolic III protein, mouse</Term>
        <Codes>
          <Code code="C1610831" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-Nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fcgr3_protein_mouse" name="Fcgr3 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fcgr3 protein, mouse</Term>
        <Term>CD16 protein, mouse</Term>
        <Term>FcgammaRIII protein, mouse</Term>
        <Term>Fc receptor, IgG, low affinity III protein, mouse</Term>
        <Term>Fc gamma receptor RIII, mouse</Term>
        <Codes>
          <Code code="C1451691" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD2" name="Antigen, CD2">
        <Definition>Glycoprotein members of the immunoglobulin superfamily which participate in T-cell adhesion and activation. They are expressed on most peripheral T-lymphocytes, natural killer cells, and thymocytes, and function as co-receptors or accessory molecules in the T-cell receptor complex.</Definition>
        <Definition>T-cell surface antigen CD2 (351 aa, 39 kD) is a cell fate protein that is encoded by the human CD2 gene and has a role in induction of apoptosis.</Definition>
        <Definition>leukocyte surface antigen long known as the sheep red blood cell receptor (SRBCR); involved in helper and cytotoxic T lymphocyte activation.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD2</Term>
        <Term>CD 002 ANTIGENS</Term>
        <Term>CD2 Antigens</Term>
        <Term>T11 Erythrocyte-Binding Glycoprotein</Term>
        <Term>Antigens, CD2</Term>
        <Term>Erythrocyte-Binding Glycoprotein, T11</Term>
        <Term>ANTIGENS CD 002</Term>
        <Term>CD2 Antigen</Term>
        <Term>T11 Erythrocyte Binding Glycoprotein</Term>
        <Term>T AAG ERYTHROCYTE BINDING GLYCOPROTEIN 011</Term>
        <Codes>
          <Code code="C0108773" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:CD2-1_cell_adhesion_protein_rat, OTE:CDw92_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Il13ra1_protein_rat" name="Il13ra1 protein, rat">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Il13ra1 protein, rat</Term>
        <Term>interleukin 13 receptor, alpha 1 protein, rat</Term>
        <Codes>
          <Code code="C1528380" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_13_Receptor_alpha1_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD5" name="Antigen, CD5">
        <Definition>Glycoproteins expressed on all mature T-cells, thymocytes, and a subset of mature B-cells. Antibodies specific for CD5 can enhance T-cell receptor-mediated T-cell activation. The B-cell-specific molecule CD72 is a natural ligand for CD5. (From Abbas et al., Cellular and Molecular Immunology, 2d ed, p156)</Definition>
        <Definition>lymphocyte marker expressed on T and the Ly-1 subset of B cells; sends accessory signals necessary for CD3-mediated T cell activation, possibly via phosphorylation of inositol phosphate; Ly-1 B cells have a propensity for autoantibody production.</Definition>
        <Definition>T-cell surface glycoprotein CD5 (495 aa, ~54 kDa) is encoded by the human CD5 gene. This protein may be involved in regulating the proliferation of T-cells.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD5</Term>
        <Term>Antigens, CD5</Term>
        <Term>Leu 1 Antigen</Term>
        <Term>CD 005 ANTIGENS</Term>
        <Term>CD5 Antigens</Term>
        <Term>ANTIGENS CD 005</Term>
        <Term>CD5 Antigen</Term>
        <Term>T1 Antigen</Term>
        <Term>Leu-1 Antigen</Term>
        <Codes>
          <Code code="C0054964" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cd5_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ctla4_protein_rat" name="Ctla4 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ctla4 protein, rat</Term>
        <Term>cytotoxic T-lymphocyte-associated protein 4, rat</Term>
        <Codes>
          <Code code="C3180233" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Cytotoxic_T_Lymphocyte_Antigen_4</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD7" name="Antigen, CD7">
        <Definition>Differentiation antigens expressed on pluripotential hematopoietic cells, most human thymocytes, and a major subset of peripheral blood T-lymphocytes. They have been implicated in integrin-mediated cellular adhesion and as signalling receptors on T-cells.</Definition>
        <Definition>T-cell antigen CD7 (240 aa, ~25 kDa) is encoded by the human CD7 gene. This protein plays a role in the development and function of lymphoid cells.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD7</Term>
        <Term>CD 007 ANTIGENS</Term>
        <Term>Antigens, CD7</Term>
        <Term>CD7 Antigen</Term>
        <Term>ANTIGENS CD 007</Term>
        <Term>CD7 Antigens</Term>
        <Codes>
          <Code code="C0054968" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BST-2_protein_rat" name="BST-2 protein, rat">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BST-2 protein, rat</Term>
        <Term>tetherin protein, rat</Term>
        <Term>CD317 antigen, rat</Term>
        <Codes>
          <Code code="C2976701" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD9" name="Antigen, CD9">
        <Definition>A subtype of tetraspanin proteins that play a role in cell adhesion, cell motility, and tumor metastasis. CD9 antigens take part in the process of platelet activation and aggregation, the formation of paranodal junctions in neuronal tissue, and the fusion of sperm with egg.</Definition>
        <Definition>CD9 antigen (228 aa, ~25 kDa) is encoded by the human CD9 gene. This protein is involved in both sperm-egg fusion and platelet degranulation.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD9</Term>
        <Term>CD9 Antigen</Term>
        <Term>Motility-Related Protein-1</Term>
        <Term>Motility Related Protein 1</Term>
        <Term>Tetraspanin 29</Term>
        <Term>Leukemia-Associated Cell Surface Antigen p24</Term>
        <Term>p24 CD9 Antigen</Term>
        <Term>Antigens, CD9</Term>
        <Term>Leukemia Associated Cell Surface Antigen p24</Term>
        <Term>Tetraspanin-29</Term>
        <Term>27 kDa Diphtheria Toxin Receptor Associated Protein</Term>
        <Term>DRAP27 Protein</Term>
        <Term>27 kDa Diphtheria Toxin Receptor-Associated Protein</Term>
        <Term>CD9 Antigens</Term>
        <Term>p24-CD9 Antigen</Term>
        <Codes>
          <Code code="C0054970" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cd9_protein_mouse, OTE:CD9_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Drosophila" name="Drosophila">
        <Definition>A genus of small, American flies, Diptera. The best known species is D. Melanogaster, often called the fruit fly, but more correctly termed the vinegar fly. First investigated by T.H.Morgan and his group, it has been extensively used in genetic studies. More recently it has been used for studies of embryonic development.</Definition>
        <Definition>A genus of small, American flies, Diptera. The best known species is D. Melanogaster, often called the fruit fly, but more correctly termed the vinegar fly. First investigated by T.H.Morgan and his group, it has been extensively used in genetic studies. More recently it has been used for studies of embryonic development.(On-line Medical Dictionary)</Definition>
        <Definition>A genus of small, two-winged flies containing approximately 900 described species. These organisms are the most extensively studied of all genera from the standpoint of genetics and cytology.</Definition>
        <SemanticType code="T204" name="Eukaryote"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Drosophila</Term>
        <Term>Fruit Flies, Drosophila</Term>
        <Term>Drosophila Fallen, 1823</Term>
        <Term>drosophila</Term>
        <Term>Fruit Fly, Drosophila</Term>
        <Term>Flies, Drosophila Fruit</Term>
        <Term>Fruit Fly</Term>
        <Term>Drosophilas</Term>
        <Term>Drosophila Fruit Flies</Term>
        <Term>Fly, Drosophila Fruit</Term>
        <Term>fly fruit</Term>
        <Term>Drosophila &lt;fruit fly, subgenus&gt;</Term>
        <Term>Drosophila &lt;fruit fly, genus&gt;</Term>
        <Term>fruit fly &lt;Drosophila&gt;</Term>
        <Term>Drosophila Fruit Fly</Term>
        <Term>Drosophila (Drosophila)</Term>
        <Term>Drosophila (Drosophila) Fallen, 1823</Term>
        <Term>fruit fly</Term>
        <Codes>
          <Code code="C1504613" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Diptera</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:low_density_lipoprotein_receptor-related_protein_1_Xenopus" name="low density lipoprotein receptor-related protein 1, Xenopus">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">low density lipoprotein receptor-related protein 1, Xenopus</Term>
        <Term>lrp1 protein, Xenopus</Term>
        <Term>CD91 protein, Xenopus</Term>
        <Term>alpha2-macroglobulin endocytic surface receptor, Xenopus</Term>
        <Codes>
          <Code code="C2604185" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:LDL_Receptor_Related_Protein_1</Relation>
          <Relation name="Narrower">OTE:lrp1_2_protein_Xenopus, OTE:lrp1_1_protein_Xenopus</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NON_Mouse" name="NON Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NON Mouse</Term>
        <Term>NON</Term>
        <Codes>
          <Code code="C1513853" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DEC-205_receptors" name="DEC-205 receptors">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DEC-205 receptors</Term>
        <Term>MR6 antigen</Term>
        <Term>receptor, DEC-205</Term>
        <Term>DEC-205 receptor</Term>
        <Term>gp200-MR6</Term>
        <Term>CD205 antigen</Term>
        <Codes>
          <Code code="C0297523" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:LY75_protein_human, OTE:Ly75_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CEACAM6_protein_rat" name="CEACAM6 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CEACAM6 protein, rat</Term>
        <Codes>
          <Code code="C3490855" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:randomized_design" name="randomized design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">randomized design</Term>
        <Term>randomized studies</Term>
        <Term>randomised designs</Term>
        <Term>randomized study</Term>
        <Term>randomised study</Term>
        <Term>randomised design</Term>
        <Term>randomized trials</Term>
        <Term>randomised trials</Term>
        <Term>randomised trial</Term>
        <Term>randomized trial</Term>
        <Term>randomised studies</Term>
        <Term>randomized designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#randomized_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:group_randomized_design, OTE:cluster_randomized_design, OTE:randomized_cross-over_design, OTE:randomized_clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ACI_Rat_Strain" name="ACI, Rat Strain">
        <Definition>Median survival 113 weeks in males, 108 weeks in females. Spontaneous tumors 46% testes, 16% adrenal, 5% pituitary, 6% skin and ear duct and fewer of other types in males; 21% pituitary, 13% uterus, 11% mammary gland, 6% adrenal and fewer of other types in females.  Will grow transplantable Morris hepatomas 3924A which can be used as a model for the treatment of liver cancer (Yang et al 1995).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ACI, Rat Strain</Term>
        <Codes>
          <Code code="C14392" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:cadherin-5" name="cadherin-5">
        <Definition>VE-cadherin (784 aa, 88 kD) is a cell adhesion process protein that is encoded by the human CDH5 gene and has a role in homophilic cell adhesion.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">cadherin-5</Term>
        <Term>vascular endothelial cadherin</Term>
        <Term>CD144 antigen</Term>
        <Term>cadherin 5</Term>
        <Term>7B4 antigen</Term>
        <Term>VE-cadherin</Term>
        <Codes>
          <Code code="C0300423" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cdh5_protein_mouse, OTE:CDH5_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:biliary_glycoprotein_I" name="biliary glycoprotein I">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">biliary glycoprotein I</Term>
        <Term>CEA-related cell adhesion molecule 1</Term>
        <Term>biliary glycoprotein A</Term>
        <Term>cell-CAM 105</Term>
        <Term>CEACAM1</Term>
        <Term>nonspecific cross-reacting antigen 160</Term>
        <Term>cellCAM 105</Term>
        <Term>C-CAM protein</Term>
        <Term>C-CAM1</Term>
        <Term>CD66a antigen</Term>
        <Codes>
          <Code code="C0378910" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD66_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly6a_protein_mouse" name="Ly6a protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly6a protein, mouse</Term>
        <Term>Ly-6A.2 protein, mouse</Term>
        <Term>Ly-6E.1 protein, mouse</Term>
        <Term>Sca-1 protein, mouse</Term>
        <Term>stem cell antigen-1, mouse</Term>
        <Term>TAP protein, mouse</Term>
        <Term>Sca-1 antigen, mouse</Term>
        <Term>Ly6A-E protein, mouse</Term>
        <Term>lymphocyte antigen 6 complex, locus A protein, mouse</Term>
        <Term>T-cell-activating protein, mouse</Term>
        <Codes>
          <Code code="C0168338" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
          <Relation name="Narrower">OTE:Ly6A-4_antigen_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:asialogalactofetuin" name="asialogalactofetuin">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">asialogalactofetuin</Term>
        <Codes>
          <Code code="C0104346" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:asialofetuin</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SIGLEC5_protein_human" name="SIGLEC5 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SIGLEC5 protein, human</Term>
        <Term>siglec-5 antigen, human</Term>
        <Term>CD170 antigen, human</Term>
        <Term>sialic acid-binding Ig-like lectin-5</Term>
        <Codes>
          <Code code="C0757620" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Japanese_White_Rabbit" name="Japanese White Rabbit">
        <Definition>A white colored rabbit characterized by efficient superovulation and spontaneous formation of lymphoma. It is used as an animal model for Guillan-Barre syndrome in humans, toxicology, virology.</Definition>
        <Definition>A white colored rabbit characterized by efficient superovulation and spontaneous formation of lymphoma. It is used as an animal model for Guillan-Barre syndrome in humans, toxicology, virology. (NCI)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Japanese White Rabbit</Term>
        <Term>JAPANESE WHITE</Term>
        <Term>Japanese White</Term>
        <Term>Japanese white rabbit</Term>
        <Codes>
          <Code code="C3714806" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rabbit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:quasi-experimental_clinical_trial" name="quasi-experimental clinical trial">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">quasi-experimental clinical trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#quasi-experimental_clinical_trials" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:quasi-experimental_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57L_J_Mouse" name="C57L/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57L/J Mouse</Term>
        <Term>C57L/J</Term>
        <Codes>
          <Code code="C14519" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:UN1_sialoglycoprotein_human" name="UN1 sialoglycoprotein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">UN1 sialoglycoprotein, human</Term>
        <Codes>
          <Code code="C1448466" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD43</Relation>
          <Relation name="Narrower">OTE:SPN_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Rhesus_Monkey" name="Rhesus Monkey">
        <Definition>A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans.</Definition>
        <Definition>species of the genus MACACA inhabiting India, China, and other parts of Asia; the species is used extensively in biomedical research and adapts very well to living with humans.</Definition>
        <Definition>A pale brown macaque (Macaca mulatta) native to India, China, and other parts of Asia; often used in medical research. A medium-sized diurnal primate, the Macaca mulatta has a diet of plant material and insects that it can store in pouches in its mouth. The rhesus monkey has an inquisitive, destructive nature with a tendency to bite and pinch; captive breeds are used almost exclusively for medical research. The rhesus monkey has a long history in biomedical research owing to its relative ease in upkeep, most famously utilized in the study of the rhesus factor in human blood groups, the effects of space travel on humans, as well as being the first cloned and transgenic primate.</Definition>
        <Definition>A pale brown macaque, Macaca mulatta.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Rhesus Monkey</Term>
        <Term>Monkeys, Rhesus</Term>
        <Term>Rhesus</Term>
        <Term>monkey rhesus</Term>
        <Term>Macaca mulatta</Term>
        <Term>Macaque, Rhesus</Term>
        <Term>Macaca mulatta (Zimmermann, 1780)</Term>
        <Term>Macaca mulatta (organism)</Term>
        <Term>rhesus monkey</Term>
        <Term>Rhesus Monkeys</Term>
        <Term>mulattas, Macaca</Term>
        <Term>Macaques, Rhesus</Term>
        <Term>Rhesus monkey</Term>
        <Term>Macaca mulattas</Term>
        <Term>rhesus macaque</Term>
        <Term>RHESUS</Term>
        <Term>Rhesus macaque</Term>
        <Term>Rhesus Macaques</Term>
        <Term>mulatta, Macaca</Term>
        <Term>rhesus macaques</Term>
        <Term>monkeys rhesus</Term>
        <Term>Rhesus Macaque</Term>
        <Term>Monkey, Rhesus</Term>
        <Term>rhesus monkeys</Term>
        <Codes>
          <Code code="C0024400" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Macaque</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Aleuts" name="Aleuts">
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Aleuts</Term>
        <Term>Aleut</Term>
        <Term>Aleuts (ethnic group)</Term>
        <Term>aleut</Term>
        <Term>RaceAlaskanNativeAleut</Term>
        <Codes>
          <Code code="C0085766" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inuits</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:F344_Rat_Strain" name="F344, Rat Strain">
        <Definition>Most animals older than 2 years exhibit small local areas of nephritis; less than 25% show severe nephritis (Snell 1967). Tumors: Mammary tumors 41% in females and 23% in males, pituitary adenomas 36% in females and 24% in males, testicular interstitial cell tumors 85% in males. Other tumor types less common (Sass et al 1975). Thyroid carcinoma 22% (Lindsey et al 1968). Interstitial cell testicular tumors 65%, mononuclear cell leukemia 24%, subcutaneous fibroadenoma 9% in females. Both sexes have a 5% incidence of nodular hyperplasia of the liver.</Definition>
        <Definition>Derived by Curtiss and Dunning (1920) at Columbia University and disseminated to Heston (1949) and then to the NIH (1951). The Fischer 344 rat has an albino coat and genotype c.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">F344, Rat Strain</Term>
        <Term>F344</Term>
        <Term>FISCHER 344</Term>
        <Term>Fischer 344</Term>
        <Codes>
          <Code code="C14401" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:A_J_Mouse" name="A/J Mouse">
        <Definition>Derived by Strong (1921) from a cross between the Cold Spring harbor and Bagg Albino stocks. The A strain mouse has an albino coat (genotype a,b,c) and is susceptible to carcinogen-induced lung adenomas and cleft palate formation in response to cortisone. Also, the strain has defective macrophage function reminiscent of lps mutation common to other strains.</Definition>
        <Definition>Derived by Strong (1921) from a cross between the Cold Spring harbor and Bagg Albino stocks. The A strain mouse has an albino coat (genotype a,b,c) and is susceptible to carcinogen-induced lung adenomas and cleft palate formation in response to cortisone. Also, the strain has defective macrophage function reminiscent of lps mutation common to other strains. The A strain has intermediate breeding performance with a high ratio of females at birth and a low litter size at weaning.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">A/J Mouse</Term>
        <Term>A/J</Term>
        <Codes>
          <Code code="C14650" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:WN_Rat_Strain" name="WN, Rat Strain">
        <Definition>Anterior pituitary tumors nearly 100% in females over 18 months of age, pheochromocytomas or preneoplastic nodules in adrenal medulla about 40% in males, granulocytic leukemia 14% in animals over 18 months of age. Rarely show hyperplastic cortical nodules or adrenal cortical adenomas. High incidence of severe chronic nephritis. (Snell 1967). High 10-week body weight in males (19/23), and high relative heart weight in 10-week old males (19/23) (Tanase et al 1982).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">WN, Rat Strain</Term>
        <Term>WN</Term>
        <Codes>
          <Code code="C14380" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD248_protein_human" name="CD248 protein, human">
        <Definition>Endosialin (757 aa, ~81 kDa) is encoded by the human CD248 gene. This protein may play a role in angiogenesis.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD248 protein, human</Term>
        <Term>CD164 sialomucin-like 1 protein, human</Term>
        <Term>CD248 antigen, human</Term>
        <Term>CD164L1 protein, human</Term>
        <Term>endosialin protein, human</Term>
        <Term>FB5 protein, human</Term>
        <Term>Tem1 protein, human</Term>
        <Term>tumor endothelial marker 1 precursor protein, human</Term>
        <Codes>
          <Code code="C1437495" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Infant_Postmature" name="Infant, Postmature">
        <Definition>An infant born at or after 42 weeks of gestation.</Definition>
        <SemanticType code="T100" name="Age Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Infant, Postmature</Term>
        <Term>Postmature Infants</Term>
        <Term>Postmature Infant</Term>
        <Term>Infants, Postmature</Term>
        <Codes>
          <Code code="C0021293" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Infants_Newborn</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CByB6F1_J-Foxn1-nu_Mouse" name="CByB6F1/J-Foxn1-nu Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CByB6F1/J-Foxn1-nu Mouse</Term>
        <Term>CByB6F1/J-Foxn1-nu</Term>
        <Term>CByB6F1/J-Hfh1l-nu</Term>
        <Codes>
          <Code code="C15162" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Nude_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Receptor_OX40" name="Receptor, OX40">
        <Definition>A protein being studied in the treatment of cancer. Substances that attach to OX-40 on the surface of T cells (a type of white blood cell) may help the T cells grow and kill more cancer cells. OX-40 is a type of tumor necrosis factor (TNF) receptor.</Definition>
        <Definition>Tumor necrosis factor receptor superfamily member 4 (277 aa, ~29 kDa) is encoded by the human TNFRSF4 gene. This protein plays a role in signal transduction pathways that mediate apoptosis inhibition and inflammatory responses.</Definition>
        <Definition>A tumor necrosis family receptor with specificity for OX40 LIGAND. It is found on the surface of activated T-LYMPHOCYTES where it plays a role in enhancing cytokine production and proliferation of CD4-POSITIVE T-LYMPHOCYTES. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Receptor, OX40</Term>
        <Term>CD134 Antigens</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 04</Term>
        <Term>Receptors, OX40</Term>
        <Term>CD 134 ANTIGENS</Term>
        <Term>CD134 Antigen</Term>
        <Term>Tumor Necrosis Factor Receptor Superfamily, Member 4</Term>
        <Term>OX40 Receptors</Term>
        <Term>OX40 Receptor</Term>
        <Term>RECEPTORS TUMOR NECROSIS FACTOR MEMBER 04</Term>
        <Term>Receptors, Tumor Necrosis Factor, Member 4</Term>
        <Term>RECEPTORS OX 40</Term>
        <Term>ANTIGENS CD 134</Term>
        <Term>Antigens, CD134</Term>
        <Term>Antigen, CD134</Term>
        <Codes>
          <Code code="C0248554" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Tnfrsf4_protein_rat, OTE:TNFRSF4_protein_human, OTE:Tnfrsf4_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin_13_Receptor_alpha1_Subunit" name="Interleukin 13 Receptor alpha1 Subunit">
        <Definition>An interleukin receptor subunit with specificity for INTERLEUKIN-13. It dimerizes with the INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT to form the TYPE II INTERLEUKIN-4 RECEPTOR which has specificity for both INTERLEUKIN-4 and INTERLEUKIN-13. Signaling of this receptor subunit occurs through the interaction of its cytoplasmic domain with JANUS KINASES such as the TYK2 KINASE.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin 13 Receptor alpha1 Subunit</Term>
        <Term>CD213a1 Antigen</Term>
        <Term>Interleukin-13 Receptor alpha1 Chain</Term>
        <Term>INTERLEUKIN 013 RECEPTOR ALPHA 1 SUBUNIT</Term>
        <Term>Antigens, CD213a1</Term>
        <Term>Interleukin 13 Receptor alpha1 Chain</Term>
        <Term>CD 213A1 ANTIGENS</Term>
        <Term>Interleukin-4, 13 Receptor Shared Subunit</Term>
        <Term>Interleukin-13 Receptor alpha1 Subunit [Chemical/Ingredient]</Term>
        <Term>INTERLEUKIN 004 Z 013 RECEPTOR SHARED SUBUNIT</Term>
        <Term>Interleukin-13 Receptor alpha1 Subunit</Term>
        <Term>CD213a1 Antigens</Term>
        <Term>Interleukin 4, 13 Receptor Shared Subunit</Term>
        <Term>Antigen, CD213a1</Term>
        <Term>IL-13Ralpha1</Term>
        <Term>ANTIGENS CD 213A1</Term>
        <Codes>
          <Code code="C0527729" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:IL13RA1_protein_human, OTE:Il13ra1_protein_rat, OTE:Il13ra1_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fc_gamma_IIB_receptors" name="Fc gamma IIB receptors">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fc gamma IIB receptors</Term>
        <Term>receptor, Fc gamma IIB</Term>
        <Term>Fc gamma receptor IIB</Term>
        <Term>CD32b antigen</Term>
        <Term>Fc gamma RIIB</Term>
        <Codes>
          <Code code="C0215033" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
          <Relation name="Narrower">OTE:FcgammaRIIB1, OTE:FcgammaRIIb2</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:non-experimental_design" name="non-experimental design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">non-experimental design</Term>
        <Term>nonexperimental studies</Term>
        <Term>nonexperimental designs</Term>
        <Term>nonexperimental trials</Term>
        <Term>nonexperimental study</Term>
        <Term>nonexperimental trial</Term>
        <Term>non-experimental designs</Term>
        <Term>non-experimental study</Term>
        <Term>non-experimental trials</Term>
        <Term>non-experimental trial</Term>
        <Term>non-experimental studies</Term>
        <Term>nonexperimental design</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#non-experimental_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Inuits" name="Inuits">
        <Definition>Inuktitut-speakers generally associated with the northern polar region.</Definition>
        <Definition>A general term for a group of culturally similar indigenous peoples inhabiting the Arctic regions of Canada, Greenland, Russia and the United States. In Alaska, the term Eskimo is commonly used, because it includes both Yupik and Inupiat, while Inuit is not accepted as a collective term. In Canada and Greenland, the term Eskimo has fallen out of favor, as it is considered pejorative by the natives and has been replaced by the term Inuit.</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Inuits</Term>
        <Term>Inuit population</Term>
        <Term>inuits</Term>
        <Term>Inuit</Term>
        <Term>inuit</Term>
        <Codes>
          <Code code="C0086484" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ethnic_Groups</Relation>
          <Relation name="Narrower">OTE:Inupiats, OTE:Aleuts, OTE:Kalaallits</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Common_gamma-Chain_Protein" name="Common gamma-Chain Protein">
        <Definition>The interleukin 2 (IL2) receptor gamma chain (IL2RG) is an important signalling component of many interleukin receptors (e.g., IL2,IL4,IL7,IL9, and IL15) and is thus referred to as the common gamma chain. It is necessary for normal growth and differentiation of T cells, B cells, natural killer cells, glioma cells, and cells of the monocyte lineage. Mutations in this X-chromosome-linked gene cause X-linked severe combined immunodeficiency (XSCID). (from LocusLink and OMIM)</Definition>
        <Definition>An interleukin receptor subunit that was originally discovered as a component of the INTERLEUKIN 2 RECEPTOR. It was subsequently found to be a component of several other receptors including the INTERLEUKIN 4 RECEPTOR, the INTERLEUKIN 7 RECEPTOR, the INTERLEUKIN-9 RECEPTOR, the INTERLEUKIN-15 RECEPTOR, and the INTERLEUKIN-21 RECEPTOR. Mutations in the gene for the interleukin receptor common gamma chain have been associated with X-LINKED COMBINED IMMUNODEFICIENCY DISEASES.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Common gamma-Chain Protein</Term>
        <Term>INTERLEUKIN 004 RECEPTOR GAMMA SUBUNIT</Term>
        <Term>Interleukin 21 Receptor gamma Subunit</Term>
        <Term>Interleukin Receptor Common gamma-Chain</Term>
        <Term>INTERLEUKIN 007 RECEPTOR GAMMA SUBUNIT</Term>
        <Term>Interleukin-7 Receptor gamma Chain</Term>
        <Term>Interleukin Receptor Common gamma Chain</Term>
        <Term>Interleukin 2 Receptor gamma Subunit</Term>
        <Term>Interleukin 7 Receptor gamma Chain</Term>
        <Term>Interleukin 4 Receptor gamma Chain</Term>
        <Term>Interleukin-15 Receptor gamma Chain</Term>
        <Term>Interleukin-7 Receptor gamma Subunit</Term>
        <Term>CD 132 ANTIGENS</Term>
        <Term>Receptors, Interleukin Common gamma Chain</Term>
        <Term>INTERLEUKIN 015 RECEPTOR GAMMA SUBUNIT</Term>
        <Term>ANTIGENS CD 132</Term>
        <Term>Interleukin 2 Receptor gamma Chain</Term>
        <Term>Interleukin-4 Receptor gamma Subunit</Term>
        <Term>CD132 Antigen</Term>
        <Term>Interleukin Receptor Common gamma Subunit</Term>
        <Term>Interleukin 7 Receptor gamma Subunit</Term>
        <Term>gamma-Chain Protein, Common</Term>
        <Term>Interleukin-21 Receptor gamma Chain</Term>
        <Term>Antigen, CD132</Term>
        <Term>Common Cytokine Receptor gamma Subunit</Term>
        <Term>Interleukin 15 Receptor gamma Chain</Term>
        <Term>INTERLEUKIN 021 RECEPTOR GAMMA SUBUNIT</Term>
        <Term>Common gamma Chain Protein</Term>
        <Term>Interleukin-21 Receptor gamma Subunit</Term>
        <Term>INTERLEUKIN 002 RECEPTOR GAMMA SUBUNIT</Term>
        <Term>CD132 Antigens</Term>
        <Term>Interleukin-4 Receptor gamma Chain</Term>
        <Term>Antigens, CD132</Term>
        <Term>Interleukin 21 Receptor gamma Chain</Term>
        <Term>Interleukin-15 Receptor gamma Subunit</Term>
        <Term>Interleukin-2 Receptor gamma Chain</Term>
        <Term>Cytokine Receptor Common gamma Chain</Term>
        <Term>Interleukin 4 Receptor gamma Subunit</Term>
        <Term>Interleukin 15 Receptor gamma Subunit</Term>
        <Term>Interleukin-2 Receptor gamma Subunit</Term>
        <Codes>
          <Code code="C1334204" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Il2rg_protein_mouse, OTE:IL2RG_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD151" name="Antigen CD151">
        <Definition>Tetraspanin proteins found associated with LAMININ-binding INTEGRINS. The CD151 antigens may play a role in the regulation of CELL MOTILITY.</Definition>
        <Definition>CD151 antigen (253 aa, ~28 kDa) is encoded by the human CD151 gene. This protein plays a role in both cell adhesion and signal transduction.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen CD151</Term>
        <Term>CD151 Antigen</Term>
        <Term>Antigens, CD151</Term>
        <Term>Antigen, CD151</Term>
        <Term>CD151, Antigen</Term>
        <Term>Tetraspanin 24</Term>
        <Term>CD151 Antigens</Term>
        <Codes>
          <Code code="C1621248" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cd151_protein_rat, OTE:Cd151_protein_mouse, OTE:CD151_antigen_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD30_Antigen" name="CD30 Antigen">
        <Definition>A member of the tumor necrosis factor receptor superfamily that may play a role in the regulation of NF-KAPPA B and APOPTOSIS. They are found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; NEUTROPHILS; EOSINOPHILS; MAST CELLS and NK CELLS. Overexpression of CD30 antigen in hematopoietic malignancies make the antigen clinically useful as a biological tumor marker. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.</Definition>
        <Definition>Tumor necrosis factor receptor superfamily member 8 (595 aa, ~ 64 kDa) is encoded by the human TNFRSF8 gene. This protein is involved in ligand-mediated signal transduction, the positive regulation of apoptosis and the inhibition of cell proliferation.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD30 Antigen</Term>
        <Term>Cluster of diff antigen 30</Term>
        <Term>Lymphoid Activation Antigen CD30</Term>
        <Term>CD30 Antigens</Term>
        <Term>CD30 (Ki-1) antigen</Term>
        <Term>Antigen, Ki-1</Term>
        <Term>Antigens, Ki 1</Term>
        <Term>Antigens, CD30 [Chemical/Ingredient]</Term>
        <Term>CD30 antigen</Term>
        <Term>Ki-1 antigen</Term>
        <Term>Lymphocyte antigen CD30</Term>
        <Term>Lymphocyte Activation Antigen CD30</Term>
        <Term>Receptor, TNFRSF8</Term>
        <Term>Antigen CD30</Term>
        <Term>Ber-H2 Antigens</Term>
        <Term>CD30 - Cluster of differentiation antigen 30</Term>
        <Term>CD30L Receptor</Term>
        <Term>TNFRSF8</Term>
        <Term>Cluster of differentiation antigen 30</Term>
        <Term>TNF Receptor 8</Term>
        <Term>Cytokine Receptor CD30</Term>
        <Term>Antigens, Ki-1</Term>
        <Term>ANTIGENS CD 030</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPT SUPERFAMILY MEMBER 8</Term>
        <Term>Lymphocyte antigen CD30 (substance)</Term>
        <Term>Ber H2 Antigens</Term>
        <Term>Ber H2 Antigen</Term>
        <Term>Ber-H2</Term>
        <Term>Tumor Necrosis Factor Receptor Superfamily, Member 8</Term>
        <Term>Antigens, Ber-H2</Term>
        <Term>KI ANTIGENS 01</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 08</Term>
        <Term>Ki 1 Antigens</Term>
        <Term>Ki-1 Antigen</Term>
        <Term>Tumor Necrosis Factor Receptor Superfamily Member 8</Term>
        <Term>Ber-H2 Antigen</Term>
        <Term>ANTIGENS KI 01</Term>
        <Term>TNFRSF8 RECEPT</Term>
        <Term>TNFRSF8 Receptor</Term>
        <Term>CD30 - Cluster of diff ag 30</Term>
        <Term>CD 030 ANTIGENS</Term>
        <Term>Ki 1 Antigen</Term>
        <Term>CD30 Ag</Term>
        <Term>Antigen, CD30</Term>
        <Term>CD30</Term>
        <Term>BER H02 ANTIGENS</Term>
        <Term>Antigen, Ber-H2</Term>
        <Term>Ki-1</Term>
        <Term>Antigens, CD30</Term>
        <Term>Ki-1 Antigens</Term>
        <Codes>
          <Code code="C0054950" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NOD_Lt_Mouse" name="NOD/Lt Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NOD/Lt Mouse</Term>
        <Term>NOD/Lt</Term>
        <Codes>
          <Code code="C37418" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Scgb2a2_protein_mouse" name="Scgb2a2 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Scgb2a2 protein, mouse</Term>
        <Term>secretoglobin, family 2A, member 2, mouse</Term>
        <Codes>
          <Code code="C3180076" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mammaglobin-A</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:meta_analysis_of_individual_participant_data" name="meta analysis of individual participant data">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">meta analysis of individual participant data</Term>
        <Term>review of individual patient data</Term>
        <Term>ipd review</Term>
        <Term>meta-analysis of individual patient data</Term>
        <Term>individual patient data metaanalysis</Term>
        <Term>metaanalysis of individual patient data</Term>
        <Term>individual patient data meta analysis</Term>
        <Term>ipd meta-analysis</Term>
        <Term>meta-analysis of individual participant data</Term>
        <Term>mipd</Term>
        <Term>ipd meta analysis</Term>
        <Term>metaanalysis of individual participant data</Term>
        <Term>meta analysis of individual patient data</Term>
        <Term>ipd metaanalysis</Term>
        <Term>individual patient data meta-analysis</Term>
        <Term>individual patient data review</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#meta_analysis_of_individual_participant_data" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:meta_analysis</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DBA_2_Mouse" name="DBA/2 Mouse">
        <Definition>Derived from crosses made by Little in 1929-1930 between DBA progenitors. The DBA/2 mouse has a d H2 haplotype and carries the Cdh23ahl mutation that results in a progressive hearing loss beginning at 3-4 weeks of age and severe hearing loss after 3 months of age. Alleles GpnmbR150X and Tyrp1isa contribute to an eye phenotype that closely resembles human hereditary glaucoma. The DBA/2 mouse strain shows severe intolerance to alcohol and morphine and is naturally CD94 deficient. (NCI)</Definition>
        <Definition>Derived from crosses made by Little in 1929-1930 between DBA progenitors. The DBA/2 mouse has a d H2 haplotype and carries the Cdh23ahl mutation that results in a progressive hearing loss beginning at 3-4 weeks of age and severe hearing loss after 3 months of age. Alleles GpnmbR150X and Tyrp1isa contribute to an eye phenotype that closely resembles human hereditary glaucoma. The DBA/2 mouse strain shows severe intolerance to alcohol and morphine and is naturally CD94 deficient.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DBA/2 Mouse</Term>
        <Term>DBA/2</Term>
        <Codes>
          <Code code="C14604" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:leu_13_antigen" name="leu 13 antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">leu 13 antigen</Term>
        <Term>CD225 antigen</Term>
        <Term>leu-13 antigen</Term>
        <Term>interferon induced transmembrane protein 1</Term>
        <Codes>
          <Code code="C0064779" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
          <Relation name="Narrower">OTE:IFITM1_protein_human, OTE:IFITM1_protein_rat, OTE:Ifitm1_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tnfsf6_protein_rat" name="Tnfsf6 protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tnfsf6 protein, rat</Term>
        <Term>Apt1Lg1 protein, rat</Term>
        <Term>tumor necrosis factor (ligand) superfamily, member 6, rat</Term>
        <Term>Fasl protein, rat</Term>
        <Codes>
          <Code code="C1677778" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Necrosis_Factor_Ligand_Superfamily_Member_6</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Pigeon" name="Pigeon">
        <Definition>A member of the Columbidae family of birds, most commonly referring to the species Columba livia.</Definition>
        <Definition>Family in the order COLUMBIFORMES, comprised of pigeons or doves. They are BIRDS with short legs, stout bodies, small heads, and slender bills. Some sources call the smaller species doves and the larger pigeons, but the names are interchangeable.</Definition>
        <Definition>A member of the Columbidae family of birds with a stout body and short neck. This term most commonly refers to the species Columba livia, or rock pigeon.</Definition>
        <Definition>any of a widely distributed family (Columbidae, order Columbiformes) of birds with a stout body, rather short legs, and smooth and compact plumage; especially, a member of any of numerous varieties of the rock dove that exist in domestication and in the feral state in cities and towns throughout most of the world.</Definition>
        <SemanticType code="T012" name="Bird"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Pigeon</Term>
        <Term>Genus Columba</Term>
        <Term>Pigeons, Domestic</Term>
        <Term>Columba</Term>
        <Term>Pigeon, NOS</Term>
        <Term>Common pigeon</Term>
        <Term>pigeon</Term>
        <Term>FAMILY COLUMBIDAE</Term>
        <Term>carrier pigeon</Term>
        <Term>Pigeon, Domestic</Term>
        <Term>Columba livia</Term>
        <Term>Genus Columba (organism)</Term>
        <Term>Rock pigeon</Term>
        <Term>Columba livia (organism)</Term>
        <Term>Rock Dove</Term>
        <Term>PIGEON</Term>
        <Term>Feral Pigeon</Term>
        <Term>Domestic Pigeons</Term>
        <Term>Dove, NOS</Term>
        <Term>Pigeons</Term>
        <Term>961 FAMILY COLUMBIDAE</Term>
        <Term>Dove</Term>
        <Term>Pigeon (organism)</Term>
        <Term>Pigeons, Rock</Term>
        <Term>Pigeon, Rock</Term>
        <Term>rock dove</Term>
        <Term>Rock Doves</Term>
        <Term>Pigeon, Feral</Term>
        <Term>domestic pigeon</Term>
        <Term>Columbidae</Term>
        <Term>Rock Pigeon</Term>
        <Term>Blue rock dove</Term>
        <Term>Columba livia Gmelin, JF, 1789</Term>
        <Term>Rock dove</Term>
        <Term>Domestic Pigeon</Term>
        <Term>Dove, Rock</Term>
        <Term>Feral Pigeons</Term>
        <Term>Doves, Rock</Term>
        <Term>dove</Term>
        <Term>Family Columbidae (organism)</Term>
        <Term>Doves</Term>
        <Term>pigeons</Term>
        <Term>Pigeons, Feral</Term>
        <Term>Rock Pigeons</Term>
        <Term>Family Columbidae</Term>
        <Codes>
          <Code code="C91812" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Aves</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MA_MyJ_Mouse" name="MA/MyJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MA/MyJ Mouse</Term>
        <Term>MA/MyJ</Term>
        <Codes>
          <Code code="C14512" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ifitm1_protein_mouse" name="Ifitm1 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ifitm1 protein, mouse</Term>
        <Term>fragilis protein 2, mouse</Term>
        <Term>Mil-2 protein, mouse</Term>
        <Term>interferon-induced transmembrane protein 1, mouse</Term>
        <Codes>
          <Code code="C2975616" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:leu_13_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klra10_protein_mouse" name="Klra10 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klra10 protein, mouse</Term>
        <Term>LY49J antigen, mouse</Term>
        <Term>Ly-49J antigen, mouse</Term>
        <Term>killer cell lectin-like receptor subfamily A, member 10 protein, mouse</Term>
        <Term>Ly49J protein, mouse</Term>
        <Term>LY-49j protein, mouse</Term>
        <Codes>
          <Code code="C0769514" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigens_CD321" name="Antigens, CD321">
        <Definition>A cell adhesion protein that is found within TIGHT JUNCTIONS of ENDOTHELIAL CELLS and on the CELL MEMBRANE surface of circulating PLATELETS.</Definition>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigens, CD321</Term>
        <Term>Junctional Adhesion Molecule A</Term>
        <Term>Receptor, F11</Term>
        <Term>F11 Receptor</Term>
        <Term>Antigen, CD321</Term>
        <Term>CD321 Antigens</Term>
        <Term>Receptors, F11</Term>
        <Term>CD321 Antigen</Term>
        <Term>F11 Receptors</Term>
        <Codes>
          <Code code="C1422839" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd163_protein_mouse" name="Cd163 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd163 protein, mouse</Term>
        <Term>CD163 antigen, mouse</Term>
        <Codes>
          <Code code="C1570090" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD163_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:HPA-15b_protein_human" name="HPA-15b protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">HPA-15b protein, human</Term>
        <Term>HPA-15b antigen, human</Term>
        <Codes>
          <Code code="C1569041" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD109_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:AB_TL_Zebrafish" name="AB/TL Zebrafish">
        <Definition>A wild-type zebrafish line.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">AB/TL Zebrafish</Term>
        <Term>AB/TL</Term>
        <Codes>
          <Code code="C79986" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Aged" name="Aged">
        <Definition>How long something has existed; elapsed time since birth. (NCI)</Definition>
        <Definition>The process of growing old and showing the effects of time.</Definition>
        <Definition>An age group comprised by people 65 years of age and older.</Definition>
        <Definition>A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.</Definition>
        <Definition>How long something has existed; elapsed time since birth.</Definition>
        <SemanticType code="T032" name="Organism Attribute"/>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Aged</Term>
        <Term>senior citizen</Term>
        <Term>Geriatric state</Term>
        <Term>older adult</Term>
        <Term>old age</Term>
        <Term>Current chronological age (observable entity)</Term>
        <Term>Has age</Term>
        <Term>Senescence</Term>
        <Term>Advanced age</Term>
        <Term>Current chronological age</Term>
        <Term>Elderly (population group)</Term>
        <Term>Geriatric period of life</Term>
        <Term>age</Term>
        <Term>Elderly person (person)</Term>
        <Term>Senior citizen, NOS</Term>
        <Term>Old age</Term>
        <Term>elderly</Term>
        <Term>Age - descriptor</Term>
        <Term>AGE</Term>
        <Term>Old age (qualifier value)</Term>
        <Term>OLD AGE</Term>
        <Term>Aged 65 and Over</Term>
        <Term>Senium</Term>
        <Term>Elderly person</Term>
        <Term>Chronlogical Age</Term>
        <Term>Elderly (Over 65)</Term>
        <Term>aged</Term>
        <Term>Age (qualifier value)</Term>
        <Term>Old-age</Term>
        <Term>aged person</Term>
        <Term>aged persons</Term>
        <Term>Old age - period</Term>
        <Term>Elderly</Term>
        <Term>Old-age (finding)</Term>
        <Term>Elderly person, NOS</Term>
        <Term>Senior citizen</Term>
        <Term>Age</Term>
        <Term>Senior Citizen</Term>
        <Term>geriatric</Term>
        <Term>Age, NOS</Term>
        <Term>ELDERLY</Term>
        <Codes>
          <Code code="C0001792" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Adults</Relation>
          <Relation name="Narrower">OTE:Aged_80_and_over, OTE:Elderly_Frail</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_CD164" name="Antigen, CD164">
        <Definition>A sialomucin protein that functions as a cell adhesion molecule. It is a negative regulator of certain types of HEMATOPOIETIC STEM CELLS.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen, CD164</Term>
        <Term>CD 164 ANTIGENS</Term>
        <Term>Endolyn</Term>
        <Term>CD164 Antigen</Term>
        <Term>ANTIGENS CD 164</Term>
        <Term>CD164 Antigens</Term>
        <Term>Antigens, CD164</Term>
        <Codes>
          <Code code="C0916861" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cd164_protein_rat, OTE:CD164_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DW_J_Mouse" name="DW/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DW/J Mouse</Term>
        <Term>DW/J</Term>
        <Codes>
          <Code code="C15031" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Myd116_protein_rat" name="Myd116 protein, rat">
        <SemanticType code="T130" name="Indicator, Reagent, or Diagnostic Aid"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Myd116 protein, rat</Term>
        <Term>progression elevated gene-3 protein, rat</Term>
        <Term>myeloid differentiation primary response gene 116 protein, rat</Term>
        <Term>Gadd34 protein, rat</Term>
        <Term>growth arrest-DNA damage inducible 34 protein, rat</Term>
        <Codes>
          <Code code="C1430913" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Soluble_Glycoprotein_130" name="Soluble Glycoprotein 130">
        <Definition>A circulating form of cytokine receptor gp130.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Soluble Glycoprotein 130</Term>
        <Term>sgp130</Term>
        <Term>Glycoprotein 130, Soluble</Term>
        <Term>Soluble gp130</Term>
        <Term>gp130, Soluble</Term>
        <Codes>
          <Code code="C2350152" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Cytokine_Receptor_gp130</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fas_protein_mouse" name="Fas protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fas protein, mouse</Term>
        <Term>Fas (TNF receptor superfamily member) protein, mouse</Term>
        <Term>Tnfrsf6 protein, mouse</Term>
        <Term>tumor necrosis factor receptor superfamily, member 6 protein, mouse</Term>
        <Codes>
          <Code code="C1454643" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD95</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SWR_J_Mouse" name="SWR/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SWR/J Mouse</Term>
        <Term>SWR/J</Term>
        <Codes>
          <Code code="C14427" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:India_Zebrafish" name="India Zebrafish">
        <Definition>A wild-type zebrafish line, the stock of which was obtained from an expedition to Darjeeling, India.</Definition>
        <Definition>A wild-type zebrafish line, the stock of which was obtained from an expedition to Darjeeling, India.(ZFin)</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">India Zebrafish</Term>
        <Term>India - zebrafish</Term>
        <Term>IND</Term>
        <Term>India</Term>
        <Codes>
          <Code code="C79976" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:rapid_review_" name="rapid review'">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">rapid review'</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#rapid_review'" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:review_of_literature_</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Study_Design" name="Study Design">
        <Definition>Terminology related to the plan detailing how a study will be performed in order to represent the phenomenon under examination, to answer the research questions that have been asked, and defining the methods of data analysis.</Definition>
        <Definition>A plan detailing how a trial or study will be performed in order to represent the phenomenon under examination, to answer the research questions that have been asked, and defining the methods of data analysis. Study design is driven by the research hypothesis being posed, study subject/population/sample available, logistics/resources: technology, support, networking, collaborative support, etc.</Definition>
        <Definition>The terminology that includes concepts relevant to the Clinical Data Interchange Standards Consortium (CDISC) Standard for the Exchange of Non-clinical Data (SEND) study design.</Definition>
        <Definition>Describes the role the study plays in determining the interventions a subject receives.</Definition>
        <Definition>A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.</Definition>
        <Definition>A plan detailing how a nonclinical study will be performed in order to represent the phenomenon under examination, to answer the research questions that have been asked, and defining the methods of data analysis. Study design is driven by the research hypothesis that is being posed, study subject/population/sample available, logistics/resources: technology, support, networking, collaborative support, etc.</Definition>
        <Definition>A plan detailing how a study will be performed in order to represent the phenomenon under examination, to answer the research questions that have been asked, and defining the methods of data analysis. Study design is driven by research hypothesis being posed, study subject/population/sample available, logistics/resources: technology, support, networking, collaborative support, etc.
Describes the role the study plays in determining the interventions a subject receives. [NCIT_14.05d] [Contributing_Source_CDISC]</Definition>
        <Definition>A plan detailing how a study will be performed in order to represent the phenomenon under examination, to answer the research questions that have been asked, and defining the methods of data analysis. Study design is driven by research hypothesis being posed, study subject/population/sample available, logistics/resources: technology, support, networking, collaborative support, etc.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Study Design</Term>
        <Term>DESIGN</Term>
        <Term>CDISC SEND Study Design Terminology</Term>
        <Term>study design</Term>
        <Term>Design, Research</Term>
        <Term>Nonclinical Study Design</Term>
        <Term>research design</Term>
        <Term>Study Type</Term>
        <Term>Experiment Design</Term>
        <Term>Experimental Design</Term>
        <Term>Research Design</Term>
        <Term>design research</Term>
        <Term>SEND-DESIGN</Term>
        <Term>SDESIGN</Term>
        <Term>STYPE</Term>
        <Term>research strategy (individual study)</Term>
        <Term>Research Designs</Term>
        <Term>Designs, Research</Term>
        <Codes>
          <Code code="C0035171" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Terminology</Relation>
          <Relation name="Narrower">OTE:prevalence_study, OTE:clinical_trial, OTE:pilot_study, OTE:before-after_design, OTE:retrospective_design, OTE:controlled_design, OTE:epidemiological_design, OTE:non-randomized_design, OTE:reliability_design, OTE:case_history, OTE:meta_analysis, OTE:trend_design, OTE:cross-over_design, OTE:double_blind_design, OTE:single_blind_design, OTE:human_study, OTE:non-comparative_design, OTE:diagnostic_study, OTE:quantitative_study, OTE:psychometric_study, OTE:descriptive_study, OTE:in_vitro_study, OTE:solomon_four_group_design, OTE:records_review, OTE:cross-sectional_study, OTE:observational_study, OTE:survey, OTE:animal_study, OTE:time_design, OTE:database_study, OTE:cohort_study, OTE:focus_group, OTE:longitudinal_design, OTE:randomized_design, OTE:experimental_design, OTE:feasibility_study, OTE:qualitative_study, OTE:correlational_design, OTE:non-controlled_design, OTE:parallel_design, OTE:head_to_head_design, OTE:registry_study, OTE:evaluation, OTE:stepped_wedge_design, OTE:validity_design, OTE:community_trial, OTE:non-experimental_design, OTE:n-of-1_design, OTE:open_design, OTE:case_study, OTE:comparative_study, OTE:factorial_design, OTE:theoretical_design, OTE:case_series, OTE:pragmatic_design, OTE:adaptive_design, OTE:ecological_study, OTE:time_and_motion_study, OTE:in_vivo_study, OTE:analytical_design, OTE:prospective_study, OTE:interview, OTE:literature_review</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Zebrafish" name="Zebrafish">
        <Definition>Brachydanio rerio, species of small freshwater aquarium fish with a transparent embryo making it possible to follow progeny of single cells until quite late stages of development. This, together with the availability of mutant lines make it an important preparation for the study of vertebrate cell lineage and developmental biology.(On-line Medical Dictionary)</Definition>
        <Definition>Brachydanio rerio, species of small freshwater aquarium fish with a transparent embryo making it possible to follow progeny of single cells until quite late stages of development. This, together with the availability of mutant lines make it an important preparation for the study of vertebrate cell lineage and developmental biology.</Definition>
        <Definition>freshwater fish used in vertebrate genetic research and as a model for development.</Definition>
        <Definition>An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. They are used in embryological studies and to study the effects of certain chemicals on development.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Zebrafish</Term>
        <Term>Danio rerio</Term>
        <Term>Zebra danio</Term>
        <Term>leopard danio</Term>
        <Term>zebra fish</Term>
        <Term>Danio rerio frankei</Term>
        <Term>Zebra Danio</Term>
        <Term>Danio rerio (organism)</Term>
        <Term>Danio frankei</Term>
        <Term>Cyprinus rerio</Term>
        <Term>Brachydanio rerio frankei</Term>
        <Term>Danio rerio (Hamilton, 1822)</Term>
        <Term>Brachydanio rerio</Term>
        <Term>zebrafish</Term>
        <Term>Zebrafishes</Term>
        <Term>Zebra Fish</Term>
        <Term>zebra danio</Term>
        <Term>Cyprinus rerio Hamilton, 1822</Term>
        <Codes>
          <Code code="C14287" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Fish</Relation>
          <Relation name="Narrower">OTE:SJD_Zebrafish, OTE:Tubingen_Zebrafish, OTE:Nadia_Zebrafish, OTE:Tupfel_Long_Fin_Zebrafish, OTE:C32_Zebrafish, OTE:SJA_Zebrafish, OTE:AB_Zebrafish, OTE:Singapore_Zebrafish, OTE:Wild_Type_Unspecified_Zebrafish, OTE:Indonesia_Zebrafish, OTE:SJD_C32_Zebrafish, OTE:AB_Tubingen_Zebrafish, OTE:India_Zebrafish, OTE:AB_TL_Zebrafish, OTE:Tupfel_Long_Fin_Nacre_Zebrafish, OTE:WIK_Zebrafish, OTE:Darjeeling_Zebrafish, OTE:Ekkwill_Zebrafish, OTE:WIK_AB_Zebrafish, OTE:Hong_Kong_Zebrafish, OTE:HK_SING_Zebrafish, OTE:Cologne_Zebrafish, OTE:HK_AB_Zebrafish, OTE:AB_C32_Zebrafish, OTE:RIKEN_WT_Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:E_Selectin" name="E Selectin">
        <Definition>This gene plays a role in inflammation by mediating cellular adhesion to vasculature.</Definition>
        <Definition>E-Selectin is expressed by cytokine-stimulated endothelial cells and is thought responsible for accumulation of neutrophils, monocytes, and memory T-cells at sites of inflammation. Neutrophil accumulation at sites of inflammation is mediated by cell adhesion molecules including the CD18 integrins on leukocytes and the selectins (P- and E-selectin on endothelium and L-selectin on leukocytes). E-Selectin exhibits homologous structural features to L-selectin, including lectin- and EGF-like domains followed by SCR domains. E-Selectin recognizes Lewis X family- or Lewis A family-related sialylated carbohydrate groups. (from OMIM 131210 and NCI)</Definition>
        <Definition>Cell adhesion molecule and CD antigen that mediates neutrophil, monocyte, and memory T-cell adhesion to cytokine-activated endothelial cells. E-selectin recognizes sialylated carbohydrate groups related to the Lewis X or Lewis A family.</Definition>
        <Definition>Encoded by human SELE Gene (Selectin Family), 610-aa 66.5-kD E-Selectin precursor is a cytokine-induced endothelia type I membrane protein with features homologous to LYAM1: a C-type lectin domain, an EGF-like domain, six cysteine-containing SCR (sushi) domains. Likely having an evolutionary history with LYAM1, GRMP, and complement binding proteins, ELAM1 mediates cell adhesion binding of endothelial cells to leukocytes, such as Neutrophils, during inflammatory responses. ELAM1 recognizes glycolipid polylactosamine derivatives and may be involved in the pathogenesis of atherosclerosis. An aa149 polymorphism is associated with higher risk of coronary artery disease and ELAM1 is a diagnostic indicator of glaucoma. (from LocusLink, Swiss-Prot, OMIM, and NCI)</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">E Selectin</Term>
        <Term>E-selectin</Term>
        <Term>CD62E Antigen</Term>
        <Term>selectin E</Term>
        <Term>Selectin, E</Term>
        <Term>ELAM1</Term>
        <Term>Selectin E (Endothelial Adhesion Molecule 1) Gene</Term>
        <Term>SELE</Term>
        <Term>ELAM</Term>
        <Term>LECAM2</Term>
        <Term>Cell Adhesion Molecule E-Selectin</Term>
        <Term>E-Selectin</Term>
        <Term>Antigen, CD62E</Term>
        <Term>Leukocyte Endothelial Cell Adhesion Molecule 2</Term>
        <Term>CD 062 E ANTIGENS</Term>
        <Term>LECAM-2</Term>
        <Term>elam</Term>
        <Term>e-selectin</Term>
        <Term>ELAM-1</Term>
        <Term>Lymphocyte antigen CD62E</Term>
        <Term>CD62E Antigens</Term>
        <Term>ELAM (endothelial leukocyte adhesion molecule)</Term>
        <Term>Endothelial Leukocyte Adhesion Molecule-1</Term>
        <Term>ELAM 001</Term>
        <Term>SELECTIN E</Term>
        <Term>Antigens, CD62E</Term>
        <Term>ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1</Term>
        <Term>ANTIGENS CD 062 E</Term>
        <Term>Endothelial Adhesion Molecule 1</Term>
        <Term>CD62E</Term>
        <Term>ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 001</Term>
        <Term>e selectin</Term>
        <Term>SELE gene</Term>
        <Term>ESEL</Term>
        <Term>endothelial leukocyte adhesion molecule</Term>
        <Term>E-Selectin [Chemical/Ingredient]</Term>
        <Term>Endothelial Leukocyte Adhesion Molecule 1</Term>
        <Term>SELE Gene</Term>
        <Term>LECAM 002</Term>
        <Term>Lymphocyte antigen CD62E (substance)</Term>
        <Term>E selectin</Term>
        <Term>E-SELECTIN</Term>
        <Codes>
          <Code code="C0115305" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:SELE_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BL_Ka_Mouse" name="C57BL/Ka Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BL/Ka Mouse</Term>
        <Term>C57BL/Ka</Term>
        <Codes>
          <Code code="C37387" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD86_protein_human" name="CD86 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD86 protein, human</Term>
        <Term>BU63 protein, human</Term>
        <Term>CTLA-4 counter-receptor B7.2, human</Term>
        <Term>B7.2 protein, human</Term>
        <Term>ETC-1 protein, human</Term>
        <Term>FUN-1 protein, human</Term>
        <Term>CD86 antigen (CD28 antigen ligand 2, B7-2 antigen), human</Term>
        <Term>B70 antigen, human</Term>
        <Codes>
          <Code code="C1528560" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD86</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mcam_protein_rat" name="Mcam protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mcam protein, rat</Term>
        <Term>l-gicerin protein, rat</Term>
        <Term>melanoma cell adhesion molecule, rat</Term>
        <Term>Muc18 protein, rat</Term>
        <Codes>
          <Code code="C1570020" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD146_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:case_comparison_design" name="case comparison design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">case comparison design</Term>
        <Term>case-comparison studies</Term>
        <Term>case-compeer study</Term>
        <Term>case-compeer studies</Term>
        <Term>case referent study</Term>
        <Term>case-comparison trial</Term>
        <Term>case compeer study</Term>
        <Term>case comparison trial</Term>
        <Term>case referent studies</Term>
        <Term>case-referent studies</Term>
        <Term>case comparison designs</Term>
        <Term>case comparison study</Term>
        <Term>case compeer studies</Term>
        <Term>case-comparison study</Term>
        <Term>case-referent study</Term>
        <Term>case comparison studies</Term>
        <Term>case comparison trials</Term>
        <Term>case-comparison trials</Term>
        <Term>case-comparison design</Term>
        <Term>case-comparison designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#case_comparison_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:comparative_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tnfrsf13c_protein_mouse" name="Tnfrsf13c protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tnfrsf13c protein, mouse</Term>
        <Term>B-cell activation factor receptor protein, mouse</Term>
        <Term>tumor necrosis factor receptor superfamily, member 13c protein, mouse</Term>
        <Term>BAFF-R protein, mouse</Term>
        <Codes>
          <Code code="C1434885" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:B_Cell_Activation_Factor_Receptor</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:case_history" name="case history">
        <Definition>collected data concerning an individual, including family, environment, medical history and any other information that may be useful in analysis and diagnois of medical condition.</Definition>
        <Definition>Clinical presentations that may be followed by evaluative studies that eventually lead to a diagnosis. [Case report | MeSH_2014] </Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">case history</Term>
        <Term>Case Studies</Term>
        <Term>Case History</Term>
        <Term>Case Histories</Term>
        <Term>Case Study</Term>
        <Term>cases history</Term>
        <Term>CASE HIST</Term>
        <Term>case histories</Term>
        <Codes>
          <Code code="C0085970" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mus_musculus_castaneus" name="Mus musculus castaneus">
        <Definition>A subspecies of common house mouse (Mus musculus).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mus musculus castaneus</Term>
        <Term>Mus castaneus</Term>
        <Term>Southeastern Asian House Mouse</Term>
        <Codes>
          <Code code="C2347307" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mus_musculus</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:antigens_CD69" name="antigens, CD69">
        <Definition>Early activation antigen CD69 (199 aa, ~23 kDa) is encoded by the human CD69 gene. This protein plays a role in signal transduction in natural killer cells and platelets.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">antigens, CD69</Term>
        <Term>AIM antigen</Term>
        <Term>early activation antigen EA1</Term>
        <Term>p60, early T-cell activation antigen</Term>
        <Term>AIM molecule</Term>
        <Term>Leu-23 antigen</Term>
        <Term>early activation antigen CD69</Term>
        <Term>activation antigen EA1</Term>
        <Term>CD69 antigen</Term>
        <Term>activation inducer molecule antigen</Term>
        <Codes>
          <Code code="C0108800" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cd69_protein_mouse, OTE:Cd69_protein_rat, OTE:CD69_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mammaglobin-A" name="Mammaglobin-A">
        <Definition>A secretoglobin that is produced by the MAMMARY GLAND of HUMANS and may be involved in the binding of ANDROGENS and other STEROIDS. The expression of this protein in normal breast epithelium and in human breast cancer has made it an important histological marker.</Definition>
        <Definition>Mammaglobin-A (93 aa, ~10 kDa) is encoded by the human SCGB2A2 gene. This protein may be involved in the development of mammary glands.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mammaglobin-A</Term>
        <Term>Secretoglobin Family 2A Member 2</Term>
        <Term>Mammaglobin A</Term>
        <Term>Mammaglobin 1</Term>
        <Codes>
          <Code code="C3203084" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
          <Relation name="Narrower">OTE:SCGB2A2_protein_human, OTE:Scgb2a2_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD4-ricin_A_chain_conjugate" name="CD4-ricin A chain conjugate">
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD4-ricin A chain conjugate</Term>
        <Term>rCD4-dgA</Term>
        <Codes>
          <Code code="C0645994" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD4</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:TNFSF8_protein_human" name="TNFSF8 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">TNFSF8 protein, human</Term>
        <Term>tumor necrosis factor (ligand) superfamily, member 8 protein, human</Term>
        <Term>CD30 ligand, human</Term>
        <Term>CD30LG protein, human</Term>
        <Term>CD30L protein, human</Term>
        <Codes>
          <Code code="C1671930" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD30_Ligand</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Receptors_Interleukin-1_Type_I" name="Receptors, Interleukin-1 Type I">
        <Definition>An interleukin-1 receptor subtype that is involved in signaling cellular responses to INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The binding of this receptor to its ligand causes its favorable interaction with INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN and the formation of an activated receptor complex.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Receptors, Interleukin-1 Type I</Term>
        <Term>Receptor Type I, Interleukin 1</Term>
        <Term>CDw121a Antigens</Term>
        <Term>Interleukin-1 Receptors Type I</Term>
        <Term>CD121a Antigens</Term>
        <Term>Receptors, Interleukin 1 Type I</Term>
        <Term>Interleukin-1 Receptor Type I</Term>
        <Term>Antigens, CDw121a</Term>
        <Term>INTERLEUKIN 001 RECEPTOR TYPE I</Term>
        <Term>Interleukin 1 Receptor Type I</Term>
        <Term>Interleukin 1 Receptors Type I</Term>
        <Term>INTERLEUKIN 001 RECEPTORS TYPE I</Term>
        <Term>CD 121A ANTIGENS</Term>
        <Term>Receptor Type I, Interleukin-1</Term>
        <Term>ANTIGENS CD 121A W</Term>
        <Term>RECEPTORS INTERLEUKIN 001 TYPE I</Term>
        <Codes>
          <Code code="C0391754" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:IL1R1_protein_rat, OTE:IL1R1_protein_human, OTE:IL1R1_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Il17r_protein_mouse" name="Il17r protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Il17r protein, mouse</Term>
        <Term>Il17ra protein, mouse</Term>
        <Term>IL-17ra protein, mouse</Term>
        <Term>Cdw217 protein, mouse</Term>
        <Term>interleukin 17 receptor protein, mouse</Term>
        <Term>VDw217 protein, mouse</Term>
        <Codes>
          <Code code="C1433234" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_Interleukin-17</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SKH1-Hr_hr" name="SKH1-Hr hr">
        <Definition>An uncharacterized and non-pedigreed hairless albino mouse strain that is immunocompetent and euthymic.</Definition>
        <Definition>An uncharacterized and non-pedigreed hairless albino mouse strain that is immunocompetent and euthymic. (NCI)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SKH1-Hr hr</Term>
        <Codes>
          <Code code="C98782" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:TNF-sR75" name="TNF-sR75">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">TNF-sR75</Term>
        <Codes>
          <Code code="C0255811" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Necrosis_Factor_Receptor_Type_II</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd81_protein_mouse" name="Cd81 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd81 protein, mouse</Term>
        <Term>CD 81 antigen, mouse</Term>
        <Term>TSPAN28 protein, mouse</Term>
        <Codes>
          <Code code="C1452162" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD81_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tnfrsf9_protein_mouse" name="Tnfrsf9 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tnfrsf9 protein, mouse</Term>
        <Term>tumor necrosis factor receptor superfamily, member 9, mouse</Term>
        <Term>Ly63 protein, mouse</Term>
        <Term>lymphocyte antigen-63, mouse</Term>
        <Codes>
          <Code code="C0527565" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD137</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin_2_Receptor_alpha" name="Interleukin 2 Receptor alpha">
        <Definition>Interleukin-2 receptor alpha chain (272 aa, 31 kD) is a cell fate protein that is encoded by the human IL2RA gene and has roles in immune response, cell proliferation, apoptosis and signal transduction.</Definition>
        <Definition>A low affinity interleukin-2 receptor subunit that combines with the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN to form a high affinity receptor for INTERLEUKIN-2.</Definition>
        <Definition>This gene plays a role in clathrin-independent endocytosis and immune functions.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin 2 Receptor alpha</Term>
        <Term>Receptor alpha, Interleukin-2</Term>
        <Term>Interleukin 2 Receptors alpha</Term>
        <Term>INTERLEUKIN 2 RECEPTOR, ALPHA</Term>
        <Term>Interleukin 2 Receptor alpha Chain</Term>
        <Term>INTERLEUKIN 002 RECEPTOR ALPHA SUBUNIT</Term>
        <Term>Antigen, CD25</Term>
        <Term>T-CELL GROWTH FACTOR RECEPTOR</Term>
        <Term>CD25 Antigen</Term>
        <Term>IL-2Ralpha</Term>
        <Term>IL-2R</Term>
        <Term>ANTIGENS CD 025</Term>
        <Term>IL2RA Gene</Term>
        <Term>TAC ANTIGEN</Term>
        <Term>Interleukin-2 Receptor alpha Subunit</Term>
        <Term>Low Affinity Interleukin 2 Receptor</Term>
        <Term>Receptors alpha, Interleukin-2</Term>
        <Term>IL2RA gene</Term>
        <Term>IL2R, ALPHA CHAIN</Term>
        <Term>IL2R</Term>
        <Term>Interleukin-2 Receptors alpha</Term>
        <Term>TAC PEPTIDE P 055</Term>
        <Term>TCGFR</Term>
        <Term>Interleukin 2 Receptor, Alpha Gene</Term>
        <Term>interleukin 2 receptor, alpha</Term>
        <Term>CD25 Antigens</Term>
        <Term>Interleukin-2 Receptor alpha Subunit [Chemical/Ingredient]</Term>
        <Term>Interleukin-2Ralpha</Term>
        <Term>Interleukin 2Ralpha</Term>
        <Term>Interleukin 2 Receptor, Alpha</Term>
        <Term>Tac P55 Peptide</Term>
        <Term>CD 025 ANTIGENS</Term>
        <Term>Interleukin 2 Receptor</Term>
        <Term>Interleukin-2 Receptor alpha</Term>
        <Term>INTERLEUKIN 002 RECEPTORS ALPHA</Term>
        <Term>alpha-subunit, Receptor, Interleukin-2</Term>
        <Term>Interleukin-2 Receptor alpha Chain</Term>
        <Term>Interleukin 2 Receptor alpha Subunit</Term>
        <Term>IL-2 Receptor</Term>
        <Term>IL2 RECEPTOR</Term>
        <Term>IL 2Ralpha</Term>
        <Term>Interleukin-2 Receptor Alpha Chain</Term>
        <Term>Antigens, CD25</Term>
        <Term>CD25</Term>
        <Term>IL2RA</Term>
        <Codes>
          <Code code="C1101536" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:IL2RA_protein_human, OTE:Il2ra_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:narrative_review" name="narrative review">
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">narrative review</Term>
        <Term>narrative reviews</Term>
        <Term>narrative analysis</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#narrative_review" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:literature_review</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD59a_protein_mouse" name="CD59a protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD59a protein, mouse</Term>
        <Codes>
          <Code code="C2714590" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD59</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:sentinel_surveillance" name="sentinel surveillance">
        <Definition>Monitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort such as in a geographic area or population subgroup to estimate trends in larger population. (From Last, Dictionary of Epidemiology, 2d ed)</Definition>
        <Definition>Monitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort such as in a geographic area or population subgroup to estimate trends in larger population. [From Last, Dictionary of Epidemiology, 2d ed] [MeSH_2014]</Definition>
        <SemanticType code="T057" name="Occupational Activity"/>
        <SemanticType code="T081" name="Quantitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">sentinel surveillance</Term>
        <Term>Surveillances, Sentinel</Term>
        <Term>Surveillance, Sentinel</Term>
        <Term>Sentinel Surveillance</Term>
        <Term>Sentinel Surveillances</Term>
        <Term>population surveillance</Term>
        <Codes>
          <Code code="C0242791" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:population_surveillance</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:graft_survival" name="graft survival">
        <Definition>The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host.</Definition>
        <SemanticType code="T042" name="Organ or Tissue Function"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">graft survival</Term>
        <Term>Survivals, Graft</Term>
        <Term>Survival, Graft</Term>
        <Term>survival graft</Term>
        <Term>Graft Survivals</Term>
        <Term>Graft Survival</Term>
        <Codes>
          <Code code="C0018131" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Outcome_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C3H_HeSnJ_Mouse" name="C3H/HeSnJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C3H/HeSnJ Mouse</Term>
        <Term>C3H/HeSnJ</Term>
        <Codes>
          <Code code="C37372" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:retrospective_case_series" name="retrospective case series">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">retrospective case series</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#retrospective_case_series" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:case_series</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129S_SvEv_Mouse" name="129S/SvEv Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129S/SvEv Mouse</Term>
        <Term>129S/SvEv</Term>
        <Codes>
          <Code code="C37334" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Immunodeficient_Mouse" name="Immunodeficient Mouse">
        <Definition>Any mouse strain with a faulty immune system such that its ability to fight infectious disease is compromised or ablated. Immunodeficient mice may be derived by inbreeding or genetic engineering. Immunodeficiency may also be induced by some chemicals, heavy metals, alkylating agents, radiation, and thymectomy.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Immunodeficient Mouse</Term>
        <Codes>
          <Code code="C15156" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mouse_Strains</Relation>
          <Relation name="Narrower">OTE:SCID_Mouse, OTE:NIH-III_Mouse, OTE:Nude_Mouse, OTE:Rag1_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:fms_Like_Tyrosine_Kinase_3" name="fms Like Tyrosine Kinase 3">
        <Definition>A receptor tyrosine kinase that is involved in HEMATOPOIESIS. It is closely related to FMS PROTO-ONCOGENE PROTEIN and is commonly mutated in acute MYELOID LEUKEMIA.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">fms Like Tyrosine Kinase 3</Term>
        <Term>FMS LIKE TYROSINE KINASE 003</Term>
        <Term>Fetal Liver Kinase 3</Term>
        <Term>CD135 Antigen</Term>
        <Term>CD 135 ANTIGENS</Term>
        <Term>Fetal Liver Kinase-2</Term>
        <Term>ANTIGENS CD 135</Term>
        <Term>fms-Like Tyrosine Kinase 3</Term>
        <Term>CD135 Antigens</Term>
        <Term>Stem Cell Tyrosine Kinase 1</Term>
        <Term>Fetal Liver Kinase 2</Term>
        <Term>Fetal Liver Kinase-3</Term>
        <Term>Antigens, CD135</Term>
        <Term>Antigen, CD135</Term>
        <Codes>
          <Code code="C0287186" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:FLT3_protein_human, OTE:flt3_protein_zebrafish, OTE:FLT3_protein_rat, OTE:Flt3_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:difucosyl_lactosamine" name="difucosyl lactosamine">
        <SemanticType code="T119" name="Lipid"/>
        <SemanticType code="T118" name="Carbohydrate"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">difucosyl lactosamine</Term>
        <Codes>
          <Code code="C0246541" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:sialosyl_dimeric_Leantigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Leu-11_Antigens" name="Leu-11 Antigens">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Leu-11 Antigens</Term>
        <Term>Leu 11 Antigens</Term>
        <Term>Antigens, Leu-11</Term>
        <Codes>
          <Code code="C0125494" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Il2rg_protein_mouse" name="Il2rg protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Il2rg protein, mouse</Term>
        <Term>CRgamma, mouse</Term>
        <Term>interleukin 2 receptor gamma chain, mouse</Term>
        <Term>cytokine receptor gamma chain, mouse</Term>
        <Codes>
          <Code code="C1568754" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_gamma-Chain_Protein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:asialofetuin_12_peptide" name="asialofetuin 12 peptide">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">asialofetuin 12 peptide</Term>
        <Term>AsF12 peptide</Term>
        <Codes>
          <Code code="C0251381" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:rapid_review" name="rapid review">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">rapid review</Term>
        <Term>rapid reviews</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#rapid_review" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:literature_review</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cynomolgus_Monkey" name="Cynomolgus Monkey">
        <Definition>The macaque, Macaca fascicularis.</Definition>
        <Definition>A macaque, Macaca fascicularis (M. cynomolgus), found mostly in southeastern Asia, Borneo, and the Philippines.</Definition>
        <Definition>A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula.</Definition>
        <Definition>found in most of Southeast Asia; long tailed; used in research instead of rhesus.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cynomolgus Monkey</Term>
        <Term>Long-tailed macaque</Term>
        <Term>Cynomolgus monkey</Term>
        <Term>Crab-Eating Macaques</Term>
        <Term>Macaca fascicularis (organism)</Term>
        <Term>Macaque, Crab-Eating</Term>
        <Term>Crab Eating Macaque</Term>
        <Term>Crab-Eating Monkeys</Term>
        <Term>cynomolgus monkeys</Term>
        <Term>CYNOMOLGUS</Term>
        <Term>Monkey, Crab-Eating</Term>
        <Term>Monkeys, Crab-Eating</Term>
        <Term>Crab-eating macaque</Term>
        <Term>Cynomolgus</Term>
        <Term>cynomolgus monkey</Term>
        <Term>Monkey, Crab Eating</Term>
        <Term>Common macaque</Term>
        <Term>Macaca cynomolgus</Term>
        <Term>crab eating macaque</Term>
        <Term>Macaca irus</Term>
        <Term>Macaques, Crab-Eating</Term>
        <Term>Crab-Eating Macaque</Term>
        <Term>Macaca fascicularis</Term>
        <Term>Crab Eating Monkey</Term>
        <Term>Monkey, Cynomolgus</Term>
        <Term>Cynomolgus Monkeys</Term>
        <Term>Monkeys, Cynomolgus</Term>
        <Term>Crab-Eating Monkey</Term>
        <Term>long-tailed macaque</Term>
        <Codes>
          <Code code="C14232" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Macaque</Relation>
          <Relation name="Narrower">OTE:Cynomolgus_Maritius_Monkey</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Caviidae" name="Caviidae">
        <Definition>Taxonomic family which includes Guinea pigs, wild cavies, and the capybara.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Caviidae</Term>
        <Term>Family Caviidae (organism)</Term>
        <Term>Family Caviidae</Term>
        <Codes>
          <Code code="C0018382" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rodentia</Relation>
          <Relation name="Narrower">OTE:Guinea_Pig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fcgr2b_protein_mouse" name="Fcgr2b protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fcgr2b protein, mouse</Term>
        <Term>Fc receptor, IgG, low affinity IIb protein, mouse</Term>
        <Term>Ly-17 protein, mouse</Term>
        <Term>Fc gamma RIIB protein, mouse</Term>
        <Term>CD32 protein, mouse</Term>
        <Term>FcgammaRIIB protein, mouse</Term>
        <Term>Ly17 protein, mouse</Term>
        <Codes>
          <Code code="C1452605" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Itga7_protein_rat" name="Itga7 protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Itga7 protein, rat</Term>
        <Term>integrin alpha 7, rat</Term>
        <Codes>
          <Code code="C1721218" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:integrin_alpha7</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL5RA_protein_human" name="IL5RA protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL5RA protein, human</Term>
        <Term>interleukin-5 receptor alpha, human</Term>
        <Term>IL-5Ralpha, human</Term>
        <Term>hIL-5Ralpha, human</Term>
        <Term>interleukin 5 receptor, alpha protein, human</Term>
        <Codes>
          <Code code="C1451756" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_5_Receptor_alpha_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CDH5_protein_human" name="CDH5 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CDH5 protein, human</Term>
        <Term>cadherin 5, type 2, VE-cadherin (vascular epithelium), human</Term>
        <Codes>
          <Code code="C1741231" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cadherin-5</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:alpha-Fetoprotein_Deficiency" name="alpha-Fetoprotein Deficiency">
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">alpha-Fetoprotein Deficiency</Term>
        <Codes>
          <Code code="C1863081" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SD_Rij_Rat_Strain" name="SD/Rij, Rat Strain">
        <Definition>Less sensitive to the induction of mammary tumors by DMBA than two samples of outbred Sprague-Dawley rats; mean life-span 743-22 days.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SD/Rij, Rat Strain</Term>
        <Codes>
          <Code code="C14381" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ross_Chicken" name="Ross Chicken">
        <Definition>A small white-colored broiler breed that averages 4-5.5 pounds when fully grown, with females averaging 120 eggs laid per year. Two substrains exist of Ross chickens; the Ross 308 and the Ross 708. The Ross 308 weighs between 3.8-5.5 pounds and is slightly smaller than the Ross 708 which can grow to be larger than 5.5 pounds. The Ross 708 is bred specifically for high meat yield and ease in deboning. (NCI)</Definition>
        <Definition>A small white-colored broiler breed that averages 4-5.5 pounds when fully grown, with females averaging 120 eggs laid per year. Two substrains exist of Ross chickens; the Ross 308 and the Ross 708. The Ross 308 weighs between 3.8-5.5 pounds and is slightly smaller than the Ross 708 which can grow to be larger than 5.5 pounds. The Ross 708 is bred specifically for high meat yield and ease in deboning.</Definition>
        <SemanticType code="T012" name="Bird"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ross Chicken</Term>
        <Term>Ross</Term>
        <Term>ROSS</Term>
        <Codes>
          <Code code="C77099" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Chicken</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FLT3_protein_human" name="FLT3 protein, human">
        <Definition>Fms-related receptor tyrosine kinase; growth factor receptor for hematopoietic stem and progenitor cells. (LocusLink)</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FLT3 protein, human</Term>
        <Term>CD135 antigen, human</Term>
        <Term>STK-1 kinase, human</Term>
        <Term>stem cell tyrosine kinase 1 protein, human</Term>
        <Term>fms-related tyrosine kinase 3 protein, human</Term>
        <Term>FLK2 protein, human</Term>
        <Term>fetal liver kinase-2 protein, human</Term>
        <Codes>
          <Code code="C0251006" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:fms_Like_Tyrosine_Kinase_3</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Plaur_protein_rat" name="Plaur protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Plaur protein, rat</Term>
        <Term>plasminogen activator, urokinase receptor, rat</Term>
        <Term>CD87 antigen, rat</Term>
        <Codes>
          <Code code="C2002173" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Plasminogen_Activator_Urokinase_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Uridine_5-Prime_Monophosphate_Hydrolase_Deficiency_Hemolytic_Anemia_due_to" name="Uridine 5-Prime Monophosphate Hydrolase Deficiency, Hemolytic Anemia due to">
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Uridine 5-Prime Monophosphate Hydrolase Deficiency, Hemolytic Anemia due to</Term>
        <Term>UMPH1 Deficiency</Term>
        <Term>Pyrimidine 5-Prime Nucleotidase Deficiency, Hemolytic Anemia due to</Term>
        <Term>Hemolytic Anemia due to UMPH1 Deficiency</Term>
        <Term>Hemolytic Anemia due to Uridine 5-Prime Monophosphate Hydrolase Deficiency</Term>
        <Term>Hemolytic Anemia due to P5N Deficiency</Term>
        <Codes>
          <Code code="C1849507" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-Nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Pancreatic_Islet_Transplantation" name="Pancreatic Islet Transplantation">
        <Definition>The transference of pancreatic islets within an individual, between individuals of the same species, or between individuals of different species.</Definition>
        <Definition>transferring pancreatic islet cells within an individual or between individuals of the same or different species.</Definition>
        <Definition>&lt;p&gt;Islet cell transplantation places cells from an organ donor into the body of another person. It is used experimentally to treat &lt;a href='http://www.nlm.nih.gov/medlineplus/diabetestype1.html'&gt;type 1 diabetes&lt;/a&gt;. Islets are cells found in clusters throughout the pancreas. They are made up of several types of cells. The islets contain beta cells, which make insulin. Insulin is a hormone that helps the body use glucose for energy. &lt;/p&gt;&lt;p&gt;In type 1 diabetes, the beta cells of the pancreas no longer make insulin. A person who has type 1 diabetes must take insulin daily to live. Transplanted islet cells, however, can take over the work of the destroyed cells. Once implanted, the beta cells in these islets begin to make and release insulin. Researchers hope islet transplantation will help people with type 1 diabetes live without daily insulin injections. &lt;/p&gt;&lt;p &gt;NIH: National Institute of Diabetes and Digestive and Kidney Diseases &lt;/p&gt;</Definition>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Pancreatic Islet Transplantation</Term>
        <Term>TRANSPL ISLANDS OF LANGERHANS</Term>
        <Term>Transplantation, Islets of Langerhans</Term>
        <Term>islet cell transplantation</Term>
        <Term>ISLANDS OF PANCREAS TRANSPL</Term>
        <Term>islets pancreatic transplantation</Term>
        <Term>TRANSPL ISLANDS OF PANCREAS</Term>
        <Term>ISLANDS OF LANGERHANS TRANSPL</Term>
        <Term>Transplantation, Islands of Pancreas</Term>
        <Term>cell islet transplants</Term>
        <Term>Islets Transplantation, Pancreatic</Term>
        <Term>Pancreatic Islets Transplantation</Term>
        <Term>Grafting, Islets of Langerhans</Term>
        <Term>islet cells transplantation</Term>
        <Term>islet transplantation</Term>
        <Term>ISLET TRANSPL</Term>
        <Term>Islet Transplantation</Term>
        <Term>TRANSPL ISLET</Term>
        <Term>Transplantation, Pancreatic Islets</Term>
        <Term>Transplantation of islet cells</Term>
        <Term>islet cell transplant</Term>
        <Term>PANCREATIC ISLETS TRANSPL</Term>
        <Term>Transplantations, Islet</Term>
        <Term>Islet Cell Transplantation</Term>
        <Term>Islets of Langerhans Transplantation</Term>
        <Term>pancreatic islet transplantation</Term>
        <Term>Islands of Langerhans Transplantation</Term>
        <Term>Transplantation, Islands of Langerhans</Term>
        <Term>Islet cell transplant (procedure)</Term>
        <Term>TRANSPL ISLETS OF LANGERHANS</Term>
        <Term>Islet Transplantations</Term>
        <Term>Transplant islets of Langerhan</Term>
        <Term>Islet cell transplant</Term>
        <Term>islet transplantations</Term>
        <Term>cell transplantation islet</Term>
        <Term>Transplantation, Islet</Term>
        <Term>Islands of Pancreas Transplantation</Term>
        <Term>islets of Langerhans transplantation</Term>
        <Term>cell islets transplantation</Term>
        <Term>TRANSPL PANCREATIC ISLETS</Term>
        <Term>islets transplantation</Term>
        <Term>ISLETS TRANSPL</Term>
        <Term>cell islets transplant</Term>
        <Term>Transplantation of islets of Langerhans</Term>
        <Codes>
          <Code code="C15352" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Organ_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tumor_Necrosis_Factor_Ligand_Superfamily_Member_6" name="Tumor Necrosis Factor Ligand Superfamily Member 6">
        <Definition>A transmembrane protein belonging to the tumor necrosis factor superfamily that was originally discovered on cells of the lymphoid-myeloid lineage, including activated T-LYMPHOCYTES and NATURAL KILLER CELLS. It plays an important role in immune homeostasis and cell-mediated toxicity by binding to the FAS RECEPTOR and triggering APOPTOSIS.</Definition>
        <Definition>FAS ligand is a TNF family, type II transmembrane protein expressed on many cell types and secreted from T-cells upon TCR ligation by MHC/peptide complexes residing on antigen presenting cells. FAS ligand triggers cell death by binding to the cell surface receptor FAS, another transmembrane protein member of the TNF receptor family. FAS ligand is expressed in activated splenocytes and thymocytes, consistent with its involvement in T-cell-mediated cytotoxicity, and in the liver, lung, ovary, and heart, where its function is unclear. (from OMIM 134638 and NCI)</Definition>
        <Definition>This gene is an important regulator of apoptosis.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tumor Necrosis Factor Ligand Superfamily Member 6</Term>
        <Term>Fas Ligand (FasL)</Term>
        <Term>Fas Ligand</Term>
        <Term>Fas ligand (TNF superfamily, member 6)</Term>
        <Term>Antigen, CD178</Term>
        <Term>CD95 LIGAND</Term>
        <Term>FAS LIGAND</Term>
        <Term>TNFSF6</Term>
        <Term>FASLG gene</Term>
        <Term>APOPTOSIS ANTIGEN LIGAND</Term>
        <Term>FasL</Term>
        <Term>FasL Protein</Term>
        <Term>CD178 Antigen</Term>
        <Term>TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 6</Term>
        <Term>FAS-Ligand</Term>
        <Term>TNF Superfamily, Member 6</Term>
        <Term>Antigens, CD178</Term>
        <Term>CD178 ANTIGEN</Term>
        <Term>TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 006</Term>
        <Term>Fas Ligand Protein [Chemical/Ingredient]</Term>
        <Term>APT1LG1</Term>
        <Term>CD178 Antigens</Term>
        <Term>CD95L</Term>
        <Term>CD178</Term>
        <Term>ANTIGENS CD 178</Term>
        <Term>Fas-L</Term>
        <Term>CD95 Ligand</Term>
        <Term>Apoptosis Antigen Ligand 1</Term>
        <Term>CD 178 ANTIGENS</Term>
        <Term>APOPTOSIS ANTIGEN LIGAND 1</Term>
        <Term>Fas Ligand Protein</Term>
        <Term>FASLG Gene</Term>
        <Term>Fas Ligand (TNF Superfamily, Member 6) Gene</Term>
        <Term>FASL</Term>
        <Term>CD95 Antigen Ligand</Term>
        <Term>FASLG</Term>
        <Codes>
          <Code code="C0253023" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Tnfsf6_protein_rat, OTE:Fasl_protein_mouse, OTE:FASLG_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:RIIIS_J_Mouse" name="RIIIS/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">RIIIS/J Mouse</Term>
        <Term>RIIIS/J</Term>
        <Codes>
          <Code code="C37433" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:oval_cell_marker_OV-6" name="oval cell marker OV-6">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">oval cell marker OV-6</Term>
        <Term>OV-6 antigen</Term>
        <Term>OV6 antigen</Term>
        <Codes>
          <Code code="C0758612" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Quail" name="Quail">
        <Definition>A member of the Phasianidae family of pheasants that includes several genera, including Cotumix, Anurophasis, Perdicula and Ophrysia.</Definition>
        <Definition>small gallinaceous game birds.</Definition>
        <Definition>Common name for two distinct groups of BIRDS in the order GALLIFORMES: the New World or American quails of the family Odontophoridae and the Old World quails in the genus COTURNIX, family Phasianidae.</Definition>
        <SemanticType code="T012" name="Bird"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Quail</Term>
        <Term>quail</Term>
        <Term>Quail, NOS</Term>
        <Term>Quail (organism)</Term>
        <Term>QUAIL</Term>
        <Term>Quails</Term>
        <Codes>
          <Code code="C91813" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Aves</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD52_antigen" name="CD52 antigen">
        <Definition>CAMPATH-1 antigen (61 aa, ~7 kDa) is encoded by the human CD52 gene. This protein may play a role in spermatogenesis and lymphocyte biology.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD52 antigen</Term>
        <Term>Campath-1 antigen</Term>
        <Term>CD52 antigen, human</Term>
        <Term>CDW52 Antigen</Term>
        <Term>Human leukocyte antigen HLA-Bw52 antigen</Term>
        <Term>CDw52 antigen</Term>
        <Term>CDw52-Clust dif ag workshop 52</Term>
        <Term>CD52 protein, human</Term>
        <Term>Campath-1 receptor</Term>
        <Term>CD52 Ag</Term>
        <Term>Cluster of differentiation antigen (workshop) 52</Term>
        <Term>HE5 antigen, human</Term>
        <Term>CDw52</Term>
        <Term>Lymphocyte antigen CDw52</Term>
        <Term>CDW52</Term>
        <Term>CD52 Antigen</Term>
        <Term>HLA-Bw52 antigen</Term>
        <Term>Lymphocyte antigen CDw52 (substance)</Term>
        <Term>CD52</Term>
        <Term>Campath-1H antigen</Term>
        <Term>CAMPATH-1 antigen, human</Term>
        <Term>CAMPATH-1 Antigen</Term>
        <Term>Human leucocyte antigen HLA-Bw52 antigen</Term>
        <Term>CDw52 antigen, human</Term>
        <Term>Epididymal Secretory Protein E5</Term>
        <Term>CDw52 - Cluster of differentiation antigen (workshop) 52</Term>
        <Term>Lymphocyte antigen CD52</Term>
        <Term>Cambridge Pathology 1 Antigen</Term>
        <Term>Clust of diff ag (workshop) 52</Term>
        <Codes>
          <Code code="C0376272" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cd52_protein_mouse, OTE:CD52_protein_human, OTE:Cd52_protein_rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Arabs" name="Arabs">
        <Definition>Members of a Semitic people inhabiting the Arabian peninsula or other countries of the Middle East and North Africa. The term may be used with reference to ancient, medieval, or modern ethnic or cultural groups. (From Random House Unabridged Dictionary, 2d ed)</Definition>
        <SemanticType code="T204" name="Eukaryote"/>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Arabs</Term>
        <Term>Colotis</Term>
        <Term>Arabs (ethnic group)</Term>
        <Term>arabs</Term>
        <Term>arab ethnic group</Term>
        <Term>arab</Term>
        <Term>Arab</Term>
        <Term>orange tips</Term>
        <Codes>
          <Code code="C0282540" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ethnic_Groups</Relation>
          <Relation name="Narrower">OTE:Palestinians</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CBA_J_Mouse" name="CBA/J Mouse">
        <Definition>Developed by Strong (1920), the CBA/J mouse was disseminated to Andervont (1947) and then to Jackson Laboratory (1948). The CBA/J strain carries the gene for retinal degeneration (rd).</Definition>
        <Definition>Developed by Strong (1920), the CBA/J mouse was disseminated to Andervont (1947) and then to Jackson Laboratory (1948). The CBA/J strain carries the gene for retinal degeneration (rd) and has a high gross tumor incidence, including lymphoma, hepatoma, and mammary tumors. The CBA/J mice exhibit an intermediate life span with good breeding performance.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CBA/J Mouse</Term>
        <Term>CBA/J</Term>
        <Codes>
          <Code code="C37399" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:hospital-based_case_control_design" name="hospital-based case control design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">hospital-based case control design</Term>
        <Term>hospital-based case control studies</Term>
        <Term>hospital based case-control studies</Term>
        <Term>hospital based case control trial</Term>
        <Term>hospital based case-control study</Term>
        <Term>hospital-based case-control study</Term>
        <Term>hospital-based case control study</Term>
        <Term>hospital-based case control designs</Term>
        <Term>hospital-based case-control trials</Term>
        <Term>hospital based case control design</Term>
        <Term>hospital-based case control trials</Term>
        <Term>hospital based case-control trial</Term>
        <Term>hospital-based case-control studies</Term>
        <Term>hospital based case control study</Term>
        <Term>hospital based case-control design</Term>
        <Term>hospital-based case-control designs</Term>
        <Term>hospital based case control studies</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#hospital_based_case_control_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:case_control_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Male" name="Male">
        <Definition>A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)</Definition>
        <Definition>An individual who reports to be male, the sex that ordinarily produces sperm.</Definition>
        <Definition>&lt;p&gt;Male&lt;/p&gt;</Definition>
        <Definition>An individual who reports belonging to the cultural gender role distinction of male.</Definition>
        <Definition>use in conjunction with a disease, disorder, dysfunction, body system, or function which is gender specific.</Definition>
        <Definition>An animal who is observed by researcher or clinician to be male, the sex that ordinarily produces sperm.</Definition>
        <Definition>Used for all-male populations when sex is pertinent to the focus of the study. For comparison of sexes use HUMAN SEX DIFFERENCES.</Definition>
        <Definition>A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both.</Definition>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <SemanticType code="T032" name="Organism Attribute"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Male</Term>
        <Term>Male structure (body structure)</Term>
        <Term>Male Gender, Self Reported</Term>
        <Term>MALE</Term>
        <Term>Male (finding)</Term>
        <Term>male gender</Term>
        <Term>Male, Self-Reported</Term>
        <Term>Male structure</Term>
        <Term>human male</Term>
        <Term>males</Term>
        <Term>Sex Male</Term>
        <Term>M</Term>
        <Term>male</Term>
        <Term>Male individual, NOS</Term>
        <Term>man</Term>
        <Term>Male Sex, Self Report</Term>
        <Term>Male Gender</Term>
        <Term>Male Phenotype</Term>
        <Term>Males (Human)</Term>
        <Term>MAN</Term>
        <Term>MALE SEX</Term>
        <Term>Human Males</Term>
        <Term>Male, NOS</Term>
        <Term>Male individual</Term>
        <Term>Males</Term>
        <Term>sex male</Term>
        <Term>Male Gender [Disease/Finding]</Term>
        <Term>Male Gender, Self Report</Term>
        <Term>Human, Male</Term>
        <Term>Male, Self-Report</Term>
        <Codes>
          <Code code="C0086582" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Gender_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD32c_antigen" name="CD32c antigen">
        <Definition>Expressed as 4 alternative isoforms in monocytes, macrophages, polymorphonuclear cells, and natural killer cells (Isoform 1) by human FCGR2C Gene, IgG Fc Receptor IIC is a type I cell surface protein with 2 IgC2 domains and a low affinity receptor for aggregated IgG Fc region. FCGR2C binding to IgG initiates essential effector and regulatory cellular responses against foreign pathogens and soluble antigens that induce phagocytosis of antigen-antibody complexes, removing them from circulation, and modulate B-cell antibody production. FCGR2C contains two cytoplasmic ITAM activator motifs involved in cell activation upon receptor aggregation. Isoform 4 may be soluble. (NCI)</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD32c antigen</Term>
        <Term>CD32 Antigen</Term>
        <Term>Fc gamma IIC receptors</Term>
        <Term>Low Affinity IgG Fc Fragment Receptor IIC</Term>
        <Term>Low Affinity Immunoglobulin Gamma Fc Region Receptor IIC</Term>
        <Term>Fc-Gamma RIIC</Term>
        <Term>IgG Fc Receptor IIC</Term>
        <Term>Fc gamma receptor IIC</Term>
        <Term>FCGR2C protein, human</Term>
        <Term>CD32</Term>
        <Term>receptor, Fc gamma IIC</Term>
        <Term>FCGR2C</Term>
        <Term>Fc-Gamma-RIIC</Term>
        <Term>FcRIIC</Term>
        <Term>Fc gamma RIIC</Term>
        <Codes>
          <Code code="C0215037" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Slot" name="slot">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">slot</Term>
        <Relations>
          <Relation name="Broader">owl:Thing</Relation>
          <Relation name="Narrower">OTE:Gender_Slot, OTE:Study_Design_Slot, OTE:Ehnicity_Slot, OTE:Publication_Type_Slot, OTE:Language_Slot, OTE:Intervention_Comparator_Slot, OTE:Outcome_Slot, OTE:Species_Slot, OTE:Population_Type_Slot, OTE:Age_Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Middle_Aged" name="Middle Aged">
        <Definition>A person between young adult and elderly, approximately 40-60 years of age.</Definition>
        <SemanticType code="T100" name="Age Group"/>
        <SemanticType code="T079" name="Temporal Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Middle Aged</Term>
        <Term>Middle-age (finding)</Term>
        <Term>Middle Adult</Term>
        <Term>Middle Age</Term>
        <Term>Middle aged</Term>
        <Term>aged middle</Term>
        <Term>mid-life</Term>
        <Term>Middle age</Term>
        <Term>middle age</Term>
        <Term>Middle Ages</Term>
        <Term>ages middle</Term>
        <Term>midlife</Term>
        <Term>middle ages</Term>
        <Term>middle aged</Term>
        <Term>middle-age</Term>
        <Term>Middle-age</Term>
        <Term>MIDDLE AGE</Term>
        <Term>mid life</Term>
        <Codes>
          <Code code="C0205847" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Adults</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Myd116_protein_mouse" name="Myd116 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Myd116 protein, mouse</Term>
        <Term>myeloid differentiation primary response gene 116 protein, mouse</Term>
        <Codes>
          <Code code="C1448614" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:W_Nhg_Rat_Strain" name="W/Nhg, Rat Strain">
        <Definition>High incidence (97% in females, 36% in males) of spontaneous thymomas starting from about one year of age. They sometimes caused dyspnea, and were occasionally the cause of death, but were not associated with any myopathies or autoimmune disease (Murray et al 1985).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">W/Nhg, Rat Strain</Term>
        <Codes>
          <Code code="C14391" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:OX40Ig" name="OX40Ig">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">OX40Ig</Term>
        <Term>OX40 immunoglobulin</Term>
        <Codes>
          <Code code="C0913471" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:lrp1_2_protein_Xenopus" name="lrp1.2 protein, Xenopus">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">lrp1.2 protein, Xenopus</Term>
        <Codes>
          <Code code="C2975933" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:low_density_lipoprotein_receptor-related_protein_1_Xenopus</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129P2_OlaHsd_Mouse" name="129P2/OlaHsd Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129P2/OlaHsd Mouse</Term>
        <Term>129P2/OlaHsd</Term>
        <Codes>
          <Code code="C37325" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Gerbil" name="Gerbil">
        <Definition>A small mammal belonging to the Gerbillinae subfamily, this omnivorous rodent grows to be 6-12 inches in length, with the tail making up approximately half of its total length. The most common spontaneous tumors that form in gerbils are ovarian tumors and skin carcinomas of the ears, feet, mid-abdomen, and tail base. The average gestational period of the gerbil embryo is 35 days and the gerbil has a life span of 3-4 years. Gerbils are docile, social creatures and can be housed as pairs or in groups of three.</Definition>
        <Definition>A subfamily of the Muridae consisting of several genera including Gerbillus, Rhombomys, Tatera, Meriones, and Psammomys.</Definition>
        <Definition>Any of the small mammals belonging to the Gerbillinae subfamily.</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T015" name="Mammal"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Gerbil</Term>
        <Term>Gerbils</Term>
        <Term>gerbils</Term>
        <Term>gerbil</Term>
        <Term>Subfamily Gerbillinae</Term>
        <Term>allergy testing gerbil (lab test)</Term>
        <Term>Gerbil, NOS</Term>
        <Term>Gerbillinae</Term>
        <Term>Gerbil antigen</Term>
        <Term>Subfamily Gerbillinae (organism)</Term>
        <Term>allergy testing gerbil</Term>
        <Term>GERBIL</Term>
        <Codes>
          <Code code="C77807" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Muridae</Relation>
          <Relation name="Narrower">OTE:Mongolian_Gerbil</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD24_protein_human" name="CD24 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD24 protein, human</Term>
        <Term>cluster w-4 antigen, human</Term>
        <Term>CD24A protein, human</Term>
        <Term>CD24 antigen (small cell lung carcinoma cluster 4 antigen), human</Term>
        <Codes>
          <Code code="C1506119" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD24</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd63_protein_rat" name="Cd63 protein, rat">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd63 protein, rat</Term>
        <Term>Cd63 antigen, rat</Term>
        <Codes>
          <Code code="C1571103" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD63</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:randomized_clinical_trial_" name="randomized clinical trial'">
        <Definition>A study in which the participants are assigned by chance to separate groups that compare different treatments; neither the researchers nor the participants can choose which group. Using chance to assign people to groups means that the groups will be similar and that the treatments they receive can be compared objectively. At the time of the trial, it is not known which treatment is best. It is the patient's choice to be in a randomized trial.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">randomized clinical trial'</Term>
        <Term>Trials, Randomized Clinical</Term>
        <Term>randomized clinical trials</Term>
        <Term>clinical randomized trials</Term>
        <Term>Clinical Trials, Randomized</Term>
        <Term>CLIN TRIALS RANDOMIZED</Term>
        <Term>TRIALS RANDOMIZED CLIN</Term>
        <Term>randomized clinical trial</Term>
        <Term>Randomized Clinical Trials</Term>
        <Term>Randomized Clinical Trial</Term>
        <Term>clinical randomize trials</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#randomized_clinical_trial'" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Chinese_Americans" name="Chinese Americans">
        <Definition>any person with Chinese ethnic background whose home or birthplace is in the Americas.</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Chinese Americans</Term>
        <Term>Americans, Chinese</Term>
        <Term>American, Chinese</Term>
        <Term>americans chinese</Term>
        <Term>chinese americans</Term>
        <Term>Chinese American</Term>
        <Codes>
          <Code code="C0008121" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Asian_Americans</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:alpha3_Integrin" name="alpha3, Integrin">
        <Definition>An integrin alpha subunit that occurs as alternatively spliced isoforms. The isoforms are differentially expressed in specific cell types and at specific developmental stages. Integrin alpha3 combines with INTEGRIN BETA1 to form INTEGRIN ALPHA3BETA1 which is a heterodimer found primarily in epithelial cells.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">alpha3, Integrin</Term>
        <Term>ANTIGENS CD 049C</Term>
        <Term>Fusion Regulatory Protein-2</Term>
        <Term>Antigen, CD49c</Term>
        <Term>CD49c Antigen</Term>
        <Term>Fusion Regulatory Protein 2</Term>
        <Term>CD 049C ANTIGENS</Term>
        <Term>Antigens, CD49c</Term>
        <Term>INTEGRIN ALPHA A 03</Term>
        <Term>FRP-2</Term>
        <Term>Integrin alpha3</Term>
        <Term>alpha(3) Integrin</Term>
        <Term>CD49c Antigens</Term>
        <Codes>
          <Code code="C0297434" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SJA_Zebrafish" name="SJA Zebrafish">
        <Definition>An inbred line of *AB zebrafish. Unlike *AB, which is bred to retain polymorphisms, this subline is bred to reduce polymorphism and is at least 85% monomorphic.</Definition>
        <Definition>An inbred line of *AB zebrafish. Unlike *AB, which is bred to retain polymorphisms, this subline is bred to reduce polymorphism and is at least 85% monomorphic.(ZFin)</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SJA Zebrafish</Term>
        <Term>SJA</Term>
        <Codes>
          <Code code="C2700311" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Autograft" name="Autograft">
        <Definition>Trasplante en el cual el sitio donante y el sitio receptor son parte del mismo organismo</Definition>
        <Definition>A graft transferred from one location to another within the same individual.</Definition>
        <Definition>transplantation from another site in or on the body of the same individual.</Definition>
        <Definition>A transplantation where the donor and recipient spots are part of the same organism</Definition>
        <Definition>Transplant comprised of an individual's own tissue, transferred from one part of the body to another.</Definition>
        <Definition>Transplantation of an individual's own tissue from one site to another site.</Definition>
        <SemanticType code="T122" name="Biomedical or Dental Material"/>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Autograft</Term>
        <Term>AUTOL TRANSPL</Term>
        <Term>autograft</Term>
        <Term>Autologous transplantation</Term>
        <Term>Autogenous graft</Term>
        <Term>autografting</Term>
        <Term>Autografts</Term>
        <Term>autochtonous graft</Term>
        <Term>Autologous graft</Term>
        <Term>autotransplant</Term>
        <Term>autografts</Term>
        <Term>Autochthonous graft</Term>
        <Term>autotransplantation</Term>
        <Term>Autotransplantions</Term>
        <Term>Autologous Transplantations</Term>
        <Term>Transplants, Autologous</Term>
        <Term>Autograft (substance)</Term>
        <Term>Autologous Transplant</Term>
        <Term>Autologous Transplants</Term>
        <Term>autologous transplantation</Term>
        <Term>Transplant, Autologous</Term>
        <Term>Autograft Material</Term>
        <Term>Transplantation, Autologous</Term>
        <Term>Autochtonous graft</Term>
        <Term>Transplantations, Autologous</Term>
        <Term>Autotransplants</Term>
        <Term>Autologous Transplantation</Term>
        <Term>autologous grafting</Term>
        <Term>Autogenous transplantation</Term>
        <Term>Autoplast</Term>
        <Term>Autografting</Term>
        <Term>autotransplants</Term>
        <Term>Autotransplantation</Term>
        <Term>Transplantation, autogenous</Term>
        <Term>Autotransplant</Term>
        <Term>Autotransplantion</Term>
        <Term>autogenous graft</Term>
        <Term>TRANSPL AUTOL</Term>
        <Term>Autograftings</Term>
        <Term>Autogenous transplantation (procedure)</Term>
        <Codes>
          <Code code="C0559189" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Graft</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:scoping_review_" name="scoping review'">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">scoping review'</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#scoping_review'" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:review_of_literature_</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:health_survey" name="health survey">
        <Definition>A systematic collection of factual data pertaining to health and disease in a human population within a given geographic area. [Health surveys | MeSH_2014]</Definition>
        <Definition>a systematic collection of factual data pertaining to health and disease in a human population within a given geographic area.</Definition>
        <Definition>A systematic collection of factual data pertaining to health and disease in a human population within a given geographic area.</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">health survey</Term>
        <Term>survey health</Term>
        <Term>Survey, Health</Term>
        <Term>Health Survey</Term>
        <Term>health surveys</Term>
        <Term>Health Surveys</Term>
        <Term>Surveys, Health</Term>
        <Term>Health surveys</Term>
        <Codes>
          <Code code="C0018762" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:survey</Relation>
          <Relation name="Narrower">OTE:surveillance</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NIH_Mouse" name="NIH Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NIH Mouse</Term>
        <Term>NIH</Term>
        <Codes>
          <Code code="C14476" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Receptors_KIR3DL2" name="Receptors, KIR3DL2">
        <Definition>A KIR receptor that has specificity for HLA-A3 ANTIGEN. It is an inhibitory receptor that contains D0, D1, and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Receptors, KIR3DL2</Term>
        <Term>CD 158 K ANTIGENS</Term>
        <Term>p140 KIR3DL2 Inhibitory Receptor</Term>
        <Term>Antigen, CD158k</Term>
        <Term>KIR3DL2 Receptors</Term>
        <Term>Receptor, KIR3DL2</Term>
        <Term>CD158k Antigens</Term>
        <Term>ANTIGENS CD 158 K</Term>
        <Term>p140-KIR3DL2 Inhibitory Receptor</Term>
        <Term>Killer Cell Immunoglobulin-Like Receptor 3DL2</Term>
        <Term>CD158k Antigen</Term>
        <Term>KIR3DL2 Receptor</Term>
        <Term>Killer Cell Immunoglobulin Like Receptor 3DL2</Term>
        <Term>Inhibitory Receptor, p140-KIR3DL2</Term>
        <Term>Antigens, CD158k</Term>
        <Term>RECEPTORS KIR 03 DL 02</Term>
        <Term>Receptor, p140-KIR3DL2 Inhibitory</Term>
        <Codes>
          <Code code="C0971508" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:KIR3DL2_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:stepped_wedge_design" name="stepped wedge design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">stepped wedge design</Term>
        <Term>stepped wedge trials</Term>
        <Term>stepped wedge trial</Term>
        <Term>stepped wedge studies</Term>
        <Term>stepped wedge study</Term>
        <Term>stepped wedge designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#stepped_wedge_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Long-Term_Effects_Secondary_to_Cancer_Therapy_in_Children" name="Long-Term Effects Secondary to Cancer Therapy in Children">
        <SemanticType code="T033" name="Finding"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Long-Term Effects Secondary to Cancer Therapy in Children</Term>
        <Term>effects secondary to cancer therapy in children, long term</Term>
        <Term>cancer therapy in children, long-term effects secondary to</Term>
        <Term>cancer therapy in children, long term effects secondary to</Term>
        <Term>effects secondary to cancer therapy in children, long-term</Term>
        <Codes>
          <Code code="C8279" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Long-Term_Effects_Secondary_to_Cancer_Therapy</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NMRI_Mouse" name="NMRI Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NMRI Mouse</Term>
        <Term>NMRI</Term>
        <Codes>
          <Code code="C37416" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Intraoperative_Neurophysiological_Monitoring" name="Intraoperative Neurophysiological Monitoring">
        <Definition>The systematic checking of the condition and function of a patient's CENTRAL NERVOUS SYSTEM during the course of a surgical operation.</Definition>
        <SemanticType code="T060" name="Diagnostic Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Intraoperative Neurophysiological Monitoring</Term>
        <Term>Monitoring, Intraoperative Neurophysiologic</Term>
        <Term>Intraoperative Neurophysiologic Monitorings</Term>
        <Term>Monitoring, Intraoperative Neurophysiological</Term>
        <Term>Intraoperative neurophysiological monitoring</Term>
        <Term>Intraoperative Neurophysiologic Monitoring</Term>
        <Term>Neurophysiologic Monitorings, Intraoperative</Term>
        <Term>Neurophysiological Monitoring, Intraoperative</Term>
        <Term>Neurophysiologic Monitoring, Intraoperative</Term>
        <Term>Intraop neurophys monitoring</Term>
        <Term>Monitorings, Intraoperative Neurophysiologic</Term>
        <Term>Intraoperative neurophysiological monitoring (regime/therapy)</Term>
        <Codes>
          <Code code="C0430853" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Monitoring_Intraoperative</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:OrganTransplantExtraction_Template" name="organtransplantextraction template">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">organtransplantextraction template</Term>
        <Relations>
          <Relation name="Broader">OTE:Template</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IGSF8_protein_human" name="IGSF8 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IGSF8 protein, human</Term>
        <Term>CD81P3 protein, human</Term>
        <Term>keratinocytes associated transmembrane protein 4, human</Term>
        <Term>KCT4 protein, human</Term>
        <Term>CD81 partner 3 protein, human</Term>
        <Term>EWI-2 protein, human</Term>
        <Term>immunoglobulin superfamily, member 8 protein, human</Term>
        <Term>CD316 antigen, human</Term>
        <Codes>
          <Code code="C1432340" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:EWI-2wint_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Hominidae" name="Hominidae">
        <Definition>Family of the suborder HAPLORHINI (Anthropoidea) comprising bipedal primate MAMMALS. It includes modern man (HOMO SAPIENS) and the great apes: gorillas (GORILLA GORILLA), chimpanzees (PAN PANISCUS and PAN TROGLODYTES), and orangutans (PONGO PYGMAEUS).</Definition>
        <Definition>A taxonomic family that was originally restricted to humans and their extinct relatives, but now also includes the gorilla, orangutan, chimpanzee and bonobo.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Hominidae</Term>
        <Term>hominid</Term>
        <Term>hominids</Term>
        <Term>Hominid</Term>
        <Term>Hominidae Gray, 1825</Term>
        <Term>Man-like primates</Term>
        <Term>Family Hominidae</Term>
        <Term>Hominids</Term>
        <Term>hominidae</Term>
        <Term>Family Hominidae (organism)</Term>
        <Term>Pongidae</Term>
        <Term>Family of man</Term>
        <Codes>
          <Code code="C0019874" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Primate</Relation>
          <Relation name="Narrower">OTE:Human, OTE:Chimpanzee</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd37_protein_mouse" name="Cd37 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd37 protein, mouse</Term>
        <Term>CD37 antigen, mouse</Term>
        <Codes>
          <Code code="C1611585" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:single_case_study" name="single case study">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">single case study</Term>
        <Term>single case report</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#single_case_study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:case_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Siglece_protein_mouse" name="Siglece protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Siglece protein, mouse</Term>
        <Term>Siglecl1 protein, mouse</Term>
        <Term>sialic acid binding Ig-like lectin E, mouse</Term>
        <Term>MIS protein, mouse</Term>
        <Term>SIGLEC-like 1 protein, mouse</Term>
        <Term>mSiglec-E</Term>
        <Term>siglec-E antigen, mouse</Term>
        <Term>myeloid inhibitory siglec protein, mouse</Term>
        <Codes>
          <Code code="C0965121" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:serum_creatinine" name="serum creatinine">
        <Definition>A quantitative measurement of the amount of creatinine present in a sample of serum.</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">serum creatinine</Term>
        <Term>Serum creatinine</Term>
        <Term>Serum Creatinine Test</Term>
        <Term>Creatinine measurement, serum (procedure)</Term>
        <Term>serum creatinine measurement</Term>
        <Term>serum creatinine level</Term>
        <Term>Creatinine measurement, serum</Term>
        <Term>creatinine procedure serum</Term>
        <Term>Creatinine.serum</Term>
        <Term>Serum Creatinine Measurement</Term>
        <Term>serum creatinine measurement (lab test)</Term>
        <Term>creatinine serum test</Term>
        <Term>creatinine serum</Term>
        <Term>serum creatinine tests</Term>
        <Term>serum creatinine test</Term>
        <Codes>
          <Code code="C0201976" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Outcome_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:prospective_study" name="prospective study">
        <Definition>A research study that follows over time groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke and those who do not smoke) and compares them for a particular outcome (such as lung cancer).</Definition>
        <Definition>Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.</Definition>
        <Definition>Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. [MeSH_2014]</Definition>
        <Definition>Used in records discussing issues involved in the process of conducting studies of observations of the same individual or group over an extended period of time, usually to generate prognostic data or incidence rates related to a particular disorder, event, or behavior.</Definition>
        <Definition> a longitudinal epidemiologic study in which the groups of individuals (cohorts) are selected on the basis of factors that are to be examined for their effects on outcomes, e.g., the effect of exposure to a specific risk factor on the eventual development of a particular disease, and are then followed over a period of time to determine the incidence rates of the outcomes in question in relation to the original factors. Called also cohort s.“Prospective” usually implies a cohort selected in the present and followed into the future, but the cohort method can also be applied to existing longitudinal historical data, such as insurance or medical records: a cohort is identified and classified as to exposure to some factor at some date in the past and followed up to the present to determine incidence rates of the outcome. This is called a historical prospective study, prospective study of past data, or retrospective cohort study. Cf. retrospective s. [Emtree_2014] [ Dorland's Medical Dictionary_2011]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">prospective study</Term>
        <Term>projective study</Term>
        <Term>Prospective Study</Term>
        <Term>prospective cohort study</Term>
        <Term>Prospective Studies</Term>
        <Term>study, prospective</Term>
        <Term>prospective method</Term>
        <Term>prospective studies</Term>
        <Term>prospective longitudinal study</Term>
        <Term>Study, Prospective</Term>
        <Term>Studies, Prospective</Term>
        <Term>Prospective Cohort Study</Term>
        <Codes>
          <Code code="C0033522" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NBL_Rat_Strain" name="NBL, Rat Strain">
        <Definition>Good reproductive performance. Hyperplasia and dysplasia of the dorsolateral prostate caused by implantation of testosterone and estradiol-17-filled silastic capsules. Prolonged implantation leads to prostatic carcinoma (Leav et al 1988, 1989).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NBL, Rat Strain</Term>
        <Codes>
          <Code code="C14410" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Inupiats" name="Inupiats">
        <Definition>Members of the INUIT ethnic group geographically-associated with northern ALASKA.</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Inupiats</Term>
        <Term>inupiat</Term>
        <Term>Inupiat</Term>
        <Codes>
          <Code code="C1258940" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inuits</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Moderate_Resolution_Imaging_Spectroradiometer" name="Moderate Resolution Imaging Spectroradiometer">
        <Definition>A remote sensing system for observing Earth from orbiting satellites.</Definition>
        <SemanticType code="T073" name="Manufactured Object"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Moderate Resolution Imaging Spectroradiometer</Term>
        <Codes>
          <Code code="C3661482" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Satellite_Imagery</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CRDH_Rat_Strain" name="CRDH, Rat Strain">
        <Definition>Non-insulin-dependent overt diabetes: blood glucose 384+/- 134 mg/dl (plasma insulin at 60 min following intragastric glucose load 83.3 +/-10.2mU/mL) and hypertension blood pressure 176 +/-8mmHg. There was severe diffuse diabetic glomerulosclerosis and severe hypertensive changes in arteries and arterioles characterised by fibrinoid necrosis and/or onion skin lesions as well as smooth muscle hyperplasia. Myocardial changes were prominent, with foci of ischemic necrosis and hyperplastic vascular changes.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CRDH, Rat Strain</Term>
        <Codes>
          <Code code="C14398" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Pharmacokinetics" name="Pharmacokinetics">
        <Definition>The characteristic movements of drugs within biological systems, as affected by absorption, distribution, binding, elimination, biotransformation, and excretion; particularly the rates of such movements. (NCI)</Definition>
        <Definition>how a drug is absorbed, distributed, metabolized, and eliminated by the body</Definition>
        <Definition>Used for the mechanism, dynamics and kinetics of exogenous chemical and drug absorption, biotransformation, distribution, release, transport, uptake and elimination as a function of dosage, extent and rate of metabolic processes.</Definition>
        <Definition>Dynamic and kinetic mechanisms of exogenous chemical and DRUG LIBERATION; ABSORPTION; BIOLOGICAL TRANSPORT; TISSUE DISTRIBUTION; BIOTRANSFORMATION; elimination; and DRUG TOXICITY as a function of dosage, and rate of METABOLISM. LADMER, ADME and ADMET are abbreviations for liberation, absorption, distribution, metabolism, elimination, and toxicology.</Definition>
        <Definition>The activity of drugs in the body over a period of time, including the processes by which drugs are absorbed, distributed in the body, localized in the tissues, and excreted.</Definition>
        <Definition>distribution and effectiveness of a drug throughout the body as a function of route, schedule, vehicle, chemical isomer, metabolism, and other factors.</Definition>
        <Definition>The characteristic movements of drugs within biological systems, as affected by absorption, distribution, binding, elimination, biotransformation, and excretion; particularly the rates of such movements.</Definition>
        <SemanticType code="T169" name="Functional Concept"/>
        <SemanticType code="T039" name="Physiologic Function"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Pharmacokinetics</Term>
        <Term>Kinetics, Drug</Term>
        <Term>PK</Term>
        <Term>Drug Kinetics</Term>
        <Term>PHARMACOKIN</Term>
        <Term>drug kinetics</Term>
        <Term>pharmacokinetics</Term>
        <Term>Pharmacokinetic aspects</Term>
        <Term>mechanism of action</Term>
        <Codes>
          <Code code="C0031327" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Intervention_Comparator_Category</Relation>
          <Relation name="Narrower">OTE:tissue_distribution, OTE:biochemical_transport, OTE:absorption, OTE:binding, OTE:toxicokinetics</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Telemetry" name="Telemetry">
        <Definition>Transmission of the readings of instruments to a remote location by means of wires, radio waves, or other means. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)</Definition>
        <Definition>measurements made at a distance from the subject which are transmitted by radio signals.</Definition>
        <Definition>Process of measuring and transmitting quantitative information and recording at a remote location.</Definition>
        <SemanticType code="T060" name="Diagnostic Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Telemetry</Term>
        <Term>telemetry</Term>
        <Term>telemetry (procedure)</Term>
        <Term>Telemetries</Term>
        <Codes>
          <Code code="C0039451" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Physiologic_Monitoring</Relation>
          <Relation name="Narrower">OTE:Remote_Sensing_Technology</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:open_design" name="open design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">open design</Term>
        <Term>open studies</Term>
        <Term>open study</Term>
        <Term>open designs</Term>
        <Term>open trial</Term>
        <Term>open trials</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#open_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:open_label_design, OTE:open_clinical_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cynomolgus_Maritius_Monkey" name="Cynomolgus Maritius Monkey">
        <Definition>The macaque, Macaca fascicularis, which originates from Mauritius.</Definition>
        <Definition>A medium-sized macaque that tends to be an opportunistic omnivore, the Macaca fascicularis has grey-brown or reddish-brown fur that lightens ventrally, and cheek whiskers. This macaque also has forward directed eyes that allow for binocular vision. The cynomolgus monkey is most commonly utilized in the pre-clinical setting for neuroscience pre-clinical research and has also been shown to be a reservoir for the Ebola virus, monkey pox, and B-virus. Nafovanny is the largest captive breeder and supplier of cynomolgus monkeys to the biomedical research community.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cynomolgus Maritius Monkey</Term>
        <Term>CYNOMOLGUS MAURITIUS</Term>
        <Term>Cynomolgus Maritius</Term>
        <Codes>
          <Code code="C2699535" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Cynomolgus_Monkey</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:asialofetuin-DTPA_complex" name="asialofetuin-DTPA complex">
        <SemanticType code="T109" name="Organic Chemical"/>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">asialofetuin-DTPA complex</Term>
        <Term>ALF-DTPA</Term>
        <Codes>
          <Code code="C0612946" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:RBF_DnJ_Mouse" name="RBF/DnJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">RBF/DnJ Mouse</Term>
        <Term>RBF/DnJ</Term>
        <Codes>
          <Code code="C37430" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ITGA6_protein_human" name="ITGA6 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ITGA6 protein, human</Term>
        <Codes>
          <Code code="C3850450" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Integrin_alpha6</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:alpha_HML-1" name="alpha HML-1">
        <Definition>Integrin alpha-E (1179 aa, ~130 kDa) is encoded by the human ITGAE gene. This protein plays a role in cell adhesion and may be involved in activation of intestinal intraepithelial lymphocytes.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">alpha HML-1</Term>
        <Term>CD103 antigen</Term>
        <Term>HML-1 subunit alpha</Term>
        <Term>HML-1 antigen, human</Term>
        <Term>CD103 protein, human</Term>
        <Term>Mucosal lymphocyte-1 antigen, human</Term>
        <Term>HML-1 alpha subunit</Term>
        <Term>integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide), human</Term>
        <Term>ITGAE protein, human</Term>
        <Codes>
          <Code code="C1141628" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_E_integrins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:human_epithelial_antigen-125" name="human epithelial antigen-125">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">human epithelial antigen-125</Term>
        <Term>HEA125 antigen, human</Term>
        <Term>BerEP4 antigen</Term>
        <Term>BerEP4 antigen, human</Term>
        <Term>HEA-125 antigen, human</Term>
        <Codes>
          <Code code="C0758615" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
          <Relation name="Narrower">OTE:Ber-EP4_antigen_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD231_antigen_human" name="CD231 antigen, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD231 antigen, human</Term>
        <Codes>
          <Code code="C2003688" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C5AR1_protein_human" name="C5AR1 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C5AR1 protein, human</Term>
        <Term>complement C5a receptor, human</Term>
        <Term>C5AR protein, human</Term>
        <Term>C5a receptor, human</Term>
        <Term>C5R1, human</Term>
        <Term>complement component 5a receptor 1, human</Term>
        <Term>CD88 antigen, human</Term>
        <Term>complement component 5 receptor 1, human</Term>
        <Term>C5a anaphylatoxin chemotactic receptor, human</Term>
        <Codes>
          <Code code="C1454453" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptor_Anaphylatoxin_C5a</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Slamf1protein_mouse" name="Slamf1protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Slamf1protein, mouse</Term>
        <Term>signaling lymphocytic activation molecule family member 1, mouse</Term>
        <Term>CD150 protein, mouse</Term>
        <Codes>
          <Code code="C1741098" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD150_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:reliability_design" name="reliability design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">reliability design</Term>
        <Term>reliability study</Term>
        <Term>reliability designs</Term>
        <Term>reliability studies</Term>
        <Term>reliability trial</Term>
        <Term>reliability trials</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#reliability_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:antigen_CD96" name="antigen, CD96">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">antigen, CD96</Term>
        <Term>CD96 antigen</Term>
        <Codes>
          <Code code="C0760963" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Dpp4_protein_mouse" name="Dpp4 protein, mouse">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Dpp4 protein, mouse</Term>
        <Term>dipeptidylpeptidase 4, mouse</Term>
        <Term>Cd26 protein, mouse</Term>
        <Codes>
          <Code code="C2743186" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Dipeptidyl-Peptidase_IV</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FCGR3B_protein_human" name="FCGR3B protein, human">
        <Definition>Expressed (as NA-1, NA-2, and SH allelic forms) specifically by neutrophils and stimulated eosinophils, human FCGR3B Gene encodes 233-aa 26-kDa (precursor) monomeric IgG Fc Receptor IIIB, a glycosylated (inhibits IgG3 interaction) low affinity receptor for monomeric or aggregated Fc region of IgG, attached to membrane by a GPI-anchor, and containing 2 IgC2 domains. FCGR3B also exists as a soluble receptor produced by proteolytic cleavage. Unlike FCGR3A, FCGR3B is not capable of mediating antibody-dependent cytotoxicity and phagocytosis; FCGR3B may serve as a trap for immune complexes in the peripheral circulation without activating neutrophils. Amino acid conservation between CD16, other Fc receptors, and related Ig suggest similar structures and modes of association. (NCI)</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FCGR3B protein, human</Term>
        <Term>Fc gamma receptor IIIB, human</Term>
        <Term>CD16 protein, human</Term>
        <Term>Fc gamma RIIIb protein, human</Term>
        <Term>FcgammaRIIIB, human</Term>
        <Term>FCGR3B receptor, human</Term>
        <Term>CD16b antigen, human</Term>
        <Term>Fc fragment of IgG, low affinity IIIb, receptor for (CD16), human</Term>
        <Term>Fc gamma IIIb receptor, human</Term>
        <Codes>
          <Code code="C0966831" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd69_protein_rat" name="Cd69 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd69 protein, rat</Term>
        <Codes>
          <Code code="C2744534" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:antigens_CD69</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MPLP_protein_human" name="MPLP protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MPLP protein, human</Term>
        <Term>myeloproliferative leukemia P protein, human</Term>
        <Term>MPL-P protein, human</Term>
        <Codes>
          <Code code="C2742261" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:MPL_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:literature_review" name="literature review">
        <Definition>An article or book published after examination of published material on a subject. It may be comprehensive to various degrees and the time range of material scrutinized may be broad or narrow, but the reviews most often desired are reviews of the current literature. The textual material examined may be equally broad and can encompass, in medicine specifically, clinical material as well as experimental research or case reports. State-of-the-art reviews tend to address more current matters. [MeSH_2014]</Definition>
        <Definition>Used in records discussing issues involved in the process of conducting surveys of previously published material.</Definition>
        <Definition>Significant review of original research. [Emtree_2014]</Definition>
        <Definition>Work consisting of published material which provides an examination of recent or current literature. Reviews can cover a wide range of subject matter of various levels of completeness or comprehensiveness based on analyses of publications on the subject. The presence of research findings or case reports does not preclude designation as a review.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">literature review</Term>
        <Term>review of reported cases</Term>
        <Term>review</Term>
        <Term>Review of Literature</Term>
        <Term>review literature</Term>
        <Term>review, multicase</Term>
        <Term>review of literature</Term>
        <Term>literature reviews</Term>
        <Term>Review (of Literature)</Term>
        <Term>literature reviewing</Term>
        <Term>review, academic</Term>
        <Term>Review Literature</Term>
        <Term>Literature Review</Term>
        <Term>reviews</Term>
        <Codes>
          <Code code="C0282441" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:umbrella_review, OTE:narrative_review, OTE:scoping_review, OTE:overview_of_reviews, OTE:systematic_review, OTE:evidence_report, OTE:rapid_review</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Octogenarians" name="Octogenarians">
        <SemanticType code="T100" name="Age Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Octogenarians</Term>
        <Term>octogenarian</Term>
        <Term>octogenarians</Term>
        <Term>Octogenarian</Term>
        <Codes>
          <Code code="C0028829" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Aged_80_and_over</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:opinion_paper" name="opinion paper">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">opinion paper</Term>
        <Term>discussion piece</Term>
        <Term>opinion piece</Term>
        <Term>opinion pieces</Term>
        <Term>discussion papers</Term>
        <Term>opinion papers</Term>
        <Term>discussion paper</Term>
        <Term>discussion pieces</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#opinion_paper" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Chromosome_Marker" name="Chromosome Marker">
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <SemanticType code="T049" name="Cell or Molecular Dysfunction"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Chromosome Marker</Term>
        <Term>marker chromosome</Term>
        <Term>marker chromosomes (diagnosis)</Term>
        <Term>Markers, Chromosome</Term>
        <Term>chromosomes marker</Term>
        <Term>Chromosome Markers</Term>
        <Term>chromosome markers</Term>
        <Term>Extra unidentified structurally abnormal chromosome</Term>
        <Term>Marker chromosomes</Term>
        <Term>chromosome marker</Term>
        <Term>Extra unidentified structurally abnormal chromosome (disorder)</Term>
        <Term>Marker chromosome</Term>
        <Term>Marker, Chromosome</Term>
        <Codes>
          <Code code="C0008631" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Genetic_Marker</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Bst1_protein_mouse" name="Bst1 protein, mouse">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Bst1 protein, mouse</Term>
        <Term>bone marrow stromal cell antigen 1, mouse</Term>
        <Codes>
          <Code code="C2930537" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:bone_marrow_stromal_cell_antigen_1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NKG2D-L_protein_mouse" name="NKG2D-L protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NKG2D-L protein, mouse</Term>
        <Codes>
          <Code code="C2713636" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Klrk1_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Suffolk_Sheep" name="Suffolk Sheep">
        <Definition>A strain of sheep originally derived in England in the 1880s from a cross between a Southdown ram and a Norfolk Horned ewe. The Suffolk sheep has a white-colored body, black face and legs, and has a wool type of medium. (NCI)</Definition>
        <Definition>A strain of sheep originally derived in England in the 1880s from a cross between a Southdown ram and a Norfolk Horned ewe. The Suffolk sheep has a white-colored body, black face and legs, and has a wool type of medium.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Suffolk Sheep</Term>
        <Term>Suffolk sheep (organism)</Term>
        <Term>SUFFOLK</Term>
        <Term>Suffolk sheep</Term>
        <Codes>
          <Code code="C106572" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Sheep</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:uncontrolled_longitudinal_design" name="uncontrolled longitudinal design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">uncontrolled longitudinal design</Term>
        <Term>uncontrolled longitudinal studies</Term>
        <Term>uncontrolled longitudinal designs</Term>
        <Term>uncontrolled longitudinal study</Term>
        <Term>uncontrolled longitudinal trials</Term>
        <Term>uncontrolled longitudinal trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#uncontrolled_longitudinal_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:longitudinal_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Skin_Reaction_Secondary_to_Radiation_Therapy" name="Skin Reaction Secondary to Radiation Therapy">
        <SemanticType code="T033" name="Finding"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Skin Reaction Secondary to Radiation Therapy</Term>
        <Codes>
          <Code code="C8283" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:adverse_reaction</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Population_Type_Category" name="Population Type Category">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Population Type Category</Term>
        <Relations>
          <Relation name="Broader">OTE:Population_Category</Relation>
          <Relation name="Narrower">OTE:Graft, OTE:Transplant_Recipient, OTE:Organ_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:public_health_surveillance" name="public health surveillance">
        <Definition>The ongoing, systematic collection, analysis, and interpretation of health-related data with the purpose of preventing or controlling disease or injury, or of identifying unusual events of public health importance, followed by the dissemination and use of information for public health action. (From Am J Prev Med 2011;41(6):636)</Definition>
        <Definition>The ongoing, systematic collection, analysis, and interpretation of health-related data with the purpose of preventing or controlling disease or injury, or of identifying unusual events of public health importance, followed by the dissemination and use of information for public health action. [From Am J Prev Med 2011;41(6):636] [MeSH_2014]</Definition>
        <SemanticType code="T058" name="Health Care Activity"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">public health surveillance</Term>
        <Term>health public surveillance</Term>
        <Term>Public Health Surveillance</Term>
        <Term>Public health surveillance</Term>
        <Term>Surveillance, Public Health</Term>
        <Term>population surveillance</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#public_health_surveillance" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:population_surveillance</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:P_Selectin" name="P Selectin">
        <Definition>This gene plays a role in cellular adhesion and mediates immune and endothelial cell interactions.</Definition>
        <Definition>P-selectin (830 aa, 91 kD) is a cell adhesion process protein that is encoded by the human SELP gene and has a role in cell adhesion.</Definition>
        <Definition>Cell adhesion molecule and CD antigen that mediates the adhesion of neutrophils and monocytes to activated platelets and endothelial cells.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">P Selectin</Term>
        <Term>ANTIGENS CD 062P</Term>
        <Term>SELP gene</Term>
        <Term>GRANULOCYTE MEMBRANE PROTEIN</Term>
        <Term>PADGEM-Pl act gr ext mem prot</Term>
        <Term>SELP</Term>
        <Term>CD62P Antigen</Term>
        <Term>P selectin</Term>
        <Term>P-selectin</Term>
        <Term>CD62P</Term>
        <Term>p-selectin</Term>
        <Term>selectin P (granule membrane protein 140kDa, antigen CD62)</Term>
        <Term>SELECTIN P</Term>
        <Term>PADGEM - Platelet activation dependent granule external membrane protein</Term>
        <Term>p-Selectin</Term>
        <Term>Platelet alpha-Granule Membrane Protein</Term>
        <Term>Cluster of differentiation antigen 62</Term>
        <Term>Platelet alpha Granule Membrane Protein</Term>
        <Term>P-Selectin</Term>
        <Term>GMP140</Term>
        <Term>Pl act dep gran ext membr prot</Term>
        <Term>Platelet activation depend granule external membrane protein</Term>
        <Term>Cluster of diff antigen 62</Term>
        <Term>Lymphocyte antigen CD62 (substance)</Term>
        <Term>GRMP</Term>
        <Term>cd62p</Term>
        <Term>Selectin P (Granule Membrane Protein 140kDa, Antigen CD62) Gene</Term>
        <Term>Antigen, CD62P</Term>
        <Term>P-Selectin [Chemical/Ingredient]</Term>
        <Term>PADGEM</Term>
        <Term>PSEL</Term>
        <Term>PADGEM - Platelet activat dep granule external membr protein</Term>
        <Term>Antigens, CD62P</Term>
        <Term>p selectin</Term>
        <Term>GMP-140</Term>
        <Term>Lymphocyte antigen CD62</Term>
        <Term>LECAM-3</Term>
        <Term>PLATELET ALPHA-GRANULE MEMBRANE PROTEIN</Term>
        <Term>Selectin, P</Term>
        <Term>LECAM 003</Term>
        <Term>CD 062 P ANTIGENS</Term>
        <Term>Platelet activation dependent granule external membrane protein</Term>
        <Term>CD62 - Cluster of differentiation antigen 62</Term>
        <Term>CD62P Antigens</Term>
        <Term>SELP Gene</Term>
        <Term>Lymphocyte antigen CD62P</Term>
        <Term>P-SELECTIN</Term>
        <Term>CD62 - Cluster of diff ag 62</Term>
        <Term>CD62</Term>
        <Codes>
          <Code code="C0134835" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:SELP_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd151_protein_mouse" name="Cd151 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd151 protein, mouse</Term>
        <Term>PETA-3 protein, mouse</Term>
        <Term>CD151 antigen, mouse</Term>
        <Term>Tspan24 protein, mouse</Term>
        <Codes>
          <Code code="C2974878" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD151</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Heart_and_Lung_Transplantation" name="Heart and Lung Transplantation">
        <Definition>The simultaneous, or near simultaneous, transference of heart and lungs from one human or animal to another.</Definition>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Heart and Lung Transplantation</Term>
        <Term>Heart Lung Grafting</Term>
        <Term>Heart-Lung Transplantation</Term>
        <Term>Heart-Lung Grafting</Term>
        <Term>Heart Lung Transplantation</Term>
        <Codes>
          <Code code="C15247" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Organ_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FcepsilonRI_protein_rat" name="FcepsilonRI protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FcepsilonRI protein, rat</Term>
        <Term>FCER1A protein, rat</Term>
        <Codes>
          <Code code="C2973604" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD23</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Population_Type_Slot" name="Population Type Slot">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Population Type Slot</Term>
        <Relations>
          <Relation name="Broader">OTE:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:phase_IIa_trial" name="phase IIa trial">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">phase IIa trial</Term>
        <Term>trial phase IIa</Term>
        <Term>trial phase 2a</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#phase_IIa_trial" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NCR1_protein_human" name="NCR1 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NCR1 protein, human</Term>
        <Term>LY94 protein, human</Term>
        <Term>p46 NK cell receptor, human</Term>
        <Term>NKp46, human</Term>
        <Term>natural cytotoxicity triggering receptor 1, human</Term>
        <Term>p46 natural killer cell receptor, human</Term>
        <Term>NKp46 protein, human</Term>
        <Codes>
          <Code code="C0674917" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Natural_Cytotoxicity_Triggering_Receptor_1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:KIR2DL2_protein_human" name="KIR2DL2 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">KIR2DL2 protein, human</Term>
        <Term>CD158k antigen, human</Term>
        <Term>CD158B1 antigen, human</Term>
        <Term>killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 protein, human</Term>
        <Codes>
          <Code code="C1741807" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_KIR2DL2</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FCAR_protein_human" name="FCAR protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FCAR protein, human</Term>
        <Term>CD89 protein, human</Term>
        <Term>Fc fragment of IgA, receptor protein, human</Term>
        <Codes>
          <Code code="C2350837" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Fcreceptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129P4_RrJ_Mouse" name="129P4/RrJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129P4/RrJ Mouse</Term>
        <Term>129P4/RrJ</Term>
        <Codes>
          <Code code="C37330" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:phase_I_II_trial" name="phase I/II trial">
        <Definition>A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II. [NCIT_14.08d] [Contributing_Source_CDISC]</Definition>
        <Definition>A trial to study the safety, dosage levels, and response to a new treatment. [NCIT_14.08d]</Definition>
        <Definition> A clinical research protocol designed to study the safety, dosage levels and response to new treatment. Phase I/II trials combine a Phase I and a Phase II trial of the same treatment into a single protocol. [NCIT_14.08d]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">phase I/II trial</Term>
        <Term>trial phase1/2</Term>
        <Term>trial phase 1-2</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#phase_I/II_trial" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:clinical_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD85j_antigen_human" name="CD85j antigen, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD85j antigen, human</Term>
        <Codes>
          <Code code="C1450066" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:LILRB1_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ekkwill_Zebrafish" name="Ekkwill Zebrafish">
        <Definition>A wild-type zebrafish line, the stock of which was obtained from Ekkwill Breeders (Florida).(ZFin)</Definition>
        <Definition>A wild-type zebrafish line, the stock of which was obtained from Ekkwill Breeders (Florida).</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ekkwill Zebrafish</Term>
        <Term>Ekkwill</Term>
        <Term>EKW</Term>
        <Codes>
          <Code code="C79971" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Wild_Type_Unspecified_Zebrafish" name="Wild Type Unspecified Zebrafish">
        <Definition>A designation used to describe a wild-type zebrafish line that is of unknown stock.</Definition>
        <Definition>A designation used to describe a wild-type zebrafish line that is of unknown stock.(ZFin)</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Wild Type Unspecified Zebrafish</Term>
        <Term>Wild Type Unspecified</Term>
        <Term>Wild Type Zebrafish Unspecified</Term>
        <Term>WT</Term>
        <Term>Wild Type Unspecified - zebrafish</Term>
        <Term>Unspecified Wild Type Zebrafish</Term>
        <Codes>
          <Code code="C2700323" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:non-comparative_design" name="non-comparative design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">non-comparative design</Term>
        <Term>non-comparative study</Term>
        <Term>noncomparative trials</Term>
        <Term>non-comparative trial</Term>
        <Term>non-comparative designs</Term>
        <Term>non-comparative studies</Term>
        <Term>noncomparative designs</Term>
        <Term>noncomparative studies</Term>
        <Term>non-comparative trials</Term>
        <Term>noncomparative study</Term>
        <Term>noncomparative design</Term>
        <Term>noncomparative trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#non-comparative_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly33_protein_mouse" name="Ly33 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly33 protein, mouse</Term>
        <Term>Ly-33 protein, mouse</Term>
        <Term>lymphocyte antigen 33 protein, mouse</Term>
        <Codes>
          <Code code="C2351660" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CEACAM8_protein_human" name="CEACAM8 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CEACAM8 protein, human</Term>
        <Term>CGM6 protein, human</Term>
        <Term>NCA-95 antigen, human</Term>
        <Term>NCA-100 antigen, human</Term>
        <Term>antigen CD66b, human</Term>
        <Term>carcinoembryonic antigen-related cell adhesion molecule 8, human</Term>
        <Term>CD66b antigen, human</Term>
        <Term>CD67 antigen, human</Term>
        <Codes>
          <Code code="C0376896" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FcepsilonRI_alpha-chain_human" name="FcepsilonRI alpha-chain, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FcepsilonRI alpha-chain, human</Term>
        <Term>Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide precursor, human</Term>
        <Codes>
          <Code code="C2742545" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD23</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CA8_protein_human" name="CA8 protein, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CA8 protein, human</Term>
        <Term>carbonic anhydrase VIII protein, human</Term>
        <Term>HCA-RP VIII protein, human</Term>
        <Codes>
          <Code code="C1447097" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:case_study" name="case study">
        <Definition>Clinical presentations that may be followed by evaluative studies that eventually lead to a diagnosis. [MeSH_2014]</Definition>
        <Definition>An uncontrolled observational study containing a detailed report of the diagnosis, treatment, and follow-up of an individual patient. Case reports also contain some demographic information about the patient (for example, age, gender, ethnic origin).</Definition>
        <Definition>An uncontrolled observational study containing a detailed report of the diagnosis, treatment, and follow-up of an individual patient. Case reports also contain some demographic information about the patient (for example, age, gender, ethnic origin). [NCIT_14.05d]</Definition>
        <Definition>A detailed report of the diagnosis, treatment, and follow-up of an individual patient. Case reports also contain some demographic information about the patient (for example, age, gender, ethnic origin).</Definition>
        <Definition>A study that identifies and samples individuals with a particular disease or condition, noting characteristics of the disease or condition and persons afflicted. Case studies are often used to call attention to new diseases or to diseases entering new populations. [Emtree_2014] [Dorland's Medical Dictionary_2011]</Definition>
        <Definition>A detailed report of the diagnosis, treatment, and follow-up of an individual patient. Case reports also contain some demographic information about the patient (for example, age, gender, ethnic origin). [Case study | NCIT_14.05d]</Definition>
        <Definition>Used for original items reporting clinical work on not more than 4 individual cases. [Emtree_2014]</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code=" Research Activity" name=" Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">case study</Term>
        <Term>Case report</Term>
        <Term>case studies</Term>
        <Term>case trial</Term>
        <Term>case report</Term>
        <Term>Case Studies</Term>
        <Term>case reports</Term>
        <Term>case trials</Term>
        <Term>Case Study</Term>
        <Term>case designs</Term>
        <Term>case history</Term>
        <Term>case design</Term>
        <Term>case histories</Term>
        <Term>Case Report</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#case_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:case_base_design, OTE:single_case_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klrk1_protein_mouse" name="Klrk1 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klrk1 protein, mouse</Term>
        <Term>NKG2D protein, mouse</Term>
        <Term>NKG2-D protein, mouse</Term>
        <Term>killer cell lectin-like receptor subfamily K, member 1, mouse</Term>
        <Codes>
          <Code code="C1871394" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_K</Relation>
          <Relation name="Narrower">OTE:NKG2D-L_protein_mouse, OTE:NKG2D-S_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CAST_EiJ_Mouse" name="CAST/EiJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CAST/EiJ Mouse</Term>
        <Term>CAST/EiJ</Term>
        <Codes>
          <Code code="C37394" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Broiler_Chicken" name="Broiler Chicken">
        <Definition>Derived from a cross between a white cornish male and a barred rock female in the 1930s, modern broiler chickens are an F2 hybrid of broiler breeds characterized by high fecundity and fast growth.</Definition>
        <Definition>Derived from a cross between a white cornish male and a barred rock female in the 1930s, modern broilers are an F2 hybrid of broiler breeds characterized by high fecundity and fast growth. Broiler chickens are raised commercially for their meat and will grow to be 3-6 pounds by 8 weeks of age but tend to be afflicted by health problems related to this fast growth, including skeletal weakness, congestive heart failure, and a decrease in fertility.</Definition>
        <SemanticType code="T012" name="Bird"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Broiler Chicken</Term>
        <Term>Chicken, broiler</Term>
        <Term>Broiler chicken</Term>
        <Term>Cornish Cross</Term>
        <Term>BROILER BREEDS</Term>
        <Term>Broiler Breeds</Term>
        <Term>Broiler chicken (organism)</Term>
        <Term>Cornish Giants</Term>
        <Term>Rock-Cornish</Term>
        <Codes>
          <Code code="C76362" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Chicken</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NU_J_Foxn1-nu_Mouse" name="NU/J Foxn1-nu Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NU/J Foxn1-nu Mouse</Term>
        <Term>NU/J Hfh1l-nu</Term>
        <Term>NU/J Foxn1-nu</Term>
        <Codes>
          <Code code="C15163" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Nude_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ICR_BR_Mouse" name="ICR BR Mouse">
        <Definition>Derived from Rockefeller Swiss mice that were disseminated to the Institute of Cancer Research in Philadelphia (1948).</Definition>
        <Definition>Derived from Rockefeller Swiss mice that were disseminated to the Institute of Cancer Research in Philadelphia (1948). The ICR BR strain is a general purpose model that is employed in safety and efficacy testing, aging studies, pseudo pregnancy, and as a surgical model.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ICR BR Mouse</Term>
        <Term>CD1 (ICR) BR</Term>
        <Codes>
          <Code code="C76183" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:population_surveillance" name="population surveillance">
        <Definition>Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. [MeSH_2014]</Definition>
        <Definition>Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy.</Definition>
        <SemanticType code="T058" name="Health Care Activity"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">population surveillance</Term>
        <Term>Population Surveillance</Term>
        <Term>Surveillance, Population</Term>
        <Codes>
          <Code code="C0032687" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:surveillance</Relation>
          <Relation name="Narrower">OTE:public_health_surveillance, OTE:sentinel_surveillance, OTE:biosurveillance</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FLT3_protein_rat" name="FLT3 protein, rat">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FLT3 protein, rat</Term>
        <Term>FMS-like tyrosine kinase 3, rat</Term>
        <Term>fetal liver kinase-2 protein, rat</Term>
        <Term>FMS-like tyrosine kinase 3 fms-related tyrosine kinase 3, rat</Term>
        <Codes>
          <Code code="C2352357" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:fms_Like_Tyrosine_Kinase_3</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD200_protein_human" name="CD200 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD200 protein, human</Term>
        <Codes>
          <Code code="C1611989" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD200_membrane_glycoprotein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL17RA_protein_human" name="IL17RA protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL17RA protein, human</Term>
        <Term>IL-17RA protein, human</Term>
        <Term>IL17R protein, human</Term>
        <Term>interleukin 17 receptor protein, human</Term>
        <Codes>
          <Code code="C0669927" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_Interleukin-17</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DIT33_protein_Dirofilaria_immitis" name="DIT33 protein, Dirofilaria immitis">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DIT33 protein, Dirofilaria immitis</Term>
        <Term>protein 33, Dirofilaria immitis</Term>
        <Codes>
          <Code code="C0530022" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:PROCR_protein_human" name="PROCR protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">PROCR protein, human</Term>
        <Term>EPCR protein, human</Term>
        <Term>CCD41 protein, human</Term>
        <Term>CD201 antigen, human</Term>
        <Term>protein C receptor, endothelial, human</Term>
        <Term>endothelial cell protein C receptor , human</Term>
        <Codes>
          <Code code="C1312737" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:time_design" name="time design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">time design</Term>
        <Term>time designs</Term>
        <Term>time studies</Term>
        <Term>time trial</Term>
        <Term>time series</Term>
        <Term>time series analysis</Term>
        <Term>time trials</Term>
        <Term>multiple time series</Term>
        <Term>time study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#time_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:interrupted_time_series_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:KIR2DL3_protein_human" name="KIR2DL3 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">KIR2DL3 protein, human</Term>
        <Term>p58 natural killer cell receptor family protein, human</Term>
        <Term>p58 NK cell receptor, clone cl-6</Term>
        <Term>NKAT2 protein, human</Term>
        <Term>killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 protein, human</Term>
        <Term>p58 antigen, human</Term>
        <Term>natural killer associated transcript 2 protein, human</Term>
        <Term>MHC class-I specific NK receptor protein, human</Term>
        <Codes>
          <Code code="C0296537" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_KIR2DL3</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:KIR3DL2_protein_human" name="KIR3DL2 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">KIR3DL2 protein, human</Term>
        <Term>killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 protein, human</Term>
        <Term>NKAT4 protein, human</Term>
        <Codes>
          <Code code="C1430235" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_KIR3DL2</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:clinical_audit" name="clinical audit">
        <Definition>A detailed review and evaluation of selected clinical records by qualified professional personnel to improve the quality of patient care and outcomes. The clinical audit was formally introduced in 1993 into the United Kingdom's National Health Service. [MeSH_2014]</Definition>
        <Definition>A detailed review and evaluation of selected clinical records by qualified professional personnel to improve the quality of patient care and outcomes. The clinical audit was formally introduced in 1993 into the United Kingdom's National Health Service.</Definition>
        <SemanticType code="T058" name="Health Care Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">clinical audit</Term>
        <Term>Clinical governance</Term>
        <Term>Audit, Clinical</Term>
        <Term>Clinical Audit</Term>
        <Term>Audits, Clinical</Term>
        <Term>Clinical Audits</Term>
        <Codes>
          <Code code="C1956094" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:records_review</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:HB-6_antigen" name="HB-6 antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">HB-6 antigen</Term>
        <Codes>
          <Code code="C0121097" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Musca_domestica" name="Musca domestica">
        <Definition>Common housefly.</Definition>
        <Definition>Flies of the species Musca domestica (family MUSCIDAE), which infest human habitations throughout the world and often act as carriers of pathogenic organisms.</Definition>
        <SemanticType code="T204" name="Eukaryote"/>
        <SemanticType code="T109" name="Organic Chemical"/>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Musca domestica</Term>
        <Term>Musca oceanica</Term>
        <Term>house fly</Term>
        <Term>Musca flavipennis</Term>
        <Term>House fly</Term>
        <Term>Musca stomoxidea</Term>
        <Term>Musca domestica (organism)</Term>
        <Term>MUSCA DOMESTICA</Term>
        <Term>Musca umbraculata</Term>
        <Term>Musca divisa</Term>
        <Term>Musca aurulans</Term>
        <Term>Musca nigricans</Term>
        <Term>Musca nancauriensis</Term>
        <Term>Musca flavifacies</Term>
        <Term>Musca analis</Term>
        <Term>Musca sanctae-helenae</Term>
        <Term>Degeeria dawsoni</Term>
        <Term>Musca minor</Term>
        <Term>domestica, Musca</Term>
        <Term>Musca rufiventris</Term>
        <Term>Musca atrifrons</Term>
        <Term>Housefly</Term>
        <Term>Musca determinata</Term>
        <Term>Musca vicaria</Term>
        <Term>Musca antiquissima</Term>
        <Term>Musca frontalis</Term>
        <Term>Musca multispina</Term>
        <Term>Musca aurifacies</Term>
        <Term>Musca vicina</Term>
        <Term>Musca cuthbertsoni</Term>
        <Term>Musca australia</Term>
        <Term>Musca fulvescens</Term>
        <Term>House Fly</Term>
        <Term>Musca harpyia</Term>
        <Term>Musca vaccina</Term>
        <Term>Musca tiberina</Term>
        <Term>Sphora nigricans</Term>
        <Term>Volucella domestica</Term>
        <Term>Musca vagatoria</Term>
        <Term>Musca pampasiana</Term>
        <Term>Musca flavinervis</Term>
        <Term>Musca domestica major</Term>
        <Term>Musca chilensis</Term>
        <Term>Musca australis</Term>
        <Term>domesticas, Musca</Term>
        <Term>Musca domesticas</Term>
        <Term>Musca taitensis</Term>
        <Term>Musca consanguinea</Term>
        <Term>Musca rufifrons</Term>
        <Term>Houseflies</Term>
        <Term>Ascaris conosoma</Term>
        <Term>Musca soror</Term>
        <Term>Musca campicola</Term>
        <Term>Degeeria obscura</Term>
        <Term>Musca rivularis</Term>
        <Term>Musca sordidissima</Term>
        <Term>Musca pellucens</Term>
        <Term>house fly allergenic extract</Term>
        <Term>Musca contigua</Term>
        <Term>Musca divaricata</Term>
        <Term>Musca domestica antigen</Term>
        <Term>Musca domestica (invertebrate)</Term>
        <Term>Musca domestica (homeopathic remedies)</Term>
        <Term>Sphora australis</Term>
        <Term>Musca basilaris</Term>
        <Term>Musca vicina (organism)</Term>
        <Codes>
          <Code code="C1446657" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Diptera</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:open_label_randomized_controlled_design" name="open label randomized controlled design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">open label randomized controlled design</Term>
        <Term>open label randomized controlled study</Term>
        <Term>open-label randomized controlled studies</Term>
        <Term>open label rcts</Term>
        <Term>open-label randomized controlled trials</Term>
        <Term>open label randomised controlled study</Term>
        <Term>open label rct</Term>
        <Term>open-label randomized controlled study</Term>
        <Term>open label randomised controlled studies</Term>
        <Term>open label randomised controlled trials</Term>
        <Term>open label randomized controlled trial</Term>
        <Term>open label randomised controlled design</Term>
        <Term>open-label rct</Term>
        <Term>open label randomised controlled trial</Term>
        <Term>open-label randomised controlled trials</Term>
        <Term>open-label randomised controlled study</Term>
        <Term>open label randomized controlled designs</Term>
        <Term>open-label randomised controlled design</Term>
        <Term>open-label randomised controlled studies</Term>
        <Term>open-label randomized controlled designs</Term>
        <Term>open-label randomised controlled designs</Term>
        <Term>open label randomised controlled designs</Term>
        <Term>open-label randomized controlled design</Term>
        <Term>open-label randomized controlled trial</Term>
        <Term>open-label rcts</Term>
        <Term>open-label randomised controlled trial</Term>
        <Term>open label randomized controlled studies</Term>
        <Term>open label randomized controlled trials</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#open_label_randomized_controlled_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:randomized_controlled_trial, OTE:open_label_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Hampshire_Pig" name="Hampshire Pig">
        <Definition>One of the oldest original early American pig strains, the Hampshire pig originated from the Old English breed and was imported to North American in the mid-1800s. The Hampshire pig has black skin and hair covering most of its body with a white portion of skin covering its front limbs and back. The Hampshire pig is one of the larger pig breeds used in biomedical research.</Definition>
        <Definition>One of the oldest original early American pig strains, the Hampshire pig originated from the Old English breed and was imported to North American in the mid-1800s. The Hampshire pig has black skin and hair covering most of its body with a white portion of skin covering its front limbs and back. The Hampshire pig is one of the larger pig breeds used in biomedical research. (NCI)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Hampshire Pig</Term>
        <Term>Hampshire pig</Term>
        <Term>Hampshire pig (organism)</Term>
        <Term>HAMPSHIRE</Term>
        <Term>Hampshire</Term>
        <Codes>
          <Code code="C0324247" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Pig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:African_Green_Monkey" name="African Green Monkey">
        <Definition>A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannas of Africa. The African green monkey (C. pygerythrus) is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research.</Definition>
        <Definition>The diurnal primate, Chlorocebus sabaeus.</Definition>
        <Definition>A medium-sized diurnal primate that is omnivorous, Chlorocebus sabaeus has a life span of 10 years in the wild and 25 years in captivity. The African green monkey has been in use in scientific research since the 1950s and its tissues are used to produce vaccines for polio and smallpox. Additionally Vero cells, an African green monkey kidney epithelial cell line, are widely used in immunology and infectious disease research.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">African Green Monkey</Term>
        <Term>Cercopithecus aethiops</Term>
        <Term>Cercopithecus pygerythrus</Term>
        <Term>Chlorocebus pygerythrus</Term>
        <Term>Monkey, African Green</Term>
        <Term>African green monkey</Term>
        <Term>aethiops, Cercopithecus</Term>
        <Term>Cercopithecus aethiops pygerythrus</Term>
        <Term>Chlorocebus aethiops</Term>
        <Term>Chlorocebus pygerythrus (F. Cuvier, 1821)</Term>
        <Term>Green monkey guenon</Term>
        <Term>savanah monkey</Term>
        <Term>Chlorocebus aethiops pygerythrus</Term>
        <Term>African Green</Term>
        <Term>Monkey, Green</Term>
        <Term>Grivet monkey guenon</Term>
        <Term>Vervet Monkey</Term>
        <Term>African green monkeys</Term>
        <Term>green monkey</Term>
        <Term>pygerythrus, Cercopithecus</Term>
        <Term>Green Monkeys</Term>
        <Term>Vervet monkey guenon</Term>
        <Term>Chlorocebus aethiops (organism)</Term>
        <Term>Monkeys, Green</Term>
        <Term>Vervet monkey</Term>
        <Term>Green Monkey</Term>
        <Term>AFRICAN GREEN</Term>
        <Term>vervet monkey</Term>
        <Term>Green monkey</Term>
        <Term>Green Monkey, African</Term>
        <Codes>
          <Code code="C1504085" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Monkey</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:alpha_E_integrins" name="alpha E integrins">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">alpha E integrins</Term>
        <Term>alphaE integrin</Term>
        <Term>integrin alphaE</Term>
        <Term>integrin alpha E</Term>
        <Codes>
          <Code code="C0292863" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Itgae_protein_mouse, OTE:integrin_alpha_E2_mouse, OTE:alpha_HML-1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD2-1_cell_adhesion_protein_rat" name="CD2-1 cell adhesion protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD2-1 cell adhesion protein, rat</Term>
        <Codes>
          <Code code="C1143736" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD2</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Drug_Response_Biomarkers" name="Drug Response Biomarkers">
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Drug Response Biomarkers</Term>
        <Term>Biomarkers, Drug Response</Term>
        <Term>Response Biomarkers, Drug</Term>
        <Codes>
          <Code code="C1955888" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Biomarkers_Pharmacological</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly75_protein_mouse" name="Ly75 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly75 protein, mouse</Term>
        <Term>CD205 antigen, mouse</Term>
        <Term>lymphocyte antigen 75, mouse</Term>
        <Term>CD205 protein, mouse</Term>
        <Codes>
          <Code code="C1742420" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:DEC-205_receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Il18r1_protein_mouse" name="Il18r1 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Il18r1 protein, mouse</Term>
        <Term>interleukin-1 receptor-related protein, mouse</Term>
        <Term>interleukin 18 receptor 1 protein, mouse</Term>
        <Term>Il1rrp protein, mouse</Term>
        <Term>IL-1 receptor-related protein, mouse</Term>
        <Term>IL-1Rrp protein, mouse</Term>
        <Codes>
          <Code code="C1447430" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_18_Receptor_alpha_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:absorption" name="absorption">
        <Definition>The process of penetration of a substance into a living organism. This process could involve specialized and/or non-specialized mechanisms, active transport or passive movement, and carrier system(s). The common routes of absorption in mammals include the organs of the respiratory and gastrointestinal systems, and the skin.</Definition>
        <Definition>The process of taking nutrients from the digestive system into the blood so they can be used in the body.</Definition>
        <Definition>The process in which one material is retained by another, including, but not limited to the physical dissolution of a gas, liquid, or solid in a liquid, a gas or liquid in a solid, attachment of molecules of a gas, vapor, liquid, or dissolved substance to a solid surface by physical forces.</Definition>
        <Definition>The process in which radiated energy is partially or completely retained in the matter which it traverses.</Definition>
        <Definition>The branch of pharmacokinetics that studies the process by which a drug is absorbed by the body.</Definition>
        <SemanticType code="T067" name="Phenomenon or Process"/>
        <SemanticType code="T091" name="Biomedical Occupation or Discipline"/>
        <SemanticType code="T169" name="Functional Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">absorption</Term>
        <Term>Energy Absorption</Term>
        <Term>Biological Absorption</Term>
        <Term>Material Absorption</Term>
        <Term>ABSORPTION</Term>
        <Term>absorption characteristics</Term>
        <Term>Absorption</Term>
        <Term>Pharmacokinetics: Absorption</Term>
        <Term>FDA RPS Pharmacokinetics: Absorption</Term>
        <Term>Absorbance</Term>
        <Codes>
          <Code code="C2698776" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Pharmacokinetics</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Bone_Graft" name="Bone Graft">
        <Definition>&lt;p&gt;A bone graft transplants bone tissue. Surgeons use bone grafts to repair and rebuild &lt;a href='http://www.nlm.nih.gov/medlineplus/bonediseases.html'&gt;diseased bones&lt;/a&gt; in your hips, knees, spine, and sometimes other bones and joints. Grafts can also repair bone loss caused by some types of &lt;a href='http://www.nlm.nih.gov/medlineplus/fractures.html'&gt;fractures&lt;/a&gt; or cancers. Once your body accepts the bone graft, it provides a framework for growth of new, living bone.&lt;/p&gt;&lt;p&gt;If the transplanted bone comes from another person, it is called an allograft. Most allograft bone comes from donors who have died. Tissue banks screen these donors and disinfect and test the donated bone to make sure it is safe to use. If the transplanted bone comes from another part of your own body, it is called an autograft. Autograft bone often comes from your ribs, hips or a leg. &lt;/p&gt;</Definition>
        <Definition>Grafts obtained from a donor or produced artificially (i.e., synthetic) for the structural replacement of a diseased or injured bone. These grafts may be of biological origin, obtained from the body of the same person (i.e., autograft), from another person (i.e., allograft, typically from cadavers), from other natural sources (e.g., natural hydroxyapatite), or less frequently, from a different animal species (i.e., xenografts). These grafts may be made of synthetic materials such as ceramic and synthetic polymer or a combination of natural and synthetic materials (i.e., composite grafts), including living elements and synthetic materials developed using bioengineering techniques (i.e., bioartificial). Bone grafts are used for reconstructive and/or plastic surgery to increase body mass and provide mechanical support; they may also provide a framework for bone growth.</Definition>
        <SemanticType code="T122" name="Biomedical or Dental Material"/>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Bone Graft</Term>
        <Term>bone graft</Term>
        <Term>bone graft materials</Term>
        <Term>bone graft [material]</Term>
        <Term>Graft, bone</Term>
        <Term>Bone graft</Term>
        <Term>Graft;bone</Term>
        <Term>Bone graft material</Term>
        <Term>bone grafts</Term>
        <Term>Bone Grafts</Term>
        <Term>Bone graft material (product)</Term>
        <Term>Bone graft material (substance)</Term>
        <Term>Bone graft - material</Term>
        <Term>Grafts, Bone</Term>
        <Codes>
          <Code code="C0181075" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Organ_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Lysosomal_Associated_Membrane_Protein_3" name="Lysosomal Associated Membrane Protein 3">
        <Definition>Lysosome-associated membrane glycoprotein 3 (416 aa, ~44 kDa) is encoded by the human LAMP3 gene. This protein is involved in dendritic cell function.</Definition>
        <Definition>A lysosomal-associated membrane glycoprotein that is expressed at high levels in mature DENDRITIC CELLS.</Definition>
        <Definition>CD63 antigen (238 aa, ~256 kDa) is encoded by the human CD63 gene. This protein is involved in signal transduction and may play a role in growth regulation.</Definition>
        <Definition>This gene is involved in antigen processing and immune responses.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Lysosomal Associated Membrane Protein 3</Term>
        <Term>LAMP-3</Term>
        <Term>Ocular Melanoma-Associated Antigen</Term>
        <Term>LAMP</Term>
        <Term>Melanoma-Associated Antigen ME491</Term>
        <Term>CD63 Antigen (Melanoma 1 Antigen)</Term>
        <Term>Lysosomal-Associated Membrane Protein 3</Term>
        <Term>CD208 Antigen</Term>
        <Term>DCLAMP</Term>
        <Term>LAMP3 protein, human</Term>
        <Term>Protein TSC403</Term>
        <Term>Lysosomal-Associated Membrane Glycoprotein 3</Term>
        <Term>CD208</Term>
        <Term>Tetraspanin-30</Term>
        <Term>lysosomal-associated membrane protein 3, human</Term>
        <Term>DC-LAMP</Term>
        <Term>Lysosomal-Associated Membrane Protein 3 Gene</Term>
        <Term>Lysosomal-Associated Membrane Protein 3 [Chemical/Ingredient]</Term>
        <Term>DC LAMP Protein</Term>
        <Term>Tspan-30</Term>
        <Term>LAMP3 gene</Term>
        <Term>TSC403 protein, human</Term>
        <Term>LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEIN, DENDRITIC CELL-SPECIFIC</Term>
        <Term>CD208 protein, human</Term>
        <Term>Antigens, CD208</Term>
        <Term>LAMP3 Protein</Term>
        <Term>LAMP3</Term>
        <Term>lysosomal-associated membrane protein 3</Term>
        <Term>TSC403 Protein</Term>
        <Term>DC-LAMP Protein</Term>
        <Term>CD63 Antigen</Term>
        <Term>Melanoma-Associated Antigen MLA1</Term>
        <Term>Lysosome-Associated Membrane Glycoprotein 3</Term>
        <Term>LAMP 3 Protein</Term>
        <Term>TSC403</Term>
        <Term>DC-Lysosome-Associated Membrane Glycoprotein</Term>
        <Term>Granulophysin</Term>
        <Term>Lysosome-Associated Membrane Glycoprotein, Dendritic Cell-Specific</Term>
        <Term>CD208 Antigens</Term>
        <Term>LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 3</Term>
        <Term>LAMP3 Gene</Term>
        <Term>LAMP-3 Protein</Term>
        <Codes>
          <Code code="C1579759" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD164_protein_human" name="CD164 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD164 protein, human</Term>
        <Term>MUC-24 protein, human</Term>
        <Term>MULTI-glycosylated core protein 24, human</Term>
        <Term>CD164 antigen, sialomucin, human</Term>
        <Codes>
          <Code code="C1506042" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD164</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Lysosomal_Associated_Membrane_Protein_2" name="Lysosomal Associated Membrane Protein 2">
        <Definition>An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. Loss of expression of lysosomal-associated membrane protein 2 is associated with GLYCOGEN STORAGE DISEASE TYPE IIB.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Lysosomal Associated Membrane Protein 2</Term>
        <Term>Lysosomal-Associated Membrane Protein 2</Term>
        <Term>LGP110 Protein</Term>
        <Term>Lymphocyte antigen CD107B (substance)</Term>
        <Term>Lysosomal-Associated Membrane Protein 2 [Chemical/Ingredient]</Term>
        <Term>LAMPB</Term>
        <Term>LGP-B Protein</Term>
        <Term>LAMP2 gene</Term>
        <Term>CD107B</Term>
        <Term>ANTIGENS CD 107 B</Term>
        <Term>Lymphocyte antigen CD107B</Term>
        <Term>LAMP2 Protein</Term>
        <Term>LGP B Protein</Term>
        <Term>CD 107 B ANTIGENS</Term>
        <Term>LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 2</Term>
        <Term>CD107b Antigens</Term>
        <Term>LGP110</Term>
        <Term>CD107b Antigen</Term>
        <Term>LYSOSOMAL MEMBRANE GLYCOPROTEIN, 110-KD</Term>
        <Term>LAMP2</Term>
        <Term>lysosomal-associated membrane protein 2</Term>
        <Term>LYSOSOMAL ASSOCIATED MEMBRANE PROTEIN 002</Term>
        <Term>LYSOSOME-ASSOCIATED MEMBRANE PROTEIN B</Term>
        <Term>Antigens, CD107b</Term>
        <Term>CD107b</Term>
        <Codes>
          <Code code="C1416790" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:LAMP2_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Lysosomal_Associated_Membrane_Protein_1" name="Lysosomal Associated Membrane Protein 1">
        <Definition>This gene is involved in cell adhesion and may be involved in tumor cell metastasis.</Definition>
        <Definition>An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. In PLATELETS and T-LYMPHOCYTES it may play a role in the cellular degranulation process.</Definition>
        <Definition>Lysosome-associated membrane glycoprotein 1 (417 aa, ~45 kDa) is encoded by the human LAMP1 gene. This membrane glycoprotein is involved in selectin-mediated cell adhesion and may be involved in tumor cell metastasis.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Lysosomal Associated Membrane Protein 1</Term>
        <Term>LAMP1</Term>
        <Term>lysosomal-associated membrane protein 1</Term>
        <Term>LGP120</Term>
        <Term>Lysosomal-Associated Membrane Protein 1 [Chemical/Ingredient]</Term>
        <Term>LAMP1 Protein</Term>
        <Term>Lysosome-Associated Membrane Protein 1</Term>
        <Term>LYSOSOMAL MEMBRANE GLYCOPROTEIN, 120-KD</Term>
        <Term>CD107A</Term>
        <Term>LGP120 Protein</Term>
        <Term>CD107a Antigen</Term>
        <Term>ANTIGENS CD 107 A</Term>
        <Term>Lysosome-Associated Membrane Glycoprotein 1</Term>
        <Term>Antigens, CD107a</Term>
        <Term>LYSOSOME-ASSOCIATED MEMBRANE PROTEIN A</Term>
        <Term>LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 1</Term>
        <Term>LAMP1 Gene</Term>
        <Term>LAMPA Protein</Term>
        <Term>Lysosome-Associated Membrane Glycoprotein 1, human</Term>
        <Term>CD 107 A ANTIGENS</Term>
        <Term>LYSOSOMAL ASSOCIATED MEMBRANE PROTEIN 001</Term>
        <Term>CD107a</Term>
        <Term>CD107a Antigens</Term>
        <Term>Lysosomal-Associated Membrane Protein 1</Term>
        <Term>Lymphocyte antigen CD107A</Term>
        <Term>Lysosomal-Associated Membrane Protein 1 Gene</Term>
        <Term>LAMPA</Term>
        <Term>Lymphocyte antigen CD107A (substance)</Term>
        <Term>CD107 Antigen-Like Family Member A</Term>
        <Term>LAMP1 gene</Term>
        <Codes>
          <Code code="C1416788" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:biosurveillance" name="biosurveillance">
        <Definition>Monitoring of information sources of potential value in detecting an emerging epidemic, whether naturally occurring or the result of bioterrorism.</Definition>
        <Definition>Monitoring of information sources of potential value in detecting an emerging epidemic, whether naturally occurring or the result of bioterrorism. [MeSH_2014]</Definition>
        <SemanticType code="T058" name="Health Care Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">biosurveillance</Term>
        <Term>Biosurveillances</Term>
        <Term>Biosurveillance</Term>
        <Term>population surveillance</Term>
        <Codes>
          <Code code="C2350596" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:population_surveillance</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:published_erratum" name="published erratum">
        <Definition>Work consisting of an acknowledgment of an error, issued by a publisher, editor, or author. It customarily cites the source where the error occurred, giving complete bibliographic data for retrieval. In the case of books and monographs, author, title, imprint, paging, and other helpful references will be given; in the case of journal articles, the author, title, paging, and journal reference will be shown. An erratum notice is variously cited as Errata or Corrigenda. [MeSH_2014]</Definition>
        <Definition>Work consisting of an acknowledgment of an error, issued by a publisher, editor, or author. It customarily cites the source where the error occurred, giving complete bibliographic data for retrieval. In the case of books and monographs, author, title, imprint, paging, and other helpful references will be given; in the case of journal articles, the author, title, paging, and journal reference will be shown. An erratum notice is variously cited as Errata or Corrigenda.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">published erratum</Term>
        <Term>Errata</Term>
        <Term>Corrigenda</Term>
        <Term>Published Erratum</Term>
        <Term>corrigenda</Term>
        <Term>errata</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#published_erratum" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mcp_protein_rat" name="Mcp protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mcp protein, rat</Term>
        <Term>CD46 antigen, rat</Term>
        <Term>membrane cofactor protein, rat</Term>
        <Codes>
          <Code code="C1566870" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD46</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:double_blind_comparison" name="double blind comparison">
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">double blind comparison</Term>
        <Term>double-blind comparison</Term>
        <Term>Research design [1977-1989]</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#double_blind_comparison" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:double_blind_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD82_protein_human" name="CD82 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD82 protein, human</Term>
        <Term>R2 leukocyte antigen, human</Term>
        <Term>C33 antigen, human</Term>
        <Term>IA4 antigen, human</Term>
        <Term>IA4 protein, human</Term>
        <Term>suppression of tumorigenicity 6, prostate protein, human</Term>
        <Term>CD82 antigen, human</Term>
        <Term>R2 antigen, human</Term>
        <Term>kangai 1 protein, human</Term>
        <Term>KAI1 protein, human</Term>
        <Codes>
          <Code code="C1528437" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:KAI1_Protein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:white_paper" name="white paper">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">white paper</Term>
        <Term>white papers</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#white_paper" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:government_publication</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Transmembrane_Activator_and_CAML_Interactor_Protein" name="Transmembrane Activator and CAML Interactor Protein">
        <Definition>A tumor necrosis factor receptor superfamily member found expressed on peripheral B-LYMPHOCYTES. It has specificity for B-CELL MATURATION ANTIGEN and TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Transmembrane Activator and CAML Interactor Protein</Term>
        <Term>Antigens, CD267</Term>
        <Term>Antigen, CD267</Term>
        <Term>CD267 Antigens</Term>
        <Term>Tumor Necrosis Factor Receptor Superfamily, Member 13b</Term>
        <Term>CD 267 ANTIGENS</Term>
        <Term>TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 13 B</Term>
        <Term>ANTIGENS CD 267</Term>
        <Term>TACI Receptor</Term>
        <Term>CD267 Antigen</Term>
        <Codes>
          <Code code="C1706295" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:TNFRSF13B_protein_human, OTE:Tnfrsf13b_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Insulin_receptor_beta_subunit_human" name="Insulin receptor beta subunit, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Insulin receptor beta subunit, human</Term>
        <Codes>
          <Code code="C1721315" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:INSR_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klra1_protein_mouse" name="Klra1 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klra1 protein, mouse</Term>
        <Term>Ly49a protein, mouse</Term>
        <Term>killer cell lectin-like receptor, subfamily A, member 1, moue</Term>
        <Term>Ly49a antigen, mouse</Term>
        <Term>T-cell surface glycoprotein YE1-48, mouse</Term>
        <Codes>
          <Code code="C2351931" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ACE2_protein_human" name="ACE2 protein, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ACE2 protein, human</Term>
        <Term>angiotensin I converting enzyme (peptidyl-dipeptidase A) 2, human</Term>
        <Term>ACEH protein, human</Term>
        <Term>angiotensin converting enzyme 2, human</Term>
        <Codes>
          <Code code="C1610422" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:angiotensin_converting_enzyme_2</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ace2_protein_rat" name="Ace2 protein, rat">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ace2 protein, rat</Term>
        <Term>angiotensin I converting enzyme (peptidyl-dipeptidase A) 2, rat</Term>
        <Codes>
          <Code code="C1721298" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:angiotensin_converting_enzyme_2</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:TNFR_p80" name="TNFR p80">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">TNFR p80</Term>
        <Codes>
          <Code code="C0528094" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Necrosis_Factor_Receptor_Type_II</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Retnlb_protein_mouse" name="Retnlb protein, mouse">
        <SemanticType code="T125" name="Hormone"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Retnlb protein, mouse</Term>
        <Term>RELMB protein, mouse</Term>
        <Term>FIZZ2 protein, mouse</Term>
        <Term>cysteine-rich secreted protein FIZZ2, mouse</Term>
        <Term>resistin-like molecule beta, mouse</Term>
        <Term>RELMbeta, mouse</Term>
        <Term>resistin-like beta, mouse</Term>
        <Codes>
          <Code code="C1432093" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Hormones_Ectopic</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:California_Rabbit" name="California Rabbit">
        <Definition>One of the larger rabbit breeds, the Californian has a rounded, medium-length body with a short coat that is white with black on the nose, ears, feet, legs, and tail. This lagomorph also has pink eye color with genotype np.</Definition>
        <Definition>One of the larger rabbit breeds, the Californian has a rounded, medium-length body with a short coat that is white with black on the nose, ears, feet, legs, and tail. This lagomorph also has pink eye color with genotype np. Like most rabbit breeds, the California rabbit is predisposed to developing cancer, especially uterine adenocarcinoma as well as lymphomas, sarcomas, and other carcinomas. This breed also develops respiratory disorders and cardiac disease. The California rabbit is utilized in biomedical research for a variety of purposes, including cardiovascular and ophthalmological research.</Definition>
        <Definition>One of the larger rabbit breeds, the Californian has a rounded, medium-length body with a short coat that is white with black on the nose, ears, feet, legs, and tail. This lagomorph also has pink eye color with genotype np. Like most rabbit breeds, the California rabbit is predisposed to developing cancer, especially uterine adenocarcinoma as well as lymphomas, sarcomas, and other carcinomas. This breed also develops respiratory disorders and cardiac disease.  The California rabbit is utilized in biomedical research for a variety of purposes, including cardiovascular and ophthalmological research.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">California Rabbit</Term>
        <Term>CALIFORNIA</Term>
        <Term>California</Term>
        <Term>California rabbit</Term>
        <Codes>
          <Code code="C0324542" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rabbit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Prom1_protein_mouse" name="Prom1 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Prom1 protein, mouse</Term>
        <Term>prominin 1 protein, mouse</Term>
        <Term>CD133 protein, mouse</Term>
        <Term>AC133 protein, mouse</Term>
        <Codes>
          <Code code="C1612147" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:AC133_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:double_blinded_randomized_controlled_trial" name="double blinded randomized controlled trial">
        <Definition>A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.  [Double-blind method | MeSH_2014]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">double blinded randomized controlled trial</Term>
        <Term>double blinded rct</Term>
        <Term>double blinded randomised controlled designs</Term>
        <Term>double blinded randomised controlled design</Term>
        <Term>double-blinded randomized controlled study</Term>
        <Term>double-blinded randomized controlled design</Term>
        <Term>double blinded randomised controlled trials</Term>
        <Term>double blinded randomized controlled studies</Term>
        <Term>Double-Masked Study</Term>
        <Term>double blinded randomised controlled study</Term>
        <Term>double blinded randomized controlled trials</Term>
        <Term>double-blinded randomized controlled trial</Term>
        <Term>Double-Masked Method</Term>
        <Term>double-blinded randomised controlled designs</Term>
        <Term>double-blinded randomised controlled design</Term>
        <Term>double-blinded randomised controlled trials</Term>
        <Term>double-blinded randomized controlled designs</Term>
        <Term>double blinded randomized controlled design</Term>
        <Term>double-blinded randomised controlled study</Term>
        <Term>double-blinded rct</Term>
        <Term>double-blinded randomized controlled trials</Term>
        <Term>double blinded rcts</Term>
        <Term>Research design [1977-1989]</Term>
        <Term>Double-Blind Study</Term>
        <Term>double-blinded randomised controlled trial</Term>
        <Term>double-blinded randomized controlled studies</Term>
        <Term>double blinded randomised controlled studies</Term>
        <Term>double-blinded rcts</Term>
        <Term>double blinded randomized controlled study</Term>
        <Term>double blinded randomised controlled trial</Term>
        <Term>double blinded randomized controlled designs</Term>
        <Term>double-blinded randomised controlled studies</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#double_blinded_randomized_controlled_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:randomized_controlled_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tupfel_Long_Fin_Nacre_Zebrafish" name="Tupfel Long Fin Nacre Zebrafish">
        <Definition>A wild-type zebrafish line established from the breeding of Tupfel long fin parents and the subsequent selection and inbreeding of fish lacking melanophore pigmentation.(ZFin)</Definition>
        <Definition>A wild-type zebrafish line established from the breeding of Tupfel long fin parents and the subsequent selection and inbreeding of fish lacking melanophore pigmentation.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tupfel Long Fin Nacre Zebrafish</Term>
        <Term>Tupfel Long Fin Nacre - zebrafish</Term>
        <Term>TLN</Term>
        <Term>Tupfel Long Fin Nacre</Term>
        <Codes>
          <Code code="C2700316" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd83_protein_mouse" name="Cd83 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd83 protein, mouse</Term>
        <Term>CD83 antigen, mouse</Term>
        <Codes>
          <Code code="C1611613" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD83_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Armadillo" name="Armadillo">
        <Definition>Burrowing, chiefly nocturnal mammals of the family Dasypodidae having bodies and heads encased in small bony plates. They are widely distributed in the warmer parts of the Americas.</Definition>
        <Definition>Any of several small, burrowing, chiefly nocturnal mammals with body covered with strong horny plates.</Definition>
        <Definition>This gene is involved in signal transduction and regulation of transcription.</Definition>
        <SemanticType code="T204" name="Eukaryote"/>
        <SemanticType code="T015" name="Mammal"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Armadillo</Term>
        <Term>Family Dasypodidae</Term>
        <Term>CTNNB1 Gene</Term>
        <Term>Armadillo &lt;pillbug genus&gt;</Term>
        <Term>armadillo</Term>
        <Term>CADHERIN-ASSOCIATED PROTEIN, BETA</Term>
        <Term>Armadillo Dumeril, 1816</Term>
        <Term>Armadillo, NOS</Term>
        <Term>Armadillos</Term>
        <Term>Dasypodidae</Term>
        <Term>CTNNB</Term>
        <Term>catenin (cadherin-associated protein), beta 1, 88kDa</Term>
        <Term>Family Dasypodidae (organism)</Term>
        <Term>CATENIN, BETA-1</Term>
        <Term>CTNNB1</Term>
        <Term>FAMILY DASYPODIDAE</Term>
        <Term>863 FAMILY DASYPODIDAE</Term>
        <Term>Mammals, Armadillos</Term>
        <Term>CTNNB1 gene</Term>
        <Term>beta-catenin</Term>
        <Term>Catenin (Cadherin-Associated Protein), Beta 1, 88kDa Gene</Term>
        <Codes>
          <Code code="C14185" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Cingulata</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Chicken" name="Chicken">
        <Definition>Gallo</Definition>
        <Definition>Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA.</Definition>
        <Definition>common name for the species Gallus gallus, the domestic fowl; descended from the red jungle fowl of Southeast Asia.</Definition>
        <Definition>Junglefowl</Definition>
        <Definition>The common domestic fowl, Gallus gallus.</Definition>
        <Definition>The common domestic fowl, Gallus gallus. (NCI)</Definition>
        <SemanticType code="T168" name="Food"/>
        <SemanticType code="T012" name="Bird"/>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Chicken</Term>
        <Term>chicken flavor</Term>
        <Term>Chicken - meat</Term>
        <Term>Bantam (organism)</Term>
        <Term>bantam</Term>
        <Term>Gallus domesticus</Term>
        <Term>chicken allergenic extract</Term>
        <Term>chicken</Term>
        <Term>Domestic fowl ancestor</Term>
        <Term>Domestic fowl ancestor, NOS</Term>
        <Term>Chicken - meat (substance)</Term>
        <Term>Bantam</Term>
        <Term>Red jungle fowl</Term>
        <Term>Chicken, NOS</Term>
        <Term>CHICKEN</Term>
        <Term>Chicken Meat</Term>
        <Term>Bantam Chicken</Term>
        <Term>Chicken meat</Term>
        <Term>Gallus gallus domesticus</Term>
        <Term>Chickens</Term>
        <Term>Red junglefowl, NOS</Term>
        <Term>chicken meat</Term>
        <Term>Chicken antigen</Term>
        <Term>Gallus gallus (organism)</Term>
        <Term>chickens</Term>
        <Term>Gallus gallus</Term>
        <Term>Chicken Flavor</Term>
        <Term>Poultry</Term>
        <Term>Red junglefowl</Term>
        <Codes>
          <Code code="C1365945" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Aves</Relation>
          <Relation name="Narrower">OTE:Broiler_Chicken, OTE:Leghorn_Chicken, OTE:Ross_Chicken</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BALB_c-Hfh11nu_X_DD_1" name="BALB/c-Hfh11nu X DD/1">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BALB/c-Hfh11nu X DD/1</Term>
        <Codes>
          <Code code="C14773" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CBy_Cg-Foxn1-nu</Relation>
          <Relation name="Narrower">OTE:KSN_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD8beta_antigen_rat" name="CD8beta antigen, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD8beta antigen, rat</Term>
        <Codes>
          <Code code="C2603828" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD8</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Yucatan_Minipig" name="Yucatan Minipig">
        <Definition>A strain of Yucatan pig that is found in the wild in Costa Rica and Mexico. It is a hairless, black or grey colored swine and weighs less than 70 kilograms at adulthood. It is used extensively in biomedical research.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Yucatan Minipig</Term>
        <Term>Yucatan Miniature Swine</Term>
        <Term>YUCATAN MINIPIG</Term>
        <Codes>
          <Code code="C91818" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Minipig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD207_protein_human" name="CD207 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD207 protein, human</Term>
        <Term>CD207 antigen, langerin protein, human</Term>
        <Term>langerin protein, human</Term>
        <Term>langerin, human</Term>
        <Codes>
          <Code code="C1432643" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:prevalence_study" name="prevalence study">
        <SemanticType code="T081" name="Quantitative Concept"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">prevalence study</Term>
        <Term>Prevalence Studies</Term>
        <Term>Prevalence Study</Term>
        <Term>prevalence studies</Term>
        <Term>Studies, Prevalence</Term>
        <Term>Study, Prevalence</Term>
        <Term>Prevalence studies [1989]</Term>
        <Term>Epidemiologic methods [1975-89]</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#prevalence_study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ICAM1_protein_human" name="ICAM1 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ICAM1 protein, human</Term>
        <Term>intercellular adhesion molecule 1p, human</Term>
        <Codes>
          <Code code="C3493229" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Intercellular_Adhesion_Molecule-1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NOD_CB17-Prkdc-scid_J_Mouse" name="NOD.CB17-Prkdc-scid/J Mouse">
        <Definition>Originally derived by Prochazka et al (1992) at Jackson Laboratories, by crossing a C.B-17 congenic background mouse with the scid mutation to a diabetes-susceptible non-obese diabetic (NOD) mouse. This mouse is albino in color with coat genotype Tyrc.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NOD.CB17-Prkdc-scid/J Mouse</Term>
        <Term>NOD/LtSz-Prkdc-scid/J</Term>
        <Term>NOD.CB17-Prkdc-scid/J</Term>
        <Term>NOD.SCID</Term>
        <Term>NOD SCID</Term>
        <Codes>
          <Code code="C15167" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:SCID_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Train-of-Four_Monitoring" name="Train-of-Four Monitoring">
        <Definition>Measuring the response of a muscle to four consecutive stimuli delivered along the path of the muscle's innervating nerve to test the level of NEUROMUSCULAR BLOCKADE.</Definition>
        <SemanticType code="T060" name="Diagnostic Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Train-of-Four Monitoring</Term>
        <Term>Train of Four Monitoring</Term>
        <Term>Monitoring, Train-of-Four</Term>
        <Codes>
          <Code code="C1301770" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Neuromuscular_Monitoring</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fcgr4_protein_mouse" name="Fcgr4 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fcgr4 protein, mouse</Term>
        <Term>FcgammaRIV protein, mouse</Term>
        <Codes>
          <Code code="C1999842" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Thy-1_2_Antigen" name="Thy-1.2 Antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Thy-1.2 Antigen</Term>
        <Term>Antigen, Thy-1.2</Term>
        <Term>Thy 1.2 Antigen</Term>
        <Codes>
          <Code code="C0145796" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_Thy-1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:OM_Rat_Strain" name="OM, Rat Strain">
        <Definition>Spontaneous thyroid carcinoma 33% (Lindsey et al 1968). Adrenal cortical tumors 94% and pituitary tumors 8-18% at 18 months (Hansen et al 1973). In animals over 18 months Snell found adenomas or carcinomas of adrenal cortex 73% in males and 95% in females, pituitary tumors 25%, granulosa cell tumors of the ovary 33% in females. High blood pressure (3/23), reaching 154+/-1.0 (SEM) mmHg at 10 weeks of age (Tanase et al 1982). Mammary tumors 26-30%. High incidence of retinal degeneration in animals over 10 months (von Sallman and Grimes 1972, 1974). High systolic blood pressure (2/17) (Hansen et al 1973).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">OM, Rat Strain</Term>
        <Codes>
          <Code code="C14382" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
          <Relation name="Narrower">OTE:OM_N_substrain</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:PWK_Mouse" name="PWK Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">PWK Mouse</Term>
        <Term>PWK</Term>
        <Codes>
          <Code code="C37429" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD79B_protein_human" name="CD79B protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD79B protein, human</Term>
        <Term>CD79B antigen, human</Term>
        <Term>immunoglobulin-associated beta protein, human</Term>
        <Term>CD79B antigen (immunoglobulin-associated beta), human</Term>
        <Codes>
          <Code code="C1506376" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD79</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin_18_Receptor_alpha_Subunit" name="Interleukin 18 Receptor alpha Subunit">
        <Definition>A subunit of the interleukin-18 receptor that is responsible of extracellular binding of IL-18.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin 18 Receptor alpha Subunit</Term>
        <Term>IL1 Receptor Related Protein</Term>
        <Term>CDw218a Antigen</Term>
        <Term>INTERLEUKIN 018 RECEPTOR ALPHA SUBUNIT</Term>
        <Term>Interleukin 18 Receptor alpha Chain</Term>
        <Term>CDw218a Antigens</Term>
        <Term>Antigen, CDw218a</Term>
        <Term>Interleukin 18 Receptor 1</Term>
        <Term>Interleukin-18 Receptor alpha Subunit [Chemical/Ingredient]</Term>
        <Term>CD 218A ANTIGENS W</Term>
        <Term>IL1 Receptor-Related Protein</Term>
        <Term>Antigens, CDw218a</Term>
        <Term>Interleukin-18 Receptor alpha Subunit</Term>
        <Term>Interleukin-18 Receptor alpha Chain</Term>
        <Term>ANTIGENS CD 218A W</Term>
        <Codes>
          <Code code="C1706290" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:IL18R1_protein_human, OTE:Il18r1_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:lrp1_1_protein_Xenopus" name="lrp1.1 protein, Xenopus">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">lrp1.1 protein, Xenopus</Term>
        <Codes>
          <Code code="C2975932" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:low_density_lipoprotein_receptor-related_protein_1_Xenopus</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BL_10ScSnJ_Mouse" name="C57BL/10ScSnJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BL/10ScSnJ Mouse</Term>
        <Term>C57BL/10ScSnJ</Term>
        <Codes>
          <Code code="C37378" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SEMA4D_protein_human" name="SEMA4D protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SEMA4D protein, human</Term>
        <Term>CD100 antigen, human</Term>
        <Term>semaphorin 4D, human</Term>
        <Codes>
          <Code code="C1506356" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:antigen_CD100</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NIH_Minipig" name="NIH Minipig">
        <Definition>An inbred strain of miniature swine developed by Sachs et al at the NIH in 1976 from a cross between a Hormel pig and a Vita Vet miniature pig.</Definition>
        <Definition>An inbred strain of miniature swine developed by Sachs et al at the NIH in 1976 from a cross between a Hormel pig and a Vita Vet miniature pig. (NCI)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NIH Minipig</Term>
        <Term>NIH MINIPIG</Term>
        <Term>NIH SLA Miniature Swine</Term>
        <Codes>
          <Code code="C3828814" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Minipig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:adaptive_design" name="adaptive design">
        <Definition>Indicate if the study includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (usually interim data) from subjects in the study.</Definition>
        <Definition> A study design which includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and/or hypotheses based on analysis of data, usually interim data. [NCIT_14.05d] [Contributing_Source_CDISC]</Definition>
        <Definition>A study design which includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and/or hypotheses based on analysis of data, usually interim data.</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <SemanticType code=" Research Activity" name=" Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">adaptive design</Term>
        <Term>adaptive designs</Term>
        <Term>adaptive trials</Term>
        <Term>ADAPT</Term>
        <Term>Adaptive Design</Term>
        <Term>adaptive studies</Term>
        <Term>adaptive study</Term>
        <Term>adaptive trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#adaptive_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BALB_cCrl_Mouse" name="BALB/cCrl Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BALB/cCrl Mouse</Term>
        <Term>BALB/cCrl</Term>
        <Codes>
          <Code code="C37361" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD320_antigen_human" name="CD320 antigen, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD320 antigen, human</Term>
        <Codes>
          <Code code="C2714210" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd24a_protein_mouse" name="Cd24a protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd24a protein, mouse</Term>
        <Term>J11d antigen, mouse</Term>
        <Term>R13-AG protein, mouse</Term>
        <Term>heat stable antigen, mouse</Term>
        <Term>X62 heat stable antigen, mouse</Term>
        <Term>heat stable antigen B2A2, mouse</Term>
        <Term>HSA protein, mouse</Term>
        <Term>cluster of differentiation 24 protein, mouse</Term>
        <Term>heat-stable antigen B2A2, mouse</Term>
        <Term>Ly-52 protein, mouse</Term>
        <Term>M1-69-J11d heat-stable antigen, mouse</Term>
        <Term>CD24a antigen, mouse</Term>
        <Term>M1-69-J11d-HSA protein, mouse</Term>
        <Term>M1/69-J11D heat stable antigen, mouse</Term>
        <Codes>
          <Code code="C0535803" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD24</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:community_trial" name="community trial">
        <Definition> The Community Trial is a planned experiment that involves administering an exposure within a community in order to elucidate its impact on the incidence of a specific disease in that community. The community trial is a choice when exposure cannot be prevented among control group. [NCIT_14.05d] </Definition>
        <Definition>The Community Trial is a planned experiment that involves administering an exposure within a community in order to elucidate its impact on the incidence of a specific disease in that community. The community trial is a choice when exposure cannot be prevented among control group.</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">community trial</Term>
        <Term>community study</Term>
        <Term>community designs</Term>
        <Term>community trials</Term>
        <Term>Community Trial</Term>
        <Term>community design</Term>
        <Term>community studies</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#community_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fc_gamma_receptor_IIA" name="Fc gamma receptor IIA">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fc gamma receptor IIA</Term>
        <Term>CD32a antigen</Term>
        <Term>Fc gamma IIA receptors</Term>
        <Term>FcgammaRIIA</Term>
        <Term>Fc gamma RIIA</Term>
        <Term>receptor, Fc gamma IIA</Term>
        <Codes>
          <Code code="C0215027" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Markers_Laboratory" name="Markers, Laboratory">
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Markers, Laboratory</Term>
        <Term>Marker, Laboratory</Term>
        <Term>Laboratory Marker</Term>
        <Term>Laboratory Markers</Term>
        <Codes>
          <Code code="C0162490" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:deltaIK17_antigen" name="deltaIK17 antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">deltaIK17 antigen</Term>
        <Term>deltaIK17</Term>
        <Codes>
          <Code code="C0536969" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD1b_antigen" name="CD1b antigen">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD1b antigen</Term>
        <Term>CD1b - Cluster of diff ag 1b</Term>
        <Term>Cluster of diff antigen 1b</Term>
        <Term>Lymphocyte antigen CD1b (substance)</Term>
        <Term>Lymphocyte antigen CD1b</Term>
        <Term>Cluster of differentiation antigen 1b</Term>
        <Term>CD1b - Cluster of differentiation antigen 1b</Term>
        <Codes>
          <Code code="C0963785" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FcepsilonRI_gamma-chain_human" name="FcepsilonRI gamma-chain, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FcepsilonRI gamma-chain, human</Term>
        <Term>Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide precursor, human</Term>
        <Codes>
          <Code code="C2742550" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD23</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Surrogate_Endpoints" name="Surrogate Endpoints">
        <Definition>A biomarker that is intended to substitute for a clinical endpoint. A surrogate endpoint is expected to predict clinical benefit (or harm or lack of benefit or harm) based on epidemiologic, therapeutic, pathophysiologic, or other scientific evidence. The term surrogate endpoint applies primarily to endpoints in therapeutic intervention trials; however, it may sometimes apply in natural history or epidemiologic studies. The use of biomarkers as surrogate endpoints in a clinical trial requires the specification of the clinical endpoints that are being substituted, class of therapeutic intervention being applied, and characteristics of population and disease state in which the substitution is being made.(Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharm Ther 69 (3): 89-95, 2001)</Definition>
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Surrogate Endpoints</Term>
        <Term>surrogate endpoints</Term>
        <Term>End Points, Surrogate</Term>
        <Term>End Point, Surrogate</Term>
        <Term>Surrogate Endpoint</Term>
        <Term>Endpoints, Surrogate</Term>
        <Term>Surrogate End Point</Term>
        <Term>Surrogate End Points</Term>
        <Term>Endpoint, Surrogate</Term>
        <Term>surrogate endpoint</Term>
        <Term>surrogate end points</Term>
        <Codes>
          <Code code="C0162488" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:comment" name="comment">
        <Definition>A written explanation, observation or criticism added to textual material.</Definition>
        <Definition>A written explanation, observation or criticism added to textual material. [NCIT_14.05d] [Contributing_Source_BRIDG]</Definition>
        <Definition>Work consisting of a critical or explanatory note written to discuss, support, or dispute an article or other presentation previously published. It may take the form of an article, letter, editorial, etc. It appears in publications under a variety of names: comment, commentary, editorial comment, viewpoint, etc. [MeSH_2014]</Definition>
        <Definition>Work consisting of a critical or explanatory note written to discuss, support, or dispute an article or other presentation previously published. It may take the form of an article, letter, editorial, etc. It appears in publications under a variety of names: comment, commentary, editorial comment, viewpoint, etc.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">comment</Term>
        <Term>viewpoints</Term>
        <Term>Comment</Term>
        <Term>Viewpoint</Term>
        <Term>Published Comment</Term>
        <Term>Remarks</Term>
        <Term>viewpoint</Term>
        <Term>Remark</Term>
        <Term>Commentary</Term>
        <Term>comments</Term>
        <Term>commentary</Term>
        <Term>Comments</Term>
        <Term>Editorial Comment</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#comment" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SCGB2A2_protein_human" name="SCGB2A2 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SCGB2A2 protein, human</Term>
        <Term>H-MAM protein, human</Term>
        <Term>UGB2 protein, human</Term>
        <Term>mammaglobin-1, human</Term>
        <Term>MGB1 protein, human</Term>
        <Term>SG3A2 protein, human</Term>
        <Term>secretoglobin, family 2A, member 2 protein, human</Term>
        <Codes>
          <Code code="C1609207" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mammaglobin-A</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CAM_123-6_antigen" name="CAM 123-6 antigen">
        <SemanticType code="T118" name="Carbohydrate"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CAM 123-6 antigen</Term>
        <Term>cancer-associated mucin 123-6</Term>
        <Term>CAM 123-6</Term>
        <Codes>
          <Code code="C0253369" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CA-15-3_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:file_review" name="file review">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">file review</Term>
        <Term>review of files</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#file_review" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:records_review</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Wild_Type_Mouse" name="Wild Type Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Wild Type Mouse</Term>
        <Codes>
          <Code code="C14418" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly78_protein_mouse" name="Ly78 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly78 protein, mouse</Term>
        <Term>radioprotective 105kD protein, mouse</Term>
        <Term>lymphocyte antigen 78 protein, mouse</Term>
        <Term>CD180 protein, mouse</Term>
        <Term>RP105 protein, mouse</Term>
        <Codes>
          <Code code="C1454469" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:TNFRSF1A_protein_human" name="TNFRSF1A protein, human">
        <Definition>This protein is a member of the TNF-receptor superfamily. It is one of the major receptors for the tumor necrosis factor-alpha. This receptor can activate NF-kappaB, mediate apoptosis, and function as a regulator of inflammation. Antiapoptotic protein BCL2-associated athanogene 4 (BAG4/SODD) and adaptor proteins TRADD and TRAF2 have been shown to interact with this receptor, and thus play regulatory roles in the signal transduction mediated by the receptor. Germline mutations of the extracellular domains of this receptor were found to be associated with the autosomal dominant periodic fever syndrome. The impaired receptor clearance is thought to be a mechanism of the disease. (LocusLink)</Definition>
        <Definition>TNFR1 is a 55 kD high-affinity cell surface receptor for tumor necrosis factor. Activated receptor interacts with death domains of TRADD to activate apoptosis and NFKB cascades. TRADD-interacting FADD proteolytically activates caspase-8. TNFR1 may activate PIP5K2B and may induce MAP kinase activation via MADD. (from OMIM 191190 and NCI)</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">TNFRSF1A protein, human</Term>
        <Term>tumor necrosis factor receptor superfamily, member 1A protein, human</Term>
        <Term>tumor necrosis factor binding protein 1, human</Term>
        <Codes>
          <Code code="C1453722" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Necrosis_Factor_Receptor_1A</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL6ST_protein_human" name="IL6ST protein, human">
        <Definition>Widely expressed (not restricted to IL6 responsive cells) by human IL6ST Gene (Type I Cytokine Receptor 2 Family), heterodimeric type I membrane protein (isoform 1) and secreted (isoform 2) Interleukin 6 Signal Transducer contains 5 fibronectin type III domains, an Ig-like C2-type domain, a BOX 1 motif required for JAK interaction/activation, and a WSXWS motif necessary for protein folding, intracellular transport, and cell-surface receptor binding. Part of cytokine receptor complexes, IL6ST is a signal transducer dependent on receptor binding for activation by many cytokines (IL6, CNTF, LIF, IL11, CT1, and OSM) that can utilize gp130 in signal transmission. IL6ST may regulate myocyte apoptosis and have a role in embryonic development. Isoform 2 is an autoantigen in rheumatoid arthritis but it is not specific to RA. (NCI)</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL6ST protein, human</Term>
        <Term>IL6R-beta protein, human</Term>
        <Term>CD130 protein, human</Term>
        <Term>CDw130 protein, human</Term>
        <Term>glycoprotein subunit 130, cytokine receptor, human</Term>
        <Term>cytokine receptor gp130, human</Term>
        <Term>GP130 cytokine receptor subunit, human</Term>
        <Term>CDw130 antigen</Term>
        <Term>interleukin 6 signal transducer (gp130, oncostatin M receptor) protein, human</Term>
        <Codes>
          <Code code="C1366325" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Cytokine_Receptor_gp130</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly-49W_receptor" name="Ly-49W receptor">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly-49W receptor</Term>
        <Codes>
          <Code code="C0965465" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BALB_cRl_Mouse" name="BALB/cRl Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BALB/cRl Mouse</Term>
        <Term>BALB/cRl</Term>
        <Codes>
          <Code code="C37363" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL1R2_protein_human" name="IL1R2 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL1R2 protein, human</Term>
        <Term>interleukin 1 receptor, type II, human</Term>
        <Term>IL-1R2 protein, human</Term>
        <Term>CD121b antigen, human</Term>
        <Term>interleukin-1 receptor 2, human</Term>
        <Codes>
          <Code code="C1701550" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_Interleukin-1_Type_II</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BTN3A1_protein_human" name="BTN3A1 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BTN3A1 protein, human</Term>
        <Term>CD277 protein, human</Term>
        <Codes>
          <Code code="C3181415" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ncr1_protein_mouse" name="Ncr1 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ncr1 protein, mouse</Term>
        <Term>Ly94 protein, mouse</Term>
        <Term>MAR1 (mouse activating receptor 1) protein, mouse</Term>
        <Term>natural cytotoxicity triggering receptor 1, mouse</Term>
        <Term>NKp46 protein, mouse</Term>
        <Codes>
          <Code code="C0765731" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BR_cdJ_Mouse" name="C57BR/cdJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BR/cdJ Mouse</Term>
        <Term>C57BR/cdJ</Term>
        <Codes>
          <Code code="C37390" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Micropig" name="Micropig">
        <Definition>A Yucatan or other pig breed that is bred specifically for its small size. The micropig weighs between 14-20kg at sexual maturity.</Definition>
        <Definition>A Yucatan or other pig breed that is bred specifically for its small size. The micropig weighs between 14-20kg at sexual maturity. (NCI)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Micropig</Term>
        <Term>MICROPIG</Term>
        <Codes>
          <Code code="C77106" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Pig</Relation>
          <Relation name="Narrower">OTE:Yucatan_Micropig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Vertebrata" name="Vertebrata">
        <Definition>A subphylum of animals consisting of those having a bony or cartilaginous vertebral column.</Definition>
        <Definition>Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes.</Definition>
        <SemanticType code="T010" name="Vertebrate"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Vertebrata</Term>
        <Term>vertebrate</Term>
        <Term>Vertebrata S.F.Gray, 1821</Term>
        <Term>vertebrates</Term>
        <Term>Vertebrate Animals</Term>
        <Term>Vertebrates</Term>
        <Term>Subphylum Vertebrata (organism)</Term>
        <Term>Vertebrate</Term>
        <Term>Vertebrata Cuvier, 1812</Term>
        <Term>Subphylum Vertebrata</Term>
        <Term>vertebrata</Term>
        <Codes>
          <Code code="C14282" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Animal</Relation>
          <Relation name="Narrower">OTE:Amphibia, OTE:Fish, OTE:Aves, OTE:Mammalia</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Lewis_Rat_Strain" name="Lewis, Rat Strain">
        <Definition>Derived from Wistar stock by the laboratory of Dr. Lewis at the Wistar Institute in the 1940s and 1950s, the Lewis is a white albino rat with genotype a, TyrC. The Lewis rat has a MHC haplotype of RT1A'.</Definition>
        <Definition>Derived from Wistar stock by the laboratory of Dr. Lewis at the Wistar Institute in the 1940s and 1950s, the Lewis is a white albino rat with genotype a, TyrC. The Lewis rat has a MHC haplotype of RT1A'. (NCI)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Lewis, Rat Strain</Term>
        <Term>LEWIS</Term>
        <Codes>
          <Code code="C106538" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Sdc1_protein_mouse" name="Sdc1 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Sdc1 protein, mouse</Term>
        <Term>syndecan 1 protein, mouse</Term>
        <Term>CD138 antigen, mouse</Term>
        <Term>syndecan-1 protein, mouse</Term>
        <Codes>
          <Code code="C1506025" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Syndecan-1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:quasi-experimental_design" name="quasi-experimental design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">quasi-experimental design</Term>
        <Term>quasi experimental designs</Term>
        <Term>quasi experimental study</Term>
        <Term>quasiexperimental design</Term>
        <Term>quasi-experimental trials</Term>
        <Term>quasiexperimental study</Term>
        <Term>quasi experimental trials</Term>
        <Term>quasi-experimental designs</Term>
        <Term>quasiexperimental designs</Term>
        <Term>quasiexperimental trials</Term>
        <Term>quasi-experimental study</Term>
        <Term>quasi-experimental studies</Term>
        <Term>quasiexperimental trial</Term>
        <Term>quasiexperimental studies</Term>
        <Term>quasi experimental studies</Term>
        <Term>quasi-experimental trial</Term>
        <Term>quasi experimental design</Term>
        <Term>quasi experimental trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#quasi_experimental_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:controlled_design</Relation>
          <Relation name="Narrower">OTE:quasi-experimental_clinical_trial, OTE:quasi_randomized_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ptprc_protein_rat" name="Ptprc protein, rat">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ptprc protein, rat</Term>
        <Term>protein tyrosine phosphatase, receptor type, C protein, rat</Term>
        <Term>RT7 antigens</Term>
        <Term>CD45 antigen, rat</Term>
        <Term>RT7 antigen</Term>
        <Codes>
          <Code code="C0206053" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD45_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BDIX_Rat_Strain" name="BDIX, Rat Strain">
        <Definition>Strain widely used in carcinogenesis and teratogenesis studies. Highly susceptible to the transplacental induction of malignant tumors of the central nervous system by ethyl nitrosourea (Druckrey et al 1970). A transplantable monocytic-myeloid leukemia L5222 induced by ethyl nitrosourea has been used as a model for chemotherapy (Ivankovic and Zeller 1974). Transplantable colon tumor PROb grows progressively and metastasizes, whereas REGb grows slowly and is then rejected (Blottiere et al 1992a,b).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BDIX, Rat Strain</Term>
        <Codes>
          <Code code="C14387" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DBA_1J_Mouse" name="DBA/1J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DBA/1J Mouse</Term>
        <Term>DBA/1J</Term>
        <Codes>
          <Code code="C37403" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:GADD45B_protein_human" name="GADD45B protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">GADD45B protein, human</Term>
        <Term>GADD45BETA protein, human</Term>
        <Term>growth arrest and DNA-damage-inducible, beta protein, human</Term>
        <Term>MYD118 protein, human</Term>
        <Codes>
          <Code code="C1504732" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Receptors_KIR2DL4" name="Receptors, KIR2DL4">
        <Definition>A KIR receptor that has specificity for HLA-G antigen. It contains D0 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Receptors, KIR2DL4</Term>
        <Term>ANTIGENS CD 158 D</Term>
        <Term>KIR2DL4 Receptors</Term>
        <Term>Antigens, CD158d</Term>
        <Term>RECEPTORS KIR 02 DL 04</Term>
        <Term>KIR2DL4 Receptor</Term>
        <Term>Receptor, KIR2DL4</Term>
        <Term>CD158d Antigen</Term>
        <Term>Killer Cell Immunoglobulin Like Receptor 2DL4</Term>
        <Term>Killer Cell Immunoglobulin-Like Receptor 2DL4</Term>
        <Term>Antigen, CD158d</Term>
        <Term>CD 158 D ANTIGENS</Term>
        <Term>CD158d Antigens</Term>
        <Codes>
          <Code code="C1743908" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:KIR2DL4_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:101_Rl_Mouse" name="101/Rl Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">101/Rl Mouse</Term>
        <Term>101/Rl</Term>
        <Codes>
          <Code code="C37319" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MS4A2_protein_human" name="MS4A2 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MS4A2 protein, human</Term>
        <Term>FcepsilonRI beta-chain, human</Term>
        <Term>FCER1B protein, human</Term>
        <Term>Fc-epsilon receptor I beta-chain, human</Term>
        <Term>IgE receptor beta-chain, human</Term>
        <Term>membrane-spanning 4-domains, subfamily A, member 2 protein, human</Term>
        <Codes>
          <Code code="C1571424" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD23</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129S2_SvPasIco_Mouse" name="129S2/SvPasIco Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129S2/SvPasIco Mouse</Term>
        <Term>129S2/SvPasIco</Term>
        <Codes>
          <Code code="C37338" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Receptors_KIR2DL1" name="Receptors, KIR2DL1">
        <Definition>A KIR receptor that has specificity for HLA-C ANTIGENS. It is an inhibitory receptor that contains D1 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail. It is similar in structure and function to the KIR2DL2 RECEPTOR and the KIR2DL3 RECEPTORS.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Receptors, KIR2DL1</Term>
        <Term>Antigens, CD158a</Term>
        <Term>Killer Cell Immunoglobulin-Like Receptor 2DL1</Term>
        <Term>CD158a Antigens</Term>
        <Term>Natural Killer Associated Transcript 1</Term>
        <Term>RECEPTORS KIR 02 DL 01</Term>
        <Term>CD158a Antigen</Term>
        <Term>CD 158 A ANTIGENS</Term>
        <Term>ANTIGENS CD 158 A</Term>
        <Term>Antigen, CD158a</Term>
        <Term>Killer Cell Immunoglobulin Like Receptor 2DL1</Term>
        <Term>Natural Killer-Associated Transcript 1</Term>
        <Term>KIR2DL1 Receptors</Term>
        <Codes>
          <Code code="C1744322" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:KIR2DL1_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MOLF_EiJ_Mouse" name="MOLF/EiJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MOLF/EiJ Mouse</Term>
        <Term>MOLF/EiJ</Term>
        <Codes>
          <Code code="C37412" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Receptors_KIR2DL3" name="Receptors, KIR2DL3">
        <Definition>A KIR receptor that has specificity for HLA-C ANTIGEN. It is an inhibitory receptor that contains D1 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail. It is similar in structure and function to the KIR2DL2 RECEPTORS and the KIR2DL3 RECEPTORS.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Receptors, KIR2DL3</Term>
        <Term>ANTIGENS CD 158 B</Term>
        <Term>CD 158 B ANTIGENS</Term>
        <Term>Natural Killer Associated Transcript 2</Term>
        <Term>Antigens, CD158b</Term>
        <Term>RECEPTORS KIR 02 DL 03</Term>
        <Term>CD158b Antigens</Term>
        <Term>KIR2DL3 Receptors</Term>
        <Term>CD158b Antigen</Term>
        <Term>Antigen, CD158b</Term>
        <Term>Natural Killer-Associated Transcript 2</Term>
        <Term>Killer Cell Immunoglobulin-Like Receptor 2DL3</Term>
        <Term>Killer Cell Immunoglobulin Like Receptor 2DL3</Term>
        <Codes>
          <Code code="C1739772" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:KIR2DL3_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Receptors_KIR2DL2" name="Receptors, KIR2DL2">
        <Definition>A KIR receptor that has specificity for HLA-C ANTIGENS. It is an inhibitory receptor that contains D1 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail. It is similar in structure and function to the KIR2DL1 RECEPTORS and the KIR2DL3 RECEPTORS.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Receptors, KIR2DL2</Term>
        <Term>CD158b1 Antigens</Term>
        <Term>RECEPTORS KIR 02 DL 02</Term>
        <Term>KIR2DL2 Receptors</Term>
        <Term>KIR2DL2 Receptor</Term>
        <Term>ANTIGENS CD 158 B 01</Term>
        <Term>Receptor, KIR2DL2</Term>
        <Term>CD158b1 Antigen</Term>
        <Term>Antigen, CD158b1</Term>
        <Term>Natural Killer Associated Transcript 6</Term>
        <Term>Natural Killer-Associated Transcript 6</Term>
        <Term>CD 158 B 01 ANTIGENS</Term>
        <Term>Killer Cell Immunoglobulin like Receptor 2DL2</Term>
        <Term>Killer Cell Immunoglobulin-like Receptor 2DL2</Term>
        <Term>Antigens, CD158b1</Term>
        <Codes>
          <Code code="C1744321" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:KIR2DL2_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SS_Rat_Strain" name="SS, Rat Strain">
        <Definition>Derived by Rapp from a colony of Sprague-Dawley rats that were initially derived by LK Dahl at Brookhaven National Laboratories. The SS rat strain has been selected for its acute salt sensitivity, leading to the development of hypertension, diabetes, nephropathy, cardiac hypertrophy, heart failure, cholesterolemia, hyperinsulinemia, hypertriglyceridemia. This rat strain is used as an animal model in the study of human hypertension.</Definition>
        <Definition>Derived by Rapp from a colony of Sprague-Dawley rats that were initially derived by LK Dahl at Brookhaven National Laboratories. The SS rat strain has been selected for its acute salt sensitivity.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SS, Rat Strain</Term>
        <Term>Dahl-S</Term>
        <Term>DAHL-S</Term>
        <Codes>
          <Code code="C76186" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MOLD_RkJ_Mouse" name="MOLD/RkJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MOLD/RkJ Mouse</Term>
        <Term>MOLD/RkJ</Term>
        <Codes>
          <Code code="C37411" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:historical_article" name="historical article">
        <Definition>An article or portion of an article giving an account of past events or circumstances significant in a field of study, a profession, a discovery, an invention, etc. The concept of history is very wide, ranging from the dawn of time to the present. This publication type is often checked in conjunction with BIOGRAPHY.</Definition>
        <Definition>An article or portion of an article giving an account of past events or circumstances significant in a field of study, a profession, a discovery, an invention, etc. The concept of history is very wide, ranging from the dawn of time to the present. This publication type is often checked in conjunction with BIOGRAPHY. [MeSH_2014]</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">historical article</Term>
        <Term>historical articles</Term>
        <Term>historical survey</Term>
        <Term>Historical Article</Term>
        <Codes>
          <Code code="C0282446" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:article</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Il17rb_protein_mouse" name="Il17rb protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Il17rb protein, mouse</Term>
        <Term>Evi27 protein, mouse</Term>
        <Term>interleukin 17 receptor B, mouse</Term>
        <Term>interleukin 17B receptor, mouse</Term>
        <Codes>
          <Code code="C1312817" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_Interleukin-17</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BL_Mouse" name="C57BL Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BL Mouse</Term>
        <Term>Inbred C57BL Mouse</Term>
        <Term>Mouse, Inbred C57BL</Term>
        <Term>C57BL</Term>
        <Term>C57BL Mice, Inbred</Term>
        <Term>Mice, Inbred C57BL</Term>
        <Term>MICE INBRED CA57BL</Term>
        <Term>C57BL Mouse, Inbred</Term>
        <Term>Inbred C57BL Mice</Term>
        <Term>C57BL Mice</Term>
        <Term>Mouse, C57BL</Term>
        <Term>Mice, C57BL</Term>
        <Codes>
          <Code code="C0025921" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:PROM1_protein_human" name="PROM1 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">PROM1 protein, human</Term>
        <Term>prominin 1 protein, human</Term>
        <Term>AC133 antigen, human</Term>
        <Term>CD133 protein, human</Term>
        <Term>AC133 protein, human</Term>
        <Codes>
          <Code code="C0673026" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:AC133_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:cluster_quasi_randomized_controlled_design" name="cluster quasi randomized controlled design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">cluster quasi randomized controlled design</Term>
        <Term>cluster quasi randomised controlled designs</Term>
        <Term>cluster quasi-randomized controlled studies</Term>
        <Term>cluster quasi-randomized controlled study</Term>
        <Term>cluster quasi randomized controlled studies</Term>
        <Term>cluster quasi-randomised controlled studies</Term>
        <Term>cluster quasi-randomized controlled designs</Term>
        <Term>cluster quasi-randomised controlled design</Term>
        <Term>cluster quasi-randomised controlled study</Term>
        <Term>Controlled clinical design</Term>
        <Term>Controlled Clinical Trial</Term>
        <Term>cluster quasi-randomised controlled designs</Term>
        <Term>cluster quasi-randomized controlled trials</Term>
        <Term>cluster quasi randomized controlled study</Term>
        <Term>cluster quasi-randomized controlled design</Term>
        <Term>cluster quasi randomised controlled studies</Term>
        <Term>cluster quasi-randomised controlled trials</Term>
        <Term>cluster quasi randomized controlled trial</Term>
        <Term>cluster quasi-randomised controlled trial</Term>
        <Term>cluster quasi randomised controlled design</Term>
        <Term>cluster quasi randomised controlled trials</Term>
        <Term>cluster quasi randomised controlled trial</Term>
        <Term>cluster quasi randomised controlled study</Term>
        <Term>cluster quasi randomized controlled designs</Term>
        <Term>cluster quasi-randomized controlled trial</Term>
        <Term>cluster quasi randomized controlled trials</Term>
        <Term>Cluster non-randomized controlled design</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#cluster_quasi_randomized_controlled_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:quasi_randomized_controlled_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:legislation" name="legislation">
        <Definition>The enactment of laws and ordinances and their regulation by official organs of a nation, state, or other legislative organization. It refers also to health-related laws and regulations in general or for which there is no specific heading.</Definition>
        <Definition> Works consisting of the text of proposed or enacted legislation that may be in the form of bills, laws, statutes, ordinances, or government regulations.CATALOG: use when 20% or more of the content consists of the text of laws, statutes, ordinances, or government regulations. Do not use for works that are merely discussion of law, etc.  [MeSH_2014]</Definition>
        <Definition>Works consisting of the text of proposed or enacted legislation that may be in the form of bills, laws, statutes, ordinances, or government regulations.</Definition>
        <SemanticType code="T089" name="Regulation or Law"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">legislation</Term>
        <Term>statutes and laws</Term>
        <Term>Legislation as Topic</Term>
        <Term>Legal case</Term>
        <Term>STATUTES LAWS</Term>
        <Term>Laws and Statutes</Term>
        <Term>Legal cases</Term>
        <Term>Statutes and Laws</Term>
        <Term>legislations</Term>
        <Term>Legislation</Term>
        <Term>LAWS STATUTES</Term>
        <Term>Legislation (documents)</Term>
        <Codes>
          <Code code="C0023252" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly6_protein_mouse" name="Ly6 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly6 protein, mouse</Term>
        <Term>Ly-6 protein, mouse</Term>
        <Term>Ly27 protein, mouse</Term>
        <Term>lymphocyte antigen 6 complex protein, mouse</Term>
        <Codes>
          <Code code="C2351659" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SDC1_protein_human" name="SDC1 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SDC1 protein, human</Term>
        <Term>syndecan-1 protein, human</Term>
        <Term>syndecan 1 protein, human</Term>
        <Term>desmosealin, human</Term>
        <Term>CD138 antigen, human</Term>
        <Codes>
          <Code code="C0753253" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Syndecan-1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NT5E_protein_human" name="NT5E protein, human">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NT5E protein, human</Term>
        <Term>CD73 antigen, human</Term>
        <Term>5'-nucleotidase, ecto (CD73) protein, human</Term>
        <Term>CD73 protein, human</Term>
        <Codes>
          <Code code="C2932861" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-Nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Gtlf3b_protein_mouse" name="Gtlf3b protein, mouse">
        <SemanticType code="T130" name="Indicator, Reagent, or Diagnostic Aid"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Gtlf3b protein, mouse</Term>
        <Term>gene trap locus F3b protein, mouse</Term>
        <Term>F3-2 protein, mouse</Term>
        <Codes>
          <Code code="C1309187" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:KAI1_Protein" name="KAI1 Protein">
        <Definition>A widely expressed transmembrane glycoprotein that functions as a METASTASIS suppressor protein. It is underexpressed in a variety of human NEOPLASMS.</Definition>
        <Definition>Kangai 1 Protein, a metastasis suppressor protein encoded by the 80 kb human KAI1 gene (TM4SF family), is expressed in many tissues and has four putative transmembrane domains and a large extracellular domain having three potential N-glycosylation sites. KAI1 appears to be up regulated in activated T-cells. p53 activates the gene by interacting with sequences in a 5-prime upstream region. Loss of p53 appears to cause down-regulation of KAI1. Similar to leukocyte cell surface glycoproteins involved in cell adhesion and signal transduction, KAI1 is a likely homologue of mouse leukocyte surface antigen R2. Associated with CD4 or CD8, KAI1 delivers co-stimulatory signals for the TCR/CD3 pathway. KAI1 expression at the transcription or posttranscription level is often down regulated during tumor progression. (from SWISS-PROT, OMIM, and NCI)</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">KAI1 Protein</Term>
        <Term>Antigen, CD82</Term>
        <Term>Lymphocyte antigen CD82 (substance)</Term>
        <Term>Metastasis Suppressor Kangai 1</Term>
        <Term>Antigens, CD82 [Chemical/Ingredient]</Term>
        <Term>ANTIGENS CD 082</Term>
        <Term>CD82 Antigens</Term>
        <Term>CD82 Antigen</Term>
        <Term>IA4</Term>
        <Term>Kangai-1 Protein</Term>
        <Term>KANGAI 001 PROTEIN</Term>
        <Term>Lymphocyte antigen CD82</Term>
        <Term>Suppressor of Tumorigenicity-6</Term>
        <Term>R2 Leukocyte Antigen</Term>
        <Term>Antigens, CD82</Term>
        <Term>CD82</Term>
        <Term>Kangai 1 Protein</Term>
        <Term>Antigen CD82</Term>
        <Term>Inducible Membrane Protein R2</Term>
        <Term>Leukocyte Surface Antigen R2</Term>
        <Term>KAI1</Term>
        <Term>C33 Antigen</Term>
        <Term>R2 Leukocyte Surface Antigen</Term>
        <Term>Prostate Cancer Antimetastasis Gene Kai1</Term>
        <Term>Suppressor of Tumorigenicity 6</Term>
        <Codes>
          <Code code="C0286983" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Cd82_antigen_mouse, OTE:Cd82_protein_rat, OTE:CD82_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Prdl-b_protein_Hydra_attenuata" name="Prdl-b protein, Hydra attenuata">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Prdl-b protein, Hydra attenuata</Term>
        <Codes>
          <Code code="C1308572" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Lifr_protein_rat" name="Lifr protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Lifr protein, rat</Term>
        <Term>leukemia inhibitory factor receptor, rat</Term>
        <Term>leukemia inhibitory factor receptor alpha subunit, rat</Term>
        <Codes>
          <Code code="C1506607" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Leukemia_Inhibitory_Factor_Receptor_alpha_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd52_protein_rat" name="Cd52 protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd52 protein, rat</Term>
        <Term>CD52 antigen, rat</Term>
        <Codes>
          <Code code="C1609379" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD52_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BUF_Rat_Strain" name="BUF, Rat Strain">
        <Definition>Derived from Buffalo stock of H. Morris to the NIH in 1950 and disseminated from Charles River since 1998, the Buffalo is a white albino rat, genotype c.</Definition>
        <Definition>Derived from Buffalo stock of H. Morris to the NIH in 1950 and disseminated from Charles River since 1998, the Buffalo is a white albino rat, genotype c. The incidence of spontaneous tumor formation includes anterior pituitary and adrenal cortex in upwards of 30% of aged rats. The Buffalo rat is used most commonly in oncology and carcinogenesis research. Low incidence of dental caries. Spontaneous tumors of anterior pituitary 30%, and of adrenal cortex 25% in older animals. Survival 58% at 2 years of age with thyroid carcinoma in 25% (Lindsey et al 1968). Low incidence of renal neoplasms (Snell 1967). High incidence of tumors of the anterior pituitary, adrenal medulla and adrenal cortex in animals over 18 months old (Snell1965).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BUF, Rat Strain</Term>
        <Term>BUFFALO</Term>
        <Term>Buffalo Rat</Term>
        <Codes>
          <Code code="C14396" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:micp75TNFR_protein_mouse" name="micp75TNFR protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">micp75TNFR protein, mouse</Term>
        <Codes>
          <Code code="C1958783" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Necrosis_Factor_Receptor_Type_II</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:feasibility_study" name="feasibility study">
        <Definition>Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">feasibility study</Term>
        <Term>Feasibility Studies</Term>
        <Term>Feasibility studies</Term>
        <Term>Feasibility Study</Term>
        <Term>Study, Feasibility</Term>
        <Term>feasibility trial</Term>
        <Term>feasibility trials</Term>
        <Term>feasibility designs</Term>
        <Term>feasibility studies</Term>
        <Term>feasibility design</Term>
        <Term>Studies, Feasibility</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#feasibility_study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:cross-over_design" name="cross-over design">
        <Definition> A type of clinical study in which each study subject receives the same series of treatments but in a random order that differs across arms of the study. Each subject serves as their own control in this type of study. [NCIT_14.05d] 
</Definition>
        <Definition>Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. [MeSH_2014]</Definition>
        <Definition>Participants receive one of two or more alternative intervention(s) during the initial epoch of the study and receive other intervention(s) during the subsequent epoch(s) of the study. [NCIT_14.05d] [Contributing_Source_CDISC]</Definition>
        <Definition>A crossover design, sometimes called a counterbalanced design, is a type of experimental design in which every subject is exposed to every treatment in a balanced fashion. If there are just two treatments, at Time 1 half of the subjects receive Treatment A and the other half receive Treatment B. At Time 2 they ‘cross over,’ with the first half receiving Treatment B and the second half receiving Treatment A. Crossover designs are ‘Latin square’ designs in which each of k treatments is administered to each of k groups of subjects at k points in time (where k is equal to or greater than 2). They can also be used in assessing reliability when parallel forms are used. [Dictionary of nursing theory and research_2010]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">cross-over design</Term>
        <Term>Cross-over</Term>
        <Term>crossover designs</Term>
        <Term>crossover studies</Term>
        <Term>crossover study design</Term>
        <Term>crossover design</Term>
        <Term>cross over study</Term>
        <Term>crossover trial</Term>
        <Term>cross-over trial</Term>
        <Term>cross-over studies</Term>
        <Term>Crossover</Term>
        <Term>cross-over designs</Term>
        <Term>cross-over study</Term>
        <Term>crossover trials</Term>
        <Term>cross-over study designs</Term>
        <Term>crossover study</Term>
        <Term>crossover procedure</Term>
        <Term>cross-over trials</Term>
        <Term>procedure, crossover</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#cross-over_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:double_blind_crossover_design_, OTE:randomized_cross-over_design_, OTE:non-randomized_cross-over_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mic2l1_protein_mouse" name="Mic2l1 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mic2l1 protein, mouse</Term>
        <Term>CD99 antigen-like 2 protein, mouse</Term>
        <Term>MIC2 (monoclonal Imperial Cancer Research Fund 2)-like 1 protein, mouse</Term>
        <Term>CD99L2 protein, mouse</Term>
        <Term>Xap89 protein, mouse</Term>
        <Codes>
          <Code code="C1259125" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:parallel_design" name="parallel design">
        <Definition>Participants are assigned to one of two or more arms in parallel for the duration of the study. [NCIT_14.05d] [Contributing_Source_CDISC]
</Definition>
        <Definition>A type of clinical study in which subjects are assigned to one of two treatment arms at the beginning of the trial and continue in that arm throughout the length of the trial. Study subjects are only exposed to the treatment that is assigned to the particular study arm they are enrolled in. [NCIT_14.05d] </Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">parallel design</Term>
        <Term>parallel trials</Term>
        <Term>parallel trial</Term>
        <Term>parallel study</Term>
        <Term>parallel studies</Term>
        <Term>parallel designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#parallel_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:suprabasin_protein_mouse" name="suprabasin protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">suprabasin protein, mouse</Term>
        <Term>Sbsn protein, mouse</Term>
        <Codes>
          <Code code="C1173184" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD59_protein_human" name="CD59 protein, human">
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD59 protein, human</Term>
        <Term>CD59 antigen, human</Term>
        <Term>20 kDa homologous restriction factor, human</Term>
        <Term>HRF20 protein, human</Term>
        <Term>CD59 glycoprotein, human</Term>
        <Term>CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344) protein, human</Term>
        <Term>CD59 antigen p18-20, human</Term>
        <Term>HRF-20 protein, human</Term>
        <Term>homologous restriction factor 20, human</Term>
        <Codes>
          <Code code="C1504686" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD59</Relation>
          <Relation name="Narrower">OTE:placental_anemia-inducing_factor</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:pragmatic_design" name="pragmatic design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">pragmatic design</Term>
        <Term>pragmatic study</Term>
        <Term>pragmatic studies</Term>
        <Term>pragmatic trial</Term>
        <Term>pragmatic designs</Term>
        <Term>pragmatic trials</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#pragmatic_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:pragmatic_clinical_trial_</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD200_membrane_glycoprotein" name="CD200 membrane glycoprotein">
        <Definition>OX-2 membrane glycoprotein (278 aa, ~31 kDa) is encoded by the human CD200 gene. This protein may play a role in the mediation of both activity and proliferation of myeloid lineage cells.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD200 membrane glycoprotein</Term>
        <Term>CD200 Antigen</Term>
        <Term>MRC OX-2 antigen</Term>
        <Term>MRC OX-2 glycoprotein</Term>
        <Term>CD200</Term>
        <Term>CD200 antigen</Term>
        <Term>antigens, CD200</Term>
        <Term>OX-2 Membrane Glycoprotein</Term>
        <Term>OX-2 membrane glycoprotein</Term>
        <Codes>
          <Code code="C0066862" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:CD200_protein_human, OTE:CD200_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fc_epsilon_RI" name="Fc epsilon RI">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fc epsilon RI</Term>
        <Term>epsilon RI, Fc</Term>
        <Codes>
          <Code code="C0162825" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD23</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ber-EP4_antigen_human" name="Ber-EP4 antigen, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ber-EP4 antigen, human</Term>
        <Codes>
          <Code code="C1701148" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:human_epithelial_antigen-125</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Human" name="Human">
        <Definition>Members of the species Homo sapiens.</Definition>
        <Definition>a general term for grouping human subject control terms; do not index, use NTs instead.</Definition>
        <Definition>The bipedal primate mammal, Homo sapiens; belonging to man or mankind; pertaining to man or to the race of man; use of man as experimental subject or unit of analysis in research.</Definition>
        <SemanticType code="T016" name="Human"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Human</Term>
        <Term>Man</Term>
        <Term>Humans</Term>
        <Term>Human, General</Term>
        <Term>FAMILY OF MAN</Term>
        <Term>MAN</Term>
        <Term>Homo sapiens Linnaeus, 1758</Term>
        <Term>Homo sapiens (organism)</Term>
        <Term>Man, Modern</Term>
        <Term>Man (Taxonomy)</Term>
        <Term>85B FAMILY OF MAN</Term>
        <Term>humans</Term>
        <Term>human</Term>
        <Term>Human - origin (qualifier value)</Term>
        <Term>Modern Man</Term>
        <Term>Man and woman</Term>
        <Term>homo sapiens</Term>
        <Term>Human - origin</Term>
        <Term>Homo sapiens</Term>
        <Term>man</Term>
        <Codes>
          <Code code="C0086418" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Hominidae</Relation>
          <Relation name="Narrower">OTE:Man, OTE:Woman</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:psychometric_study" name="psychometric study">
        <Definition>[A study based on ... ] The science of measuring "psychological" aspects of a person such as knowledge, skills, abilities, or personality. Measurement of these unobservable phenomena is difficult and much of the research and accumulated art of this discipline is designed to reliably define and then quantify. [psychometrics | NCIT_14.10d] </Definition>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">psychometric study</Term>
        <Term>psychometric trial</Term>
        <Term>psychometric studies</Term>
        <Term>psychometric designs</Term>
        <Term>psychometric trials</Term>
        <Term>psychometric design</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#psychometric_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:antigen_X-80" name="antigen X-80">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">antigen X-80</Term>
        <Term>X-80 antigen</Term>
        <Codes>
          <Code code="C0292739" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Minipig" name="Minipig">
        <Definition>Genetically developed small pigs for use in biomedical research. There are several strains - Yucatan miniature, Sinclair miniature, and Minnesota miniature.</Definition>
        <Definition>strains of small pigs developed for use in biomedical research.</Definition>
        <Definition>A Yucatan, Gottingen, or other pig breed that is bred specifically for its small size. The Minipig weighs between 20-30kg at sexual maturity.</Definition>
        <Definition>A Yucatan, Gottingen, or other pig breed that is bred specifically for its small size. The Minipig weighs between 20-30kg at sexual maturity. (NCI)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Minipig</Term>
        <Term>mini pig</Term>
        <Term>Swines, Miniature</Term>
        <Term>Swine, Miniature</Term>
        <Term>Miniature Swine</Term>
        <Term>Minipigs</Term>
        <Term>MINIPIG</Term>
        <Term>miniature swine</Term>
        <Term>Miniature Swines</Term>
        <Term>minipig</Term>
        <Term>mini pigs</Term>
        <Codes>
          <Code code="C77107" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Pig</Relation>
          <Relation name="Narrower">OTE:NIH_Minipig, OTE:Yucatan_Minipig, OTE:Sinclair_Minipig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:research_report" name="research report">
        <Definition>Detailed account or statement or formal record of data resulting from empirical inquiry.</Definition>
        <Definition>Detailed account or statement or formal record of data resulting from empirical inquiry. [MeSH_2015]</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">research report</Term>
        <Term>Research Report</Term>
        <Term>research reports</Term>
        <Term>Research Reports</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#research_report" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SIGLEC6_protein_human" name="SIGLEC6 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SIGLEC6 protein, human</Term>
        <Term>OB-BP1 protein, human</Term>
        <Term>Siglec-6 protein, human</Term>
        <Term>sialic acid binding Ig-like lectin 6 protein, human</Term>
        <Codes>
          <Code code="C0908151" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CBA_CaH_Mouse" name="CBA/CaH Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CBA/CaH Mouse</Term>
        <Term>CBA/CaH</Term>
        <Codes>
          <Code code="C37397" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:clinical_trial" name="clinical trial">
        <Definition>&lt;p&gt;Clinical trials are research studies that test how well new medical approaches work in people. Each study answers scientific questions and tries to find better ways to prevent, screen for, diagnose, or treat a disease. Clinical trials may also compare a new treatment to a treatment that is already available.&lt;/p&gt;&lt;p&gt;Every clinical trial has a protocol, or action plan, for conducting the trial. The plan describes what will be done in the study, how it will be conducted, and why each part of the study is necessary. Each study has its own rules about who can take part. Some studies need volunteers with a certain disease. Some need healthy people. Others want just men or just women.&lt;/p&gt;&lt;p&gt;In the United States, an independent committee of physicians, statisticians, and members of the community must approve and monitor the protocol. They make sure that the risks are small and are worth the potential benefits.&lt;/p&gt;&lt;p &gt;NIH: National Institutes of Health&lt;/p&gt;</Definition>
        <Definition>Pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.</Definition>
        <Definition>A type of research study that tests how well new medical approaches work in people. These studies test new methods of screening, prevention, diagnosis, or treatment of a disease.</Definition>
        <Definition>A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. [NCIT_14.05d] </Definition>
        <Definition>A type of research study that tests how well new medical approaches work in people. These studies test new methods of screening, prevention, diagnosis, or treatment of a disease. [NCIT_14.05d] </Definition>
        <Definition>Work that is the report of a pre-planned clinical study of the safety, efficacy, or optimum dosage schedule of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in humans selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. While most clinical trials concern humans, this publication type may be used for clinical veterinary articles meeting the requisites for humans. Specific headings for specific types and phases of clinical trials are also available.</Definition>
        <Definition>&lt;p&gt;&lt;b&gt;Description:&lt;/b&gt;Healthcare provided or withheld in the course of conducting research&lt;/p&gt;</Definition>
        <Definition>controlled study designed to assess the safety and efficacy of new drugs, devices, treatments, or preventive measures in humans by comparing two or more interventions or regimens; prefer specific phase NTs.</Definition>
        <Definition>A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioral treatments, process-of-care changes, and preventive care.(World Health Organization, International Clinical Trials Registry Platform)</Definition>
        <Definition>&lt;p&gt;The set of actions that define an experiment to assess the effectiveness and/or safety of a biopharmaceutical product (food, drug, device, etc.). In definition mood, this set of actions is often embodied in a clinical trial protocol; in event mood, this designates the aggregate act of applying the actions to one or more subjects.&lt;/p&gt;</Definition>
        <Definition>&lt;p&gt;&lt;b&gt;Definition:&lt;/b&gt;The specific manufactured drug is part of a clinical trial.&lt;/p&gt;</Definition>
        <Definition>Systematic, planned studies to evaluate the safety and efficacy of drugs, devices, or diagnostic or therapeutic practices. Used only when the methodology is the focus of discussion.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T078" name="Idea or Concept"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">clinical trial</Term>
        <Term>Clinical Trials</Term>
        <Term>Clinical Trials, Unspecified</Term>
        <Term>Clinical Trial Generic</Term>
        <Term>clinical trials</Term>
        <Term>Clinical Trials as Topic</Term>
        <Term>Clinical Trial</Term>
        <Term>Clinical Trial as Topic</Term>
        <Term>Clinical Trial - SubstanceAdminSubstitutionNotAllowedReason</Term>
        <Term>CLINICAL TRIALS</Term>
        <Term>observation - clinical trial</Term>
        <Term>Clinical Trial [Publication Type]</Term>
        <Term>Clinical trials</Term>
        <Term>Clinical trial</Term>
        <Term>Trial</Term>
        <Term>Clinical trial (procedure)</Term>
        <Term>trial, clinical</Term>
        <Codes>
          <Code code="C1552009" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:controlled_clinical_trial, OTE:pragmatic_clinical_trial, OTE:non-randomized_clinical_trial, OTE:phase_I_trial, OTE:phase_I_II_trial, OTE:phase_IV_trial, OTE:phase_IIa_trial, OTE:phase_III_trial, OTE:randomized_clinical_trial_, OTE:phase_IIIb_trial, OTE:phase_II_III_trial, OTE:phase_IIIa_trial, OTE:phase_IIb_trial, OTE:phase_II_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SJD_C32_Zebrafish" name="SJD/C32 Zebrafish">
        <Definition>A wild-type zebrafish line.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SJD/C32 Zebrafish</Term>
        <Term>SJD/C32</Term>
        <Codes>
          <Code code="C79988" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:patient_education_handout" name="patient education handout">
        <Definition>Works consisting of a handout or self-contained informative material used to explain a procedure or a condition or the contents of a specific article in a biomedical journal and written in non-technical language for the patient or consumer.</Definition>
        <Definition>Works consisting of a handout or self-contained informative material used to explain a procedure or a condition or the contents of a specific article in a biomedical journal and written in non-technical language for the patient or consumer. [MeSH_2014]</Definition>
        <SemanticType code="T073" name="Manufactured Object"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">patient education handout</Term>
        <Term>Patient Education Handout</Term>
        <Term>Consumer Information Handout</Term>
        <Term>patient education handouts</Term>
        <Term>Consumer Handout</Term>
        <Codes>
          <Code code="C0949915" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Young_Adult" name="Young Adult">
        <Definition>An indefinite term describing a person who has reached sexual maturity but whose character and personality are still developing. In psychology this generally covers the age range of 20-40.</Definition>
        <Definition>A person between 19 and 24 years of age.</Definition>
        <SemanticType code="T100" name="Age Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Young Adult</Term>
        <Term>ADULT, YOUNG</Term>
        <Term>Adult, Young</Term>
        <Term>young adult</Term>
        <Term>Young adults</Term>
        <Term>Adult Youth</Term>
        <Term>Young Adults</Term>
        <Term>Adults, Young</Term>
        <Term>Young Adult [Disease/Finding]</Term>
        <Codes>
          <Code code="C0238598" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Adults</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:head_to_head_design" name="head to head design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">head to head design</Term>
        <Term>head-to-head designs</Term>
        <Term>head to head studies</Term>
        <Term>head to head trials</Term>
        <Term>head to head trial</Term>
        <Term>head-to-head study</Term>
        <Term>head-to-head studies</Term>
        <Term>head-to-head trials</Term>
        <Term>head-to-head design</Term>
        <Term>head to head study</Term>
        <Term>head-to-head trial</Term>
        <Term>head to head designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#head_to_head_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:retracted_publication" name="retracted publication">
        <Definition>Work consisting of the designation of an article or book as retracted in whole or in part by an author or authors or an authorized representative. It identifies a citation previously published and now retracted through a formal issuance from the author, publisher, or other authorized agent, and is distinguished from RETRACTION OF PUBLICATION, which identifies the citation retracting the original published item.</Definition>
        <Definition>Work consisting of the designation of an article or book as retracted in whole or in part by an author or authors or an authorized representative. It identifies a citation previously published and now retracted through a formal issuance from the author, publisher, or other authorized agent, and is distinguished from RETRACTION OF PUBLICATION, which identifies the citation retracting the original published item. [MeSH_2014]</Definition>
        <Definition>Work consisting of a statement issued by one or more authors of an article or a book, withdrawing or disavowing acknowledgment of their participation in performing research or writing the results of their study. In indexing, the retraction is sent to the editor of the publication in which the article appeared and is published under the rubric "retraction" or in the form of a letter. This publication type designates the author's statement of retraction: it should be differentiated from RETRACTED PUBLICATION which labels the retracted publication.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">retracted publication</Term>
        <Term>Retraction of Publication</Term>
        <Term>Retracted Publication</Term>
        <Term>retracted publications</Term>
        <Codes>
          <Code code="C0282432" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:retrospective_case_control_design" name="retrospective case control design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">retrospective case control design</Term>
        <Term>retrospective case-control trial</Term>
        <Term>retrospective case-control trials</Term>
        <Term>retrospective case-control designs</Term>
        <Term>retrospective case control trials</Term>
        <Term>retrospective case control study</Term>
        <Term>retrospective case-control studies</Term>
        <Term>retrospective case control designs</Term>
        <Term>retrospective case-control study</Term>
        <Term>retrospective case control trial</Term>
        <Term>retrospective case control studies</Term>
        <Term>retrospective case-control design</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#retrospective_case_control_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:retrospective_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:recombinant_soluble_CD4" name="recombinant soluble CD4">
        <Definition>A recombinant form of CD4 antigen with anti-HIV application. Recombinant soluble T4 antigen (rsT4) is derived from cell surface antigen CD4 lacking its transmembrane and cytoplasmic domains, thereby the agent is mobile within tissues. rsT4 binds to the envelope glycoprotein gp110 of HIV and prevents the binding of virus to CD4 positive lymphocytes, resulting in an inhibition of virus infectivity.</Definition>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">recombinant soluble CD4</Term>
        <Term>soluble CD4</Term>
        <Term>sT4 (recombinant)</Term>
        <Term>soluble T4</Term>
        <Codes>
          <Code code="C0210233" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD4</Relation>
          <Relation name="Narrower">OTE:SK_F_106528</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:non-randomized_design" name="non-randomized design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">non-randomized design</Term>
        <Term>nonrandomised designs</Term>
        <Term>nonrandomised study</Term>
        <Term>nonrandomized study</Term>
        <Term>non-randomised design</Term>
        <Term>non-randomised trials</Term>
        <Term>nonrandomised trials</Term>
        <Term>non-randomized trials</Term>
        <Term>nonrandomized design</Term>
        <Term>nonrandomized studies</Term>
        <Term>non-randomised study</Term>
        <Term>non-randomized designs</Term>
        <Term>non-randomized study</Term>
        <Term>non-randomised trial</Term>
        <Term>non-randomized trial</Term>
        <Term>non-randomised designs</Term>
        <Term>nonrandomized trials</Term>
        <Term>non-randomized studies</Term>
        <Term>nonrandomised studies</Term>
        <Term>nonrandomised trial</Term>
        <Term>nonrandomized trial</Term>
        <Term>nonrandomized designs</Term>
        <Term>nonrandomised design</Term>
        <Term>non-randomised studies</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#non-randomized_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:quantitative_study" name="quantitative study">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">quantitative study</Term>
        <Term>quantitative studies</Term>
        <Term>numerical study</Term>
        <Term>quantitative design</Term>
        <Term>numerical studies</Term>
        <Term>quantitative designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#quantitative_study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:in_vivo_study" name="in vivo study">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">in vivo study</Term>
        <Term>in vivo design</Term>
        <Term>in vivo designs</Term>
        <Term>in vivo studies</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#in_vivo" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL2RB_protein_human" name="IL2RB protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL2RB protein, human</Term>
        <Term>CD112 antigen, human</Term>
        <Term>interleukin 2 receptor, beta protein, human</Term>
        <Codes>
          <Code code="C1259013" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_2_Receptor_beta</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ptprc_protein_mouse" name="Ptprc protein, mouse">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ptprc protein, mouse</Term>
        <Term>protein tyrosine phosphatase, receptor type C protein, mouse</Term>
        <Term>Ly-5 antigen, mouse</Term>
        <Term>CD45 antigen, mouse</Term>
        <Term>protein tyrosine phosphatase, receptor type, C protein, mouse</Term>
        <Codes>
          <Code code="C1870007" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD45_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:randomized_clinical_trial" name="randomized clinical trial">
        <Definition>A study in which the participants are assigned by chance to separate groups that compare different treatments; neither the researchers nor the participants can choose which group. Using chance to assign people to groups means that the groups will be similar and that the treatments they receive can be compared objectively. At the time of the trial, it is not known which treatment is best. It is the patient's choice to be in a randomized trial. [NCIT_14.05d] </Definition>
        <Definition>Used for original reports of prospective clinical studies in which the (comparative) efficacy of one or more medical interventions in humans is evaluated; also used for prospective clinical veterinary trials in which the (comparative) efficacy of one or more medical interventions in animals is evaluated. [Clinical trial | Embase_2014]</Definition>
        <Definition>Used as a drug subheading when the clinical trial of a drug is reported. [Clinical trial | Embase_2014]</Definition>
        <Definition>A study in which the participants are assigned by chance to separate groups that compare different treatments; neither the researchers nor the participants can choose which group. Using chance to assign people to groups means that the groups will be similar and that the treatments they receive can be compared objectively. At the time of the trial, it is not known which treatment is best. It is the patient's choice to be in a randomized trial.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">randomized clinical trial</Term>
        <Term>randomised clinical designs</Term>
        <Term>Trials, Randomized Clinical</Term>
        <Term>randomized clinical trials</Term>
        <Term>randomised clinical trial</Term>
        <Term>Clinical Trials, Randomized</Term>
        <Term>randomised clinical study</Term>
        <Term>randomised clinical design</Term>
        <Term>randomized clinical designs</Term>
        <Term>Randomized Clinical Trials</Term>
        <Term>randomised clinical studies</Term>
        <Term>clinical randomized trials</Term>
        <Term>randomised clinical trials</Term>
        <Term>CLIN TRIALS RANDOMIZED</Term>
        <Term>randomized clinical design</Term>
        <Term>TRIALS RANDOMIZED CLIN</Term>
        <Term>randomized clinical studies</Term>
        <Term>Randomized Clinical Trial</Term>
        <Term>clinical randomize trials</Term>
        <Term>randomized clinical study</Term>
        <Codes>
          <Code code="C0206034" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:randomized_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IgG2c_receptor" name="IgG2c receptor">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IgG2c receptor</Term>
        <Term>immunoglobulin G2c receptor</Term>
        <Codes>
          <Code code="C0913472" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:KIR2DL4_protein_human" name="KIR2DL4 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">KIR2DL4 protein, human</Term>
        <Term>killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 protein, human</Term>
        <Term>CD158D antigen, human</Term>
        <Codes>
          <Code code="C1741806" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_KIR2DL4</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BB_Rat_Strain" name="BB, Rat Strain">
        <Definition>BB: The development of lymphocytic thyroiditis is not affected by iodine treatment according to Allen (1992), though Ebner et al (1992) found the opposite. Epitope specificities of collagen-induced arthritis studied by Cremer et al (1992). A lymphopenic, nondiabetic substrain BB-DR has very low T-cell numbers, depressed B-lymphocyte numbers and a complete absence of peripheral CD8+ T cells characteristics of the susceptible BB strain(Joseph et al 1993). Transfusing of BB-DR thymocytes into nude rats transfers the autoimmune insulin-dependent diabetes mellitus (Whalen et al 1995).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BB, Rat Strain</Term>
        <Codes>
          <Code code="C14394" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:AKR_N_Mouse" name="AKR/N Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">AKR/N Mouse</Term>
        <Term>AKR/N</Term>
        <Codes>
          <Code code="C37355" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Domestic_Short_Hair_Cat" name="Domestic Short Hair Cat">
        <Definition>The name for a short-haired cat that does not have a pedigree nor belong to a specific cat breed.</Definition>
        <Definition>The name for a short-haired cat that does not have a pedigree nor belong to a specific cat breed. The domestic short-hair cat is a small carnivorous crepuscular mammal that has short fur length and is more slender and active than the domestic long-haired cat. It may have varied coat length and coat color in a single or multi-colored pattern. The domestic short-hair cat has a flexible, compact body and long tail that enhances balance, as well as keen eyesight and retractable claws. The female cat exhibits high fecundity; sexual maturation in the female occurs between 6-12 months of age, producing up to 3 litters of 4-8 kittens per year. Male domestic long-hair cats become sexually mature at 9-22 months. The gestational period of the cat embryo is 63-65 days and the average lifespan of a domestic short haired cat is 10-15 years. The domestic short-hair cat is used most commonly in medical research involving viral pathogenesis and vaccination studies.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Domestic Short Hair Cat</Term>
        <Term>DOMESTIC SHORT HAIR</Term>
        <Term>Domestic Short Hair</Term>
        <Codes>
          <Code code="C2699798" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Felidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:PERA_EiJ_Mouse" name="PERA/EiJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">PERA/EiJ Mouse</Term>
        <Term>PERA/EiJ</Term>
        <Codes>
          <Code code="C37428" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Il2rb_protein_mouse" name="Il2rb protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Il2rb protein, mouse</Term>
        <Term>CD122 antigen, mouse</Term>
        <Term>interleukin 2 receptor, beta chain protein, mouse</Term>
        <Term>IL-15Rbeta protein, mouse</Term>
        <Term>Il-2Rbeta protein, mouse</Term>
        <Codes>
          <Code code="C1701899" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_2_Receptor_beta</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NOD_LtJ_Mouse" name="NOD/LtJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NOD/LtJ Mouse</Term>
        <Term>NOD/LtJ</Term>
        <Codes>
          <Code code="C37419" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BN_Rat_Strain" name="BN, Rat Strain">
        <Definition>The common rat, Rattus norvegicus.</Definition>
        <Definition>Originally from China and now ubiquitous, Rattus norvegicus is the founder strain for many strains of rat used in biomedical research today. The brown rat has a coarse brown or black coat with a pale underside, and a long nearly hairless tail. Tumors of epithelium 28% in males, 2% in females. Ureter tumors 20% in females, 6% in males. Most common neoplastic lesions in males were urinary bladder carcinoma 35%, pancreas islet adenoma 15%, pituitary adenoma 14%, lymphoreticular sarcoma 14%, adrenal cortex adenoma 12%, medullary thyroid carcinoma 9%, adrenal pheochromocytoma 8%. Four other types of tumors were observed. In females: pituitary adenoma 26%, ureter carcinoma 22%, adrenal cortical adenoma 19%, cervix sarcoma 15%, mammary gland fibroadenoma 11%, islet adenoma 11%. Twelve other tumor types were observed (Burek and Hollander 1975a).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BN, Rat Strain</Term>
        <Term>BROWN NORWAY</Term>
        <Term>Brown Norway Rat</Term>
        <Codes>
          <Code code="C14395" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FASLG_protein_human" name="FASLG protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FASLG protein, human</Term>
        <Term>Fas ligand (TNF superfamily, member 6), human</Term>
        <Term>FASL protein, human</Term>
        <Term>CD178 protein, human</Term>
        <Term>TNFSF6 protein, human</Term>
        <Term>APT1LG1 protein, human</Term>
        <Codes>
          <Code code="C1675724" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Necrosis_Factor_Ligand_Superfamily_Member_6</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Kidney_Transplantation" name="Kidney Transplantation">
        <Definition>The transference of a kidney from one human or animal to another.</Definition>
        <Definition>The transfer of a healthy kidney from a donor to a patient for the purpose of replacing one of the failing kidneys of the patient.</Definition>
        <Definition>transference of a kidney within an individual, between individuals of the same species, or between individuals of different species.</Definition>
        <Definition>&lt;p&gt;A kidney transplant is an operation that places a healthy kidney in your body. The transplanted kidney takes over the work of the two kidneys that &lt;a href='http://www.nlm.nih.gov/medlineplus/kidneyfailure.html'&gt;failed&lt;/a&gt;, so you no longer need &lt;a href='http://www.nlm.nih.gov/medlineplus/dialysis.html'&gt;dialysis&lt;/a&gt;. &lt;/p&gt;&lt;p&gt;During a transplant, the surgeon places the new kidney in your lower abdomen and connects the artery and vein of the new kidney to your artery and vein. Often, the new kidney will start making urine as soon as your blood starts flowing through it. But sometimes it takes a few weeks to start working. &lt;/p&gt;&lt;p&gt;Many transplanted kidneys come from donors who have died. Some come from a living family member. The wait for a new kidney can be long.&lt;/p&gt;&lt;p&gt;If you have a transplant, you must take drugs for the rest of your life, to keep your body from rejecting the new kidney.&lt;/p&gt;&lt;p &gt;NIH: National Institute of Diabetes and Digestive and Kidney Diseases&lt;/p&gt;</Definition>
        <SemanticType code="T058" name="Health Care Activity"/>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Kidney Transplantation</Term>
        <Term>Renal Transplantations</Term>
        <Term>renal transplant (treatment)</Term>
        <Term>TRANSPLANTATION OF KIDNEY</Term>
        <Term>Transplantations, Kidney</Term>
        <Term>Renal Transplantation Procedures</Term>
        <Term>Grafting, Kidney</Term>
        <Term>RENAL TRANSPLANT</Term>
        <Term>Kidney Grafting</Term>
        <Term>Transplantations, Renal</Term>
        <Term>TRANSPL KIDNEY</Term>
        <Term>Renal Transplantation</Term>
        <Term>RENAL ALTRNSPLJ IMPLTJ GRF W/RCP NEPHRECTOMY</Term>
        <Term>Kidney transplant</Term>
        <Term>KIDNEY: TRANSPLANTATIONS AND TRANSPOSITIONS</Term>
        <Term>Structure of transplanted kidney (body structure)</Term>
        <Term>Transplant of kidney</Term>
        <Term>Renal transplantation</Term>
        <Term>Renal allotransplantation, implantation of graft; without recipient nephrectomy</Term>
        <Term>Transplantation of kidney</Term>
        <Term>kidneys transplants</Term>
        <Term>Transplant kidney</Term>
        <Term>kidneys transplant</Term>
        <Term>Kidney Transplant</Term>
        <Term>Structure of transplanted kidney</Term>
        <Term>RENAL TRANSPL</Term>
        <Term>presence; kidney transplant</Term>
        <Term>kidney transplantation</Term>
        <Term>transplanted kidney</Term>
        <Term>Kidney transplantation, NOS</Term>
        <Term>Transplant of kidney (procedure)</Term>
        <Term>renal transplant</Term>
        <Term>RENAL ALTRNSPLJ IMPLTJ GRF W/O RCP NEPHRECTOMY</Term>
        <Term>Kidney Transplantations</Term>
        <Term>Transplanted kidney</Term>
        <Term>Transplant;renal</Term>
        <Term>Renal allotransplantation, implantation of graft; with recipient nephrectomy</Term>
        <Term>Encounter due to Kidney transplanted</Term>
        <Term>Renal transplant</Term>
        <Term>Transplantation, Kidney</Term>
        <Term>renal transplantation</Term>
        <Term>Kidney replaced by transplant</Term>
        <Term>examination of transplanted kidney</Term>
        <Term>kidney transplant procedure</Term>
        <Term>KIDNEY TRANSPLANT</Term>
        <Term>Kidney Transplants</Term>
        <Term>KIDNEY TRANSPL</Term>
        <Term>Kidney transplant status</Term>
        <Term>Transplantation, Renal</Term>
        <Term>Transplant of kidney, NOS</Term>
        <Term>Kidneys--Transplantation</Term>
        <Term>Renal graft</Term>
        <Term>TRANSPL RENAL</Term>
        <Term>presence; graft, kidney</Term>
        <Term>kidney transplants</Term>
        <Term>kidney transplantation procedure</Term>
        <Term>Kidney transplantation</Term>
        <Term>Entire transplanted kidney</Term>
        <Term>1-71D KIDNEY: TRANSPLANTATIONS AND TRANSPOSITIONS</Term>
        <Term>Entire transplanted kidney (body structure)</Term>
        <Term>Renal transplant, NOS</Term>
        <Term>kidney transplant</Term>
        <Term>Tx - Kidney transplantation</Term>
        <Term>Tx - Renal transplantation</Term>
        <Term>renal graft</Term>
        <Term>kidney transplanted</Term>
        <Term>renal transplants</Term>
        <Term>transplanted kidney (physical finding)</Term>
        <Codes>
          <Code code="C0372303" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Organ_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:PTPNS1_protein_human" name="PTPNS1 protein, human">
        <Definition>Encoded as 3 isoforms by human PTPNS1 Gene (SIRP/Ig Families), ubiquitous (high in brain) N-glycosylated Tyrosine Phosphatase SHP Substrate 1 is a type I membrane protein cell surface CD47 receptor that contains an Ig-V-type and 2 Ig-C1-type domains. A negative receptor tyrosine kinase regulator to cell adhesion, growth factors, or insulin and phosphorylated by receptor signal transduction, PTPNS1 recruits SH2 domain PTPs as signaling PTP substrates. PTPNS1 induces membrane translocation of PTPN6, -11, and other cytosolic partners; negatively regulates phagocytosis, mast cell activation, and dendritic cell activation/maturation; and regulates neural adhesion, neurite outgrowth, glial attachment, synaptogenesis, and synaptic function. Dephosphorylated by PTPN11 (PTPN6 in macrophages), PTPNS1 appears to bind GRB2, PTK2B, and FGR; forms a stable complex with JAK2; and binds SCAP1/SCAP2, recruiting FYB. (NCI)</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">PTPNS1 protein, human</Term>
        <Term>SIRPalpha2 protein, human</Term>
        <Term>protein tyrosine phosphatase, non-receptor type substrate 1, human</Term>
        <Term>signal-regulatory protein alpha, human</Term>
        <Term>SIRPA protein, human</Term>
        <Term>SIRPalpha1 protein, human</Term>
        <Term>SHPS1 protein, human</Term>
        <Term>signal-regulatory protein alpha-1, human</Term>
        <Term>SHPS-1 protein, human</Term>
        <Term>CD172a protein, human</Term>
        <Codes>
          <Code code="C0671702" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NCAM1_protein_human" name="NCAM1 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NCAM1 protein, human</Term>
        <Term>neural cell adhesion molecule 1 protein, human</Term>
        <Term>CD56 antigen, human</Term>
        <Term>CD56 protein, human</Term>
        <Codes>
          <Code code="C1999531" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD56</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ncr3_protein_mouse" name="Ncr3 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ncr3 protein, mouse</Term>
        <Term>Ly117 antigen, mouse</Term>
        <Term>natural cytotoxicity triggering receptor 3 protein, mouse</Term>
        <Codes>
          <Code code="C2351873" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:HK_AB_Zebrafish" name="HK/AB Zebrafish">
        <Definition>A wild-type zebrafish line that is a hybrid of the Hong Kong and AB wild-type lines.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">HK/AB Zebrafish</Term>
        <Term>HK/AB</Term>
        <Codes>
          <Code code="C79972" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Nude_Mouse" name="Nude Mouse">
        <Definition>A hairless mutant mouse with thymic hypoplasia, lacking T-cells. They are unable to reject transplants.</Definition>
        <Definition>A type of laboratory mouse that is hairless, lacks a normal thymus gland, and has a defective immune system because of a genetic mutation.  Athymic, nude mice are often used in cancer research because they do not reject tumor cells, from mice or other species.</Definition>
        <Definition>A hairless mutant mouse with thymic hypoplasia, lacking T-cells.  They are unable to reject transplants.</Definition>
        <Definition>mutant mouse homozygous for the recessive gene, nude, which fail to develop a thymus.</Definition>
        <Definition>Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.</Definition>
        <Definition>A type of laboratory mouse that is hairless, lacks a normal thymus gland, and has a defective immune system because of a genetic mutation. Athymic, nude mice are often used in cancer research because they do not reject tumor cells, from mice or other species.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Nude Mouse</Term>
        <Term>athymic mouse</Term>
        <Term>nude mice</Term>
        <Term>mice nude</Term>
        <Term>Nude Mice</Term>
        <Term>Mice, Athymic</Term>
        <Term>Athymic Mouse</Term>
        <Term>Mouse, Nude</Term>
        <Term>Athymic Nude Mouse</Term>
        <Term>Nude</Term>
        <Term>Athymic Mice</Term>
        <Term>nude mouse</Term>
        <Term>Mouse, Athymic</Term>
        <Term>athymic, nude mouse</Term>
        <Term>Mice, Nude</Term>
        <Term>Nude mouse</Term>
        <Codes>
          <Code code="C14239" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Immunodeficient_Mouse</Relation>
          <Relation name="Narrower">OTE:NU_J_Foxn1-nu_Mouse, OTE:BALB_c_Nude_Mouse, OTE:NU_NU_Mouse, OTE:B6_Cg-Foxn1-nu_Mouse, OTE:CBy_Cg-Foxn1-nu, OTE:CD-1_Nude_Mouse, OTE:CByB6F1_J-Foxn1-nu_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd101_protein_mouse" name="Cd101 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd101 protein, mouse</Term>
        <Term>Igsf2 protein, mouse</Term>
        <Term>immunoglobulin superfamily, member 2 protein, mouse</Term>
        <Term>Cd101 antigen, mouse</Term>
        <Term>EWI-101 protein, mouse</Term>
        <Codes>
          <Code code="C1570814" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ST_bJ_Mouse" name="ST/bJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ST/bJ Mouse</Term>
        <Term>ST/bJ</Term>
        <Codes>
          <Code code="C37441" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:field_survey" name="field survey">
        <Definition>A descriptive or analytic study of risk factors or disease determinants in populations. Most epidemiologic and some genetic studies fit within this category.</Definition>
        <Definition>A descriptive or analytic study of risk factors or disease determinants in populations. Most epidemiologic and some genetic studies fit within this category. [NCIT_14.08d]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">field survey</Term>
        <Term>field surveys</Term>
        <Term>Field Survey</Term>
        <Codes>
          <Code code="C1517184" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:survey</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Lag3_protein_mouse" name="Lag3 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Lag3 protein, mouse</Term>
        <Term>lymphocyte-activation gene 3 protein, mouse</Term>
        <Term>CD223 protein, mouse</Term>
        <Codes>
          <Code code="C1451296" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD223_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Infants_Newborn" name="Infants, Newborn">
        <Definition>an infant human from birth through 6 weeks of age; also index with appropriate human and clinical research terms.</Definition>
        <Definition>An infant during the first month after birth.</Definition>
        <SemanticType code="T100" name="Age Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Infants, Newborn</Term>
        <Term>Newborn Infants</Term>
        <Term>Newborns</Term>
        <Term>Newborn</Term>
        <Term>Newborn Infant</Term>
        <Term>Neonates</Term>
        <Term>Neonate</Term>
        <Term>Infant, Newborn</Term>
        <Codes>
          <Code code="C0021289" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Infant</Relation>
          <Relation name="Narrower">OTE:Infants_Premature, OTE:Infant_Low_Birth_Weight, OTE:Infant_Postmature</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:letter" name="letter">
        <Definition>A written message addressed to a person or organization. [NCIT_14.05d] [Contributing_Source_ FDA]</Definition>
        <Definition>A written message addressed to a person or organization.</Definition>
        <Definition>Work consisting of written or printed communication between individuals or between persons and representatives of corporate bodies. The correspondence may be personal or professional. In medical and other scientific publications the letter is usually from one or more authors to the editor of the journal or book publishing the item being commented upon or discussed. LETTER is often accompanied by COMMENT. [MeSH_2014]</Definition>
        <Definition>Work consisting of written or printed communication between individuals or between persons and representatives of corporate bodies. The correspondence may be personal or professional. In medical and other scientific publications the letter is usually from one or more authors to the editor of the journal or book publishing the item being commented upon or discussed. LETTER is often accompanied by COMMENT.</Definition>
        <SemanticType code="T201" name="Clinical Attribute"/>
        <SemanticType code="T073" name="Manufactured Object"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">letter</Term>
        <Term>Letter:Find:Pt:{Setting}:Doc:{Provider}</Term>
        <Term>Letter:Finding:Point in time:{Setting}:Document:{Provider}</Term>
        <Term>letter [publication type]</Term>
        <Term>Letter</Term>
        <Term>Letter [Publication Type]</Term>
        <Term>Collected Correspondence</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#letter" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
          <Relation name="Narrower">OTE:letter_to_the_editor</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:qualitative_study" name="qualitative study">
        <Definition>Any type of research that employs nonnumeric information to explore individual or group characteristics, producing findings not arrived at by statistical procedures or other quantitative means. (Qualitative Inquiry: A Dictionary of Terms Thousand Oaks, CA: Sage Publications, 1997)</Definition>
        <Definition>Research that derives data from observation, interviews, or verbal interactions and focuses on the meanings and interpretations of the participants (From Holloway and Wheeler, "Ethical issues in qualitative nursing research," Nursing Ethics, 1995 Sep; 2(3): 223-232). [MeSH_2014]</Definition>
        <Definition>A type of research methodology that produces descriptive data, with little emphasis given to numerical quantification. Used only when the methodology or research itself is the focus of discussion.</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">qualitative study</Term>
        <Term>qualitative designs</Term>
        <Term>qualitative research</Term>
        <Term>Research, Qualitative</Term>
        <Term>research qualitative</Term>
        <Term>qualitative design</Term>
        <Term>Qualitative Research</Term>
        <Term>Qualitative research</Term>
        <Term>qualitative studies</Term>
        <Codes>
          <Code code="C0949415" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:6-O-sulfo_de-N-acetylsialyl_Lewis_X" name="6-O-sulfo de-N-acetylsialyl Lewis X">
        <SemanticType code="T118" name="Carbohydrate"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">6-O-sulfo de-N-acetylsialyl Lewis X</Term>
        <Term>6-O-sulfo de-N-acetylsialyl Le(X)</Term>
        <Codes>
          <Code code="C0969136" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD15_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Hormones_Ectopic" name="Hormones, Ectopic">
        <Definition>Hormones released from neoplasms or from other cells that are not the usual sources of hormones.</Definition>
        <SemanticType code="T125" name="Hormone"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Hormones, Ectopic</Term>
        <Term>Ectopic Hormones</Term>
        <Codes>
          <Code code="C0019933" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
          <Relation name="Narrower">OTE:resistin-like_gamma_mouse, OTE:resistin-like_gamma_rat, OTE:Retnlb_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129X1_SvJ_Mouse" name="129X1/SvJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129X1/SvJ Mouse</Term>
        <Term>129X1/SvJ</Term>
        <Term>129X1</Term>
        <Term>129/SvJ</Term>
        <Codes>
          <Code code="C14579" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Programmed_Cell_Death_1_Protein" name="Programmed Cell Death 1 Protein">
        <Definition>An inhibitory T-lymphocyte receptor that has specificity for CD274 ANTIGEN and PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN. Signaling by the receptor limits T cell proliferation and INTERFERON GAMMA synthesis. The receptor also may play an essential role in the regulatory pathway that induces PERIPHERAL TOLERANCE.</Definition>
        <Definition>Programmed cell death protein 1 (288 aa, ~32 kDa) is encoded by the human PDCD1 gene. This protein is involved in the regulation of apoptosis.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Programmed Cell Death 1 Protein</Term>
        <Term>PD1 Receptor</Term>
        <Term>Programmed Cell Death Protein 1</Term>
        <Term>hPD-1</Term>
        <Term>Antigen, CD279</Term>
        <Term>CD279</Term>
        <Term>CD279 Antigen</Term>
        <Term>Protein PD-1</Term>
        <Term>Receptor, PD-1</Term>
        <Term>Programmed Cell Death 1 Receptor</Term>
        <Term>PD-1 Receptor</Term>
        <Term>PD 1 Receptor</Term>
        <Term>Antigens, CD279</Term>
        <Term>Antigen CD279</Term>
        <Term>Programmed Cell Death 1 Receptor [Chemical/Ingredient]</Term>
        <Term>CD279 Antigens</Term>
        <Term>Receptor, PD1</Term>
        <Codes>
          <Code code="C2986635" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Pdcd1_protein_mouse, OTE:PDCD1_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:RIII_2J_Mouse" name="RIII/2J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">RIII/2J Mouse</Term>
        <Term>RIII/2J</Term>
        <Codes>
          <Code code="C37432" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Double_Lung_Transplantation" name="Double Lung Transplantation">
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Double Lung Transplantation</Term>
        <Term>DLTx - Double lung transplant</Term>
        <Term>Double-lung transplantation</Term>
        <Term>LUNG TRANSPLANT 2 W/O CARDIOPULMONARY BYPASS</Term>
        <Term>LUNG TRANSPLANT DOUBLE</Term>
        <Term>Lung transplant, double (bilateral sequential or en bloc); without cardiopulmonary bypass</Term>
        <Term>a double lung transplantation</Term>
        <Term>Double lung transplant</Term>
        <Term>Bilateral lung transplantation</Term>
        <Term>Double Lung Transplant</Term>
        <Term>Double lung transplant (procedure)</Term>
        <Term>double lung transplantation</Term>
        <Term>Lung transplant double</Term>
        <Term>double lung transplant</Term>
        <Term>double lung transplantation (treatment)</Term>
        <Term>Bilat lung transplant</Term>
        <Codes>
          <Code code="C0371482" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Lung_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin_5_Receptor_alpha_Subunit" name="Interleukin 5 Receptor alpha Subunit">
        <Definition>A low affinity interleukin-5 receptor subunit that combines with the CYTOKINE RECEPTOR COMMON BETA SUBUNIT to form a high affinity receptor for INTERLEUKIN-5. Several isoforms of the interleukin-5 receptor alpha subunit exist due to multiple ALTERNATIVE SPLICING.</Definition>
        <Definition>Interleukin-5 receptor subunit alpha (420 aa, 48 kD) is a cell division process protein that is encoded by the human IL5RA gene and has roles in cell proliferation and signal transduction.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin 5 Receptor alpha Subunit</Term>
        <Term>IL5RA</Term>
        <Term>Interleukin 5 Receptor Alpha</Term>
        <Term>Interleukin 5 Receptor alpha Chain</Term>
        <Term>Interleukin-5 Receptor alpha Chain</Term>
        <Term>Interleukin 5 Receptor</Term>
        <Term>Receptor, Interleukin-5, alpha Subunit</Term>
        <Term>Antigen, CD125</Term>
        <Term>Interleukin-5 Receptor alpha Subunit</Term>
        <Term>Interleukin 5 Receptor, Alpha</Term>
        <Term>Antigens, CD125</Term>
        <Term>Interleukin 5 Receptor Alpha Subunit</Term>
        <Term>Interleukin-5 Receptor alpha Subunit [Chemical/Ingredient]</Term>
        <Term>alpha-Subunit, Receptor, Interleukin-5</Term>
        <Term>CD125 Antigen</Term>
        <Term>CD125 Antigens</Term>
        <Term>CD125</Term>
        <Term>INTERLEUKIN 005 RECEPTOR ALPHA SUBUNIT</Term>
        <Term>Interleukin 5 Receptor Type 3</Term>
        <Term>Interleukin-5 Receptor Subunit Alpha</Term>
        <Term>CD 125 ANTIGENS</Term>
        <Term>ANTIGENS CD 125</Term>
        <Codes>
          <Code code="C1704269" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:interleukin-5-_receptor_alpha_mouse, OTE:IL5RA_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Therapeutic_Drug_Monitoring" name="Therapeutic Drug Monitoring">
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Therapeutic Drug Monitoring</Term>
        <Term>Encounter for therapeutic drug monitoring</Term>
        <Term>Encounter for therapeutic drug level monitoring</Term>
        <Term>Drug Monitoring, Therapeutic</Term>
        <Term>Monitoring, Therapeutic Drug</Term>
        <Term>Therapeutic drug monitor</Term>
        <Codes>
          <Code code="C2910943" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Drug_Monitoring</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD1d_antigen_mouse" name="CD1d antigen, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD1d antigen, mouse</Term>
        <Term>antigen-presenting glycoprotein CD1d1, mouse</Term>
        <Codes>
          <Code code="C3711492" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD1d</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:systematic_review_" name="systematic review'">
        <Definition>Work in which the author outlines a systematic approach to the relevant literature as part of the review.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">systematic review'</Term>
        <Term>Review, Systematic</Term>
        <Term>reviews systematic</Term>
        <Term>review systematic</Term>
        <Term>systematic review</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#systematic_review'" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:review_of_literature_</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fish" name="Fish">
        <Definition>A group of cold-blooded, aquatic vertebrates having gills, fins, a cartilaginous or bony endoskeleton, and elongated bodies covered with scales.</Definition>
        <Definition>A grouping of jawed and jawless vertebrate animals usually having fins and a covering of scales or plates, breathing by means of gills, and living almost entirely in the water.</Definition>
        <Definition>fish with lateral fins, gills in separate gill clefts, skin covered with placoid scales, cartilaginous skeleton, no bone present and spriacles connecting to pharynx; most are marine.</Definition>
        <Definition>Any jawed or jawless organisms in the phylum Chordata including the jawless fish, armored fish, cartilaginous fish, ray-finned fish and lobe-finned fish.</Definition>
        <Definition>A group of invertebrate chordates (CHORDATA, NONVERTEBRATE) in the subphylum Craniota. They include the single order Myxiniformes, which comprise various HAGFISHES.</Definition>
        <Definition>any of numerous cold-blooded strictly aquatic craniate vertebrates that include the bony fishes and usually the cartilaginous and jawless fishes and that have typically an elongated somewhat spindle-shaped body terminating in a broad caudal fin, limbs in the form of fins when present at all, and a 2-chambered heart by which blood is sent through thoracic gills to be oxygenated.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <SemanticType code="T109" name="Organic Chemical"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fish</Term>
        <Term>Class Chondrichthyes</Term>
        <Term>pisces</Term>
        <Term>Class Chondrichthyes (organism)</Term>
        <Term>Fishes</Term>
        <Term>Dipnoi</Term>
        <Term>Hyperotretus</Term>
        <Term>CLASS CHONDRICHTHYES - CARTILAGINOUS FISHES</Term>
        <Term>Fish extract</Term>
        <Term>FISH</Term>
        <Term>Fish, NOS</Term>
        <Term>fish &lt;Hyperoartia&gt;</Term>
        <Term>fish &lt;Chondrichthyes&gt;</Term>
        <Term>Chondrichthyes</Term>
        <Term>Actinistia</Term>
        <Term>lobe-finned fishes</Term>
        <Term>cartilaginous fish</Term>
        <Term>Pisces</Term>
        <Term>Finfish</Term>
        <Term>Dipneusti</Term>
        <Term>fish &lt;Actinopterygii&gt;</Term>
        <Term>fish &lt;Hyperotreti&gt;</Term>
        <Term>Actinopterygi</Term>
        <Term>Hyperoartia</Term>
        <Term>Hyperotreti</Term>
        <Term>cartilaginous fishes</Term>
        <Term>fish</Term>
        <Term>lobe-finned fishes &lt;coelacanthimorph&gt;</Term>
        <Term>SECTION C FISHES</Term>
        <Term>Fish (NOS)</Term>
        <Term>Cartilaginous fish</Term>
        <Term>Coelacanthimorpha</Term>
        <Term>dipnoans</Term>
        <Term>Class Actinopterygii (organism)</Term>
        <Term>Class Actinopterygii</Term>
        <Term>Actinopterygii</Term>
        <Term>C03-C17 CLASS CHONDRICHTHYES - CARTILAGINOUS FISHES</Term>
        <Term>fish - EntityCode</Term>
        <Term>FISHES</Term>
        <Term>Fish (organism)</Term>
        <Term>fishes</Term>
        <Term>Dipnomorpha</Term>
        <Term>fish &lt;Dipnoi&gt;</Term>
        <Codes>
          <Code code="C0998806" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Vertebrata</Relation>
          <Relation name="Narrower">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cow" name="Cow">
        <Definition>Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.</Definition>
        <Definition>The domesticated ungulates, Bos primigenius taurus and Bos primigenius indicus.</Definition>
        <Definition>use to refer to Bos taurus, a domestic bovine animal regardless of sex or age.</Definition>
        <Definition>Domesticated bovine animals usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.</Definition>
        <Definition>Domesticated ungulates that are raised for beef, dairy products, and leather, and used for labor.</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T015" name="Mammal"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cow</Term>
        <Term>cortical white matter</Term>
        <Term>bulls</Term>
        <Term>Cows</Term>
        <Term>Cattle, cow</Term>
        <Term>allergy testing cow</Term>
        <Term>BOVINE SPECIES</Term>
        <Term>BOVINE</Term>
        <Term>Bovine Species</Term>
        <Term>Domestic Cow</Term>
        <Term>allergy testing cow (lab test)</Term>
        <Term>Cow antigen</Term>
        <Term>bull</Term>
        <Term>Bull</Term>
        <Term>Bos taurus Linnaeus, 1758</Term>
        <Term>Bos taurus</Term>
        <Term>Bovine species</Term>
        <Term>domestic cow</Term>
        <Term>Auroch</Term>
        <Term>Female adult cattle (organism)</Term>
        <Term>801 BOVINE SPECIES</Term>
        <Term>Bovine, NOS</Term>
        <Term>bovid</Term>
        <Term>Bulls</Term>
        <Term>Bos primigenius</Term>
        <Term>Bos primigenius taurus</Term>
        <Term>Cattle</Term>
        <Term>Bos bovis</Term>
        <Term>Bos primigenius Bojanus, 1827</Term>
        <Term>Cows, Domestic</Term>
        <Term>Bovine</Term>
        <Term>bovines</Term>
        <Term>cow</Term>
        <Term>Cattle (organism)</Term>
        <Term>bovine</Term>
        <Term>domestic cattle</Term>
        <Term>Female adult cattle</Term>
        <Term>Cow, Domestic</Term>
        <Term>Bos taurus (organism)</Term>
        <Term>Aurochs</Term>
        <Term>Domestic Cows</Term>
        <Term>Domestic cattle</Term>
        <Codes>
          <Code code="C1140701" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Bovidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Squirrel_Monkey" name="Squirrel Monkey">
        <Definition>A small diurnal primate with nails instead of claws, Saimiri sciureus.</Definition>
        <Definition>genus of the family Cebidae consisting of four species: S. boliviensis, S. orstedii (red-backed squirrel monkey), S. sciureus (common squirrel monkey), and S. ustus; they inhabit tropical rain forests in Central and South America; S. sciureus is used extensively in research studies.</Definition>
        <Definition>A genus of the family CEBIDAE consisting of four species: S. boliviensis, S. orstedii (red-backed squirrel monkey), S. sciureus (common squirrel monkey), and S. ustus. They inhabit tropical rain forests in Central and South America. S. sciureus is used extensively in research studies.</Definition>
        <Definition>A small diurnal primate with nails instead of claws, the Saimiri sciureus has close-cropped fur that is olive at the shoulders tending toward orange at the back, with a black mouth and white around its throat, ears, and eyes. The squirrel monkey's long tail is used primarily for balance and it has the largest brain, proportionally, of all the primates. Squirrel monkeys are used in a wide variety of biomedical research applications.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Squirrel Monkey</Term>
        <Term>Squirrel Monkeys</Term>
        <Term>Squirrel monkeys</Term>
        <Term>Saimiri (organism)</Term>
        <Term>Saimiri</Term>
        <Term>South American Squirrel Monkey</Term>
        <Term>Moss monkey</Term>
        <Term>Squirrel monkey</Term>
        <Term>Saimirus</Term>
        <Term>Genus Saimiri (organism)</Term>
        <Term>squirrel monkey</Term>
        <Term>Saimirii</Term>
        <Term>Monkeys, Squirrel</Term>
        <Term>Monkey, Squirrel</Term>
        <Term>SQUIRREL</Term>
        <Term>Squirrel</Term>
        <Term>Genus Saimiri</Term>
        <Term>Common Squirrel Monkey</Term>
        <Term>Saimiri, NOS</Term>
        <Term>Saimiri sciureus</Term>
        <Codes>
          <Code code="C77114" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Monkey</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:AKR_Mouse" name="AKR Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">AKR Mouse</Term>
        <Term>Mice, Inbred AKR</Term>
        <Term>Inbred AKR Mice</Term>
        <Term>Mice, AKR</Term>
        <Term>Inbred AKR Mouse</Term>
        <Term>Mouse, AKR</Term>
        <Term>AKR Mouse, Inbred</Term>
        <Term>Mouse, Inbred AKR</Term>
        <Term>AKR</Term>
        <Term>AKR Mice, Inbred</Term>
        <Term>AKR Mice</Term>
        <Codes>
          <Code code="C37354" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin_2_Receptor_beta" name="Interleukin 2 Receptor beta">
        <Definition>This gene is involved in the regulation of myeloid cell development.</Definition>
        <Definition>IL2 receptor beta (551 aa, 61 kD) is a cell communication process protein that is encoded by the human IL2RB gene and has a role in signal transduction.</Definition>
        <Definition>A receptor subunit that is a shared component of the INTERLEUKIN 2 RECEPTOR and the INTERLEUKIN-15 RECEPTOR. High affinity receptor complexes are formed with each of these receptors when their respective alpha subunits are combined with this beta subunit and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin 2 Receptor beta</Term>
        <Term>CD122</Term>
        <Term>Interleukin 2 Receptor beta Subunit</Term>
        <Term>CD122 Antigens</Term>
        <Term>Interleukin 2 Receptor, Beta Gene</Term>
        <Term>Interleukin-2-15 Receptor-beta</Term>
        <Term>INTERLEUKIN 2 RECEPTOR, BETA</Term>
        <Term>interleukin-2 receptor beta</Term>
        <Term>CD122 Antigen</Term>
        <Term>IL2 Receptor Beta</Term>
        <Term>Interleukin 2-15 Receptors-beta</Term>
        <Term>Interleukin-2 Receptor beta</Term>
        <Term>Interleukin 2, 15 Receptor beta Subunit</Term>
        <Term>INTERLEUKIN 002 RECEPTOR BETA SUBUNIT</Term>
        <Term>INTERLEUKIN 002 015 RECEPTOR BETA SUBUNIT</Term>
        <Term>IL 2R BETA</Term>
        <Term>Antigens, CD122</Term>
        <Term>Interleukin-Binding Peptide p75</Term>
        <Term>CD122 ANTIGEN</Term>
        <Term>Interleukin-2 Receptor beta Subunit [Chemical/Ingredient]</Term>
        <Term>Interleukin-2, 15 Receptor beta Subunit</Term>
        <Term>INTERLEUKIN 015 RECEPTOR BETA SUBUNIT</Term>
        <Term>IL-2Rbeta2</Term>
        <Term>ANTIGENS CD 122</Term>
        <Term>IL 2 15 Receptor beta</Term>
        <Term>Interleukin Binding Peptide p75</Term>
        <Term>Receptor-beta, IL-2-15</Term>
        <Term>CD 122 ANTIGENS</Term>
        <Term>IL 2Rbeta2</Term>
        <Term>Interleukin 15 Receptor beta Subunit</Term>
        <Term>IL2RB</Term>
        <Term>Interleukin 2 15 Receptor beta</Term>
        <Term>Interleukin-15 Receptor beta Subunit</Term>
        <Term>P70-75</Term>
        <Term>interleukin 2 receptor, beta</Term>
        <Term>Intermediate Affinity Interleukin 2 Receptor</Term>
        <Term>Interleukin-2 Receptor beta Chain</Term>
        <Term>IL-2R BETA</Term>
        <Term>Interleukin 2 Receptor Beta</Term>
        <Term>Medium Affinity Interleukin 2 Receptor</Term>
        <Term>IL-2-15 Receptor-beta</Term>
        <Term>IL2RB gene</Term>
        <Term>Interleukin 2 Receptor beta Chain</Term>
        <Term>Interleukin-2 Receptor beta Subunit</Term>
        <Term>IL2RB Gene</Term>
        <Term>Interleukin 2 15 Receptors beta</Term>
        <Codes>
          <Code code="C1173313" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Il2rb_protein_rat, OTE:IL2RB_protein_human, OTE:Il2rb_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Jew" name="Jew">
        <Definition>An ethnic group with historical ties to the land of ISRAEL and the religion of JUDAISM.</Definition>
        <SemanticType code="T098" name="Population Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Jew</Term>
        <Term>Jewish, follower of religion (person)</Term>
        <Term>Jewish, follower of religion</Term>
        <Term>jewish [follower of religion]</Term>
        <Term>jews</Term>
        <Term>Jews</Term>
        <Term>jewish</Term>
        <Term>Jewish</Term>
        <Term>jew</Term>
        <Term>JEWISH</Term>
        <Codes>
          <Code code="C0022389" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ethnic_Groups</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fcgr2b_protein_rat" name="Fcgr2b protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fcgr2b protein, rat</Term>
        <Term>Fc receptor, IgG, low affinity IIb protein, rat</Term>
        <Term>FcgammaRIIB protein, rat</Term>
        <Codes>
          <Code code="C1452606" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Intercellular_Adhesion_Molecule-1" name="Intercellular Adhesion Molecule-1">
        <Definition>A cell-surface ligand involved in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue.</Definition>
        <Definition>LFA-1 is a receptor for ICAM1, a surface molecule constitutively expressed on some tissues and induced on others in inflammation. The interaction of LFA-1 with ICAM provides essential accessory adhesion signals in many immune interactions, including those between T- and B-lymphocytes and cytotoxic T-cells and their targets.</Definition>
        <Definition>Similar to NCAM, ICAM-1 is a ligand for LFA antigens with a role in leukocyte adhesion and inflammation. Its production in a variety of cells is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue. ICAM-1 protein is the major human rhinovirus receptor. (from OMIM 147840 and NCI)</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Intercellular Adhesion Molecule-1</Term>
        <Term>Antigen, CD54</Term>
        <Term>Antigens, CD54</Term>
        <Term>CD54 Antigen</Term>
        <Term>Glycoprotein ICAM 1 (human clone pHRVr1 deblocked protein moiety reduced)</Term>
        <Term>INTERCELLULAR ADHESION MOLECULE 001</Term>
        <Term>ICAM 001</Term>
        <Term>ICAM-1</Term>
        <Term>CD54 Antigens</Term>
        <Term>ANTIGENS CD 054</Term>
        <Term>CD 054 ANTIGENS</Term>
        <Term>Intercellular Adhesion Molecule 1</Term>
        <Codes>
          <Code code="C0063695" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:ICAM1_protein_human, OTE:Icam1_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:solomon_four_group_design" name="solomon four group design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">solomon four group design</Term>
        <Term>solomon four group trials</Term>
        <Term>solomon four-group studies</Term>
        <Term>solomon four-group design</Term>
        <Term>solomon four group trial</Term>
        <Term>solomon four-group trial</Term>
        <Term>solomon four group study</Term>
        <Term>solomon four group designs</Term>
        <Term>solomon four-group trials</Term>
        <Term>solomon four-group designs</Term>
        <Term>solomon four-group study</Term>
        <Term>solomon four group studies</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#solomon_four_group_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C32_Zebrafish" name="C32 Zebrafish">
        <Definition>A wild-type Zebrafish line.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C32 Zebrafish</Term>
        <Term>C32 - zebrafish</Term>
        <Term>C32</Term>
        <Codes>
          <Code code="C2700320" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:oligodendrocyte_O_antigen_rat" name="oligodendrocyte O antigen, rat">
        <SemanticType code="T109" name="Organic Chemical"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">oligodendrocyte O antigen, rat</Term>
        <Codes>
          <Code code="C1435566" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ace2_protein_mouse" name="Ace2 protein, mouse">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ace2 protein, mouse</Term>
        <Term>angiotensin I converting enzyme (peptidyl-dipeptidase A) 2, mouse</Term>
        <Codes>
          <Code code="C1721297" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:angiotensin_converting_enzyme_2</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LRP1_protein_human" name="LRP1 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LRP1 protein, human</Term>
        <Term>low density lipoprotein receptor-related protein 1, human</Term>
        <Term>CD91 antigen, human</Term>
        <Codes>
          <Code code="C1259504" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:LDL_Receptor_Related_Protein_1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd53_protein_rat" name="Cd53 protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd53 protein, rat</Term>
        <Term>MRC OX-44 antigen</Term>
        <Term>Ox-44 protein, rat</Term>
        <Codes>
          <Code code="C2975741" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD53</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mouse_Strains" name="Mouse Strains">
        <Definition>Breeds of mice utilized for biological research.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mouse Strains</Term>
        <Codes>
          <Code code="C1513684" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mouse</Relation>
          <Relation name="Narrower">OTE:Wild_Type_Mouse, OTE:Immunodeficient_Mouse, OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Wistar_Unilever_Rat_Strain" name="Wistar Unilever, Rat Strain">
        <Definition>A Wistar substrain that was disseminated to Glaxo Laboratory (UK) from the Wistar Institute in Philadelphia in 1933, then to the Dutch Institution for Nutrition (Amsterdam, The Netherlands) and maintained by Unilever Company (Vlaardingen, The Netherlands) from 1941. This strain is now disseminated by Harland Nederland. The Wistar Unilever rat is an albino, genotype c, with pink eyes and very docile manner, making it a popular choice in multidisciplinary biomedical research worldwide. The breed is specifically involved in developmental toxicity and carcinogenesis studies as well as being used as an animal model for vitamin A deficiency in humans.</Definition>
        <Definition>A Wistar substrain that was disseminated to Glaxo Laboratory (UK) from the Wistar Institute in Philadelphia in 1933, then to the Dutch Institution for Nutrition (Amsterdam, The Netherlands) and maintained by Unilever Company (Vlaardingen, The Netherlands) from 1941. This strain is now disseminated by Harland Nederland. The Wistar Unilever rat is an albino, genotype c and pink eyes.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Wistar Unilever, Rat Strain</Term>
        <Term>WISTAR WU</Term>
        <Term>Wistar WU</Term>
        <Codes>
          <Code code="C76193" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:PL_J_Mouse" name="PL/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">PL/J Mouse</Term>
        <Term>PL/J</Term>
        <Codes>
          <Code code="C15049" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD38_Antigens" name="CD38 Antigens">
        <Definition>This gene is involved in both signal transduction and the metabolism of ADP-ribose.</Definition>
        <Definition>A bifunctional enzyme that catalyzes the synthesis and HYDROLYSIS of CYCLIC ADP-RIBOSE (cADPR) from NAD+ to ADP-RIBOSE. It is a cell surface molecule which is predominantly expressed on LYMPHOID CELLS and MYELOID CELLS.</Definition>
        <Definition>membrane associated enzymes; converts NAD to cyclic ADP ribose; CD (2+) activates second messenger and ADP ribose.</Definition>
        <Definition>ADP-ribosyl cyclase 1 (300 aa, ~34 kDa) is encoded by the human CD38 gene. This protein is involved in both ADP-ribose metabolism and signal transduction.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD38 Antigens</Term>
        <Term>Leukocyte 17</Term>
        <Term>Cyclic ADP-Ribose Hydrolase 1</Term>
        <Term>NIM-R5 Antigen</Term>
        <Term>Cyclase CD38, ADPR</Term>
        <Term>Lymphocyte antigen CD38 (substance)</Term>
        <Term>Cluster of diff antigen 38</Term>
        <Term>ANTIGENS CD 038</Term>
        <Term>CD 038 ANTIGENS</Term>
        <Term>Antigen, T10</Term>
        <Term>ADPR Cyclase CD38</Term>
        <Term>CD38</Term>
        <Term>Antigens, CD38 [Chemical/Ingredient]</Term>
        <Term>Leucocyte 17</Term>
        <Term>ADP-ribosyl cyclase 1</Term>
        <Term>Acute Lymphoblastic Leukemia Cells Antigen CD38</Term>
        <Term>T10</Term>
        <Term>CD38 molecule</Term>
        <Term>CD38 Gene</Term>
        <Term>NAD(+) nucleosidase</Term>
        <Term>CD38 gene</Term>
        <Term>Cyclase T10, ADPR</Term>
        <Term>ADPR Cyclase T10</Term>
        <Term>OKT10 - Ortho Kung T10</Term>
        <Term>Lymphocyte Differentiation Antigen CD38</Term>
        <Term>cd38 antigen</Term>
        <Term>T-cell lineage 10</Term>
        <Term>T10 - T-cell lineage 10</Term>
        <Term>EC3.2.2.5</Term>
        <Term>CD38 Ag</Term>
        <Term>CD38 Antigen</Term>
        <Term>NIM R5 Antigen</Term>
        <Term>ADP-Ribosyl Cyclase 1</Term>
        <Term>CD38 Molecule Gene</Term>
        <Term>CD38 - Cluster of differentiation antigen 38</Term>
        <Term>CD38 - Cluster of diff ag 38</Term>
        <Term>Antigens, CD38</Term>
        <Term>cADPr Hydrolase 1</Term>
        <Term>Ortho Kung T10</Term>
        <Term>T10 Antigen</Term>
        <Term>CD38 ANTIGEN</Term>
        <Term>ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE</Term>
        <Term>CD38, ADPR Cyclase</Term>
        <Term>Lymphocyte antigen CD38</Term>
        <Term>ECTO-NICOTINAMIDE ADENINE DINUCLEOTIDE GLYCOHYDROLASE</Term>
        <Term>Cluster of differentiation antigen 38</Term>
        <Codes>
          <Code code="C1413221" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CMRF-56_antigen" name="CMRF-56 antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CMRF-56 antigen</Term>
        <Term>CMRF56</Term>
        <Codes>
          <Code code="C0769171" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:TNFRSF4_protein_human" name="TNFRSF4 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">TNFRSF4 protein, human</Term>
        <Term>ACT35 protein, human</Term>
        <Term>OX40 protein, human</Term>
        <Term>CD134 antigen, human</Term>
        <Term>tumor necrosis factor receptor superfamily, member 4 protein, human</Term>
        <Codes>
          <Code code="C1608540" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptor_OX40</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MyD88_protein_Xenopus" name="MyD88 protein, Xenopus">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MyD88 protein, Xenopus</Term>
        <Term>Toll/IL-1 receptor binding protein MyD88, Xenopus</Term>
        <Codes>
          <Code code="C1506316" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd48_protein_rat" name="Cd48 protein, rat">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd48 protein, rat</Term>
        <Term>MRC OX-45 antigen, rat</Term>
        <Term>Cd48 antigen, rat</Term>
        <Codes>
          <Code code="C1609639" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD48_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mongolian_Gerbil" name="Mongolian Gerbil">
        <Definition>A rodent belonging to subfamily Gerbillinae, Meriones unguiculatus is the most common species of the gerbil subfamily. The Mongolian gerbil was first imported into the United States in 1954 by Dr. Victor Schwentker. Most gerbils used in pre-clinical research are agouti-colored and comprise less than 0.5% of total rodent usage annually. The average gestational period of the gerbil embryo is 35 days and the gerbil has a life span of 3-4 years. Gerbils are docile, social creatures and can be housed as pairs or in groups of three. Charles River Laboratories currently disseminates gerbils for scientific research from stocks initially derived at Tumblebrook Farms (1995).</Definition>
        <Definition>A rodent belonging to subfamily Gerbillinae, Meriones unguiculatus.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mongolian Gerbil</Term>
        <Term>Meriones unguiculatus (organism)</Term>
        <Term>Clawed Jird</Term>
        <Term>MONGOLIAN</Term>
        <Term>Mongolian gerbil</Term>
        <Term>Meriones unguiculatus</Term>
        <Term>Mongolian Jird</Term>
        <Term>Mongolian jird</Term>
        <Term>Mongolian</Term>
        <Codes>
          <Code code="C0324939" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Gerbil</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:fibrinopeptide_A_phospho-Ser-" name="fibrinopeptide A, phospho-Ser(3)-">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">fibrinopeptide A, phospho-Ser(3)-</Term>
        <Term>fibrinopeptide A, phosphoseryl(3)-</Term>
        <Term>FpAP peptide</Term>
        <Term>3-phospho-Ser-fibrinopeptide A</Term>
        <Codes>
          <Code code="C1569807" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Fibrinopeptide_A</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SPN_protein_human" name="SPN protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SPN protein, human</Term>
        <Term>galactoglycoprotein, human</Term>
        <Term>sialophorin (leukosialin, CD43) protein, human</Term>
        <Term>gpL-115 protein, human</Term>
        <Term>LSGP protein, human</Term>
        <Term>CD43 protein, human</Term>
        <Term>sialophorin protein, human</Term>
        <Codes>
          <Code code="C1434437" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:UN1_sialoglycoprotein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:bone_marrow_stromal_cell_antigen_1" name="bone marrow stromal cell antigen 1">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">bone marrow stromal cell antigen 1</Term>
        <Term>ADP-ribosyl cyclase 2</Term>
        <Term>BST1</Term>
        <Term>BST1 gene</Term>
        <Term>BM stromal cell antigen 1</Term>
        <Term>CD157 antigen</Term>
        <Term>CD157</Term>
        <Term>NAD(+) nucleosidase</Term>
        <Term>BONE MARROW STROMAL CELL ANTIGEN 1</Term>
        <Codes>
          <Code code="C0255325" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Bst1_protein_mouse, OTE:Bst1_protein_rat, OTE:BST1_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Il4r_protein_rat" name="Il4r protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Il4r protein, rat</Term>
        <Term>interleukin 4 receptor, rat</Term>
        <Term>interleukin-4 Receptor alpha, rat</Term>
        <Codes>
          <Code code="C1611533" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin-4_Receptor_alpha_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD52_protein_human" name="CD52 protein, human">
        <Definition>CAMPATH-1 antigen (61 aa, ~7 kDa) is encoded by the human CD52 gene. This protein may play a role in spermatogenesis and lymphocyte biology.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD52 protein, human</Term>
        <Term>CAMPATH-1 antigen, human</Term>
        <Term>CD52 antigen, human</Term>
        <Term>CDw52 antigen, human</Term>
        <Term>HE5 antigen, human</Term>
        <Codes>
          <Code code="C0376272" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD52_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:GFR" name="GFR">
        <Definition>A kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time.</Definition>
        <Definition>rate at which plasma is filtered by the glomerular filtration membrane into Bowman's space; determined by the permeabiliy of the membrane, hydrostatic pressure in the glomerular capillaries and Bowman's space, and the colloid osmotic pressure exerted by the proteins of the capillary plasma.</Definition>
        <Definition>The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance.</Definition>
        <SemanticType code="T060" name="Diagnostic Procedure"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">GFR</Term>
        <Term>Glomerular Filtration Rates</Term>
        <Term>rate filtration glomerular</Term>
        <Term>Rap guanine nucleotide exchange factor (GEF) 5</Term>
        <Term>MRGEF</Term>
        <Term>Rate, Glomerular Filtration</Term>
        <Term>RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 5</Term>
        <Term>gfr</Term>
        <Term>KIAA0277</Term>
        <Term>RAPGEF5</Term>
        <Term>Filtration Rates, Glomerular</Term>
        <Term>MR-GEF</Term>
        <Term>Glomerular filtration rate</Term>
        <Term>filtration glomerular rate</Term>
        <Term>MRAS-REGULATED GUANINE NUCLEOTIDE EXCHANGE FACTOR</Term>
        <Term>GUANINE NUCLEOTIDE EXCHANGE FACTOR FOR RAP1</Term>
        <Term>RAPGEF5 gene</Term>
        <Term>Filtration Rate, Glomerular</Term>
        <Term>Glomerular filtration rate (observable entity)</Term>
        <Term>Rates, Glomerular Filtration</Term>
        <Term>glomerular filtration rate</Term>
        <Term>Glomerular Filtration Rate</Term>
        <Term>M-Ras-regulated GEF</Term>
        <Term>Glomerular filtration rate, NOS</Term>
        <Codes>
          <Code code="C1424601" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Outcome_Category</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SCID_Mouse" name="SCID Mouse">
        <Definition>genetically immunodeficient mouse strain used to model human severe combined immunodeficiency syndrome and to construct experimental immunologic chimeras; the most notable artificial chimera is the SCID- hu mouse, which has a virtual human immune system.</Definition>
        <Definition>Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice.</Definition>
        <Definition>Severe combined immunodeficient (SCID) mice like their human counterparts with immunodeficiency diseases are helpless not only to fight infection but also to reject transplanted tissue. These animals lack both T and B-cells and are used extensively in researches of immune disease or tissue transplantation.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SCID Mouse</Term>
        <Term>SCID Mice</Term>
        <Term>severe combined immune deficiency</Term>
        <Term>scid mouse</Term>
        <Term>scid mice</Term>
        <Term>IMMUNODEFIC MICE SEVERE COMBINED</Term>
        <Term>Mouse, SCID</Term>
        <Term>SEVERE COMBINED IMMUNODEFIC MICE</Term>
        <Term>Mice, SCID</Term>
        <Term>SCID mouse</Term>
        <Term>SCID</Term>
        <Term>Severe Combined Immunodeficient Mice</Term>
        <Term>Immunodeficient Mice, Severe Combined</Term>
        <Codes>
          <Code code="C14294" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Immunodeficient_Mouse</Relation>
          <Relation name="Narrower">OTE:NOD_CB17-Prkdc-scid_J_Mouse, OTE:B6_CB17-Prkdc-scid_SzJ_Mouse, OTE:Fox_Chase_SCID_Mouse, OTE:CBySmn_CB17-Prkdc-scid_J_Mouse, OTE:SCID_Beige_Mouse, OTE:C3Smn_CB17-Prkdc-scid_J_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Lagomorpha" name="Lagomorpha">
        <Definition>The taxonomic order of mammals which include hares, rabbits and pikas.</Definition>
        <Definition>order of herbivorous mammals (class Eutheria) resembling rodents (order Rodentia) but having two pairs of upper incisors one behind the other; it includes the rabbits, hares, and pikas.</Definition>
        <Definition>An order of small mammals comprising two families, Ochotonidae (pikas) and Leporidae (RABBITS and HARES). Head and body length ranges from about 125 mm to 750 mm. Hares and rabbits have a short tail, and the pikas lack a tail. Rabbits are born furless and with both eyes and ears closed. HARES are born fully haired with eyes and ears open. All are vegetarians. (From Nowak, Walker's Mammals of the World, 5th ed, p539-41)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Lagomorpha</Term>
        <Term>Lagomorphs</Term>
        <Term>Lagomorph, NOS</Term>
        <Term>Order Lagomorpha (organism)</Term>
        <Term>Lagomorpha Brandt, 1855</Term>
        <Term>86A-86C ORDER LAGOMORPHA</Term>
        <Term>Lagomorph</Term>
        <Term>Order Lagomorpha</Term>
        <Term>ORDER LAGOMORPHA</Term>
        <Codes>
          <Code code="C79106" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mammalia</Relation>
          <Relation name="Narrower">OTE:Leporidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129P2_SvOla_Mouse" name="129P2/SvOla Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129P2/SvOla Mouse</Term>
        <Term>129P2/SvOla</Term>
        <Codes>
          <Code code="C37326" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:single_blind_design" name="single blind design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">single blind design</Term>
        <Term>single blind studies</Term>
        <Term>single blind trial</Term>
        <Term>single blind designs</Term>
        <Term>single blind trials</Term>
        <Term>single blind method</Term>
        <Term>single blind methods</Term>
        <Term>single blind study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#Single_Blind_Study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:bibliography" name="bibliography">
        <Definition>A work consisting of a list of books, articles, documents, publications, and other items, usually on a single subject or related subjects. [MeSH_2014]</Definition>
        <Definition>A work consisting of a list of books, articles, documents, publications, and other items, usually on a single subject or related subjects.</Definition>
        <SemanticType code="T073" name="Manufactured Object"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">bibliography</Term>
        <Term>Bibliography</Term>
        <Term>Abstracts</Term>
        <Term>bibliographies</Term>
        <Term>Indexes</Term>
        <Term>Resource Guides</Term>
        <Term>Biobibliography</Term>
        <Term>biographies</Term>
        <Codes>
          <Code code="C0005358" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:umbrella_review" name="umbrella review">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">umbrella review</Term>
        <Term>umbrella reviews</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#umbrella_review" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:literature_review</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:umbrella_review_" name="umbrella review'">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">umbrella review'</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#umbrella_review'" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:review_of_literature_</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Csf2rb1_protein_mouse" name="Csf2rb1 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Csf2rb1 protein, mouse</Term>
        <Term>IL-3, IL-5, GM-CSFR receptor beta chain protein, mouse</Term>
        <Term>betac protein, mouse</Term>
        <Term>colony stimulating factor 2 receptor, beta 1, low-affinity (granulocyte-macrophage) protein, mouse</Term>
        <Term>IL-3 IL-5 GM-CSF receptor beta subunit protein, mouse</Term>
        <Term>AIC2B protein, mouse</Term>
        <Codes>
          <Code code="C1307065" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:GM-CSF_IL-3_IL-5_Receptor_Common_beta-Chain</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ABP_LeJ_Mouse" name="ABP/LeJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ABP/LeJ Mouse</Term>
        <Term>ABP/LeJ</Term>
        <Codes>
          <Code code="C37352" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:double_blinded_randomized_controlled_trial_" name="double blinded randomized controlled trial'">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">double blinded randomized controlled trial'</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#double_blinded_randomized_controlled_trial'" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:double_blind_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Vstm3_protein_rat" name="Vstm3 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Vstm3 protein, rat</Term>
        <Term>WUCAM protein, rat</Term>
        <Term>TIGIT protein, rat</Term>
        <Codes>
          <Code code="C3181428" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD28_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:AB_Zebrafish" name="AB Zebrafish">
        <Definition>A zebrafish line derived from the mating of two lines, A and B, obtained in Albany, Oregon. Haploid offspring from individual females of the AB line were screened for healthy, good looking embryos. Females obtained from the screening were used to breed future generations by crossing them to unselected males. This procedure reduced the number of lethal mutations so that this line can be used for parthenogenesis.</Definition>
        <Definition>A zebrafish line derived from the mating of two lines, A and B, obtained in Albany, Oregon. Haploid offspring from individual females of the AB line were screened for healthy, good looking embryos. Females obtained from the screening were used to breed future generations by crossing them to unselected males. This procedure reduced the number of lethal mutations so that this line can be used for parthenogenesis.(ZFin)</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">AB Zebrafish</Term>
        <Term>AB - Zebrafish</Term>
        <Term>AB</Term>
        <Codes>
          <Code code="C2700382" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:polyethylene_glycol-asialofetuin_complex" name="polyethylene glycol-asialofetuin complex">
        <SemanticType code="T109" name="Organic Chemical"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">polyethylene glycol-asialofetuin complex</Term>
        <Term>PEG modified asialofetuin</Term>
        <Term>PEG-asialofetuin</Term>
        <Codes>
          <Code code="C0655320" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:alpha_Fetoproteins</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:in_vitro_study" name="in vitro study">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">in vitro study</Term>
        <Term>in vitro design</Term>
        <Term>in vitro studies</Term>
        <Term>in vitro designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#in_vitro" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:interrupted_time_series_with_comparison_group" name="interrupted time series with comparison group">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">interrupted time series with comparison group</Term>
        <Term>interrupted time series with comparison groups</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#interrupted_time_series_with_comparison_group" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:interrupted_time_series_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cat" name="Cat">
        <Definition>A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.</Definition>
        <Definition>The domestic cat, Felis catus, of the carnivore family Felidae, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 5th ed, p1192)</Definition>
        <Definition>&lt;p&gt;Computed axial tomography&lt;/p&gt;</Definition>
        <Definition>The domestic cat, Felis catus. (NCI)</Definition>
        <Definition>A series of detailed pictures of areas inside the body; the pictures are created by a computer linked to an x-ray machine.</Definition>
        <Definition>&lt;p&gt;Computed tomography (CT) is a type of imaging. It uses special x-ray equipment to make cross-sectional pictures of your body. &lt;/p&gt;&lt;p&gt;Doctors use CT scans to look for&lt;/p&gt;&lt;ul&gt;&lt;li&gt; Broken bones&lt;/li&gt; &lt;li&gt; Cancers&lt;/li&gt; &lt;li&gt; Blood clots&lt;/li&gt; &lt;li&gt; Signs of heart disease&lt;/li&gt; &lt;li&gt; Internal bleeding&lt;/li&gt; &lt;/ul&gt;&lt;p&gt;During a CT scan, you lie still on a table. The table slowly passes through the center of a large X-ray machine. The test is painless. During some tests you receive a contrast dye, which makes parts of your body show up better in the image.&lt;/p&gt;&lt;p &gt;NIH: National Cancer Institute&lt;/p&gt;</Definition>
        <Definition>Taxonomic family which includes domestic and wild cats such as lions and tigers.</Definition>
        <Definition>An enzyme that catalyzes the acetylation of chloramphenicol to yield chloramphenicol 3-acetate. Since chloramphenicol 3-acetate does not bind to bacterial ribosomes and is not an inhibitor of peptidyltransferase, the enzyme is responsible for the naturally occurring chloramphenicol resistance in bacteria. The enzyme, for which variants are known, is found in both gram-negative and gram-positive bacteria. EC 2.3.1.28.</Definition>
        <Definition>Genus in the family FELIDAE comprised of small felines including the domestic cat, Felis catus (CATS) and its ancestor the wild cat, Felis silvestris.</Definition>
        <Definition>Tomography using x-ray transmission and a computer algorithm to reconstruct the image.</Definition>
        <Definition>Bacterial chloramphenicol-O-acetyltransferase protein (219 aa, 26 kD) is encoded by the bacterial chloramphenicol-O-acetyltransferase (cat) gene. This enzyme detoxifies the antibiotic chloramphenicol via acetylation to yield chloramphenicol 3-acetate. The presence of this enzyme confers chloramphenicol resistance to bacteria, which is used as a marker for selection in molecular techniques that utilize genetic transfection.</Definition>
        <Definition>The cat family in the order CARNIVORA comprised of muscular, deep-chested terrestrial carnivores with a highly predatory lifestyle.</Definition>
        <Definition>radiography in which a three dimensional image of a body structure is constructed by computer from a series of plane cross sectional images made along an axis.</Definition>
        <Definition>The domestic cat, Felis catus.</Definition>
        <Definition>refers to all members of the cat family, from the breeds of domestic cats through the great cats.</Definition>
        <Definition>The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801)</Definition>
        <Definition>Bacterial chloramphenicol-O-acetyltransferase (cat) gene encodes chloramphenicol-O-acetyltransferase protein, an enzyme that acetylates the antiobiotic chloramphenicol to yield chloramphenicol 3-acetate. This product is not an inhibitor of peptidyltransferase, the enzyme responsible for natural chloramphenicol resistance in bacteria. The cat gene is used to select chloramphenicol-resistant colonies following genetic transfection of bacteria.</Definition>
        <Definition>bacterial enzyme which detoxifies the antibiotic chloramphenicol the gene therefore confers chloramphenicol resistance, which can be used as a marker or selector in genetic transfection experiments.</Definition>
        <SemanticType code="T060" name="Diagnostic Procedure"/>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T015" name="Mammal"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cat</Term>
        <Term>Felid</Term>
        <Term>X-Ray CT Scan</Term>
        <Term>cats scan</Term>
        <Term>chloramphenicol o-acetyltransferase</Term>
        <Term>computerized tomography (procedure)</Term>
        <Term>computed axial tomography</Term>
        <Term>CAT Enzyme</Term>
        <Term>X-Ray CAT Scans</Term>
        <Term>Cat, Domestic</Term>
        <Term>CAT scan</Term>
        <Term>Computerised transverse axial tomography</Term>
        <Term>FELINE SPECIES</Term>
        <Term>CTT scan</Term>
        <Term>Computed Tomography, X Ray</Term>
        <Term>CAT - Comp axial tomography</Term>
        <Term>Wildcat</Term>
        <Term>computerised tomography</Term>
        <Term>Feline Species</Term>
        <Term>Chloramphenicol O Acetyltransferase</Term>
        <Term>Computerized tomography without IV contrast</Term>
        <Term>Chloramphenicol Acetyl Transferase</Term>
        <Term>Computed tomography procedure</Term>
        <Term>Felis silvestris catus</Term>
        <Term>Computerised axial tomography</Term>
        <Term>CT scan, without IV contrast</Term>
        <Term>Family Felidae (organism)</Term>
        <Term>Chloramphenicol acetyltransferase (substance)</Term>
        <Term>Xray Computed Tomography</Term>
        <Term>X-Ray Computerized Tomography</Term>
        <Term>Felis silvestris</Term>
        <Term>Tomography, Xray Computed</Term>
        <Term>Computerized Tomography</Term>
        <Term>Felids</Term>
        <Term>Tomography, X Ray Computer Assisted</Term>
        <Term>Domestic cat</Term>
        <Term>emi scan</Term>
        <Term>Felis silvestris (organism)</Term>
        <Term>cat III</Term>
        <Term>feline</Term>
        <Term>X Ray, CT</Term>
        <Term>Computerised transaxial tomography</Term>
        <Term>CT - Computerized tomography</Term>
        <Term>cat scanning</Term>
        <Term>Tomography, X Ray Computerized</Term>
        <Term>chloramphenicol acetyltransferase</Term>
        <Term>tomodensitometry</Term>
        <Term>CT X Ray</Term>
        <Term>CT scan</Term>
        <Term>CAT scan, NOS</Term>
        <Term>Chloramphenicol acetyltransferase</Term>
        <Term>scan ct</Term>
        <Term>c.a.t. scan</Term>
        <Term>EMI scan</Term>
        <Term>cat Gene</Term>
        <Term>Genus Felis (organism)</Term>
        <Term>cat procedure scan</Term>
        <Term>computer assisted tomography</Term>
        <Term>Felinae</Term>
        <Term>Computerized tomography</Term>
        <Term>allergy testing cat (lab test)</Term>
        <Term>Felis sylvestris catus</Term>
        <Term>Tomodensitometry</Term>
        <Term>CT Scans, X-Ray</Term>
        <Term>CT XRAY</Term>
        <Term>Computerized transverse axial tomography</Term>
        <Term>X-Ray CT Scans</Term>
        <Term>TOMOGRAPHY TRANSM COMPUTED</Term>
        <Term>Transacetylase, Chloramphenicol</Term>
        <Term>Computerized axial tomography (procedure)</Term>
        <Term>Tomography, X-Ray Computer Assisted</Term>
        <Term>Family Felidae</Term>
        <Term>Computerized axial tomography, NOS</Term>
        <Term>CT (computerized tomography)</Term>
        <Term>CT</Term>
        <Term>Computerized Axial Tomography</Term>
        <Term>Cat (antigen)</Term>
        <Term>Subfamily Felinae</Term>
        <Term>Computed X Ray Tomography</Term>
        <Term>Chloramphenicol Transacetylase</Term>
        <Term>cat I</Term>
        <Term>Computed axial tomography</Term>
        <Term>CHLORAMPHENICOL ACETYLTRANSFERASE O</Term>
        <Term>Cats</Term>
        <Term>CAT Scans, X-Ray</Term>
        <Term>allergy testing cat</Term>
        <Term>c a t scan</Term>
        <Term>computerized axial tomography</Term>
        <Term>Acinonychinae</Term>
        <Term>Scans, X-Ray CT</Term>
        <Term>Computerized transaxial tomography, NOS</Term>
        <Term>Computerized tomograph scan</Term>
        <Term>CT Scan, X Ray</Term>
        <Term>Tomography, X-Ray Computed</Term>
        <Term>Computerised tomography</Term>
        <Term>Chloramphenicol Acetyltransferase</Term>
        <Term>Transmission Computed Tomography</Term>
        <Term>CAT Scan</Term>
        <Term>CAT - Computerised axial tomography</Term>
        <Term>Felid, NOS</Term>
        <Term>Mammals, Cats</Term>
        <Term>CAT Scans</Term>
        <Term>computing tomography</Term>
        <Term>C.A.T. scan NOS</Term>
        <Term>Computerized transaxial tomography without IV contrast</Term>
        <Term>catting</Term>
        <Term>Computer-assisted transaxial tomography</Term>
        <Term>CT SCAN</Term>
        <Term>Feline, NOS</Term>
        <Term>domesticus felis</Term>
        <Term>Computerized Tomography, X Ray</Term>
        <Term>Computerised tomograph scan</Term>
        <Term>CAT Scan, X Ray</Term>
        <Term>CT scans</Term>
        <Term>Felis</Term>
        <Term>Domestic Cat</Term>
        <Term>CAT Scan, X-Ray</Term>
        <Term>scan cat</Term>
        <Term>ctt</Term>
        <Term>X-Ray Tomography, Computed</Term>
        <Term>X Ray Tomography, Computed</Term>
        <Term>Felis domesticus</Term>
        <Term>Computerized tomogram</Term>
        <Term>Tomography, Computed X-Ray</Term>
        <Term>CT - Computerised tomography</Term>
        <Term>EC 2.3.1.28</Term>
        <Term>Computed tomography</Term>
        <Term>Felis catus Linnaeus, 1758</Term>
        <Term>Chloramphenicol O-Acetyltransferase</Term>
        <Term>X Ray Computerized Tomography</Term>
        <Term>Domestic Cats</Term>
        <Term>Computed Tomography, Xray</Term>
        <Term>CAT - Computerized axial tomography</Term>
        <Term>Scans, X-Ray CAT</Term>
        <Term>Feline species</Term>
        <Term>Scan, X-Ray CT</Term>
        <Term>X-Ray CAT Scan</Term>
        <Term>computed x-ray tomography</Term>
        <Term>x-ray computed tomography</Term>
        <Term>computed tomography (procedure)</Term>
        <Term>Felidae</Term>
        <Term>FAMILY FELIDAE - FELIDS</Term>
        <Term>80A FELINE SPECIES</Term>
        <Term>CT scan without IV contrast</Term>
        <Term>Wild cat, NOS</Term>
        <Term>cats</Term>
        <Term>ct scanning</Term>
        <Term>Tomography, Transmission Computed</Term>
        <Term>Computerized axial tomography</Term>
        <Term>Tomography, X Ray Computed</Term>
        <Term>Subfamily Felinae (organism)</Term>
        <Term>Computerised axial tomogram</Term>
        <Term>domestic cat</Term>
        <Term>Computerized axial tomogram</Term>
        <Term>Computerised tomogram</Term>
        <Term>Computed Tomography</Term>
        <Term>CT Scans</Term>
        <Term>Computed X-Ray Tomography</Term>
        <Term>Computerised transverse axial tomogram</Term>
        <Term>Computed Tomography, Transmission</Term>
        <Term>5-08 COMPUTERIZED TOMOGRAPHY</Term>
        <Term>Genus Felis</Term>
        <Term>Computerized transverse axial tomogram</Term>
        <Term>cat II</Term>
        <Term>X-Ray Computed Tomography</Term>
        <Term>tomography</Term>
        <Term>felines</Term>
        <Term>Felis catus</Term>
        <Term>CAT</Term>
        <Term>Chloramphenicol O-acetyltransferase</Term>
        <Term>Scan, X-Ray CAT</Term>
        <Term>X-Ray Computer Assisted Tomography</Term>
        <Term>Computerized Tomography, X-Ray</Term>
        <Term>X Ray Computer Assisted Tomography</Term>
        <Term>assisted computer tomography</Term>
        <Term>cat scans</Term>
        <Term>COMPUTERIZED TOMOGRAPHY</Term>
        <Term>Computerized transaxial tomography, without IV contrast</Term>
        <Term>cat</Term>
        <Term>CT Scan, X-Ray</Term>
        <Term>888-889 FAMILY FELIDAE - FELIDS</Term>
        <Term>computerized tomography</Term>
        <Term>tomography, computed</Term>
        <Term>Computed Tomography, X-Ray</Term>
        <Term>Wild cat</Term>
        <Term>Chloramphenicol Acetyl Transferase Gene</Term>
        <Term>cat scan procedure</Term>
        <Term>Acetyltransferase, Chloramphenicol</Term>
        <Term>Cat (organism)</Term>
        <Term>O-Acetyltransferase, Chloramphenicol</Term>
        <Term>Felis catus (organism)</Term>
        <Term>Felis domestica</Term>
        <Term>computed tomography x rays</Term>
        <Term>X Rays, CT</Term>
        <Term>CT X Rays</Term>
        <Term>ctt scan</Term>
        <Term>Computerized transaxial tomography</Term>
        <Term>Tomography, X-Ray Computerized</Term>
        <Term>Subfamily Acinonychinae</Term>
        <Term>Cats, Domestic</Term>
        <Term>Tomographies, Computed X-Ray</Term>
        <Term>Acetyl-CoA-chloramphenicol 3-O-acetyltransferase</Term>
        <Term>computed tomography</Term>
        <Term>Chloramphenicol O-Acetyltransferase [Chemical/Ingredient]</Term>
        <Term>Enzyme, CAT</Term>
        <Codes>
          <Code code="C1270185" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Felidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd5_protein_mouse" name="Cd5 protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd5 protein, mouse</Term>
        <Term>Ly-A antigen, mouse</Term>
        <Term>Ly-12 antigen, mouse</Term>
        <Term>CD5 antigen, mouse</Term>
        <Term>Ly-1 antigen, mouse</Term>
        <Term>Lyt-1 antigen, mouse</Term>
        <Codes>
          <Code code="C2351668" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD5</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Nt5e_protein_rat" name="Nt5e protein, rat">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Nt5e protein, rat</Term>
        <Term>5' nucleotidase, ecto, rat</Term>
        <Codes>
          <Code code="C2932863" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-Nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly-6C_antigen_mouse" name="Ly-6C antigen, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly-6C antigen, mouse</Term>
        <Term>Ly6C antigen, mouse</Term>
        <Codes>
          <Code code="C1530208" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129_Sv_Mouse" name="129/Sv Mouse">
        <Definition>Derived by Dunn (1928) from a mouse/chinchilla cross, the 129/Sv substrain has been recognized as a member of the Parental subgroup of substrains. Strain 129/SvJ was genetically contaminated in 1978 by an unknown strain and differs from other 129 substrains at 25% of SSLP genetic markers, therefore a nomenclature re-designation of 129cX/Sv has been suggested.</Definition>
        <Definition>Derived by Dunn (1928) from a mouse/chinchilla cross, the 129/Sv substrain has been recognized as a member of the Parental subgroup of substrains.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129/Sv Mouse</Term>
        <Term>129/SV</Term>
        <Term>129/Sv</Term>
        <Codes>
          <Code code="C37320" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ecological_study" name="ecological study">
        <Definition>a statistical study exploring hypotheses by comparing groups, rather than individuals, e.g., comparing rates of breast cancer and levels of fat intake by country. [Dorland's illustrated medical dictionary_2011]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ecological study</Term>
        <Term>ecologic study</Term>
        <Term>ecological studies</Term>
        <Term>ecological designs</Term>
        <Term>ecological design</Term>
        <Term>population-based study</Term>
        <Term>ecologic studies</Term>
        <Term>Population Based Study</Term>
        <Term>population based study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#ecological_study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:ecological_cross-sectional_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:OFA_SD_Rat_Strain" name="OFA SD, Rat Strain">
        <Definition>A hairless Sprague-Dawley rat from the Charles River affiliate IFFA Credo (Labresle, France).</Definition>
        <Definition>A hairless Sprague-Dawley rat from the Charles River affiliate IFFA Credo (Labresle, France). (NCI)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">OFA SD, Rat Strain</Term>
        <Term>ICO:OFA (SD)</Term>
        <Codes>
          <Code code="C76187" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FCGR2A_protein_human" name="FCGR2A protein, human">
        <Definition>Expressed in monocytes, macrophages, neutrophils, eosinophils, platelets, NK cells, and T- and B-lymphocytes by human FCGR2A Gene, 281-aa (mature) IgG Fc Receptor IIA is a type I cell surface membrane protein with 2 extracellular IgC2 domains and a low affinity receptor for aggregated IgG Fc region. FCGR2A binding to IgG initiates essential effector and regulatory cellular responses against foreign pathogens and soluble antigens that induce phagocytosis of antigen-antibody complexes, removing them from circulation, and modulate B-cell antibody production. An Arg167His polymorphism affects efficiency of IgG2 recognition. (NCI)</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FCGR2A protein, human</Term>
        <Term>Fcgamma2RA protein, human</Term>
        <Term>Fc fragment of IgG, low affinity IIa, receptor for (CD32) protein, human</Term>
        <Codes>
          <Code code="C1448238" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tpt1_protein_rat" name="Tpt1 protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tpt1 protein, rat</Term>
        <Term>lens epithelial protein, rat</Term>
        <Term>tumor protein, translationally-controlled 1, rat</Term>
        <Codes>
          <Code code="C1455501" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:translationally_controlled_tumor_protein_p23</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Intervention_Comparator_Category" name="Intervention / Comparator Category">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Intervention / Comparator Category</Term>
        <Relations>
          <Relation name="Broader">OTE:Terminology</Relation>
          <Relation name="Narrower">OTE:Pharmacokinetics, OTE:Serum, OTE:Blood, OTE:Physiologic_Monitoring, OTE:Mycophenolic_Acid</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly-49W2_receptor" name="Ly-49W2 receptor">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly-49W2 receptor</Term>
        <Codes>
          <Code code="C0965466" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL2RA_protein_human" name="IL2RA protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL2RA protein, human</Term>
        <Term>interleukin 2 receptor, alpha protein, human</Term>
        <Term>CD25 antigen, human</Term>
        <Codes>
          <Code code="C1700887" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_2_Receptor_alpha</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tumor_Markers_Biological" name="Tumor Markers, Biological">
        <Definition>Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tumor Markers, Biological</Term>
        <Term>MARKERS TUMOR METAB</Term>
        <Term>METAB MARKERS NEOPL</Term>
        <Term>MARKER BIOL TUMOR</Term>
        <Term>TUMOR MARKERS BIOCHEM</Term>
        <Term>MARKERS BIOCHEM TUMOR</Term>
        <Term>Neoplasm Metabolite Marker</Term>
        <Term>TUMOR METAB MARKER</Term>
        <Term>Tumor Markers, Biologic</Term>
        <Term>Neoplasm Metabolite Markers</Term>
        <Term>Biochemical Tumor Markers</Term>
        <Term>Metabolite Marker, Neoplasm</Term>
        <Term>Tumor Metabolite Marker</Term>
        <Term>Marker, Biological Tumor</Term>
        <Term>NEOPL METAB MARKERS</Term>
        <Term>BIOL TUMOR MARKERS</Term>
        <Term>Metabolite Markers, Neoplasm</Term>
        <Term>Tumor Markers, Biochemical</Term>
        <Term>MARKERS BIOL TUMOR</Term>
        <Term>MARKER BIOCHEM TUMOR</Term>
        <Term>Metabolite Markers, Tumor</Term>
        <Term>Markers, Neoplasm Metabolite</Term>
        <Term>MARKER TUMOR METAB</Term>
        <Term>Biologic Tumor Markers</Term>
        <Term>MARKER NEOPL METAB</Term>
        <Term>Marker, Biologic Tumor</Term>
        <Term>TUMOR MARKERS BIOL</Term>
        <Term>Tumor Marker, Biologic</Term>
        <Term>Markers, Biological Tumor</Term>
        <Term>Tumor Marker, Biochemical</Term>
        <Term>BIOL TUMOR MARKER</Term>
        <Term>Biological Tumor Marker</Term>
        <Term>Markers, Carcinogen</Term>
        <Term>BIOCHEM TUMOR MARKERS</Term>
        <Term>Marker, Neoplasm Metabolite</Term>
        <Term>Marker, Biochemical Tumor</Term>
        <Term>Tumor Metabolite Markers</Term>
        <Term>METAB MARKERS TUMOR</Term>
        <Term>Tumor Marker, Biological</Term>
        <Term>Markers, Biologic Tumor</Term>
        <Term>Markers, Tumor Metabolite</Term>
        <Term>Marker, Tumor Metabolite</Term>
        <Term>Biological Tumor Markers</Term>
        <Term>Biologic Tumor Marker</Term>
        <Term>MARKERS NEOPL METAB</Term>
        <Term>Metabolite Marker, Tumor</Term>
        <Term>Carcinogen Markers</Term>
        <Term>Markers, Biochemical Tumor</Term>
        <Term>Biochemical Tumor Marker</Term>
        <Codes>
          <Code code="C0041366" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
          <Relation name="Narrower">OTE:TCTP_protein_Drosophila, OTE:VWA2_protein_human, OTE:Antigen_Ki_67, OTE:Mammaglobin-A, OTE:human_epithelial_antigen-125, OTE:alpha_Fetoproteins, OTE:Nephroblastoma_Overexpressed_Protein, OTE:Antxr1_protein_mouse, OTE:HBME-1_antigen, OTE:translationally_controlled_tumor_protein_p23, OTE:FAM101A_protein_human, OTE:CAR-3_antigen, OTE:CA8_protein_human, OTE:Adnab-9, OTE:Hormones_Ectopic</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BY55_protein_human" name="BY55 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BY55 protein, human</Term>
        <Term>CD160 antigen</Term>
        <Term>antigen, CD160</Term>
        <Term>CD160 antigen, human</Term>
        <Term>CD160 protein, human</Term>
        <Codes>
          <Code code="C0757560" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NCR2_protein_human" name="NCR2 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NCR2 protein, human</Term>
        <Term>lymphocyte antigen 95 homolog protein, human</Term>
        <Term>natural cytotoxicity triggering receptor 2, human</Term>
        <Term>NKp44 protein, human</Term>
        <Term>p44 natural killer cell receptor, human</Term>
        <Term>CD336 antigen, human</Term>
        <Codes>
          <Code code="C2350724" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Natural_Cytotoxicity_Triggering_Receptor_2</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Physiologic_Monitoring" name="Physiologic Monitoring">
        <Definition>The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine.</Definition>
        <SemanticType code="T058" name="Health Care Activity"/>
        <SemanticType code="T074" name="Medical Device"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Physiologic Monitoring</Term>
        <Term>Monitoring, Physiological</Term>
        <Term>physiologic monitoring</Term>
        <Term>Physiologic Monitors</Term>
        <Term>monitors physiological</Term>
        <Term>MONITORING PHYSIOL</Term>
        <Term>physiological monitoring</Term>
        <Term>Physiological Monitoring</Term>
        <Term>Monitors, Physiologic</Term>
        <Term>Monitoring, Physiologic</Term>
        <Term>PHYSIOL MONITORING</Term>
        <Codes>
          <Code code="C0026429" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Intervention_Comparator_Category</Relation>
          <Relation name="Narrower">OTE:Telemetry, OTE:Actigraphy, OTE:Blood_Glucose_Self-Monitoring, OTE:Monitoring_Intraoperative, OTE:Neuromuscular_Monitoring, OTE:Drug_Monitoring, OTE:Polysomnographies</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd1d1_protein_mouse" name="Cd1d1 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd1d1 protein, mouse</Term>
        <Term>CD1d1 antigen, mouse</Term>
        <Term>Cd1d protein, mouse</Term>
        <Term>Ly-38 antigen, mouse</Term>
        <Codes>
          <Code code="C2351712" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD1d</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL10RB_protein_human" name="IL10RB protein, human">
        <Definition>Interleukin-10 Receptor Beta Chain (325 aa, 37 kD) is a cell motility protein that is encoded by the human IL10RB gene and has roles in immune response and signal transduction.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL10RB protein, human</Term>
        <Term>CRF2-4 protein, human</Term>
        <Term>CRFB4 protein, human</Term>
        <Term>CRF2-4 cytokine receptor, human</Term>
        <Term>interleukin 10 receptor, beta protein, human</Term>
        <Codes>
          <Code code="C0217502" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin-10_Receptor_beta_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Syndecan-1" name="Syndecan-1">
        <Definition>Syndecan-1 (310 aa, ~32 kDa) is encoded by the human SDC1 gene. This protein is involved in the mediation of cell adhesion, signaling and cytoskeletal organization.</Definition>
        <Definition>A syndecan that interacts with EXTRACELLULAR MATRIX PROTEINS and plays a role CELL PROLIFERATION and CELL MIGRATION.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Syndecan-1</Term>
        <Term>CD 138 ANTIGENS</Term>
        <Term>CD138 Antigen</Term>
        <Term>SYNDECAN 01</Term>
        <Term>Antigens, CD138</Term>
        <Term>Antigen, CD138</Term>
        <Term>CD138 Antigens</Term>
        <Term>Syndecan 1</Term>
        <Term>ANTIGENS CD 138</Term>
        <Codes>
          <Code code="C1609943" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:SDC1_protein_human, OTE:Sdc1_protein_mouse, OTE:Sdc1_protein_rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD65s_antigen_human" name="CD65s antigen, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD65s antigen, human</Term>
        <Term>CD65 antigen, sialylated, human</Term>
        <Codes>
          <Code code="C1311638" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:prospective_case_series" name="prospective case series">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">prospective case series</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#prospective_case_series" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:case_series</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cingulata" name="Cingulata">
        <Definition>A taxonomic order of mammals with armor-like exoskeletons, of which the only surviving member is the armadillo.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cingulata</Term>
        <Term>Order Cingulata (organism)</Term>
        <Term>Order Cingulata</Term>
        <Codes>
          <Code code="C2699222" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mammalia</Relation>
          <Relation name="Narrower">OTE:Armadillo</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NEP-2_protein_C_elegans" name="NEP-2 protein, C elegans">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NEP-2 protein, C elegans</Term>
        <Codes>
          <Code code="C2976688" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Neprilysin</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SIGLEC8_protein_human" name="SIGLEC8 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SIGLEC8 protein, human</Term>
        <Term>SIGLEC 8 protein, human</Term>
        <Term>SIGLEC-8 protein, human</Term>
        <Term>Sialoadhesin family member-2 protein, human</Term>
        <Term>sialic acid binding Ig-like lectin 8 protein, human</Term>
        <Codes>
          <Code code="C0912027" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Chinese_Hamster" name="Chinese Hamster">
        <Definition>Originating in the deserts of northern China and Mongolia and kept in captivity since 1919, these hamsters exhibit a whitish/grey/brown coat color with a black stripe down the spine.</Definition>
        <Definition>Originating in the deserts of northern China and Mongolia and kept in captivity since 1919, these hamsters exhibit a whitish/grey/brown coat color with a black stripe down the spine, and have a life span of two to three years. The Chinese hamster has a relatively long thin body and tail in comparison to other hamster breeds and is crepuscular year round in captivity. Of note, Chinese hamster ovary cell lines are highly transfectable and are used in a variety of pre-clinical research applications.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Chinese Hamster</Term>
        <Term>Chinese Hamsters</Term>
        <Term>Cricetulus griseus</Term>
        <Term>Chinese hamster</Term>
        <Term>Cricetulus barabensis griseus</Term>
        <Term>Striped-back hamster</Term>
        <Term>Cricetulus aureus</Term>
        <Term>Cricetulus griseus (Milne-Edwards, 1867)</Term>
        <Term>Hamster, Chinese</Term>
        <Term>Hamsters, Chinese</Term>
        <Term>Chinese hamsters</Term>
        <Term>CHINESE</Term>
        <Term>chinese hamster</Term>
        <Term>Chinese</Term>
        <Codes>
          <Code code="C0018555" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Hamster</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:nonconsecutive_case_series" name="nonconsecutive case series">
        <Definition>A clinical study that includes some, but not all, of the eligible patients identified by the researchers during the study registration period. This type of study does not usually have a control group.</Definition>
        <Definition>A clinical study that includes some, but not all, of the eligible patients identified by the researchers during the study registration period. This type of study does not usually have a control group. [NCIT_14.08d]</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">nonconsecutive case series</Term>
        <Term>Nonconsecutive Case Series</Term>
        <Codes>
          <Code code="C2985409" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:case_series</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tupfel_Long_Fin_Zebrafish" name="Tupfel Long Fin Zebrafish">
        <Definition>A wild-type zebrafish line that has long-fins and spots (Tupfel). This line was established from the rearing of mixed eggs of well-laying females.</Definition>
        <Definition>A wild-type zebrafish line that has long-fins and spots (Tupfel). This line was established from the rearing of mixed eggs of well-laying females.(ZFin)</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tupfel Long Fin Zebrafish</Term>
        <Term>Tupfel Long Fin</Term>
        <Term>TL</Term>
        <Term>Tupfel Long Fin - zebrafish</Term>
        <Codes>
          <Code code="C79983" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Mustelidae" name="Mustelidae">
        <Definition>A family of terrestrial carnivores with long, slender bodies, long tails, and anal scent glands. They include badgers, weasels, martens, FERRETS; MINKS; wolverines, polecats, and OTTERS.</Definition>
        <Definition>Taxonomic family which includes the Ferret.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Mustelidae</Term>
        <Term>Mustelid</Term>
        <Term>884 FAMILY MUSTELIDAE - MUSTELIDS</Term>
        <Term>FAMILY MUSTELIDAE - MUSTELIDS</Term>
        <Term>Mustelids</Term>
        <Term>Family Mustelidae</Term>
        <Term>Family Mustelidae (organism)</Term>
        <Codes>
          <Code code="C0325034" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Carnivora</Relation>
          <Relation name="Narrower">OTE:Ferret</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SCID_Beige_Mouse" name="SCID Beige Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SCID Beige Mouse</Term>
        <Term>SCID Beige</Term>
        <Term>CB-17/IcrCrl-scid-bgBR</Term>
        <Term>C.B-17/IcrCrl-scid-bgBR</Term>
        <Codes>
          <Code code="C1519130" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:SCID_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129P1_ReJLacFib_Mouse" name="129P1/ReJLacFib Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129P1/ReJLacFib Mouse</Term>
        <Term>129P1/ReJLacFib</Term>
        <Codes>
          <Code code="C37323" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Markers_Immunologic" name="Markers, Immunologic">
        <SemanticType code="T080" name="Qualitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Markers, Immunologic</Term>
        <Term>Marker, Immunologic</Term>
        <Term>IMMUNOL MARKERS</Term>
        <Term>Immunologic Marker</Term>
        <Term>MARKERS IMMUNOL</Term>
        <Term>Immune Markers</Term>
        <Term>MARKER IMMUNOL</Term>
        <Term>Immunologic Markers</Term>
        <Term>Immune Marker</Term>
        <Term>Marker, Immune</Term>
        <Term>IMMUNOL MARKER</Term>
        <Term>Markers, Immune</Term>
        <Codes>
          <Code code="C0162489" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Gadd45b_protein_rat" name="Gadd45b protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Gadd45b protein, rat</Term>
        <Term>growth arrest and DNA-damage-inducible 45 beta protein, rat</Term>
        <Codes>
          <Code code="C1700657" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Skin_Graft" name="Skin Graft">
        <Definition>Grafts obtained from a donor or produced artificially (i.e., synthetic) that are intended to replace an area of diseased or injured skin. Skin grafts used in humans may be of biological origin, obtained mainly from the body of the same person (i.e., autograft), from another person (i.e., allograft, typically from cadavers), and less frequently, from a different species (i.e., xenografts); synthetic polymeric membranes (e.g., hydrogels); or a combination of natural and synthetic materials (i.e., composite grafts), including living elements and synthetic materials developed using bioengineering techniques (i.e., bioartificial). Skin grafts are used in the healing of extensive skin losses, including large wounds and burns. Biological autografts and some bioengineered products are intended for use as permanent implants, while other skin grafts must be removed after a few days.</Definition>
        <Definition>Skin that is moved from one part of the body to another.</Definition>
        <Definition>The grafting of skin in humans or animals from one site to another to replace a lost portion of the body surface skin.</Definition>
        <Definition>grafting skin from one site to another within an individual or between individuals of the same or different species.</Definition>
        <Definition>Grafts used in the treatment of skin loss, usually caused by burn injuries.</Definition>
        <SemanticType code="T122" name="Biomedical or Dental Material"/>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <SemanticType code="T024" name="Tissue"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Skin Graft</Term>
        <Term>Skin Graftings</Term>
        <Term>dermatoplasty</Term>
        <Term>Skin grafting</Term>
        <Term>Skin Transplantation</Term>
        <Term>Skin grafting, NOS</Term>
        <Term>Transplantations, Skin</Term>
        <Term>skin grafts</Term>
        <Term>Grafts, Skin</Term>
        <Term>Skin grafts</Term>
        <Term>Skin Grafts</Term>
        <Term>SKIN TRANSPL</Term>
        <Term>Skin graft material</Term>
        <Term>TRANSPL SKIN</Term>
        <Term>Dermatoplasty, NOS</Term>
        <Term>graft skin</Term>
        <Term>Skin-grafting</Term>
        <Term>Grafting, Skin</Term>
        <Term>Repair of skin</Term>
        <Term>SKIN GRAFT</Term>
        <Term>Skin Grafting</Term>
        <Term>Dermatoplasties</Term>
        <Term>Transplantation, Skin</Term>
        <Term>Transplanted skin (body structure)</Term>
        <Term>Skin Transplantations</Term>
        <Term>skin graft material</Term>
        <Term>skin graft (treatment)</Term>
        <Term>skin transplant</Term>
        <Term>Graftings, Skin</Term>
        <Term>skin grafting</Term>
        <Term>Skin graft operation (procedure)</Term>
        <Term>Skin graft</Term>
        <Term>Skin graft NOS</Term>
        <Term>skin graft</Term>
        <Term>Dermatoplasty</Term>
        <Term>Skin graft operation</Term>
        <Term>Graft;skin</Term>
        <Term>skin transplants</Term>
        <Term>Skin graft material (substance)</Term>
        <Term>Transplanted skin</Term>
        <Term>Repair of skin (procedure)</Term>
        <Term>skin transplantation</Term>
        <Codes>
          <Code code="C12842" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Graft</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:integrin_beta1C" name="integrin beta1C">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">integrin beta1C</Term>
        <Term>integrin beta(1C)</Term>
        <Codes>
          <Code code="C0911723" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD29</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fc_epsilon_RII" name="Fc epsilon RII">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fc epsilon RII</Term>
        <Term>epsilon RII, Fc</Term>
        <Codes>
          <Code code="C0162826" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD23</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Nt5e_protein_mouse" name="Nt5e protein, mouse">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Nt5e protein, mouse</Term>
        <Term>5' nucleotidase, ecto protein, mouse</Term>
        <Codes>
          <Code code="C2932862" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:5_-Nucleotidase</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Leu-M1_antigen" name="Leu-M1 antigen">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Leu-M1 antigen</Term>
        <Term>LeuM1 antigen</Term>
        <Codes>
          <Code code="C0914033" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD15_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:MPLK_protein_human" name="MPLK protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">MPLK protein, human</Term>
        <Term>MPL-K protein, human</Term>
        <Term>myeloproliferative leukemia K protein, human</Term>
        <Codes>
          <Code code="C0652198" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:MPL_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:randomized_cross-over_design_" name="randomized cross-over design'">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">randomized cross-over design'</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#randomized_cross-over_design'" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cross-over_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:M520_Rat_Strain" name="M520, Rat Strain">
        <Definition>Low frequency of pancreatic exocrine tumours. By 12-15 months of age develop small local areas of nephritis that progress by 22-24 months to moderate to severe nephritis in 75% of animals (Snell 1967). About 33% of females over 18 months develop tumours of the uterus of endometrial origin. Adrenocortical adenomas (about 20% in males and 40% in females over 18 months of age), and phaeochromocytomas or preneoplastic nodules in adrenal medulla (about 67% of males over 21 months of age) (Snell 1965). Low blood pressure (21/23), reaching 121_1.2 (SEM) mmHg at 10 weeks of age. Resistant to development of methylcholanthrene -induced thyroiditis (Glover et al 1969).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">M520, Rat Strain</Term>
        <Codes>
          <Code code="C14409" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:AC133-2_antigen" name="AC133-2 antigen">
        <SemanticType code="T118" name="Carbohydrate"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">AC133-2 antigen</Term>
        <Codes>
          <Code code="C1138500" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:AC133_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:oligodendrocyte_O_antigen_mouse" name="oligodendrocyte O antigen, mouse">
        <SemanticType code="T109" name="Organic Chemical"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">oligodendrocyte O antigen, mouse</Term>
        <Term>O antigen, oligodendrocyte surface, mouse</Term>
        <Codes>
          <Code code="C1429294" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Nephroblastoma_Overexpressed_Protein" name="Nephroblastoma Overexpressed Protein">
        <Definition>A CCN protein family member found at high levels in NEPHROBLASTOMA cells. It is found both intracellularly and in the EXTRACELLULAR MATRIX and may play a role in the regulation of CELL PROLIFERATION and EXTRACELLULAR MATRIX synthesis.</Definition>
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Nephroblastoma Overexpressed Protein</Term>
        <Term>CCN3 Protein</Term>
        <Term>Nephroblastoma Overexpressed Gene Product</Term>
        <Term>IGFBP9 Protein</Term>
        <Term>Nephroblastoma Overexpressed Protein [Chemical/Ingredient]</Term>
        <Term>NOVH Protein</Term>
        <Codes>
          <Code code="C2350412" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
          <Relation name="Narrower">OTE:Nov_protein_mouse, OTE:NOV_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:pre-and-post_design" name="pre-and-post design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">pre-and-post design</Term>
        <Term>pre-post study</Term>
        <Term>pretest posttest studies</Term>
        <Term>pre-post trials</Term>
        <Term>pre-and-post designs</Term>
        <Term>pre-post design</Term>
        <Term>pretest posttest study</Term>
        <Term>pretest posttest trial</Term>
        <Term>pre-and-post study</Term>
        <Term>pre-post studies</Term>
        <Term>pre-and-post studies</Term>
        <Term>pre-and-post trial</Term>
        <Term>pre-and-post trials</Term>
        <Term>pre-post designs</Term>
        <Term>pre-test post-test study</Term>
        <Term>pretest posttest trials</Term>
        <Term>pre-test post-test trials</Term>
        <Term>pre-test post-test designs</Term>
        <Term>pre-test post-test trial</Term>
        <Term>pre-post trial</Term>
        <Term>pre-test post-test studies</Term>
        <Term>pre-test post-test design</Term>
        <Term>pre-post tests</Term>
        <Term>pretest posttest design</Term>
        <Term>pretest posttest designs</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#pre-and-post_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:before-after_design</Relation>
          <Relation name="Narrower">OTE:pre-test_post-test_control_group_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FH-4_antigen" name="FH-4 antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FH-4 antigen</Term>
        <Codes>
          <Code code="C0246539" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:sialosyl_dimeric_Leantigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:AKR_J_Mouse" name="AKR/J Mouse">
        <Definition>Originally disseminated by Detweiler and carried by Furth (1928-1936) and the Rockefeller Institute for subsequent generations. The AKR mouse has an albino coat (genotype a, B, c) and is highly susceptible to leukemias. The strain is viremic from birth in that all tissues express the AKV retrovirus and copies of the AKV genome are integrated in the mouse genome, which is associated with leukemia development. The AKR strain is also a source of the Thy1.1 thymocyte antigen, which is expressed on thymocyte, bone marrow and T cell progenitors and is used as a marker for a variety of stem cells.</Definition>
        <Definition>Originally disseminated by Detweiler and carried by Furth (1928-1936) and the Rockefeller Institute for subsequent generations. The AKR mouse has an albino coat (genotype a, B, c) and is highly susceptible to leukemias. The strain is viremic from birth in that all tissues express the AKV retrovirus and copies of the AKV genome are integrated in the mouse genome, which is associated with leukemia development. The AKR strain is also a source of the Thy1.1 thymocyte antigen, which is expressed on thymocyte, bone marrow and T cell progenitors and is used as a marker for a variety of stem cells. The strain has a low reproductive performance with small litter sizes at birth and weaning.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">AKR/J Mouse</Term>
        <Term>AKR/J</Term>
        <Codes>
          <Code code="C14505" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD55_Antigen" name="CD55 Antigen">
        <Definition>intrinsic red blood cell protein that prevents the assembly of convertase on the cell surface, thus protecting the cell from injury by autologous complement.</Definition>
        <Definition>This gene plays a role in the regulation of the complement cascade.</Definition>
        <Definition>GPI-linked membrane proteins broadly distributed among hematopoietic and non-hematopoietic cells. CD55 prevents the assembly of C3 CONVERTASE or accelerates the disassembly of preformed convertase, thus blocking the formation of the membrane attack complex.</Definition>
        <Definition>Complement decay-accelerating factor (381 aa, ~41 kDa) is encoded by the human CD55 gene. This protein plays a role in the negative regulation of the complement cascade.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD55 Antigen</Term>
        <Term>DECAY-ACCELERATING FACTOR FOR COMPLEMENT</Term>
        <Term>Decay accelerating factor</Term>
        <Term>Lymphocyte antigen CD55</Term>
        <Term>CD 055 ANTIGENS</Term>
        <Term>CD55 Gene</Term>
        <Term>DAF</Term>
        <Term>Decay-Accelerating Factor, Complement</Term>
        <Term>CR</Term>
        <Term>CD55</Term>
        <Term>Complement Decay Accelerating Factor</Term>
        <Term>CD55 antigen</Term>
        <Term>CD Antigen CD55</Term>
        <Term>decay accelerating factor</Term>
        <Term>Cluster of diff antigen 55</Term>
        <Term>ANTIGENS CD 055</Term>
        <Term>CD55 molecule, decay accelerating factor for complement (Cromer blood group)</Term>
        <Term>CD55 Molecule, Decay Accelerating Factor for Complement (Cromer Blood Group) Gene</Term>
        <Term>CD55 Antigens</Term>
        <Term>Decay accelerating factor (substance)</Term>
        <Term>DAF - Decay accelerating factor</Term>
        <Term>Complement decay accelerating factor</Term>
        <Term>Antigens, CD55</Term>
        <Term>CROM</Term>
        <Term>CD55 gene</Term>
        <Term>Decay Accelerating Factor</Term>
        <Term>daf</Term>
        <Term>CD55 - Cluster of diff ag 55</Term>
        <Term>TC</Term>
        <Term>CD55 - Cluster of differentiation antigen 55</Term>
        <Term>CD55 ANTIGEN</Term>
        <Term>Complement Decay-Accelerating Factor</Term>
        <Term>Antigens, CD55 [Chemical/Ingredient]</Term>
        <Term>DAF - Decay accelerating fact</Term>
        <Term>Decay-Accelerating Factor</Term>
        <Term>Cluster of differentiation antigen 55</Term>
        <Codes>
          <Code code="C0108793" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:decay-accelerating_factor_1_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD1e_antigen" name="CD1e antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD1e antigen</Term>
        <Codes>
          <Code code="C0963018" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD1</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin_17_Receptor_B" name="Interleukin 17 Receptor B">
        <Definition>Interleukin-17 receptor B (502 aa, ~56 kDa) is encoded by the human IL17RB gene. This protein plays a role in both cytokine binding and interleukin-mediated signaling.</Definition>
        <Definition>Specific for IL-17B and IL-17E</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin 17 Receptor B</Term>
        <Term>Interleukin-17 Receptor B</Term>
        <Codes>
          <Code code="C1706285" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_Interleukin-17</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Itga7_protein_mouse" name="Itga7 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Itga7 protein, mouse</Term>
        <Term>integrin alpha 7, mouse</Term>
        <Codes>
          <Code code="C1721217" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:integrin_alpha7</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FHH_Rat_Strain" name="FHH, Rat Strain">
        <Definition>Origin: An outbred stock of fawn hooded rats introduced into Europe by Tschopp in the early 1970s. Maintained as an outbred stock until the mid-1980s, then brother x sister mating initiated by A.P. Provoost to produce two strains designated FHH (also known as FHR) and FHL, which differ in hypertension and proteinuria.  FHH develops focal and segmental glomerular sclerosis, systemic hypertension and proteinuria at a young age, but these effects are more marked in FHH than FHL (Simons et al, 1993). The renal disease and hypertension are under independent genetic control, and both appear to be independent of the red-eyed dilution gene which causes platelet storage disease (Brown et al,1996)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FHH, Rat Strain</Term>
        <Term>Fawn Hooded Hypertension</Term>
        <Codes>
          <Code code="C14403" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Perissodactyla" name="Perissodactyla">
        <Definition>The taxonomic order of mammals that includes odd-toed ungulates such as horses, zebras, tapirs, and rhinoceroses.</Definition>
        <Definition>An order of ungulates having an odd number of toes, including the horse, tapir, and rhinoceros. (Dorland, 27th ed)</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Perissodactyla</Term>
        <Term>ORDER PERISSODACTYLA - ODD-TOED HOOFED MAMMALS</Term>
        <Term>Odd-toed ungulate</Term>
        <Term>8A ORDER PERISSODACTYLA - ODD-TOED HOOFED MAMMALS</Term>
        <Term>Odd-toed hoofed mammals</Term>
        <Term>Perissodactylas</Term>
        <Term>Order Perissodactyla (organism)</Term>
        <Term>Order Perissodactyla</Term>
        <Term>odd toed hoofed mammal</Term>
        <Codes>
          <Code code="C79107" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mammalia</Relation>
          <Relation name="Narrower">OTE:Equidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tnfrsf6_protein_rat" name="Tnfrsf6 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tnfrsf6 protein, rat</Term>
        <Term>Tumor necrosis factor receptor superfamily, member 6 protein, rat</Term>
        <Term>Fas protein, rat</Term>
        <Codes>
          <Code code="C1454644" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD95</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:H-type-1_antigen" name="H-type-1 antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">H-type-1 antigen</Term>
        <Term>H-type-1 carbohydrate antigen</Term>
        <Codes>
          <Code code="C0911685" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin_17_Receptor_C" name="Interleukin 17 Receptor C">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin 17 Receptor C</Term>
        <Term>Interleukin-17 Receptor C</Term>
        <Codes>
          <Code code="C1706286" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_Interleukin-17</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:hairy_cell_leukemia_antigen_HC2_human" name="hairy cell leukemia antigen, HC2, human">
        <SemanticType code="T109" name="Organic Chemical"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">hairy cell leukemia antigen, HC2, human</Term>
        <Term>HC2 antigen, human</Term>
        <Term>hairy cell leukemia-associated antigen, human</Term>
        <Codes>
          <Code code="C1429435" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Differentiation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin_17_Receptor_D" name="Interleukin 17 Receptor D">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin 17 Receptor D</Term>
        <Term>Interleukin-17 Receptor D</Term>
        <Codes>
          <Code code="C1706287" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_Interleukin-17</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin_17_Receptor_E" name="Interleukin 17 Receptor E">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin 17 Receptor E</Term>
        <Term>Interleukin-17 Receptor E</Term>
        <Codes>
          <Code code="C1706288" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_Interleukin-17</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:incidence_study" name="incidence study">
        <SemanticType code="T081" name="Quantitative Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">incidence study</Term>
        <Term>Studies, Incidence</Term>
        <Term>Study, Incidence</Term>
        <Term>Incidence Studies</Term>
        <Term>incidence studies</Term>
        <Term>Incidence Study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#incidence_study" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:cohort_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:STS_A_Mouse" name="STS/A Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">STS/A Mouse</Term>
        <Term>STS/A</Term>
        <Codes>
          <Code code="C37442" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Species_Slot" name="Species Slot">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Species Slot</Term>
        <Relations>
          <Relation name="Broader">OTE:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Hyp1_protein_Hydra_attenuata" name="Hyp1 protein, Hydra attenuata">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Hyp1 protein, Hydra attenuata</Term>
        <Codes>
          <Code code="C1308005" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:biological_markers</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Guinea_Pig" name="Guinea Pig">
        <Definition>The domesticated guinea pig, Cavia porcellus. (NCI)</Definition>
        <Definition>The domesticated guinea pig, Cavia porcellus.</Definition>
        <Definition>A common name used for the family Caviidae. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.</Definition>
        <Definition>stout-bodied nearly tailless domesticated cavy; often kept as a pet and widely used in research.</Definition>
        <Definition>A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Guinea Pig</Term>
        <Term>allergy testing Guinea pig (lab test)</Term>
        <Term>Wild guinea pig, NOS</Term>
        <Term>guinea-pigs</Term>
        <Term>Cavy, NOS</Term>
        <Term>Guinea pig</Term>
        <Term>cavies</Term>
        <Term>cavia</Term>
        <Term>Genus Cavia (organism)</Term>
        <Term>Pigs, Guinea</Term>
        <Term>Cavia porcellus (organism)</Term>
        <Term>Cavia porcellus</Term>
        <Term>Mixed breed guinea-pig</Term>
        <Term>Mixed breed guinea pig</Term>
        <Term>Wild guinea pig</Term>
        <Term>Guinea pigs</Term>
        <Term>guinea pigs</Term>
        <Term>guinea pig</Term>
        <Term>Guinea-pig</Term>
        <Term>Cavy</Term>
        <Term>GUINEA PIG</Term>
        <Term>Pig, Guinea</Term>
        <Term>Cavia cobaya</Term>
        <Term>cavi</Term>
        <Term>Cavia aperea porcellus</Term>
        <Term>Guinea pig, NOS</Term>
        <Term>Cavia, NOS</Term>
        <Term>cavy</Term>
        <Term>Guinea Pigs</Term>
        <Term>Genus Cavia</Term>
        <Term>cavia cobaya</Term>
        <Term>Mammals, Guinea Pigs</Term>
        <Term>Domestic guinea pig</Term>
        <Term>allergy testing Guinea pig</Term>
        <Term>Cavia</Term>
        <Codes>
          <Code code="C2097384" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Caviidae</Relation>
          <Relation name="Narrower">OTE:Hartley_Guinea_Pig, OTE:Dunkin_Hartley_Guinea_Pig, OTE:Hartley_Albino_Hairless_Guinea_Pig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ehnicity_Slot" name="Ehnicity Slot">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ehnicity Slot</Term>
        <Relations>
          <Relation name="Broader">OTE:Slot</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD53_protein_human" name="CD53 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD53 protein, human</Term>
        <Term>CD53 antigen, human</Term>
        <Term>MOX44 protein, human</Term>
        <Term>TSPAN25 protein, human</Term>
        <Codes>
          <Code code="C2975742" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD53</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ICR_Mouse" name="ICR Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ICR Mouse</Term>
        <Term>ICR Mice</Term>
        <Term>Inbred ICR Mouse</Term>
        <Term>mice icr</Term>
        <Term>icr mice</Term>
        <Term>Mouse, ICR</Term>
        <Term>Mouse, Inbred ICR</Term>
        <Term>Inbred ICR Mice</Term>
        <Term>ICR Mice, Inbred</Term>
        <Term>ICR</Term>
        <Term>ICR Mouse, Inbred</Term>
        <Term>Mice, Inbred ICR</Term>
        <Term>Mice, ICR</Term>
        <Codes>
          <Code code="C37408" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SK_F_106528" name="SK&amp;F 106528">
        <SemanticType code="T109" name="Organic Chemical"/>
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SK&amp;F 106528</Term>
        <Term>SK&amp;F-106528</Term>
        <Codes>
          <Code code="C0994615" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:recombinant_soluble_CD4</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Lyb-2_antigen_human" name="Lyb-2 antigen, human">
        <Definition>CD72 antigen (359 aa, 40 kD) is a cell adhesion process protein that is encoded by the human CD72 gene and has a role in cell adhesion.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Lyb-2 antigen, human</Term>
        <Term>CD72 protein, human</Term>
        <Term>AFTR antigen, human</Term>
        <Term>CD72 antigen, human</Term>
        <Codes>
          <Code code="C0081944" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Receptor_Thrombopoietin" name="Receptor, Thrombopoietin">
        <Definition>Cell surface receptors that are specific for THROMBOPOIETIN. They signal through interaction with JANUS KINASES such as JANUS KINASE 2.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Receptor, Thrombopoietin</Term>
        <Term>Receptors, Thrombopoietin</Term>
        <Term>CD110 Antigens</Term>
        <Term>Antigens, CD110</Term>
        <Term>Thrombopoietin Receptors</Term>
        <Term>ANTIGENS CD 110</Term>
        <Term>Ligand Receptor, MPL</Term>
        <Term>MPL Ligand Receptor</Term>
        <Term>CD 110 ANTIGENS</Term>
        <Term>Thrombopoietin Receptor</Term>
        <Term>Receptor, MPL Ligand</Term>
        <Codes>
          <Code code="C1706293" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:Mpl_protein_mouse, OTE:MPL_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd37_protein_rat" name="Cd37 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd37 protein, rat</Term>
        <Term>CD37 antigen, rat</Term>
        <Codes>
          <Code code="C1611033" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Goat" name="Goat">
        <Definition>Cabra doméstica</Definition>
        <Definition>Domestic goat</Definition>
        <Definition>Any one of several species in the genus Capra, most commonly Capra hircus.</Definition>
        <Definition>any of various hollow-horned ruminant mammals of the genus Capra related to the sheep but of lighter build and with backwardly arching horns, a short tail, and usually straight hair.</Definition>
        <Definition>Any of various hollow-horned, bearded ruminant mammals of the genus Capra, originally of mountainous areas of the Old World, especially any of the domesticated forms of C. hircus, raised for wool, milk, and meat. (from American Heritage Dictionary on line)</Definition>
        <Definition>Any of numerous agile, hollow-horned RUMINANTS of the genus Capra, in the family Bovidae, closely related to the SHEEP.</Definition>
        <SemanticType code="T059" name="Laboratory Procedure"/>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Goat</Term>
        <Term>caprid</Term>
        <Term>Caprine species</Term>
        <Term>Capra hircus</Term>
        <Term>Capra</Term>
        <Term>Caprine Species</Term>
        <Term>802 CAPRINE SPECIES</Term>
        <Term>Mammals, Goats</Term>
        <Term>Goat (organism)</Term>
        <Term>Capra hircus hircus</Term>
        <Term>domestic goat</Term>
        <Term>Capra hircus aegagrus (organism)</Term>
        <Term>Caprine, NOS</Term>
        <Term>Capra hircus aegagrus</Term>
        <Term>Goats</Term>
        <Term>allergy testing goat (lab test)</Term>
        <Term>Capra aegagrus hircus</Term>
        <Term>goat</Term>
        <Term>allergy testing goat</Term>
        <Term>Capras</Term>
        <Term>CAPRINE SPECIES</Term>
        <Term>caprine</Term>
        <Term>GOAT</Term>
        <Term>Capra hircus (organism)</Term>
        <Term>goats</Term>
        <Codes>
          <Code code="C0018019" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Bovidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SLURP-1_protein_rat" name="SLURP-1 protein, rat">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SLURP-1 protein, rat</Term>
        <Codes>
          <Code code="C2742346" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:LILRB5_protein_human" name="LILRB5 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">LILRB5 protein, human</Term>
        <Term>leukocyte Ig-like receptor B5, human</Term>
        <Codes>
          <Code code="C2352530" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD63_protein_human" name="CD63 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD63 protein, human</Term>
        <Term>CD63-related protein, human</Term>
        <Term>tspan-30 protein, human</Term>
        <Term>CD63-related antigen, human</Term>
        <Term>CD63 antigen, human</Term>
        <Term>tetraspanin-30 protein, human</Term>
        <Term>MLA1 protein, human</Term>
        <Codes>
          <Code code="C1612112" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD63</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD69_protein_human" name="CD69 protein, human">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD69 protein, human</Term>
        <Term>early activation antigen CD69, human</Term>
        <Term>CD69 antigen, human</Term>
        <Codes>
          <Code code="C2744535" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:antigens_CD69</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Fcgr3_protein_rat" name="Fcgr3 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Fcgr3 protein, rat</Term>
        <Term>Fc receptor, IgG, low affinity III protein, rat</Term>
        <Term>Fc gamma receptor RIII, rat</Term>
        <Term>FcgammaRIII protein, rat</Term>
        <Codes>
          <Code code="C1702804" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Talpidae_Family_Mole" name="Talpidae Family Mole">
        <Definition>A small, mammal of the family Talpidae that lives underground and feeds on small invertebrates. The mole has tiny covered eyes that are believed to be able to distinguish night from day, and not much else.</Definition>
        <Definition>Any of numerous burrowing mammals found in temperate regions and having minute eyes often covered with skin.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Talpidae Family Mole</Term>
        <Term>mole</Term>
        <Term>Moles</Term>
        <Term>FAMILY TALPIDAE</Term>
        <Term>846 FAMILY TALPIDAE</Term>
        <Term>Family Talpidae (organism)</Term>
        <Term>Family Talpidae</Term>
        <Term>Mole, NOS</Term>
        <Term>Talpidae</Term>
        <Term>Mole</Term>
        <Codes>
          <Code code="C0324740" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mammalia</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Il18rap_protein_rat" name="Il18rap protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Il18rap protein, rat</Term>
        <Term>interleukin 18 receptor accessory protein, rat</Term>
        <Codes>
          <Code code="C1436520" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Interleukin_18_Receptor_beta_Subunit</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD81_Antigen" name="CD81 Antigen">
        <Definition>Tetraspanin proteins that are involved in a variety of cellular functions including BASEMENT MEMBRANE assembly, and in the formation of a molecular complexes on the surface of LYMPHOCYTES.</Definition>
        <Definition>CD81 antigen (236 aa, ~26 kDa) is encoded by the human CD81 gene. This protein is involved in the regulation of the immune response and can promote Hepatitis C infection by binding to viral envelope proteins..</Definition>
        <Definition>This gene may play a role in signal transduction.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T028" name="Gene or Genome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD81 Antigen</Term>
        <Term>CD81</Term>
        <Term>CD81 Antigens</Term>
        <Term>TSPAN28</Term>
        <Term>Lymphocyte antigen CD81 (substance)</Term>
        <Term>Tetraspanin-28</Term>
        <Term>Antigens, CD81</Term>
        <Term>Antigens, CD81 [Chemical/Ingredient]</Term>
        <Term>Target Of The Antiproliferative Antibody 1</Term>
        <Term>TARGET OF ANTIPROLIFERATIVE ANTIBODY 1</Term>
        <Term>CD81 Gene</Term>
        <Term>26 kDa Cell Surface Protein TAPA-1</Term>
        <Term>TAPA1</Term>
        <Term>CD81 ANTIGEN</Term>
        <Term>Tetraspanin 28</Term>
        <Term>Antigen, TAPA-1</Term>
        <Term>Antigen, CD81</Term>
        <Term>Tspan-28</Term>
        <Term>TAPA-1 Antigen</Term>
        <Term>CD81 gene</Term>
        <Term>TAPA 1 Antigen</Term>
        <Term>TAPA-1</Term>
        <Term>CD81 molecule</Term>
        <Term>Lymphocyte antigen CD81</Term>
        <Term>CD81 Molecule Gene</Term>
        <Term>CD81 antigen</Term>
        <Codes>
          <Code code="C0084715" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:CD81_protein_human, OTE:Cd81_protein_mouse, OTE:Cd81_protein_rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ecological_cross-sectional_study" name="ecological cross-sectional study">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ecological cross-sectional study</Term>
        <Term>ecological cross-sectional trial</Term>
        <Term>ecological cross sectional designs</Term>
        <Term>ecological cross sectional design</Term>
        <Term>ecological cross-sectional design</Term>
        <Term>ecological cross sectional trial</Term>
        <Term>ecological cross-sectional trials</Term>
        <Term>ecological cross-sectional studies</Term>
        <Term>ecological cross sectional studies</Term>
        <Term>ecological cross sectional trials</Term>
        <Term>ecological cross-sectional designs</Term>
        <Term>ecological cross sectional study</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#ecological_cross_sectional_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:ecological_study, OTE:cross-sectional_study</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin-13_Receptor_alpha2_Subunit" name="Interleukin-13 Receptor alpha2 Subunit">
        <Definition>An interleukin-13 receptor subunit that is closely-related to the INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT. The receptor is found as a monomeric protein and has been considered to be a decoy receptor for interleukin-13 due the fact that it lacks cytoplasmic signaling domains.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin-13 Receptor alpha2 Subunit</Term>
        <Term>Interleukin-13 alpha2 Receptor</Term>
        <Term>Antigen, CD213a2</Term>
        <Term>alpha2 Receptor, Interleukin-13</Term>
        <Term>Receptor alpha2, Interleukin-13</Term>
        <Term>Receptor, Interleukin-13 alpha2</Term>
        <Term>Interleukin 13 Receptor alpha2</Term>
        <Term>CD213a2 Antigen</Term>
        <Term>INTERLEUKIN 013 RECEPTOR ALPHA 2 SUBUNIT</Term>
        <Term>Interleukin 13 Receptor alpha2 Subunit</Term>
        <Term>Interleukin 13 Decoy Receptor</Term>
        <Term>CD213a2 Antigens</Term>
        <Term>Interleukin-13 Decoy Receptor</Term>
        <Term>Interleukin-13 Receptor alpha2</Term>
        <Term>Interleukin-13 Receptor alpha2 Chain</Term>
        <Term>IL-13 Receptor alpha2</Term>
        <Term>Antigens, CD213a2</Term>
        <Term>IL13Ralpha2</Term>
        <Term>Decoy Receptor, Interleukin-13</Term>
        <Term>Interleukin 13 Receptor alpha2 Chain</Term>
        <Term>RECEPTOR INTERLEUKIN 013 ALPHA 2</Term>
        <Term>Receptor alpha2, IL-13</Term>
        <Term>IL 13 Receptor alpha2</Term>
        <Codes>
          <Code code="C0968296" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:IL17REL_protein_human" name="IL17REL protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">IL17REL protein, human</Term>
        <Term>interleukin 17 receptor E-like protein, human</Term>
        <Codes>
          <Code code="C2933227" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptors_Interleukin-17</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BR_Mouse" name="C57BR Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BR Mouse</Term>
        <Term>C57BR</Term>
        <Codes>
          <Code code="C37389" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:single_blinded_randomized_controlled_trial" name="single blinded randomized controlled trial">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">single blinded randomized controlled trial</Term>
        <Term>single-blinded randomized controlled trial</Term>
        <Term>single-blinded rct</Term>
        <Term>single blinded randomized controlled design</Term>
        <Term>single-blinded randomized controlled design</Term>
        <Term>single-blinded rcts</Term>
        <Term>single blinded randomised controlled studies</Term>
        <Term>single-blinded randomised controlled study</Term>
        <Term>single-blinded randomized controlled study</Term>
        <Term>single blinded randomized controlled designs</Term>
        <Term>single-blinded randomised controlled studies</Term>
        <Term>single blinded randomised controlled designs</Term>
        <Term>single-blinded randomized controlled designs</Term>
        <Term>single blinded randomized controlled trials</Term>
        <Term>single blinded randomised controlled trial</Term>
        <Term>single-blinded randomised controlled trial</Term>
        <Term>single-blinded randomised controlled trials</Term>
        <Term>single-blinded randomised controlled designs</Term>
        <Term>single-blinded randomized controlled trials</Term>
        <Term>single blinded rcts</Term>
        <Term>single blinded randomised controlled study</Term>
        <Term>single-blinded randomized controlled studies</Term>
        <Term>single blinded randomised controlled trials</Term>
        <Term>single-blinded randomised controlled design</Term>
        <Term>single blinded randomized controlled studies</Term>
        <Term>single blinded rct</Term>
        <Term>single blinded randomized controlled study</Term>
        <Term>single blinded randomised controlled design</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#single_blinded_randomized_controlled_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:randomized_controlled_trial</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Liver_Transplantation" name="Liver Transplantation">
        <Definition>Přenesení části jater nebo celého orgánu z člověka nebo zvířete do druhého těla.</Definition>
        <Definition>The transfer of a healthy liver allograft from a donor to a patient.</Definition>
        <Definition>&lt;p&gt;Your liver is the largest organ inside your body. It helps your body digest food, store energy, and remove poisons. You cannot live without a liver that works. If your liver fails, your doctor may put you on a waiting list for a liver transplant. Doctors do liver transplants when other treatment cannot keep a damaged liver working.&lt;/p&gt;&lt;p&gt;During a liver transplantation, the surgeon removes the diseased liver and replaces it with a healthy one. Most transplant livers come from a donor who has died. Sometimes there is a living donor. This is when a healthy person donates part of his or her liver for a specific patient.&lt;/p&gt;&lt;p&gt;The most common reason for a transplant in adults is &lt;a href='http://www.nlm.nih.gov/medlineplus/cirrhosis.html'&gt;cirrhosis&lt;/a&gt;. This is scarring of the liver, caused by injury or long-term disease. The most common reason in children is biliary atresia, a disease of the &lt;a href='http://www.nlm.nih.gov/medlineplus/bileductdiseases.html'&gt;bile ducts&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;If you have a transplant, you must take drugs the rest of your life to help keep your body from rejecting the new liver.&lt;/p&gt; &lt;p &gt;NIH: National Institute of Diabetes and Digestive and Kidney Diseases&lt;/p&gt;</Definition>
        <Definition>transference of the liver within an individual, between individuals of the same species, or between individuals of different species.</Definition>
        <Definition>The transference of a part of or an entire liver from one human or animal to another.</Definition>
        <SemanticType code="T033" name="Finding"/>
        <SemanticType code="T061" name="Therapeutic or Preventive Procedure"/>
        <SemanticType code="T023" name="Body Part, Organ, or Organ Component"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Liver Transplantation</Term>
        <Term>transplanted liver (physical finding)</Term>
        <Term>LTx - Liver transplant</Term>
        <Term>Grafting, Liver</Term>
        <Term>TRANSPL LIVER</Term>
        <Term>Finding of transplanted liver on examination</Term>
        <Term>hepatic transplantation</Term>
        <Term>Liver allotransplantation; heterotopic, partial or whole, from cadaver or living donor, any age</Term>
        <Term>Transplantation of Liver</Term>
        <Term>liver transplantations</Term>
        <Term>liver transplants</Term>
        <Term>LIVER TRANSPLANT</Term>
        <Term>Liver Transplantation Procedures</Term>
        <Term>TRANSPL HEPATIC</Term>
        <Term>Transplantation, Hepatic</Term>
        <Term>liver transplant</Term>
        <Term>Transplanted liver</Term>
        <Term>HEPATIC TRANSPL</Term>
        <Term>LTX - Liver transplant</Term>
        <Term>Transplantation of liver (procedure)</Term>
        <Term>livers transplants</Term>
        <Term>Structure of transplanted liver (body structure)</Term>
        <Term>Graftings, Liver</Term>
        <Term>liver graft</Term>
        <Term>Liver Graftings</Term>
        <Term>Liver Grafting</Term>
        <Term>liver transplant (treatment)</Term>
        <Term>Transplant;liver</Term>
        <Term>Entire transplanted liver (body structure)</Term>
        <Term>LVR ALTRNSPLJ HTRTPC PRTL/WHL DON ANY AGE</Term>
        <Term>Hepatic Transplantation</Term>
        <Term>Transplantations, Liver</Term>
        <Term>liver transplanted</Term>
        <Term>Transplantations, Hepatic</Term>
        <Term>TRANSPLANTATION OF LIVER</Term>
        <Term>Hepatic transplantation</Term>
        <Term>Transplantation of liver</Term>
        <Term>LIVER TRANSPL</Term>
        <Term>Tx - Liver transplantation</Term>
        <Term>Liver transplantation</Term>
        <Term>liver transplantation procedure</Term>
        <Term>Structure of transplanted liver</Term>
        <Term>transplanted liver</Term>
        <Term>transplantation of liver</Term>
        <Term>Transplantation of liver, NOS</Term>
        <Term>Liver transplant</Term>
        <Term>Transplantation, Liver</Term>
        <Term>Liver--Transplantation</Term>
        <Term>LVR ALTRNSPLJ ORTHOTOPIC PRTL/WHL DON ANY AGE</Term>
        <Term>Hepatic Transplantations</Term>
        <Term>Liver Transplant</Term>
        <Term>liver transplanting</Term>
        <Term>liver transplantation</Term>
        <Term>Entire transplanted liver</Term>
        <Term>Liver Transplantations</Term>
        <Term>Liver allotransplantation; orthotopic, partial or whole, from cadaver or living donor, any age</Term>
        <Codes>
          <Code code="C0372197" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Organ_Transplantation</Relation>
          <Relation name="Narrower">OTE:Orthotopic_Liver_Transplantation</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:KLRD1_protein_human" name="KLRD1 protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">KLRD1 protein, human</Term>
        <Term>CD94 antigen, human</Term>
        <Term>Kp43 antigen, human</Term>
        <Term>killer cell lectin-like receptor subfamily D, member 1 protein, human</Term>
        <Codes>
          <Code code="C1506359" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:NK_Cell_Lectin-Like_Receptor_Subfamily_D</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57L_Mouse" name="C57L Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57L Mouse</Term>
        <Term>C57L</Term>
        <Codes>
          <Code code="C1511388" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Interleukin_8A_Receptors" name="Interleukin 8A Receptors">
        <Definition>High-affinity G-protein-coupled receptors for INTERLEUKIN-8 present on NEUTROPHILS; MONOCYTES; and BASOPHILS.</Definition>
        <Definition>High Affinity Interleukin-8 Receptor A (350 aa, 40 kD) is a cell motility protein that is encoded by the human IL8RA gene and has roles in inflammatory response, chemotaxis and signal transduction.</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Interleukin 8A Receptors</Term>
        <Term>MDNCF Receptors</Term>
        <Term>CXC CHEMOKINE RECEPT 1</Term>
        <Term>CXC CHEMOKINE RECEPTOR 001</Term>
        <Term>Interleukin 8A Receptor</Term>
        <Term>Receptors, CXCR1</Term>
        <Term>Receptors, IL-8A</Term>
        <Term>Antigens, CDw128a</Term>
        <Term>RECEPT CXCR1</Term>
        <Term>Receptor, IL-8A</Term>
        <Term>Receptors, Interleukin 8A</Term>
        <Term>RECEPT IL 8A</Term>
        <Term>CXCR1 Receptor</Term>
        <Term>ANTIGENS CD 128AW</Term>
        <Term>NAP 01 RECEPT</Term>
        <Term>Receptors, Interleukin-8A</Term>
        <Term>CXC Chemokine Receptor 1</Term>
        <Term>INTERLEUKIN 8 RECEPT TYPE A</Term>
        <Term>IL 8A RECEPT</Term>
        <Term>Receptors, MDNCF</Term>
        <Term>Receptor, Interleukin 8A</Term>
        <Term>CXCR1 Receptors</Term>
        <Term>IL 8A Receptors</Term>
        <Term>High Affinity Interleukin-8 Receptor A</Term>
        <Term>RECEPTORS INTERLEUKIN 008A</Term>
        <Term>IL 008A RECEPTORS</Term>
        <Term>INTERLEUKIN 8A RECEPTS</Term>
        <Term>NAP-1 Receptor</Term>
        <Term>CXCR1 RECEPT</Term>
        <Term>MDNCF RECEPT</Term>
        <Term>High Affinity Interleukin 8 Receptor A</Term>
        <Term>IL 8A Receptor</Term>
        <Term>IL-8A Receptor</Term>
        <Term>Interleukin-8A Receptors</Term>
        <Term>IL-8A Receptors</Term>
        <Term>CDw128a Antigens</Term>
        <Term>CXCR 001 RECEPTORS</Term>
        <Term>Receptor, CXCR1</Term>
        <Term>Receptor, NAP-1</Term>
        <Term>INTERLEUKIN 008A RECEPTORS</Term>
        <Term>Interleukin 8 Receptor Type A</Term>
        <Term>RECEPTORS CXCR 001</Term>
        <Term>NAP 1 Receptor</Term>
        <Term>CD 128AW ANTIGENS</Term>
        <Codes>
          <Code code="C0526339" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:CXCR1-like_protein_mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SM_J_Mouse" name="SM/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SM/J Mouse</Term>
        <Term>SM/J</Term>
        <Codes>
          <Code code="C14612" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Remote_Sensing_Technology" name="Remote Sensing Technology">
        <Definition>Observation and aquisition of physical data from a distance by viewing and making measurements from a distance or receiving transmitted data from observations made at distant location.</Definition>
        <SemanticType code="T066" name="Machine Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Remote Sensing Technology</Term>
        <Term>Technology, Remote Sensing</Term>
        <Term>Remote Sensing Technologies</Term>
        <Term>Technologies, Remote Sensing</Term>
        <Codes>
          <Code code="C2936613" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Telemetry</Relation>
          <Relation name="Narrower">OTE:Satellite_Imagery</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd82_antigen_mouse" name="Cd82 antigen, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd82 antigen, mouse</Term>
        <Term>Kai1 protein, mouse</Term>
        <Term>C33 antigen, mouse</Term>
        <Term>kangai 1 (suppression of tumorigenicity 6, prostate) protein, mouse</Term>
        <Term>inducible membrane protein R2, mouse</Term>
        <Codes>
          <Code code="C1528438" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:KAI1_Protein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tnfrsf4_protein_mouse" name="Tnfrsf4 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tnfrsf4 protein, mouse</Term>
        <Term>tumor necrosis factor receptor superfamily, member 4, mouse</Term>
        <Term>CD134 antigen, mouse</Term>
        <Term>OX40 protein, mouse</Term>
        <Codes>
          <Code code="C1680590" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Receptor_OX40</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C57BL_10_Mouse" name="C57BL/10 Mouse">
        <Definition>Derived by Little (1921) from A Lathrop stocks and separated out before 1937, the C57BL/10 mouse has a black coat and carries a Y chromosome of Asian Mus musculus origin and a LINE-1 element from Mus spretus. Substrain C57BL/10 differs from other substrains at multiple loci, including H9, Igh2 and Lv, on chromosome 4 and has a high incidence of spontaneous mutations.</Definition>
        <Definition>Derived by Little (1921) from A Lathrop stocks and separated out before 1937. The C57BL/10 strain carries a Y chromosome of Asian Mus musculus origin and a LINE-1 element from Mus spretus, suggesting that up to 6.5% of the genome is Mus spretus in origin. Substrain C57BL/10 differs from other substrains at multiple loci, including H9, Igh2 and Lv, on chromosome 4 and has a high incidence of spontaneous mutations. The mouse model has a 30% spontaneous tumor formation in both sexes, these tumors are comprised mostly of lymphomas. The C57BL/10 strain exhibits good reproductive performance.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C57BL/10 Mouse</Term>
        <Term>C57BL/10</Term>
        <Codes>
          <Code code="C37376" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:nested_case_control_design" name="nested case control design">
        <Definition>A study in which a group or cohort of individuals is followed for a certain length of time or until a specific outcome is reached. Studies of this type incorporate the strengths of both cohort and case-control studies but eliminates a portion of the methodologic challenges inherent in both types of studies. [NCIT_14.05d] </Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">nested case control design</Term>
        <Term>nested case control trial</Term>
        <Term>nested case control studies</Term>
        <Term>nested case-control study</Term>
        <Term>nested case-control designs</Term>
        <Term>nested case-control trials</Term>
        <Term>nested case control trials</Term>
        <Term>nested case-control design</Term>
        <Term>nested case-control trial</Term>
        <Term>nested case control study</Term>
        <Term>nested case control designs</Term>
        <Term>nested case-control studies</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#nested_case_control_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:case_control_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C3Smn_CB17-Prkdc-scid_J_Mouse" name="C3Smn.CB17-Prkdc-scid/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C3Smn.CB17-Prkdc-scid/J Mouse</Term>
        <Term>C3Smn.CB17-Prkdc-scid/J</Term>
        <Term>C3Smn.C-Prkdc-scid/J</Term>
        <Codes>
          <Code code="C15165" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:SCID_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:L-endoglin_protein_human" name="L-endoglin protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">L-endoglin protein, human</Term>
        <Codes>
          <Code code="C2607815" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:ENG_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:129S1_SvImJ_Mouse" name="129S1/SvImJ Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">129S1/SvImJ Mouse</Term>
        <Term>129S1/SvImJ</Term>
        <Codes>
          <Code code="C37336" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Actigraphy" name="Actigraphy">
        <Definition>measurement of physical activity; can attach device to body to record activity (actigraph watch).</Definition>
        <Definition>The measurement and recording of MOTOR ACTIVITY to assess rest/activity cycles.</Definition>
        <SemanticType code="T060" name="Diagnostic Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Actigraphy</Term>
        <Term>actigraphy</Term>
        <Term>actigraphy (procedure)</Term>
        <Codes>
          <Code code="C1171301" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Physiologic_Monitoring</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Indonesia_Zebrafish" name="Indonesia Zebrafish">
        <Definition>A wild-type zebrafish line, the stock of which was obtained from an Indonesian fish dealer.</Definition>
        <SemanticType code="T013" name="Fish"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Indonesia Zebrafish</Term>
        <Term>INDO</Term>
        <Term>Indonesia</Term>
        <Codes>
          <Code code="C2987743" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Zebrafish</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:disease_frequency_survey" name="disease frequency survey">
        <Definition>A study in which participants are examined at only a single time for characteristics of a disease.</Definition>
        <Definition>Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.</Definition>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">disease frequency survey</Term>
        <Term>Survey, Cross-Sectional</Term>
        <Term>Analysis, Cross Sectional</Term>
        <Term>Cross Sectional Analysis</Term>
        <Term>Analyses, Cross Sectional</Term>
        <Term>Cross-Sectional Study</Term>
        <Term>Cross Sectional Analyses</Term>
        <Term>cross-sectional study</Term>
        <Term>DIS FREQUENCY SURVEYS</Term>
        <Term>Disease Frequency Surveys</Term>
        <Term>Study, Cross-Sectional</Term>
        <Term>CROSS SECTIONAL STUDIES</Term>
        <Term>Cross-Sectional Studies</Term>
        <Term>Disease Frequency Survey</Term>
        <Term>surveys, disease frequency</Term>
        <Term>Surveys, Cross-Sectional</Term>
        <Term>Cross-Sectional Analyses</Term>
        <Term>Cross Sectional Studies</Term>
        <Term>Cross Sectional Survey</Term>
        <Term>SURVEYS DIS FREQUENCY</Term>
        <Term>Analysis, Cross-Sectional</Term>
        <Term>Survey, Disease Frequency</Term>
        <Term>Cross-Sectional Survey</Term>
        <Term>CROSS SECTIONAL ANAL</Term>
        <Term>cross-sectional studies</Term>
        <Term>Cross-Sectional Surveys</Term>
        <Term>Analyses, Cross-Sectional</Term>
        <Term>ANAL CROSS SECTIONAL</Term>
        <Term>Cross-Sectional Analysis</Term>
        <Term>Studies, Cross-Sectional</Term>
        <Term>Surveys, Disease Frequency</Term>
        <Term>disease frequency surveys</Term>
        <Term>cross sectional study</Term>
        <Codes>
          <Code code="C0010362" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:survey</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:TNFRSF13B_protein_human" name="TNFRSF13B protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">TNFRSF13B protein, human</Term>
        <Term>TACI protein, human</Term>
        <Term>tumor necrosis factor receptor superfamily, member 13B protein, human</Term>
        <Term>CD267 antigen, human</Term>
        <Term>lymphocyte-specific TACI protein, human</Term>
        <Codes>
          <Code code="C0666480" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Transmembrane_Activator_and_CAML_Interactor_Protein</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Artiodactyla" name="Artiodactyla">
        <Definition>The taxonomic order of mammals that includes even-toed ungulates such as pigs, cows, goats and sheep.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Artiodactyla</Term>
        <Term>ORDER ARTIODACTYLA - EVEN-TOED HOOFED MAMMALS</Term>
        <Term>Artiodactylas</Term>
        <Term>8B-8C ORDER ARTIODACTYLA - EVEN-TOED HOOFED MAMMALS</Term>
        <Term>even toed hoofed mammal</Term>
        <Term>Order Artiodactyla</Term>
        <Term>Order Artiodactyla (organism)</Term>
        <Term>Even-toed ungulate</Term>
        <Term>Cloven-hoofed ungulate</Term>
        <Term>Artiodactyl</Term>
        <Term>Even-toed hoofed mammals</Term>
        <Codes>
          <Code code="C79105" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Mammalia</Relation>
          <Relation name="Narrower">OTE:Bovidae, OTE:Suidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Infants_Premature" name="Infants, Premature">
        <Definition>human born before the normal gestation period has elapsed, before 32 weeks of gestation.</Definition>
        <Definition>&lt;p&gt;Each year, nearly 500,000 babies are premature, or preemies. That's 1 of every 8 infants born in the United States. A premature birth is when a baby is born before 37 completed weeks of pregnancy. A full-term pregnancy is 40 weeks.&lt;/p&gt;&lt;p&gt;Important growth and development occur throughout pregnancy - especially in the final months and weeks. Because they are born too early, preemies &lt;a href='http://www.nlm.nih.gov/medlineplus/birthweight.html'&gt;weigh much less&lt;/a&gt; than full-term babies. They may have health problems because their organs did not have enough time to develop. Preemies need special medical care in a neonatal intensive care unit, or NICU. They stay there until their organ systems can work on their own. &lt;/p&gt;&lt;p &gt;Centers for Disease Control and Prevention&lt;/p&gt;</Definition>
        <Definition>A human infant born before 37 weeks of GESTATION.</Definition>
        <SemanticType code="T100" name="Age Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Infants, Premature</Term>
        <Term>Premature Infants</Term>
        <Term>Infant, Premature</Term>
        <Term>Preterm Infant</Term>
        <Term>Premature Infant</Term>
        <Term>Preterm Infants</Term>
        <Term>Infants, Preterm</Term>
        <Term>Infant, Preterm</Term>
        <Codes>
          <Code code="C0021294" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Infants_Newborn</Relation>
          <Relation name="Narrower">OTE:Infant_Extremely_Premature</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Infant_Very_Low_Birth_Weight" name="Infant, Very Low Birth Weight">
        <Definition>An infant whose weight at birth is less than 1500 grams (3.3 lbs), regardless of gestational age.</Definition>
        <SemanticType code="T047" name="Disease or Syndrome"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Infant, Very Low Birth Weight</Term>
        <Term>Infants, Very-Low-Birth-Weight</Term>
        <Term>Very-Low-Birth-Weight Infant</Term>
        <Term>Very Low Birth Weight Infant</Term>
        <Term>VLBW INFANT</Term>
        <Term>Very-Low-Birth-Weight Infants</Term>
        <Term>Infant, Very-Low-Birth-Weight</Term>
        <Term>INFANT VLBW</Term>
        <Codes>
          <Code code="C0282667" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Infant_Low_Birth_Weight</Relation>
          <Relation name="Narrower">OTE:Infant_Extremely_Low_Birth_Weight</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:survey" name="survey">
        <Definition>A document used in a method of data collection that involves interviewing (or giving questionnaires to) a representative and often large group of people.</Definition>
        <Definition>An examination or inspection carried out with specific aims in mind, a search for particular kinds of information. This sense is carried in a number of specific kinds of research designs in which questionnaires, inventories or interviews may be employed to gather information about attitudes, opinions or preferences in a society or some segment of it. [The Penguin Dictionary of Psychology, 2009]</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">survey</Term>
        <Term>survey instrument</Term>
        <Term>Survey Instrument</Term>
        <Term>4</Term>
        <Term>Survey</Term>
        <Term>surveys</Term>
        <Term>questionnaire or interview</Term>
        <Term>Surveys</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#survey" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Study_Design</Relation>
          <Relation name="Narrower">OTE:health_care_survey, OTE:field_survey, OTE:disease_frequency_survey, OTE:health_survey</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Common_Rattus_Norvegicus_Strains" name="Common Rattus Norvegicus Strains">
        <Definition>Rat breeds, belonging to the species Rattus norvegicus, that are commonly used as experimental organisms.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Common Rattus Norvegicus Strains</Term>
        <Codes>
          <Code code="C1516725" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rat</Relation>
          <Relation name="Narrower">OTE:SD_Rat_Strain, OTE:DA_Rat_Strain, OTE:Z_Rat_Strain, OTE:WH_Rat_Strain, OTE:OM_Rat_Strain, OTE:LIS_Rat_Strain, OTE:LEC_Rat_Strain, OTE:LOU_C_Rat_Strain, OTE:BDVI_Rat_Strain, OTE:M520_Rat_Strain, OTE:LEW_Rat_Strain, OTE:FH_Rat_Strain, OTE:A990_Rat_Strain, OTE:LE_Rat_Strain, OTE:NZR_Rat_Strain, OTE:ACI_Seg_Rat_Strain, OTE:HMT_Rat_Strain, OTE:E3_Rat_Strain, OTE:CRDH_Rat_Strain, OTE:BUF_Rat_Strain, OTE:Wistar_Unilever_Rat_Strain, OTE:A28807_Rat_Strain, OTE:OXYS_Rat_Strain, OTE:LH_Rat_Strain, OTE:FHH_Rat_Strain, OTE:NBL_Rat_Strain, OTE:COP_Rat_Strain, OTE:IR_Rat_Strain, OTE:GH_Rat_Strain, OTE:OFA_SD_Rat_Strain, OTE:BDII_Rat_Strain, OTE:Lewis_Rat_Strain, OTE:BDIX_Rat_Strain, OTE:WAG_Rat_Strain, OTE:BB_Rat_Strain, OTE:BN_Rat_Strain, OTE:SHR_Rat_Strain, OTE:WF_Rat_Strain, OTE:DONRYU_Rat_Strain, OTE:SD_Rij_Rat_Strain, OTE:SS_Rat_Strain, OTE:ACI_Rat_Strain, OTE:W_Nhg_Rat_Strain, OTE:F344_Rat_Strain, OTE:WN_Rat_Strain, OTE:WKY_Rat_Strain, OTE:WIST_Rat_Strain</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:BDP_J_Mouse" name="BDP/J Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">BDP/J Mouse</Term>
        <Term>BDP/J</Term>
        <Codes>
          <Code code="C14595" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C3H_HeN_Mouse" name="C3H/HeN Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C3H/HeN Mouse</Term>
        <Term>C3H/HeN</Term>
        <Codes>
          <Code code="C37370" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:P1A_protein_human" name="P1A protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">P1A protein, human</Term>
        <Codes>
          <Code code="C1505255" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:ITGB3_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Flt3_protein_mouse" name="Flt3 protein, mouse">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Flt3 protein, mouse</Term>
        <Term>FMS-like tyrosine kinase 3 protein, mouse</Term>
        <Term>fetal liver kinase-2 protein, mouse</Term>
        <Term>Flk-2 protein, mouse</Term>
        <Term>stem cell tyrosine kinase 1 protein, mouse</Term>
        <Term>STK-1 kinase protein, mouse</Term>
        <Codes>
          <Code code="C1453716" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:fms_Like_Tyrosine_Kinase_3</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:SJL_Mouse" name="SJL Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">SJL Mouse</Term>
        <Term>SJL</Term>
        <Codes>
          <Code code="C37437" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Elderly_Frail" name="Elderly, Frail">
        <Definition>Older adults or aged individuals who are lacking in general strength and are unusually susceptible to disease or to other infirmity.</Definition>
        <Definition>older adults who are lacking in general strength and are unusually susceptible to disease or to other infirmity.</Definition>
        <SemanticType code="T100" name="Age Group"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Elderly, Frail</Term>
        <Term>Elder, Frail</Term>
        <Term>Elders, Frail</Term>
        <Term>Frail Elders</Term>
        <Term>Frail Elderly</Term>
        <Term>Frail Elder</Term>
        <Codes>
          <Code code="C0079377" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Aged</Relation>
          <Relation name="Narrower">OTE:Functionally-Impaired_Elderly, OTE:Frail_Older_Adults</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:quasi_randomized_design" name="quasi randomized design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">quasi randomized design</Term>
        <Term>quasi randomized designs</Term>
        <Term>quasi-randomised studies</Term>
        <Term>quasi randomized trial</Term>
        <Term>quasi randomized trials</Term>
        <Term>quasi-randomized studies</Term>
        <Term>quasi randomised design</Term>
        <Term>quasi-randomized trials</Term>
        <Term>quasi-randomised trial</Term>
        <Term>quasi randomised trials</Term>
        <Term>quasi-randomised design</Term>
        <Term>quasi-randomized design</Term>
        <Term>quasi randomised study</Term>
        <Term>quasi randomised studies</Term>
        <Term>quasi-randomised study</Term>
        <Term>quasi randomized study</Term>
        <Term>quasi randomised trial</Term>
        <Term>quasi-randomized designs</Term>
        <Term>quasi randomised designs</Term>
        <Term>quasi randomized studies</Term>
        <Term>quasi-randomized study</Term>
        <Term>quasi-randomised trials</Term>
        <Term>quasi-randomised designs</Term>
        <Term>quasi-randomized trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#quasi_randomized_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:quasi-experimental_design</Relation>
          <Relation name="Narrower">OTE:quasi_randomized_controlled_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cd47_protein_mouse" name="Cd47 protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cd47 protein, mouse</Term>
        <Term>CD47 antigen (Rh-related antigen, integrin-associated signal transducer), mouse</Term>
        <Codes>
          <Code code="C1506698" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD47</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NU_NU_Mouse" name="NU/NU Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NU/NU Mouse</Term>
        <Term>NU/NU</Term>
        <Term>Crl:NU/NU-nuBR</Term>
        <Codes>
          <Code code="C15155" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Nude_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Chinchillidae" name="Chinchillidae">
        <Definition>Taxonomic family which includes Chinchillas and viscachas.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Chinchillidae</Term>
        <Term>87C FAMILY CHINCHILLIDAE</Term>
        <Term>Family Chinchillidae (organism)</Term>
        <Term>chinchillas and viscachas</Term>
        <Term>Family Chinchillidae</Term>
        <Term>FAMILY CHINCHILLIDAE</Term>
        <Codes>
          <Code code="C0324984" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rodentia</Relation>
          <Relation name="Narrower">OTE:Chinchilla</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Cricetidae" name="Cricetidae">
        <Definition>A taxonomic family of rodents that includes hamsters, voles, and lemmings.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Cricetidae</Term>
        <Term>Cricetid</Term>
        <Term>Cricetids</Term>
        <Codes>
          <Code code="C0080350" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rodentia</Relation>
          <Relation name="Narrower">OTE:Hamster</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Child" name="Child">
        <Definition>Offspring; the product of reproduction or replication.</Definition>
        <Definition>A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.</Definition>
        <Definition>Used specifically for children, regardless of age, whose parents had significant experiences or conditions, e.g., alcoholism, fame, or political persecution. Limited to human populations.</Definition>
        <Definition>A human descendant (son or daughter) of any age.</Definition>
        <Definition>&lt;p&gt;The player of the role is a child of the scoping entity.&lt;/p&gt;</Definition>
        <Definition>A son or a daughter.</Definition>
        <Definition>A person who is not yet an adult. The specific cut-off age will vary by purpose.</Definition>
        <Definition>&lt;p&gt;The player of the role is a child of the scoping entity, in a generic sense.&lt;/p&gt;</Definition>
        <Definition>header term for indexing children when age groups are unknown; if age groups are given index most specific age.</Definition>
        <Definition>&lt;p&gt;&lt;b&gt;Description:&lt;/b&gt;Dependent biological, adopted, foster child as specified by coverage policy or program.&lt;/p&gt;</Definition>
        <SemanticType code="T100" name="Age Group"/>
        <SemanticType code="T099" name="Family Group"/>
        <SemanticType code="T170" name="Intellectual Product"/>
        <SemanticType code="T078" name="Idea or Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Child</Term>
        <Term>Children (0-21)</Term>
        <Term>child find</Term>
        <Term>Relationship - Child</Term>
        <Term>offspring</Term>
        <Term>Child, NOS</Term>
        <Term>Child of</Term>
        <Term>Human, Child</Term>
        <Term>offsprings</Term>
        <Term>Child - RoleCode</Term>
        <Term>CHILDREN</Term>
        <Term>Childhood age person</Term>
        <Term>kids</Term>
        <Term>of child</Term>
        <Term>progeny</Term>
        <Term>child</Term>
        <Term>Child Youth</Term>
        <Term>children</Term>
        <Term>child (family member)</Term>
        <Term>Child (person)</Term>
        <Term>Childhood age person (person)</Term>
        <Term>Children</Term>
        <Term>CHILD</Term>
        <Term>Offspring</Term>
        <Term>Child [Disease/Finding]</Term>
        <Term>child of</Term>
        <Term>0-11 years old</Term>
        <Term>Progeny</Term>
        <Term>Child of (finding)</Term>
        <Term>kid</Term>
        <Codes>
          <Code code="C1546495" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Age_Groups</Relation>
          <Relation name="Narrower">OTE:Child_Preschool</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:ITGA7_protein_human" name="ITGA7 protein, human">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">ITGA7 protein, human</Term>
        <Term>integrin, alpha 7, human</Term>
        <Codes>
          <Code code="C1721216" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:integrin_alpha7</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:DA_Rat_Strain" name="DA, Rat Strain">
        <Definition>DA: Urinary bladder tumors 54% in males and 14% in females, with a peak incidence at 25-30 months of age (Deerberg et al 1985). High incidence of hormone-dependent endometrial adenocarcinoma. A transplantable cell line (RUCA-I) derived from such a tumor in DA rats can produce these tumors in ectopic sites. The rate of proliferation is reduced by tamoxifen, and this cell line appears to be a suitable model for the study of molecular aspects of estrogen and tamoxifen-dependent gene expression.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">DA, Rat Strain</Term>
        <Codes>
          <Code code="C14385" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Late_Adverse_Effect" name="Late Adverse Effect">
        <Definition>Any symptom or condition which is a result of a medical intervention but arises months or years after it.</Definition>
        <Definition>Side effects of cancer treatment that appear months or years after treatment has ended. Late effects include physical and mental problems and second cancers.</Definition>
        <SemanticType code="T046" name="Pathologic Function"/>
        <SemanticType code="T033" name="Finding"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Late Adverse Effect</Term>
        <Term>Adverse Late Effects</Term>
        <Term>late effects</Term>
        <Term>Aftereffect</Term>
        <Term>Late Adverse Reaction</Term>
        <Term>Late effect of medical intervention</Term>
        <Term>Late effect of</Term>
        <Term>Late effect</Term>
        <Codes>
          <Code code="C4808" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:adverse_reaction</Relation>
          <Relation name="Narrower">OTE:Late_Radiation_Injury</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Chimpanzee" name="Chimpanzee">
        <Definition>The common chimpanzee, a species of the genus Pan, family HOMINIDAE. It lives in Africa, primarily in the tropical rainforests. There are a number of recognized subspecies.</Definition>
        <Definition>Pan troglodytes, an anthropoid ape that inhabits the tropical rain forests of Africa and is used for experimental purposes because of its susceptibility to some human diseases and in behavioral studies because of its high level of intelligence.</Definition>
        <Definition>The anthropoid ape, Pan troglodytes.</Definition>
        <Definition>genus of primates in the Hominidae (Pongidae) family, includes tailess tropical apes noted for high level of intelligence such as chimpanzee and bonobo (pygmy chimpanzee).</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Chimpanzee</Term>
        <Term>chimpanzees</Term>
        <Term>troglodyte, Pan</Term>
        <Term>Chimpanzees</Term>
        <Term>CHIMPANZEE</Term>
        <Term>Chimpanzee troglodytes</Term>
        <Term>Pan</Term>
        <Term>Common Chimpanzee</Term>
        <Term>Genus Pan (organism)</Term>
        <Term>Chimp</Term>
        <Term>Pan Species</Term>
        <Term>Pan troglodytes (organism)</Term>
        <Term>Pan troglodytes</Term>
        <Term>Pan, NOS</Term>
        <Term>Chimpanzee troglodyte</Term>
        <Term>troglodytes, Chimpanzee</Term>
        <Term>Pan troglodyte</Term>
        <Term>Genus Pan</Term>
        <Term>Common chimpanzee</Term>
        <Term>troglodytes, Pan</Term>
        <Term>troglodyte, Chimpanzee</Term>
        <Term>chimpanzee</Term>
        <Term>Pan Genus</Term>
        <Codes>
          <Code code="C14297" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Hominidae</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CDw60_antigen" name="CDw60 antigen">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CDw60 antigen</Term>
        <Term>CDw60 - Cluster of differentiation antigen (workshop) 60</Term>
        <Term>Lymphocyte antigen CDw60</Term>
        <Term>Lymphocyte antigen CDw60 (substance)</Term>
        <Term>CDw60-Clust dif ag workshop 60</Term>
        <Term>Clust of diff ag (workshop) 60</Term>
        <Term>Cluster of differentiation antigen (workshop) 60</Term>
        <Term>UM4D4 antigen</Term>
        <Codes>
          <Code code="C0081955" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:6C2_molecule</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:FCGR2B_protein_human" name="FCGR2B protein, human">
        <Definition>Expressed as 3 alternative isoforms in monocytes, neutrophils, macrophages, basophils, eosinophils, Langerhans cells, B cells, platelets, and placental endothelial by human FCGR2B Gene, IgG Fc Receptor IIB is a type I cell surface protein with 2 IgC2 domains and the most broadly distributed low affinity receptor for aggregated IgG Fc region. FCGR2B binding to IgG initiates essential effector and regulatory cellular responses against foreign pathogens and soluble antigens that induce phagocytosis of antigen-antibody complexes, removing them from circulation, and modulate B-cell antibody production. FCGR2B contains a cytoplasmic ITIM motif involved in down modulation of previous cell activation by BCR, TCR or another Fc receptor; phosphorylated ITIM binds to PTPN6/SHP-1 SH2 domain. Chromosome translocation t(1;22)(q22;q11) leads to FCGR2B hyperexpression in a follicular lymphoma. (NCI)</Definition>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">FCGR2B protein, human</Term>
        <Term>FcgammaRIIB protein, human</Term>
        <Term>Fc fragment of IgG, low affinity IIb, receptor for (CD32) protein, human</Term>
        <Codes>
          <Code code="C1452607" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:IgG_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:A_He_Mouse" name="A/He Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">A/He Mouse</Term>
        <Term>A/He</Term>
        <Codes>
          <Code code="C14652" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:semaphorin_7A_protein_rat" name="semaphorin 7A protein, rat">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">semaphorin 7A protein, rat</Term>
        <Term>Sema7a protein, rat</Term>
        <Codes>
          <Code code="C3181502" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Receptor_Anaphylatoxin_C5a" name="Receptor, Anaphylatoxin C5a">
        <Definition>A G-protein-coupled receptor that signals an increase in intracellular calcium in response to the potent ANAPHYLATOXIN peptide COMPLEMENT C5A.</Definition>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Receptor, Anaphylatoxin C5a</Term>
        <Term>Receptor, Complement 5a</Term>
        <Term>RECEPT COMPLEMENT 5A</Term>
        <Term>ANTIGENS CD 088</Term>
        <Term>ANAPHYLATOXIN C5A RECEPT</Term>
        <Term>Antigens, CD88</Term>
        <Term>CD 088 ANTIGENS</Term>
        <Term>C5A RECEPT</Term>
        <Term>COMPLEMENT 5A RECEPT</Term>
        <Term>Anaphylatoxin C5a Receptor</Term>
        <Term>Antigen, CD88</Term>
        <Term>RECEPTOR COMPLEMENT 05 A</Term>
        <Term>COMPLEMENT A 05 AR RECEPTOR</Term>
        <Term>Receptors, C5a</Term>
        <Term>RECEPTOR ANAPHYLATOXIN C 05 A</Term>
        <Term>RECEPT ANAPHYLATOXIN C5A</Term>
        <Term>Complement 5a Receptor</Term>
        <Term>CD88 Antigen</Term>
        <Term>CD88 Antigens</Term>
        <Term>ANAPHYLATOXIN C 05 A RECEPTOR</Term>
        <Term>C5a Receptors</Term>
        <Codes>
          <Code code="C0056196" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD</Relation>
          <Relation name="Narrower">OTE:C5L2_protein_rat, OTE:C5AR1_protein_human</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:NZC_Mouse" name="NZC Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">NZC Mouse</Term>
        <Term>NZC</Term>
        <Codes>
          <Code code="C37423" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:toxicokinetics" name="toxicokinetics">
        <Definition>The branch of pharmacology that deals with the rate at which a substance will enter the body and what effects that substance will have on the body.</Definition>
        <Definition>Evaluation of the absorption, distribution, metabolism and excretion of a substance in relation to its toxicity in an animal.</Definition>
        <Definition>The pharmacokinetic mechanisms of the toxic effects of a substance.</Definition>
        <SemanticType code="T091" name="Biomedical Occupation or Discipline"/>
        <SemanticType code="T169" name="Functional Concept"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">toxicokinetics</Term>
        <Term>toxicokinetic</Term>
        <Term>Toxicokinetics</Term>
        <Term>TOXICOKINETICS</Term>
        <Codes>
          <Code code="C0282690" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Pharmacokinetics</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:haldisin_protein_human" name="haldisin protein, human">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">haldisin protein, human</Term>
        <Term>LYPD5 protein, human</Term>
        <Codes>
          <Code code="C3711100" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Plasminogen_Activator_Urokinase_Receptors</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Tnfrsf1a_protein_mouse" name="Tnfrsf1a protein, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Tnfrsf1a protein, mouse</Term>
        <Term>tumor necrosis factor receptor superfamily, member 1a protein, mouse</Term>
        <Term>Tnfr1 protein, mouse</Term>
        <Codes>
          <Code code="C1453724" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Necrosis_Factor_Receptor_1A</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Duroc_Pig" name="Duroc Pig">
        <Definition>An older breed of American domestic pig, the Duroc breed is of medium length with a muscular, large-framed body. This pig breed is red-colored with partially drooping ears and is one of the most aggressive breeds of swine.</Definition>
        <Definition>An older breed of American domestic pig, the Duroc breed is of medium length with a muscular, large-framed body. This pig breed is red-colored with partially drooping ears and is one of the most aggressive breeds of swine. The Duroc breed is also one of the largest sized breeds in use in biomedical research but its size and temperament make it a less popular choice in research.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Duroc Pig</Term>
        <Term>Duroc pig</Term>
        <Term>Duroc pig (organism)</Term>
        <Term>Duroc-cross</Term>
        <Term>DUROC-CROSS</Term>
        <Codes>
          <Code code="C77101" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Pig</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Publication_Type" name="Publication Type">
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Publication Type</Term>
        <Term>MeSH Descriptors Class 2</Term>
        <Term>publication types</Term>
        <Term>publication type</Term>
        <Term>PT</Term>
        <Codes>
          <Code code="C1256743" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Terminology</Relation>
          <Relation name="Narrower">OTE:address, OTE:biography, OTE:letter, OTE:article, OTE:review_of_literature_, OTE:interactive_tutorial, OTE:research_report, OTE:abstract, OTE:scientific_publication, OTE:periodical_index, OTE:dictionary, OTE:comment, OTE:duplicate_publication, OTE:opinion_paper, OTE:published_erratum, OTE:patient_education_handout, OTE:directory, OTE:lecture, OTE:legislation, OTE:conference_proceedings, OTE:editorial, OTE:bibliography, OTE:government_publication, OTE:retracted_publication, OTE:interview, OTE:festschrift, OTE:technical_report</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Klra4_protein_mouse" name="Klra4 protein, mouse">
        <SemanticType code="T123" name="Biologically Active Substance"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Klra4 protein, mouse</Term>
        <Term>Ly49d antigen, mouse</Term>
        <Term>killer cell lectin-like receptor, subfamily A, member 4, mouse</Term>
        <Term>Ly-49d antigen, mouse</Term>
        <Codes>
          <Code code="C2351933" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Ly-49_Antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Antigen_Ki_67" name="Antigen Ki 67">
        <Definition>Antigen KI-67 protein (3256 aa, ~359 kDa) is encoded by the human MKI67 gene. This protein is required for cell proliferation.</Definition>
        <Definition>A CELL CYCLE and tumor growth marker which can be readily detected using IMMUNOCYTOCHEMISTRY methods. Ki-67 is a nuclear antigen present only in the nuclei of cycling cells.</Definition>
        <SemanticType code="T130" name="Indicator, Reagent, or Diagnostic Aid"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Antigen Ki 67</Term>
        <Term>Ki-67 Antigen</Term>
        <Term>MIB-1 Antigen</Term>
        <Term>Antigen Ki-67</Term>
        <Term>Ki 67 Antigen</Term>
        <Term>ANTIGEN KI 067</Term>
        <Term>Antigen, MIB-1</Term>
        <Term>MIB 1 Antigen</Term>
        <Term>MIB 1 Protein</Term>
        <Term>KI ANTIGEN 67</Term>
        <Term>MIB-1 Protein</Term>
        <Term>Antigen, Ki-67</Term>
        <Term>Ki-67, Antigen</Term>
        <Term>Antigen Ki67</Term>
        <Term>Ki67, Antigen</Term>
        <Codes>
          <Code code="C0208804" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Tumor_Markers_Biological</Relation>
          <Relation name="Narrower">OTE:Mki67_protein_mouse, OTE:chmadrin</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Blood_Glucose_Self-Monitoring" name="Blood Glucose Self-Monitoring">
        <Definition>Self evaluation of whole blood glucose levels outside the clinical laboratory. A digital or battery-operated reflectance meter may be used. It has wide application in controlling unstable insulin-dependent diabetes.</Definition>
        <SemanticType code="T060" name="Diagnostic Procedure"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Blood Glucose Self-Monitoring</Term>
        <Term>Glucose, Blood, Self Monitoring</Term>
        <Term>BGSM</Term>
        <Term>Monitoring, Home Blood Glucose</Term>
        <Term>Blood Glucose Self-Monitorings</Term>
        <Term>Home Blood Glucose Monitoring</Term>
        <Term>Sugar Self-Monitorings, Blood</Term>
        <Term>Glucose, Blood, Self-Monitoring</Term>
        <Term>Blood Glucose Self Monitoring</Term>
        <Term>Self-Monitoring, Blood Glucose</Term>
        <Term>Blood Sugar Self-Monitorings</Term>
        <Term>Glucose Self-Monitorings, Blood</Term>
        <Term>Self-Monitorings, Blood Sugar</Term>
        <Term>Self-Monitorings, Blood Glucose</Term>
        <Term>Self-Monitoring, Blood Sugar</Term>
        <Term>Blood Sugar Self Monitoring</Term>
        <Term>Self Monitoring, Blood Glucose</Term>
        <Term>Blood Sugar Self-Monitoring</Term>
        <Term>Sugar Self-Monitoring, Blood</Term>
        <Term>Glucose Self-Monitoring, Blood</Term>
        <Codes>
          <Code code="C0005803" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Physiologic_Monitoring</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:resistin-like_gamma_mouse" name="resistin-like gamma, mouse">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T125" name="Hormone"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">resistin-like gamma, mouse</Term>
        <Term>FIZZ3 protein, mouse</Term>
        <Term>RELMgamma, mouse</Term>
        <Term>resistin-like molecule gamma, mouse</Term>
        <Term>RELMG protein, mouse</Term>
        <Term>RELMgamma protein, mouse</Term>
        <Codes>
          <Code code="C1435221" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Hormones_Ectopic</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Bsg_protein_mouse" name="Bsg protein, mouse">
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Bsg protein, mouse</Term>
        <Term>EMMPRIN protein, mouse</Term>
        <Term>basigin-2 protein, mouse</Term>
        <Term>HT-7 protein, mouse</Term>
        <Term>membrane glycoprotein 42, mouse</Term>
        <Term>basigin protein, mouse</Term>
        <Term>5A11 protein, mouse</Term>
        <Term>HT7 antigen, mouse</Term>
        <Term>CD147 antigen, mouse</Term>
        <Codes>
          <Code code="C1506235" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigen_CD147</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C-CAM2" name="C-CAM2">
        <SemanticType code="T126" name="Enzyme"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C-CAM2</Term>
        <Term>CEACAM2</Term>
        <Codes>
          <Code code="C0966269" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:CD66_antigen</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:interrupted_time_series_without_comparison_group" name="interrupted time series without comparison group">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">interrupted time series without comparison group</Term>
        <Term>interrupted time series without comparison groups</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#interrupted_time_series_without_comparison_group" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:interrupted_time_series_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Outcome_Category" name="Outcome Category">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Outcome Category</Term>
        <Relations>
          <Relation name="Broader">OTE:Terminology</Relation>
          <Relation name="Narrower">OTE:death, OTE:biological_markers, OTE:graft_survival, OTE:mortality, OTE:GFR, OTE:serum_creatinine, OTE:adverse_reaction, OTE:adverse_events, OTE:cost-effectiveness, OTE:transplant_rejection, OTE:patient_survival</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:YBR_Mouse" name="YBR Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">YBR Mouse</Term>
        <Term>YBR</Term>
        <Codes>
          <Code code="C1520205" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Rag1_Mouse" name="Rag1 Mouse">
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Rag1 Mouse</Term>
        <Term>Rag1</Term>
        <Codes>
          <Code code="C1514714" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Immunodeficient_Mouse</Relation>
          <Relation name="Narrower">OTE:NOD_129S7-Rag1-tm1Mom_Mouse, OTE:C_129S7-Rag1-tm1Mom_Mouse, OTE:B6_129-Rag1-tm1Mom_Mouse, OTE:B6_129S7-Rag1-tm1Mom_Mouse</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ly-49W1_receptor" name="Ly-49W1 receptor">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ly-49W1 receptor</Term>
        <Codes>
          <Code code="C0965467" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_Ly</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:CD4-IgG1_hinge_fusion_protein_recombinant" name="CD4-IgG1 hinge fusion protein, recombinant">
        <SemanticType code="T121" name="Pharmacologic Substance"/>
        <SemanticType code="T129" name="Immunologic Factor"/>
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">CD4-IgG1 hinge fusion protein, recombinant</Term>
        <Term>CD4 H23 protein, recombinant</Term>
        <Codes>
          <Code code="C1437273" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Antigens_CD4</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Muridae" name="Muridae">
        <Definition>Taxonomic family which includes mice, rats, and gerbils.</Definition>
        <Definition>A family of the order Rodentia containing 250 genera including the two genera Mus (MICE) and Rattus (RATS), from which the laboratory inbred strains are developed. The fifteen subfamilies are SIGMODONTINAE (New World mice and rats), CRICETINAE, Spalacinae, Myospalacinae, Lophiomyinae, ARVICOLINAE, Platacanthomyinae, Nesomyinae, Otomyinae, Rhizomyinae, GERBILLINAE, Dendromurinae, Cricetomyinae, MURINAE (Old World mice and rats), and Hydromyinae.</Definition>
        <Definition>A family of the order Rodentia containing 250 genera including the two genera Mus and Rattus, from which the laboratory inbred strains are developed. The fifteen subfamilies are HESPEROMYINAE (New World mice and rats), Cricetinae, Spalacinae, Myospalacinae, Lophiomyinae, Platacanthomyinae, Nesomyinae, Otomyinae, Rhizomyinae, MICROTINAE (Arvicolinae), GERBILLINAE, Dendromurinae, Cricetomyinae, Murinae (Old World mice and rats), and Hydromyinae.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Muridae</Term>
        <Term>murines</Term>
        <Term>Family Muridae (organism)</Term>
        <Term>murid</Term>
        <Term>muridae</Term>
        <Term>Murid</Term>
        <Term>Family Muridae</Term>
        <Term>Murids</Term>
        <Codes>
          <Code code="C0026802" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Rodentia</Relation>
          <Relation name="Narrower">OTE:Mastomys, OTE:Gerbil, OTE:Mouse, OTE:Rat</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:C3H_HeJ_Mouse" name="C3H/HeJ Mouse">
        <Definition>Derived from the C3H progenitor strain that was passed to Heston in 1941 and to Jackson Lab in 1947. The C3H/HeJ mouse has an agouti coat color (genotype +, rd) and 90% of non-fostered offspring developed mammary tumors by 11 months or age. Fostered offspring have a high incidence of hepatomas.</Definition>
        <Definition>Derived from the C3H progenitor strain that was passed to Heston in 1941 and to Jackson Lab in 1947. The C3H/HeJ mouse has an agouti coat color and genotype +, rd.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">C3H/HeJ Mouse</Term>
        <Term>CEH/HEJ</Term>
        <Term>C3H/HeJ</Term>
        <Codes>
          <Code code="C37369" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Inbred_Mouse_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:WF_Rat_Strain" name="WF, Rat Strain">
        <Definition>A Wistar substrain derived by Furth (1945), this inbred rat strain is a white albino with pink eyes, genotype c. The Wistar Furth rat carries a heteropyenotic Y chromosome that is used as a cellular marker.</Definition>
        <Definition>In females tumors include 27% pituitary, 21% mammary, 3% adrenal, 9% leukemia (generalized), 7% lymphoma (malignant), 3% lipomas and 4% unclassified (Kim et al 1960). Mean life span 21 months in females and 23 months in males. Leukemia 15-22% characterised by an unusual type of mononuclear cell containing reddish granules. Incidence of spontaneous pituitary tumors 38% in rats older than 10 months of age, increasing to a maximum of 69% at 28-32 months of age. Higher incidence in females (71%) than in males (35%)</Definition>
        <Definition>A Wistar substrain derived by Furth (1945), this inbred rat strain is a white albino with pink eyes, genotype c. The Wistar Furth rat carries a heteropyenotic Y chromosome that is used as a cellular marker. Leukemia develops in 15-22% of these rats, which is characterized by mononuclear cells with reddish granules. The Wistar Furth rat exhibits good reproductive performance and is docile, with an averages life span of 22 months.</Definition>
        <SemanticType code="T015" name="Mammal"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">WF, Rat Strain</Term>
        <Term>WISTAR FURTH</Term>
        <Term>Wistar Furth Rat</Term>
        <Codes>
          <Code code="C14390" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Common_Rattus_Norvegicus_Strains</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:Ncr3_protein_rat" name="Ncr3 protein, rat">
        <SemanticType code="T116" name="Amino Acid, Peptide, or Protein"/>
        <SemanticType code="T192" name="Receptor"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">Ncr3 protein, rat</Term>
        <Term>rNKp30, rat</Term>
        <Term>natural killer receptor RNKP30, rat</Term>
        <Term>natural cytotoxicity triggering receptor 3 protein, rat</Term>
        <Term>NKp30 protein, rat</Term>
        <Codes>
          <Code code="C1742925" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Natural_Cytotoxicity_Triggering_Receptor_3</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:interactive_tutorial" name="interactive tutorial">
        <Definition>Video recordings or other files in which the progress of the instruction or content is determined by user response. [MeSH_2014]</Definition>
        <Definition>Video recordings or other files in which the progress of the instruction or content is determined by user response.</Definition>
        <SemanticType code="T170" name="Intellectual Product"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">interactive tutorial</Term>
        <Term>Interactive Media</Term>
        <Term>Interactive Tutorial</Term>
        <Term>interactive media</Term>
        <Term>interactive tutorials</Term>
        <Codes>
          <Code code="C1956025" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:Publication_Type</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:controlled_before-after_design" name="controlled before-after design">
        <Definition>A study in which observations are made before and after an intervention, both in a group that receives the intervention and in a control group that does not. [Controlled Before-After Studies | MeSH_2015]</Definition>
        <SemanticType code="T081" name="Quantitative Concept"/>
        <SemanticType code="T062" name="Research Activity"/>
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">controlled before-after design</Term>
        <Term>controlled before-and-after designs</Term>
        <Term>controlled before-and-after trial</Term>
        <Term>controlled before-after trials</Term>
        <Term>controlled before-after designs</Term>
        <Term>controlled before-and-after studies</Term>
        <Term>controlled before-after studies</Term>
        <Term>controlled before-and-after trials</Term>
        <Term>controlled before-and-after design</Term>
        <Term>controlled before-and-after study</Term>
        <Term>controlled before-after study</Term>
        <Term>controlled before-after trial</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#controlled_before-after_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:before-after_design</Relation>
        </Relations>
      </Concept>
      <Concept code="OTE:group_randomized_design" name="group randomized design">
        <Source name="OrganTransplantExtraction"/>
        <Term preferred="true">group randomized design</Term>
        <Term>group randomised studies</Term>
        <Term>group randomised trial</Term>
        <Term>group randomized designs</Term>
        <Term>group randomized studies</Term>
        <Term>group randomized trials</Term>
        <Term>group randomised study</Term>
        <Term>group randomised trials</Term>
        <Term>group randomized trial</Term>
        <Term>group randomised designs</Term>
        <Term>group randomized study</Term>
        <Term>group randomised design</Term>
        <Codes>
          <Code code="http://edda.dbmi.pitt.edu/ontologies/StudyDesigns.owl#group_randomized_design" source="Code"/>
        </Codes>
        <Relations>
          <Relation name="Broader">OTE:randomized_design</Relation>
        </Relations>
      </Concept>
    </Concepts>
    <Options>
      <Option name="window.size" value="-1"/>
      <Option name="source.filter" value=""/>
      <Option name="ignore.acronyms" value="false"/>
      <Option name="semantic.type.filter" value=""/>
      <Option name="ignore.digitss" value="false"/>
      <Option name="default.search.method" value="best-match"/>
      <Option name="ordered.mode" value="false"/>
      <Option name="ignore.small.words" value="true"/>
      <Option name="partial.match.theshold" value="0.5"/>
      <Option name="ignore.common.words" value="false"/>
      <Option name="ignore.used.words" value="true"/>
      <Option name="select.best.candidate" value="false"/>
      <Option name="word.window.size" value="3"/>
      <Option name="overlap.mode" value="true"/>
      <Option name="partial.mode" value="false"/>
      <Option name="stem.words" value="true"/>
      <Option name="language.filter" value=""/>
      <Option name="subsumption.mode" value="true"/>
      <Option name="contiguous.mode" value="false"/>
      <Option name="enable.search.cache" value="false"/>
      <Option name="score.concepts" value="true"/>
    </Options>
  </Terminology>
</Template>
